Citrus Sinensis ID: 021507
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | 2.2.26 [Sep-21-2011] | |||||||
| O49840 | 426 | Protein kinase 2B, chloro | yes | no | 0.922 | 0.673 | 0.778 | 1e-130 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.922 | 0.673 | 0.762 | 1e-123 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.887 | 0.669 | 0.626 | 2e-97 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.755 | 0.573 | 0.705 | 4e-95 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.819 | 0.655 | 0.633 | 3e-91 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.755 | 0.573 | 0.677 | 3e-90 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.852 | 0.681 | 0.584 | 4e-85 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.768 | 0.487 | 0.626 | 5e-85 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.813 | 0.620 | 0.591 | 1e-84 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.861 | 0.678 | 0.569 | 1e-84 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 464 bits (1193), Expect = e-130, Method: Compositional matrix adjust.
Identities = 229/294 (77%), Positives = 255/294 (86%), Gaps = 7/294 (2%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQL HPNLVKL+GYC+EGENRLLVYEFMPKGSLENHLFRRG QPL+WA+RM
Sbjct: 134 WL-TEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRM 192
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFGLAKAGPTGD+THVSTQ
Sbjct: 193 KVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQ 252
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+KVG+EQSLVDWA PYL
Sbjct: 253 VMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYL 312
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+MSEVLA L++LE+ K
Sbjct: 313 GDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTKPG 372
Query: 264 AKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSHRQSPRVR 311
+ +Q + R + V+KSP R R L++TP ASPLP+H SPRVR
Sbjct: 373 TGVGNRQAQIDSPRGSNGSIVQKSPRRYSYDRPLLHITPGASPLPTHNHSPRVR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1137), Expect = e-123, Method: Compositional matrix adjust.
Identities = 222/291 (76%), Positives = 245/291 (84%), Gaps = 4/291 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQL HPNLV L+GYC EGENRLLVYEFMPKGSLENHLFRRG QPL+WA+RM
Sbjct: 137 WL-TEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRM 195
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+FNAKLSDFGLAKAGPTGD THVST+
Sbjct: 196 KVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTK 255
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+SGR A+D + G E SLVDWA PYL
Sbjct: 256 VIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYL 315
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA-PKN 262
DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN + KLRP+MSEVL LE+LE+ K
Sbjct: 316 GDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESVAKP 375
Query: 263 SAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSHRQSPRVR 311
K +Q E R ++KSP+R R L+MTP ASPLPS+ QSPRVR
Sbjct: 376 GTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPSYTQSPRVR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 355 bits (911), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 178/284 (62%), Positives = 220/284 (77%), Gaps = 8/284 (2%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKV 85
EVNYLGQ HPNLVKLIGYCLE E+RLLVYEFMP+GSLENHLFRRG QPLSW +R+KV
Sbjct: 123 EVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKV 182
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
A+GAAKGL FLH+AE+ VIYRDFK SNILLD+E+NAKLSDFGLAK GPTGD++HVST++M
Sbjct: 183 ALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIM 242
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+LSGR AVDK + EQ LV+WA+P L++
Sbjct: 243 GTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLAN 302
Query: 206 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL----EAPK 261
KRKLFR++D +L QY + A ATLAL+CL E KLRP M+EV++ LE + EA
Sbjct: 303 KRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNEAGG 362
Query: 262 NSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPS 303
+ + Q R++ V + + P +++ + + TA P PS
Sbjct: 363 RNIDMVQRRMRRRSDSVAINQKPNAGFARQTAVGVIATAYPRPS 406
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 168/238 (70%), Positives = 200/238 (84%), Gaps = 3/238 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAV 81
W EVNYLGQ H +LVKLIGYCLE E+RLLVYEFMP+GSLENHLFRRG QPLSW +
Sbjct: 119 WL-AEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKL 177
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
R+KVA+GAAKGL FLH +E++VIYRDFK SNILLD+E+NAKLSDFGLAK GP GD++HVS
Sbjct: 178 RLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVS 237
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
T+VMGTHGYAAPEY+ATG LTTKSDVYSFGVVLLELLSGR AVDK + E++LV+WAKP
Sbjct: 238 TRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKP 297
Query: 202 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259
YL +KRK+FR++D +L QY + A ATL+L+CL E KLRP MSEV++ LE +++
Sbjct: 298 YLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQS 355
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 335 bits (858), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 164/259 (63%), Positives = 201/259 (77%), Gaps = 4/259 (1%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKV 85
E+NYLGQL HPNLVKLIGYCLE E+RLLVYEFM +GSLENHLFRRG QPLSW R+++
Sbjct: 122 EINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRM 181
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
A+GAA+GL FLH+A+ QVIYRDFKASNILLD+ +NAKLSDFGLA+ GP GD +HVST+VM
Sbjct: 182 ALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVM 241
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT GYAAPEY+ATG L+ KSDVYSFGVVLLELLSGR A+DK + E +LVDWA+PYL++
Sbjct: 242 GTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTN 301
Query: 206 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAK 265
KR+L R+MD +L GQY A A LAL C++ + K RP M+E++ +E L K ++K
Sbjct: 302 KRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASK 361
Query: 266 LSQSEPHRQTGPVTVRKSP 284
Q P + + KSP
Sbjct: 362 -EQQNPQISIDNI-INKSP 378
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (850), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 160/236 (67%), Positives = 191/236 (80%), Gaps = 1/236 (0%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVN+LGQL HPNLVKLIGYC E ++RLLVYEFM +GSLENHLFR+ PLSW+ RM
Sbjct: 117 WL-TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRM 175
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+A+GAAKGL FLH+AE VIYRDFK SNILLD+++ AKLSDFGLAKAGP GD THVST+
Sbjct: 176 MIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 235
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+GR +VDKT+ EQ+LVDWA+P L
Sbjct: 236 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKL 295
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259
+DKRKL +I+D +L QY +AA A +LA CL+ PK RP MS+V+ LE L+
Sbjct: 296 NDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC 351
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (805), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 162/277 (58%), Positives = 201/277 (72%), Gaps = 12/277 (4%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ---PLSWA 80
W TE+NYLGQL HPNLVKLIGYCLE E RLLVYEFM KGSLENHLF G + PLSW
Sbjct: 112 WL-TEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPLSWI 170
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
+R+KVA+ AAKGL FLH +VIYRD KASNILLD++FNAKLSDFGLA+ GP G++++V
Sbjct: 171 LRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQSYV 230
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
ST+VMGT GYAAPEYV+TG L +SDVYSFGVVLLELL GR A+D + EQ+LVDWA+
Sbjct: 231 STRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNLVDWAR 290
Query: 201 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE-- 258
PYL+ +RK+ I+DT+L QY + A A++A+QCL+ EPK RP M +V+ L +L+
Sbjct: 291 PYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQDS 350
Query: 259 --APKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 293
P N L + + G K+ + QR+ LN
Sbjct: 351 VVKPANVDPLKVKDTKKLVG----LKTEDKYQRNGLN 383
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (805), Expect = 5e-85, Method: Compositional matrix adjust.
Identities = 151/241 (62%), Positives = 190/241 (78%), Gaps = 2/241 (0%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+NYLG L HPNLVKL+GYC+E + RLLVYEFMP+GSLENHLFRR PL W++RMK+A+
Sbjct: 190 EINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIAL 248
Query: 88 GAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
GAAKGL+FLH+ A VIYRDFK SNILLD E+NAKLSDFGLAK P +THVST+VMG
Sbjct: 249 GAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMG 308
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 206
T+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GR ++DK + E +LV+WA+P+L DK
Sbjct: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDK 368
Query: 207 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKL 266
R+ +R++D +L G + K A LA QCL+ + K+RP+MSEV+ +L+ L K+ A
Sbjct: 369 RRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASA 428
Query: 267 S 267
S
Sbjct: 429 S 429
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 152/257 (59%), Positives = 192/257 (74%), Gaps = 4/257 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W EV +LGQL HPNLVKLIGYC E +R+L+YE+M +GS+EN+LF R PLSWA+RM
Sbjct: 127 WL-AEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRM 185
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K+A GAAKGL FLH+A+ VIYRDFK SNILLD ++NAKLSDFGLAK GP GD++HVST+
Sbjct: 186 KIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTR 245
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
+MGT+GYAAPEY+ TG LT SDVYSFGVVLLELL+GR ++DK++ EQ+L+DWA P L
Sbjct: 246 IMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLL 305
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
+K+K+ I+D K+ +YP KA AA LA CLN PK RP M +++ LE L+A +
Sbjct: 306 KEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEE 365
Query: 264 AKLSQSEPHRQTGPVTV 280
A L P Q +T+
Sbjct: 366 ALLV---PPVQKAVITI 379
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 155/272 (56%), Positives = 200/272 (73%), Gaps = 4/272 (1%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMK 84
TE+NYLGQL HPNLVKLIGYCLE E+RLLVYEFM KGSLENHLFRRG +PL W +R+
Sbjct: 120 TEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLRVN 179
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
VA+ AAKGL FLH +VIYRD KASNILLDA++NAKLSDFGLA+ GP GD ++VST+V
Sbjct: 180 VALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVSTRV 239
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
MGT+GYAAPEY+++G L +SDVYSFGV+LLE+LSG+ A+D + E++LVDWA+PYL+
Sbjct: 240 MGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWARPYLT 299
Query: 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSA 264
KRK+ I+D +L QY + A A++A+QCL+ EPK RP M +V+ L++L+ N
Sbjct: 300 SKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQ--DNLG 357
Query: 265 KLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTP 296
K SQ+ P + T + + + P
Sbjct: 358 KPSQTNPVKDTKKLGFKTGTTKSSEKRFTQKP 389
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | ||||||
| 225425762 | 420 | PREDICTED: protein kinase 2B, chloroplas | 0.916 | 0.678 | 0.857 | 1e-142 | |
| 255558180 | 419 | Protein kinase APK1A, chloroplast precur | 0.913 | 0.677 | 0.861 | 1e-141 | |
| 224099729 | 418 | predicted protein [Populus trichocarpa] | 0.916 | 0.681 | 0.833 | 1e-136 | |
| 224111270 | 417 | predicted protein [Populus trichocarpa] | 0.916 | 0.683 | 0.826 | 1e-135 | |
| 356500447 | 414 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.887 | 0.666 | 0.839 | 1e-132 | |
| 356498210 | 422 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.887 | 0.654 | 0.839 | 1e-132 | |
| 48209875 | 420 | putative protein kinase [Solanum demissu | 0.916 | 0.678 | 0.798 | 1e-131 | |
| 357486685 | 410 | Protein kinase 2B [Medicago truncatula] | 0.909 | 0.690 | 0.804 | 1e-130 | |
| 113205211 | 401 | Protein kinase APK1B, chloroplast precur | 0.909 | 0.705 | 0.803 | 1e-130 | |
| 297817892 | 426 | hypothetical protein ARALYDRAFT_484186 [ | 0.922 | 0.673 | 0.782 | 1e-128 |
| >gi|225425762|ref|XP_002277256.1| PREDICTED: protein kinase 2B, chloroplastic [Vitis vinifera] gi|296086406|emb|CBI31995.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1317), Expect = e-142, Method: Compositional matrix adjust.
Identities = 247/288 (85%), Positives = 266/288 (92%), Gaps = 3/288 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR+
Sbjct: 136 WL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRI 194
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+VAIGAA+GL+FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ
Sbjct: 195 RVAIGAARGLSFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 254
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTK+G+EQ+LVDWAKPYL
Sbjct: 255 VMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKIGVEQNLVDWAKPYL 314
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKR+LFRIMDTKL GQYPQK A AATLALQCLN E K+RPRMSEVLA LE++++PKN+
Sbjct: 315 GDKRRLFRIMDTKLEGQYPQKGAFMAATLALQCLNTEAKVRPRMSEVLATLEQIQSPKNA 374
Query: 264 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 311
AK QSE H T + V+KSP+RQQ SPLN+TP ASPLPS+RQSPRVR
Sbjct: 375 AKHIQSEQH--TVSIPVQKSPLRQQHSPLNLTPRASPLPSYRQSPRVR 420
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558180|ref|XP_002520117.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223540609|gb|EEF42172.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1309), Expect = e-141, Method: Compositional matrix adjust.
Identities = 249/289 (86%), Positives = 265/289 (91%), Gaps = 5/289 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEV YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR+
Sbjct: 135 WL-TEVRYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRI 193
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVA+GAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAK GPTGDRTHVSTQ
Sbjct: 194 KVAVGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKEGPTGDRTHVSTQ 253
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTKVGIEQ+LVDWAKPYL
Sbjct: 254 VMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVGIEQNLVDWAKPYL 313
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
SDKRKLFRIMDTKLGGQYPQK+AH AA LALQCL+ E K RPRMSEVLA LE++E+PK +
Sbjct: 314 SDKRKLFRIMDTKLGGQYPQKSAHMAANLALQCLSTEAKARPRMSEVLATLEQIESPKTA 373
Query: 264 AKLSQSE-PHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 311
+LS SE P Q + VRKSPMRQ SPLN+TP+ASPLPSHRQSPRVR
Sbjct: 374 GRLSHSEHPSIQ---IPVRKSPMRQHHSPLNLTPSASPLPSHRQSPRVR 419
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099729|ref|XP_002311595.1| predicted protein [Populus trichocarpa] gi|222851415|gb|EEE88962.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1261), Expect = e-136, Method: Compositional matrix adjust.
Identities = 240/288 (83%), Positives = 258/288 (89%), Gaps = 3/288 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQLHHPNLVKLIGYC+EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR+
Sbjct: 134 WL-TEVNYLGQLHHPNLVKLIGYCVEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRV 192
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ
Sbjct: 193 KVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 252
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTKVG+EQ+L DWAKPYL
Sbjct: 253 VMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVGVEQNLADWAKPYL 312
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKRKLFRIMDTKLGGQYPQK A AA LALQCL+NE K+RPRMSEVLA LE +E+PK +
Sbjct: 313 GDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSNEAKVRPRMSEVLATLENIESPKGA 372
Query: 264 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 311
AK S+SE +QT VR+SPMR +P +ASPLPSH QSPR+R
Sbjct: 373 AKNSRSE--QQTVQTPVRQSPMRHHHAPGTPPASASPLPSHHQSPRLR 418
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111270|ref|XP_002315799.1| predicted protein [Populus trichocarpa] gi|222864839|gb|EEF01970.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1256), Expect = e-135, Method: Compositional matrix adjust.
Identities = 238/288 (82%), Positives = 256/288 (88%), Gaps = 3/288 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA+R+
Sbjct: 133 WL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAIRI 191
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ
Sbjct: 192 KVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 251
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGTHGYAAPEYVATGRLT KSDVYSFGVVLLE LSGR AVDK+KVG+EQ+LVDW KPYL
Sbjct: 252 VMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEFLSGRRAVDKSKVGVEQNLVDWVKPYL 311
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKRKLFRIMDTKLGGQYPQK A AA LALQCL+ E K+RPRMSEVLA LE++E+PK +
Sbjct: 312 GDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSTEAKVRPRMSEVLATLEQIESPKGA 371
Query: 264 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 311
K Q E QT VR+SPMR RSP+ T +ASPLPSH QSPR+R
Sbjct: 372 VKNIQLE--HQTVQTPVRQSPMRHHRSPVIPTASASPLPSHHQSPRLR 417
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500447|ref|XP_003519043.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1229), Expect = e-132, Method: Compositional matrix adjust.
Identities = 235/280 (83%), Positives = 253/280 (90%), Gaps = 4/280 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQL+HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW+VRM
Sbjct: 128 WL-TEVNYLGQLYHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWSVRM 186
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVSTQ
Sbjct: 187 KVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVSTQ 246
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKT G+EQ+LVDWAKPYL
Sbjct: 247 VMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTITGMEQNLVDWAKPYL 306
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
SDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+E K RP M+EVLA LE++EAPK +
Sbjct: 307 SDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPPMTEVLATLEQIEAPKTA 366
Query: 264 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 303
+ S SE HR P VRKSP R RSPLN+TPTASPLP+
Sbjct: 367 GRNSHSEHHRLQTP--VRKSPAR-NRSPLNLTPTASPLPA 403
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498210|ref|XP_003517946.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1228), Expect = e-132, Method: Compositional matrix adjust.
Identities = 235/280 (83%), Positives = 253/280 (90%), Gaps = 4/280 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQL+HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW+VRM
Sbjct: 128 WL-TEVNYLGQLYHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWSVRM 186
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVSTQ
Sbjct: 187 KVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVSTQ 246
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKT G+EQ+LVDWAKPYL
Sbjct: 247 VMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTITGMEQNLVDWAKPYL 306
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
SDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+E K RP M+EVLA LE++EAPK +
Sbjct: 307 SDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPPMTEVLATLEQIEAPKTA 366
Query: 264 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 303
+ S SE HR P VRKSP R RSPLN+TPTASPLP+
Sbjct: 367 GRNSHSEHHRVQTP--VRKSPAR-NRSPLNLTPTASPLPA 403
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|48209875|gb|AAT40481.1| putative protein kinase [Solanum demissum] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1216), Expect = e-131, Method: Compositional matrix adjust.
Identities = 230/288 (79%), Positives = 252/288 (87%), Gaps = 3/288 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQL HPNLVKLIGYC++G+N LLVYEFMPKGSLENHLFRRGPQPL+WA R+
Sbjct: 136 WL-TEVNYLGQLRHPNLVKLIGYCIDGDNHLLVYEFMPKGSLENHLFRRGPQPLNWATRI 194
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAA+GL FLHDA+ QVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVSTQ
Sbjct: 195 KVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVSTQ 254
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVD TKVGIEQ+LVDWAKPYL
Sbjct: 255 VMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDNTKVGIEQNLVDWAKPYL 314
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKRKLFRIMDTKL GQYPQK A+TAA LA QCL+NEPKLRP+MSEVL LE L++PK
Sbjct: 315 GDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSNEPKLRPKMSEVLTALEELQSPKGV 374
Query: 264 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 311
+KLS +E PV V SPMR RSPL+MTP+ASP ++++SPR R
Sbjct: 375 SKLSHTEHRAIPSPVAV--SPMRHHRSPLHMTPSASPFQAYQKSPRGR 420
|
Source: Solanum demissum Species: Solanum demissum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357486685|ref|XP_003613630.1| Protein kinase 2B [Medicago truncatula] gi|87241133|gb|ABD32991.1| Protein kinase [Medicago truncatula] gi|355514965|gb|AES96588.1| Protein kinase 2B [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1213), Expect = e-130, Method: Compositional matrix adjust.
Identities = 231/287 (80%), Positives = 255/287 (88%), Gaps = 4/287 (1%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW++RM
Sbjct: 127 WL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWSIRM 185
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVSTQ
Sbjct: 186 KVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVSTQ 245
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
V+GT GYAAPEYVATGRLT KSDVYSFGVV+LELLSGR AVDKT G++Q+LVDWAKPYL
Sbjct: 246 VVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDKTIAGVDQNLVDWAKPYL 305
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKR+LFRIMD+KL GQYPQK A AATLALQCLN E K RP M+EVLA LE++EAPK++
Sbjct: 306 GDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPSMTEVLATLEQIEAPKHA 365
Query: 264 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRV 310
++ S SE HR P VR+SP R R+P +TPTASPLPS RQSPR
Sbjct: 366 SRNSLSEHHRVHAP--VRRSPAR-NRTPSYVTPTASPLPSVRQSPRA 409
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|113205211|gb|AAT39953.2| Protein kinase APK1B, chloroplast precursor, putative [Solanum demissum] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 229/285 (80%), Positives = 251/285 (88%), Gaps = 2/285 (0%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
TEVNYLGQL HPNLVKLIGYC++G+N LLVYEFMPKGSLENHLFRRGPQPL+WA R+KVA
Sbjct: 119 TEVNYLGQLRHPNLVKLIGYCIDGDNHLLVYEFMPKGSLENHLFRRGPQPLNWATRIKVA 178
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
IGAA+GL FLHDA+ QVIYRDFKASNILLDAEFN+KLSDFGLAKAGPTGDRTHVSTQVMG
Sbjct: 179 IGAARGLAFLHDAKEQVIYRDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVSTQVMG 238
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 206
T GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVD KVGIEQ+LVDWAKPYL DK
Sbjct: 239 TQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDNAKVGIEQNLVDWAKPYLGDK 298
Query: 207 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKL 266
RKLFRIMDTKL GQYPQK A+TAA LA QCL+NEPKLRP+MSEVL LE L++PK +KL
Sbjct: 299 RKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSNEPKLRPKMSEVLTALEELQSPKGVSKL 358
Query: 267 SQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 311
S +E PV V SPMR RSPL+MTP+ASPL ++++SPR R
Sbjct: 359 SHTEHRAIPSPVAV--SPMRHHRSPLHMTPSASPLQAYQKSPRGR 401
|
Source: Solanum demissum Species: Solanum demissum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297817892|ref|XP_002876829.1| hypothetical protein ARALYDRAFT_484186 [Arabidopsis lyrata subsp. lyrata] gi|297322667|gb|EFH53088.1| hypothetical protein ARALYDRAFT_484186 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1197), Expect = e-128, Method: Compositional matrix adjust.
Identities = 230/294 (78%), Positives = 255/294 (86%), Gaps = 7/294 (2%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQL HPNLVKL+GYC+EGENRLLVYEFMPKGSLENHLFRRG QPL+WA+RM
Sbjct: 134 WL-TEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRM 192
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFGLAKAGPTGD+THVSTQ
Sbjct: 193 KVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQ 252
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+KVG+EQSLVDWA PYL
Sbjct: 253 VMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYL 312
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+MSEVLA L++LE+ K
Sbjct: 313 GDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTKPG 372
Query: 264 AKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSHRQSPRVR 311
+ +Q + R + V+KSP R R L++TP ASPLPSH SPRVR
Sbjct: 373 TGIGNRQAQIDSPRGSNGSVVQKSPRRYSYDRPLLHITPGASPLPSHNHSPRVR 426
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | ||||||
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.919 | 0.671 | 0.776 | 2.3e-117 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.922 | 0.673 | 0.762 | 8.4e-113 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.893 | 0.674 | 0.692 | 5.8e-98 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.778 | 0.625 | 0.740 | 2.9e-96 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.897 | 0.659 | 0.621 | 3.6e-89 | |
| TAIR|locus:2019180 | 399 | AT1G74490 [Arabidopsis thalian | 0.781 | 0.609 | 0.685 | 1.3e-86 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.826 | 0.660 | 0.632 | 9.1e-84 | |
| TAIR|locus:2064712 | 462 | RIPK "RPM1-induced protein kin | 0.752 | 0.506 | 0.680 | 5.1e-83 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.752 | 0.570 | 0.680 | 6.4e-83 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.909 | 0.624 | 0.575 | 2.2e-82 |
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 2.3e-117, P = 2.3e-117
Identities = 229/295 (77%), Positives = 254/295 (86%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQL HPNLVKL+GYC+EGENRLLVYEFMPKGSLENHLFRRG QPL+WA+RM
Sbjct: 134 WL-TEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRM 192
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFGLAKAGPTGD+THVSTQ
Sbjct: 193 KVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQ 252
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+KVG+EQSLVDWA PYL
Sbjct: 253 VMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYL 312
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+MSEVLA L++LE+ K
Sbjct: 313 GDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTKPG 372
Query: 264 AKLSQSE-----PHRQTGPVTVRKSPMRQQ--RSPLNMTPTASPLPSHRQSPRVR 311
+ + P G + V+KSP R R L++TP ASPLP+H SPRVR
Sbjct: 373 TGVGNRQAQIDSPRGSNGSI-VQKSPRRYSYDRPLLHITPGASPLPTHNHSPRVR 426
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
Identities = 222/291 (76%), Positives = 245/291 (84%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVNYLGQL HPNLV L+GYC EGENRLLVYEFMPKGSLENHLFRRG QPL+WA+RM
Sbjct: 137 WL-TEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRM 195
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+FNAKLSDFGLAKAGPTGD THVST+
Sbjct: 196 KVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTK 255
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+SGR A+D + G E SLVDWA PYL
Sbjct: 256 VIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYL 315
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA-PKN 262
DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN + KLRP+MSEVL LE+LE+ K
Sbjct: 316 GDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESVAKP 375
Query: 263 SAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSHRQSPRVR 311
K +Q E R ++KSP+R R L+MTP ASPLPS+ QSPRVR
Sbjct: 376 GTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPSYTQSPRVR 426
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
Identities = 200/289 (69%), Positives = 225/289 (77%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
W EV+ LG+LHH NLVKLIGYC +G++ RLLVYE+MPKGSLENHLFRRG +P+ W R
Sbjct: 134 WL-AEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENHLFRRGAEPIPWRTR 192
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+KVAIGAA+GL FLH+A QVIYRDFKASNILLD+EFNAKLSDFGLAK GPTGDRTHVST
Sbjct: 193 IKVAIGAARGLAFLHEA--QVIYRDFKASNILLDSEFNAKLSDFGLAKVGPTGDRTHVST 250
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
QVMGT GYAAPEYVATGR+T KSDVYSFGVVLLELLSGR VDKTKVG+E++LVDWA PY
Sbjct: 251 QVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKVGVERNLVDWAIPY 310
Query: 203 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 262
L DKRK+FRIMDTKLGGQYP K A A ALQCLN EPKLRP+MS+VL+ LE LE
Sbjct: 311 LGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSDVLSTLEELEMTLK 370
Query: 263 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 311
S +S S + S +QR TP A P+ S R+ RVR
Sbjct: 371 SGSISNSVMKLTSSS----SSFTAKQRV---RTPVADPVLSSRRCRRVR 412
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
Identities = 183/247 (74%), Positives = 215/247 (87%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEV+YLG+LHH NLVKLIGYCLEGE RLLVYE+MPKGSLENHLFRRG +P+ W RM
Sbjct: 135 WL-TEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLFRRGAEPIPWKTRM 193
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVA AA+GL+FLH+A+ VIYRDFKASNILLD +FNAKLSDFGLAKAGPTGDRTHV+TQ
Sbjct: 194 KVAFSAARGLSFLHEAK--VIYRDFKASNILLDVDFNAKLSDFGLAKAGPTGDRTHVTTQ 251
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
V+GT GYAAPEY+ATGRLT+KSDVYSFGVVLLELLSGR +DK+KVG+E++LVDWA PYL
Sbjct: 252 VIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKVGVERNLVDWAIPYL 311
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
D+RK+FRIMDTKLGGQYP K A AA +AL+CLN EPKLRP M++VL+ L++LE +S
Sbjct: 312 VDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMADVLSTLQQLET--SS 369
Query: 264 AKLSQSE 270
K+ ++
Sbjct: 370 KKMGSTQ 376
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 890 (318.4 bits), Expect = 3.6e-89, P = 3.6e-89
Identities = 179/288 (62%), Positives = 221/288 (76%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAV 81
W EVNYLGQ HPNLVKLIGYCLE E+RLLVYEFMP+GSLENHLFRRG QPLSW +
Sbjct: 131 WL-AEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTL 189
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
R+KVA+GAAKGL FLH+AE+ VIYRDFK SNILLD+E+NAKLSDFGLAK GPTGD++HVS
Sbjct: 190 RLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVS 249
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
T++MGT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+LSGR AVDK + EQ LV+WA+P
Sbjct: 250 TRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARP 309
Query: 202 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL---- 257
L++KRKLFR++D +L QY + A ATLAL+CL E KLRP M+EV++ LE +
Sbjct: 310 LLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLN 369
Query: 258 EAPKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPS 303
EA + + Q R++ V + + P +++ + + TA P PS
Sbjct: 370 EAGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTAVGVIATAYPRPS 417
|
|
| TAIR|locus:2019180 AT1G74490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
Identities = 168/245 (68%), Positives = 201/245 (82%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W + EVNYLG+LHHPNLVKLIGY LE E+RLLVYE +P GSLENHLF R LSW++RM
Sbjct: 136 WLR-EVNYLGRLHHPNLVKLIGYSLENEHRLLVYEHLPNGSLENHLFERSSSVLSWSLRM 194
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
KVAIGAA+GL FLH+A QVIYRDFKA+NILLD+ FNAKLSDFGLAK GP +R+HV+T+
Sbjct: 195 KVAIGAARGLCFLHEANDQVIYRDFKAANILLDSGFNAKLSDFGLAKEGPKDNRSHVTTE 254
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGT GYAAPEY+ATG LTTK DVYSFGVVLLE+LSGR +DK+K E++LVDWA PYL
Sbjct: 255 VMGTEGYAAPEYLATGHLTTKCDVYSFGVVLLEILSGRRVIDKSKSREEENLVDWATPYL 314
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
DKRK+FRIMDTKL GQYPQKAA + LALQC+ + K+RP M EV+++LE++ P++
Sbjct: 315 RDKRKVFRIMDTKLVGQYPQKAAFMMSFLALQCIG-DVKVRPSMLEVVSLLEKVPIPRHR 373
Query: 264 AKLSQ 268
S+
Sbjct: 374 KSRSK 378
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
Identities = 167/264 (63%), Positives = 204/264 (77%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAV 81
W E+NYLGQL HPNLVKLIGYCLE E+RLLVYEFM +GSLENHLFRRG QPLSW
Sbjct: 119 WL-AEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNT 177
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
R+++A+GAA+GL FLH+A+ QVIYRDFKASNILLD+ +NAKLSDFGLA+ GP GD +HVS
Sbjct: 178 RVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVS 237
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK-VGIEQSLVDWAK 200
T+VMGT GYAAPEY+ATG L+ KSDVYSFGVVLLELLSGR A+DK + VG E +LVDWA+
Sbjct: 238 TRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVG-EHNLVDWAR 296
Query: 201 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260
PYL++KR+L R+MD +L GQY A A LAL C++ + K RP M+E++ +E L
Sbjct: 297 PYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQ 356
Query: 261 KNSAKLSQSEPHRQTGPVTVRKSP 284
K ++K Q P + + KSP
Sbjct: 357 KEASK-EQQNPQISIDNI-INKSP 378
|
|
| TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 5.1e-83, Sum P(2) = 5.1e-83
Identities = 160/235 (68%), Positives = 186/235 (79%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEV +LGQL H NLVKLIGYC E E+R LVYEFMP+GSLEN LFRR L W+ RM
Sbjct: 135 WL-TEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRRYSASLPWSTRM 193
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K+A GAA GL FLH+AE+ VIYRDFKASNILLD+++ AKLSDFGLAK GP GD THVST+
Sbjct: 194 KIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 253
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGT GYAAPEY+ TG LT +SDVYSFGVVLLELL+GR +VDK + EQ+LVDWA+P L
Sbjct: 254 VMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSREQNLVDWARPML 313
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258
+D RKL RIMD +L GQY + A AATLA QCL++ PK RP MS V++IL L+
Sbjct: 314 NDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILNDLK 368
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 160/235 (68%), Positives = 191/235 (81%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W TEVN+LGQL HPNLVKLIGYC E ++RLLVYEFM +GSLENHLFR+ PLSW+ RM
Sbjct: 117 WL-TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRM 175
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+A+GAAKGL FLH+AE VIYRDFK SNILLD+++ AKLSDFGLAKAGP GD THVST+
Sbjct: 176 MIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 235
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+GR +VDKT+ EQ+LVDWA+P L
Sbjct: 236 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKL 295
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258
+DKRKL +I+D +L QY +AA A +LA CL+ PK RP MS+V+ LE L+
Sbjct: 296 NDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 350
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 2.2e-82, P = 2.2e-82
Identities = 171/297 (57%), Positives = 212/297 (71%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
W E+N+LG L HP+LVKL+GYC+E + RLLVYEFMP+GSLENHLFRR PL W+VRM
Sbjct: 154 WL-AEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRR-TLPLPWSVRM 211
Query: 84 KVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
K+A+GAAKGL FLH+ AE VIYRDFK SNILLD E+NAKLSDFGLAK P ++HVST
Sbjct: 212 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVST 271
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
+VMGT+GYAAPEYV TG LTTKSDVYSFGVVLLE+L+GR +VDK++ EQ+LV+W +P+
Sbjct: 272 RVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVRPH 331
Query: 203 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 262
L DK++ +R++D +L G Y K A A +A QCLN + K RP+MSEV+ L+ L K+
Sbjct: 332 LLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLKD 391
Query: 263 SAKLSQS----EP------HRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 309
A S S +P Q G R P + S LN+ P ASP RQSP+
Sbjct: 392 FASSSSSFQTMQPVAKNGVRTQGGGFVSRNGPPMRSLSSLNL-PQASPYRYARQSPK 447
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O49840 | APK2B_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7789 | 0.9228 | 0.6737 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 311 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-41 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-04 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 9e-46
Identities = 72/239 (30%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + + +L HPN+V+L+G C +GE +V E+MP G L + L R+ + L+ ++
Sbjct: 48 FLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQ 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A+ AKG+ +L ++RD A N L+ K+SDFGL++ D
Sbjct: 107 MALQIAKGMEYLES--KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----R 159
Query: 145 MGTHGYA-----APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
G APE + G+ T+KSDV+SFGV+L E+ + G
Sbjct: 160 KRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL---------G--------E 202
Query: 200 KPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
+PY +S++ L + D G + P+ L LQC +P+ RP SE++ L
Sbjct: 203 QPYPGMSNEEVLELLED---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-44
Identities = 75/240 (31%), Positives = 114/240 (47%), Gaps = 39/240 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HPN+VKL+G C E E ++V E+MP G L ++L + P+ LS + +
Sbjct: 48 FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLS 107
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A+ A+G+ +L I+RD A N L+ K+SDFGL++ D V
Sbjct: 108 FALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK--- 162
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
G + APE + G+ T+KSDV+SFGV+L E+ + G
Sbjct: 163 ---GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL---------G--------E 202
Query: 200 KPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVLAIL 254
+PY +S+ L + G K + L LQC +P+ RP SE++ IL
Sbjct: 203 EPYPGMSNAEVLEYLKK----GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-43
Identities = 55/155 (35%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E+ L +L+HPN+VKL G + + LV E+ GSL++ L LS ++
Sbjct: 38 LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILR 96
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+ + +GL +LH + +I+RD K NILLD+ KL+DFGL+K +
Sbjct: 97 ILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKT 152
Query: 144 VMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLEL 177
++GT Y APE + G + KSD++S GV+L EL
Sbjct: 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 75/248 (30%), Positives = 109/248 (43%), Gaps = 45/248 (18%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-------FRRGPQPL 77
F E + +L HPN+V+L+G C E E LV E+M G L ++L L
Sbjct: 43 FLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL 102
Query: 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 137
S + AI AKG+ +L + ++RD A N L+ + K+SDFGL++ D
Sbjct: 103 SLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160
Query: 138 THVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 192
T G + APE + G T+KSDV+SFGV+L E+ + G
Sbjct: 161 Y-----RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL---------G-- 204
Query: 193 QSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRM 247
A PY LS++ L + G K + L L C +P+ RP
Sbjct: 205 ------ATPYPGLSNEEVLEYLRK----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTF 254
Query: 248 SEVLAILE 255
SE++ LE
Sbjct: 255 SELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 72/240 (30%), Positives = 113/240 (47%), Gaps = 40/240 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HPN+VKL+G C E E +V E+M G L ++L + P+ LS + +
Sbjct: 48 FLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLS 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A+ A+G+ +L I+RD A N L+ K+SDFGL++ D
Sbjct: 107 FALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK---- 160
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
G + APE + G+ T+KSDV+SFGV+L E+ + G
Sbjct: 161 --RGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL---------G--------E 201
Query: 200 KPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVLAIL 254
+PY +S++ L + + G + + L LQC +P+ RP SE++ IL
Sbjct: 202 QPYPGMSNEEVLEYLKN----GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-41
Identities = 78/241 (32%), Positives = 116/241 (48%), Gaps = 24/241 (9%)
Query: 14 HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73
+S T E+ L +L HPN+V+LI + ++ LV E+ G L ++L R G
Sbjct: 36 SEKSKKDQTAR--REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG 93
Query: 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 133
PLS K+A+ +GL +LH +I+RD K NILLD K++DFGLAK
Sbjct: 94 --PLSEDEAKKIALQILRGLEYLHSN--GIIHRDLKPENILLDENGVVKIADFGLAKKL- 148
Query: 134 TGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 192
+ ++T V GT Y APE + G K DV+S GV+L ELL+G+
Sbjct: 149 LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK----------- 196
Query: 193 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEV 250
+ L + + RI+ L P+ ++ + L +CLN +P RP E+
Sbjct: 197 --PPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
Query: 251 L 251
L
Sbjct: 255 L 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 7e-41
Identities = 64/233 (27%), Positives = 95/233 (40%), Gaps = 31/233 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E+ L +L HPN+V+L + + LV E+ G L + L +RG A
Sbjct: 44 ILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYL 103
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
I L +LH +++RD K NILLD + + KL+DFGLA+ G++ T V
Sbjct: 104 RQI--LSALEYLHSK--GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV 157
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
GT Y APE + D++S GV+L ELL+G+ P
Sbjct: 158 -GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK-------------------PPFP 197
Query: 205 DKRKLFRIMDTKLGGQYPQKAAH-----TAATLALQCLNNEPKLRPRMSEVLA 252
+L + + P A L + L +P+ R E L
Sbjct: 198 GDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 59/161 (36%), Positives = 91/161 (56%), Gaps = 14/161 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + + L HPNLV+L+G L+G +V E+M KGSL ++L RG ++ A ++
Sbjct: 47 FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVS 141
A+ +G+ +L E ++RD A N+L+ + AK+SDFGLAK G + V
Sbjct: 107 FALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK 164
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 181
+ APE + + +TKSDV+SFG++L E+ S GR
Sbjct: 165 --------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 29/233 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVR 82
+ E+ L L HPN+V+ G E +N L ++ E++ GSL + L + G P +R
Sbjct: 46 LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR 104
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
K +GL +LH +++RD K +NIL+D++ KL+DFG AK + +
Sbjct: 105 -KYTRQILEGLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
V GT + APE + +D++S G ++E+ +G KP
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG-------------------KPP 202
Query: 203 LSDKRK----LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
S+ L++I + + P+ + A +CL +PK RP E+L
Sbjct: 203 WSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 69/243 (28%), Positives = 119/243 (48%), Gaps = 22/243 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
F+ E+ L L H N+VK G C + G + L+ E++P GSL ++L R Q ++
Sbjct: 53 FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRL 111
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ + KG+ +L + I+RD A NIL+++E K+SDFGLAK P +
Sbjct: 112 LLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVK 169
Query: 143 Q-----VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
+ + + APE + T + ++ SDV+SFGV L EL + D ++ + L
Sbjct: 170 EPGESPIF----WYAPECLRTSKFSSASDVWSFGVTLYELFT-YG--DPSQSPPAEFLRM 222
Query: 198 WAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAIL 254
+ + R+++ K G + P+ + L C EP+ RP ++++ I+
Sbjct: 223 IGIA--QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
Query: 255 ERL 257
+RL
Sbjct: 281 DRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 70/232 (30%), Positives = 106/232 (45%), Gaps = 33/232 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E++ L L HPN+VK IG ++ ++ E+ GSL + + GP P S
Sbjct: 46 IMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV 105
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ +GL +LH E VI+RD KA+NIL + KL+DFG+ A D + V
Sbjct: 106 YQV--LQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGV--ATKLNDVSKDDASV 159
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY-- 202
+GT + APE + +T SD++S G ++ELL+G PY
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN------------------PPYYD 201
Query: 203 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVL 251
L+ LFRI+ +P + L +QC +P LRP ++L
Sbjct: 202 LNPMAALFRIVQD----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL 249
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 8/155 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L + HPN+VK G L+ + +V EF GSL++ L + Q L+ + V
Sbjct: 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCK 105
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMG 146
KGL +LH + +I+RD KA+NILL ++ KL DFGL+ T R ++G
Sbjct: 106 ELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVG 159
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
T + APE + K+D++S G+ +EL G+
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 5e-28
Identities = 66/243 (27%), Positives = 115/243 (47%), Gaps = 39/243 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F TE + +GQ HPN+++L G + +++ E+M GSL+ L R + +
Sbjct: 52 FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVG 110
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ G A G+ +L +E ++RD A NIL+++ K+SDFGL++ R S
Sbjct: 111 MLRGIASGMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEAT 162
Query: 145 MGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 197
T G + APE +A + T+ SDV+SFG+V+ E++S G
Sbjct: 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE---------------- 206
Query: 198 WAKPY--LSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
+PY +S++ + + D +L P L L C + RP S++++ L
Sbjct: 207 --RPYWDMSNQDVIKAVEDGYRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
Query: 255 ERL 257
+++
Sbjct: 263 DKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-27
Identities = 72/226 (31%), Positives = 109/226 (48%), Gaps = 40/226 (17%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLS--WAV 81
TE N L +++HP +VKL Y + E +L LV E+ P G L +HL + G + + +A
Sbjct: 42 TERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA 100
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHV 140
+ +A+ +LH +IYRD K NILLDA+ + KL+DFGLAK G RT+
Sbjct: 101 EIVLALE------YLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN- 151
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
GT Y APE + D +S GV+L E+L+G+
Sbjct: 152 --TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------P 191
Query: 201 PYLSDKRKLF--RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
P+ ++ RK +I+ L ++P+ + A L L +P R
Sbjct: 192 PFYAEDRKEIYEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 78/240 (32%), Positives = 117/240 (48%), Gaps = 17/240 (7%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
+E+ +G+L HPN+VKLIG C + L++E++ +L L + LSW R K+A
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIA 786
Query: 87 IGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
IG AK L FLH V+ + I++D + L L T + +S+
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS--- 842
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
Y APE T +T KSD+Y FG++L+ELL+G+ D + G+ S+V+WA+ SD
Sbjct: 843 ---AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSD 898
Query: 206 KRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 263
L +D + G Q LAL C +P RP ++VL LE +S
Sbjct: 899 CH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 72/234 (30%), Positives = 112/234 (47%), Gaps = 25/234 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E L Q HPN+VKLIG C++ + +V E +P GSL L R+ L+ ++
Sbjct: 39 FLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQ 97
Query: 85 VAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+++ AA G+ +L ES+ I+RD A N L+ K+SDFG+++ G T
Sbjct: 98 MSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 202
+ APE + GR T++SDV+S+G++L E S PY
Sbjct: 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLG-----------------DTPYP 197
Query: 203 -LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
+S+++ RI ++ PQ L LQC +P+ RP SE+ L+
Sbjct: 198 GMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ--------- 75
F+ E L H N+VK G C EG+ ++V+E+M G L L GP
Sbjct: 55 FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 76 ---PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132
L+ + +++A+ A G+ +L A ++RD N L+ + K+ DFG+++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV 172
Query: 133 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
T D V M + PE + + TT+SDV+SFGVVL E+ +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 80/297 (26%), Positives = 115/297 (38%), Gaps = 22/297 (7%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLE---NHLFRRGPQPLSWA 80
F E+ L L H PN+VKL + + + LV E++ GSLE + R+GP S A
Sbjct: 44 FLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA 103
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK----AGPTG 135
+ + I L +LH +I+RD K NILLD + KL DFGLAK G T
Sbjct: 104 LFILAQI--LSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159
Query: 136 DRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 192
+ + +GT GY APE + ++ SD++S G+ L ELL+G + K
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 193 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
S L + + A+ L + L +PK R S L+
Sbjct: 220 TSQT-LKIILELPTPSLASPLSPSNPELISKAASD----LLKKLLAKDPKNRLSSSSDLS 274
Query: 253 I-LERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSP 308
L K S +P + S LN + S
Sbjct: 275 HDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSN 331
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------- 74
F+ E + L HPN+V L+G C + + +++E++ G L L R P
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 75 ----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130
L + + +AI A G+ +L + ++RD A N L+ K+SDFGL++
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
Query: 131 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ D V ++ + + PE + G+ TT+SD++SFGVVL E+ S
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-24
Identities = 72/234 (30%), Positives = 115/234 (49%), Gaps = 28/234 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +LHH NLV+L+G L +V E M KG+L N L RG +S ++
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVSTQ 143
++ A+G+ +L ++++RD A NIL+ + AK+SDFGLA+ G G D + + +
Sbjct: 105 FSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK 162
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY 202
+ APE + + ++KSDV+S+GV+L E+ S GR K + + V+
Sbjct: 163 ------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE----- 211
Query: 203 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256
K +R M+ P+ L C EPK RP ++ LE+
Sbjct: 212 -----KGYR-MEP------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L +L HPN+V+ +G E +N + E +P GSL L + G P +R+
Sbjct: 52 EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP-VIRLYTR- 109
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-- 145
GL +LHD ++RD K +NIL+D KL+DFG+AK V
Sbjct: 110 QILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAK 159
Query: 146 ---GTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
G+ + APE +A G +D++S G +LE+ +G KP
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG-------------------KP 200
Query: 202 YLSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
S +F+I +K P + A L+CL +P LRP +E+L
Sbjct: 201 PWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 6e-24
Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 43/240 (17%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------PQPL 77
EV L +L+HPN++K E +V E+ G L + ++ Q L
Sbjct: 47 LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL 106
Query: 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGD 136
W V++ L +LH ++++RD K NI L + KL DFG++K T D
Sbjct: 107 DWFVQL------CLALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196
T V GT Y +PE KSD++S G VL EL + + + + L
Sbjct: 159 --LAKTVV-GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELA 212
Query: 197 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLAI 253
+I+ GQYP + ++ L L +P+ RP ++++L
Sbjct: 213 -------------LKILK----GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 9e-24
Identities = 53/159 (33%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HPNLV+L G C + +V E+M G L N+L R L +
Sbjct: 46 FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLD 104
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + + +L + I+RD A N L+ + K+SDFGLA+ D + S+Q
Sbjct: 105 MCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQ- 159
Query: 145 MGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT +A PE R ++KSDV+SFGV++ E+ S
Sbjct: 160 -GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-23
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E L +L +++ L+ +V E+ G L L + +PL + I
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
GL LH ++++RD K+ N+ LDA N K+ D G+AK D T+ + ++GT
Sbjct: 109 QILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGT 164
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 207
Y +PE KSDV++ GVVL E +G+ D G +L+
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI----------L 211
Query: 208 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
K+ R + + Y Q+ A L QCL + + RP ++L
Sbjct: 212 KIIRGVFPPVSQMYSQQLAQ----LIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 8e-23
Identities = 74/245 (30%), Positives = 113/245 (46%), Gaps = 46/245 (18%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS----WA 80
F E + + QL HP +V+LIG C GE +LV E P G L +L +R P+S A
Sbjct: 43 FLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA 101
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
++ A G+ +L ++RD A N+LL AK+SDFG+++A G +
Sbjct: 102 HQV------AMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153
Query: 141 STQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 194
+T T G + APE + G+ ++KSDV+S+GV L E S G
Sbjct: 154 AT----TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYG-------------- 195
Query: 195 LVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
AKPY + K ++ G+ P++ ++ L C P+ RP SE+
Sbjct: 196 ----AKPY--GEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELE 249
Query: 252 AILER 256
+ R
Sbjct: 250 STFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 65/244 (26%), Positives = 111/244 (45%), Gaps = 34/244 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--------FRRGPQP 76
F E + + + + ++V+L+G G+ L+V E M KG L+++L G P
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
+ +++A A G+ +L A + ++RD A N ++ + K+ DFG+ + D
Sbjct: 116 PTLQKFIQMAAEIADGMAYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196
+ + + APE + G TTKSDV+SFGVVL E+ +L
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA---------------TLA 218
Query: 197 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+PY LS++ L ++D GG P+ L C PK+RP E+++
Sbjct: 219 --EQPYQGLSNEEVLKFVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
Query: 253 ILER 256
L+
Sbjct: 274 SLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-22
Identities = 69/235 (29%), Positives = 112/235 (47%), Gaps = 11/235 (4%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAV 81
W + E+N L L+H N+VK G C E + L+ E++P GSL ++L + L+ A
Sbjct: 53 WKK-EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQ 108
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-V 140
+ A +G+ +LH I+RD A N+LLD + K+ DFGLAKA P G + V
Sbjct: 109 LLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 166
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
+ A E + + + SDV+SFGV L ELL+ C ++ + ++ +
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQ 225
Query: 201 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
++ R L +++ + P+ L C E K RP ++ IL+
Sbjct: 226 GQMTVVR-LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 58/165 (35%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---QPLSWAV 81
F E + +L H LV+L C E E +V E+M KGSL + L + G L V
Sbjct: 48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLV 106
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
M I A+G+ +L I+RD A NIL+ K++DFGLA+ D + +
Sbjct: 107 DMAAQI--AEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGLARL--IEDDEYTA 160
Query: 142 TQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC 182
+ G + APE GR T KSDV+SFG++L E+++ GR
Sbjct: 161 RE--GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-22
Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 28/236 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F E + + QL H NLV+L+G +E + L +V E+M KGSL ++L RG L +
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVST 142
K ++ + + +L + ++RD A N+L+ + AK+SDFGL K A T D +
Sbjct: 106 KFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 163
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 201
+ + APE + + +TKSDV+SFG++L E+ S GR V ++ ++ + K
Sbjct: 164 K------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKG 215
Query: 202 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
Y D P + QC + + RP ++ LE +
Sbjct: 216 YKMDA---------------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-22
Identities = 57/157 (36%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVR 82
FQ EV L +L H +L+ L C GE ++ E M KGSL F R P Q L A
Sbjct: 49 FQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASL 106
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ +A A+G+ +L E I+RD A NIL+ + K++DFGLA+ + ++S+
Sbjct: 107 IDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSS 162
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ + APE + G +TKSDV+SFG++L E+ +
Sbjct: 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-22
Identities = 66/254 (25%), Positives = 110/254 (43%), Gaps = 42/254 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ--------- 75
FQ E + + HPN+VKL+G C G+ L++E+M G L L R P+
Sbjct: 55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 76 -----------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 124
PLS ++ +A A G+ +L +E + ++RD N L+ K++
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIA 172
Query: 125 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184
DFGL++ + D S + PE + R TT+SDV+++GVVL E+ S
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS----- 227
Query: 185 DKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 242
G++ PY ++ + ++ + D + P L C + P
Sbjct: 228 ----YGMQ--------PYYGMAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPS 274
Query: 243 LRPRMSEVLAILER 256
RP + + IL+R
Sbjct: 275 DRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 8e-22
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 37 HPNLVKLIG-YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95
P +VK G + EGE + V E+M GSL + L + G + V +A KGL +
Sbjct: 58 SPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDY 114
Query: 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPE 154
LH + +I+RD K SN+L++++ K++DFG++K T D+ + T V GT Y +PE
Sbjct: 115 LH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPE 170
Query: 155 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR-KLFRIM 213
+ + +D++S G+ LLE G+ P+L + F +M
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKF------------------PFLPPGQPSFFELM 212
Query: 214 DTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVL 251
G P + + ++ CL +PK RP +E+L
Sbjct: 213 QAICDGPPPSLPAEEFSPEFRDFISA-CLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 14/153 (9%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL----ENHLFRRGPQP-LSWAVRMKVA 86
+ + HP++V+L+G CL L+ + MP G L NH G Q L+W V++
Sbjct: 63 MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI--- 118
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
AKG+++L E ++++RD A N+L+ + K++DFGLAK ++ + +
Sbjct: 119 ---AKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ A E + T KSDV+S+GV + EL++
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-21
Identities = 51/154 (33%), Positives = 86/154 (55%), Gaps = 12/154 (7%)
Query: 32 LGQLHH---PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 88
L +H P +V G L N + EFM GSL+ + GP P+ + K+A+
Sbjct: 54 LQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE--ILGKIAVA 111
Query: 89 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGT 147
+GLT+L++ ++++RD K SNIL+++ KL DFG+ +G+ + ++ +GT
Sbjct: 112 VVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGT 165
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
Y +PE + G+ T KSDV+S G+ ++EL G+
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-21
Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 23/244 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLE-GENRL-LVYEFMPKGSLENHLFRR-----GPQPL 77
F+ E+ L L H N+VK G C G L LV E++P GSL ++L + + L
Sbjct: 52 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL 111
Query: 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 137
+A ++ KG+ +L + ++RD NIL+++E K+ DFGL K P D+
Sbjct: 112 LYASQI------CKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DK 162
Query: 138 THVSTQVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 195
+ + G + APE + + + SDV+SFGVVL EL + + +
Sbjct: 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFMRM 221
Query: 196 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAI 253
+ K L ++ K G+ P A A+ +C NN+P RP SE+
Sbjct: 222 MGNDKQGQMIVYHLIELL--KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279
Query: 254 LERL 257
+E +
Sbjct: 280 VEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-21
Identities = 73/238 (30%), Positives = 114/238 (47%), Gaps = 46/238 (19%)
Query: 35 LHHPNLVKLIGYCLEGENR-LLVYEFMPKGSLENHLFRRGPQ--PLSWAVRMKVAIG--A 89
HPN++ L+G CL E L+V +M G L N F R P V+ + G
Sbjct: 53 FSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNP---TVKDLIGFGLQV 107
Query: 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149
AKG+ +L A + ++RD A N +LD F K++DFGLA+ D+ + S T
Sbjct: 108 AKGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVH-NHTGA 162
Query: 150 -----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA-----VDKTKVGIEQSLVDWA 199
+ A E + T + TTKSDV+SFGV+L EL++ R A VD + +
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITV-------- 213
Query: 200 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
YL R+L + P+ + L C + +P++RP SE+++ +E++
Sbjct: 214 --YLLQGRRLLQ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-21
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 4/156 (2%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + L H NL++L G L ++V E P GSL + L + +
Sbjct: 43 FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST-Q 143
A+ A G+ +L + I+RD A NILL ++ K+ DFGL +A P + +V
Sbjct: 102 YAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ + APE + T + SDV+ FGV L E+ +
Sbjct: 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 8e-21
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 41/229 (17%)
Query: 36 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95
+ P +V G + + E+M GSL+ + + + + K+A+ KGLT+
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM--------GT 147
LH+ + ++I+RD K SNIL+++ KL DFG VS Q++ GT
Sbjct: 116 LHE-KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGT 162
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 207
Y APE + + KSD++S G+ L+EL +GR P
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFE 211
Query: 208 KLFRIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
L I++ +L G++ CL +P+ RP E+L
Sbjct: 212 LLQYIVNEPPPRLPSGKFSPDFQD----FVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLEN---HLFRRGPQPLSWAVR 82
E+ P +VK G L+ + + E+ GSL++ + +RG + + V
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVL 107
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVS 141
K+A KGL++LH ++I+RD K SNILL + KL DFG++ + + T
Sbjct: 108 GKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
GT Y APE + + SDV+S G+ LLE+ R
Sbjct: 165 ----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 42/254 (16%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL----------------- 69
+E N L Q++HP+++KL G C + LL+ E+ GSL + L
Sbjct: 52 SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111
Query: 70 -----FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 124
+ L+ + A ++G+ +L AE ++++RD A N+L+ K+S
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKIS 169
Query: 125 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184
DFGL++ D ++ + A E + TT+SDV+SFGV+L E+++
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----- 224
Query: 185 DKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243
+G PY +LF ++ T + P+ + L L C EP
Sbjct: 225 ----LG--------GNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDK 272
Query: 244 RPRMSEVLAILERL 257
RP +++ LE++
Sbjct: 273 RPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 63/240 (26%), Positives = 111/240 (46%), Gaps = 29/240 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF-------RRGPQPL 77
F+ E++ +L H N+V+L+G C E E ++ E+ G L+ L + P PL
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 137
S ++ + A G+ L + ++ ++RD A N L+ ++ K+S L+K +
Sbjct: 115 STKQKVALCTQIALGMDHL--SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172
Query: 138 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
+ ++ + APE V +TKSDV+SFGV++ E+ + + ++
Sbjct: 173 YKLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT------QGEL-------- 217
Query: 198 WAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
P+ LSD+ L R+ KL P+ L +C PK RP SE+++ L
Sbjct: 218 ---PFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-20
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 21/234 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + ++ HPNLV+L+G C ++ EFM G+L ++L Q ++ V +
Sbjct: 49 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 108
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A + + +L + I+RD A N L+ K++DFGL++ TGD
Sbjct: 109 MATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGA 165
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+ APE +A + + KSDV++FGV+L E+ + + PY
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPG 208
Query: 205 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
D +++ +++ + P+ L C P RP +E+ E +
Sbjct: 209 IDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-20
Identities = 57/227 (25%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ + +L+HP++++++G E + L E+M GS+ + L + G AV +
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTE 110
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLA-KAGPTGDRT-HVSTQV 144
+GL++LH+ +Q+I+RD K +N+L+D+ +++DFG A + G Q+
Sbjct: 111 QLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+GT + APE + + DV+S G V++E+ + + + K +L
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL--------- 219
Query: 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+F+I P+ + + L+CL +P+ RP E+L
Sbjct: 220 ----IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 6e-20
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMP---KGSLENHLFRRG-PQPLSWAV 81
E+ L +L HPN+V+L + +V+E+M G L++ + Q +
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK 107
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
++ +GL +LH +++RD K SNIL++ + KL+DFGLA+ T +
Sbjct: 108 QL------LEGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADY 158
Query: 142 TQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGVVLLELLSGR 181
T + T Y PE + AT R + D++S G +L EL G+
Sbjct: 159 TNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-20
Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-------- 76
FQ E + + +LHHPN+V L+G + + +++E++ +G L L R P
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 77 -------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
L + +AI A G+ +L + +++D A NIL+ + + K+SD GL+
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLS 171
Query: 130 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ + D V + + + PE + G+ ++ SD++SFGVVL E+ S
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 8/146 (5%)
Query: 37 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95
HP L +L C + ++RL V E++ G L H+ R G A I GL F
Sbjct: 55 HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQF 111
Query: 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 155
LH E +IYRD K N+LLD+E + K++DFG+ K G G T ++ GT Y APE
Sbjct: 112 LH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEI 167
Query: 156 VATGRLTTKSDVYSFGVVLLELLSGR 181
++ D ++ GV+L E+L+G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-20
Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 16/161 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HP LV+L G C E LV+EFM G L ++L R S +
Sbjct: 46 FIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLG 104
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + +G+ +L S VI+RD A N L+ K+SDFG+ R + Q
Sbjct: 105 MCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMT-------RFVLDDQY 155
Query: 145 MGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ G +++PE + + ++KSDV+SFGV++ E+ S
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-19
Identities = 60/237 (25%), Positives = 112/237 (47%), Gaps = 32/237 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVR 82
F E + +L H LV+L G C + +V E+M G L N+L + QP +
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQL 102
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+++ +G+ +L Q I+RD A N L+D + K+SDFGL++ D + S+
Sbjct: 103 LEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS 158
Query: 143 QVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
+G+ ++ PE + + ++KSDV++FGV++ E+ S G+ ++ V+
Sbjct: 159 --VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN---NSETVE- 212
Query: 199 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
+S +L+R P A+ + C + + + RP ++L+ +E
Sbjct: 213 ---KVSQGLRLYR----------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 49/153 (32%), Positives = 86/153 (56%), Gaps = 14/153 (9%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR----GPQPL-SWAVRMKVA 86
+G L H +V+L+G C G + LV + P GSL +H+ + PQ L +W V++
Sbjct: 63 MGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI--- 118
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
AKG+ +L E ++++R+ A NILL ++ +++DFG+A D+ + ++
Sbjct: 119 ---AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ A E + GR T +SDV+S+GV + E++S
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 10/160 (6%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN---HLFRRGPQPLSWAVRMK 84
EV + Q +HPN+VK + G+ LV ++ GSL + + RG +
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA--T 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTH-VST 142
V KGL +LH + I+RD KA NILL + + K++DFG+ A GDRT V
Sbjct: 107 VLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164
Query: 143 QVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 181
+GT + APE + K+D++SFG+ +EL +G
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 52/165 (31%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HP L++L C E +V E M GSL +L + L +
Sbjct: 48 FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID 107
Query: 85 VAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+A A G+ +L E+Q I+RD A N+L+ K++DFGLA R
Sbjct: 108 MAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLA-------RVIKEDI 157
Query: 144 VMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 181
G + APE R + KSDV+SFG++L E+++ GR
Sbjct: 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-19
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 22/227 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F +E L Q HPN+VKLIG C + + +V E +P G + L R+ L +K
Sbjct: 39 FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVK 97
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A+ AA G+ +L I+RD A N L+ K+SDFG+++ G + +
Sbjct: 98 FALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL 203
+ + APE + GR +++SDV+S+G++L E S G C + V+
Sbjct: 156 IPIK-WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE------ 208
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250
K +R+ PQK + +C + +P+ RP+ SE+
Sbjct: 209 ----KGYRM-------SCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 33/252 (13%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR---------- 72
N F EV L +L PN+++L+G C++ + ++ E+M G L L
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 73 ------GPQP-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 125
P +S++ + VA+ A G+ +L + ++RD N L+ K++D
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 126 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 185
FG+++ GD + + + + A E + G+ TT SDV++FGV L E+L C
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM-LCKEQ 240
Query: 186 KTKVGIEQSLVDWAKPYLSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 242
++ +++ A + D+ + LFR P L LQC + + +
Sbjct: 241 PYGELTDEQVIENAGEFFRDQGRQVYLFR----------PPPCPQGLYELMLQCWSRDCR 290
Query: 243 LRPRMSEVLAIL 254
RP S++ A L
Sbjct: 291 ERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-19
Identities = 68/240 (28%), Positives = 103/240 (42%), Gaps = 50/240 (20%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL----ENHLFRRGPQPLSWAVR 82
E+ + HPN+V L G+ +V E+M GSL + VR
Sbjct: 64 NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----------FVR 112
Query: 83 MKVAIGAA------KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
M A +GL +LH VI+RD K+ NILL + + KL+DFG A A T +
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKE 169
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196
++ ++ V GT + APE + K D++S G++ +E+ G
Sbjct: 170 KSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE--------------- 213
Query: 197 DWAKPYLSDK--RKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
PYL + R LF I T G + P+K + +CL +P+ RP E+L
Sbjct: 214 ---PPYLREPPLRALFLI--TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-19
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 38/210 (18%)
Query: 51 ENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 109
ENR+ + EFM GSL+ ++R+ P+ V ++A+ KGLT+L ++++RD K
Sbjct: 71 ENRISICTEFMDGGSLD--VYRKIPEH----VLGRIAVAVVKGLTYLWSL--KILHRDVK 122
Query: 110 ASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYS 169
SN+L++ KL DFG++ T ++ +GT+ Y APE ++ + SDV+S
Sbjct: 123 PSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWS 178
Query: 170 FGVVLLELLSGRCAVDKTK--------VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 221
G+ +EL GR + + + + Q +VD P L GQ+
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV-------------GQF 225
Query: 222 PQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+K H QC+ +PK RP ++
Sbjct: 226 SEKFVHFIT----QCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-19
Identities = 74/225 (32%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 23 NWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLFRRGPQPLSWA 80
+W QTE + Q +HP LV L C + E+RL V E++ G L H+ R+ P A
Sbjct: 40 DWVQTEKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA 98
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTH 139
I A L +LH E +IYRD K N+LLD+E + KL+D+G+ K G GD T
Sbjct: 99 RFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT- 153
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
+ GT Y APE + D ++ GV++ E+++GR D VG +
Sbjct: 154 --STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDN----- 204
Query: 200 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
P + + LF+++ K + P+ + AA++ LN +PK R
Sbjct: 205 -PDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 57/163 (34%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
TE + L Q P +VKL Y +G+ L LV E++P G L + L G A
Sbjct: 41 LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI 99
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS--- 141
I A L +LH + +I+RD K NIL+D+ + KL+DFGL+K G + +++
Sbjct: 100 AEIVLA--LEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 142 ---TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 180
+++GT Y APE V G+ +K+ D +S G +L E L G
Sbjct: 156 KEDKRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-19
Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 16/169 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QP 76
FQ E L L H ++VK G C +G+ ++V+E+M G L L GP QP
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113
Query: 77 ------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130
L + + +A A G+ +L A ++RD N L+ A K+ DFG+++
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
Query: 131 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ D V M + PE + + TT+SDV+SFGV+L E+ +
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 7e-19
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHL------FRRGPQPLSW 79
EVN L +L HPN+V+ ++ N+ L V E+ G L + + + W
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139
+ ++ + A D + V++RD K +NI LDA N KL DFGLAK G +
Sbjct: 109 RILTQLLL-ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSS 165
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+ +GT Y +PE + KSD++S G ++ EL +
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-19
Identities = 55/165 (33%), Positives = 86/165 (52%), Gaps = 12/165 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-----FRRGPQPLSW 79
F E + + +HPN+VKL+G CL E + ++ E M G L ++L R GP L+
Sbjct: 46 FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPT 134
+ + + AKG +L I+RD A N L+ DA+ K+ DFGLA+
Sbjct: 106 KELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK 163
Query: 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
D + + + APE + G+ TT+SDV+SFGV++ E+L+
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-19
Identities = 68/243 (27%), Positives = 119/243 (48%), Gaps = 38/243 (15%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F +E + +GQ HPN++ L G + + ++V E+M GSL+ L + Q + V
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ---FTVIQL 108
Query: 85 VAI--GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTH 139
V + G A G+ +L D ++RD A NIL+++ K+SDFGL++ P T
Sbjct: 109 VGMLRGIASGMKYLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
++ + APE +A + T+ SDV+S+G+V+ E++S G
Sbjct: 167 RGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE----------------- 207
Query: 199 AKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAIL 254
+PY +S++ + I + G + P AA L L C + RP+ ++++IL
Sbjct: 208 -RPYWEMSNQDVIKAIEE---GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
Query: 255 ERL 257
++L
Sbjct: 264 DKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-19
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ--------- 75
FQ E L L H ++V+ G C EG L+V+E+M G L L GP
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113
Query: 76 ----PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131
L+ + +A A G+ +L A ++RD N L+ K+ DFG+++
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171
Query: 132 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ D V + M + PE + + TT+SD++SFGVVL E+ +
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-19
Identities = 62/166 (37%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 23 NWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA 80
+W QTE + +HP LV L C + E+RL V EF+ G L H+ R+ P A
Sbjct: 40 DWVQTEKHVFETASNHPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA 98
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTH 139
I A L FLH E +IYRD K N+LLDAE + KL+D+G+ K G GD T
Sbjct: 99 RFYSAEISLA--LNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT- 153
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 185
+ GT Y APE + D ++ GV++ E+++GR D
Sbjct: 154 --STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-19
Identities = 67/244 (27%), Positives = 121/244 (49%), Gaps = 38/244 (15%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F +E + +GQ HPN++ L G + +++ EFM G+L++ L + Q + V
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQL 108
Query: 85 VAI--GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHV 140
V + G A G+ +L +E ++RD A NIL+++ K+SDFGL++ T D T+
Sbjct: 109 VGMLRGIAAGMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 141 STQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 196
S+ +G + APE +A + T+ SDV+S+G+V+ E++S G
Sbjct: 167 SS--LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE--------------- 209
Query: 197 DWAKPY--LSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
+PY +S++ + I D +L P L L C + RP+ ++++
Sbjct: 210 ---RPYWDMSNQDVINAIEQDYRLPP--PMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264
Query: 254 LERL 257
L+++
Sbjct: 265 LDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 8/161 (4%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
Q EV+ L L H N+V+ +G CL+ + EF+P GS+ + L R GP P V K
Sbjct: 49 LQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLP--EPVFCK 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK----AGPTGDRTHV 140
G+ +LH+ + V++RD K +N++L KL DFG A+ G G +++
Sbjct: 107 YTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+ GT + APE + KSD++S G + E+ +G+
Sbjct: 165 LKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-18
Identities = 54/155 (34%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E+ L L+H N+VK G C E L+ EF+P GSL+ +L R ++ ++K
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKY 114
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQV 144
A+ KG+ +L Q ++RD A N+L+++E K+ DFGL KA T + V +
Sbjct: 115 AVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ APE + + SDV+SFGV L ELL+
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 62/250 (24%), Positives = 106/250 (42%), Gaps = 42/250 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLF--RRGPQP 76
F +E + HPN++KLIG C E + +++ FM G L + L R G P
Sbjct: 48 FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP 107
Query: 77 LSWAVRM--KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134
++ K + A G+ +L + I+RD A N +L + ++DFGL+K +
Sbjct: 108 EKLPLQTLLKFMVDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 135 GD---RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVG 190
GD + ++ + + A E +A T+KSDV++FGV + E+ + G+ G
Sbjct: 166 GDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP----G 218
Query: 191 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL---ALQCLNNEPKLRPRM 247
+E I D G ++ L C +PK RP
Sbjct: 219 VENH----------------EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTF 262
Query: 248 SEVLAILERL 257
+++ +LE +
Sbjct: 263 TKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-18
Identities = 67/235 (28%), Positives = 99/235 (42%), Gaps = 35/235 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L L HPNLVK G + E + E+ G+LE L + L V +
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTL 106
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVM- 145
+GL +LH +++RD K +NI LD KL DFG A Q +
Sbjct: 107 QLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164
Query: 146 GTHGYAAPEYVATGRLTTK---SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
GT Y APE + G+ +D++S G V+LE+ +G+ W++
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK--------------RPWSE-- 208
Query: 203 LSDKRKLFRIMDTKLG-GQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVL 251
D F+IM +G G P + +CL ++PK RP SE+L
Sbjct: 209 -LDNE--FQIM-FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 61/236 (25%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HP LV+L G C + + +V EFM G L N+L +R + LS + +
Sbjct: 46 FIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLS 104
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ +G+ +L + I+RD A N L+ + K+SDFG+ R + +
Sbjct: 105 MCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMT-------RYVLDDEY 155
Query: 145 MGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 198
+ G ++ PE + ++KSDV+SFGV++ E+ + + K+ E+
Sbjct: 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT------EGKMPFEKKSNYE 209
Query: 199 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
+S +L+R P+ A+ T + C + +P+ RP +E+L +
Sbjct: 210 VVEMISRGFRLYR----------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
Q E L L HPN+++ LE + ++V E+ P G+L ++ +R L +
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQV 144
+ L +H +++RD K NILLD K+ DFG++K ++ T V
Sbjct: 107 FVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-V 161
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+GT Y +PE KSD+++ G VL EL S + A + + P L
Sbjct: 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PAL- 209
Query: 205 DKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+ +IM + +Y L L LN +P RP++S+++A
Sbjct: 210 ----VLKIMSGTFAPISDRYSPDLRQ----LILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 66/241 (27%), Positives = 119/241 (49%), Gaps = 34/241 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F +E + +GQ H N+++L G + + +++ E+M G+L+ +L R S +
Sbjct: 53 FLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVG 111
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVS 141
+ G A G+ +L ++ ++RD A NIL+++ K+SDFGL++ P G T
Sbjct: 112 MLRGIAAGMKYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 200
++ + APE +A + T+ SDV+SFG+V+ E++S G +
Sbjct: 170 GKI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE------------------R 209
Query: 201 PY--LSDKRKLFRIMDTKLGGQYPQKAAHTAAT--LALQCLNNEPKLRPRMSEVLAILER 256
PY +S+ + I D G + P +A L LQC + RPR +++ +L++
Sbjct: 210 PYWDMSNHEVMKAIND---GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266
Query: 257 L 257
L
Sbjct: 267 L 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 35/247 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-------- 76
F E L L H ++VK G C+EG+ ++V+E+M G L L GP
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113
Query: 77 ---LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 133
L+ + + +A A G+ +L A ++RD N L+ K+ DFG+++
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171
Query: 134 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIE 192
+ D V M + PE + + TT+SDV+S GVVL E+ + G+
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK----------- 220
Query: 193 QSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250
+P+ LS+ + I ++ Q P+ L L C EP +R + E+
Sbjct: 221 -------QPWYQLSNNEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272
Query: 251 LAILERL 257
++L+ L
Sbjct: 273 HSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 11/164 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR---------GPQ 75
F EV L +L PN+ +L+G C ++ E+M G L L + +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 76 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 135
LS++ + +A A G+ +L ++RD N L+ + K++DFG+++ +
Sbjct: 126 SLSFSTLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 136 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
D V + + A E V G+ TTKSDV++FGV L E+L+
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-18
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 7/151 (4%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 90
L ++ +V L Y E ++ L LV M G L+ H++ G A + A
Sbjct: 47 LEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQII 105
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150
GL LH + +++YRD K N+LLD N ++SD GLA G + GT GY
Sbjct: 106 CGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGY 160
Query: 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
APE + D ++ G L E+++GR
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-18
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 39/239 (16%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVY-EFMPKGSLENHLFRRGPQPLSWAV 81
N + E+ L L H +V+ G CL + L ++ E+MP GS+++ L G L+ V
Sbjct: 49 NALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETV 105
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------AGPTG 135
K +G+ +LH +++RD K +NIL D+ N KL DFG +K + TG
Sbjct: 106 TRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG 163
Query: 136 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 195
++ V GT + +PE ++ K+DV+S G ++E+L+
Sbjct: 164 MKS-----VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT---------------- 202
Query: 196 VDWAKPYLSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
KP ++ +F+I Q P + A + K RP E+L
Sbjct: 203 ---EKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 67/247 (27%), Positives = 105/247 (42%), Gaps = 37/247 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---QPLSWAV 81
F E + + +H N+V+LIG E R ++ E M G L++ L P +P S +
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 82 R--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGD 136
+ + A AKG +L E+ I+RD A N LL + AK++DFG+A+
Sbjct: 116 KDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 195
+ M + PE G T+K+DV+SFGV+L E+ S G
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM------------- 220
Query: 196 VDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
PY + +M+ GG P+ + C + P+ RP +
Sbjct: 221 -----PYPGRTNQ--EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT--- 270
Query: 253 ILERLEA 259
ILER++
Sbjct: 271 ILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-18
Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 25/233 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E L Q HPN+V+LIG C + + +V E + G L GP+ L ++
Sbjct: 40 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQ 98
Query: 85 VAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+ AA G+ +L ES+ I+RD A N L+ + K+SDFG+++ G
Sbjct: 99 MVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
+ APE + GR +++SDV+SFG++L E S +G A PY
Sbjct: 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS---------LG--------AVPYA 198
Query: 204 SDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
+ + R + G + P+ L +C +P RP S V L
Sbjct: 199 NLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVY-EFMPKGSLENHLFRRGP--QPLSWAVRMK 84
E+ L L H N+V+ +G E L ++ E++P GS+ + L G + L +
Sbjct: 58 EIETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ 116
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
V +GL +LH +++RD KA N+L+DA+ K+SDFG++K + +
Sbjct: 117 VL----EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 145 MGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 181
G+ + APE + + + K D++S G V+LE+ +GR
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 23 NWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA 80
+W QTE + Q +P LV L C + +RL LV E++ G L H+ R+ P A
Sbjct: 40 DWVQTEKHVFEQASSNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA 98
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTH 139
I A L FLH E +IYRD K N+LLDA+ + KL+D+G+ K G GD T
Sbjct: 99 RFYAAEICIA--LNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT- 153
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
+ GT Y APE + D ++ GV++ E+++GR D +
Sbjct: 154 --STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD----------IITD 201
Query: 200 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
P ++ + LF+++ K + P+ + A+ + LN +PK R
Sbjct: 202 NPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F+ E +L+HPN+V L+ L V+E++P +L L G P R+
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGP-TGD--- 136
+ + L H+ +++RD K NI++ +AK+ DFG+ P D
Sbjct: 85 MLQV--LDALACAHNQ--GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 137 -RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184
+T+V+GT Y APE + +T SD+Y++G++ LE L+G+ V
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-17
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E N + QL HP LV+L + E ++ E+M GSL + L L+ +
Sbjct: 48 FLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A+G+ F+ I+RD +A+NIL+ K++DFGLA R +
Sbjct: 107 MAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGLA-------RLIEDNEY 157
Query: 145 MGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 181
G + APE + G T KSDV+SFG++L E+++ GR
Sbjct: 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 68/247 (27%), Positives = 95/247 (38%), Gaps = 65/247 (26%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
Q E+ +L Q P + K G L+G ++ E+ GS L + G +
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLD-----ETYI 100
Query: 86 AI---GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
A GL +LH E I+RD KA+NILL E + KL+DFG VS
Sbjct: 101 AFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFG------------VSG 146
Query: 143 QV----------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 192
Q+ +GT + APE + K+D++S G+ +EL G
Sbjct: 147 QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG------------ 194
Query: 193 QSLVDWAKPYLSDK---RKLFRIMDTKLGGQYPQKAAHTAATLAL-----QCLNNEPKLR 244
+P LSD R LF I P + CLN +PK R
Sbjct: 195 -------EPPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKER 242
Query: 245 PRMSEVL 251
P E+L
Sbjct: 243 PSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
Q E+ L Q P + + G L+G ++ E++ GS + L P PL +
Sbjct: 50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATI 106
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
KGL +LH I+RD KA+N+LL + + KL+DFG+ AG D +
Sbjct: 107 LREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFV 162
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--L 203
GT + APE + K+D++S G+ +EL G P L
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE------------------PPNSDL 204
Query: 204 SDKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
R LF I L GQY + CLN +P+ RP E+L
Sbjct: 205 HPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA----CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 29/172 (16%)
Query: 32 LGQL-HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 89
L +L HP ++KL Y + E L V E+ P G L ++ + G S + A
Sbjct: 55 LTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAA 109
Query: 90 --AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-- 145
L +LH +I+RD K NILLD + + K++DFG AK +
Sbjct: 110 EILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 146 ----------------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
GT Y +PE + SD+++ G ++ ++L+G+
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 6e-17
Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 11/154 (7%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E L + HP LV L G + N LV E++P G L +HL + G P A +
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
A L +LH + ++YRD K N+LLD++ K++DFG AK RT+ + GT
Sbjct: 111 VLA--LEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGT 161
Query: 148 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 180
Y APE + + K+ D ++ G+++ E+L+G
Sbjct: 162 PEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-17
Identities = 50/158 (31%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----QPLSWAVRM 83
E L +L+HP LV L + EN LV + + G L HL ++ Q W +
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+A L +LH +I+RD K NILLD + + ++DF +A T T
Sbjct: 110 VLA------LEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TS 158
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
GT GY APE + + D +S GV E L G+
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-17
Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 29/221 (13%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E L + +HP +VKL + + ++ E+ G L L RG + R +A
Sbjct: 43 EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA- 100
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+LH +IYRD K N+LLD+ KL DFG AK +G +T GT
Sbjct: 101 CVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGT 155
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 207
Y APE + D +S G++L ELL+GR P+ D
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR------------------PPFGEDDE 197
Query: 208 KLFRIMDTKLGG----QYPQKAAHTAATLALQCLNNEPKLR 244
I + L G ++P A L Q L P+ R
Sbjct: 198 DPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 7/155 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L +L+HPN++KL+ + LV+EFM L L + + L ++
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLPESLIKSYLY 105
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+GL F H +++RD K N+L++ E KL+DFGLA++ + R + T + T
Sbjct: 106 QLLQGLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVT 161
Query: 148 HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
Y APE + + +T D++S G + ELLS R
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 26/163 (15%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN------HLFRRGPQPLSWAV 81
E N + QL +P +V++IG C E E+ +LV E G L H+ + L V
Sbjct: 46 EANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV 104
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
M G+ +L E+ ++RD A N+LL + AK+SDFGL+KA D +
Sbjct: 105 SM--------GMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYK 153
Query: 142 TQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ THG + APE + + ++KSDV+SFGV++ E S
Sbjct: 154 AK---THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 41/235 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------PQPLSWAV 81
E+ L ++HPN++ L+G +V E+ P G L + +R P+ W
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW-- 106
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
++ I +GL LH E ++++RD K++NILL A K+ D G++K +
Sbjct: 107 --RIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAK 159
Query: 142 TQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
TQ+ GT Y APE V GR + KSD++S G +L E+ + +
Sbjct: 160 TQI-GTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFA--------------PPFEA 203
Query: 201 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLA 252
+ D R +++ G+YP + L L +PKLRP ++LA
Sbjct: 204 RSMQDLR--YKVQ----RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 63/241 (26%), Positives = 95/241 (39%), Gaps = 22/241 (9%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
EV L QL H N+V L LV+E++ + LE L P L
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIW 107
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+ + + H +I+RD K NIL+ KL DFG A+A + ++ V T
Sbjct: 108 QLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 148 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR------CAVDKTKVGIEQSL--VDW 198
Y APE + K DV++ G ++ ELL G +D+ + I++ L +
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPP 223
Query: 199 AKPYLSDKRKLFRIMDT-------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+ L F + L +YP K + A CL +PK R E+L
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283
Query: 252 A 252
Sbjct: 284 Q 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 45/167 (26%), Positives = 86/167 (51%), Gaps = 12/167 (7%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP------ 76
N F E+ + +L +PN+++L+G C+ + ++ E+M G L L +R +
Sbjct: 62 NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHAN 121
Query: 77 ----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132
+S A + +A+ A G+ +L A ++RD N L+ + K++DFG+++
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 133 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+GD + + + + A E + G+ TT SDV++FGV L E+ +
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 49/268 (18%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVY---EFMPKGSLENHL----------- 69
F E+ L +L HHPN++ L+G C ENR +Y E+ P G+L + L
Sbjct: 49 FAGELEVLCKLGHHPNIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPA 105
Query: 70 FRR---GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 126
F + L+ ++ A A G+ +L +E Q I+RD A N+L+ +K++DF
Sbjct: 106 FAKEHGTASTLTSQQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADF 163
Query: 127 GLAKAGPTGDRTHVSTQVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184
GL++ G+ +V + MG + A E + TTKSDV+SFGV+L E++S
Sbjct: 164 GLSR----GEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS----- 213
Query: 185 DKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243
+G PY +L+ + + P+ L QC + P
Sbjct: 214 ----LG--------GTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYE 261
Query: 244 RPRMSEVLAILER-LEAPKNSAKLSQSE 270
RP +++ L R LEA K ++ E
Sbjct: 262 RPPFAQISVQLSRMLEARKAYVNMALFE 289
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 51/163 (31%), Positives = 88/163 (53%), Gaps = 14/163 (8%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRM 83
E+ L +L H N+V+ +G L+ ++ + E++P GS+ L G + L VR
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRN 110
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-----AGPTGDRT 138
V KGL +LH+ +I+RD K +NIL+D + K+SDFG++K + T
Sbjct: 111 FVR-QILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+ + G+ + APE V T K+D++S G +++E+L+G+
Sbjct: 168 ARPS-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 70/243 (28%), Positives = 105/243 (43%), Gaps = 30/243 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLF--RRGPQP 76
F +E + + HPN+++LIG CL+ +++ FM G L + L R G P
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP 106
Query: 77 LSWAVRMKVAIGA--AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134
+M V A G+ +L + I+RD A N +L+ N ++DFGL+K
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164
Query: 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 193
GD + A E +A TTKSDV+SFGV + E+ + G+ G+E
Sbjct: 165 GDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP----GVEN 220
Query: 194 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
S + YL +L + D L G Y +L C PK RP +
Sbjct: 221 SEI---YDYLRQGNRLKQPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCE 267
Query: 254 LER 256
LE+
Sbjct: 268 LEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLI-GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F E++ L + HPN+V L Y E + +L+ EF G+L++ + + L+
Sbjct: 49 FMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELE-RGLTEPQIR 106
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVST 142
V + L FLH +VI+RD KA NILL + + KL+DFG+ AK T +
Sbjct: 107 YVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-- 162
Query: 143 QVMGTHGYAAPEYVATGRLTT-----KSDVYSFGVVLLELLSGR 181
+GT + APE VA K+D++S G+ L+EL
Sbjct: 163 -FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 10/160 (6%)
Query: 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 80
+TN + Q P + KL + LV E++ G + + G P WA
Sbjct: 40 VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA 99
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
+ G+ LH +I+RD K N+L+D + KL+DFGL++ G
Sbjct: 100 --KQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LE 149
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ + +GT Y APE + SD +S G V+ E L G
Sbjct: 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 5/154 (3%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E++ L Q P +VK G + + +V E+ GS+ + + + + L+ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILY 106
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
KGL +LH ++ I+RD KA NILL+ E AKL+DFG+ +G D V+GT
Sbjct: 107 QTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGT 162
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+ APE + K+D++S G+ +E+ G+
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 25/229 (10%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E+ L L HPN++ + ++ L+ E+ G+L + + R+ Q + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
++++H A +++RD K NI L KL DFG++K G ++ V+
Sbjct: 107 LFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVV 162
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT Y +PE + KSD+++ G VL EL + +T +
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYEL----LTLKRTFDATNPLNLVV------- 211
Query: 206 KRKLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLA 252
+I+ G P + +++ ++L L +P+ RP EVL
Sbjct: 212 -----KIVQ---GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 53/149 (35%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 37 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR-RGPQPLSWAVRMKVAIGAAKGLT 94
HP LV L C + E+ + V E+ G L H+ +P + V +G L
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLG----LQ 115
Query: 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVSTQVMGTHGYAAP 153
+LH E++++YRD K N+LLD E K++DFGL K G GDRT ST GT + AP
Sbjct: 116 YLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAP 170
Query: 154 EYVATGRLTTKSDVYSFGVVLLELLSGRC 182
E + T D + GV++ E+L G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 57/172 (33%), Positives = 88/172 (51%), Gaps = 16/172 (9%)
Query: 26 QTEVNYLGQLHH---PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAV 81
Q EV L QL PN+ K G L+G ++ E+ GS+ L + GP +V
Sbjct: 47 QREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISV 105
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
++ + A L ++H + VI+RD KA+NIL+ N KL DFG+A A + + S
Sbjct: 106 IIREVLVA---LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRS 159
Query: 142 TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR---CAVDKTKV 189
T V GT + APE + G+ TK+D++S G+ + E+ +G VD +
Sbjct: 160 TFV-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-16
Identities = 52/166 (31%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL------FRRGPQPLS 78
F EV +L+HPN+++ +G C+E LLV EF P G L+N+L + Q
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD- 100
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
V ++A A GL +LH A+ I+ D N L A+ + K+ D+GLA D
Sbjct: 101 --VLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156
Query: 139 HVSTQVMGTHGYAAPEYVA-------TGRLTTKSDVYSFGVVLLEL 177
+ APE V T KS+++S GV + EL
Sbjct: 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 54/160 (33%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 31 YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVRMKV 85
+L QLH C + +RL V E++ G L H+ + G P + +A +
Sbjct: 62 FLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI-- 110
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
A GL FLH +IYRD K N++LDAE + K++DFG+ K G +T +
Sbjct: 111 ----AIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFC 162
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 185
GT Y APE +A D ++FGV+L E+L+G+ D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-16
Identities = 68/233 (29%), Positives = 102/233 (43%), Gaps = 38/233 (16%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMK 84
Q E+ L Q P + K G L+G ++ E++ GS + L R GP A +K
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLK 108
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ KGL +LH + I+RD KA+N+LL + + KL+DFG+ AG D
Sbjct: 109 EIL---KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTF 161
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+GT + APE + +K+D++S G+ +EL G +P S
Sbjct: 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-------------------EPPNS 202
Query: 205 D---KRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
D R LF I L G++ + CLN +P RP E+L
Sbjct: 203 DMHPMRVLFLIPKNNPPTLTGEFSK----PFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-16
Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 30/244 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLF--RRGPQP 76
F E + + HPN++KLIG L + +++ FM G L L R G +P
Sbjct: 48 FLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP 107
Query: 77 LSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134
+ ++ ++ I A G+ +L + I+RD A N +L+ ++DFGL+K +
Sbjct: 108 FTLPLQTLVRFMIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
Query: 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 193
GD + A E +A TT SDV++FGV + E+++ G+ G+E
Sbjct: 166 GDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY----AGVEN 221
Query: 194 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
S + YL +L + P L QC + EPK RP +
Sbjct: 222 SEI---YNYLIKGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268
Query: 254 LERL 257
LE +
Sbjct: 269 LELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-16
Identities = 68/233 (29%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L H LV L E E +V EFM KGSL + L + L +
Sbjct: 48 FLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ- 143
+A A G+ ++ I+RD +A+NIL+ K++DFGLA+ D + + Q
Sbjct: 107 MAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQG 162
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
+ APE GR T KSDV+SFG++L EL V K +V PY
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL------VTKGRV-----------PYP 205
Query: 204 SD-KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
R++ ++ PQ + L C +P RP + + LE
Sbjct: 206 GMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 48/155 (30%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L +L HPN++ L+ N LV+EFM LE + + L+ A +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYML 109
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+GL +LH + +++RD K +N+L+ ++ KL+DFGLA++ + +R ++ QV+ T
Sbjct: 110 MTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVV-T 165
Query: 148 HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
Y APE + R D++S G + ELL
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 31 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 90
+LG H N+V L+G C G L++ E+ G L N L R+ L+ + + A
Sbjct: 94 HLGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG- 149
KG+ FL A I+RD A N+LL K+ DFGLA+ D + S V+ +
Sbjct: 152 KGMAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNAR 204
Query: 150 ----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ APE + T +SDV+S+G++L E+ S
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 59/240 (24%), Positives = 112/240 (46%), Gaps = 34/240 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR----------RGP 74
F E + + + + ++V+L+G +G+ L++ E M +G L+++L + P
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134
L ++M I A G+ +L+ ++ ++RD A N ++ +F K+ DFG+ +
Sbjct: 116 PSLKKMIQMAGEI--ADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 194
D + + + +PE + G TT SDV+SFGVVL E+ +
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------AT 216
Query: 195 LVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
L + +PY +S+++ L +M+ L + P L C PK+RP E+++
Sbjct: 217 LAE--QPYQGMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 56/188 (29%), Positives = 78/188 (41%), Gaps = 41/188 (21%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA--- 80
+ E + L P +VKL Y + E L LV E+MP G L N L R+ P A
Sbjct: 48 VRAERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY 106
Query: 81 -VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRT 138
+ +A+ + L F+H RD K NIL+DA+ + KL+DFGL K DR
Sbjct: 107 IAELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 139 HVSTQ--------------------------VMGTHGYAAPEYVATGRLTTKSDVYSFGV 172
+ +GT Y APE + + D +S GV
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 173 VLLELLSG 180
+L E+L G
Sbjct: 219 ILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 21/193 (10%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFRRGPQPLSWAVRM 83
E L ++ HP +++L + E + R L + E++P G L ++L G S +
Sbjct: 49 HNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
I A L +LH E ++YRD K NILLD E + KL+DFG AK DRT
Sbjct: 107 ASEIVCA--LEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT--- 157
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-DKTKVGIEQSLVDWAKPY 202
+ GT Y APE + + D ++ G+++ E+L G D GI + +
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------- 210
Query: 203 LSDKRKLFRIMDT 215
L+ K + R +D
Sbjct: 211 LAGKLEFPRHLDL 223
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 9/162 (5%)
Query: 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-PLSW 79
+ + E + QL +P +V++IG C E E +LV E G L L + + +S
Sbjct: 38 VRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSN 96
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139
V + + + G+ +L ++RD A N+LL + AK+SDFGL+KA D ++
Sbjct: 97 VVELMHQV--SMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKA-LGADDSY 151
Query: 140 VSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ G + APE + + +++SDV+S+G+ + E S
Sbjct: 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 48/254 (18%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVY---EFMPKGSLENHL----------- 69
F E+ L +L HHPN++ L+G C E+R +Y E+ P G+L + L
Sbjct: 42 FAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 98
Query: 70 FRR---GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 126
F LS + A A+G+ +L ++ Q I+RD A NIL+ + AK++DF
Sbjct: 99 FAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADF 156
Query: 127 GLAKAGPTGDRTHVSTQVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184
GL++ G +V + MG + A E + TT SDV+S+GV+L E++S
Sbjct: 157 GLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----- 206
Query: 185 DKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243
+G PY +L+ + + P L QC +P
Sbjct: 207 ----LG--------GTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 254
Query: 244 RPRMSEVLAILERL 257
RP +++L L R+
Sbjct: 255 RPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 7/155 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E L +++ P +V L Y E + L LV M G L+ H++ G + L + +
Sbjct: 43 EKEILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYS 101
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
G+ LH ++YRD K N+LLD + N +LSD GLA G TQ G
Sbjct: 102 AQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAG 156
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
T+GY APE + + D ++ G + E+++GR
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 30/238 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E LGQ H N+V+L G G ++V E+M G+L++ L R+ L M
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMG 111
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ G A G+ +L +E +++ A +L++++ K+S F + D++
Sbjct: 112 MLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE----DKSEAIYTT 165
Query: 145 MGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWA 199
M +AAPE + ++ SDV+SFG+V+ E++S R D + + +++ D
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG- 224
Query: 200 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
FR+ P+ + L L C E RPR S++ +IL ++
Sbjct: 225 ----------FRL-------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 28/235 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L H LV+L E E +V E+M KGSL + L + L +
Sbjct: 48 FLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A G+ ++ I+RD +++NIL+ K++DFGLA+ D + + Q
Sbjct: 107 MAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQ- 161
Query: 145 MGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
G + APE GR T KSDV+SFG++L EL V K +V P
Sbjct: 162 -GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL------VTKGRV-----------P 203
Query: 202 YLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
Y + R++ ++ PQ + L LQC +P+ RP + + LE
Sbjct: 204 YPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 6/155 (3%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L HP +VKL+ G +LV E+MP L L R +PL A
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMR 106
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
KG+ ++H + +++RD K +N+L+ A+ K++DFGLA+ + S QV T
Sbjct: 107 MLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163
Query: 148 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
Y APE + R D+++ G + ELL+G
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 4e-15
Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 47/178 (26%)
Query: 28 EVNYLGQL-HHPNLVKLIGYCLEGENRL---LVYEFMP--------KGSLEN-H------ 68
E+ +L +L HPN+VKL+ ++ EN LV+E+M LE+ H
Sbjct: 56 EIMFLQELGDHPNIVKLLN-VIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY 114
Query: 69 -LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 127
L K L ++H VI+RD K SNILL+++ KL+DFG
Sbjct: 115 QLL--------------------KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFG 152
Query: 128 LAKAGPTGDRTH---VSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 181
LA++ + V T + T Y APE + + R T D++S G +L E+L G+
Sbjct: 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVR 82
E L P + + C + +RL V E++ G L H+ + G PQ + +A
Sbjct: 50 EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 109
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ V GL FLH +IYRD K N++LD+E + K++DFG+ K T +
Sbjct: 110 ISV------GLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TR 159
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
GT Y APE +A D +++GV+L E+L+G+ D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG---------------- 203
Query: 203 LSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
D+ +LF+ IM+ + YP+ + A ++ + P R
Sbjct: 204 -EDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-15
Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 40/238 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVY-EFMPKGSLENHLFRRGPQPLSWAV 81
+ E+ L L H +V+ G CL E L ++ E+MP GS+++ L G L+ +V
Sbjct: 51 LECEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESV 107
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------AGPTG 135
K +G+++LH + +++RD K +NIL D+ N KL DFG +K TG
Sbjct: 108 TRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 136 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 195
R+ V GT + +PE ++ K+DV+S G ++E+L+
Sbjct: 166 IRS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT---------------- 204
Query: 196 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA--ATLALQCLNNEPKLRPRMSEVL 251
KP ++ + I PQ +H + A L C+ E + RP E+L
Sbjct: 205 ---EKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 63/233 (27%), Positives = 98/233 (42%), Gaps = 25/233 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + Q HP++VKLIG E +V E P G L ++L L A +
Sbjct: 54 FLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLIL 111
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + L +L + ++RD A N+L+ + KL DFGL++ S
Sbjct: 112 YSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK 169
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+ + APE + R T+ SDV+ FGV + E+L +G+ KP+
Sbjct: 170 LPIK-WMAPESINFRRFTSASDVWMFGVCMWEILM---------LGV--------KPFQG 211
Query: 205 DKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
K I + G + P T +L +C +P RPR +E+ A L
Sbjct: 212 VKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 49/147 (33%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 37 HPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94
HP L L +C E+ V E++ G L H+ G + A I GL
Sbjct: 55 HPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI--ICGLQ 110
Query: 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154
FLH + +IYRD K N+LLD + + K++DFG+ K G+ ++ GT Y APE
Sbjct: 111 FLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPE 166
Query: 155 YVATGRLTTKSDVYSFGVVLLELLSGR 181
+ + D +SFGV+L E+L G+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 67/237 (28%), Positives = 111/237 (46%), Gaps = 32/237 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVR 82
F E N + L H LVKL + E ++ EFM KGSL + L QPL +
Sbjct: 48 FLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
I A+G+ F+ + I+RD +A+NIL+ A K++DFGLA+ D + +
Sbjct: 107 FSAQI--AEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAR 160
Query: 143 QVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
+ G + APE + G T KSDV+SFG++L+E+++ GR
Sbjct: 161 E--GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-------------- 204
Query: 199 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
P +S+ ++ R ++ P+ + ++C N P+ RP + ++L+
Sbjct: 205 --PGMSNP-EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 7e-15
Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 25/164 (15%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-FRRGPQPLSWAVR--MK 84
E++ L +L HPN+VKL+ LV+E+ L+ +L R GP + ++ M
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IKSIMY 105
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ +GL + H ++++RD K NIL++ + KL+DFGLA+A RT+ T
Sbjct: 106 QLL---RGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THE 158
Query: 145 MGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
+ T Y APE Y +T D++S G + E+++G+
Sbjct: 159 VVTLWYRAPEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-15
Identities = 68/239 (28%), Positives = 105/239 (43%), Gaps = 36/239 (15%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL------FRRGPQPLS 78
F E + +L H LV+L E E +V E+M KGSL + L + R PQ +
Sbjct: 48 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
A ++ + + + ++H RD +A+NIL+ K++DFGLA+ D
Sbjct: 107 MAAQIASGMAYVERMNYVH--------RDLRAANILVGENLVCKVADFGLARL--IEDNE 156
Query: 139 HVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
+ + Q + APE GR T KSDV+SFG++L EL + K +V
Sbjct: 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-------- 202
Query: 198 WAKPYLSD-KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
PY R++ ++ P + + L QC EP+ RP + A LE
Sbjct: 203 ---PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-15
Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK--- 84
EV + HPN+V++ L G+ +V EF+ G+L + + RM
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQ 116
Query: 85 ---VAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
V + K L+FLH +Q VI+RD K+ +ILL ++ KLSDFG
Sbjct: 117 IATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGF--CAQVSKEVPR 171
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
++GT + APE ++ T+ D++S G++++E++ G
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 54/149 (36%), Positives = 77/149 (51%), Gaps = 15/149 (10%)
Query: 38 PNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTF 95
P LV L Y + + +L L+ +++ G L HL++R S VR+ +A I A L
Sbjct: 65 PFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLA--LDH 120
Query: 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAP 153
LH + +IYRD K NILLD+E + L+DFGL+K +R + GT Y AP
Sbjct: 121 LH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAP 175
Query: 154 EYVATGRLTTKS--DVYSFGVVLLELLSG 180
E + G D +S GV+ ELL+G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 68/251 (27%), Positives = 109/251 (43%), Gaps = 42/251 (16%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR------------ 71
F E+ L +L HHPN++ L+G C L E+ P G+L + L +
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 72 --RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
LS + A A+G+ +L ++ Q I+RD A NIL+ + AK++DFGL+
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 130 KAGPTGDRTHVSTQVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 187
+ G +V + MG + A E + TT SDV+S+GV+L E++S
Sbjct: 172 R----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------- 218
Query: 188 KVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 246
+G PY +L+ + + P L QC +P RP
Sbjct: 219 -LG--------GTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 269
Query: 247 MSEVLAILERL 257
+++L L R+
Sbjct: 270 FAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 67/200 (33%), Positives = 99/200 (49%), Gaps = 29/200 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA---VRM 83
E + L +++HP +VKL Y + E +L L+ +F+ G L F R + + + V+
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKF 102
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+A A L LH +IYRD K NILLD E + KL+DFGL+K ++ S
Sbjct: 103 YLA-ELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 157
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA------------VDKTKVGI 191
GT Y APE V T +D +SFGV++ E+L+G + K K+G+
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217
Query: 192 EQSLVDWAKPYLSDKRKLFR 211
Q L A+ L R LF+
Sbjct: 218 PQFLSPEAQSLL---RALFK 234
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 23/132 (17%)
Query: 58 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 117
E M GSL+ L + G P + + K++I +GLT+L + + ++++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPEN--ILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNS 135
Query: 118 EFNAKLSDFGLAKAGPTGDRTHVSTQVM--------GTHGYAAPEYVATGRLTTKSDVYS 169
KL DFG VS Q++ GT Y +PE + T +SD++S
Sbjct: 136 RGEIKLCDFG------------VSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 170 FGVVLLELLSGR 181
G+ L+E+ GR
Sbjct: 184 LGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 3/155 (1%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E N + L H LV+L + E ++ E+M KGSL + L + +
Sbjct: 48 FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 107
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ A+G+ ++ I+RD +A+N+L+ K++DFGLA+ + T
Sbjct: 108 FSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ APE + G T KSDV+SFG++L E+++
Sbjct: 166 FPIK-WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 40/234 (17%)
Query: 36 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FR--------RGPQPLSWAVRMKV 85
HH +V+L+G +G+ L+V E M G L+++L R R P L ++M
Sbjct: 69 HH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
I A G+ +L+ + ++RD A N ++ +F K+ DFG+ + D + +
Sbjct: 127 EI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--L 203
+ APE + G TT SD++SFGVVL E+ SL + +PY L
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPYQGL 225
Query: 204 SDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
S+++ L +MD GG P L C PK+RP E++ +L+
Sbjct: 226 SNEQVLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 34/248 (13%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
Q E+ L Q P + K G L+ ++ E++ GS + L P PL +
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATI 106
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
KGL +LH + I+RD KA+N+LL KL+DFG+ AG D +
Sbjct: 107 LREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFV 162
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--L 203
GT + APE + +K+D++S G+ +EL G P+ L
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE------------------PPHSEL 204
Query: 204 SDKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260
+ LF I L G Y + CLN EP RP E+L +
Sbjct: 205 HPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLKHKFIVRFA 260
Query: 261 KNSAKLSQ 268
K ++ L++
Sbjct: 261 KKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 53/149 (35%), Positives = 75/149 (50%), Gaps = 16/149 (10%)
Query: 37 HPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHL--FRRGPQPLS--WAVRMKVAIGAAK 91
HP L +L C + +RL V EF+ G L H+ RR + + +A + A
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA----- 108
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151
L FLHD +IYRD K N+LLD E + KL+DFG+ K G +T ++ GT Y
Sbjct: 109 -LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYI 163
Query: 152 APEYVATGRLTTKSDVYSFGVVLLELLSG 180
APE + D ++ GV+L E+L G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 38/93 (40%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 149
+GL ++H A V++RD K SN+LL+ + K+ DFGLA+ A P D T T+ + T
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 150 YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
Y APE + + TK+ D++S G +L E+LS R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 53/147 (36%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 37 HPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94
HP L L YC EN V E++ G L H+ L A I GL
Sbjct: 55 HPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEI--ICGLQ 110
Query: 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154
FLH ++YRD K NILLD + + K++DFG+ K GD + GT Y APE
Sbjct: 111 FLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPE 166
Query: 155 YVATGRLTTKSDVYSFGVVLLELLSGR 181
+ + T D +SFGV+L E+L G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 64/249 (25%), Positives = 112/249 (44%), Gaps = 35/249 (14%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP------ 76
N F E+ + +L PN+++L+ C+ + ++ E+M G L L R PQ
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123
Query: 77 ---LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 133
+S++ + +A A G+ +L + ++RD N L+ + K++DFG+++
Sbjct: 124 VVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 134 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 193
+GD + + + + + E + G+ TT SDV++FGV L E+L+ C EQ
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT-LCK--------EQ 232
Query: 194 SLVDWAKPY--LSDKR------KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245
PY LSD++ + FR ++ P + L L C K RP
Sbjct: 233 -------PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285
Query: 246 RMSEVLAIL 254
E+ A L
Sbjct: 286 SFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 53/161 (32%), Positives = 83/161 (51%), Gaps = 11/161 (6%)
Query: 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 79
LI N E+ + + HPN+V + L G+ +V E++ GSL + +
Sbjct: 62 LIIN----EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139
A + + A L FLH +QVI+RD K+ NILL + + KL+DFG A T +++
Sbjct: 118 AAVCRECLQA---LEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSK 171
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
ST V GT + APE V K D++S G++ +E++ G
Sbjct: 172 RSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 38 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97
P +VK GY + + + E M + + L +R P+ + K+ + K L +L
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV- 156
+ + VI+RD K SNILLDA N KL DFG+ +G D + T+ G Y APE +
Sbjct: 132 E-KHGVIHRDVKPSNILLDASGNVKLCDFGI--SGRLVD-SKAKTRSAGCAAYMAPERID 187
Query: 157 ---ATGRLTTKSDVYSFGVVLLELLSGR 181
+ ++DV+S G+ L+EL +G+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-14
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 44/241 (18%)
Query: 37 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP--------------LSWAVR 82
H N++ L+G C + +V E+ G+L + L R P L+
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ A A+G+ FL A + I+RD A N+L+ + K++DFGLA+ D H+
Sbjct: 135 VSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDY 187
Query: 143 QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
T+G + APE + T +SDV+SFGV+L E+ + +G
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LG------- 231
Query: 198 WAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256
PY +LF+++ + PQ L C + P RP +++ L+R
Sbjct: 232 -GSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290
Query: 257 L 257
+
Sbjct: 291 M 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-14
Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 37 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96
+P L L E+ V EF+ G L H+ +G L A I GL FL
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQFL 112
Query: 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 156
H +IYRD K N++LD + + K++DFG+ K GD ++ GT Y APE +
Sbjct: 113 H--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEIL 168
Query: 157 ATGRLTTKSDVYSFGVVLLELLSGR 181
+ T D +SFGV+L E+L G+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-14
Identities = 50/156 (32%), Positives = 84/156 (53%), Gaps = 8/156 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E++ L +L+HPN+VKL+ + EN+L LV+EF+ + L+ + + +
Sbjct: 49 EISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYL 106
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+GL F H +V++RD K N+L++ E KL+DFGLA+A RT+ V
Sbjct: 107 FQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 162
Query: 147 THGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
T Y APE + + +T D++S G + E+++ R
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-14
Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR-RG-----PQPLS 78
+ EV L ++ HPN+V + RL +V E+ G L + R RG Q LS
Sbjct: 47 KKEVILLAKMKHPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS 105
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDR 137
W V++ + GL +HD ++++RD K+ NI L AKL DFG+A+ D
Sbjct: 106 WFVQISL------GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDS 155
Query: 138 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177
++ +GT Y +PE K+D++S G VL EL
Sbjct: 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-14
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 44 IGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102
+ Y E ++ L LV M G L+ H++ G + A GL LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RER 122
Query: 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 162
++YRD K NILLD + ++SD GLA P G+ + +V GT GY APE V R T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYT 179
Query: 163 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 222
D + G ++ E++ G+ + K +++ V+ R+ + + +Y
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER------------RVKEDQ--EEYS 225
Query: 223 QKAAHTAATLALQCLNNEPKLR 244
+K + A ++ Q L +P R
Sbjct: 226 EKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-14
Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 36/242 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRG----PQPLSWAV 81
E++ L QL HPN++K + +E +V E G L + F++ P+ W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
+++ L +H ++++RD K +N+ + A KL D GL + +T +
Sbjct: 112 FVQLC----SALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAA 163
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
++GT Y +PE + KSD++S G +L E+ + + P
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SP 205
Query: 202 YLSDKRKLFRIMDTKLGGQY-PQKAAHTAATL---ALQCLNNEPKLRPRMSEVLAILERL 257
+ DK L+ + Y P A H + L +C+N +P+ RP +S VL + + +
Sbjct: 206 FYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
Query: 258 EA 259
A
Sbjct: 266 HA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 14/160 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL----ENHLFRRGPQPL-SW 79
F E + + HP+LV+L+G CL +L V + MP G L H G Q L +W
Sbjct: 56 FMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139
V++ AKG+ +L E ++++RD A N+L+ + + K++DFGLA+ ++ +
Sbjct: 115 CVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ + A E + + T +SDV+S+GV + EL++
Sbjct: 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 34/241 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-------- 76
F+ E +L HPN+V L+G + + +++ + L L R P
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 77 ------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130
L A + + A G+ FL + V+++D N+L+ + N K+SD GL +
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 131 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 190
D + + + +PE + G+ + SD++S+GVVL E+ S G
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YG 223
Query: 191 IEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249
++ PY + + ++ + P TL L+C N P RPR +
Sbjct: 224 LQ--------PYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKD 275
Query: 250 V 250
+
Sbjct: 276 I 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 71/242 (29%), Positives = 108/242 (44%), Gaps = 28/242 (11%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L QL H NLV LI + LV+EF+ L++ + P L + K
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLF 107
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVM 145
+G+ F H +I+RD K NIL+ KL DFG A+ A P G+ V T +
Sbjct: 108 QILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDYV 161
Query: 146 GTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR------CAVDKTKVGIEQSLVDW 198
T Y APE V + D+++ G ++ E+L+G +D+ I + L +
Sbjct: 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY-HIIKCLGNL 220
Query: 199 AKPY--LSDKRKLFRIM---DTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249
+ + K LF M + K L ++P K + LA QCL +P RP S+
Sbjct: 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQ 279
Query: 250 VL 251
+L
Sbjct: 280 LL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-13
Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 7/153 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ + +L +PN+V + L G+ +V E++ GSL + + A + +
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL 125
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
A L FLH +QVI+RD K+ N+LL + + KL+DFG A T +++ ST V GT
Sbjct: 126 QA---LEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GT 178
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ APE V K D++S G++ +E++ G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 22/153 (14%)
Query: 37 HPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLF-----RRGPQPLS--WAVRMKVAIG 88
HP L L C + ++RL V E++ G L +F R+ +P S +A + +A
Sbjct: 55 HPFLTALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLA-- 108
Query: 89 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148
L FLH VIYRD K NILLDAE + KL+DFG+ K G T +T GT
Sbjct: 109 ----LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTP 160
Query: 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
Y APE + D ++ GV++ E+++G+
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 61/256 (23%), Positives = 108/256 (42%), Gaps = 34/256 (13%)
Query: 37 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVR 82
H N++ L+G C + ++ E+ KG+L L R P + LS+
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ A A+G+ +L + I+RD A N+L+ + K++DFGLA+ D ++
Sbjct: 137 VSCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
+ APE + T +SDV+SFG+++ E+ + +G PY
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT---------LG--------GSPY 237
Query: 203 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 261
+LF+++ P H L +C + P RP +++ L+++ A
Sbjct: 238 PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297
Query: 262 NSAKLSQSEPHRQTGP 277
+ L S P Q P
Sbjct: 298 SEEYLDLSMPFEQYSP 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 28/237 (11%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKV 85
E++ L QL+HPN++K + +E +V E G L + F++ + + K
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
+ + +H +V++RD K +N+ + A KL D GL + + +T + ++
Sbjct: 112 FVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLV 167
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT Y +PE + KSD++S G +L E+ QS P+ D
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGD 209
Query: 206 KRKLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258
K LF + YP + + L C+ +P RP + V I +++
Sbjct: 210 KMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 44 IGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102
+ Y E ++ L LV M G L+ H++ G + A GL LH + +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QER 122
Query: 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 162
++YRD K NILLD + ++SD GLA P G + +V GT GY APE V R T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYT 179
Query: 163 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 222
D ++ G +L E+++G+ + K I KR+ + ++ +Y
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKI--------------KREEVERLVKEVQEEYS 225
Query: 223 QKAAHTAATLALQCLNNEPKLR 244
+K + A +L L +PK R
Sbjct: 226 EKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 24/160 (15%)
Query: 31 YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVRMKV 85
+L QLH C + +RL V E++ G L + + G P + +A + +
Sbjct: 62 FLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI 112
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
GL FLH +IYRD K N++LD+E + K++DFG+ K T +
Sbjct: 113 ------GLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFC 162
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 185
GT Y APE +A D ++FGV+L E+L+G+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
Q E++ L + HPN+V G L + +V E+ GSL++ +++ PLS V
Sbjct: 48 QQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYV 106
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV- 144
KGL +LH E+ I+RD K +NILL + + KL+DFG VS Q+
Sbjct: 107 CRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFG------------VSAQLT 152
Query: 145 ---------MGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLEL 177
+GT + APE A G K D+++ G+ +EL
Sbjct: 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 61/169 (36%), Positives = 82/169 (48%), Gaps = 19/169 (11%)
Query: 26 QTEVNYLGQL-HHPNLVKLIGYC-----LEGENRLLVYEFMPKGS---LENHLFRRGPQP 76
+ E N L L +HPN+VK G L G LV E GS L L G Q
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG-QR 124
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
L A+ + GA GL LH+ +++I+RD K +NILL E KL DFG++ A T
Sbjct: 125 LDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTST 181
Query: 137 RTHVSTQVMGTHGYAAPEYVATGR-----LTTKSDVYSFGVVLLELLSG 180
R +T V GT + APE +A + + DV+S G+ +EL G
Sbjct: 182 RLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 35/257 (13%)
Query: 37 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVR 82
H N++ L+G C + ++ E+ KG+L +L R P + L++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ A A+G+ +L A + I+RD A N+L+ + K++DFGLA+ D +T
Sbjct: 137 VSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
+ APE + T +SDV+SFGV+L E+ + +G PY
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LG--------GSPY 237
Query: 203 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAP 260
+LF+++ P H + +C + P RP +++ L+R L
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297
Query: 261 KNSAKLSQSEPHRQTGP 277
L S P Q P
Sbjct: 298 STDEYLDLSVPFEQYSP 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 28/238 (11%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKV 85
E++ L QL+HPN++K +E +V E G L + F++ + + K
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
+ L +H +V++RD K +N+ + A KL D GL + + +T + ++
Sbjct: 112 FVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLV 167
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT Y +PE + KSD++S G +L E+ + P+ D
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA------------------LQSPFYGD 209
Query: 206 KRKLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259
K L+ + YP + L C+N +P+ RP ++ V + +R+ A
Sbjct: 210 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 36/228 (15%)
Query: 38 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF----RRGPQPL-SWAVRMKVAIGAAKG 92
P + +L+G CL +L V + MP G L +++ R G Q L +W V++ AKG
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 93 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152
+++L + ++++RD A N+L+ + + K++DFGLA+ + + + + A
Sbjct: 122 MSYLEEV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 153 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFR 211
E + R T +SDV+S+GV + EL++ G AKPY R++
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMT---------FG--------AKPYDGIPAREIPD 222
Query: 212 IMDTKLGGQYPQKAAHTAAT--LALQCLNNEPKLRPRMSEVLAILERL 257
+++ G + PQ T + ++C + + RPR E++ R+
Sbjct: 223 LLEK--GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 44/243 (18%)
Query: 37 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVR 82
H N++ L+G C + ++ E+ KG+L +L R P + LS+
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ A A+G+ +L A + I+RD A N+L+ + K++DFGLA+ D H+
Sbjct: 143 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 195
Query: 143 QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
T+G + APE + T +SDV+SFGV+L E+ + +G
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG------- 239
Query: 198 WAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256
PY +LF+++ P + + C + P RP +++ L+R
Sbjct: 240 -GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298
Query: 257 LEA 259
+ A
Sbjct: 299 ILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 11/172 (6%)
Query: 10 HLELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69
HLE+ I N E+ L + + P +V G + E M GSL+ L
Sbjct: 39 HLEIKPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 94
Query: 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
+ G P + KV+I KGLT+L + + ++++RD K SNIL+++ KL DFG++
Sbjct: 95 KKAGRIPEQ--ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
Query: 130 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
G D ++ +GT Y +PE + + +SD++S G+ L+E+ GR
Sbjct: 152 --GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 34 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF------RRGPQPLSWAVRMKVAI 87
QL HPN+V+ LE + +V + + L H +R + W + +++ +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
L +LH E ++++RD +NI+L + ++DFGLAK T V+GT
Sbjct: 125 A----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGT 176
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177
Y+ PE V K+DV++FG +L ++
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-13
Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 9/157 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E++ L +L HPN+V L ++ E+RL L++EF+ L+ +L A +K
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSY 106
Query: 87 I-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
+ +G+ F H +V++RD K N+L+D + KL+DFGLA+A G V T +
Sbjct: 107 LYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA--FGIPVRVYTHEV 162
Query: 146 GTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 181
T Y APE + + R +T D++S G + E+ + +
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 9e-13
Identities = 53/155 (34%), Positives = 78/155 (50%), Gaps = 13/155 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYC-LEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E + L +L HP +V + C + ENR+ + EF+ G L HL + G P A
Sbjct: 68 EKSILMELSHPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA 125
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
+ A +LH +IYRD K N+LLD + + K++DFG AK P DRT +
Sbjct: 126 ELVLA--FEYLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LC 176
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT Y APE + + D ++ GV+L E ++G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-13
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-FRRG-----PQPLSWAV 81
EV L + HPN+V+ E N +V ++ G L + +RG Q L W V
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
++ +A L +HD ++++RD K+ NI L + KL DFG+A+ ++
Sbjct: 109 QICLA------LKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA 158
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
+GT Y +PE KSD+++ G VL E+ + + A + G ++LV
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNLV----- 210
Query: 202 YLSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVL 251
K+ R G YP ++H + L Q P+ RP ++ +L
Sbjct: 211 -----LKIIR-------GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E+ L QL HPNLV LI + +L LV+E+ L + + P+ + + K+
Sbjct: 50 EIRMLKQLKHPNLVNLI-EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKII 106
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQV 144
+ + F H + I+RD K NIL+ + KL DFG A+ GP D T
Sbjct: 107 WQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDY 160
Query: 145 MGTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLSG 180
+ T Y APE V + DV++ G V ELL+G
Sbjct: 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-13
Identities = 59/231 (25%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F + + QL H +LVKL G C+ EN ++V E++ G L+ L R +S ++
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-HREKNNVSLHWKLD 105
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFN---AKLSDFGLAK-AGPTGD 136
VA A L +L D ++++ + NIL+ E KLSD G+ +
Sbjct: 106 VAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163
Query: 137 RTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 194
R + APE + G+ LT +D +SFG LLE+ S
Sbjct: 164 RVERIPWI-------APECIRNGQASLTIAADKWSFGTTLLEICS--------------- 201
Query: 195 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245
+ LS + + + P A L QC +P RP
Sbjct: 202 ---NGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 49/161 (30%), Positives = 85/161 (52%), Gaps = 9/161 (5%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVY-EFMPKGSLENHLFRRGPQPLSW 79
N + E+ L L H +V+ G CL E +L ++ E+MP GS+++ L G L+
Sbjct: 49 NALECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTE 105
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139
V + +G+++LH + +++RD K +NIL D+ N KL DFG +K T +
Sbjct: 106 NVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG 163
Query: 140 VSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ V GT + +PE ++ K+DV+S ++E+L+
Sbjct: 164 TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 54/154 (35%), Positives = 76/154 (49%), Gaps = 15/154 (9%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
EV +L QL HPN ++ G L+ LV E+ GS + L +PL +
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITH 128
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMG 146
GA +GL +LH +I+RD KA NILL KL+DFG A K+ P + +G
Sbjct: 129 GALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVG 179
Query: 147 THGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 177
T + APE + G+ K DV+S G+ +EL
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 65/220 (29%), Positives = 92/220 (41%), Gaps = 28/220 (12%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
TE L HP L L Y + +RL V E+ G L HL R A
Sbjct: 44 TESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 102
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
I +A L +LH V+YRD K N++LD + + K++DFGL K G + T
Sbjct: 103 EIVSA--LGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFC 156
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT Y APE + D + GVV+ E++ GR Y D
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQD 199
Query: 206 KRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
KLF I+ ++ ++P+ + A +L L +PK R
Sbjct: 200 HEKLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 44 IGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102
+ Y E ++ L LV M G L+ H++ G + A GL L +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RER 122
Query: 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 162
++YRD K NILLD + ++SD GLA P G+ V +V GT GY APE + + T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYT 179
Query: 163 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 222
D + G ++ E++ G+ K K +++ VD R+ + + +Y
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR------------RVKEDQ--EEYS 225
Query: 223 QKAAHTAATLALQCLNNEPKLR 244
+K + A ++ L PK R
Sbjct: 226 EKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 53/174 (30%), Positives = 87/174 (50%), Gaps = 15/174 (8%)
Query: 10 HLELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69
HLE+ I N E+ L + + P +V G + E M GSL+ L
Sbjct: 39 HLEIKPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 94
Query: 70 --FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 127
+R P+ + KV+I +GL +L + + Q+++RD K SNIL+++ KL DFG
Sbjct: 95 KEAKRIPE----EILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFG 149
Query: 128 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
++ G D ++ +GT Y +PE + + +SD++S G+ L+EL GR
Sbjct: 150 VS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 28 EVNYLGQLHHPNLVKL----IGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWA 80
E+N L +L HPN+V + +G L + +V E++ K +E QP +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM-----KQPFLQS 106
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
+ + G+ LHD + +++RD K SN+LL+ K+ DFGLA+ G
Sbjct: 107 EVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKP 162
Query: 141 STQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 181
TQ++ T Y APE + +T D++S G + ELL+ +
Sbjct: 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 52/154 (33%), Positives = 76/154 (49%), Gaps = 16/154 (10%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR--RGPQPLS--WAVRMKVA 86
L + HP LV L Y + ++L V +++ G L HL R P+P + +A + A
Sbjct: 50 LKNVKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASA 108
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+G +LH +IYRD K NILLD++ + L+DFGL K G +T ++ G
Sbjct: 109 LG------YLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCG 158
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
T Y APE + D + G VL E+L G
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 28 EVNYLGQLHHPNLVKL----IGYCLEGENRLLVYEFMPK--GSLENHLFRRGPQPLSWAV 81
E+ L L HPN+V+L +G L+ + LV E+ + SL +++ P P S +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQDLASLLDNM----PTPFSESQ 109
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ + +GL +LH E+ +I+RD K SN+LL + K++DFGLA+ G
Sbjct: 110 VKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPM 165
Query: 142 TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
T + T Y APE + T + D+++ G +L ELL+ +
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 51/175 (29%), Positives = 76/175 (43%), Gaps = 27/175 (15%)
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K+A+ K L +LH ++ VI+RD K SN+L++ KL DFG+ +G D + T
Sbjct: 107 KIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVD-SVAKTI 162
Query: 144 VMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD 197
G Y APE + KSDV+S G+ ++EL +GR D K +Q +V+
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
P L ++ D +CL K RP E+L
Sbjct: 223 EPSPQLPAEKFSPEFQD-----------------FVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 25/179 (13%)
Query: 28 EVNYLGQLHHPNLVKLIG-YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E+ L ++HPN+VK + GE ++L+ EFM GSLE L+ VA
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQF-LA-----DVA 174
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVM 145
G+ +LH +++RD K SN+L+++ N K++DFG+++ T D + S +
Sbjct: 175 RQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---V 229
Query: 146 GTHGYAAPEYVAT----GRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
GT Y +PE + T G + D++S GV +LE GR + G DWA
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWA 282
|
Length = 353 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 44 IGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102
+ Y E ++ L LV M G L+ H++ G + A GL LH
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--REN 122
Query: 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 162
+YRD K NILLD + ++SD GLA P G+ +GT GY APE + R T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLNNQRYT 179
Query: 163 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 222
D + G ++ E++ G+ K +++ VD R+++T+ Y
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR------------RVLETE--EVYS 225
Query: 223 QKAAHTAATLALQCLNNEPKLR 244
K + A ++ L +PK R
Sbjct: 226 AKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 7/162 (4%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFRRGPQPLSWA 80
N + E+ L L H +V+ G + R L E MP GS+++ L G L+
Sbjct: 49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTEN 106
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
V K +G+++LH + +++RD K +NIL D+ N KL DFG +K T +
Sbjct: 107 VTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT 164
Query: 141 STQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+ V GT + +PE ++ K+D++S G ++E+L+ +
Sbjct: 165 GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 69/207 (33%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E N L + HP +V LI Y + +L L+ E++ G L HL R G A
Sbjct: 50 ERNILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE 108
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVM 145
I A L LH + +IYRD K NILLDA+ + KL+DFGL K G TH
Sbjct: 109 ISLA--LEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FC 161
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAK-- 200
GT Y APE + D +S G ++ ++L+G A ++ K I++ L K
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDKILK--GKLN 218
Query: 201 --PYLSD------KRKLFRIMDTKLGG 219
PYL+ K+ L R ++LG
Sbjct: 219 LPPYLTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 50/156 (32%), Positives = 85/156 (54%), Gaps = 8/156 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E++ L +L+HPN+V+L+ + EN+L LV+EF+ L+ ++ L +
Sbjct: 48 EISLLKELNHPNIVRLLD-VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYL 105
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+G+ + H +V++RD K N+L+D E KL+DFGLA+A RT+ T +
Sbjct: 106 YQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVV 161
Query: 147 THGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
T Y APE + R +T D++S G + E+++ R
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 31/232 (13%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVA 86
E+ L H N+V+ +G E + E +P GSL L + GP + +
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFG----LAKAGPTGDRTHVS 141
+GL +LHD +Q+++RD K N+L++ K+SDFG LA P +
Sbjct: 115 KQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CT 166
Query: 142 TQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
GT Y APE + G +D++S G ++E+ +G+ ++
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK-----------PPFIELG 215
Query: 200 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+P + +F++ K+ + P+ + A L+C +P R ++L
Sbjct: 216 EPQAA----MFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 37 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVR 82
H N++ L+G C + ++ E+ KG+L +L R P + +++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ A+G+ +L A + I+RD A N+L+ K++DFGLA+ D +T
Sbjct: 140 VSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ APE + T +SDV+SFGV++ E+ +
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E++ L HPN+VKL+ N ++ EF G+++ + +PL+
Sbjct: 49 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRV 107
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQ 143
V + L +LH E+++I+RD KA NIL + + KL+DFG+ AK T R
Sbjct: 108 VCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDS 162
Query: 144 VMGTHGYAAPEYV--ATGR---LTTKSDVYSFGVVLLEL 177
+GT + APE V T + K+DV+S G+ L+E+
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 47/127 (37%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 55 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 114
LV ++M G L HL + G R K I A L H + ++YRD K NIL
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSED---RAKFYI-AELVLALEHLHKYDIVYRDLKPENIL 128
Query: 115 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVV 173
LDA + L DFGL+KA T ++T + GT Y APE + + TK D +S GV+
Sbjct: 129 LDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186
Query: 174 LLELLSG 180
+ E+ G
Sbjct: 187 VFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 9/157 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG-PQPLSWAVRMKV 85
E++ + +L H N+V+L + EN+L LV+E+M K L+ ++ G L
Sbjct: 48 EISLMKELKHENIVRLHD-VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSF 105
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
KG+ F H E++V++RD K N+L++ KL+DFGLA+A T + V
Sbjct: 106 TYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 146 GTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
T Y AP+ + R +T D++S G ++ E+++GR
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 65/219 (29%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
TE L HP L L Y + +RL V E+ G L HL R A
Sbjct: 44 TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 102
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
I +A L +LH +E V+YRD K N++LD + + K++DFGL K G T +
Sbjct: 103 EIVSA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FC 157
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT Y APE + D + GVV+ E++ GR Y D
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQD 200
Query: 206 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
KLF ++ + ++P+ + A +L L +PK R
Sbjct: 201 HEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 63/222 (28%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
TE L HP L L Y + ++RL V E++ G L HL R + S
Sbjct: 44 TESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFY 100
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
L +LH +++YRD K N++LD + + K++DFGL K G T T +
Sbjct: 101 GAEIVSALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FC 156
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT Y APE + D + GVV+ E++ GR Y D
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQD 199
Query: 206 KRKLFRIM---DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
KLF ++ D K +P+ + A +L L +P R
Sbjct: 200 HEKLFELILMEDIK----FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
TE L HP L L Y + +RL V E+ G L HL R A
Sbjct: 44 TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 102
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
I +A L +LH + V+YRD K N++LD + + K++DFGL K G + T +
Sbjct: 103 EIVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FC 156
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 205
GT Y APE + D + GVV+ E++ GR Y D
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQD 199
Query: 206 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
+LF ++ + ++P+ + A +L L +PK R
Sbjct: 200 HERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K+A+ K L +L + E ++I+RD K SNILLD N KL DFG+ +G D T+
Sbjct: 111 KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSI-AKTR 166
Query: 144 VMGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGR 181
G Y APE + +SDV+S G+ L E+ +G+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 38 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPL--SWAVRMKVAIGAAKGL 93
PN+V L Y + ++ LV + G L +H+ F P+ WA M VA+ A
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHVSTQVMGTHGYAA 152
LH ++ RD +NILLD + +L+ F ++ + D V Y A
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 153 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 191
PE T D +S G +L ELL+G+ V+ GI
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-11
Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ + + +PN+V + L G+ +V E++ GSL + + A + +
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
A L FLH +QVI+RD K+ NILL + + KL+DFG A T +++ ST V GT
Sbjct: 126 QA---LDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GT 178
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ APE V K D++S G++ +E++ G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 56/158 (35%), Positives = 76/158 (48%), Gaps = 23/158 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS----LENHLFRRGPQPLSWAVRM 83
EV +L QL HPN ++ G L LV E+ GS LE H ++ Q + A
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVH--KKPLQEVEIAA-- 119
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVST 142
+ GA +GL +LH E I+RD KA NILL KL+DFG A P +
Sbjct: 120 -ICHGALQGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------AN 169
Query: 143 QVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 177
+GT + APE + G+ K DV+S G+ +EL
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+ E L QL HPN+V EGE+ LL V F G L + L + + L +
Sbjct: 47 EQEAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV 105
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+ + A L +LH E +++RD K N+ L K+ D G+A+ ++ +++
Sbjct: 106 EWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAST 161
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
++GT Y +PE + KSDV++ G + E+ + + A + + SLV
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLV------- 211
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+RI++ KL P+ + L L+ P+ RP + +L
Sbjct: 212 ------YRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLS--WAVRMKVA 86
L + HP LV L Y + +L V +F+ G L HL R P+P + +A + A
Sbjct: 50 LKNVKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASA 108
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+G +LH ++YRD K NILLD++ + L+DFGL K G T +T G
Sbjct: 109 LG------YLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCG 158
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
T Y APE + D + G VL E+L G
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 52/153 (33%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR----RGPQPLSWAVRMKVAI 87
L L HP LV L E V +++ G L HL R P+ +A + AI
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAI 109
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
G +LH +IYRD K NILLD++ + L+DFGL K G + T ++ GT
Sbjct: 110 G------YLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGT 159
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
Y APE + D + G VL E+L G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 9/154 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ + + +PN+V + L G+ +V E++ GSL + + A + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMG 146
A L FLH +QVI+RD K+ NILL + + KL+DFG A+ P + + ++G
Sbjct: 127 QA---LEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVG 178
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
T + APE V K D++S G++ +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 41/151 (27%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRLLVYEFMP--KGSLENHLFRR-GPQPLSWAVRMKVAIG 88
L ++HP+++++ + G +V +P L +L +R P P+ A+ ++ I
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQI- 166
Query: 89 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148
+GL +LH ++I+RD K NI ++ + D G A+ P + + GT
Sbjct: 167 -LEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTV 220
Query: 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
APE +A + +K+D++S G+VL E+L+
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
EV +L ++ HPN ++ G L LV E+ GS + L +PL +
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITH 132
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMG 146
GA +GL +LH +I+RD KA NILL KL+DFG A A P + +G
Sbjct: 133 GALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVG 183
Query: 147 THGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 177
T + APE + G+ K DV+S G+ +EL
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL----ENHLFRRGPQPL-SWAVR 82
E + + +P++ +L+G CL +L + + MP G L H G Q L +W V+
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ AKG+ +L E ++++RD A N+L+ + K++DFGLAK ++ + +
Sbjct: 118 I------AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ A E + T +SDV+S+GV + EL++
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 52/153 (33%), Positives = 71/153 (46%), Gaps = 13/153 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
EV +L +L HPN ++ G L LV E+ GS + L +PL V
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTH 122
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
GA +GL +LH +I+RD KA NILL KL DFG A + +GT
Sbjct: 123 GALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGT 174
Query: 148 HGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 177
+ APE + G+ K DV+S G+ +EL
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 57/200 (28%), Positives = 84/200 (42%), Gaps = 46/200 (23%)
Query: 11 LELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE-----GENRLLVYEFMP---- 61
L + + IT E+ L +L HPN+V LI +E R VY P
Sbjct: 42 LMHNEKDGFPITA--LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH 99
Query: 62 --KGSLENHLFRRGPQPLSWAVRMKVAIGAAK--------GLTFLHDAESQVIYRDFKAS 111
G LEN +K+ K G+ +LH E+ +++RD KA+
Sbjct: 100 DLSGLLENP-------------SVKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAA 144
Query: 112 NILLDAEFNAKLSDFGLAK---------AGPTGDRTHVSTQVMGTHGYAAPEYVATGR-L 161
NIL+D + K++DFGLA+ G G T T ++ T Y PE + R
Sbjct: 145 NILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204
Query: 162 TTKSDVYSFGVVLLELLSGR 181
TT D++ G V E+ + R
Sbjct: 205 TTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151
GL +H+ V+YRD K +NILLD + ++SD GLA + + H S +GTHGY
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162
Query: 152 APEYVATG-RLTTKSDVYSFGVVLLELLSG 180
APE + G + +D +S G +L +LL G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-11
Identities = 55/153 (35%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E L Q++ P +V L E LV F+ G L +HL R G LS A +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
A L LH + VIYRD K NILLD + + L DFGL K D + GT
Sbjct: 103 LCA--LENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGT 156
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
Y APE + T D ++ GV+L E+L+G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 7/153 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
EV + HH N+V + L G+ +V EF+ G+L + + A V +
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCL 125
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+ L++LH+ VI+RD K+ +ILL ++ KLSDFG ++GT
Sbjct: 126 SVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGF--CAQVSKEVPKRKSLVGT 181
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ APE ++ T+ D++S G++++E++ G
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 27/206 (13%)
Query: 57 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 116
Y+ ++N L G + L+ + A+G+ FL A ++RD A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271
Query: 117 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFG 171
K+ DFGLA+ D H S V + APE + TT SDV+S+G
Sbjct: 272 QGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 172 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 231
++L E+ SL P + + + + P A
Sbjct: 327 ILLWEIF---------------SLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYD 371
Query: 232 LALQCLNNEPKLRPRMSEVLAILERL 257
+ ++C N+EP+ RP + I+E L
Sbjct: 372 IMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 18/162 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIG-YCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAV 81
+ E+ L +HP +VKL+G + +G+ +++ EF P G+++ + RG V
Sbjct: 56 YMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV 114
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHV 140
+ + A L +LH ++I+RD KA N+LL + + KL+DFG+ AK T R
Sbjct: 115 ICRQMLEA---LQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR--- 166
Query: 141 STQVMGTHGYAAPEYVATGRLTT-----KSDVYSFGVVLLEL 177
+GT + APE V + K+D++S G+ L+E+
Sbjct: 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 70/241 (29%), Positives = 105/241 (43%), Gaps = 36/241 (14%)
Query: 26 QTEVNYLGQLH-HPNLVKLIGYCLE-----GENRLLVYEFMPKGS---LENHLFRRGPQP 76
+ E N L L HPN+VK G + G+ LV E GS L +RG +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER- 120
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
+ + + A GL LH ++ I+RD K +NILL E KL DFG++ A T
Sbjct: 121 MEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTST 177
Query: 137 RTHVSTQVMGTHGYAAPEYVATGR-----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 191
R +T V GT + APE +A + + DV+S G+ +EL G
Sbjct: 178 RLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG----------- 225
Query: 192 EQSLVDWAKPYLSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250
+ L D L R LF+I + P+ ++ +CL + + RP +S++
Sbjct: 226 DPPLAD-----LHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
Query: 251 L 251
L
Sbjct: 281 L 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 26 QTEVNYLGQL-HHPNLVKLIGYCLE-----GENRL-LVYEFMPKGSLENHL--FRRGPQP 76
+ E N L + +HPN+ G ++ +++L LV E GS+ + + R+ +
Sbjct: 50 KEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR 109
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTG 135
L + +GL +LH E++VI+RD K NILL KL DFG+ A+ T
Sbjct: 110 LKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 136 DRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSG 180
R + GT + APE +A +SDV+S G+ +EL G
Sbjct: 168 GRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 30/170 (17%)
Query: 92 GLTFL-------HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
GL F+ H +I+RD K++NILL + KL DFG +K V
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
GT Y APE + K+D++S GV+L ELL+ + +P+
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK------------------RPF-- 245
Query: 205 DKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
D + +M L G+Y P + + L+++PK RP S++L
Sbjct: 246 DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 44/210 (20%)
Query: 58 EFMPKGSL-----ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 112
E+M GSL P+ V ++ KGL FL + E +I+RD K +N
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPED----VLRRITYAVVKGLKFLKE-EHNIIHRDVKPTN 133
Query: 113 ILLDAEFNAKLSDFGLAKAGPTGD-RTHVSTQVMGTHGYAAPEYV----ATGRLT--TKS 165
+L++ KL DFG+ +G+ ++ +G Y APE + T +S
Sbjct: 134 VLVNGNGQVKLCDFGV-----SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQS 188
Query: 166 DVYSFGVVLLELLSGRCA----VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 221
DV+S G+ +LE+ GR ++VD P L
Sbjct: 189 DVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL------------------ 230
Query: 222 PQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
P + A +CLN P RP +++L
Sbjct: 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLFRRGPQPLSWAV 81
E+ L L H N++ + + +R +VYE M + H R Q LS
Sbjct: 54 EIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDH 109
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
+GL ++H A V++RD K SN+LL+A + K+ DFGLA+ T ++
Sbjct: 110 CQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFM 165
Query: 142 TQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGR 181
T+ + T Y APE + TT DV+S G + ELL GR
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 49/242 (20%), Positives = 102/242 (42%), Gaps = 32/242 (13%)
Query: 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRL----LVYEFMPKGSLENHLFRRGPQP 76
+ + + E+ L ++ N++K+ G+ ++ + L L+ E+ +G L L +
Sbjct: 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL--DKEKD 118
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
LS+ ++ +AI KGL L+ ++ Y++ + + L+ + K+ GL K +
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177
Query: 137 RTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 194
+V+ V Y + + + T K D+YS GVVL E+ +G K+ E
Sbjct: 178 FKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG-------KIPFEN- 224
Query: 195 LVDWAKPYLSDKRKLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
++++ ++ K P + C +++ RP + E+L
Sbjct: 225 ---------LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275
Query: 254 LE 255
L
Sbjct: 276 LS 277
|
Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 27 TEVNYLGQLHHPNLVKLI-GYCLEGENRLLVYEFMP--KGSLENHLFRRGPQPLSWAVRM 83
E++ L + H ++ LI Y + V MP K L ++ R GP PL A+ +
Sbjct: 135 REIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+ + A L +LH +I+RD K NI LD NA L DFG A T
Sbjct: 191 QRRLLEA--LAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178
GT +PE +A K+D++S G+VL E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151
GL +H+ V+YRD K +NILLD + ++SD GLA + + H S +GTHGY
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162
Query: 152 APEYVATGR-LTTKSDVYSFGVVLLELLSG 180
APE + G + +D +S G +L +LL G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 58/191 (30%), Positives = 81/191 (42%), Gaps = 63/191 (32%)
Query: 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149
A+G+ FL A + I+RD A NILL K+ DFGLA+
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-----------------DI 223
Query: 150 YAAPEYVATG--RL---------------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 192
Y P+YV G RL TT+SDV+SFGV+L E+ S +G
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG-- 272
Query: 193 QSLVDWAKPYLSDK------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 246
A PY + R+L T++ P+ A ++ L C +N P+ RP
Sbjct: 273 ------ASPYPGVQIDEEFCRRLKE--GTRMRA--PEYATPEIYSIMLDCWHNNPEDRPT 322
Query: 247 MSEVLAILERL 257
SE++ IL L
Sbjct: 323 FSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+TE L + + + Y + + +L L+ +++ G L HL +R R K
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--------ERFK 103
Query: 85 -----VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139
+ G L H + +IYRD K NILLD+ + L+DFGL+K D
Sbjct: 104 EQEVQIYSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVE 161
Query: 140 VSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
+ GT Y AP+ V G D +S GV++ ELL+G A T G + S +
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG--ASPFTVDGEKNSQAE 219
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
++ RI+ K YPQ+ + A + + L +PK R
Sbjct: 220 ISR----------RIL--KSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 50/241 (20%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRG------PQPLSW 79
E L +L HP +VK LE + ++ E+ L+ L + Q W
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139
+++ + G+ ++H + ++++RD KA NI L K+ DFG+++
Sbjct: 112 FIQLLL------GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCD 160
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG-----IEQS 194
++T GT Y +PE + +KSD++S G +L E+ C + G +
Sbjct: 161 LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM----CCLAHAFEGQNFLSVVLR 216
Query: 195 LVDWAKPYLSDK--RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+V+ P L + R+L IM + LN +P LRP +E+L
Sbjct: 217 IVEGPTPSLPETYSRQLNSIMQSM--------------------LNKDPSLRPSAAEILR 256
Query: 253 I 253
Sbjct: 257 N 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 8/111 (7%)
Query: 74 PQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132
PQPLS + +KV + +GL +LH A +++RD K N+L+++ K+ DFGLA+
Sbjct: 97 PQPLS-SDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153
Query: 133 PTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGR 181
+ H++ +V+ T Y APE + G T+ D++S G + ELL R
Sbjct: 154 EPDESKHMTQEVV-TQYYRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-10
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E+ L L H N++ L + E+ V E + G+ + L P +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQ 116
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
I +GL ++H A V++RD K SNIL++ + K+ DFGLA+ + T +
Sbjct: 117 I--LRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVS 167
Query: 147 THGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 181
T Y APE + T + + D++S G + E+L G+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-10
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 148
GL LH + ++IYRD K N+LLD + N ++SD GLA K G + + + GT
Sbjct: 109 GLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTP 161
Query: 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
G+ APE + D ++ GV L E+++ R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 31/175 (17%)
Query: 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 146
A+G+ FL A + I+RD A NILL K+ DFGLA+ P R + +
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-- 204
+ APE + TT+SDV+SFGV+L E+ S +G A PY
Sbjct: 242 ---WMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG--------ASPYPGVQ 281
Query: 205 -DKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
++ R+ D T++ + P+ A + L C +PK RP S ++ IL L
Sbjct: 282 INEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMGTH 148
GL ++H A V++RD K N+L++A+ K+ DFGLA+ P + + T+ + T
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173
Query: 149 GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
Y APE + + + TK+ DV+S G +L ELL +
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 21/163 (12%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHL-----FRRGPQPL-SWA 80
E++ L ++ H N+V+L + E RL LV+E++ L+ H+ F + P+ + ++
Sbjct: 51 EISLLKEMQHGNIVRLQD-VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYL 108
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTH 139
++ +G+ + H +V++RD K N+L+D NA KL+DFGLA+A RT
Sbjct: 109 YQI------LRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
Query: 140 VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 181
T + T Y APE + R +T D++S G + E+++ +
Sbjct: 161 --THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 28/174 (16%)
Query: 26 QTEVNYLGQ-------LHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHL------FR 71
+ +V L Q L H N++ ++ C+E GE ++Y +M G+L+ L
Sbjct: 49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEA 108
Query: 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK- 130
PQ LS + +AI A G+++LH VI++D A N ++D E K++D L++
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRD 166
Query: 131 AGPT-----GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
P GD + + M A E + ++ SDV+SFGV+L EL++
Sbjct: 167 LFPMDYHCLGDNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 49/203 (24%)
Query: 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130
PL ++ + A+G+ FL A I+RD A N+LL AK+ DFGLA+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 131 AGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC-- 182
D + S V+ + + APE + T +SDV+S+G++L E+ S G+
Sbjct: 261 -----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
Query: 183 ---AVDK-----TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 234
V+ K G + S D+A P +++ IM
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPP------EIYSIMKM------------------- 350
Query: 235 QCLNNEPKLRPRMSEVLAILERL 257
C N EP RP S++ +++R
Sbjct: 351 -CWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 9e-10
Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 4/93 (4%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHG 149
+GL +LH A VI+RD K SNIL+++ + K+ DFGLA+ P D T+ + T
Sbjct: 114 RGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 150 YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
Y APE + + TK+ D++S G + ELL+ +
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF--RRGPQPLSWAVRMKV 85
EV + H N+V++ L G+ +V EF+ G+L + + R + ++ V
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AV 121
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
+ K L+ LH VI+RD K+ +ILL + KLSDFG ++
Sbjct: 122 CLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKSLV 177
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT + APE ++ + D++S G++++E++ G
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 48/159 (30%), Positives = 68/159 (42%), Gaps = 19/159 (11%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGP----QPLSWAV 81
TE + L LVKL+ Y + + L L E++P G L G +
Sbjct: 50 TERDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA 108
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
M A+ A L ++H RD K N L+DA + KL+DFGL+K T +
Sbjct: 109 EMFEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
V+G+ Y APE + D +S G +L E L G
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 15/155 (9%)
Query: 35 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE----NHLFRRGPQPLSWAVRMKVAIGAA 90
L HPN+++ +G C+E LLV+E+ G L+ + R L RM I A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA- 110
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150
G+T +H + ++ D N L ++ K+ D+G+ + D +
Sbjct: 111 -GVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 151 AAPEYVAT--GRL-----TTKSDVYSFGVVLLELL 178
APE V G L T S+V++ GV L EL
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 28 EVNYLGQLHHPNLVKL----------IGYCLEGENRLLVYEFMPK---GSLENHLFRRGP 74
E+ L QL+H N+V L + + + LV+E+M G LE+ L
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134
+ MK + +GL + H ++RD K SNILL+ + KL+DFGLA+ +
Sbjct: 116 DHI--KSFMKQLL---EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 135 GDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 181
+ + +V+ T Y PE + R DV+S G +L EL + +
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 60/257 (23%), Positives = 95/257 (36%), Gaps = 39/257 (15%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS----LENHLFRRGPQPLSWAV 81
Q E+ QL HPN++ + + +V M GS L+ H F G L+ A
Sbjct: 47 QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAF 105
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF----GLAKAGPTGDR 137
+K L ++H I+R KAS+ILL + LS + K G
Sbjct: 106 ILK---DVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160
Query: 138 THVSTQVMGTH-GYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGRCA----VDKTKVG 190
H + + + +PE + KSD+YS G+ EL +G + T++
Sbjct: 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG-HVPFKDMPATQML 219
Query: 191 IEQSLVDWAKPYLSDKRKLFRIMD------TKLGGQYPQKAAHTAAT---------LALQ 235
+E+ V P L DK D + + + T
Sbjct: 220 LEK--VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL 277
Query: 236 CLNNEPKLRPRMSEVLA 252
CL +P+ RP S++L
Sbjct: 278 CLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 19/159 (11%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKV 85
EV + H N+V++ L GE ++ EF+ G+L + + R + ++ V
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TV 122
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG----LAKAGPTGDRTHVS 141
+ L +LH VI+RD K+ +ILL + KLSDFG ++K P
Sbjct: 123 CESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------R 174
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
++GT + APE ++ T+ D++S G++++E++ G
Sbjct: 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRR----GPQPLSWAVRMKVA 86
L + HP LV L + + ++L V +++ G L HL R P+ +A + A
Sbjct: 50 LKNVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 108
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+G +LH ++YRD K NILLD++ + L+DFGL K + T ++ G
Sbjct: 109 LG------YLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCG 158
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
T Y APE + D + G VL E+L G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 54/186 (29%), Positives = 80/186 (43%), Gaps = 34/186 (18%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-TQVMGTHG 149
+ L ++H A V +RD K NIL +A+ K+ DFGLA+ T + T + T
Sbjct: 114 RALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 150 YAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV----------- 196
Y APE + + T D++S G + E+L+G+ V + L+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
Query: 197 ------DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN----EPKLRPR 246
+ A+ YLS RK K + QK + A LAL+ L +PK RP
Sbjct: 232 ISRVRNEKARRYLSSMRK-------KQPVPFSQKFPN-ADPLALRLLERLLAFDPKDRPT 283
Query: 247 MSEVLA 252
E LA
Sbjct: 284 AEEALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-PLSWAVRMKVAIGAA 90
+ QL H +LV G C+ G+ ++V E++ GSL+ +L + +SW +++VA A
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLA 110
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH-- 148
L FL D + + + A N+LL E + K + K G V + +
Sbjct: 111 WALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI 168
Query: 149 GYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 207
+ PE + + L+ +D +SFG L E+ SG D L ++
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQK 213
Query: 208 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245
KL + + + Q P A L QC++ EP RP
Sbjct: 214 KL-QFYEDRH--QLPAPKWTELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 50/159 (31%), Positives = 71/159 (44%), Gaps = 22/159 (13%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHL-FRRG---PQP--LSWA 80
E L ++ HPN+V E + L +V E+ G L + +RG P+ L W
Sbjct: 48 EAVLLAKMKHPNIVAF-KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRT 138
V+M + + H E +V++RD K+ NI L KL DFG A+ P
Sbjct: 107 VQMCLGVQ--------HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---A 155
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177
+ T V GT Y PE KSD++S G +L EL
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+TE N L + + + Y + E +L L+ +++ G + HL++R S ++
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSED-EVR 108
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
G L H + ++YRD K NILLD+E + L+DFGL+K + ++ +
Sbjct: 109 FYSGEII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSF 166
Query: 145 MGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 180
GT Y APE + K+ D +S G+++ ELL+G
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 7 LHSHLELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66
L S E+ RS + +F E + + + P +V+L + + +V E+MP G L
Sbjct: 75 LLSKFEMIKRS---DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV 131
Query: 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 126
N L P WA + A L +H +I+RD K N+LLD + KL+DF
Sbjct: 132 N-LMSNYDVPEKWAKFYTAEVVLA--LDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 127 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLELLSG 180
G T V GT Y +PE + + G + D +S GV L E+L G
Sbjct: 187 GTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 17/163 (10%)
Query: 28 EVNYLGQLHHPNLVKLIGYCL----EGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAV 81
E+ L H N++ + + ++ +V + M E+ L QPL+
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEH 108
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG--DRTH 139
+GL ++H A VI+RD K SN+L++ + ++ DFG+A+ + + +
Sbjct: 109 IRYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 140 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 181
T+ + T Y APE + + TT D++S G + E+L GR
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 28 EVNYLGQLHHPNLVKLIGYC---LEGENR-----LLVYEFMP---KGSLENHLFRRGPQP 76
E+ L L H N+V LI C NR LV+EF G L N +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPT 134
+ ++M + GL ++H +++++RD KA+NIL+ + KL+DFGLA+A
Sbjct: 121 IKKVMKMLL-----NGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSK 173
Query: 135 GDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLEL 177
+ + T + T Y PE + R D++ G ++ E+
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 28 EVNYLGQLH---HPNLVKLIGYCL----EGENRL-LVYEFMPKGSLENHLFRRGPQPLSW 79
EV L L HPN+V+L C + E +L LV+E + + L +L + P+P
Sbjct: 51 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVP 108
Query: 80 AVRMK-VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
+K + +GL FLH +V++RD K NIL+ + KL+DFGLA+
Sbjct: 109 TETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 163
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
T V+ T Y APE + T D++S G + E+ +
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 45/135 (33%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 55 LVYEFMPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKA 110
+V E+MP G L N L P WA + +A+ A + F+H RD K
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKP 170
Query: 111 SNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKS 165
N+LLD + KL+DFG K G T V GT Y +PE + + G +
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228
Query: 166 DVYSFGVVLLELLSG 180
D +S GV L E+L G
Sbjct: 229 DWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 22/172 (12%)
Query: 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS--- 78
++F+ E + L + P + +L + +N LV E+ P G L + L R
Sbjct: 45 VSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDM 103
Query: 79 ---WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 135
+ + +AI + + ++H RD K N+L+D + KL+DFG A A T
Sbjct: 104 AQFYLAELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSA-ARLTA 154
Query: 136 DRTHVSTQVMGTHGYAAPEYVATGRLTTKS------DVYSFGVVLLELLSGR 181
++ S +GT Y APE + T K D +S GV+ E++ GR
Sbjct: 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 52/173 (30%), Positives = 73/173 (42%), Gaps = 27/173 (15%)
Query: 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 146
AKG+ FL A + I+RD A NILL K+ DFGLA+ P R + +
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LS 204
+ APE + T +SDV+SFGV+L E+ S +G A PY +
Sbjct: 246 --KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVK 286
Query: 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
+ R + + P L C + EP RP SE++ L L
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMK 84
+E L ++HP V L G + LV EF+ G L R R P + +
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ L F + ++YRD K N+LLD + K++DFG AK T RT+ +
Sbjct: 140 IV------LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYT---L 188
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT Y APE + +D ++ G+ + E+L G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 28 EVNYLGQL---HHPNLVKLIGYC----LEGENRL-LVYEFMPKGSLENHLFRRGPQPLSW 79
E+ L QL HPN+V+L+ C + E +L LV+E + + L +L + P+P
Sbjct: 48 EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLP 105
Query: 80 AVRMKVAIGA-AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
+K + +G+ FLH ++++RD K NIL+ ++ K++DFGLA+
Sbjct: 106 PETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFE 160
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177
T V+ T Y APE + T D++S G + EL
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 25/230 (10%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
++E++ L H +VK + LL+ E+ G L + +R + L + +V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEV 171
Query: 86 AIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + + L + S+ +++RD K++NI L KL DFG +K V++
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
GT Y APE R + K+D++S GV+L ELL+ +P+
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKG 273
Query: 205 DKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
++ IM L G+Y P + L L+ P LRP ++L
Sbjct: 274 PSQR--EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 54/180 (30%), Positives = 76/180 (42%), Gaps = 18/180 (10%)
Query: 12 ELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71
EL + + F E L H NL++ +G C E LLV EF P G L+ +L
Sbjct: 29 ELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRS 88
Query: 72 R------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 125
P P ++A A GL LH ++ I+ D N LL A+ K+ D
Sbjct: 89 CRKAELMTPDPT---TLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGD 143
Query: 126 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGRL-----TTKSDVYSFGVVLLELL 178
+GL+ D Q+ + APE V G L T +S+V+S GV + EL
Sbjct: 144 YGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 45/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
EV+ L L H N+V L ++ LV+E++ K L+ ++ G V++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-Y 111
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+GL + H +V++RD K N+L++ KL+DFGLA+A +T+ S +V+ T
Sbjct: 112 QILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-T 167
Query: 148 HGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 181
Y P+ + + +T+ D++ G + E+ SGR
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 32 LGQLHHPNLVKLIGYC----LEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
L HPN+V+L+ C + E ++ LV+E + + L +L + P L +
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-TQVM 145
+GL FLH + +++RD K NIL+ + KL+DFGLA+ ++ T V+
Sbjct: 115 RQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVV 168
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178
T Y APE + T D++S G + E+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 4e-08
Identities = 72/252 (28%), Positives = 108/252 (42%), Gaps = 48/252 (19%)
Query: 28 EVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
EV L +L HPN+VKL E + V+E+M +G+L + R +P S +V +
Sbjct: 47 EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSII 105
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR----THVST 142
+GL +H +RD K N+L+ K++DFGLA+ R +VST
Sbjct: 106 YQILQGLAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVST 161
Query: 143 QVMGTHGYAAPEYVATGRLTTKS---DVYSFGVVLLELLS------GRCAVD---KTKVG 190
+ Y APE + R T+ S D+++ G ++ EL + G +D K
Sbjct: 162 R-----WYRAPEILL--RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK---- 210
Query: 191 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-----------AAHTAATLALQCLNN 239
I L K + KL KLG ++PQ A+ A L L
Sbjct: 211 ICSVLGTPTKQDWPEGYKLAS----KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRW 266
Query: 240 EPKLRPRMSEVL 251
+PK RP S+ L
Sbjct: 267 DPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149
AKG++FL A I+RD A NILL K+ DFGLA+ V
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ APE + T +SDV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 17/139 (12%)
Query: 55 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 114
+V E++ G L G P+ A RM A L +LH+ +++RD K N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMA-RMYFA-ETVLALEYLHN--YGIVHRDLKPDNLL 133
Query: 115 LDAEFNAKLSDFGLAKAG-------------PTGDRTHVSTQVMGTHGYAAPEYVATGRL 161
+ + + KL+DFGL+K G R + QV GT Y APE +
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 162 TTKSDVYSFGVVLLELLSG 180
D ++ G++L E L G
Sbjct: 194 GKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 29/165 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPK----------GSLENHLFRRGPQP 76
E+ L +L H N+V+L L + +L LV+E+ + G ++ + +
Sbjct: 49 EICLLKELKHKNIVRLYD-VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK----- 102
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
S+ ++ KGL F H V++RD K N+L++ KL+DFGLA+A
Sbjct: 103 -SFMFQL------LKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSG 180
R + S +V+ T Y P+ + +L +T D++S G + EL +
Sbjct: 154 RCY-SAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 23/183 (12%)
Query: 7 LHSHLELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 65
L S E+ RS + +F E + + + P +V+L Y + + L +V E+MP G L
Sbjct: 75 LLSKFEMIKRS---DSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL 130
Query: 66 ENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 121
N L P WA + +A+ A + F+H RD K N+LLD +
Sbjct: 131 VN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHL 181
Query: 122 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLEL 177
KL+DFG T V GT Y +PE + + G + D +S GV L E+
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 178 LSG 180
L G
Sbjct: 241 LVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 11/147 (7%)
Query: 36 HHPNLVKLIGYCLEGE-NRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 93
HPN+++LI + + RL LV+E M E L + +PL K L
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153
+H + + +RD K NIL+ + KL+DFG + T+ + T Y AP
Sbjct: 114 DHMH--RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAP 167
Query: 154 EYVAT-GRLTTKSDVYSFGVVLLELLS 179
E + T G K D+++ G V E+LS
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-08
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 11/156 (7%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
Q E+ + H N+V G L + + EF GSL++ GP LS + V
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYV 111
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQV 144
+ +GL +LH ++RD K +NILL + KL+DFG+ A+ T +
Sbjct: 112 SRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSF 166
Query: 145 MGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLEL 177
+GT + APE A R D+++ G+ +EL
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL--LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E+ L +L H N+V L+ LE ++ L++++ + F R + +S M
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 86 AI--GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA----KLSDFGLA-------KAG 132
++ G+ +LH + V++RD K +NIL+ E K+ D GLA K
Sbjct: 112 SLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 133 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 179
D V+ T Y APE + R TK+ D+++ G + ELL+
Sbjct: 170 ADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 45/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
EV+ L L H N+V L ++ LV+E++ K L+ +L G V++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-F 111
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+GL + H +V++RD K N+L++ KL+DFGLA+A +T+ S +V+ T
Sbjct: 112 QLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-T 167
Query: 148 HGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 181
Y P+ + + +T+ D++ G + E+ +GR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 7/155 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
EV+ L L H N+V L LV+E++ L+ +L G V++
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI-FMF 110
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+GL++ H + ++++RD K N+L++ + KL+DFGLA+A +T+ S +V+ T
Sbjct: 111 QLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-T 166
Query: 148 HGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 181
Y P+ + + +T D++ G +L E+ +GR
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 54/245 (22%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR-RGPQPLSWAVR 82
+F+T + + Q+ H +L + G C+ G ++V EF+ G L+ L + +G P++W +
Sbjct: 63 FFET-ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--------DAEFNAKLSDFGLAKAGPT 134
+ VA A L++L D +++ + A NILL + F KLSD G++ +
Sbjct: 120 ITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVSFTALS 176
Query: 135 GDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLEL-------LSGRCAVDK 186
R ++ + APE V G L+T +D +SFG LLE+ L R +K
Sbjct: 177 --REERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230
Query: 187 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 246
+ + K +L P+ + ATL QCL EP RP
Sbjct: 231 ER-------------FYEKKHRL------------PEPSCKELATLISQCLTYEPTQRPS 265
Query: 247 MSEVL 251
+L
Sbjct: 266 FRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
Q E+ + + H N+V G L E + E+ GSL++ GP LS V
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYV 111
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQV 144
+GL +LH ++RD K +NILL + KL+DFG+ AK T +
Sbjct: 112 CRETLQGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSF 166
Query: 145 MGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLEL 177
+GT + APE A G D+++ G+ +EL
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 50/188 (26%), Positives = 68/188 (36%), Gaps = 39/188 (20%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW----AV 81
TE L L HP L L LV ++ P G L L +R QP
Sbjct: 49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR--QPGKCLSEEVA 105
Query: 82 RMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
R A + A L +LH ++YRD K NILL + LSDF L+K
Sbjct: 106 RFYAAEVLLA--LEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 141 ---------------------------STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 173
S +GT Y APE ++ + D ++ G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 174 LLELLSGR 181
L E+L G
Sbjct: 222 LYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150
+GL ++H A+ +I+RD K SN+ ++ + K+ DFGLA+ T D T + T Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 183
Query: 151 AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
APE + ++ D++S G ++ ELL+GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 53/223 (23%), Positives = 84/223 (37%), Gaps = 62/223 (27%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA----VRM 83
E + L + + +VKL + +N V +++P G + + L R G A +
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAEL 110
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVST 142
AI + + F+H RD K NIL+D + + KL+DFGL TG R TH S
Sbjct: 111 TCAIESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLC----TGFRWTHDSK 158
Query: 143 --------------------------------------------QVMGTHGYAAPEYVAT 158
++GT Y APE +
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 159 GRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDWAK 200
T D +S GV+L E+L G+ + T + +++W
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 50/194 (25%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVR 82
E + L + +P +VKL Y + EN L L+ E++P G + L ++ + +
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-------------- 128
+AI + L ++H RD K N+LLDA+ + KLSDFGL
Sbjct: 110 TILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161
Query: 129 --AKAGPTGDRTHVSTQ--------------------VMGTHGYAAPEYVATGRLTTKSD 166
+ A P+ +S +GT Y APE + D
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221
Query: 167 VYSFGVVLLELLSG 180
+S GV++ E+L G
Sbjct: 222 WWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 14/95 (14%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 147
KGL ++H A +I+RD K N+ ++ + K+ DFGLA+ +++ G T
Sbjct: 129 KGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVVT 178
Query: 148 HGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 181
Y APE + T D++S G ++ E+L+G+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T + T + T Y
Sbjct: 135 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYR 189
Query: 152 APEYVATGRLTTKSDVYSFGVVLLELLSG 180
APE + D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150
+GL ++H A +I+RD K SNI ++ + K+ DFGLA+ T D T + T Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEM---TGYVATRWY 181
Query: 151 AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
APE + ++ D++S G ++ ELL+G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 7/172 (4%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E + L L H N+V L E V+E+M L ++ + + VR+
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMF 110
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
+GL ++H +++RD K N+L+ KL+DFGLA+A +T+ S V T
Sbjct: 111 QLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--T 166
Query: 148 HGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 198
Y P+ + ++ D++ G + +E+L G+ A EQ W
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 46/178 (25%), Positives = 67/178 (37%), Gaps = 45/178 (25%)
Query: 40 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTF 95
+VK+ + N L+ EF+P G + L ++ + +AI A L F
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---------------GPTGD---- 136
+H RD K N+LLDA+ + KLSDFGL P D
Sbjct: 123 IH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 137 --------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
R ++ +GT Y APE D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 41 VKLIGYCLEGENRL-LVYEFMPKGSLENHLFR---RGPQPLS--WAVRMKVAIGAAKGLT 94
+ + Y + EN L LV ++ G L L + R P+ ++ + M +AI + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154
++H RD K NIL+D + +L+DFG + D T S+ +GT Y +PE
Sbjct: 123 YVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 155 YV-----ATGRLTTKSDVYSFGVVLLELLSG 180
+ G+ + D +S GV + E+L G
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 1e-06
Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 18/168 (10%)
Query: 26 QTEVNYLGQL-HHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLS 78
+ E+N L + HH N+ G ++ + LV EF GS+ + + L
Sbjct: 50 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 109
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
+ +GL+ LH + +VI+RD K N+LL KL DFG++ DRT
Sbjct: 110 EEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT 164
Query: 139 -HVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 180
+GT + APE +A KSD++S G+ +E+ G
Sbjct: 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T + + T + T Y
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 152 APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 193
APE + D++S G ++ E L GR +D+ IEQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 27/94 (28%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK-AGPTGDRTHVSTQVMGTH 148
+GL ++H A V++RD K +N+ ++ E K+ DFGLA+ P ++ + T
Sbjct: 125 RGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 149 GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
Y +P + + TK+ D+++ G + E+L+G+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 34 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF-RRGPQPLSWAVRMKVAIGAAKG 92
Q+ H ++V L G C+ ++V EF+ G L+ LF R L+ + KVA A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASA 117
Query: 93 LTFLHDAESQVIYRDFKASNILL-----DAEFNA--KLSDFGLAKAGPTGDRTHVSTQ-V 144
L++L D + +++ + NILL D E KLSD G+ P T +S Q
Sbjct: 118 LSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PI---TVLSRQEC 168
Query: 145 MGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLEL-LSGRCAV-DKTKVGIEQSLVDWAKP 201
+ + APE V + L+ +D +SFG L E+ +G + DKT
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-------------- 214
Query: 202 YLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRP 245
L++K + + GQ + A L C+N +P RP
Sbjct: 215 -LAEKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 20/146 (13%)
Query: 46 YCLEGENRL-LVYEFMPKGSLENHLFR---RGPQPLS--WAVRMKVAIGAAKGLTFLHDA 99
Y + EN L LV ++ G L L + R P+ ++ + M +AI + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--- 156
RD K N+LLD + +L+DFG + D T S+ +GT Y +PE +
Sbjct: 126 ------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 157 --ATGRLTTKSDVYSFGVVLLELLSG 180
G+ + D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 37/155 (23%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
TE + L ++HP++++L G + L+ +P+ + + + + ++ + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+ + +LH E+++I+RD KA NI ++ + L DFG A P + G
Sbjct: 189 RSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
T APE +A D++S G+VL E+ +
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 57/205 (27%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLS--WAV 81
+ E + L + + +VKL + +N V +++P G + + L R P+ L+ +
Sbjct: 49 KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---------- 131
+ +AI + + F+H RD K NIL+D + + KL+DFGL
Sbjct: 109 ELTLAIESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160
Query: 132 -----------GPT-----------GDRTHVSTQ-------------VMGTHGYAAPEYV 156
P+ GDR Q ++GT Y APE +
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220
Query: 157 ATGRLTTKSDVYSFGVVLLELLSGR 181
T D +S GV+L E+L G+
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 39/173 (22%), Positives = 77/173 (44%), Gaps = 30/173 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA- 86
E+ + ++ H N++ L+ +EG+ LV + M L+ + R+ +R+ +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--------IRLTESQ 120
Query: 87 -----IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-------AGPT 134
+ GL LH + ++RD +NI ++++ K++DFGLA+ +
Sbjct: 121 VKCILLQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 135 GDRTHVS-----TQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGR 181
+ T + T Y APE + + D++S G + ELL+G+
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
Q EV HPN++ G ++ FM GS + L P+ +S A+
Sbjct: 44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI 103
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD----FGLAKAGPTG--- 135
+ GA +GL +LH ++ I+R+ KAS+IL+ + LS + L + G
Sbjct: 104 GNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161
Query: 136 -DRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 181
D ST V+ + +PE + KSD+YS G+ EL +GR
Sbjct: 162 YDFPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 24 WFQTEVNYLGQLHHPNLVKL--------IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ 75
+ E+ LG+L+H N++K+ Y + + +Y FM + F +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA-----FDWKDR 263
Query: 76 PLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 133
PL R MK + A + ++HD ++I+RD K NI L+ + L DFG A
Sbjct: 264 PLLKQTRAIMKQLLCA---VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 134 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+R +GT +PE +A +D++S G++LL++LS
Sbjct: 319 K-EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ G ++ V+ T Y
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV-TRYYR 184
Query: 152 APEYVATGRLTTKSDVYSFGVVLLELLSGR 181
APE + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T + + T + T Y
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 152 APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 193
APE + D++S G ++ E L G +D+ IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 58/223 (26%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLS--WAV 81
+ E + L + + +V+L + +N V +++P G + + L R G P+ L+ +
Sbjct: 49 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL---------AKAG 132
+ A+ + + F+H RD K NIL+D + + KL+DFGL +K
Sbjct: 109 ELTCAVESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 133 PTGD---------------------------------RTH---VSTQVMGTHGYAAPEYV 156
+GD R H ++ ++GT Y APE +
Sbjct: 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220
Query: 157 ATGRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDW 198
T D +S GV+L E+L G+ + +T + + +++W
Sbjct: 221 LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-06
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 14/95 (14%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 147
GL ++H A +I+RD K N+ ++ + K+ DFGLA+ H ++ G T
Sbjct: 128 CGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 177
Query: 148 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
Y APE + ++ D++S G ++ E+L+G+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 41/166 (24%), Positives = 62/166 (37%), Gaps = 45/166 (27%)
Query: 52 NRLLVYEFMPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 107
N L+ EF+P G + L ++ + + +AI + L F+H RD
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH--------RD 126
Query: 108 FKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------------------------- 138
K N+LLD++ + KLSDFGL RT
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 139 ----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
++ +GT Y APE D +S GV++ E+L G
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149
A G+ FL A ++RD A N+L+ K+ DFGLA+ D S +
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----DIMRDSNYISKGST 301
Query: 150 Y-----AAPEYVATGRLTTKSDVYSFGVVLLELLS 179
+ APE + TT SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 22/147 (14%)
Query: 46 YCLEGENRL-LVYEFMPKGSLENHLFR---RGPQPLS--WAVRMKVAIGAAKGLTFLHDA 99
Y + EN L LV ++ G L L + R P+ ++ + M +AI + L ++H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH-- 125
Query: 100 ESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHVSTQVMGTHGYAAPEYV-- 156
RD K N+LLD + +L+DFG + G T S +GT Y +PE +
Sbjct: 126 ------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPDYISPEILQA 177
Query: 157 ---ATGRLTTKSDVYSFGVVLLELLSG 180
GR + D +S GV + E+L G
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 26 QTEVNYLGQL-HHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLS 78
+ E+N L + HH N+ G ++ + LV EF GS+ + + L
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
+ +GL LH +VI+RD K N+LL KL DFG++ DRT
Sbjct: 120 EDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT 174
Query: 139 -HVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 180
+GT + APE +A +SD++S G+ +E+ G
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 8/151 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK--GSLENHLFRRGPQPLSWAVRMKV 85
E L +L HP ++ L+ + G LV +PK L +L R +PL A V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGAR-LRPLGLAQVTAV 265
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
A + ++H +I+RD K N+L++ + L DFG A T +
Sbjct: 266 ARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176
GT APE +A T D++S G+V+ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 45/188 (23%), Positives = 75/188 (39%), Gaps = 33/188 (17%)
Query: 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP--KGSLENHLFR--RGPQ 75
L+ F E L HP +V + C +G+ VY MP +G L + +
Sbjct: 44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKE 100
Query: 76 PLSWAVRMKVAIGA--------AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 127
LS + K ++GA + ++H V++RD K NILL + D+G
Sbjct: 101 SLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWG 158
Query: 128 LA-------------KAGPTGDRTHVST---QVMGTHGYAAPEYVATGRLTTKSDVYSFG 171
A T +++GT Y APE + + +D+Y+ G
Sbjct: 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG 218
Query: 172 VVLLELLS 179
V+L ++L+
Sbjct: 219 VILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150
+GL ++H A +I+RD K SN+ ++ + ++ DFGLA+ D T + T Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEM---TGYVATRWY 181
Query: 151 AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
APE + ++ D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 7/93 (7%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150
+GL + H +V++RD K N+L+ KL+DFGLA+A +T+ S +V+ T Y
Sbjct: 114 RGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWY 169
Query: 151 AAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 181
P+ V G +T D++ G + E+ +GR
Sbjct: 170 RPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 5/154 (3%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L L N+V+L LV+E++ K LE L P +
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY 107
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
K + + H ++ +++RD K N+L+ KL DFG A+ G + T+ + T
Sbjct: 108 QLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVAT 164
Query: 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
Y +PE + D++S G +L EL G+
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 28/94 (29%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150
+GL+++H + +++RD K N+L+ KL+DFGLA+A T+ S +V+ T Y
Sbjct: 114 RGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNEVV-TLWY 169
Query: 151 AAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCA 183
P+ + + +T D++ G + +E++ G A
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 7e-05
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 33/188 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHL---FRRGPQPLSWAVR 82
EVN + +L H N+V+ I L N+ L + EF G L ++ ++ + A+
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI- 120
Query: 83 MKVAIGAAKGLTFLHDAE-----SQVIYRDFKASNILLD----------AEFN------- 120
+ + L + H+ + +V++RD K NI L A+ N
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 121 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGVVLLELL 178
AK+ DFGL+K H +GT Y +PE + T KSD+++ G ++ EL
Sbjct: 181 AKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 179 SGRCAVDK 186
SG+ K
Sbjct: 238 SGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 55 LVYEFMP---KGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 110
LV+E++ K ++++ RGP +PL KG+ H + V++RD K
Sbjct: 83 LVFEYLDSDLKKFMDSN--GRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKP 138
Query: 111 SNILLDAEFNA-KLSDFGLAKAG--PTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSD 166
N+L+D + K++D GL +A P TH +++ T Y APE + +T D
Sbjct: 139 QNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV-TLWYRAPEVLLGSTHYSTPVD 194
Query: 167 VYSFGVVLLELLSG 180
++S G + E+
Sbjct: 195 IWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 33/108 (30%), Positives = 56/108 (51%), Gaps = 10/108 (9%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLEN--HLFRRGPQPLSWAVR 82
Q E + L P +V L Y L+ N + LV E++ G +++ H++ + ++
Sbjct: 52 QAERDALALSKSPFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA---- 106
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130
+K A L +LH +I+RD K N+L+ E + KL+DFGL+K
Sbjct: 107 VKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 35/111 (31%), Positives = 49/111 (44%), Gaps = 18/111 (16%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLS------ 78
+ E + L + P +V L Y + L L+ EF+P G L L + S
Sbjct: 49 KAERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRF 105
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
+ +AI A L F+H RD K NIL+D + KLSDFGL+
Sbjct: 106 YMAECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRG------PQPLSW 79
E+ L +L HPN++ L L +R L++++ F R P L
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK----- 130
++ + G+ +LH + V++RD K +NIL+ E K++D G A+
Sbjct: 108 SMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 131 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 179
P D V+ T Y APE + R TK+ D+++ G + ELL+
Sbjct: 166 LKPLADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 30/205 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRG------PQPLSW 79
E+ L +L HPN++ L L +R L++++ F R P L
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK----- 130
+ + G+ +LH + V++RD K +NIL+ E K++D G A+
Sbjct: 108 GMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 131 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKV 189
P D V+ T Y APE + R TK+ D+++ G + ELL+ +
Sbjct: 166 LKPLADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
Query: 190 GIEQSLVDWAKPYLSDK-RKLFRIM 213
I+ S PY D+ ++F +M
Sbjct: 222 DIKTS-----NPYHHDQLDRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.99 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.25 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.87 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.83 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.68 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.61 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.58 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.58 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.44 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.39 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.31 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.76 | |
| PLN02236 | 344 | choline kinase | 96.73 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.45 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.43 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.37 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.96 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.92 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.89 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.87 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.72 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.61 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.37 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.23 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.05 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.04 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.87 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.4 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.28 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.25 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.13 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.1 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=341.36 Aligned_cols=233 Identities=25% Similarity=0.379 Sum_probs=192.2
Q ss_pred hHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC-eeEEEEecCCCCChHHHhhhc
Q 021507 3 LFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 3 ~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~ 72 (311)
|+|+.++|...+ ......+++++.+|++++++.+|||||.+|+.|..++ .++++||||+||+|++.+...
T Consensus 93 G~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~ 172 (364)
T KOG0581|consen 93 GTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV 172 (364)
T ss_pred cEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc
Confidence 556666655322 3334567888999999999999999999999999998 499999999999999998665
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
+ .+++...-+++.++++||.|||.. .+||||||||+|||++..|.|||||||.+...... ...+++||..|||
T Consensus 173 g--~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMs 245 (364)
T KOG0581|consen 173 G--RIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMS 245 (364)
T ss_pred C--CCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccC
Confidence 4 499999999999999999999952 45999999999999999999999999999876443 4567899999999
Q ss_pred ccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH-HHHHHHH
Q 021507 153 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAAT 231 (311)
Q Consensus 153 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ 231 (311)
||.+.+..|+.++||||||++++|+.+|+.||..... + ..+.-.+...+-.......|.. +++++++
T Consensus 246 PERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-----------~-~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 246 PERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-----------P-YLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred hhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-----------C-CCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 9999999999999999999999999999999976411 0 1111222222222233445565 8999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|+..||++||.+||++.+++++-
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCH
Confidence 99999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=321.69 Aligned_cols=234 Identities=22% Similarity=0.274 Sum_probs=188.1
Q ss_pred hhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEe-EEEeCCe-eEEEEecCCCCChHHHh
Q 021507 2 FLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIG-YCLEGEN-RLLVYEFMPKGSLENHL 69 (311)
Q Consensus 2 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l 69 (311)
||+||-+.++... ..-....++++..|+.+|++|+|||||++++ .|.+++. ++||||||.+|+|..+|
T Consensus 32 Fg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmI 111 (375)
T KOG0591|consen 32 FGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMI 111 (375)
T ss_pred chheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHH
Confidence 6666665554422 2223456778999999999999999999998 4555554 89999999999999999
Q ss_pred hh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCC--CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccc
Q 021507 70 FR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAES--QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 70 ~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
+. ...+.+++..+|+++.|++.||..+|+.-. .|+||||||.||+++.+|.|||+|||+++.+.... ....+.+
T Consensus 112 k~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~V 189 (375)
T KOG0591|consen 112 KHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLV 189 (375)
T ss_pred HHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhc
Confidence 53 344569999999999999999999998333 49999999999999999999999999999865433 3466789
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc-hH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QK 224 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 224 (311)
||+.||+||.+.+.+|+.+||||||||++|||+.-++||.+.+.. ++.+.+....-...| ..
T Consensus 190 GTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~-----------------~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 190 GTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL-----------------SLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred CCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH-----------------HHHHHHHcCCCCCCcHHH
Confidence 999999999999999999999999999999999999999986431 222222233223345 67
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++..+..||..|+..||+.||+...++..+
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 899999999999999999999855444433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=342.00 Aligned_cols=238 Identities=29% Similarity=0.425 Sum_probs=205.8
Q ss_pred hhHHHhHHHHHHhhh-----h-HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCC
Q 021507 2 FLFNFLHSHLELHAR-----S-LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ 75 (311)
Q Consensus 2 ~~~~~~~~~~~~~~~-----~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (311)
||.||+++...-... + .....+.|.+|+++|++|+|+|||++++++..++.+||||||++.|+|.++|+.....
T Consensus 219 FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~ 298 (468)
T KOG0197|consen 219 FGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGG 298 (468)
T ss_pred cceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCC
Confidence 778888776654211 1 1224467999999999999999999999999988999999999999999999876666
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccc
Q 021507 76 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 155 (311)
Q Consensus 76 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 155 (311)
.+...+.+.++.|||+|++||++++ +|||||-..||||++++.+||+|||+++...+. .+.......-...|.|||.
T Consensus 299 ~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa 375 (468)
T KOG0197|consen 299 LLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEA 375 (468)
T ss_pred ccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHH
Confidence 7999999999999999999999765 999999999999999999999999999954433 3333444445678999999
Q ss_pred cccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHH
Q 021507 156 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 234 (311)
Q Consensus 156 ~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 234 (311)
+..+.++.+|||||||++||||+| |+.||.+.. .....+.++...+...|..|++++.++|.
T Consensus 376 ~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~GyRlp~P~~CP~~vY~lM~ 438 (468)
T KOG0197|consen 376 LNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERGYRLPRPEGCPDEVYELMK 438 (468)
T ss_pred HhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhccCcCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999 999998753 45677888899999999999999999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 235 QCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 235 ~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.||+.+|++|||++.+...|+.+..
T Consensus 439 ~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 439 SCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHhhCCcccCCCHHHHHHHHHHhhh
Confidence 9999999999999999999887643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=346.83 Aligned_cols=229 Identities=27% Similarity=0.372 Sum_probs=192.5
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
||+++|..++++.. .......++...+|++|.++|+|||||+++++|++.+++|||.|+|..++|..++
T Consensus 30 gFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~ 109 (592)
T KOG0575|consen 30 GFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELL 109 (592)
T ss_pred cceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHH
Confidence 56666666554432 1122335677889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
+++ +++++.++..++.||+.||.|||+++ |+|||||..|++++++.+|||+|||+|........ ...+.+||+.
T Consensus 110 Krr--k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPN 183 (592)
T KOG0575|consen 110 KRR--KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKKTLCGTPN 183 (592)
T ss_pred Hhc--CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCccc--ccceecCCCc
Confidence 754 45999999999999999999999765 99999999999999999999999999998754322 2567899999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.....+..+||||+||++|.|++|++||+........ .++.. .....|...+.++
T Consensus 184 YIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety----------------~~Ik~--~~Y~~P~~ls~~A 245 (592)
T KOG0575|consen 184 YIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY----------------NKIKL--NEYSMPSHLSAEA 245 (592)
T ss_pred ccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH----------------HHHHh--cCcccccccCHHH
Confidence 99999999999999999999999999999999999986542221 12222 2235567889999
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||.++|+.||.+|||+++++.+
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=324.67 Aligned_cols=230 Identities=26% Similarity=0.401 Sum_probs=187.6
Q ss_pred ChhHHHhHHHHHHh--------hhh--HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH--------ARS--LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+|++||.++|.+.+ .++ ..+..+.+.+|+++|+.++|||||.+++++..++.+|+|||||.||+|.++|+
T Consensus 22 sfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~ 101 (429)
T KOG0595|consen 22 SFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR 101 (429)
T ss_pred ceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH
Confidence 48999999888754 122 44567788999999999999999999999999999999999999999999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC------CcEEEecccccccCCCCCCcceeccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------FNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~------~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
+++ .+++.++..++.||+.||++||+ ++||||||||+|||++.. -.+||+|||+|+..... ....+.
T Consensus 102 ~~~--~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tl 174 (429)
T KOG0595|consen 102 RRG--RLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETL 174 (429)
T ss_pred HcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHh
Confidence 775 49999999999999999999996 459999999999999765 35899999999986533 235678
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK 224 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
+|++.|||||++....|+.|+|+||+|+|+|+|++|+.||+......-...+ ..........+..
T Consensus 175 cGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~---------------~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 175 CGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI---------------KKGNEIVPVLPAE 239 (429)
T ss_pred hCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---------------hccccccCchhhh
Confidence 9999999999999999999999999999999999999999875432111111 1111222234455
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
.+..+.+++...|..++.+|.+..+-..
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhh
Confidence 6667778888888888888887766554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=329.45 Aligned_cols=220 Identities=32% Similarity=0.542 Sum_probs=188.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCC-eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.|.+|+.+|.+++|||||+++|++.+.. ..++||||+++|+|.+++.......++...++.++.||+.||.|||+.+
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 668999999999999999999999999887 7899999999999999997744456999999999999999999999643
Q ss_pred CCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcceeccccccccccCccccc--cCCCCCCCceehhHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--TGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l 177 (311)
. ||||||||+|||++.++ ++||+|||+++...... .......||..|||||++. ...|+.++||||||+++|||
T Consensus 163 ~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl 239 (362)
T KOG0192|consen 163 P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL 239 (362)
T ss_pred C-eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence 3 99999999999999998 99999999998754322 1233368999999999999 56899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+||..||..... ............+...+..++..+..+|.+||..||.+||++.+++..|+.+
T Consensus 240 ~t~~~Pf~~~~~----------------~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 240 LTGEIPFEDLAP----------------VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred HHCCCCCCCCCH----------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 999999987542 1222333344455566777999999999999999999999999999999887
Q ss_pred cCC
Q 021507 258 EAP 260 (311)
Q Consensus 258 ~~~ 260 (311)
...
T Consensus 304 ~~~ 306 (362)
T KOG0192|consen 304 MSH 306 (362)
T ss_pred HHh
Confidence 543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=324.51 Aligned_cols=210 Identities=27% Similarity=0.359 Sum_probs=175.2
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
+..+|+++|++|+|||||+++++|+..+..||||||++||.|.+.+..++. +.+.....++.|++.|+.|||+.+ |
T Consensus 222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G--I 297 (475)
T KOG0615|consen 222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG--I 297 (475)
T ss_pred hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC--c
Confidence 357999999999999999999999999999999999999999999976654 788888999999999999999755 9
Q ss_pred eecCCCCCceEeCCC---CcEEEecccccccCCCCCCcceeccccccccccCccccccCCC---CCCCceehhHHHHHHH
Q 021507 104 IYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL---TTKSDVYSFGVVLLEL 177 (311)
Q Consensus 104 vH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~l 177 (311)
+||||||+|||++.+ ..+||+|||+|+..+. .....+.+||+.|.|||++.+... ..+.|||||||++|-+
T Consensus 298 ~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvc 374 (475)
T KOG0615|consen 298 IHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVC 374 (475)
T ss_pred ccccCCcceEEeccCCcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEE
Confidence 999999999999776 6699999999997653 234667899999999999987653 3377999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc-c--cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-K--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++|.+||.+..... .+.+++.. + +.......++.+..+||.+||..||++|||+.|+|++-
T Consensus 375 LsG~pPFS~~~~~~----------------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 375 LSGYPPFSEEYTDP----------------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred eccCCCcccccCCc----------------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 99999998653211 11122111 1 22234568899999999999999999999999999875
Q ss_pred Hh
Q 021507 255 ER 256 (311)
Q Consensus 255 ~~ 256 (311)
+-
T Consensus 439 W~ 440 (475)
T KOG0615|consen 439 WF 440 (475)
T ss_pred hh
Confidence 43
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=321.11 Aligned_cols=238 Identities=28% Similarity=0.436 Sum_probs=189.2
Q ss_pred ChhHHHhHHHHH---HhhhhHHHH-----HHHHHHHHHHHhcCCCCCccceEeEEEeCC--eeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLE---LHARSLLLI-----TNWFQTEVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~---~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~ 70 (311)
.||+|+++...+ +.+.+.... .+.+.+|+++|.+|+|||||++++.....+ .++++|||+.+|+|.+++.
T Consensus 29 s~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~ 108 (313)
T KOG0198|consen 29 SFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIK 108 (313)
T ss_pred cceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHH
Confidence 367777777653 444433333 566899999999999999999999754444 6899999999999999998
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCC-CCCcceeccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTH 148 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~gt~ 148 (311)
+.+. .+++..+..+..||++||+|||+++ |+||||||+|||++. ++.+||+|||++..... ...........||+
T Consensus 109 ~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp 185 (313)
T KOG0198|consen 109 RYGG-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTP 185 (313)
T ss_pred HcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCc
Confidence 7765 6999999999999999999999654 999999999999999 79999999999987553 11122244578999
Q ss_pred cccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHH
Q 021507 149 GYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 227 (311)
Q Consensus 149 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
.|||||++.++ ....++|||||||++.||+||..||.... .....+..+.........|..++.
T Consensus 186 ~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~~~~~~~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 186 NYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---------------EEAEALLLIGREDSLPEIPDSLSD 250 (313)
T ss_pred cccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---------------chHHHHHHHhccCCCCCCCcccCH
Confidence 99999999853 33459999999999999999999998630 011222233333333366778999
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
+..+++.+|+..||.+|||+++++++...
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 99999999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=305.66 Aligned_cols=247 Identities=22% Similarity=0.255 Sum_probs=192.3
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
.||+||-|++-+.. ..+...+.+-..||+++|++|+|+|+|.++++|.....+++|+|||+. ++.+.+.
T Consensus 14 SYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe 92 (396)
T KOG0593|consen 14 SYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELE 92 (396)
T ss_pred cceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHH
Confidence 48899999988754 444566788899999999999999999999999999999999999988 6666665
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
. .+.+++...+.+++.|++.|+.|+|+++ ++||||||+||||+.+|.+||||||+|+...... ..-+..+.|.||
T Consensus 93 ~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDYVATRWY 167 (396)
T KOG0593|consen 93 R-YPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDYVATRWY 167 (396)
T ss_pred h-ccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCc--chhhhhhhhhhc
Confidence 4 3456999999999999999999999654 9999999999999999999999999999865322 224567889999
Q ss_pred cCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhccccccchhhhhHhhhcc---------cCC
Q 021507 151 AAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRIMDTK---------LGG 219 (311)
Q Consensus 151 ~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---------~~~ 219 (311)
+|||.+.| .+|+.+.||||+||++.||++|.+.|.+...-.....+ ....+.......++..-..- ...
T Consensus 168 RaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~e 247 (396)
T KOG0593|consen 168 RAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPE 247 (396)
T ss_pred cChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCcc
Confidence 99999988 58999999999999999999999999886653332222 11222222111111110000 000
Q ss_pred C---CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 220 Q---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 220 ~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
. .-+..+..+.+|+.+||+.||.+|++.++++++
T Consensus 248 pLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 248 PLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred chhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0 112456689999999999999999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=313.81 Aligned_cols=246 Identities=25% Similarity=0.298 Sum_probs=192.2
Q ss_pred hhHHHhHHHHHHhhh-hHHHHHHH--------HHHHHHHHhcCC-CCCccceEeEEEeCC-eeEEEEecCCCCChHHHhh
Q 021507 2 FLFNFLHSHLELHAR-SLLLITNW--------FQTEVNYLGQLH-HPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 2 ~~~~~~~~~~~~~~~-~~~~~~~~--------~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~ 70 (311)
||.||+++..+.... .+...++. =.||++-|++|+ |||||++++++.+.+ .+|+|||||+. +|+++++
T Consensus 23 fGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK 101 (538)
T KOG0661|consen 23 FGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMK 101 (538)
T ss_pred ceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHh
Confidence 788888887775421 11222111 248999999998 999999999999988 89999999976 9999998
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
.+ .+.+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+....... -+..+.|.+|
T Consensus 102 ~R-~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWY 175 (538)
T KOG0661|consen 102 DR-NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP---YTEYVSTRWY 175 (538)
T ss_pred hc-CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecccccccccccCCC---cchhhhcccc
Confidence 87 6779999999999999999999995 4599999999999999888999999999998655443 3467889999
Q ss_pred cCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh--hcccccc---chhhhhHhhhcccCCCCc--
Q 021507 151 AAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD--WAKPYLS---DKRKLFRIMDTKLGGQYP-- 222 (311)
Q Consensus 151 ~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~~-- 222 (311)
+|||++.. +.|+.+.|+||+|||++|+.+-++.|.+.++..+...+. .+.|... ....+...+...+....+
T Consensus 176 RAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~ 255 (538)
T KOG0661|consen 176 RAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSP 255 (538)
T ss_pred cchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCC
Confidence 99998765 568999999999999999999999999877644333221 1112111 122333333333322221
Q ss_pred -----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 223 -----QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 223 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
...+.++.++|.+||.+||.+||||.+++++.
T Consensus 256 l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 256 LKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 24788999999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=315.47 Aligned_cols=231 Identities=25% Similarity=0.343 Sum_probs=192.3
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
.|++|++|+..+.. ...-..-.++..+|-.+|.+| .||.|+++|..|.++..+|+|+||+++|+|.++
T Consensus 85 SYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~ 164 (604)
T KOG0592|consen 85 SYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDL 164 (604)
T ss_pred cceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHH
Confidence 47888888776643 111122344677899999999 899999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc---------c
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---------H 139 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------~ 139 (311)
|.+.+. +++.....++.+|+.||+|||+ +|||||||||+|||++++|+++|+|||.++.+...... .
T Consensus 165 i~K~Gs--fde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a 240 (604)
T KOG0592|consen 165 IKKYGS--FDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQA 240 (604)
T ss_pred HHHhCc--chHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccc
Confidence 977654 9999999999999999999996 45999999999999999999999999999876543222 1
Q ss_pred ee--ccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc
Q 021507 140 VS--TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 217 (311)
Q Consensus 140 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (311)
.. ..++||..|++||++.+...+..+|||+||||+|.|+.|.+||.+.++.. ...+++. +
T Consensus 241 ~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl----------------iFqkI~~--l 302 (604)
T KOG0592|consen 241 SSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL----------------IFQKIQA--L 302 (604)
T ss_pred cCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----------------HHHHHHH--h
Confidence 11 45899999999999999999999999999999999999999999865421 1122222 2
Q ss_pred CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...++.+.++.+.+|+.++|..||.+|+|+++|.++
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 346778888999999999999999999999999865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=301.54 Aligned_cols=229 Identities=28% Similarity=0.350 Sum_probs=184.9
Q ss_pred ChhHHHhHHHHHHh---hhhH--------HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARSL--------LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||.||+.+..+.. +.++ ....+..++|..||.+++||.||.++..|++.+.+|+|+||+.||.|..+|
T Consensus 37 ~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL 116 (357)
T KOG0598|consen 37 SFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL 116 (357)
T ss_pred CCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHH
Confidence 46777766655432 1111 123445778999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
++.+. +++..+.-++.+|+.||.|||+.+ ||||||||+|||++.+|+++|+|||+++..... .....+.+||+.
T Consensus 117 ~~eg~--F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~e 190 (357)
T KOG0598|consen 117 QREGR--FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTPE 190 (357)
T ss_pred HhcCC--cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCcc
Confidence 76654 999999999999999999999655 999999999999999999999999999864332 223556899999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|||||++.+.+|+.++|.||||+++|+|++|.+||.+.+.... ..+++..+ ....+...+.+.
T Consensus 191 YmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~----------------~~~I~~~k-~~~~p~~ls~~a 253 (357)
T KOG0598|consen 191 YMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM----------------YDKILKGK-LPLPPGYLSEEA 253 (357)
T ss_pred ccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----------------HHHHhcCc-CCCCCccCCHHH
Confidence 9999999999999999999999999999999999987653211 11122222 223344578899
Q ss_pred HHHHHhcccCCCCCCC----CHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP----RMSEVLA 252 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp----t~~~~l~ 252 (311)
++++.++|..||++|. ++.++.+
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 9999999999999996 4555543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=328.28 Aligned_cols=240 Identities=30% Similarity=0.490 Sum_probs=204.2
Q ss_pred ChhHHHhHHHHHHh--------------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH--------------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
+||.||+++...+. -.+....+++|+||++++..|+|||||+++|+|.+++..|||+|||..|+|.
T Consensus 498 aFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~ 577 (774)
T KOG1026|consen 498 AFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLH 577 (774)
T ss_pred hhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHH
Confidence 58999998877643 2233337889999999999999999999999999999999999999999999
Q ss_pred HHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCC
Q 021507 67 NHLFRRGP------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134 (311)
Q Consensus 67 ~~l~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 134 (311)
++|....+ .+++..+.+.|+.||+.|+.||-++. +|||||-..|+||+++..|||+|||+++..-.
T Consensus 578 eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~VKIsDfGLsRdiYs 655 (774)
T KOG1026|consen 578 EFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVVKISDFGLSRDIYS 655 (774)
T ss_pred HHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEEEecccccchhhhh
Confidence 99965432 23889999999999999999999765 99999999999999999999999999987655
Q ss_pred CCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhh
Q 021507 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 213 (311)
Q Consensus 135 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (311)
.+.+.......-..+|||||.+..++|+++|||||+|+++||+++ |..||.+... ++..+.+
T Consensus 656 sDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-----------------~EVIe~i 718 (774)
T KOG1026|consen 656 SDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-----------------QEVIECI 718 (774)
T ss_pred hhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----------------HHHHHHH
Confidence 555555544555779999999999999999999999999999999 9999987432 2233333
Q ss_pred hcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 214 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
........|.+++.++++||..||+.+|++||++.||-..|+.+..
T Consensus 719 ~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 719 RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 3343467889999999999999999999999999999999988654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=314.64 Aligned_cols=210 Identities=26% Similarity=0.409 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
-++.+.+|+.+|+..+|+|||.+++.|...+.+|+||||++||+|.+.+.... +++.++..++.++++||+|||.
T Consensus 313 ~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~-- 387 (550)
T KOG0578|consen 313 KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHA-- 387 (550)
T ss_pred chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHh--
Confidence 34568899999999999999999999999999999999999999999885443 9999999999999999999995
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
++|+|||||.+|||++.+|.+||+|||++..+..... ...+.+||+.|||||++....|+.+.||||||++++||+-|
T Consensus 388 ~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG 465 (550)
T KOG0578|consen 388 RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG 465 (550)
T ss_pred cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence 4599999999999999999999999999987654432 35678999999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhc-ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||-..+.- ..+..+-.. ......+..++..+++|+.+||..|+++|+++.|+|++
T Consensus 466 EPPYlnE~Pl----------------rAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 466 EPPYLNENPL----------------RALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCccCCChH----------------HHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 9999753221 111111111 12234567899999999999999999999999999975
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=311.98 Aligned_cols=232 Identities=25% Similarity=0.332 Sum_probs=199.4
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCe-eEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l 69 (311)
+||-+++.+|-.-. .+.....++...+|+.+++++.|||||.+.+.|++++. .+|||+||+||+|.+.|
T Consensus 16 afG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i 95 (426)
T KOG0589|consen 16 AFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLI 95 (426)
T ss_pred ccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHH
Confidence 58888888876643 33334466688999999999999999999999999988 89999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
...+..-++++.+.+++.|++.|+.|||+ ++|+|||||+.||+++.++.|+|+|||+++...... ....+.+||+.
T Consensus 96 ~~~k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~ 171 (426)
T KOG0589|consen 96 KEQKGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPY 171 (426)
T ss_pred HHHhhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCc
Confidence 77776779999999999999999999995 559999999999999999999999999999876543 23567899999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+.||++.+.+|+.++|||||||++|||++-+++|.+.+.. .+...+........+..++.++
T Consensus 172 YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----------------~Li~ki~~~~~~Plp~~ys~el 234 (426)
T KOG0589|consen 172 YMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----------------ELILKINRGLYSPLPSMYSSEL 234 (426)
T ss_pred ccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----------------HHHHHHhhccCCCCCccccHHH
Confidence 99999999999999999999999999999999999875531 1222222223456678899999
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+|..||..+|..||++.+++..
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999999975
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=328.21 Aligned_cols=239 Identities=22% Similarity=0.273 Sum_probs=195.3
Q ss_pred ChhHHHhHHHHHH-h-------hhhHHHHHHHHHHHHHHHhcCC-CCCccceEeE-EEe---C---CeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLEL-H-------ARSLLLITNWFQTEVNYLGQLH-HPNLVKLIGY-CLE---G---ENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~-~~~---~---~~~~lv~e~~~~~~ 64 (311)
||++||++...+- . ....+...+.+++|+++|++|+ |+|||.++|. ... + -.++|+||||.||+
T Consensus 49 GFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~ 128 (738)
T KOG1989|consen 49 GFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGS 128 (738)
T ss_pred CcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCc
Confidence 7999999887765 1 2235667788999999999995 9999999993 221 1 23579999999999
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc----e
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH----V 140 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~----~ 140 (311)
|-+++.++....|++.++++|+.|+++|+++||..+..|||||||-+||||+.+|.+||||||.+...-...... .
T Consensus 129 Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ 208 (738)
T KOG1989|consen 129 LVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNY 208 (738)
T ss_pred HHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHH
Confidence 999998776667999999999999999999999988889999999999999999999999999997432221100 0
Q ss_pred ---eccccccccccCcccc---ccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhh
Q 021507 141 ---STQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 214 (311)
Q Consensus 141 ---~~~~~gt~~y~aPE~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (311)
.-....|+.|+|||.+ .+.+++.|+|||||||+||-||+...||+... ...++.
T Consensus 209 ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------------------~laIln 268 (738)
T KOG1989|consen 209 VEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------------------KLAILN 268 (738)
T ss_pred HHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------------ceeEEe
Confidence 0123579999999976 56789999999999999999999999998752 134445
Q ss_pred cccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 215 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 215 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.++.....+.+++.+.+||+.||+.||.+||++-+++..+-.+..
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 555444556899999999999999999999999999998877654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=284.72 Aligned_cols=247 Identities=24% Similarity=0.265 Sum_probs=189.3
Q ss_pred hhHHHhHHHHHHhh----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 2 FLFNFLHSHLELHA----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 2 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
||+||.+++.+... +...-+.....||++.|+.++|+||+.+.|+|...+.+.+|+||++. +|+..|+.
T Consensus 15 ~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd 93 (318)
T KOG0659|consen 15 YGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKD 93 (318)
T ss_pred eEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcc
Confidence 67777777766431 11111334578999999999999999999999999999999999986 99999866
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
+. ..++...+..++.++++||+|||++. |+||||||+|+|++.+|.+||+|||+++.+........ ..+-|.+|+
T Consensus 94 ~~-i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYR 168 (318)
T KOG0659|consen 94 KN-IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYR 168 (318)
T ss_pred cc-cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCcccc--cceeeeecc
Confidence 54 56999999999999999999999755 99999999999999999999999999998776554432 237799999
Q ss_pred CccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhh--hhhhccccccchhhh--------hHhhhcccCCC
Q 021507 152 APEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKRKL--------FRIMDTKLGGQ 220 (311)
Q Consensus 152 aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 220 (311)
|||.+.|. .|+...|+||.|||+.||+-|.+.|.+.+.-.+.. +.....|.......+ .+.........
T Consensus 169 APELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~ 248 (318)
T KOG0659|consen 169 APELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN 248 (318)
T ss_pred ChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc
Confidence 99999886 69999999999999999999998887765432221 122222222211111 11111111121
Q ss_pred CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 221 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.-..++.++.+|+.+||.+||.+|+++.+++++-
T Consensus 249 lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 249 LFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 2345677789999999999999999999998763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=298.36 Aligned_cols=223 Identities=26% Similarity=0.330 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+..|+.++||||+.++..|..+..+|+||.||.+|++.+.++..-+..+++..+..|+.++++||.|||.
T Consensus 67 ~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~-- 144 (516)
T KOG0582|consen 67 DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ-- 144 (516)
T ss_pred hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh--
Confidence 357789999999999999999999999999999999999999999999988878889999999999999999999995
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCC-Cccee-ccccccccccCcccccc--CCCCCCCceehhHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-RTHVS-TQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~ 176 (311)
+|.||||||+.||||+.+|.|||+|||.+..+.... ..... ....||+.|||||++.. ..|+.|+||||||++..|
T Consensus 145 ~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~E 224 (516)
T KOG0582|consen 145 NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACE 224 (516)
T ss_pred cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHH
Confidence 559999999999999999999999999886543332 22222 56789999999999654 379999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+|+.||............-...|+... ...........++..++.++..||..||.+|||++++++.
T Consensus 225 LA~G~aPf~k~pPmkvLl~tLqn~pp~~~--------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 225 LAHGHAPFSKYPPMKVLLLTLQNDPPTLL--------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HhcCCCCcccCChHHHHHHHhcCCCCCcc--------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 99999999875432111111000110000 0111122233567799999999999999999999999964
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=311.04 Aligned_cols=219 Identities=28% Similarity=0.421 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeC-CeeEEEEecCCCCChHHHhhhcC--------------------------
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRG-------------------------- 73 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-------------------------- 73 (311)
.+.+.+|+.++.++ +||||+++++++... +..|+||||+++|+|.+++....
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (338)
T cd05102 54 HKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133 (338)
T ss_pred HHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcc
Confidence 45688999999999 899999999988754 45799999999999999986432
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC
Q 021507 74 ----------------------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 119 (311)
Q Consensus 74 ----------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~ 119 (311)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDiKp~Nil~~~~~ 211 (338)
T cd05102 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR--KCIHRDLAARNILLSENN 211 (338)
T ss_pred ccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC--CEECCCCccceEEEcCCC
Confidence 12477888999999999999999965 599999999999999999
Q ss_pred cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhh
Q 021507 120 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198 (311)
Q Consensus 120 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 198 (311)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 212 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------- 284 (338)
T cd05102 212 VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------- 284 (338)
T ss_pred cEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------
Confidence 999999999976433222222233456678999999998899999999999999999997 999997643211
Q ss_pred ccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 199 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.....+........+..++..+.+++.+||..||++|||+.++++.|+.+.
T Consensus 285 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 285 ---------EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred ---------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011111111222334567788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.24 Aligned_cols=210 Identities=29% Similarity=0.436 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 20 LITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
...+.+.+|+.++++++ ||||+++++++.....+|+||||+.||+|.+++.+.+ .+.+..+..++.|++.|++|||+
T Consensus 61 ~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~ 138 (370)
T KOG0583|consen 61 KLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHS 138 (370)
T ss_pred ccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHh
Confidence 34556779999999998 9999999999999999999999999999999997743 48999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCC-CcEEEecccccccCCCCCCcceeccccccccccCccccccCC-CC-CCCceehhHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT-TKSDVYSFGVVLL 175 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Di~slG~il~ 175 (311)
++ |+||||||+|||++.+ +++||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||
T Consensus 139 ~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy 214 (370)
T KOG0583|consen 139 RG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILY 214 (370)
T ss_pred CC--EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHH
Confidence 55 9999999999999999 999999999998763 2223366789999999999999977 76 6899999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH-HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA-AHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.|++|..||+..+... +... ........|..+ +.++..|+.+||..||.+|+++.++++.
T Consensus 215 ~ml~G~~PF~d~~~~~-----------------l~~k-i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 215 VLLCGRLPFDDSNVPN-----------------LYRK-IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred HHHhCCCCCCCccHHH-----------------HHHH-HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 9999999999743211 1111 112223456666 9999999999999999999999999944
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=303.81 Aligned_cols=235 Identities=58% Similarity=0.973 Sum_probs=194.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCC-eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.|.+|++++.+++|||+|+++|||.+.+ +.+||+||+.+|+|.++|......+++|..+++|+.++|+||+|||...
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 345999999999999999999999999998 5999999999999999997654326999999999999999999999743
Q ss_pred -CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc-cccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 101 -SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV-MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 101 -~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
..|+|||||+.|||+|++...||+|||+++..... ... .... .||.+|+|||+...+..+.++||||||+++.|++
T Consensus 195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI 272 (361)
T ss_pred CCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence 26999999999999999999999999999764431 111 1122 7999999999999999999999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC-CCCch-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQ-KAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
+|+.+.+............|..+..... .+..+++..+. ..++. ..-..+..+..+|++.+|.+||++.++++.|+.
T Consensus 273 tgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 273 TGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred hCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 9999888655444444666665555444 66677777765 44443 466668899999999999999999999999966
Q ss_pred hcC
Q 021507 257 LEA 259 (311)
Q Consensus 257 ~~~ 259 (311)
+..
T Consensus 352 ~~~ 354 (361)
T KOG1187|consen 352 ILS 354 (361)
T ss_pred hcc
Confidence 543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=305.37 Aligned_cols=247 Identities=24% Similarity=0.227 Sum_probs=188.7
Q ss_pred hhHHHhHHHHHHh---hhh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHh
Q 021507 2 FLFNFLHSHLELH---ARS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 2 ~~~~~~~~~~~~~---~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 69 (311)
||.||.+++.+.. +.+ ....-....||+.||++|+||||+++.+.+.+. +.+|||+|||+. +|.-++
T Consensus 130 yg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl 208 (560)
T KOG0600|consen 130 YGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLL 208 (560)
T ss_pred hhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhh
Confidence 8999999988865 111 112334567899999999999999999999877 689999999987 999988
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
... ...|++.++..+++||+.||+|||+. ||+|||||..||||+++|.+||+|||+|+.+....... -+..+-|.+
T Consensus 209 ~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~--gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLW 284 (560)
T KOG0600|consen 209 SSP-GVKFTEPQIKCYMKQLLEGLEYCHSR--GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLW 284 (560)
T ss_pred cCC-CcccChHHHHHHHHHHHHHHHHHhhc--CeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEee
Confidence 543 35599999999999999999999965 59999999999999999999999999999765544332 445677999
Q ss_pred ccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh--hhccccccchh--hhh--HhhhcccCC---
Q 021507 150 YAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAKPYLSDKR--KLF--RIMDTKLGG--- 219 (311)
Q Consensus 150 y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~--~~~--~~~~~~~~~--- 219 (311)
|+|||++.|. .|+.+.|+||.||||.||+.|++.|.+.++-.+...+ ....|...... .+. ..+......
T Consensus 285 YRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~ 364 (560)
T KOG0600|consen 285 YRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRR 364 (560)
T ss_pred ccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccch
Confidence 9999999887 6999999999999999999999999988764433322 11111111111 000 000000000
Q ss_pred --CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 220 --QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 220 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.-...+....+|+..+|..||.+|.|+.++++.
T Consensus 365 l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 365 LRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0012456788899999999999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=310.36 Aligned_cols=206 Identities=29% Similarity=0.464 Sum_probs=179.1
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
.+.+|+-||+.+.||||+++|+++++..++|+|.||++||-|.+++..+++ +++.++.+++.||+.|+.|||..+ |
T Consensus 58 ~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~--i 133 (786)
T KOG0588|consen 58 GIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFN--I 133 (786)
T ss_pred chhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhc--c
Confidence 478999999999999999999999999999999999999999999977664 999999999999999999999765 9
Q ss_pred eecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCC-CCCceehhHHHHHHHHhCCC
Q 021507 104 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRC 182 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~ 182 (311)
+||||||+|+|++..+++||+|||.|.....+ ....+.+|++.|.+||++.|.+|. .++||||.|+|||.|++|++
T Consensus 134 cHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~L 210 (786)
T KOG0588|consen 134 CHRDLKPENLLLDVKNNIKIADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKL 210 (786)
T ss_pred eeccCCchhhhhhcccCEeeeccceeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCC
Confidence 99999999999999999999999999764332 235677999999999999999875 58999999999999999999
Q ss_pred ccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 183 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 183 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
||++.+... -+.++... ....|..++.++++||++||..||.+|.|++||+++.
T Consensus 211 PFdDdNir~----------------LLlKV~~G--~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 211 PFDDDNIRV----------------LLLKVQRG--VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred CCCCccHHH----------------HHHHHHcC--cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 999754311 11111112 2356788999999999999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=282.82 Aligned_cols=211 Identities=27% Similarity=0.382 Sum_probs=181.8
Q ss_pred HHHHHHhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHH
Q 021507 8 HSHLELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87 (311)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 87 (311)
-+.++.+.....+..+...+|..+|+.+.||+++++++.+.+.+.+||||||++||.|.+++++.++ +++..+.-++.
T Consensus 74 mKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAA 151 (355)
T KOG0616|consen 74 MKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAA 151 (355)
T ss_pred hhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHH
Confidence 3444455555555666788999999999999999999999999999999999999999999966543 99999999999
Q ss_pred HHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCce
Q 021507 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 167 (311)
Q Consensus 88 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 167 (311)
+|+.||+|||+.+ |++|||||+|||++.+|.+||+|||+|+..... .-+.+||+.|+|||++...+++.++|-
T Consensus 152 eivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDW 224 (355)
T KOG0616|consen 152 EIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDW 224 (355)
T ss_pred HHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhH
Confidence 9999999999755 999999999999999999999999999875443 456799999999999999999999999
Q ss_pred ehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 168 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 168 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
||||+++|||+.|.+||...+. .....+++..+. .+|.-++.++.+|+.++|+.|-.+|.
T Consensus 225 WalGVLIYEMlaG~pPF~~~~~----------------~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 225 WALGVLIYEMLAGYPPFYDDNP----------------IQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHHHHHHHHHcCCCCCcCCCh----------------HHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 9999999999999999987543 112223344333 57888999999999999999999993
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=303.45 Aligned_cols=229 Identities=25% Similarity=0.311 Sum_probs=181.8
Q ss_pred ChhHHHhHHHHHHh---------h--hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---------A--RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... . .........+.+|++++++++||||+++++++..++..|+||||+.|++|.+++
T Consensus 7 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 86 (323)
T cd05571 7 TFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 86 (323)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 57788877654311 0 011222345778999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .......||+.
T Consensus 87 ~~~~--~~~~~~~~~~~~qi~~~L~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~ 160 (323)
T cd05571 87 SRER--VFSEDRARFYGAEIVSALGYLHSC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPE 160 (323)
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCcc
Confidence 6543 489999999999999999999965 49999999999999999999999999987532211 11334578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||...+... ....+.. .....+..++.++
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----------------~~~~~~~-~~~~~p~~~~~~~ 222 (323)
T cd05571 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------LFELILM-EEIRFPRTLSPEA 222 (323)
T ss_pred ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-----------------HHHHHHc-CCCCCCCCCCHHH
Confidence 999999999999999999999999999999999997643211 1111111 1123455678899
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.++|.+||..||++|| ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999999 79998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=306.54 Aligned_cols=208 Identities=29% Similarity=0.379 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
-.+.+.+|++|++.|+|||||.++++|+...+.|+|+||+.| +|..+|.+.+. ++++.+..++.+++.||.|||+.
T Consensus 44 ~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~- 119 (808)
T KOG0597|consen 44 ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSN- 119 (808)
T ss_pred HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhc-
Confidence 344588999999999999999999999999999999999987 99999976654 99999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+|.|||+||+|||+...|.+|+||||+++.+.. ...+.....||+.|||||++.+.+|+..+|+||||||+||++.|
T Consensus 120 -rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G 196 (808)
T KOG0597|consen 120 -RILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVG 196 (808)
T ss_pred -CcccccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcC
Confidence 599999999999999999999999999998654 44456778999999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++||-..... .+.+.+ .......|...+..+..++...|.+||.+|.+..+++.+
T Consensus 197 ~PPF~a~si~-----------------~Lv~~I-~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 197 QPPFYARSIT-----------------QLVKSI-LKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCCchHHHHH-----------------HHHHHH-hcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 9999764321 111111 112234566889999999999999999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=292.94 Aligned_cols=215 Identities=20% Similarity=0.352 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
...+.|.+|+.+|++++||||+++++++.+ ....++||||++||+|.+++.... .+++.....++.+++.||.|
T Consensus 60 ~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~ 137 (283)
T PHA02988 60 VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYN 137 (283)
T ss_pred HHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHH
Confidence 345778899999999999999999999877 346799999999999999996543 48899999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc--CCCCCCCceehhHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVV 173 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~i 173 (311)
||+. .+++||||||+||+++.++.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||+
T Consensus 138 lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvi 211 (283)
T PHA02988 138 LYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211 (283)
T ss_pred HHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHH
Confidence 9963 35889999999999999999999999998754322 123467889999999976 678999999999999
Q ss_pred HHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 174 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|||++|..||...+... ..............+..++..+.+++.+||+.||++|||+.++++.
T Consensus 212 l~el~~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 212 LWEIFTGKIPFENLTTKE----------------IYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHCCCCCCCCCHHH----------------HHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999998643210 0011111122223444678899999999999999999999999999
Q ss_pred HHhhc
Q 021507 254 LERLE 258 (311)
Q Consensus 254 l~~~~ 258 (311)
|+.+.
T Consensus 276 l~~~~ 280 (283)
T PHA02988 276 LSLYK 280 (283)
T ss_pred HHHHH
Confidence 98753
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=271.72 Aligned_cols=229 Identities=24% Similarity=0.278 Sum_probs=186.6
Q ss_pred ChhHHHhHHHHHHhhhhHHH----------HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELHARSLLL----------ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
.||.|+.|-+......-..+ -.+.+.+|++|-+.|+|||||++++.+.+.+..|+|+|+++|++|..-|.
T Consensus 23 ~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV 102 (355)
T KOG0033|consen 23 AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 102 (355)
T ss_pred chHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHH
Confidence 47888888776543211111 34568899999999999999999999999999999999999999988776
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC---CcEEEecccccccCCCCCCcceecccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
++. -+++..+-.++.||+++|.|+|+ ++|||||+||+|+++... .-+||+|||++..... ...-....||
T Consensus 103 ~R~--~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~---g~~~~G~~Gt 175 (355)
T KOG0033|consen 103 ARE--FYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND---GEAWHGFAGT 175 (355)
T ss_pred HHH--HHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccceEEEeCC---ccccccccCC
Confidence 653 38899999999999999999996 559999999999999543 3499999999987652 2335567899
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHh-hhc--ccCCCCchH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDT--KLGGQYPQK 224 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~ 224 (311)
+.|||||++...+|+..+|||+-|+++|-++.|.+||.+.+. ..+++. +.. .........
T Consensus 176 P~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----------------~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 176 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------------HRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred CcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----------------HHHHHHHhccccCCCCcccCc
Confidence 999999999999999999999999999999999999987321 111111 111 233345568
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++++..+|+++||..||.+|.|+.|.|++
T Consensus 239 is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 239 VTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 89999999999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=296.16 Aligned_cols=234 Identities=24% Similarity=0.286 Sum_probs=183.7
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ..........+.+|++++++++|+||+++++++.+++..++||||+.+|+|.+++
T Consensus 12 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~ 91 (285)
T cd05631 12 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHI 91 (285)
T ss_pred CCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHH
Confidence 57788776654321 1111122345788999999999999999999999999999999999999999888
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ......|+..
T Consensus 92 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~ 166 (285)
T cd05631 92 YNMGNPGFDEQRAIFYAAELCCGLEDLQRE--RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVG 166 (285)
T ss_pred HhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCC
Confidence 655545699999999999999999999965 59999999999999999999999999997643221 1234578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|+.||.......... .....+ .......+..++.++
T Consensus 167 y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~-------------~~~~~~-~~~~~~~~~~~s~~~ 232 (285)
T cd05631 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE-------------EVDRRV-KEDQEEYSEKFSEDA 232 (285)
T ss_pred ccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH-------------HHHHHh-hcccccCCccCCHHH
Confidence 999999999999999999999999999999999998654311110 001111 111123455678899
Q ss_pred HHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
.+|+.+||+.||.+||+ +++++++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.33 Aligned_cols=213 Identities=24% Similarity=0.321 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
....+.+|+.+|+.++||||+++++++..++..|+||||++||+|.+++.+. ...++++..+..++.|++.||.|||+
T Consensus 108 ~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 187 (478)
T PTZ00267 108 QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS 187 (478)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456788999999999999999999999999999999999999999988542 23458999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
. +|+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 188 ~--~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 265 (478)
T PTZ00267 188 R--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265 (478)
T ss_pred C--CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHH
Confidence 5 59999999999999999999999999998754433322344567999999999999999999999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
+|..||...... .....+........+..++..+.++|.+||..||++||++.+++.
T Consensus 266 tg~~Pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 266 TLHRPFKGPSQR-----------------EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred hCCCCCCCCCHH-----------------HHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 999999764321 111111111112234567788999999999999999999999875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=301.28 Aligned_cols=226 Identities=23% Similarity=0.299 Sum_probs=180.7
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... ........+.+.+|+.++++++||||+++++++.+++..|+||||+.|++|.+++
T Consensus 30 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 109 (329)
T PTZ00263 30 SFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL 109 (329)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHH
Confidence 47777777654321 0111223456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... .....|++.
T Consensus 110 ~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~ 180 (329)
T PTZ00263 110 RKAG--RFPNDVAKFYHAELVLAFEYLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPE 180 (329)
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChh
Confidence 6554 488999999999999999999965 4999999999999999999999999999765332 223568999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+... ....+..++..+
T Consensus 181 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~~ 242 (329)
T PTZ00263 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----------------IYEKILAG--RLKFPNWFDGRA 242 (329)
T ss_pred hcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----------------HHHHHhcC--CcCCCCCCCHHH
Confidence 999999999999999999999999999999999997543210 00111111 123345577889
Q ss_pred HHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
.+|+.+||..||.+|++ +++++.+
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999996 6777755
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=300.23 Aligned_cols=219 Identities=27% Similarity=0.468 Sum_probs=185.5
Q ss_pred hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 15 ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 15 ~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
...+.++++.=+.+++-|++|+||||+.+.++|...--+|||||||..|-|...|+.+ .+++......|.++|+.|+.
T Consensus 149 tVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~ 226 (904)
T KOG4721|consen 149 TVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMN 226 (904)
T ss_pred eehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhH
Confidence 3455666676778999999999999999999999998999999999999999999654 45889999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 174 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 174 (311)
|||.++ |||||||.-||||+.+..|||+|||-++..... ...-.+.||..|||||++...+.+.|.||||||++|
T Consensus 227 YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVL 301 (904)
T KOG4721|consen 227 YLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVL 301 (904)
T ss_pred HHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHH
Confidence 999876 999999999999999999999999999865433 224467899999999999999999999999999999
Q ss_pred HHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|||+||..||.+-+. ..+ ++..-...+....|..+++-+.-||+.||+..|..||++.+++.+|
T Consensus 302 WEmLT~EiPYkdVds----sAI------------IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 302 WEMLTGEIPYKDVDS----SAI------------IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHhcCCCccccch----hee------------EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 999999999976331 111 1111122334456788999999999999999999999999999887
Q ss_pred Hh
Q 021507 255 ER 256 (311)
Q Consensus 255 ~~ 256 (311)
+-
T Consensus 366 dI 367 (904)
T KOG4721|consen 366 DI 367 (904)
T ss_pred hh
Confidence 53
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=293.36 Aligned_cols=218 Identities=28% Similarity=0.513 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------------CCCCHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKV 85 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~ 85 (311)
...+.|.+|++++.+++||||+++++++...+..|++|||+++++|.+++..... ..+++..++.+
T Consensus 50 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 129 (283)
T cd05048 50 KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129 (283)
T ss_pred HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999965422 45888999999
Q ss_pred HHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCC
Q 021507 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 165 (311)
Q Consensus 86 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 165 (311)
+.|++.||+|||+. +++|+||||+||++++++.++|+|||++................++..|+|||.+.+..++.++
T Consensus 130 ~~~l~~al~~lH~~--~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 207 (283)
T cd05048 130 AIQIAAGMEYLSSH--HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES 207 (283)
T ss_pred HHHHHHHHHHHHhC--CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhh
Confidence 99999999999965 5999999999999999999999999999754333222223344567889999999888999999
Q ss_pred ceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 166 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 166 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
|||||||++|||++ |..||.+.... .....+........+..++.++.+|+.+||+.||.+|
T Consensus 208 Dv~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 270 (283)
T cd05048 208 DIWSFGVVLWEIFSYGLQPYYGFSNQ-----------------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARR 270 (283)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhC
Confidence 99999999999998 99999764321 1122222222333456788999999999999999999
Q ss_pred CCHHHHHHHHHh
Q 021507 245 PRMSEVLAILER 256 (311)
Q Consensus 245 pt~~~~l~~l~~ 256 (311)
|++.++++.|++
T Consensus 271 p~~~~i~~~l~~ 282 (283)
T cd05048 271 PRFKDIHTRLRS 282 (283)
T ss_pred cCHHHHHHHHhc
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=305.79 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=192.0
Q ss_pred hhHHHhHHHHHHhhhhHHH-------HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 2 FLFNFLHSHLELHARSLLL-------ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
|||||..++...-+.+... ..+.|++|+.+|++-+|.||+-+.|++..... .||+.+|+|.+|+.+|+...
T Consensus 405 FGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e- 482 (678)
T KOG0193|consen 405 FGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE- 482 (678)
T ss_pred ccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh-
Confidence 8999999887755443332 56679999999999999999999999998876 99999999999999996554
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..|...+.+.|+.||++|+.|||.++ |||+|||..||++.++++|||+|||++.....-..........|...|||||
T Consensus 483 tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPE 560 (678)
T KOG0193|consen 483 TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPE 560 (678)
T ss_pred hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHH
Confidence 44999999999999999999999755 9999999999999999999999999997533222222233456788999999
Q ss_pred cccc---CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHH
Q 021507 155 YVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 231 (311)
Q Consensus 155 ~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (311)
+++. .+|+..+|||||||++|||++|.+||..... ++.+.....-++ .+.......++++++.+
T Consensus 561 vIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifmVGrG~l-----------~pd~s~~~s~~pk~mk~ 627 (678)
T KOG0193|consen 561 VIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFMVGRGYL-----------MPDLSKIRSNCPKAMKR 627 (678)
T ss_pred HHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEEeccccc-----------CccchhhhccCHHHHHH
Confidence 9865 4799999999999999999999999984321 111111111000 01111223467889999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 232 LALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
|+..||..++++||.+.+|+..|+.+..
T Consensus 628 Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 628 LLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 9999999999999999999998888765
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=297.76 Aligned_cols=224 Identities=26% Similarity=0.434 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC-----------------CCCCCHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-----------------PQPLSWAVR 82 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~ 82 (311)
.....|.+|++++.+++||||+++++++.+.+..++||||+.+++|.+++.... ...+++..+
T Consensus 61 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (304)
T cd05096 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL 140 (304)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHH
Confidence 345679999999999999999999999999999999999999999999885432 123678889
Q ss_pred HHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCC
Q 021507 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 162 (311)
Q Consensus 83 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 162 (311)
+.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++................++..|+|||++.+..++
T Consensus 141 ~~i~~~i~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (304)
T cd05096 141 LHVALQIASGMKYLSSL--NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218 (304)
T ss_pred HHHHHHHHHHHHHHHHC--CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC
Confidence 99999999999999965 4999999999999999999999999999765433322223344567889999999888999
Q ss_pred CCCceehhHHHHHHHHh--CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCC
Q 021507 163 TKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 163 ~~~Di~slG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 240 (311)
.++||||||+++|+|++ +..||.......... .................+..++..+.+++.+||..|
T Consensus 219 ~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 288 (304)
T cd05096 219 TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIE----------NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRD 288 (304)
T ss_pred chhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHH----------HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCC
Confidence 99999999999999987 567776543211000 000000000001111223456788999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 021507 241 PKLRPRMSEVLAILE 255 (311)
Q Consensus 241 p~~Rpt~~~~l~~l~ 255 (311)
|++|||+.++.+.|+
T Consensus 289 p~~RPs~~~i~~~l~ 303 (304)
T cd05096 289 CRERPSFSDIHAFLT 303 (304)
T ss_pred chhCcCHHHHHHHHh
Confidence 999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=305.56 Aligned_cols=218 Identities=28% Similarity=0.424 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------------------
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-------------------------- 73 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------------- 73 (311)
..+.+.+|++++..+ +||||+++++++.+++..++||||++||+|.+++....
T Consensus 81 ~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (375)
T cd05104 81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM 160 (375)
T ss_pred HHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence 345788999999999 89999999999999999999999999999999985432
Q ss_pred -----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeec
Q 021507 74 -----------------------------------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 106 (311)
Q Consensus 74 -----------------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~ 106 (311)
...+++..++.++.|++.||+|||+. +++||
T Consensus 161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~ 238 (375)
T cd05104 161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK--NCIHR 238 (375)
T ss_pred cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--Ceecc
Confidence 12478889999999999999999965 59999
Q ss_pred CCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccC
Q 021507 107 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVD 185 (311)
Q Consensus 107 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 185 (311)
||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 239 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 239 DLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred CCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999976543332222223345678999999999999999999999999999998 899997
Q ss_pred CCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 186 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
..... ....+.+........+...+.++.+|+.+||+.||++||++.++++.|++
T Consensus 319 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 319 GMPVD----------------SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCch----------------HHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 64321 11111222222222334457789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.49 Aligned_cols=219 Identities=28% Similarity=0.443 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------------------
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-------------------------- 73 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------------- 73 (311)
..+.+.+|+++++.+ +|+||+++++++.+.+..|+||||+.+|+|.+++....
T Consensus 84 ~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (374)
T cd05106 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE 163 (374)
T ss_pred HHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchh
Confidence 345688999999999 89999999999999999999999999999999885421
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCC
Q 021507 74 ------------------------------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 111 (311)
Q Consensus 74 ------------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~ 111 (311)
..++++..+++++.|++.||+|||+. +++||||||+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--giiHrDLkp~ 241 (374)
T cd05106 164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK--NCIHRDVAAR 241 (374)
T ss_pred cccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CEEeccCchh
Confidence 12478889999999999999999965 5999999999
Q ss_pred ceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccc
Q 021507 112 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVG 190 (311)
Q Consensus 112 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~ 190 (311)
||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 242 Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 242 NVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred eEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 99999999999999999976543322222223345678999999988899999999999999999997 99999764321
Q ss_pred hhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 191 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
...............+..++.++.+++.+||+.||.+|||+.++++.|+++
T Consensus 322 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 322 ----------------SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ----------------HHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111122222222233445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=298.38 Aligned_cols=229 Identities=27% Similarity=0.298 Sum_probs=180.7
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+.... ........+.+.+|+.++.+++||||+++++++.+.+..|+||||+.+|+|.+++
T Consensus 5 ~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 84 (312)
T cd05585 5 SFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL 84 (312)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHH
Confidence 57788776654321 0111223456788999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ ......||+.
T Consensus 85 ~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~ 158 (312)
T cd05585 85 QREG--RFDLSRARFYTAELLCALENLHKF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPE 158 (312)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcc
Confidence 6543 489999999999999999999965 499999999999999999999999999875322211 2334578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||....... ....+... ....+..++.++
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----------------~~~~~~~~--~~~~~~~~~~~~ 220 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----------------MYRKILQE--PLRFPDGFDRDA 220 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----------------HHHHHHcC--CCCCCCcCCHHH
Confidence 999999999999999999999999999999999997643210 01111111 123455678899
Q ss_pred HHHHHhcccCCCCCCCC---HHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPR---MSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt---~~~~l~~ 253 (311)
.+++.+||..||.+||+ +.+++.+
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 99999999999999985 5666643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=298.93 Aligned_cols=214 Identities=27% Similarity=0.343 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+.+|+.+++++ +|+||+++++++.+++..|+||||+.||+|.+++..+. .+++..+..++.||+.||+|||+.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~ 124 (332)
T cd05614 47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL 124 (332)
T ss_pred HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345688899999999 59999999999999999999999999999999986543 489999999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~ 178 (311)
+|+||||||+|||++.++.+||+|||++......... ......||..|+|||++.+. .++.++|||||||++|+|+
T Consensus 125 --~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 201 (332)
T cd05614 125 --GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201 (332)
T ss_pred --CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhh
Confidence 4999999999999999999999999999764332221 12345789999999999765 4788999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
+|..||......... ......+. ......+..++..+.+++.+||..||++|| ++++++++
T Consensus 202 tg~~pf~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 202 TGASPFTLEGERNTQ-------------SEVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred cCCCCCCCCCCCCCH-------------HHHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 999999753321110 00111111 112234456788899999999999999999 67788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=292.30 Aligned_cols=221 Identities=27% Similarity=0.462 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------------CCCCHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKV 85 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~ 85 (311)
...+.+.+|++++++++|+||+++++++...+..++||||+++++|.+++..... ..+++..++.+
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 128 (291)
T cd05094 49 AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHH
Confidence 3446789999999999999999999999999999999999999999999965321 34889999999
Q ss_pred HHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCC
Q 021507 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 165 (311)
Q Consensus 86 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 165 (311)
+.|++.||+|||+. +++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++
T Consensus 129 ~~~i~~al~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 206 (291)
T cd05094 129 ASQIASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206 (291)
T ss_pred HHHHHHHHHHHHhC--CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence 99999999999965 5999999999999999999999999999764433222223344567889999999998999999
Q ss_pred ceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 166 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 166 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
|||||||++|+|++ |..||....... .............+..++..+.+++.+||..||++|
T Consensus 207 Di~slG~il~el~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 269 (291)
T cd05094 207 DVWSFGVILWEIFTYGKQPWFQLSNTE-----------------VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQR 269 (291)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhC
Confidence 99999999999998 999987543211 111111111122334567789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021507 245 PRMSEVLAILERLEA 259 (311)
Q Consensus 245 pt~~~~l~~l~~~~~ 259 (311)
|++.++++.|+++..
T Consensus 270 pt~~~v~~~l~~~~~ 284 (291)
T cd05094 270 LNIKEIYKILHALGK 284 (291)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=296.61 Aligned_cols=226 Identities=24% Similarity=0.280 Sum_probs=180.9
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||+.+++|.+++
T Consensus 13 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 92 (291)
T cd05612 13 TFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL 92 (291)
T ss_pred CCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHH
Confidence 47777776654211 1111234456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... .....|++.
T Consensus 93 ~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~ 163 (291)
T cd05612 93 RNSG--RFSNSTGLFYASEIVCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPE 163 (291)
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChh
Confidence 6554 489999999999999999999965 5999999999999999999999999999764322 223568999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||........ ...+... ....+..++..+
T Consensus 164 y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~----------------~~~i~~~--~~~~~~~~~~~~ 225 (291)
T cd05612 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI----------------YEKILAG--KLEFPRHLDLYA 225 (291)
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhC--CcCCCccCCHHH
Confidence 9999999988899999999999999999999999976432110 0111111 123445567889
Q ss_pred HHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
.+++.+||+.||.+|++ +++++++
T Consensus 226 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 226 KDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 99999999999999995 8888755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=296.25 Aligned_cols=208 Identities=26% Similarity=0.352 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|+++++.++||||+++++++..++..|+||||+++++|..++.... .+++..+..++.|++.||+|||+.
T Consensus 39 ~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~-- 114 (323)
T cd05595 39 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR-- 114 (323)
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3457789999999999999999999999999999999999999998886543 489999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++||||||+|||++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 115 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~ 192 (323)
T cd05595 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (323)
T ss_pred CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCC
Confidence 499999999999999999999999999875322111 123456899999999999999999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.||...+.... ...+... ....+..++.++.++|.+||..||++|+ ++.+++++
T Consensus 193 ~Pf~~~~~~~~----------------~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 193 LPFYNQDHERL----------------FELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCHHHH----------------HHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 99976432110 0011111 1134556788999999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=272.27 Aligned_cols=230 Identities=25% Similarity=0.347 Sum_probs=194.9
Q ss_pred hhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 2 FLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 2 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
||.||+++.-+-+ ......+..++.+|++|...|+||||+++|++|.++..+|+++||...|+|...|.
T Consensus 35 FG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~ 114 (281)
T KOG0580|consen 35 FGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQ 114 (281)
T ss_pred cccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHH
Confidence 7778877766533 22233456679999999999999999999999999999999999999999999998
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
.+....+++.....++.|++.||.|+|. ++++||||||+|+|++..|.+||+|||-+.....+ ...+.+||..|
T Consensus 115 ~~~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----kR~tlcgt~dy 188 (281)
T KOG0580|consen 115 EGRMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN----KRKTLCGTLDY 188 (281)
T ss_pred hcccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceeecCCC----Cceeeeccccc
Confidence 6666779999999999999999999995 55999999999999999999999999999764422 35678999999
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
.+||...+...+...|+|++|++.||++.|.+||...... ....++. +....+|..++..++
T Consensus 189 l~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~--k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 189 LPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIR--KVDLKFPSTISGGAA 250 (281)
T ss_pred CCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHH--HccccCCcccChhHH
Confidence 9999999999999999999999999999999999875421 1111221 223345788999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
++|.+||..+|.+|.+..+++++-.
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHHhccCccccccHHHHhhhHH
Confidence 9999999999999999999998754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=297.81 Aligned_cols=229 Identities=25% Similarity=0.308 Sum_probs=181.3
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... ..........+.+|+++++.++||||+++++++.+++..|+||||+++++|.+++
T Consensus 7 ~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l 86 (328)
T cd05593 7 TFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL 86 (328)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHH
Confidence 57778776654321 0111223356788999999999999999999999999999999999999999988
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... .......||+.
T Consensus 87 ~~~~--~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~ 160 (328)
T cd05593 87 SRER--VFSEDRTRFYGAEIVSALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPE 160 (328)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcC
Confidence 6543 489999999999999999999965 59999999999999999999999999987532211 11234578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||...+... ....+. ......+..++.++
T Consensus 161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----------------~~~~~~-~~~~~~p~~~~~~~ 222 (328)
T cd05593 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------LFELIL-MEDIKFPRTLSADA 222 (328)
T ss_pred ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----------------HHHHhc-cCCccCCCCCCHHH
Confidence 999999998899999999999999999999999997643211 011110 01123455678899
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.+++.+||..||++|+ ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=270.81 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=185.4
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~~~L~~ 67 (311)
||+.|++.+++... .....+-.+..++|++..++++||||++++++...+. ..|++++|+..|+|.+
T Consensus 33 Gfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d 112 (302)
T KOG2345|consen 33 GFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLD 112 (302)
T ss_pred CceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHH
Confidence 78888888744321 1111234455788999999999999999998876443 3899999999999999
Q ss_pred HhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce-----
Q 021507 68 HLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV----- 140 (311)
Q Consensus 68 ~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~----- 140 (311)
.|.... ...+++.+++.++.++++||++||+....++||||||.|||+++.+.++|.|||.++..........
T Consensus 113 ~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~l 192 (302)
T KOG2345|consen 113 EIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRL 192 (302)
T ss_pred HHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHH
Confidence 996543 3359999999999999999999997666799999999999999999999999999976543221111
Q ss_pred --eccccccccccCcccccc---CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc
Q 021507 141 --STQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 215 (311)
Q Consensus 141 --~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (311)
-.....|..|+|||.+.- ...+.++|||||||++|+|++|..||+..-.. ...-...+...
T Consensus 193 Qe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------------GgSlaLAv~n~ 258 (302)
T KOG2345|consen 193 QEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------------GGSLALAVQNA 258 (302)
T ss_pred HHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------------CCeEEEeeecc
Confidence 112357899999998854 45788999999999999999999999753210 00011111122
Q ss_pred ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 216 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
...-.....++..+.+++..||+.||.+||++.+++..++.+.
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 2222233348899999999999999999999999999987653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=284.96 Aligned_cols=205 Identities=24% Similarity=0.379 Sum_probs=175.2
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
.+++|++||..|+||||+++|++|+..+.+.|||||..+|.|++++..++. +++.++..++.||+.|+.|+| ++++
T Consensus 99 hIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCH--knrV 174 (668)
T KOG0611|consen 99 HIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCH--KNRV 174 (668)
T ss_pred HHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHh--hccc
Confidence 377899999999999999999999999999999999999999999976654 999999999999999999999 4669
Q ss_pred eecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCC-CCCceehhHHHHHHHHhCCC
Q 021507 104 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRC 182 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~ 182 (311)
+|||||.+|||++.++++||+|||++..+.... ..++++|++.|.+||++.|.+|. +..|-||||++||.++.|.+
T Consensus 175 vHRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtM 251 (668)
T KOG0611|consen 175 VHRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTM 251 (668)
T ss_pred eecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccc
Confidence 999999999999999999999999998764432 35678999999999999998874 57999999999999999999
Q ss_pred ccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 183 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 183 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
||++.+. ..+.+++.... -..+.-+....-||+.||..||++|-|++++..+.
T Consensus 252 PFDG~Dh-----------------k~lvrQIs~Ga--YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 252 PFDGRDH-----------------KRLVRQISRGA--YREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccCCchH-----------------HHHHHHhhccc--ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 9998653 22222222221 01223456678899999999999999999999874
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=288.59 Aligned_cols=236 Identities=26% Similarity=0.424 Sum_probs=186.8
Q ss_pred ChhHHHhHHHHHH--------------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLEL--------------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
+||.||++.+... .........+.|.+|+++++.++|+||+++++++..++..|+||||+++++|.
T Consensus 17 ~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 96 (280)
T cd05049 17 AFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96 (280)
T ss_pred CCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHH
Confidence 5788888765322 01111224578999999999999999999999999999999999999999999
Q ss_pred HHhhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCC
Q 021507 67 NHLFRRG------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134 (311)
Q Consensus 67 ~~l~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 134 (311)
+++...+ ...+++..+..++.|++.||.+||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 97 ~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~ 174 (280)
T cd05049 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174 (280)
T ss_pred HHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeeccccccceEEEcCCCeEEECCcccceeccc
Confidence 9996543 23478899999999999999999965 599999999999999999999999999875433
Q ss_pred CCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhh
Q 021507 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 213 (311)
Q Consensus 135 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (311)
...........++..|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-----------------~~~~~ 237 (280)
T cd05049 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-----------------VIECI 237 (280)
T ss_pred CcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHH
Confidence 222222333455778999999999999999999999999999998 999987543211 11111
Q ss_pred hcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 214 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
........+..++..+.+++.+||..||++||++.|+++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 122222334567889999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.25 Aligned_cols=208 Identities=29% Similarity=0.377 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|+++++.++||||+++++++..++..|+||||+.|++|.+++.+.+ .+.+..+..++.|++.||+|||+.
T Consensus 44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~-- 119 (323)
T cd05584 44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ-- 119 (323)
T ss_pred HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3457889999999999999999999999999999999999999999986554 378889999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+|+||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 120 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 197 (323)
T cd05584 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197 (323)
T ss_pred CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCC
Confidence 599999999999999999999999999875322211 233457899999999999888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.||...+... ....+... ....+..++..+.++|.+||..||++|| ++++++++
T Consensus 198 ~pf~~~~~~~----------------~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 198 PPFTAENRKK----------------TIDKILKG--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 9997643211 11111111 1234556788899999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=296.73 Aligned_cols=230 Identities=26% Similarity=0.342 Sum_probs=188.9
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
.||.||.+.+-+.. -.......+++.+|+.+|.+++++||.++|+.+..+..+|++||||.||++.+.++.
T Consensus 25 sfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~ 104 (467)
T KOG0201|consen 25 SFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS 104 (467)
T ss_pred ccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc
Confidence 37777777766643 122233445688899999999999999999999999999999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.. .+.+..+..++.+++.||.|||+++ .+|||||+.|||+..+|.+||+|||.+......... ..+++||+.||
T Consensus 105 ~~--~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwM 178 (467)
T KOG0201|consen 105 GN--ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWM 178 (467)
T ss_pred CC--CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhc--ccccccccccc
Confidence 44 2588888889999999999999755 999999999999999999999999999876544332 36789999999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 231 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (311)
|||++.+..|+.++||||||++.|||++|.+||..... ...++ .+.+.....+...+++.+.+
T Consensus 179 APEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlf-lIpk~~PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 179 APEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLF-LIPKSAPPRLDGDFSPPFKE 241 (467)
T ss_pred chhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEE-eccCCCCCccccccCHHHHH
Confidence 99999988999999999999999999999999987542 11111 11222222334478889999
Q ss_pred HHHhcccCCCCCCCCHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|+..||++||+.||+|.+++++
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhh
Confidence 9999999999999999999964
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=297.93 Aligned_cols=230 Identities=25% Similarity=0.306 Sum_probs=181.3
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ..........+.+|+++++.++||||+++++++.+++..|+||||+.|++|.+++
T Consensus 7 ~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l 86 (325)
T cd05594 7 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 86 (325)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 57888876654321 0111223345778999999999999999999999999999999999999999988
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.||+.||+|||+. ++|+||||||+|||++.++.+||+|||++........ ......||..
T Consensus 87 ~~~~--~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~ 161 (325)
T cd05594 87 SRER--VFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPE 161 (325)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcc
Confidence 5543 489999999999999999999962 4599999999999999999999999999875322211 1234568999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||...+... ....+. ......+..++.++
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----------------~~~~i~-~~~~~~p~~~~~~~ 223 (325)
T cd05594 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------LFELIL-MEEIRFPRTLSPEA 223 (325)
T ss_pred cCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----------------HHHHHh-cCCCCCCCCCCHHH
Confidence 999999999999999999999999999999999997643211 011110 01123455678889
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.+++.+||+.||++|+ ++.+++++
T Consensus 224 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 9999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.98 Aligned_cols=246 Identities=23% Similarity=0.309 Sum_probs=182.0
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||+.+++|.+++..
T Consensus 17 ~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 96 (333)
T cd06650 17 NGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 96 (333)
T ss_pred CCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH
Confidence 47777776654221 011223456789999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.+ .+++..+..++.+++.||.|||+. ++++|+||||+||+++.++.+||+|||++...... ......|+..|+
T Consensus 97 ~~--~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~ 169 (333)
T cd06650 97 AG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 169 (333)
T ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCcccc
Confidence 44 488999999999999999999963 35999999999999999999999999998754322 123456899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhh------------------------ccccccc--
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW------------------------AKPYLSD-- 205 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------------------~~~~~~~-- 205 (311)
|||++.+..++.++|+|||||++|+|++|..||.............. ..+....
T Consensus 170 aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (333)
T cd06650 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPM 249 (333)
T ss_pred CHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccc
Confidence 99999988899999999999999999999999975433211110000 0000000
Q ss_pred -hhhhhHhhhcccCCCC-chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 206 -KRKLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 206 -~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.......+........ ...++.++.+|+.+||+.||++|||+.+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 250 AIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000011111111111 12356789999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=287.77 Aligned_cols=221 Identities=27% Similarity=0.474 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC-----------CCCCCHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-----------PQPLSWAVRMKVAIG 88 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~ 88 (311)
...+.+.+|++++++++||||+++++++...+..|+||||+++++|.+++.... ...+++..++.++.|
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 128 (288)
T cd05093 49 NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128 (288)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999986432 234899999999999
Q ss_pred HHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCcee
Q 021507 89 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 168 (311)
Q Consensus 89 i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 168 (311)
++.||+|||+. +++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||
T Consensus 129 l~~aL~~lH~~--~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiw 206 (288)
T cd05093 129 IAAGMVYLASQ--HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206 (288)
T ss_pred HHHHHHHHHhC--CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHH
Confidence 99999999965 5999999999999999999999999999765332222222234457789999999988899999999
Q ss_pred hhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCH
Q 021507 169 SFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 169 slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 247 (311)
||||++|+|++ |..||....... ....+........+..++.++.+++.+||+.||.+|||+
T Consensus 207 slG~il~~l~t~g~~p~~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 269 (288)
T cd05093 207 SLGVVLWEIFTYGKQPWYQLSNNE-----------------VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNI 269 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999999998 999987543211 001111111112234567789999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 021507 248 SEVLAILERLEA 259 (311)
Q Consensus 248 ~~~l~~l~~~~~ 259 (311)
.++++.|+++..
T Consensus 270 ~~v~~~l~~~~~ 281 (288)
T cd05093 270 KEIHSLLQNLAK 281 (288)
T ss_pred HHHHHHHHHHHH
Confidence 999999988763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=288.31 Aligned_cols=214 Identities=25% Similarity=0.348 Sum_probs=171.8
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+.+..|++++++++||||+++++++.++...|+||||+.|++|.+++.......+++..+..++.|++.||+|||+. +
T Consensus 38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ 115 (277)
T cd05607 38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM--D 115 (277)
T ss_pred HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--C
Confidence 44567999999999999999999999999999999999999999988766656689999999999999999999965 5
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 182 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 182 (311)
++||||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 116 ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~ 192 (277)
T cd05607 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRT 192 (277)
T ss_pred EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987654322 1233568899999999998889999999999999999999999
Q ss_pred ccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 183 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 183 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
||.......... ........... ......++.++.+++.+||+.||++||++.|+++.+
T Consensus 193 p~~~~~~~~~~~------------~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 193 PFKDHKEKVAKE------------ELKRRTLEDEV-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCCCCcchhhHH------------HHHHHhhcccc-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 997543211100 00011111111 111235678899999999999999999997766444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.01 Aligned_cols=228 Identities=23% Similarity=0.333 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++||||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~ 122 (331)
T cd06649 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK 122 (331)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc
Confidence 345679999999999999999999999999999999999999999999996543 489999999999999999999963
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
++|+||||||+||+++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++
T Consensus 123 -~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 197 (331)
T cd06649 123 -HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI 197 (331)
T ss_pred -CCEEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 35999999999999999999999999998754322 1234568999999999998899999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhcc----------------c----------ccc---chhhhhHh-hhcccCCCCchHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAK----------------P----------YLS---DKRKLFRI-MDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~----------------~----------~~~---~~~~~~~~-~~~~~~~~~~~~~~~~l 229 (311)
|+.||................ + ... ........ ............++.++
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (331)
T cd06649 198 GRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDF 277 (331)
T ss_pred CCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHH
Confidence 999997543221111000000 0 000 00000111 11111111122467889
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.+||.+||..||++|||+++++++.
T Consensus 278 ~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 278 QEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCh
Confidence 9999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=294.28 Aligned_cols=232 Identities=23% Similarity=0.270 Sum_probs=182.6
Q ss_pred ChhHHHhHHHHHHh---h-----hhH---HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A-----RSL---LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-----~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
|||.||||+..... + ++. ....+-.+.|-.+|...++|+||++|..|.+.+++||||||++||++..+|
T Consensus 153 AfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL 232 (550)
T KOG0605|consen 153 AFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL 232 (550)
T ss_pred cceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHH
Confidence 68999998766543 1 111 122334667899999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCC--------------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-------------- 135 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------- 135 (311)
.+.+ .+++..+..++.+++.|++.||+.+ +|||||||+|+||+..|++||+|||++.-....
T Consensus 233 ~~~~--~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~ 308 (550)
T KOG0605|consen 233 MRKD--TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQI 308 (550)
T ss_pred HhcC--cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhh
Confidence 7665 4999999999999999999999655 999999999999999999999999998532110
Q ss_pred ------CCc-c------------------------eeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCcc
Q 021507 136 ------DRT-H------------------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184 (311)
Q Consensus 136 ------~~~-~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 184 (311)
... . .....+|||-|+|||++.+.+|+..+|.||||||+||||.|.+||
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF 388 (550)
T KOG0605|consen 309 NLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPF 388 (550)
T ss_pred hhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 000 0 011347999999999999999999999999999999999999999
Q ss_pred CCCccchhhhhhhhccccccchhhhhHhhhcccCCCC--chHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 021507 185 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRP---RMSEVLAI 253 (311)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---t~~~~l~~ 253 (311)
.+.+.... ..+++..+....+ ...++++..+||.+||. ||++|. .++||.++
T Consensus 389 ~s~tp~~T----------------~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 389 CSETPQET----------------YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred CCCCHHHH----------------HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 88654322 2222222211222 23457899999999999 999998 47777654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.80 Aligned_cols=214 Identities=23% Similarity=0.254 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++..++||||+++++++.+++..|+||||++|++|.+++.... .+++..+..++.|++.||+|||+.+
T Consensus 44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ 121 (333)
T cd05600 44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG 121 (333)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34568889999999999999999999999999999999999999999996543 4889999999999999999999654
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
++||||||+||+++.++.+||+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 122 --ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g 194 (333)
T cd05600 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194 (333)
T ss_pred --ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhC
Confidence 99999999999999999999999999976433 23445789999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||...+.......+... ...+...........++.++.+++.+||..+|.+||++.+++++
T Consensus 195 ~~pf~~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 195 FPPFSGSTPNETWENLKYW----------KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCCCCHHHHHHHHHhc----------cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 9999865432111100000 00000000000112467889999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=298.83 Aligned_cols=232 Identities=22% Similarity=0.227 Sum_probs=176.0
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||++||+|.+++
T Consensus 13 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l 92 (377)
T cd05629 13 AFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML 92 (377)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHH
Confidence 57788876543321 1111233456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-----------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------- 138 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------- 138 (311)
.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 93 ~~~~--~~~~~~~~~~~~ql~~aL~~LH~~--givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~ 168 (377)
T cd05629 93 IKYD--TFSEDVTRFYMAECVLAIEAVHKL--GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168 (377)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccc
Confidence 6543 488999999999999999999965 4999999999999999999999999998632110000
Q ss_pred ----------------------------------ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCcc
Q 021507 139 ----------------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184 (311)
Q Consensus 139 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 184 (311)
......+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf 248 (377)
T cd05629 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPF 248 (377)
T ss_pred cccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCC
Confidence 0001246899999999999989999999999999999999999999
Q ss_pred CCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc--hHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 021507 185 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLR---PRMSEVLAI 253 (311)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~R---pt~~~~l~~ 253 (311)
........ ...+.........+ ..++.++.++|.+||. +|.+| +++.+++.+
T Consensus 249 ~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 249 CSENSHET----------------YRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHH----------------HHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 76432110 00111100011112 2467889999999997 67765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=274.20 Aligned_cols=246 Identities=21% Similarity=0.223 Sum_probs=184.7
Q ss_pred hhHHHhHHHHHHh---hhhHHHH---H----HHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHh
Q 021507 2 FLFNFLHSHLELH---ARSLLLI---T----NWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 2 ~~~~~~~~~~~~~---~~~~~~~---~----~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 69 (311)
||.||.+++-..+ +.+-.+. . -...||+.+|.+++|||||.+..++... +.+|||||||+. +|.+++
T Consensus 89 yGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~ 167 (419)
T KOG0663|consen 89 YGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLM 167 (419)
T ss_pred ceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHH
Confidence 6777777766544 1111111 1 1256899999999999999999998754 568999999987 999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.+ .++...++..+..|++.|++|||+. .|+|||||++|+|++..|.+||+|||+|+.++..... -+..+-|.+
T Consensus 168 d~m~-q~F~~~evK~L~~QlL~glk~lH~~--wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLW 242 (419)
T KOG0663|consen 168 ETMK-QPFLPGEVKTLMLQLLRGLKHLHDN--WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLW 242 (419)
T ss_pred Hhcc-CCCchHHHHHHHHHHHHHHHHHhhc--eeEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEee
Confidence 6654 5699999999999999999999965 4999999999999999999999999999988765322 344677999
Q ss_pred ccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh--hhhccccccchhh-----------hhHhhhc
Q 021507 150 YAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL--VDWAKPYLSDKRK-----------LFRIMDT 215 (311)
Q Consensus 150 y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~-----------~~~~~~~ 215 (311)
|+|||++.|. .|+++.|+||+|||+.||+++.+.|.+..+..+... .....|....... .......
T Consensus 243 YRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn 322 (419)
T KOG0663|consen 243 YRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYN 322 (419)
T ss_pred ecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCch
Confidence 9999999886 699999999999999999999999988765332221 1111111111100 0011111
Q ss_pred ccCCCCchH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 216 KLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 216 ~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+...++.. .++...+|+..+|.+||.+|.|+++.|++
T Consensus 323 ~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 323 NLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 112222222 67889999999999999999999999875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=282.52 Aligned_cols=235 Identities=26% Similarity=0.360 Sum_probs=182.4
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+.... ..........|.+|++++++++||||+++++++...+..|+||||+.+++|.+++..
T Consensus 7 ~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 86 (252)
T cd05084 7 NFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT 86 (252)
T ss_pred cCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh
Confidence 47778776553211 111234556799999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.................+..|+
T Consensus 87 ~~-~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 163 (252)
T cd05084 87 EG-PRLKVKELIQMVENAAAGMEYLESK--HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT 163 (252)
T ss_pred CC-CCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeec
Confidence 43 3489999999999999999999964 59999999999999999999999999987543221111111112345699
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
|||.+.+..++.++|+||||+++|+|++ |..||...... .....+........+..++..+.
T Consensus 164 aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~ 226 (252)
T cd05084 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----------------QTREAIEQGVRLPCPELCPDAVY 226 (252)
T ss_pred CchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHcCCCCCCcccCCHHHH
Confidence 9999988889999999999999999998 88888653221 11111122222234456678899
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
+++.+||..+|++|||+.++++.|+
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHh
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=286.90 Aligned_cols=212 Identities=27% Similarity=0.370 Sum_probs=168.7
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQP-LSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
+...+|+.||+++.|||||+++++..+ .+.+|||+|||..|.+... ....+ +++.++++++.+++.||+|||.+
T Consensus 153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q 229 (576)
T KOG0585|consen 153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ 229 (576)
T ss_pred HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc
Confidence 357889999999999999999999875 4678999999998877542 22334 89999999999999999999976
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCC---CcceeccccccccccCccccccCC----CCCCCceehhHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGV 172 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~ 172 (311)
+ ||||||||.|+|++.+|.|||+|||.+....... ........+||+.|+|||.+.++. .+.+.||||||+
T Consensus 230 g--iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 230 G--IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred C--eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 5 9999999999999999999999999998653221 111123468999999999987742 355789999999
Q ss_pred HHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
+||.|+.|+.||.+.... .-..+++...+.......+...+.+||.+||.+||++|.++.+|..
T Consensus 308 TLYCllfG~~PF~~~~~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFEL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred hHHHhhhccCCcccchHH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 999999999999875421 1122333333332333457889999999999999999999999987
Q ss_pred HHH
Q 021507 253 ILE 255 (311)
Q Consensus 253 ~l~ 255 (311)
+..
T Consensus 372 Hpw 374 (576)
T KOG0585|consen 372 HPW 374 (576)
T ss_pred cce
Confidence 764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=299.36 Aligned_cols=221 Identities=25% Similarity=0.385 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC-------------------------
Q 021507 20 LITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------------------- 73 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------- 73 (311)
...+.|.+|+++|.++. ||||+++++++.+.+..|+|||||++|+|.+++..+.
T Consensus 82 ~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (400)
T cd05105 82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE 161 (400)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence 34567899999999996 9999999999999999999999999999999885421
Q ss_pred ---------------------------------------------------------------------CCCCCHHHHHH
Q 021507 74 ---------------------------------------------------------------------PQPLSWAVRMK 84 (311)
Q Consensus 74 ---------------------------------------------------------------------~~~~~~~~~~~ 84 (311)
...+++..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~ 241 (400)
T cd05105 162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLS 241 (400)
T ss_pred cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHH
Confidence 12478888899
Q ss_pred HHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCC
Q 021507 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 164 (311)
Q Consensus 85 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 164 (311)
++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++................++..|+|||++.+..++.+
T Consensus 242 ~~~qi~~aL~~LH~~--~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 319 (400)
T cd05105 242 FTYQVARGMEFLASK--NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL 319 (400)
T ss_pred HHHHHHHHHHHHHhC--CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch
Confidence 999999999999964 599999999999999999999999999976543322222233456788999999988899999
Q ss_pred CceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 165 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 165 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
+|||||||++|+|++ |..||....... .....+........+..++.++.+++.+||..||++
T Consensus 320 ~DiwSlGvil~ellt~g~~P~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 383 (400)
T cd05105 320 SDVWSYGILLWEIFSLGGTPYPGMIVDS----------------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEK 383 (400)
T ss_pred hhHHHHHHHHHHHHHCCCCCCcccchhH----------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhH
Confidence 999999999999997 999987542210 111111122222334567888999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 021507 244 RPRMSEVLAILERLE 258 (311)
Q Consensus 244 Rpt~~~~l~~l~~~~ 258 (311)
||++.++.+.|+++.
T Consensus 384 RPt~~~l~~~l~~l~ 398 (400)
T cd05105 384 RPSFLHLSDIVESLL 398 (400)
T ss_pred CcCHHHHHHHHHHHc
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=292.79 Aligned_cols=228 Identities=24% Similarity=0.268 Sum_probs=174.6
Q ss_pred ChhHHHhHHHHHHhh---hh--------HHHHHHHHHHH-HHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELHA---RS--------LLLITNWFQTE-VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~--------~~~~~~~~~~E-~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+..... .+ .......+.+| ..+++.++||||+++++++.+.+..|+||||+.|++|.++
T Consensus 7 ~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (325)
T cd05602 7 SFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYH 86 (325)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHH
Confidence 578888776543220 00 01112233334 4457888999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........ ......||+
T Consensus 87 ~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~--giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~ 160 (325)
T cd05602 87 LQRER--CFLEPRARFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTP 160 (325)
T ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCc
Confidence 86543 488889999999999999999965 499999999999999999999999999875322211 233457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+.... ...+... ....+..++..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------------~~~i~~~--~~~~~~~~~~~ 222 (325)
T cd05602 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----------------YDNILNK--PLQLKPNITNS 222 (325)
T ss_pred cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH----------------HHHHHhC--CcCCCCCCCHH
Confidence 99999999999999999999999999999999999976432110 0111111 11234467888
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
+.+++.+||+.||.+|+++.+.+.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHH
Confidence 999999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.18 Aligned_cols=221 Identities=29% Similarity=0.425 Sum_probs=187.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-----GPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
.....|.+|+.+|++++|||||+++|++.+.+..++++|||+||+|..+|+.. ....++....+.++.||++|+.
T Consensus 737 ~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~ 816 (1025)
T KOG1095|consen 737 QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMN 816 (1025)
T ss_pred HHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhH
Confidence 34556999999999999999999999999999999999999999999999654 1345999999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 174 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 174 (311)
||++.+ +|||||...|+|++....|||+|||+|+..-....+.......-...|||||.+..+.++.++||||||+++
T Consensus 817 YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVll 894 (1025)
T KOG1095|consen 817 YLESKH--FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLL 894 (1025)
T ss_pred HHHhCC--CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHH
Confidence 999755 999999999999999999999999999954444444433333445789999999999999999999999999
Q ss_pred HHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 175 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 175 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
||+++ |..||...+. .++...+...-+.+.|..|++.+.++|..||+.+|++||++..|++.
T Consensus 895 WEifslG~~PY~~~~n-----------------~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 895 WEIFSLGATPYPSRSN-----------------FEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred HHHHhCCCCCCCCcch-----------------HHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 99999 9999987542 22233222333667888999999999999999999999999999998
Q ss_pred HHhhcC
Q 021507 254 LERLEA 259 (311)
Q Consensus 254 l~~~~~ 259 (311)
+..+..
T Consensus 958 ~~~i~~ 963 (1025)
T KOG1095|consen 958 DPAISN 963 (1025)
T ss_pred hhhhhh
Confidence 877643
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=292.86 Aligned_cols=238 Identities=26% Similarity=0.375 Sum_probs=180.8
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... ........+.+.+|..++..+ +||||+++++++.+.+..|+||||++||+|.++
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 86 (329)
T cd05588 7 SYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFH 86 (329)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHH
Confidence 57778777654321 011122345578899999999 799999999999999999999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ......||.
T Consensus 87 ~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~ 160 (329)
T cd05588 87 MQRQR--KLPEEHARFYSAEISLALNFLHER--GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTP 160 (329)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccccccCCc
Confidence 85543 499999999999999999999965 499999999999999999999999999864222111 133457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|+|||||++|+|++|..||+....... +.........+.+.. .....+..++..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~p~~~~~~ 231 (329)
T cd05588 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN--------PDQNTEDYLFQVILE-KQIRIPRSLSVK 231 (329)
T ss_pred cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc--------ccccchHHHHHHHHc-CCCCCCCCCCHH
Confidence 99999999999999999999999999999999999974321100 000000111111111 122345667888
Q ss_pred HHHHHHhcccCCCCCCCC------HHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPR------MSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt------~~~~l~~ 253 (311)
+.+++.+||..||.+|++ +.+++++
T Consensus 232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=290.18 Aligned_cols=228 Identities=22% Similarity=0.244 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++||||+++++++..++..|+||||+.++.+..+... ...+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~- 119 (287)
T cd07848 43 VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN- 119 (287)
T ss_pred chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 456688999999999999999999999999999999999998666554422 23589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++||||||+||+++.++.+||+|||++......... ......|+..|+|||++.+..++.++|||||||++|+|++|
T Consensus 120 -~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred -CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 4999999999999999999999999999865332211 12345689999999999988899999999999999999999
Q ss_pred CCccCCCccchhhh-hhhhccccccchhhhh------Hhhh-cc------cCCCCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 181 RCAVDKTKVGIEQS-LVDWAKPYLSDKRKLF------RIMD-TK------LGGQYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 181 ~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
+.||.......... ......+......... .... .. ........++.++.+|+.+||+.||++|||
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s 277 (287)
T cd07848 198 QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL 277 (287)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC
Confidence 99998654321111 0111011000000000 0000 00 000111236778999999999999999999
Q ss_pred HHHHHHH
Q 021507 247 MSEVLAI 253 (311)
Q Consensus 247 ~~~~l~~ 253 (311)
+++++++
T Consensus 278 ~~~~l~h 284 (287)
T cd07848 278 TEQCLNH 284 (287)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=286.00 Aligned_cols=213 Identities=24% Similarity=0.341 Sum_probs=170.9
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
+.+..|+++++.++|+||+++++++..+...|+||||++||+|..++... ....+++..+..++.|++.||+|||+.
T Consensus 38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~- 116 (280)
T cd05608 38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116 (280)
T ss_pred HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678999999999999999999999999999999999999999887432 234589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+|+||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 117 -~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g 193 (280)
T cd05608 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA 193 (280)
T ss_pred -CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 599999999999999999999999999976433221 12345789999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
+.||......... ........ ......+..++..+.+++.+||+.||++|| ++++++++
T Consensus 194 ~~pf~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 194 RGPFRARGEKVEN-------------KELKQRIL-NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCCCCCCCcchhH-------------HHHHHhhc-ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 9999764321110 00001000 011133456788999999999999999999 66777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=288.91 Aligned_cols=221 Identities=21% Similarity=0.358 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|+.+++.++||||+++++++... ..++++||+.+|+|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 51 ~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~ 128 (316)
T cd05108 51 KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER 128 (316)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788999999999999999999998764 5789999999999999986543 3488999999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++
T Consensus 129 --~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t 206 (316)
T cd05108 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206 (316)
T ss_pred --CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 499999999999999999999999999987544332222223344678999999999999999999999999999997
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||++.... .....+........+..++..+.+++.+||..||.+||++.+++..+..+.
T Consensus 207 ~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 207 FGSKPYDGIPAS-----------------EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCCCCCCHH-----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999764311 111122222222334456778999999999999999999999999998875
Q ss_pred CCC
Q 021507 259 APK 261 (311)
Q Consensus 259 ~~~ 261 (311)
...
T Consensus 270 ~~~ 272 (316)
T cd05108 270 RDP 272 (316)
T ss_pred cCC
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=295.93 Aligned_cols=232 Identities=23% Similarity=0.251 Sum_probs=179.3
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... + .......+.+.+|+++++.++||||+++++++.+++..|+||||+.||+|.+++
T Consensus 13 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l 92 (364)
T cd05599 13 AFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL 92 (364)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHH
Confidence 57888877664321 0 111233456788999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc----------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH---------- 139 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------- 139 (311)
...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..........
T Consensus 93 ~~~~--~l~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 168 (364)
T cd05599 93 MKKD--TFTEEETRFYIAETILAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168 (364)
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccc
Confidence 6554 489999999999999999999965 49999999999999999999999999986532211000
Q ss_pred --------------------------eeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhh
Q 021507 140 --------------------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 193 (311)
Q Consensus 140 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 193 (311)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~- 247 (364)
T cd05599 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET- 247 (364)
T ss_pred ccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH-
Confidence 01124689999999999998999999999999999999999999986542111
Q ss_pred hhhhhccccccchhhhhHhhhcc--cCCCCchHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 021507 194 SLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSEVLAI 253 (311)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~~l~~ 253 (311)
...+.... ........++.++.++|.+||. +|.+|++ +.+++++
T Consensus 248 ---------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 248 ---------------YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred ---------------HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 01111111 1111112457789999999996 9999998 8888864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=280.83 Aligned_cols=236 Identities=28% Similarity=0.407 Sum_probs=187.8
Q ss_pred ChhHHHhHHHHHHh-------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELH-------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+...... ........+.+.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++....
T Consensus 18 ~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 97 (261)
T cd05148 18 YFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97 (261)
T ss_pred CCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC
Confidence 46777776554311 11222235568899999999999999999999999999999999999999999997655
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
...+++..++.++.+++.||.|||+. +++|+||||+||+++.++.+||+|||.+......... .....++..|+||
T Consensus 98 ~~~~~~~~~~~~~~~i~~al~~lH~~--~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~P 173 (261)
T cd05148 98 GQVLPVASLIDMACQVAEGMAYLEEQ--NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAP 173 (261)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCH
Confidence 56689999999999999999999964 5999999999999999999999999999765332211 2233456789999
Q ss_pred cccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHH
Q 021507 154 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 232 (311)
Q Consensus 154 E~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 232 (311)
|.+.+..++.++||||||+++|+|++ |..||...... ..............+..++..+.++
T Consensus 174 E~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-----------------EVYDQITAGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-----------------HHHHHHHhCCcCCCCCCCCHHHHHH
Confidence 99988889999999999999999998 89999764321 1111111222223455677889999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 233 ALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 233 i~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+.+||..||.+|||+.++++.|+.+
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 237 MLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHcCCCchhCcCHHHHHHHHhcC
Confidence 9999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=286.36 Aligned_cols=213 Identities=27% Similarity=0.389 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|+.++++++||||+++++.+.+++..|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 121 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-- 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 345788999999999999999999999999999999999999999988665555699999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||||+||++++++.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 122 ~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 599999999999999999999999999976533221 23346899999999998888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.||.+....... ......+. ......+..++..+.+|+.+||..||++|| ++++++++
T Consensus 199 ~pf~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 199 SPFRQRKEKVKR-------------EEVERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CCCCCCchhhHH-------------HHHHHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 999864321110 00111111 112234456788899999999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=269.11 Aligned_cols=215 Identities=28% Similarity=0.382 Sum_probs=181.4
Q ss_pred hHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 17 SLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
...+..+.-.+|+.||+++ .||||+++.++|+.+...++|+|.|+-|.|.|++.. ...+++....+++.|+.+|++|
T Consensus 61 ~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVey 138 (411)
T KOG0599|consen 61 TPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEY 138 (411)
T ss_pred cHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHH
Confidence 3556677778899999999 799999999999999999999999999999999954 3569999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc------CCCCCCCceeh
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT------GRLTTKSDVYS 169 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~s 169 (311)
||..+ ||||||||+|||++++.++||+|||+++....+.. ....+||++|+|||.+.- ..|+...|+||
T Consensus 139 lHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa 213 (411)
T KOG0599|consen 139 LHARN--IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWA 213 (411)
T ss_pred HHHhh--hhhcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHH
Confidence 99654 99999999999999999999999999998765543 456799999999998743 46888999999
Q ss_pred hHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHHHHHHHHHhcccCCCCCCCCH
Q 021507 170 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 170 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 247 (311)
+|+|+|.++.|.+||.-.... -.+..++..+ +......+++.+..+||.+||+.||.+|.|+
T Consensus 214 ~GVImyTLLaGcpPFwHRkQm----------------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rita 277 (411)
T KOG0599|consen 214 CGVIMYTLLAGCPPFWHRKQM----------------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITA 277 (411)
T ss_pred HHHHHHHHHcCCCchhHHHHH----------------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccH
Confidence 999999999999999754321 1122223333 3334456889999999999999999999999
Q ss_pred HHHHHHH
Q 021507 248 SEVLAIL 254 (311)
Q Consensus 248 ~~~l~~l 254 (311)
+|++.+-
T Consensus 278 ke~LaHp 284 (411)
T KOG0599|consen 278 KEALAHP 284 (411)
T ss_pred HHHhcCh
Confidence 9999753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.18 Aligned_cols=201 Identities=27% Similarity=0.341 Sum_probs=162.7
Q ss_pred HHHHHHH-HHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 24 WFQTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 24 ~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
.+.+|.. +++.++||||+++++++.+.+..|+||||+.|++|.+++.... .+++..+..++.||+.||+|||+. +
T Consensus 41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--g 116 (323)
T cd05575 41 HIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL--N 116 (323)
T ss_pred HHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--C
Confidence 3444444 5678999999999999999999999999999999999886543 489999999999999999999965 5
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 182 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 182 (311)
|+||||||+|||++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 117 ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 194 (323)
T cd05575 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194 (323)
T ss_pred eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCC
Confidence 9999999999999999999999999987532221 12334578999999999999999999999999999999999999
Q ss_pred ccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 183 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 183 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
||...+... ....+.... ...+..++..+.++|.+||+.||.+||++.
T Consensus 195 pf~~~~~~~----------------~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 195 PFYSRDTAE----------------MYDNILNKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHH----------------HHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 997643211 001111111 123445688899999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=284.04 Aligned_cols=216 Identities=25% Similarity=0.396 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------CCCCHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKG 92 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~ 92 (311)
....|.+|+.+++.++||||+++++++.+++..++||||+.+++|.+++.+... ..+++..+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999865321 236778899999999999
Q ss_pred HHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 93 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 93 l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
|+|||+. +++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||
T Consensus 132 l~~lH~~--~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (277)
T cd05062 132 MAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209 (277)
T ss_pred HHHHHHC--CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHH
Confidence 9999964 59999999999999999999999999987643332222222334577899999999888999999999999
Q ss_pred HHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 173 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 173 il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
++|+|++ |..||....... ....+........+..++..+.+++.+||+.||++|||+.+++
T Consensus 210 ~l~el~~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 272 (277)
T cd05062 210 VLWEIATLAEQPYQGMSNEQ-----------------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHH-----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999999 788987543211 1111111111123445677899999999999999999999999
Q ss_pred HHHH
Q 021507 252 AILE 255 (311)
Q Consensus 252 ~~l~ 255 (311)
+.|+
T Consensus 273 ~~l~ 276 (277)
T cd05062 273 SSIK 276 (277)
T ss_pred HHhh
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=283.73 Aligned_cols=217 Identities=26% Similarity=0.437 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC-------------CCCCHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-------------QPLSWAVRMKVA 86 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~ 86 (311)
...+.|.+|+++++.++|+||+++++++.+.+..+++|||+.+++|.+++..... ..+++..++.++
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 128 (280)
T cd05092 49 SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHH
Confidence 3456799999999999999999999999999999999999999999999865432 348899999999
Q ss_pred HHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCc
Q 021507 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 166 (311)
Q Consensus 87 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 166 (311)
.|++.||+|||+. +++|+||||+||++++++.+||+|||++................++..|+|||.+.+..++.++|
T Consensus 129 ~qi~~al~~LH~~--~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 206 (280)
T cd05092 129 SQIASGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 206 (280)
T ss_pred HHHHHHHHHHHHC--CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhh
Confidence 9999999999965 59999999999999999999999999987543322222222334567899999999999999999
Q ss_pred eehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 167 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 167 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
||||||++|+|++ |..||....... .............+..++..+.+++.+||+.||.+||
T Consensus 207 i~slG~il~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp 269 (280)
T cd05092 207 IWSFGVVLWEIFTYGKQPWYQLSNTE-----------------AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRM 269 (280)
T ss_pred HHHHHHHHHHHHcCCCCCCccCCHHH-----------------HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999999999998 999986533211 0111111111223445778899999999999999999
Q ss_pred CHHHHHHHHH
Q 021507 246 RMSEVLAILE 255 (311)
Q Consensus 246 t~~~~l~~l~ 255 (311)
++.++++.|+
T Consensus 270 ~~~~l~~~l~ 279 (280)
T cd05092 270 VIKDIHSRLQ 279 (280)
T ss_pred CHHHHHHHHh
Confidence 9999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=292.18 Aligned_cols=224 Identities=31% Similarity=0.432 Sum_probs=190.7
Q ss_pred hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 17 SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
........|.+|++++++++|||||++||+......+++|||+|.||+|.++|+..+. .++..+.+.++.+.+.||+||
T Consensus 200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YL 278 (474)
T KOG0194|consen 200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYL 278 (474)
T ss_pred ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHH
Confidence 3455677899999999999999999999999999999999999999999999977654 599999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceec-cccccccccCccccccCCCCCCCceehhHHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST-QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 175 (311)
|+.+ ++||||-..|||++.++.+||+|||+++... ...... ...-...|+|||.+....++.++|||||||++|
T Consensus 279 h~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~ 353 (474)
T KOG0194|consen 279 HSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLW 353 (474)
T ss_pred HHCC--CcchhHhHHHheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEE
Confidence 9655 9999999999999999999999999997632 121122 223467899999999999999999999999999
Q ss_pred HHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 176 ELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 176 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|+++ |..||.+.... .....++....+...+...+.++..++.+||..||++||++.++.+.+
T Consensus 354 Eif~~g~~Py~g~~~~----------------~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 354 EIFENGAEPYPGMKNY----------------EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred eeeccCCCCCCCCCHH----------------HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 9999 88899875431 222333355667777888999999999999999999999999999999
Q ss_pred HhhcCCCC
Q 021507 255 ERLEAPKN 262 (311)
Q Consensus 255 ~~~~~~~~ 262 (311)
+.+.....
T Consensus 418 ~~~~~~~~ 425 (474)
T KOG0194|consen 418 EALEKKKE 425 (474)
T ss_pred HHHHhccc
Confidence 98765544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.29 Aligned_cols=206 Identities=24% Similarity=0.301 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++||||+++++++.+++..|+||||+.||+|.+++.... .+++..+..++.|++.||.|||+.
T Consensus 74 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~- 150 (340)
T PTZ00426 74 QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL- 150 (340)
T ss_pred hHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34567889999999999999999999999999999999999999999996554 489999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 151 -~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G 224 (340)
T PTZ00426 151 -NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224 (340)
T ss_pred -CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcC
Confidence 4999999999999999999999999999764322 2345789999999999988899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
..||...+.... ...+... ....+..++..+.+++.+||+.||.+|+ ++++++++
T Consensus 225 ~~Pf~~~~~~~~----------------~~~i~~~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 225 CPPFYANEPLLI----------------YQKILEG--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCCHHHH----------------HHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999976432110 0111111 1124556678899999999999999995 88888765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.31 Aligned_cols=229 Identities=24% Similarity=0.298 Sum_probs=175.1
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+.... ........+.+.+|+++++.++|+||+++++++.+++..|+||||+++++|.+..
T Consensus 86 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-- 163 (353)
T PLN00034 86 AGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-- 163 (353)
T ss_pred CCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--
Confidence 57788877654221 1112334567899999999999999999999999999999999999999987532
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
...+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ ......|+..|+
T Consensus 164 ----~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~ 235 (353)
T PLN00034 164 ----IADEQFLADVARQILSGIAYLHRR--HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYM 235 (353)
T ss_pred ----cCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCcccc
Confidence 256778889999999999999965 599999999999999999999999999976432211 123457899999
Q ss_pred Ccccccc-----CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 152 APEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 152 aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|||++.. ...+.++|||||||++|+|++|+.||........ ...............+..++
T Consensus 236 aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--------------ASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred CccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--------------HHHHHHHhccCCCCCCCccC
Confidence 9998743 2345689999999999999999999974321110 01111111112223345678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.++.+||.+||..||++||++.|++++
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999999875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=291.60 Aligned_cols=223 Identities=27% Similarity=0.338 Sum_probs=175.7
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +.+ .....+.+.+|..++..+ +||||+++++++.+.+..|+||||++||+|.++
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~ 86 (320)
T cd05590 7 SFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFH 86 (320)
T ss_pred CCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHH
Confidence 57888877654321 111 112334567888888877 799999999999999999999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .......||+
T Consensus 87 i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~--~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~ 160 (320)
T cd05590 87 IQKSR--RFDEARARFYAAEITSALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTP 160 (320)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCc
Confidence 86543 489999999999999999999965 49999999999999999999999999987532221 1233457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+.. .....+..++.+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----------------~~~~i~~-~~~~~~~~~~~~ 222 (320)
T cd05590 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----------------LFEAILN-DEVVYPTWLSQD 222 (320)
T ss_pred cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----------------HHHHHhc-CCCCCCCCCCHH
Confidence 9999999998899999999999999999999999998644211 1111111 111234457888
Q ss_pred HHHHHHhcccCCCCCCCCH
Q 021507 229 AATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~ 247 (311)
+.+++.+||+.||.+|+++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=277.31 Aligned_cols=228 Identities=26% Similarity=0.298 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEe-----CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
.++-.||+++|++++|+||+.+++++.. -+.+|+|+|+|+ .+|...|+.+. .++...+.-++.|++.||+|+
T Consensus 65 akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyi 141 (359)
T KOG0660|consen 65 AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYI 141 (359)
T ss_pred HHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchh
Confidence 3446689999999999999999999875 356899999995 49999986553 399999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ 175 (311)
|+.+ ++||||||.|++++.+..+||+|||+|+..........-+..+.|.+|+|||++.. ..|+.+.||||.|||+.
T Consensus 142 HSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~A 219 (359)
T KOG0660|consen 142 HSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILA 219 (359)
T ss_pred hccc--ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHH
Confidence 9765 99999999999999999999999999998754322222355678999999998755 57999999999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccch--hh--------hhHhhhcccCCC---CchHHHHHHHHHHHhcccCCCC
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK--RK--------LFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPK 242 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~ 242 (311)
||++|++.|.+.+.-.+...+...-+..... .. ..+.+....... .-++.+....+|+.+||..||.
T Consensus 220 EmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~ 299 (359)
T KOG0660|consen 220 EMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPK 299 (359)
T ss_pred HHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCcc
Confidence 9999999999877644433332211111100 00 000011111001 1126678899999999999999
Q ss_pred CCCCHHHHHHHH
Q 021507 243 LRPRMSEVLAIL 254 (311)
Q Consensus 243 ~Rpt~~~~l~~l 254 (311)
+|+|++|++.+.
T Consensus 300 kRita~eAL~hP 311 (359)
T KOG0660|consen 300 KRITAEEALAHP 311 (359)
T ss_pred ccCCHHHHhcCh
Confidence 999999999753
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=298.73 Aligned_cols=232 Identities=23% Similarity=0.368 Sum_probs=193.6
Q ss_pred hhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh-c
Q 021507 2 FLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR-R 72 (311)
Q Consensus 2 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~ 72 (311)
||+||.+++...+ ..+..+..+-+..|+.+.++|+|.|||+++|.+.+++.+-|.||-++||+|.++++. .
T Consensus 588 YG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW 667 (1226)
T KOG4279|consen 588 YGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW 667 (1226)
T ss_pred eeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc
Confidence 7889999888765 334445566688999999999999999999999999999999999999999999954 3
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
++.+-++.++-.+-+||++||.|||.. .|||||||-+||||+. .|.+||.|||-++....-.. ...++.||..||
T Consensus 668 GPlKDNEstm~fYtkQILeGLkYLHen--~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETFTGTLQYM 743 (1226)
T KOG4279|consen 668 GPLKDNESTMNFYTKQILEGLKYLHEN--KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYM 743 (1226)
T ss_pred CCCccchhHHHHHHHHHHHHhhhhhhc--ceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccccccchhhh
Confidence 443348889999999999999999964 4999999999999964 68899999999987644332 356788999999
Q ss_pred CccccccC--CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 152 APEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 152 aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|||++..+ .|+.++|||||||++.||.||++||-.... ....+++.-..+.-...|...+.++
T Consensus 744 APEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs---------------pqAAMFkVGmyKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 744 APEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS---------------PQAAMFKVGMYKVHPPIPEELSAEA 808 (1226)
T ss_pred ChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC---------------hhHhhhhhcceecCCCCcHHHHHHH
Confidence 99999876 588899999999999999999999965322 2223344444445556788999999
Q ss_pred HHHHHhcccCCCCCCCCHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
..+|.+|+..||.+||++.+++.
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999986
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=277.05 Aligned_cols=216 Identities=25% Similarity=0.420 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++|+||+++++++..++..+++|||+++++|.+++.......+++..++.++.|++.||+|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-- 123 (263)
T cd05052 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 123 (263)
T ss_pred HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 346889999999999999999999999999999999999999999999765555689999999999999999999964
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |
T Consensus 124 ~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g 202 (263)
T cd05052 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 202 (263)
T ss_pred CEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence 5999999999999999999999999999765432211 1112234567999999988899999999999999999998 9
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
..||.+.... .....+........+..++.++.+++.+||..||++||++.++++.|+.+
T Consensus 203 ~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 203 MSPYPGIDLS-----------------QVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9998764321 11122222223344566788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=291.14 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=179.8
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... + .......+.+.+|+.++.++ +||||+++++++.+++..|+||||+++++|..+
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~ 86 (329)
T cd05618 7 SYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 86 (329)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHH
Confidence 57777776554321 0 11122345677899998877 899999999999999999999999999999988
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ......||.
T Consensus 87 ~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~ 160 (329)
T cd05618 87 MQRQR--KLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTP 160 (329)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCc
Confidence 85543 489999999999999999999965 499999999999999999999999999875322111 133457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||........ +.........+... ......|..++..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--------~~~~~~~~~~~~i~-~~~~~~p~~~~~~ 231 (329)
T cd05618 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--------PDQNTEDYLFQVIL-EKQIRIPRSLSVK 231 (329)
T ss_pred cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC--------cccccHHHHHHHHh-cCCCCCCCCCCHH
Confidence 99999999999999999999999999999999999964211000 00000111111111 1122356677888
Q ss_pred HHHHHHhcccCCCCCCCCH------HHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRM------SEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~------~~~l~~ 253 (311)
+.+++.+||..||++|+++ .+++++
T Consensus 232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=284.50 Aligned_cols=216 Identities=25% Similarity=0.456 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC---------------CCCCCHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---------------PQPLSWAVRMKVA 86 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~ 86 (311)
.+.|.+|++++++++||||+++++++..+...|+||||+.+++|.+++.... ...+++..++.++
T Consensus 51 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 130 (283)
T cd05090 51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHH
Confidence 3568899999999999999999999999999999999999999999985332 1347888999999
Q ss_pred HHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCc
Q 021507 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 166 (311)
Q Consensus 87 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 166 (311)
.+++.||+|||+. +++|+||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|
T Consensus 131 ~~i~~al~~lH~~--~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 208 (283)
T cd05090 131 IQIAAGMEYLSSH--FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSD 208 (283)
T ss_pred HHHHHHHHHHHhc--CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhh
Confidence 9999999999964 59999999999999999999999999998654333222233344567899999998888999999
Q ss_pred eehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 167 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 167 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
+||||+++|+|++ |..||.+.... .....+........+..++..+.+++.+||+.||.+||
T Consensus 209 v~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (283)
T cd05090 209 IWSFGVVLWEIFSFGLQPYYGFSNQ-----------------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271 (283)
T ss_pred hHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc
Confidence 9999999999998 99998753311 11111111222233455778899999999999999999
Q ss_pred CHHHHHHHHHh
Q 021507 246 RMSEVLAILER 256 (311)
Q Consensus 246 t~~~~l~~l~~ 256 (311)
++.++++.|..
T Consensus 272 ~~~~i~~~l~~ 282 (283)
T cd05090 272 RFKDIHTRLRS 282 (283)
T ss_pred CHHHHHHHhhc
Confidence 99999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=280.96 Aligned_cols=219 Identities=26% Similarity=0.432 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
......|.+|+.++++++||||+++++++.+++..+++|||+.+++|.+++..... .+++..++.++.+++.||+|||+
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~ 124 (266)
T cd05033 46 DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSE 124 (266)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence 33456788999999999999999999999999999999999999999999865433 58999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
++++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 125 --~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~ 202 (266)
T cd05033 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202 (266)
T ss_pred --CCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHH
Confidence 459999999999999999999999999998764222222222234567899999999889999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |..||...... .....+........+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 203 ~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 203 SYGERPYWDMSNQ-----------------DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ccCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 8 99998653311 11111111112223445678899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=275.53 Aligned_cols=215 Identities=27% Similarity=0.347 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
...+...|-+||+.++||.++.+|..|+.+...|+|||||+||+|..+++++..+.+++..+.-++.+++.||+|||-.+
T Consensus 120 Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG 199 (459)
T KOG0610|consen 120 KLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG 199 (459)
T ss_pred HHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc
Confidence 34457779999999999999999999999999999999999999999998888888999999999999999999999655
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCC--------------------------------C-C----------
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG--------------------------------D-R---------- 137 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------------------------------~-~---------- 137 (311)
||+|||||+||||.++|++.|+||.++...... . .
T Consensus 200 --ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~ 277 (459)
T KOG0610|consen 200 --IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESAS 277 (459)
T ss_pred --eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccc
Confidence 999999999999999999999999987532110 0 0
Q ss_pred -----------cceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccch
Q 021507 138 -----------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 206 (311)
Q Consensus 138 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 206 (311)
......++||-.|+|||++.|...+.+.|.|+||+++|||+.|..||.+.+ ..
T Consensus 278 ~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~----------------~~ 341 (459)
T KOG0610|consen 278 RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN----------------NK 341 (459)
T ss_pred ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC----------------ch
Confidence 001124679999999999999999999999999999999999999998854 33
Q ss_pred hhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC----HHHHHHH
Q 021507 207 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR----MSEVLAI 253 (311)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~~l~~ 253 (311)
..+.+++.....-.....++..+++||+++|.+||.+|.. +.||-.+
T Consensus 342 ~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 342 ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 4455555555544444578899999999999999999997 8887753
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=290.80 Aligned_cols=229 Identities=25% Similarity=0.295 Sum_probs=179.6
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +.+ .....+.+..|.+++..+ +||||+++++++.+++..|+||||+++++|..+
T Consensus 7 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~ 86 (321)
T cd05591 7 SFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQ 86 (321)
T ss_pred CCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHH
Confidence 57888877654321 111 112234567899999876 899999999999999999999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ......|+.
T Consensus 87 l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~ 160 (321)
T cd05591 87 IQRSR--KFDEPRSRFYAAEVTLALMFLHRH--GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTP 160 (321)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCc
Confidence 86543 489999999999999999999965 499999999999999999999999999875322221 133456899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+.... ...+... ....+..++.+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----------------~~~i~~~--~~~~p~~~~~~ 222 (321)
T cd05591 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL----------------FESILHD--DVLYPVWLSKE 222 (321)
T ss_pred cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcC--CCCCCCCCCHH
Confidence 99999999988999999999999999999999999986542111 1111111 11234456788
Q ss_pred HHHHHHhcccCCCCCCC-------CHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRP-------RMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rp-------t~~~~l~~ 253 (311)
+.+++.+||..||++|+ ++.+++++
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 99999999999999999 77888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=283.53 Aligned_cols=216 Identities=26% Similarity=0.418 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------CCCCHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKG 92 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~ 92 (311)
....+.+|+.+++.++|+||+++++++......|+||||+.+++|.+++..... ..+++..++.++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (277)
T cd05032 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999864321 236888999999999999
Q ss_pred HHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 93 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 93 l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
|.|||+. +++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||
T Consensus 132 l~~lH~~--~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (277)
T cd05032 132 MAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209 (277)
T ss_pred HHHHHhC--CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHH
Confidence 9999964 59999999999999999999999999987654332222233345678899999998888999999999999
Q ss_pred HHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 173 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 173 il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
++|++++ |..||...... ...+..........+..++..+.+++.+||..+|++|||+.+++
T Consensus 210 il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 210 VLWEMATLAEQPYQGLSNE-----------------EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred HHHHhhccCCCCCccCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 9999998 99999754321 11111122222234555688999999999999999999999999
Q ss_pred HHHH
Q 021507 252 AILE 255 (311)
Q Consensus 252 ~~l~ 255 (311)
+.|+
T Consensus 273 ~~l~ 276 (277)
T cd05032 273 SSLK 276 (277)
T ss_pred HHhc
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=284.61 Aligned_cols=218 Identities=24% Similarity=0.401 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------CCCCCHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKV 85 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~ 85 (311)
...+.|.+|+.++..++||||+++++++.+.+..++++||+.+++|.+++.... ...+++..++.+
T Consensus 50 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (283)
T cd05091 50 PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHH
Confidence 345678999999999999999999999999999999999999999999985321 134788899999
Q ss_pred HHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCC
Q 021507 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 165 (311)
Q Consensus 86 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 165 (311)
+.|++.||.|||+. +++||||||+||++++++.+||+|||+++...............+++.|+|||.+.+..++.++
T Consensus 130 ~~ql~~aL~~lH~~--gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (283)
T cd05091 130 VTQIAAGMEFLSSH--HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS 207 (283)
T ss_pred HHHHHHHHHHHHHc--CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch
Confidence 99999999999965 5999999999999999999999999998765433322223344567889999999888899999
Q ss_pred ceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 166 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 166 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
|||||||++|||++ |..||.+.... .....+........+..++..+.+++.+||+.+|.+|
T Consensus 208 Dv~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05091 208 DIWSYGVVLWEVFSYGLQPYCGYSNQ-----------------DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRR 270 (283)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccC
Confidence 99999999999998 88888754321 1111122222223456688889999999999999999
Q ss_pred CCHHHHHHHHHh
Q 021507 245 PRMSEVLAILER 256 (311)
Q Consensus 245 pt~~~~l~~l~~ 256 (311)
|++++++..|+.
T Consensus 271 P~~~~i~~~l~~ 282 (283)
T cd05091 271 PRFKDIHSRLRT 282 (283)
T ss_pred CCHHHHHHHhhC
Confidence 999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=295.76 Aligned_cols=233 Identities=23% Similarity=0.262 Sum_probs=177.7
Q ss_pred ChhHHHhHHHHHHhh---------h--hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELHA---------R--SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---------~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++..... . ......+.+.+|++++++++||||+++++++.+.+..|+||||++||+|.+++
T Consensus 13 ~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 92 (381)
T cd05626 13 AFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL 92 (381)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHH
Confidence 588888876544321 0 11223456889999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC------------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------------ 137 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------ 137 (311)
.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 93 ~~~~--~~~e~~~~~~~~qi~~aL~~LH~~--givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~ 168 (381)
T cd05626 93 IRME--VFPEVLARFYIAELTLAIESVHKM--GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168 (381)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccc
Confidence 6544 488999999999999999999965 599999999999999999999999998753211000
Q ss_pred ---------------------------------cceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCcc
Q 021507 138 ---------------------------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184 (311)
Q Consensus 138 ---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 184 (311)
........||..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf 248 (381)
T cd05626 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248 (381)
T ss_pred cccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCC
Confidence 00012357999999999999889999999999999999999999999
Q ss_pred CCCccchhhhhhhhccccccchhhhhHhhh--cccCCCCchHHHHHHHHHHHhcc--cCCCCCCCCHHHHHHH
Q 021507 185 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCL--NNEPKLRPRMSEVLAI 253 (311)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l--~~~p~~Rpt~~~~l~~ 253 (311)
......... ..+.. ..........++.++.+||.+|+ ..++..|+++.+++.+
T Consensus 249 ~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 249 LAPTPTETQ----------------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred cCCCHHHHH----------------HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 764321111 11111 11111122346788999999855 5556669999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.52 Aligned_cols=218 Identities=28% Similarity=0.433 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC----------------------CCCCCH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG----------------------PQPLSW 79 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~ 79 (311)
.+.+.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++.... ...+++
T Consensus 47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 126 (290)
T cd05045 47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126 (290)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCH
Confidence 3568899999999999999999999999999999999999999999885421 134788
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC
Q 021507 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 159 (311)
Q Consensus 80 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 159 (311)
..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...............++..|+|||.+.+.
T Consensus 127 ~~~~~i~~~i~~~l~~LH~~--~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 204 (290)
T cd05045 127 GDLISFAWQISRGMQYLAEM--KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHC--CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence 99999999999999999965 5999999999999999999999999999764332221112233456789999999888
Q ss_pred CCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhccc
Q 021507 160 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 238 (311)
Q Consensus 160 ~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (311)
.++.++||||||+++|+|++ |..||.+.... .+............+..++.++.+++.+||+
T Consensus 205 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~ 267 (290)
T cd05045 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWK 267 (290)
T ss_pred CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999999999998 99999764321 1122222222233455677899999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhc
Q 021507 239 NEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 239 ~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.+|++||++.++++.|+++.
T Consensus 268 ~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 268 QEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCcccCCCHHHHHHHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=280.97 Aligned_cols=215 Identities=27% Similarity=0.398 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++|+||+++++++...+..|++|||+.+++|.+++.......+++..+..++.+++.||.+||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 122 (261)
T cd05068 45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-- 122 (261)
T ss_pred HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456889999999999999999999999999999999999999999999765545689999999999999999999964
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 123 ~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g 201 (261)
T cd05068 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcC
Confidence 5999999999999999999999999999865422111 1111223457999999988899999999999999999999 9
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
+.||.+.... .....+........+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 202 ~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 202 RMPYPGMTNA-----------------EVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 9999764321 1111111112223344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.85 Aligned_cols=224 Identities=27% Similarity=0.303 Sum_probs=172.5
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHH-HHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEV-NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... ........+.+.+|. .+++.++||||+++++++.+.+..|+||||++|++|..+
T Consensus 7 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (321)
T cd05603 7 SFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFH 86 (321)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHH
Confidence 57778877654321 001112233344454 467889999999999999999999999999999999988
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++....... .......|++
T Consensus 87 l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~ 160 (321)
T cd05603 87 LQRE--RCFLEPRARFYAAEVASAIGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTP 160 (321)
T ss_pred HHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCc
Confidence 8654 3488999999999999999999965 59999999999999999999999999987532221 1233457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+.... ...+... ....+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------------~~~i~~~--~~~~~~~~~~~ 222 (321)
T cd05603 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM----------------YDNILHK--PLQLPGGKTVA 222 (321)
T ss_pred ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH----------------HHHHhcC--CCCCCCCCCHH
Confidence 99999999988999999999999999999999999976432110 0111111 12344566788
Q ss_pred HHHHHHhcccCCCCCCCCHH
Q 021507 229 AATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~ 248 (311)
+.+++.+||+.||.+|+++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 99999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=297.94 Aligned_cols=248 Identities=19% Similarity=0.211 Sum_probs=179.1
Q ss_pred ChhHHHhHHHHHHhhhhHH--HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCC
Q 021507 1 MFLFNFLHSHLELHARSLL--LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS 78 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 78 (311)
+||+||++.+......... ...+.+.+|++++++++||||+++++++..+...++|+|++. ++|..++.... .++
T Consensus 104 ~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~ 180 (391)
T PHA03212 104 AEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR--NIA 180 (391)
T ss_pred CCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC--CCC
Confidence 5788888876554311111 123457899999999999999999999999999999999995 58998886543 488
Q ss_pred HHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc
Q 021507 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 158 (311)
Q Consensus 79 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 158 (311)
+..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ .......||+.|+|||++.+
T Consensus 181 ~~~~~~i~~qi~~aL~ylH~~--~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 257 (391)
T PHA03212 181 ICDILAIERSVLRAIQYLHEN--RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLAR 257 (391)
T ss_pred HHHHHHHHHHHHHHHHHHHhC--CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcC
Confidence 999999999999999999965 599999999999999999999999999965322211 11234579999999999999
Q ss_pred CCCCCCCceehhHHHHHHHHhCCCccCCCccc-----hhh---hhhhhccc----cccc-hhhhhHhh----hccc--CC
Q 021507 159 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG-----IEQ---SLVDWAKP----YLSD-KRKLFRIM----DTKL--GG 219 (311)
Q Consensus 159 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~---~~~~~~~~----~~~~-~~~~~~~~----~~~~--~~ 219 (311)
..++.++|||||||++|+|++|..||...... ... ........ +... ........ .... ..
T Consensus 258 ~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (391)
T PHA03212 258 DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPG 337 (391)
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCC
Confidence 89999999999999999999999877533210 000 00000000 0000 00000000 0000 00
Q ss_pred CC-----chHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 220 QY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 220 ~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.. ....+.++.+||.+||..||.+|||++|++++-
T Consensus 338 ~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 338 SRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred CCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 00 113567899999999999999999999998643
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=294.31 Aligned_cols=211 Identities=23% Similarity=0.284 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.+++.++||||+++++++.+++..|+||||++||+|.+++.+. .+++..+..++.|++.||+|||+.
T Consensus 87 ~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~-- 161 (370)
T cd05596 87 SAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM-- 161 (370)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 345788999999999999999999999999999999999999999988543 388899999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC----CCCCCCceehhHHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----RLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~il~~l 177 (311)
+|+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 162 ~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyel 240 (370)
T cd05596 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (370)
T ss_pred CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHH
Confidence 499999999999999999999999999976533221 112345789999999998654 378899999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc--hHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~ 253 (311)
++|..||....... ....+.........+ ..++.++.++|.+||..+|++ |+++++++++
T Consensus 241 ltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 241 LVGDTPFYADSLVG----------------TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HhCCCCcCCCCHHH----------------HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 99999998644211 111111111111122 246889999999999999987 9999999876
Q ss_pred H
Q 021507 254 L 254 (311)
Q Consensus 254 l 254 (311)
.
T Consensus 305 ~ 305 (370)
T cd05596 305 P 305 (370)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=282.57 Aligned_cols=224 Identities=25% Similarity=0.431 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC---------CCCCHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------QPLSWAVRMKVAIGAA 90 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~i~ 90 (311)
...+.|.+|+.+++.++|+||+++++++..++..|+||||+.+++|.+++..... ..+++..+..++.|++
T Consensus 61 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05095 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHH
Confidence 3456799999999999999999999999999999999999999999999865432 2367788999999999
Q ss_pred HHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehh
Q 021507 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 170 (311)
Q Consensus 91 ~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 170 (311)
.||+|||+. +++|+||||+||+++.++.++|+|||++................++..|++||...+..++.++|+|||
T Consensus 141 ~al~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 141 SGMKYLSSL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred HHHHHHHHC--CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 999999965 499999999999999999999999999976533322222223344678999999888889999999999
Q ss_pred HHHHHHHHh--CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 171 GVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 171 G~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
||++|||++ |..||.......... .................+..++..+.+++.+||..||++||++.
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 219 GVTLWEILTLCKEQPYSQLSDEQVIE----------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred HHHHHHHHHhCCCCCccccChHHHHH----------HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 999999998 778886543211000 00000000000111122345678899999999999999999999
Q ss_pred HHHHHHH
Q 021507 249 EVLAILE 255 (311)
Q Consensus 249 ~~l~~l~ 255 (311)
++.+.|+
T Consensus 289 ~i~~~l~ 295 (296)
T cd05095 289 EIHATLL 295 (296)
T ss_pred HHHHHHh
Confidence 9999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=281.16 Aligned_cols=218 Identities=24% Similarity=0.379 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+..|+.++.+++||||+++++++. +...++++||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 52 ~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~- 128 (279)
T cd05111 52 TFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH- 128 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456788899999999999999999875 456789999999999999996543 3589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 179 (311)
+++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++
T Consensus 129 -~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~ 207 (279)
T cd05111 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207 (279)
T ss_pred -CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 499999999999999999999999999976543322222233456778999999988899999999999999999998
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
|..||.+..... ....+........+..++..+.+++.+||..||.+|||+.++++.|..+..
T Consensus 208 g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 208 GAEPYAGMRPHE-----------------VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCCCCCHHH-----------------HHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 999997643211 111112222222233456678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=296.05 Aligned_cols=232 Identities=22% Similarity=0.263 Sum_probs=177.7
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... ........+.+.+|++++++++|+||+++++.+.+++..|+||||++||+|.+++
T Consensus 13 ~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l 92 (382)
T cd05625 13 AFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL 92 (382)
T ss_pred CCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 57888887654322 1111234457889999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCC-------------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD------------- 136 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------- 136 (311)
.+.+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.+|.+||+|||++.......
T Consensus 93 ~~~~--~~~e~~~~~~~~qi~~al~~lH~~--~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 168 (382)
T cd05625 93 IRMG--IFPEDLARFYIAELTCAVESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQ 168 (382)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccc
Confidence 6543 488999999999999999999965 49999999999999999999999999975321000
Q ss_pred --------------------------------CcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCcc
Q 021507 137 --------------------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184 (311)
Q Consensus 137 --------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 184 (311)
........+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf 248 (382)
T cd05625 169 DSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248 (382)
T ss_pred ccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCC
Confidence 000012346899999999999999999999999999999999999999
Q ss_pred CCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 021507 185 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSEVLAI 253 (311)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~~l~~ 253 (311)
...+.... ...+.... ........++.++.++|.+|+ .+|.+|++ +.+++.+
T Consensus 249 ~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 249 LAQTPLET----------------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred CCCCHHHH----------------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 86542111 11111111 111122356788899998876 59999997 8887754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=287.90 Aligned_cols=240 Identities=29% Similarity=0.402 Sum_probs=184.4
Q ss_pred ChhHHHhHHHHHHh--------hhh------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEe-CCeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH--------ARS------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLE-GENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~ 64 (311)
+||.||.+.+.... +.+ .....+.+.+|+.++.++ +|+||+++++++.. +...+++|||+++++
T Consensus 19 ~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~ 98 (337)
T cd05054 19 AFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGN 98 (337)
T ss_pred cCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCC
Confidence 58899888643321 111 122234677899999999 89999999998764 456789999999999
Q ss_pred hHHHhhhcCC-----------------------------------------------------------CCCCHHHHHHH
Q 021507 65 LENHLFRRGP-----------------------------------------------------------QPLSWAVRMKV 85 (311)
Q Consensus 65 L~~~l~~~~~-----------------------------------------------------------~~~~~~~~~~~ 85 (311)
|.+++..... ..+++..+..+
T Consensus 99 L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 178 (337)
T cd05054 99 LSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISY 178 (337)
T ss_pred HHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHH
Confidence 9998854221 25889999999
Q ss_pred HHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCC
Q 021507 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 165 (311)
Q Consensus 86 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 165 (311)
+.|++.||+|||+. +|+||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++
T Consensus 179 ~~qi~~aL~~lH~~--~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 256 (337)
T cd05054 179 SFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQS 256 (337)
T ss_pred HHHHHHHHHHHHhC--CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccc
Confidence 99999999999964 5999999999999999999999999999865433222223334567789999999999999999
Q ss_pred ceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 166 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 166 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
|||||||++|+|++ |..||.+..... .....+........+...+.++.+++.+||+.+|++|
T Consensus 257 Di~SlGv~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 257 DVWSFGVLLWEIFSLGASPYPGVQIDE----------------EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred cHHHHHHHHHHHHHcCCCCCCCCCccH----------------HHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 99999999999998 999997532210 0111111112222344567789999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 021507 245 PRMSEVLAILERLE 258 (311)
Q Consensus 245 pt~~~~l~~l~~~~ 258 (311)
|++.+++++|+++.
T Consensus 321 Ps~~ell~~l~~~~ 334 (337)
T cd05054 321 PTFSELVEILGDLL 334 (337)
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.32 Aligned_cols=232 Identities=24% Similarity=0.257 Sum_probs=176.4
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... + .......+.+.+|+.++.+++|+||+++++.+.++...|+||||++||+|.+++
T Consensus 13 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l 92 (363)
T cd05628 13 AFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL 92 (363)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHH
Confidence 57888887654321 1 111223456888999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-----------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------- 138 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------- 138 (311)
.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 93 ~~~~--~l~~~~~~~~~~qi~~aL~~lH~~--givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 168 (363)
T cd05628 93 MKKD--TLTEEETQFYIAETVLAIDSIHQL--GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168 (363)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccc
Confidence 6543 489999999999999999999965 5999999999999999999999999998754221100
Q ss_pred ----------------------ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh
Q 021507 139 ----------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196 (311)
Q Consensus 139 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 196 (311)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~---- 244 (363)
T cd05628 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET---- 244 (363)
T ss_pred ccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHH----
Confidence 001235799999999999999999999999999999999999999976432111
Q ss_pred hhccccccchhhhhHhhhcccCCCCc--hHHHHHHHHHHHhcccCCCC---CCCCHHHHHHH
Q 021507 197 DWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPK---LRPRMSEVLAI 253 (311)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~---~Rpt~~~~l~~ 253 (311)
...+.........+ ..++.++.+++.+|+. +|. .||++++++++
T Consensus 245 ------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 245 ------------YKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred ------------HHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 01111111111112 2357788899988765 444 56899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=289.20 Aligned_cols=229 Identities=26% Similarity=0.361 Sum_probs=180.0
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +.+ .....+.+.+|.+++..+ +||||+++++++.+.+..|+||||+.|++|..+
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (318)
T cd05570 7 SFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFH 86 (318)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHH
Confidence 57888877654322 111 112334567899999888 799999999999999999999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.+.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ......|+.
T Consensus 87 ~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~ 160 (318)
T cd05570 87 IQRSG--RFDEPRARFYAAEIVLGLQFLHER--GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTP 160 (318)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCc
Confidence 86543 489999999999999999999965 499999999999999999999999999864322111 123456899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+.... ...+... ....+..++..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----------------~~~i~~~--~~~~~~~~~~~ 222 (318)
T cd05570 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----------------FQSILED--EVRYPRWLSKE 222 (318)
T ss_pred cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----------------HHHHHcC--CCCCCCcCCHH
Confidence 99999999999999999999999999999999999976432110 0011111 11234567888
Q ss_pred HHHHHHhcccCCCCCCCCH-----HHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRM-----SEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~-----~~~l~~ 253 (311)
+.++|.+||..||.+||++ .++++.
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=291.39 Aligned_cols=212 Identities=24% Similarity=0.277 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.+++.++|+||+++++++.+++..|+||||++|++|.+++.+.. ..+++..+..++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~- 121 (330)
T cd05601 44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM- 121 (330)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678899999999999999999999999999999999999999999996542 3599999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc------cCCCCCCCceehhHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA------TGRLTTKSDVYSFGVVL 174 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG~il 174 (311)
+|+||||||+||+++.++.+||+|||++......... ......||..|+|||++. +..++.++|||||||++
T Consensus 122 -~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 122 -GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred -CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 4999999999999999999999999999765433221 233457899999999986 45678899999999999
Q ss_pred HHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
|+|++|..||........ ...++... ........++..+.+|+.+||. +|.+||++.++++
T Consensus 200 ~el~~g~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 200 YEMIYGRSPFHEGTSAKT----------------YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred eeeccCCCCCCCCCHHHH----------------HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 999999999976432111 11111111 1111123467889999999998 9999999999986
Q ss_pred H
Q 021507 253 I 253 (311)
Q Consensus 253 ~ 253 (311)
+
T Consensus 263 h 263 (330)
T cd05601 263 H 263 (330)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=279.65 Aligned_cols=216 Identities=34% Similarity=0.571 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.|.+|++++++++||||+++++++...+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~ 122 (259)
T PF07714_consen 43 EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN 122 (259)
T ss_dssp HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34678999999999999999999999999888899999999999999999877556699999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+ ++|+||+++||+++.++.+||+|||++....................|+|||.+.+..++.++||||||+++||+++
T Consensus 123 ~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 123 N--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp T--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4 99999999999999999999999999987633333333444567789999999999999999999999999999999
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|..||..... ......+........+..++..+.+++.+||..||++||++.++++.|
T Consensus 201 ~~~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 201 LGKFPFSDYDN-----------------EEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSSGTTTTSCH-----------------HHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccc-----------------ccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 7899876422 111122222233345566888999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=285.38 Aligned_cols=219 Identities=25% Similarity=0.427 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------CCCCCHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVA 86 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~ 86 (311)
.+.+.+|+++++++ +||||+++++++.+++..|++|||+.+|+|.+++.... ...+++..+..++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred HHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence 45688999999999 69999999999999999999999999999999996532 1348889999999
Q ss_pred HHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCc
Q 021507 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 166 (311)
Q Consensus 87 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 166 (311)
.|++.||.|||+. +++|+||||+||+++.++.+||+|||.++...............++..|+|||++.+..++.++|
T Consensus 141 ~qi~~aL~~lH~~--gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (314)
T cd05099 141 YQVARGMEYLESR--RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSD 218 (314)
T ss_pred HHHHHHHHHHHHC--CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccch
Confidence 9999999999964 59999999999999999999999999997653322111111223446799999998888999999
Q ss_pred eehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 167 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 167 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
|||||+++|+|++ |..||....... ....+........+..++.++.+++.+||..||++||
T Consensus 219 iwslG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (314)
T cd05099 219 VWSFGILMWEIFTLGGSPYPGIPVEE-----------------LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP 281 (314)
T ss_pred hhHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 9999999999999 889987543211 1111111222233456678899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 021507 246 RMSEVLAILERLEA 259 (311)
Q Consensus 246 t~~~~l~~l~~~~~ 259 (311)
++.++++.|.++..
T Consensus 282 s~~~ll~~l~~~~~ 295 (314)
T cd05099 282 TFKQLVEALDKVLA 295 (314)
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.39 Aligned_cols=224 Identities=23% Similarity=0.401 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC----------CCCCCHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG----------PQPLSWAVRMKVAIGA 89 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~i 89 (311)
...+.|.+|++++++++|+||+++++++...+..|+||||+.+++|.+++.... ...+++..++.++.++
T Consensus 59 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 138 (295)
T cd05097 59 TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI 138 (295)
T ss_pred HHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999999985432 1236888999999999
Q ss_pred HHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceeh
Q 021507 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYS 169 (311)
Q Consensus 90 ~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 169 (311)
+.||+|||+. +++|+||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|+||
T Consensus 139 ~~al~~lH~~--~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 139 ASGMKYLASL--NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred HHHHHHHHhc--CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 9999999965 59999999999999999999999999997643332222223344577899999998888999999999
Q ss_pred hHHHHHHHHh--CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCH
Q 021507 170 FGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 170 lG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 247 (311)
|||++|+|++ |..||........... ................+..++..+.+++.+||..||++||++
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 286 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIEN----------TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF 286 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHH----------HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 9999999998 6678765432110000 000000000111112233467889999999999999999999
Q ss_pred HHHHHHHH
Q 021507 248 SEVLAILE 255 (311)
Q Consensus 248 ~~~l~~l~ 255 (311)
+++++.|+
T Consensus 287 ~~i~~~l~ 294 (295)
T cd05097 287 NKIHHFLR 294 (295)
T ss_pred HHHHHHHh
Confidence 99999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=290.92 Aligned_cols=226 Identities=23% Similarity=0.286 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|++++++++||||+++++++..++..|+||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~-- 122 (288)
T cd07871 47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR-- 122 (288)
T ss_pred chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 34677899999999999999999999999999999999976 9999886543 3478999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g 180 (311)
+|+||||||+||+++.++.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 123 ~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 200 (288)
T cd07871 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200 (288)
T ss_pred CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhC
Confidence 499999999999999999999999999875432221 1233567899999998866 4688999999999999999999
Q ss_pred CCccCCCccchhhhhh-hhc-cccc------cchhhhhHhhhcccC----CCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 181 RCAVDKTKVGIEQSLV-DWA-KPYL------SDKRKLFRIMDTKLG----GQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~-~~~-~~~~------~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
+.||.+.......... ... .+.. ............... ......++.++.+|+.+||..||.+|||++
T Consensus 201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~ 280 (288)
T cd07871 201 RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAE 280 (288)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHH
Confidence 9999765432211111 000 0000 000001110000000 001124567889999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
|++++
T Consensus 281 ~~l~h 285 (288)
T cd07871 281 AALRH 285 (288)
T ss_pred HHhcC
Confidence 99854
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=275.70 Aligned_cols=217 Identities=24% Similarity=0.404 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.|.+|+.++.+++||||+++++++..++..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~ 126 (266)
T cd05064 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM 126 (266)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 334678999999999999999999999999999999999999999999986543 3589999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++||||||+||+++.++.++++|||.+......... ......++..|+|||++.+..++.++|||||||++|++++
T Consensus 127 --~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~ 203 (266)
T cd05064 127 --GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203 (266)
T ss_pred --CEeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhc
Confidence 5999999999999999999999999987653222111 1122345678999999999999999999999999999775
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
|..||...... ...+.+........+..++..+.+++.+||+.+|.+||+++++++.|.++
T Consensus 204 ~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 204 YGERPYWDMSGQ-----------------DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCcCcCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999764321 11111122222234556788899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=278.42 Aligned_cols=216 Identities=28% Similarity=0.453 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC-----CCCCCHHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-----PQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
....+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.+.. ...+++..+..++.+++.||+|
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 121 (269)
T cd05044 42 EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121 (269)
T ss_pred hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999999999999999999999996432 2347889999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCC-----cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehh
Q 021507 96 LHDAESQVIYRDFKASNILLDAEF-----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 170 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 170 (311)
||+. +++|+||||+||+++.++ .++|+|||++................++..|+|||++.+..++.++|||||
T Consensus 122 lH~~--~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 199 (269)
T cd05044 122 LEQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199 (269)
T ss_pred HHhC--CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHH
Confidence 9964 599999999999999887 899999999876533322222233455778999999998899999999999
Q ss_pred HHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 171 GVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 171 G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
||++|+|++ |..||...+... ....+........+..++..+.+++.+||..+|++||++.+
T Consensus 200 G~il~ellt~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 200 GVLMWEILTLGQQPYPALNNQE-----------------VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred HHHHHHHHHcCCCCCcccCHHH-----------------HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 999999998 999997543211 11111111122334567888999999999999999999999
Q ss_pred HHHHHH
Q 021507 250 VLAILE 255 (311)
Q Consensus 250 ~l~~l~ 255 (311)
+++.|+
T Consensus 263 i~~~l~ 268 (269)
T cd05044 263 IQEILQ 268 (269)
T ss_pred HHHHHh
Confidence 999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=286.56 Aligned_cols=204 Identities=28% Similarity=0.348 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|++++++++||||+++++++.+++..|+||||+.+++|.+++.+.. .+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~-- 117 (318)
T cd05582 42 RVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL-- 117 (318)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3457789999999999999999999999999999999999999999985543 489999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|+
T Consensus 118 ~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCC
Confidence 499999999999999999999999999876433211 133457899999999999888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
.||....... ....+... ....+..++..+.+++.+||+.||++||++.+
T Consensus 196 ~p~~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 196 LPFQGKDRKE----------------TMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 9997643210 01111111 12345567888999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=284.20 Aligned_cols=220 Identities=24% Similarity=0.416 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------------CCCCHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKV 85 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~ 85 (311)
..+.+.+|+.+++.+ +||||+++++++......|+||||+.+++|.+++.+... ..+++..+..+
T Consensus 63 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (304)
T cd05101 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142 (304)
T ss_pred HHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHH
Confidence 345688999999999 899999999999999999999999999999999965421 34788889999
Q ss_pred HHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCC
Q 021507 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 165 (311)
Q Consensus 86 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 165 (311)
+.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++
T Consensus 143 ~~qi~~al~~LH~~--givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 220 (304)
T cd05101 143 TYQVARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 220 (304)
T ss_pred HHHHHHHHHHHHHC--CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchh
Confidence 99999999999965 5999999999999999999999999999865433222222233456789999999888899999
Q ss_pred ceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 166 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 166 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
||||||+++|+|++ |..||...... .+...+........+..++.++.+++.+||..+|++|
T Consensus 221 Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 283 (304)
T cd05101 221 DVWSFGVLMWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHR 283 (304)
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 99999999999998 78888654321 1111112222223345677899999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021507 245 PRMSEVLAILERLEA 259 (311)
Q Consensus 245 pt~~~~l~~l~~~~~ 259 (311)
|++.++++.|+++..
T Consensus 284 ps~~e~l~~l~~~~~ 298 (304)
T cd05101 284 PTFKQLVEDLDRILT 298 (304)
T ss_pred CCHHHHHHHHHHHHH
Confidence 999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=285.27 Aligned_cols=219 Identities=26% Similarity=0.435 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------------CCCCHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVA 86 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~ 86 (311)
.+.+.+|+.+++.+ +|+||+++++++..++..|+||||+.+++|.+++..... ..+++..++.++
T Consensus 67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 146 (307)
T cd05098 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA 146 (307)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 35688899999999 799999999999999999999999999999999965432 248889999999
Q ss_pred HHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCc
Q 021507 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 166 (311)
Q Consensus 87 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 166 (311)
.|++.||+|||+. +++|+||||+||+++.++.+||+|||.+................++..|+|||++.+..++.++|
T Consensus 147 ~qi~~aL~~lH~~--gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 224 (307)
T cd05098 147 YQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224 (307)
T ss_pred HHHHHHHHHHHHC--CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHH
Confidence 9999999999964 59999999999999999999999999987643322111112223456899999998888999999
Q ss_pred eehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 167 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 167 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
+|||||++|+|++ |..||...... .....+........+..++.++.+++.+||..+|++||
T Consensus 225 vwslG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 287 (307)
T cd05098 225 VWSFGVLLWEIFTLGGSPYPGVPVE-----------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 287 (307)
T ss_pred HHHHHHHHHHHHcCCCCCCCcCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCc
Confidence 9999999999998 88898654321 11122222222234556788999999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 021507 246 RMSEVLAILERLEA 259 (311)
Q Consensus 246 t~~~~l~~l~~~~~ 259 (311)
++.++++.|+++..
T Consensus 288 s~~evl~~l~~~~~ 301 (307)
T cd05098 288 TFKQLVEDLDRILA 301 (307)
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.02 Aligned_cols=228 Identities=26% Similarity=0.349 Sum_probs=176.8
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... +.+ .....+.+..|..++..+ +||||+++++++.+++..|+||||+.|++|.++
T Consensus 7 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~ 86 (316)
T cd05620 7 SFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFH 86 (316)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHH
Confidence 57788877654321 000 112234466788888765 899999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... .......||.
T Consensus 87 i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~ 160 (316)
T cd05620 87 IQDKG--RFDLYRATFYAAEIVCGLQFLHSK--GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTP 160 (316)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCc
Confidence 86543 488999999999999999999965 59999999999999999999999999986432211 1233467899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+... ..+.+.. .....+..++.+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-----------------~~~~~~~-~~~~~~~~~~~~ 222 (316)
T cd05620 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-----------------LFESIRV-DTPHYPRWITKE 222 (316)
T ss_pred CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHh-CCCCCCCCCCHH
Confidence 9999999999999999999999999999999999997643211 1111111 112334457788
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHHH
Q 021507 229 AATLALQCLNNEPKLRPRMS-EVLA 252 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~-~~l~ 252 (311)
+.+++.+||..||++|+++. ++++
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHc
Confidence 99999999999999999974 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.54 Aligned_cols=231 Identities=26% Similarity=0.358 Sum_probs=178.1
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... ........+.+.+|+.++.++ +||||+++++++.+.+..|+||||++|++|..+
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (327)
T cd05617 7 SYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFH 86 (327)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 57788877544321 111223345688999999998 699999999999999999999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .......||.
T Consensus 87 ~~~~~--~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~ 160 (327)
T cd05617 87 MQRQR--KLPEEHARFYAAEICIALNFLHER--GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTP 160 (327)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCc
Confidence 86543 499999999999999999999965 49999999999999999999999999987532211 1133467899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||........ ..........+.. .....+..++..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~----------~~~~~~~~~~~~~-~~~~~p~~~~~~ 229 (327)
T cd05617 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD----------MNTEDYLFQVILE-KPIRIPRFLSVK 229 (327)
T ss_pred ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc----------cccHHHHHHHHHh-CCCCCCCCCCHH
Confidence 99999999999999999999999999999999999965322110 0011111111111 122345667888
Q ss_pred HHHHHHhcccCCCCCCCCHH
Q 021507 229 AATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~ 248 (311)
+.+++.+||..||.+|+++.
T Consensus 230 ~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHHhccCHHHcCCCC
Confidence 99999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=278.00 Aligned_cols=216 Identities=31% Similarity=0.456 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC-------CCCCCHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-------PQPLSWAVRMKVAIGAAKGL 93 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l 93 (311)
..+.+.+|+++++.++|+||+++++++.++...++||||+++++|.+++.... ...+++..++.++.|++.||
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999999999999999999999999996642 24599999999999999999
Q ss_pred HHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHH
Q 021507 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 173 (311)
Q Consensus 94 ~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 173 (311)
++||+ ++++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||++
T Consensus 119 ~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 196 (262)
T cd00192 119 EYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVL 196 (262)
T ss_pred HHHHc--CCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHH
Confidence 99996 4599999999999999999999999999987654432223344567889999999988889999999999999
Q ss_pred HHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 174 LLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 174 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
+|+|++ |..||...... .....+........+..++.++.+++.+||..||++|||+.++++
T Consensus 197 l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 259 (262)
T cd00192 197 LWEIFTLGATPYPGLSNE-----------------EVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259 (262)
T ss_pred HHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999999 69999865321 111222222233445667889999999999999999999999998
Q ss_pred HHH
Q 021507 253 ILE 255 (311)
Q Consensus 253 ~l~ 255 (311)
.|+
T Consensus 260 ~l~ 262 (262)
T cd00192 260 RLE 262 (262)
T ss_pred hhC
Confidence 873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=281.18 Aligned_cols=216 Identities=26% Similarity=0.391 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~ 95 (311)
....|.+|+.++++++|+||+++++++.+.+..++||||+.|++|.+++..... ..+++..++.++.||+.||+|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 131 (277)
T cd05036 52 DESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999865432 248999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCC---cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
||+. +++|+||||+||+++.++ .+||+|||+++................+..|+|||++.+..++.++|||||||
T Consensus 132 LH~~--~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 209 (277)
T cd05036 132 LEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209 (277)
T ss_pred HHHC--CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence 9965 499999999999998765 58999999998653222111112223356799999998889999999999999
Q ss_pred HHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 173 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 173 il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
++|+|++ |..||....... ....+........+..++..+.+++.+||+.+|++||++.+++
T Consensus 210 il~el~~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl 272 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQE-----------------VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHH-----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 9999997 999997643211 1111111222234556778899999999999999999999999
Q ss_pred HHHH
Q 021507 252 AILE 255 (311)
Q Consensus 252 ~~l~ 255 (311)
+.|+
T Consensus 273 ~~l~ 276 (277)
T cd05036 273 ERIQ 276 (277)
T ss_pred HHhh
Confidence 9885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=294.70 Aligned_cols=232 Identities=26% Similarity=0.290 Sum_probs=182.2
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... + .........+.+|++++..++|+||+++++++.+++..|+||||+.|++|.+++
T Consensus 13 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 92 (350)
T cd05573 13 AFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL 92 (350)
T ss_pred CcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHH
Confidence 57777777655211 0 011133456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCC-------------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD------------- 136 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------- 136 (311)
... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 168 (350)
T cd05573 93 IRK--DVFPEETARFYIAELVLALDSVHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168 (350)
T ss_pred HHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccc
Confidence 665 3489999999999999999999964 59999999999999999999999999997654332
Q ss_pred --------------CcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhcccc
Q 021507 137 --------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202 (311)
Q Consensus 137 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 202 (311)
.........||..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~---------- 238 (350)
T cd05573 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET---------- 238 (350)
T ss_pred ccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH----------
Confidence 00112345789999999999999999999999999999999999999986542111
Q ss_pred ccchhhhhHhhh--cccCCCCchHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 021507 203 LSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAI 253 (311)
Q Consensus 203 ~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~~~l~~ 253 (311)
...+.. ..........++.++.++|.+||. ||.+|++ +++++++
T Consensus 239 ------~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 ------YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111 111111122358899999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=277.74 Aligned_cols=212 Identities=27% Similarity=0.427 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.|.+|+.++++++||||+++++++.+.+..|+||||+++|+|.+++..... .+++..++.++.+++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~-- 119 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN-- 119 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 35688899999999999999999999999999999999999999999865432 488999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||+++.++.+||+|||.+......... ......++..|+|||++.+..++.++|+||||+++|+|++ |
T Consensus 120 ~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g 198 (256)
T cd05114 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198 (256)
T ss_pred CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCC
Confidence 5999999999999999999999999998764322211 1122335568999999988889999999999999999999 9
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+.||...+.... ...+........+...+..+.+++.+||..||++||++.++++.|
T Consensus 199 ~~p~~~~~~~~~-----------------~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 199 KMPFEKKSNYEV-----------------VEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCHHHH-----------------HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999976432111 111111111122334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=278.33 Aligned_cols=213 Identities=25% Similarity=0.408 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.|.+|+.++++++||||+++++++.+.+..|+||||+.+++|.+++..... .+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~-- 119 (256)
T cd05113 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK-- 119 (256)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 35688999999999999999999999988889999999999999999865443 589999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||.||+++.++.+||+|||.+........ .......++..|++||.+.+..++.++||||||+++|+|++ |
T Consensus 120 ~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g 198 (256)
T cd05113 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198 (256)
T ss_pred CeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCC
Confidence 599999999999999999999999999876433221 11122345678999999988889999999999999999998 9
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
..||....... .............+...+..+.+++.+||..||.+||++.++++.|+
T Consensus 199 ~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 199 KMPYERFNNSE-----------------TVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCcCcCCHHH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 99997543211 11111111111223345788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=297.31 Aligned_cols=234 Identities=24% Similarity=0.255 Sum_probs=177.9
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +.+ .....+.+.+|+++|++++|+||+++++.+.+++..|+||||++||+|.+++
T Consensus 13 ~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i 92 (376)
T cd05598 13 AFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL 92 (376)
T ss_pred CCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 57888877654321 111 1123456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCC-------------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD------------- 136 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------- 136 (311)
.+.+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 93 ~~~~--~~~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~ 168 (376)
T cd05598 93 IRLG--IFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168 (376)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccc
Confidence 6543 488999999999999999999965 49999999999999999999999999975321000
Q ss_pred ----------------------------CcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCc
Q 021507 137 ----------------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 188 (311)
Q Consensus 137 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 188 (311)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 248 (376)
T cd05598 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT 248 (376)
T ss_pred ccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCC
Confidence 0000123479999999999999999999999999999999999999998654
Q ss_pred cchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 021507 189 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP---RMSEVLAI 253 (311)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~~l~~ 253 (311)
......... .............++.++.++|.+|+ .+|.+|+ ++.+++++
T Consensus 249 ~~~~~~~i~--------------~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 249 PAETQLKVI--------------NWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred HHHHHHHHh--------------ccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 321111000 00001111122346778899999976 5999999 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=286.50 Aligned_cols=228 Identities=26% Similarity=0.341 Sum_probs=176.8
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.+.. +.+ .....+.+..|..++..+ +||||+++++++..++..|+||||++||+|.++
T Consensus 7 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~ 86 (316)
T cd05592 7 SFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFH 86 (316)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHH
Confidence 57888877654322 101 112233455677777654 899999999999999999999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .......||.
T Consensus 87 ~~~~~--~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~ 160 (316)
T cd05592 87 IQSSG--RFDEARARFYAAEIICGLQFLHKK--GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTP 160 (316)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCc
Confidence 86543 489999999999999999999965 59999999999999999999999999997543222 1233457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+... ....+.. .....+..++.+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----------------~~~~i~~-~~~~~~~~~~~~ 222 (316)
T cd05592 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----------------LFDSILN-DRPHFPRWISKE 222 (316)
T ss_pred cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHc-CCCCCCCCCCHH
Confidence 9999999999899999999999999999999999998643211 1111111 112345567888
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHHH
Q 021507 229 AATLALQCLNNEPKLRPRMS-EVLA 252 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~-~~l~ 252 (311)
+.+++.+||..||.+||++. ++++
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHc
Confidence 99999999999999999865 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.05 Aligned_cols=220 Identities=25% Similarity=0.406 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
...+.+.+|+.+++++ +|+||+++++++...+..|+||||+.+++|.+++.......+++..+..++.+++.||+|||+
T Consensus 80 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 159 (302)
T cd05055 80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159 (302)
T ss_pred HHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999 899999999999999999999999999999999976544458999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
. +++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|+
T Consensus 160 ~--~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~ 237 (302)
T cd05055 160 K--NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237 (302)
T ss_pred C--CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHH
Confidence 5 59999999999999999999999999997654332222222345677899999998888999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |..||........ ..+..........+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 238 t~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 238 SLGSNPYPGMPVDSK----------------FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred hCCCCCcCCCCchHH----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 8 9999976432111 1111111112223345677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=284.04 Aligned_cols=239 Identities=27% Similarity=0.361 Sum_probs=184.6
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... ........+.+.+|++++.++ +|+||+++++++.+++..|+||||+++++|.++
T Consensus 19 ~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 98 (303)
T cd05088 19 NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 98 (303)
T ss_pred CCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHH
Confidence 58888888653311 111123445788999999999 899999999999999999999999999999999
Q ss_pred hhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCC
Q 021507 69 LFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134 (311)
Q Consensus 69 l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 134 (311)
+.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 99 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 176 (303)
T cd05088 99 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176 (303)
T ss_pred HHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC--CccccccchheEEecCCCcEEeCccccCcccch
Confidence 96432 12478999999999999999999964 599999999999999999999999999864211
Q ss_pred CCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhh
Q 021507 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 213 (311)
Q Consensus 135 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (311)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~~~~~ 236 (303)
T cd05088 177 YV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----------------LYEKL 236 (303)
T ss_pred hh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----------------HHHHH
Confidence 11 0111233567999999988889999999999999999998 999997543211 11111
Q ss_pred hcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCCC
Q 021507 214 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 261 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~~ 261 (311)
........+..++..+.+++.+||+.+|++||++++++..|..+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111122233446778999999999999999999999999998865433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=291.11 Aligned_cols=210 Identities=24% Similarity=0.305 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.+++.++||||+++++++.+++..|+||||++||+|.+++... .+++..+..++.||+.||+|||+.
T Consensus 87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~-- 161 (370)
T cd05621 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM-- 161 (370)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 445788999999999999999999999999999999999999999998543 388999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC----CCCCCceehhHHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~l 177 (311)
+|+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+.. ++.++|+|||||++|+|
T Consensus 162 ~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyel 240 (370)
T cd05621 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240 (370)
T ss_pred CeEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHH
Confidence 499999999999999999999999999976533221 1123567999999999987643 77899999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc--hHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~ 253 (311)
++|..||....... ....++........+ ..++..+.+++.+||..++.+ |+++.+++++
T Consensus 241 l~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 241 LVGDTPFYADSLVG----------------TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCCCCCCCCHHH----------------HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 99999997643211 111122111111222 246888999999999865543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.38 Aligned_cols=228 Identities=28% Similarity=0.372 Sum_probs=177.2
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.+.. +.+ .....+.+..|..++..+ +||||+++++++.+.+..|+||||++||+|.++
T Consensus 7 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~ 86 (316)
T cd05619 7 SFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFH 86 (316)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 57888877655432 000 112234466788888764 999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ......||.
T Consensus 87 l~~~~--~~~~~~~~~~~~qi~~al~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~ 160 (316)
T cd05619 87 IQSCH--KFDLPRATFYAAEIICGLQFLHSK--GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTP 160 (316)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCc
Confidence 86543 488999999999999999999965 599999999999999999999999999875322111 133457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+... ....+..++.+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----------------~~~~i~~~-~~~~~~~~~~~ 222 (316)
T cd05619 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-----------------LFQSIRMD-NPCYPRWLTRE 222 (316)
T ss_pred cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhC-CCCCCccCCHH
Confidence 9999999998899999999999999999999999997643211 11111111 11234456788
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHHH
Q 021507 229 AATLALQCLNNEPKLRPRMS-EVLA 252 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~-~~l~ 252 (311)
+.+++.+||..||++|+++. +++.
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHHc
Confidence 99999999999999999996 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=288.33 Aligned_cols=225 Identities=23% Similarity=0.264 Sum_probs=165.0
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
..+.+|+.+++.++||||+++++++.++...|+||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~-- 123 (303)
T cd07869 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY-- 123 (303)
T ss_pred hhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 357789999999999999999999999999999999996 58888875543 34889999999999999999999654
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~ 181 (311)
|+||||||+||+++.++.+||+|||++....... .......++..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 124 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 201 (303)
T cd07869 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201 (303)
T ss_pred eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987533221 112345678999999998664 5788999999999999999999
Q ss_pred CccCCCccchhh--hhhh-hccccccchhhhh---HhhhcccCCCCc---------hHHHHHHHHHHHhcccCCCCCCCC
Q 021507 182 CAVDKTKVGIEQ--SLVD-WAKPYLSDKRKLF---RIMDTKLGGQYP---------QKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 182 ~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
.||.+....... .... ...+......... ...........+ ...+..+.+|+.+||+.||.+|||
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s 281 (303)
T cd07869 202 AAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281 (303)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC
Confidence 999864321110 0000 0000000000000 000000000000 113467889999999999999999
Q ss_pred HHHHHHH
Q 021507 247 MSEVLAI 253 (311)
Q Consensus 247 ~~~~l~~ 253 (311)
+.+++++
T Consensus 282 ~~~~l~h 288 (303)
T cd07869 282 AQAALSH 288 (303)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=289.88 Aligned_cols=181 Identities=25% Similarity=0.268 Sum_probs=153.4
Q ss_pred hhHHHhHHHHHHh---hhhH----HHHHHHHHHHHHHHhcCC-C-----CCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 2 FLFNFLHSHLELH---ARSL----LLITNWFQTEVNYLGQLH-H-----PNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 2 ~~~~~~~~~~~~~---~~~~----~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
||+|.-|.+.+.+ +.++ ....++...|+++|..|+ | -|+|+++++|...++.|||+|.+. .+|+++
T Consensus 199 FGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYel 277 (586)
T KOG0667|consen 199 FGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYEL 277 (586)
T ss_pred cceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHH
Confidence 7888888777754 2121 223344556999999996 4 489999999999999999999995 599999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC--cEEEecccccccCCCCCCcceeccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
|+.+...+++...+..++.||+.||.+||. .+|||+||||+|||+...+ .|||+|||.++..... ....+.
T Consensus 278 lK~n~f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~-----vytYiQ 350 (586)
T KOG0667|consen 278 LKNNKFRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR-----VYTYIQ 350 (586)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeEEecccccccCCc-----ceeeee
Confidence 999999999999999999999999999995 4599999999999996543 5999999999874332 225677
Q ss_pred cccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccc
Q 021507 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 190 (311)
Q Consensus 147 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 190 (311)
+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.++.
T Consensus 351 SRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 351 SRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred ccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 88999999999999999999999999999999999999887763
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=281.80 Aligned_cols=207 Identities=26% Similarity=0.382 Sum_probs=166.7
Q ss_pred HHHHHHHHHHH---hcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 22 TNWFQTEVNYL---GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 22 ~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
.+.+.+|++++ +.++||||+++++++.+++..|+||||+.|++|..++.. ..+++..+..++.|++.||+|||+
T Consensus 43 ~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~ 119 (324)
T cd05589 43 VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE 119 (324)
T ss_pred HHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34566676655 566899999999999999999999999999999988743 249999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
. +++||||||+||+++.++.+||+|||++....... .......|+..|+|||++.+..++.++|||||||++|+|+
T Consensus 120 ~--~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 195 (324)
T cd05589 120 N--KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195 (324)
T ss_pred C--CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH
Confidence 5 59999999999999999999999999987532221 1133467899999999999989999999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
+|..||.+...... ...+... ....+..++..+.++|.+||..||.+|| ++.+++++
T Consensus 196 ~G~~pf~~~~~~~~----------------~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 196 VGESPFPGDDEEEV----------------FDSIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hCCCCCCCCCHHHH----------------HHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 99999986432110 0111111 1234556788899999999999999999 56777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=285.33 Aligned_cols=247 Identities=24% Similarity=0.282 Sum_probs=176.3
Q ss_pred ChhHHHhHHHHHHh----hhhH-------HHHHHHHHHHHHHHhcC---CCCCccceEeEEEe-----CCeeEEEEecCC
Q 021507 1 MFLFNFLHSHLELH----ARSL-------LLITNWFQTEVNYLGQL---HHPNLVKLIGYCLE-----GENRLLVYEFMP 61 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~~~~-------~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-----~~~~~lv~e~~~ 61 (311)
+||+||++++.... +.+. ......+.+|+.+++.+ +||||+++++++.. ....++||||+.
T Consensus 13 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~ 92 (290)
T cd07862 13 AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 92 (290)
T ss_pred CCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC
Confidence 57888887654321 1110 11223466777777766 69999999999852 356899999996
Q ss_pred CCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCccee
Q 021507 62 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141 (311)
Q Consensus 62 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 141 (311)
++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 93 -~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 166 (290)
T cd07862 93 -QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 166 (290)
T ss_pred -CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEcCCCCEEEccccceEeccCC---ccc
Confidence 4999999766556689999999999999999999965 4999999999999999999999999999764332 123
Q ss_pred ccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhh-hhhhhcc-ccccchhhhhH----hhhc
Q 021507 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLSDKRKLFR----IMDT 215 (311)
Q Consensus 142 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~~~~~~~----~~~~ 215 (311)
....|+..|+|||++.+..++.++|||||||++|+|++|..||.+....... ....... +.......... ....
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (290)
T cd07862 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 246 (290)
T ss_pred ccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccC
Confidence 3456899999999998889999999999999999999999999875432111 1111000 00000000000 0000
Q ss_pred ccCC---CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 216 KLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 216 ~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.... .....++..+.+++.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 247 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 0112456788999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=274.70 Aligned_cols=217 Identities=27% Similarity=0.405 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.|.+|++++++++||||+++++++.+ ...++||||+++++|.+++.+.....+++..++.++.|++.||+|||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 566789999999999999999999999988 8899999999999999999765434689999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
+++|+||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|+|+
T Consensus 117 --~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~ 194 (257)
T cd05040 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF 194 (257)
T ss_pred --CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHH
Confidence 5999999999999999999999999999876442221 1122345677899999998889999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
+ |..||........ .............+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 195 t~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 195 TYGEEPWAGLSGSQI----------------LKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred hCCCCCCCCCCHHHH----------------HHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 8 9999975432110 00000011111223456788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=273.42 Aligned_cols=226 Identities=26% Similarity=0.365 Sum_probs=177.3
Q ss_pred ChhHHHhHHHHH---------------HhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLE---------------LHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 65 (311)
|||+||.+.+.+ .-........+.+.+|+.+++.++||||+++++++..+...++||||+.+|+|
T Consensus 7 ~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 86 (258)
T cd05078 7 TFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSL 86 (258)
T ss_pred cchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcH
Confidence 689999876532 11222234456788899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc--------EEEecccccccCCCCCC
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGDR 137 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~--------~kl~Dfg~~~~~~~~~~ 137 (311)
.+++..+.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++. ++++|||++.....
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~--- 160 (258)
T cd05078 87 DTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK--GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--- 160 (258)
T ss_pred HHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccceEEEecccccccCCCceEEecccccccccCC---
Confidence 999965543 589999999999999999999965 5999999999999987764 69999998865322
Q ss_pred cceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCC-CccCCCccchhhhhhhhccccccchhhhhHhhhc
Q 021507 138 THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 215 (311)
Q Consensus 138 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (311)
.....++..|+|||++.+. .++.++||||||+++|+|++|. .||........ ......
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-----------------~~~~~~ 220 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-----------------LQFYED 220 (258)
T ss_pred ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----------------HHHHHc
Confidence 2234578889999999774 5788999999999999999984 66654321110 001111
Q ss_pred ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 216 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
....+...+.++.+++.+||+.||++|||++++++.|
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 --RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1223445567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=277.91 Aligned_cols=238 Identities=26% Similarity=0.354 Sum_probs=180.7
Q ss_pred ChhHHHhHHHHHHhh------------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCC
Q 021507 1 MFLFNFLHSHLELHA------------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPK 62 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~ 62 (311)
+||.||.+....... .......+.+.+|+++++.++|+||+++++++... ...+++|||+.+
T Consensus 11 ~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~ 90 (272)
T cd05075 11 EFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKH 90 (272)
T ss_pred cCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCC
Confidence 578888765433211 01123346688999999999999999999987432 246899999999
Q ss_pred CChHHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc
Q 021507 63 GSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138 (311)
Q Consensus 63 ~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 138 (311)
|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.........
T Consensus 91 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 168 (272)
T cd05075 91 GDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK--SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168 (272)
T ss_pred CcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhheEEcCCCCEEECCCCcccccCcccce
Confidence 9999887421 234589999999999999999999964 5999999999999999999999999999865433222
Q ss_pred ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhccc
Q 021507 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 217 (311)
Q Consensus 139 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (311)
.......++..|++||.+.+..++.++|||||||++|+|++ |..||...... .....+....
T Consensus 169 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~ 231 (272)
T cd05075 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----------------EIYDYLRQGN 231 (272)
T ss_pred ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCC
Confidence 11223345678999999998889999999999999999999 88999753221 0111111111
Q ss_pred CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 218 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
....+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1223445678899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=273.33 Aligned_cols=216 Identities=23% Similarity=0.385 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.+++.++|+||+++++++.+.+..|++|||+.+++|.+++.......+++..++.++.+++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~-- 122 (261)
T cd05072 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-- 122 (261)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467889999999999999999999999999999999999999999999765555689999999999999999999964
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |
T Consensus 123 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g 201 (261)
T cd05072 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG 201 (261)
T ss_pred CeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccC
Confidence 5999999999999999999999999999865432211 1222345678999999988889999999999999999998 9
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
..||....... ....+...........++.++.+++.+||..+|++||+++++++.|+++
T Consensus 202 ~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 202 KIPYPGMSNSD-----------------VMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCHHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99997543211 1111111112223345678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=281.93 Aligned_cols=224 Identities=25% Similarity=0.402 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC---------CCCCCHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---------PQPLSWAVRMKVAIGAA 90 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~ 90 (311)
...+.+.+|++++++++||||+++++++..++..+++||++.+++|.+++.+.. ...+++..++.++.|++
T Consensus 61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05051 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence 445678999999999999999999999999999999999999999999986543 12589999999999999
Q ss_pred HHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehh
Q 021507 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 170 (311)
Q Consensus 91 ~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 170 (311)
.||+|||+. +++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||
T Consensus 141 ~al~~LH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (296)
T cd05051 141 SGMRYLESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218 (296)
T ss_pred HHHHHHHHc--CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence 999999965 499999999999999999999999999876543332223334556778999999988889999999999
Q ss_pred HHHHHHHHh--CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 171 GVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 171 G~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
||++|+|++ +..||............ . ..............+..++.++.+++.+||+.||.+|||+.
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 219 GVTLWEILTLCREQPYEHLTDQQVIENA---G-------HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred HHHHHHHHhcCCCCCCCCcChHHHHHHH---H-------hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 999999998 67788654321100000 0 00000001111122344668899999999999999999999
Q ss_pred HHHHHHH
Q 021507 249 EVLAILE 255 (311)
Q Consensus 249 ~~l~~l~ 255 (311)
++++.|+
T Consensus 289 el~~~L~ 295 (296)
T cd05051 289 EIHLFLQ 295 (296)
T ss_pred HHHHHhc
Confidence 9998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=287.28 Aligned_cols=206 Identities=27% Similarity=0.320 Sum_probs=162.2
Q ss_pred HHHHHHHHhcC---CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 25 FQTEVNYLGQL---HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 25 ~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
+.+|..++..+ +||||+++++++.+.+..|+||||+.+|+|.+++.+.. .+++..+..++.||+.||+|||+.
T Consensus 40 ~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~-- 115 (330)
T cd05586 40 TIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKY-- 115 (330)
T ss_pred HHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 44566676665 69999999999999999999999999999999886543 489999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g 180 (311)
+|+||||||+|||++.++.++|+|||++........ ......||..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 116 ~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG 193 (330)
T cd05586 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193 (330)
T ss_pred CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccC
Confidence 499999999999999999999999999875322221 23345789999999998765 478999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC----CHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP----RMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----t~~~~l~~ 253 (311)
..||...+... ..+.+...........++.++.+++.+||..||.+|| ++.+++++
T Consensus 194 ~~Pf~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 194 WSPFYAEDTQQ-----------------MYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCCCCCCHHH-----------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 99997643211 0111111100011123678899999999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=286.35 Aligned_cols=210 Identities=26% Similarity=0.303 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+.+|+.+|+++. |||||.++++|++....++|||+|.||.|.+.|... . +++..+..++.|++.+++|||+.
T Consensus 78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~ 154 (382)
T KOG0032|consen 78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSL 154 (382)
T ss_pred cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhC
Confidence 3467999999999998 999999999999999999999999999999999766 2 99999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCC----CcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 175 (311)
+ ++||||||+|+|+... +.+|++|||++..... .......+||+.|+|||++.+.+|+..+||||+|+++|
T Consensus 155 g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~y 229 (382)
T KOG0032|consen 155 G--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILY 229 (382)
T ss_pred C--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHH
Confidence 4 9999999999999543 4799999999998655 23466789999999999999999999999999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc--ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.|++|.+||.+........ .+... .+.......++..+.+++++||..||.+|+|+.+++++
T Consensus 230 iLL~G~~PF~~~~~~~~~~----------------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 230 ILLSGVPPFWGETEFEIFL----------------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHhhCCCCCcCCChhHHHH----------------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999998765322111 22111 23445567889999999999999999999999999986
Q ss_pred H
Q 021507 254 L 254 (311)
Q Consensus 254 l 254 (311)
.
T Consensus 294 p 294 (382)
T KOG0032|consen 294 P 294 (382)
T ss_pred c
Confidence 3
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=276.41 Aligned_cols=218 Identities=27% Similarity=0.431 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--------------CCCCCCHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--------------GPQPLSWAVRMKVA 86 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~ 86 (311)
...+.+|+++++++ +|+||+++++++..++..+++|||+.+|+|.+++..+ ....+++..++.++
T Consensus 59 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 138 (293)
T cd05053 59 LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 34588999999999 8999999999999999999999999999999998642 23458999999999
Q ss_pred HHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCc
Q 021507 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 166 (311)
Q Consensus 87 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 166 (311)
.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|
T Consensus 139 ~qi~~al~~LH~~--~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 216 (293)
T cd05053 139 YQVARGMEFLASK--KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216 (293)
T ss_pred HHHHHHHHHHHHC--CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccc
Confidence 9999999999964 59999999999999999999999999998654332222222234566899999998888999999
Q ss_pred eehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 167 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 167 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
||||||++|++++ |..||...... .....+........+..++..+.+|+.+||..||++||
T Consensus 217 i~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 279 (293)
T cd05053 217 VWSFGVLLWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP 279 (293)
T ss_pred eeehhhHHHHHhcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc
Confidence 9999999999997 99998754321 11111222222234456678899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021507 246 RMSEVLAILERLE 258 (311)
Q Consensus 246 t~~~~l~~l~~~~ 258 (311)
|+.++++.|+++.
T Consensus 280 s~~eil~~l~~~~ 292 (293)
T cd05053 280 TFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHHHhh
Confidence 9999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=286.09 Aligned_cols=204 Identities=29% Similarity=0.343 Sum_probs=163.7
Q ss_pred HHHHHHHH-HHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 23 NWFQTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 23 ~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
+.+.+|.. +++.++||||+++++++..++..|+||||+.|++|..++.... .+++..+..++.||+.||+|||+.
T Consensus 40 ~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~-- 115 (325)
T cd05604 40 KHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI-- 115 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34455554 5777899999999999999999999999999999999886543 489999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 116 givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~ 193 (325)
T cd05604 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGL 193 (325)
T ss_pred CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCC
Confidence 599999999999999999999999999875322111 133457899999999999999999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
.||...+.... ........ ...+...+..+.+++.+||..||.+||++.+.
T Consensus 194 ~pf~~~~~~~~----------------~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 194 PPFYCRDVAEM----------------YDNILHKP--LVLRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CCCCCCCHHHH----------------HHHHHcCC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 99976432110 01111111 12234567889999999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.29 Aligned_cols=234 Identities=23% Similarity=0.239 Sum_probs=183.3
Q ss_pred ChhHHHhHHHHHHh---hh-------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC--------eeEEEEecCCC
Q 021507 1 MFLFNFLHSHLELH---AR-------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE--------NRLLVYEFMPK 62 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--------~~~lv~e~~~~ 62 (311)
+||+||.+++.... +. ........+.+|+.++..++|+||+++++.+.... ..++||||+.+
T Consensus 44 ~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~ 123 (496)
T PTZ00283 44 ATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANA 123 (496)
T ss_pred CCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCC
Confidence 58888887654321 11 11233456889999999999999999988775432 36899999999
Q ss_pred CChHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce
Q 021507 63 GSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140 (311)
Q Consensus 63 ~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 140 (311)
|+|.+++..+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 124 gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~--~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 201 (496)
T PTZ00283 124 GDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK--HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201 (496)
T ss_pred CcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccc
Confidence 99999986432 34689999999999999999999965 499999999999999999999999999976543332223
Q ss_pred eccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC
Q 021507 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 220 (311)
Q Consensus 141 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (311)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. .............
T Consensus 202 ~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----------------~~~~~~~~~~~~~ 264 (496)
T PTZ00283 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----------------EVMHKTLAGRYDP 264 (496)
T ss_pred cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----------------HHHHHHhcCCCCC
Confidence 44567999999999999999999999999999999999999999764321 0111111111223
Q ss_pred CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 221 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+..++.++.+++.+||..||.+||++.+++++
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 456678899999999999999999999999864
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=277.37 Aligned_cols=214 Identities=29% Similarity=0.444 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.|.+|+.++++++|+||+++++++. ....|++|||+.+++|.+++.......+++..+..++.+++.||+|||+.
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-- 121 (260)
T cd05070 45 PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM-- 121 (260)
T ss_pred HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456899999999999999999999875 45689999999999999999765555689999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 122 ~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g 200 (260)
T cd05070 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcC
Confidence 5999999999999999999999999999765332211 1122335567999999988889999999999999999999 8
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
..||...... .....+........+...+..+.+++.+||..||++|||+.++.+.|+.
T Consensus 201 ~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 201 RVPYPGMNNR-----------------EVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999754321 1111111222223445677889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=277.71 Aligned_cols=221 Identities=22% Similarity=0.356 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
....+.+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 50 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~ 127 (279)
T cd05109 50 PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 33456788999999999999999999998754 5789999999999999986543 348999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
. +++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||+
T Consensus 128 ~--~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~ 205 (279)
T cd05109 128 V--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELM 205 (279)
T ss_pred C--CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 5 59999999999999999999999999998654332221122233467899999998888999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |..||+..... .....+........+..++..+.+++.+||..||++||++.++++.|..+
T Consensus 206 t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 206 TFGAKPYDGIPAR-----------------EIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred cCCCCCCCCCCHH-----------------HHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 8 99999753311 11111222222223445678899999999999999999999999999877
Q ss_pred cCC
Q 021507 258 EAP 260 (311)
Q Consensus 258 ~~~ 260 (311)
...
T Consensus 269 ~~~ 271 (279)
T cd05109 269 ARD 271 (279)
T ss_pred hcC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=279.53 Aligned_cols=218 Identities=28% Similarity=0.449 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------------CCCCCH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------------PQPLSW 79 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~ 79 (311)
...+.|.+|+.++.+++||||+++++++.++...|++|||+++++|.+++.... ...+++
T Consensus 50 ~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 129 (288)
T cd05050 50 DMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129 (288)
T ss_pred HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCH
Confidence 345678999999999999999999999999999999999999999999996432 124788
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC
Q 021507 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 159 (311)
Q Consensus 80 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 159 (311)
..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.................+..|+|||.+.+.
T Consensus 130 ~~~~~~~~~i~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (288)
T cd05050 130 TEQLCIAKQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN 207 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhC--CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence 89999999999999999964 5999999999999999999999999998754332222112223446679999999888
Q ss_pred CCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhccc
Q 021507 160 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 238 (311)
Q Consensus 160 ~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (311)
.++.++|+|||||++|+|++ |..||.+..... ....+........+..++.++.+++.+||+
T Consensus 208 ~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 270 (288)
T cd05050 208 RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-----------------VIYYVRDGNVLSCPDNCPLELYNLMRLCWS 270 (288)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 99999999999999999997 888886533210 111111111112244567889999999999
Q ss_pred CCCCCCCCHHHHHHHHHh
Q 021507 239 NEPKLRPRMSEVLAILER 256 (311)
Q Consensus 239 ~~p~~Rpt~~~~l~~l~~ 256 (311)
.||++|||+.|+++.|++
T Consensus 271 ~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 271 KLPSDRPSFASINRILQR 288 (288)
T ss_pred cCcccCCCHHHHHHHhhC
Confidence 999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=280.37 Aligned_cols=216 Identities=28% Similarity=0.426 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------CCCCCHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVA 86 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~ 86 (311)
.+.|.+|++++.++ +||||+++++++.+.+..|+||||+++++|.+++.... ...+++..++.++
T Consensus 46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 125 (297)
T cd05089 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125 (297)
T ss_pred HHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHH
Confidence 45688999999999 79999999999999999999999999999999996432 1248889999999
Q ss_pred HHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCc
Q 021507 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 166 (311)
Q Consensus 87 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 166 (311)
.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .......+..|+|||++.+..++.++|
T Consensus 126 ~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~D 200 (297)
T cd05089 126 SDVATGMQYLSEK--QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSD 200 (297)
T ss_pred HHHHHHHHHHHHC--CcccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhh
Confidence 9999999999964 59999999999999999999999999986422110 011122345799999998888999999
Q ss_pred eehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 167 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 167 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
||||||++|+|++ |..||....... ....+........+..++..+.+++.+||..+|.+||
T Consensus 201 vwSlG~il~el~t~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 263 (297)
T cd05089 201 VWSFGVLLWEIVSLGGTPYCGMTCAE-----------------LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERP 263 (297)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999999997 999997643211 1111122222233455778899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 021507 246 RMSEVLAILERLEA 259 (311)
Q Consensus 246 t~~~~l~~l~~~~~ 259 (311)
+++++++.|..+..
T Consensus 264 ~~~~i~~~l~~~~~ 277 (297)
T cd05089 264 PFAQISVQLSRMLE 277 (297)
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.83 Aligned_cols=249 Identities=21% Similarity=0.227 Sum_probs=181.6
Q ss_pred ChhHHHhHHHHHHh-----hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCC
Q 021507 1 MFLFNFLHSHLELH-----ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ 75 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (311)
+||+||++...... ..+.....+.+.+|+++|++++||||+++++++...+..|+|||++. ++|.+++... .
T Consensus 104 ~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~ 180 (392)
T PHA03207 104 SEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS--G 180 (392)
T ss_pred CCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc--C
Confidence 57888887432211 11222223456789999999999999999999999999999999996 5899988433 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccc
Q 021507 76 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 155 (311)
Q Consensus 76 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 155 (311)
.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++................||..|+|||+
T Consensus 181 ~l~~~~~~~i~~ql~~aL~~LH~~--givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 258 (392)
T PHA03207 181 PLPLEQAITIQRRLLEALAYLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPEL 258 (392)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhH
Confidence 589999999999999999999965 599999999999999999999999999976544333222334678999999999
Q ss_pred cccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhh----hhhhccc----ccc-chhhh---hHhhhcccCCC--C
Q 021507 156 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS----LVDWAKP----YLS-DKRKL---FRIMDTKLGGQ--Y 221 (311)
Q Consensus 156 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~----~~~-~~~~~---~~~~~~~~~~~--~ 221 (311)
+.+..++.++|||||||++|+|++|..||.+........ ....... +.. ....+ ........... .
T Consensus 259 ~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (392)
T PHA03207 259 LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTI 338 (392)
T ss_pred hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccc
Confidence 999999999999999999999999999997654321110 0000000 000 00000 00000000000 0
Q ss_pred c-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 222 P-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 222 ~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+ ...+.++.++|.+||..||++|||+.+++.+-
T Consensus 339 ~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 339 PPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred cchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1 13456788999999999999999999999764
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=277.60 Aligned_cols=221 Identities=24% Similarity=0.354 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCCCCChHHHhhhcCC------CCCCHHHHHHHHHHHHH
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGP------QPLSWAVRMKVAIGAAK 91 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~ 91 (311)
....+.+.+|+.++++++|+||+++++++.. +...++++||+.+++|.+++..... ..+++..++.++.+++.
T Consensus 49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 128 (280)
T cd05043 49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence 3445678899999999999999999998766 4678999999999999999865322 45899999999999999
Q ss_pred HHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhH
Q 021507 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 171 (311)
Q Consensus 92 ~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 171 (311)
||+|||+. +++|+||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||
T Consensus 129 ~l~~LH~~--~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 206 (280)
T cd05043 129 GMSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFG 206 (280)
T ss_pred HHHHHHHC--CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhH
Confidence 99999964 5999999999999999999999999999765333222122233457789999999888899999999999
Q ss_pred HHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
|++|++++ |..||...+... +...+........+..++.++.+++.+||..||++|||+.++
T Consensus 207 ~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 269 (280)
T cd05043 207 VLLWELMTLGQTPYVEIDPFE-----------------MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269 (280)
T ss_pred HHHHHHhcCCCCCcCcCCHHH-----------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 99999999 999997643211 111111111222234467789999999999999999999999
Q ss_pred HHHHHhhc
Q 021507 251 LAILERLE 258 (311)
Q Consensus 251 l~~l~~~~ 258 (311)
++.|..+.
T Consensus 270 ~~~l~~~~ 277 (280)
T cd05043 270 VQCLTDFH 277 (280)
T ss_pred HHHHHHHH
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=285.32 Aligned_cols=223 Identities=25% Similarity=0.321 Sum_probs=174.6
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... + .......+.+..|..++..+ .|++|+++++++.+.+..|+||||+++|+|.++
T Consensus 12 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~ 91 (323)
T cd05616 12 SFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQ 91 (323)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHH
Confidence 57888876554321 0 01112234567788888887 589999999999999999999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... .......||+
T Consensus 92 ~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~ 165 (323)
T cd05616 92 IQQVG--RFKEPHAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTP 165 (323)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCCh
Confidence 86543 489999999999999999999965 59999999999999999999999999987532211 1233457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+.... ...+... ....+..++.+
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----------------~~~i~~~--~~~~p~~~s~~ 227 (323)
T cd05616 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------------FQSIMEH--NVAYPKSMSKE 227 (323)
T ss_pred hhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhC--CCCCCCcCCHH
Confidence 99999999999999999999999999999999999986432110 1111111 12345567889
Q ss_pred HHHHHHhcccCCCCCCCCH
Q 021507 229 AATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~ 247 (311)
+.+++.+||+.||.+|++.
T Consensus 228 ~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 228 AVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHHHcccCHHhcCCC
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=276.10 Aligned_cols=236 Identities=27% Similarity=0.367 Sum_probs=181.6
Q ss_pred ChhHHHhHHHHHHhh------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELHA------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||++.+..... .......+.|.+|++++++++|+||+++++++. ....|+||||+.+++|.+++.....
T Consensus 18 ~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~ 96 (262)
T cd05071 18 CFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMG 96 (262)
T ss_pred CCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccc
Confidence 577787765432210 000112356899999999999999999999875 4567999999999999999976544
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..+..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||.+......... ......++..|+|||
T Consensus 97 ~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE 173 (262)
T cd05071 97 KYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 173 (262)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHC--CccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHh
Confidence 5589999999999999999999964 5999999999999999999999999999765432211 122334567899999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
+..+..++.++|+|||||++|+|++ |..||....... .............+..++..+.+++
T Consensus 174 ~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLDQVERGYRMPCPPECPESLHDLM 236 (262)
T ss_pred HhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----------------HHHHHhcCCCCCCccccCHHHHHHH
Confidence 9988889999999999999999999 888987543211 1111111111223445778899999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhh
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
.+||+.||++||++.++++.|+..
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHccCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=290.54 Aligned_cols=218 Identities=24% Similarity=0.406 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------------------------
Q 021507 22 TNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-------------------------- 74 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------- 74 (311)
.+.+.+|+++|.++. ||||+++++++...+..++||||+.+|+|.+++.....
T Consensus 84 ~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (401)
T cd05107 84 KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ 163 (401)
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence 456889999999997 99999999999999999999999999999999864321
Q ss_pred ----------------------------------------------------------------------CCCCHHHHHH
Q 021507 75 ----------------------------------------------------------------------QPLSWAVRMK 84 (311)
Q Consensus 75 ----------------------------------------------------------------------~~~~~~~~~~ 84 (311)
..+++..++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 243 (401)
T cd05107 164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG 243 (401)
T ss_pred cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence 2367778899
Q ss_pred HHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCC
Q 021507 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 164 (311)
Q Consensus 85 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 164 (311)
++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.+
T Consensus 244 ~~~qi~~aL~~LH~--~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 321 (401)
T cd05107 244 FSYQVANGMEFLAS--KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL 321 (401)
T ss_pred HHHHHHHHHHHHhc--CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH
Confidence 99999999999995 4599999999999999999999999999976433222112223456788999999988889999
Q ss_pred CceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 165 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 165 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
+||||||+++|||++ |..||...... ......+........+..++.++.+++.+||..+|.+
T Consensus 322 ~DvwslGvil~e~l~~g~~P~~~~~~~----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~ 385 (401)
T cd05107 322 SDVWSFGILLWEIFTLGGTPYPELPMN----------------EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEI 385 (401)
T ss_pred hHHHHHHHHHHHHHHcCCCCCCCCCch----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhH
Confidence 999999999999998 88998653211 1111112222222344567889999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 021507 244 RPRMSEVLAILERL 257 (311)
Q Consensus 244 Rpt~~~~l~~l~~~ 257 (311)
||++.++++.|+++
T Consensus 386 RPs~~ell~~L~~~ 399 (401)
T cd05107 386 RPDFSQLVHLVGDL 399 (401)
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=280.56 Aligned_cols=213 Identities=28% Similarity=0.390 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.++++++|+||+.+++.+.+++..|+||||+.|++|.+++.......+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-- 121 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 345778999999999999999999999999999999999999999998665555699999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 122 ~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 599999999999999999999999999875432221 22346899999999999989999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
.||........... .... ........+..++.++.+|+.+||+.||.+||| +++++++
T Consensus 199 ~Pf~~~~~~~~~~~-------------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 199 SPFQQRKKKIKREE-------------VERL-VKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CCCCCCCccchHHH-------------HHhh-hhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 99976432111000 0000 001111234456778999999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=286.63 Aligned_cols=227 Identities=27% Similarity=0.354 Sum_probs=188.1
Q ss_pred ChhHHHhHHHHH-----------HhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLE-----------LHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
.||-||.+++-. +.++...+-.+++.+|++.|++++|||++.+.+.|..+...|+|||||-| +-.|++
T Consensus 38 SFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDll 116 (948)
T KOG0577|consen 38 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLL 116 (948)
T ss_pred ccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHH
Confidence 377788776644 33566667788899999999999999999999999999999999999965 888877
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.-. .+++-+..+..|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.+..... ...++||+.
T Consensus 117 eVh-kKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPy 187 (948)
T KOG0577|consen 117 EVH-KKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPY 187 (948)
T ss_pred HHH-hccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCcc
Confidence 433 356999999999999999999999876 99999999999999999999999999976432 456899999
Q ss_pred ccCccccc---cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 150 YAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 150 y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|||||++. .+.|+.++||||||++..|+...++|+..++.... +..+-....+.......+
T Consensus 188 wMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA----------------LYHIAQNesPtLqs~eWS 251 (948)
T KOG0577|consen 188 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYHIAQNESPTLQSNEWS 251 (948)
T ss_pred ccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH----------------HHHHHhcCCCCCCCchhH
Confidence 99999875 46899999999999999999999999887654222 222222222222345678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+..|+..||++-|.+|||.++++.+
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 899999999999999999999998864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=285.32 Aligned_cols=223 Identities=27% Similarity=0.351 Sum_probs=174.4
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcCCCC-CccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQLHHP-NLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +.+ .....+.+..|++++..++|+ +|+++++++.+.+..|+||||++||+|.++
T Consensus 12 ~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~ 91 (324)
T cd05587 12 SFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 91 (324)
T ss_pred cCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHH
Confidence 57778877654321 101 112334577899999999765 588899999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ ......||.
T Consensus 92 ~~~~~--~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~ 165 (324)
T cd05587 92 IQQVG--KFKEPHAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTP 165 (324)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCc
Confidence 86543 488999999999999999999965 499999999999999999999999999864322111 233457899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+.. .....+..++.+
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----------------~~~~i~~--~~~~~~~~~~~~ 227 (324)
T cd05587 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQSIME--HNVSYPKSLSKE 227 (324)
T ss_pred cccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHc--CCCCCCCCCCHH
Confidence 9999999999999999999999999999999999997643211 0111111 112345567888
Q ss_pred HHHHHHhcccCCCCCCCCH
Q 021507 229 AATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~ 247 (311)
+.+++.+||..||.+|++.
T Consensus 228 ~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHHHhhcCHHHcCCC
Confidence 9999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=283.60 Aligned_cols=220 Identities=25% Similarity=0.419 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------CCCCCHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKV 85 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~ 85 (311)
..+.+.+|+++++++ +||||+++++++..++..|++|||+.+|+|.+++.... ...+++..+..+
T Consensus 60 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (334)
T cd05100 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139 (334)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence 345788999999999 89999999999999999999999999999999986532 134788899999
Q ss_pred HHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCC
Q 021507 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 165 (311)
Q Consensus 86 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 165 (311)
+.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++
T Consensus 140 ~~qi~~al~~LH~~--givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (334)
T cd05100 140 AYQVARGMEYLASQ--KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 217 (334)
T ss_pred HHHHHHHHHHHHHC--CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchh
Confidence 99999999999964 5999999999999999999999999999765332222112223345679999999988999999
Q ss_pred ceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 166 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 166 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
||||||+++|+|++ |..||...... .....+........+..++.++.+++.+||..+|.+|
T Consensus 218 Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 280 (334)
T cd05100 218 DVWSFGVLLWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQR 280 (334)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 99999999999998 88998764321 1111111222223345567889999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021507 245 PRMSEVLAILERLEA 259 (311)
Q Consensus 245 pt~~~~l~~l~~~~~ 259 (311)
|++.++++.|+.+..
T Consensus 281 ps~~ell~~l~~~~~ 295 (334)
T cd05100 281 PTFKQLVEDLDRVLT 295 (334)
T ss_pred cCHHHHHHHHHHHhh
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=288.44 Aligned_cols=232 Identities=23% Similarity=0.235 Sum_probs=177.2
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... + .......+.+.+|+.+++.++||||+++++++.+++..|+||||++||+|.+++
T Consensus 55 ~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~ 134 (371)
T cd05622 55 AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 134 (371)
T ss_pred CCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHH
Confidence 57778777654322 0 111123345788999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .......||+.
T Consensus 135 ~~~---~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~ 208 (371)
T cd05622 135 SNY---DVPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPD 208 (371)
T ss_pred Hhc---CCCHHHHHHHHHHHHHHHHHHHHC--CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCcc
Confidence 543 388999999999999999999965 499999999999999999999999999976533221 12234679999
Q ss_pred ccCccccccCC----CCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCch
Q 021507 150 YAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQ 223 (311)
Q Consensus 150 y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 223 (311)
|+|||++.+.. ++.++|||||||++|+|++|..||...+... ....++... .......
T Consensus 209 y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------------TYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred ccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----------------HHHHHHcCCCcccCCCcC
Confidence 99999987543 7889999999999999999999998654211 111111111 1111223
Q ss_pred HHHHHHHHHHHhcccCCCCC--CCCHHHHHHHH
Q 021507 224 KAAHTAATLALQCLNNEPKL--RPRMSEVLAIL 254 (311)
Q Consensus 224 ~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~l 254 (311)
.++..+.++|.+||..++.+ |+++++++++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 57888999999999844433 77999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=278.21 Aligned_cols=228 Identities=24% Similarity=0.352 Sum_probs=189.4
Q ss_pred hhHHHhHHHHHHhh----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 2 FLFNFLHSHLELHA----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 2 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
|..|-|++|.=.-. +-..-..-.+.+|++-|+.++|||||++|++......+|+|+|.-++|+|.++|.+
T Consensus 31 FAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK 110 (864)
T KOG4717|consen 31 FAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK 110 (864)
T ss_pred eehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh
Confidence 56666666653221 11122344577899999999999999999999999999999999999999999977
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC-CCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
... .+++....+++.||+.|+.|+|+.. +|||||||+||.+. +-|.|||+|||++..+..+.. ....+|+..|
T Consensus 111 He~-Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAY 184 (864)
T KOG4717|consen 111 HEE-GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAY 184 (864)
T ss_pred hhc-cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhc
Confidence 653 4999999999999999999999765 99999999999775 458899999999987654433 4567899999
Q ss_pred cCccccccCCCCC-CCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 151 AAPEYVATGRLTT-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 151 ~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
-|||++.|..|+. +.||||||+|||-+++|++||+..+. .+.+..+++.++ ..|..++.++
T Consensus 185 SAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETLTmImDCKY--tvPshvS~eC 246 (864)
T KOG4717|consen 185 SAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETLTMIMDCKY--TVPSHVSKEC 246 (864)
T ss_pred cCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhhhhhhcccc--cCchhhhHHH
Confidence 9999999999876 68999999999999999999987543 334455555554 5688999999
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++||..||..||++|.+.++|...
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhcc
Confidence 999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.16 Aligned_cols=230 Identities=25% Similarity=0.430 Sum_probs=200.2
Q ss_pred hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 17 SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
-.++.+.+|+.|+.||-+++||||+++.|++.......||+|||++|+|+.+|+.+..+ ++..+...++..|+.|++||
T Consensus 669 ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYL 747 (996)
T KOG0196|consen 669 YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYL 747 (996)
T ss_pred ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHH
Confidence 34677889999999999999999999999999999999999999999999999877755 99999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 175 (311)
-+.+ +|||||-..||||+.+..+||+|||+++...++.... ......-..+|.|||.+...+++.+||+||+|+++|
T Consensus 748 sdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmW 825 (996)
T KOG0196|consen 748 SDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 825 (996)
T ss_pred hhcC--chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEE
Confidence 9765 9999999999999999999999999999775544221 111222356899999999999999999999999999
Q ss_pred HHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 176 ELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 176 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|.++ |..||..+. +++..+.++..++...|.+|+..|.+||..||++|..+||.+.+|+..|
T Consensus 826 EVmSyGERPYWdmS-----------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 826 EVMSYGERPYWDMS-----------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred EecccCCCcccccc-----------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 9877 999987643 4456667777888888999999999999999999999999999999999
Q ss_pred HhhcCCCCCCcc
Q 021507 255 ERLEAPKNSAKL 266 (311)
Q Consensus 255 ~~~~~~~~~~~~ 266 (311)
+++...+.+...
T Consensus 889 DklIrnP~SLk~ 900 (996)
T KOG0196|consen 889 DKLIRNPNSLKT 900 (996)
T ss_pred HHHhcCchhhcc
Confidence 998776665443
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=271.49 Aligned_cols=215 Identities=29% Similarity=0.456 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
.....+.+|++++++++||||+++++++...+..++||||+++++|.+++.... ..+++..+..++.+++.+|.|||+.
T Consensus 34 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~ 112 (250)
T cd05085 34 ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK 112 (250)
T ss_pred HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 344568899999999999999999999999999999999999999999886543 3488999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|++++
T Consensus 113 --~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred --CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 599999999999999999999999999875432211 11112234567999999988889999999999999999998
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
|..||........ ...+........+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 190 ~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 190 LGVCPYPGMTNQQA-----------------REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCHHHH-----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 9999976432111 1111112222334557789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=269.00 Aligned_cols=218 Identities=24% Similarity=0.373 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
....+.|.+|+.++++++|+||+++++++. ....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 36 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~ 113 (257)
T cd05115 36 KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG 113 (257)
T ss_pred hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345567999999999999999999999875 457899999999999999986433 358999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce-eccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
. +++|+||||+||+++.++.+||+|||++........... .....++..|+|||++.+..++.++||||||+++|++
T Consensus 114 ~--~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 191 (257)
T cd05115 114 K--NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA 191 (257)
T ss_pred c--CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 5 599999999999999999999999999975433322111 1112235689999999888899999999999999999
Q ss_pred Hh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 178 LS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 178 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
++ |..||...... .....+........+..++.++.+++.+||..||++||++.++.+.|+.
T Consensus 192 ~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 192 FSYGQKPYKKMKGP-----------------EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred hcCCCCCcCcCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 96 99999764321 1112222222334456678899999999999999999999999999876
Q ss_pred h
Q 021507 257 L 257 (311)
Q Consensus 257 ~ 257 (311)
+
T Consensus 255 ~ 255 (257)
T cd05115 255 Y 255 (257)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.94 Aligned_cols=233 Identities=24% Similarity=0.303 Sum_probs=178.0
Q ss_pred ChhHHHhHHHHHHh---hh-------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---AR-------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... +. ........|.+|+.+|++|+|||||+++++|.+ ...+|+||||+.+++|.++
T Consensus 25 gFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~l 104 (1021)
T PTZ00266 25 RFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRN 104 (1021)
T ss_pred CCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHH
Confidence 58999988765432 10 122345668899999999999999999998864 3568999999999999999
Q ss_pred hhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCeeecCCCCCceEeCC-----------------CCcEEEe
Q 021507 69 LFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAE-----SQVIYRDFKASNILLDA-----------------EFNAKLS 124 (311)
Q Consensus 69 l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~ivH~dlkp~Nil~~~-----------------~~~~kl~ 124 (311)
|.... ...+++..++.|+.||+.||+|||+.+ .+|||+||||+|||++. .+.+||+
T Consensus 105 L~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLs 184 (1021)
T PTZ00266 105 IQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184 (1021)
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEc
Confidence 86432 245999999999999999999999743 45999999999999954 2348999
Q ss_pred cccccccCCCCCCcceeccccccccccCcccccc--CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhcccc
Q 021507 125 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202 (311)
Q Consensus 125 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 202 (311)
|||++....... ......||+.|+|||++.+ ..++.++||||||||+|+|++|..||......
T Consensus 185 DFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~------------ 249 (1021)
T PTZ00266 185 DFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF------------ 249 (1021)
T ss_pred cCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH------------
Confidence 999997653321 1334578999999999865 35888999999999999999999999754321
Q ss_pred ccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 203 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..+...+.... .......+.++.+||..||..+|.+||++.+++..
T Consensus 250 ----~qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 250 ----SQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred ----HHHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 11111111111 11123457889999999999999999999999953
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.63 Aligned_cols=249 Identities=22% Similarity=0.233 Sum_probs=178.9
Q ss_pred ChhHHHhHHHHHHhhhhHHH--HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCC
Q 021507 1 MFLFNFLHSHLELHARSLLL--ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS 78 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 78 (311)
+||.||++++.+.......+ ....+.+|+++|++|+|+|||++++++..++..++|||++. ++|.+++.... ..++
T Consensus 181 ~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~l~ 258 (461)
T PHA03211 181 SEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARL-RPLG 258 (461)
T ss_pred CCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcC-CCCC
Confidence 57888888776643222111 12346789999999999999999999999999999999995 58998885543 3599
Q ss_pred HHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc
Q 021507 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 158 (311)
Q Consensus 79 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 158 (311)
+..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...............||..|+|||++.+
T Consensus 259 ~~~~~~i~~qi~~aL~yLH~~--gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 259 LAQVTAVARQLLSAIDYIHGE--GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred HHHHHHHHHHHHHHHHHHHHC--CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC
Confidence 999999999999999999965 599999999999999999999999999976543322222334579999999999999
Q ss_pred CCCCCCCceehhHHHHHHHHhCCCccCCCccc-h----hh---hhhhhccc----ccc-chhhhhHhhh----cccC---
Q 021507 159 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG-I----EQ---SLVDWAKP----YLS-DKRKLFRIMD----TKLG--- 218 (311)
Q Consensus 159 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~----~~---~~~~~~~~----~~~-~~~~~~~~~~----~~~~--- 218 (311)
..++.++|||||||++|||++|..++...... . .. ..+..... +.. ....+..... ....
T Consensus 337 ~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 416 (461)
T PHA03211 337 DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAY 416 (461)
T ss_pred CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCcc
Confidence 99999999999999999999987655322111 0 00 01111000 000 0000000000 0000
Q ss_pred -CCCc---hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 219 -GQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 219 -~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.... ...+..+.+||.+||..||.+|||+.|+|++
T Consensus 417 ~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 417 TRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 1345578999999999999999999999975
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=274.15 Aligned_cols=235 Identities=26% Similarity=0.373 Sum_probs=182.9
Q ss_pred ChhHHHhHHHHHHh------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||++....-. ........+.+.+|+.++++++|+||+++++++. .+..|++|||+.+++|.+++.....
T Consensus 18 ~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~ 96 (260)
T cd05067 18 QFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEG 96 (260)
T ss_pred ccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCC
Confidence 57888877643211 0111112356889999999999999999999874 4568999999999999999876555
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..+..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++........ .......++..|+|||
T Consensus 97 ~~~~~~~~~~i~~~i~~al~~LH~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe 173 (260)
T cd05067 97 IKLTINKLIDMAAQIAEGMAFIERK--NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPE 173 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHH
Confidence 6689999999999999999999964 599999999999999999999999999976542221 1122334567899999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++||||||+++|++++ |..||.+.+... ....+........+...+.++.+++
T Consensus 174 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----------------VIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred HhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 9988889999999999999999999 999997643211 1111112222233445677899999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHh
Q 021507 234 LQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
.+||..+|++||+++++++.|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=270.72 Aligned_cols=212 Identities=27% Similarity=0.404 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++||||+++++++.+++..|+|+||++|++|.+++.... .+++..+..++.+++.||.|||+.
T Consensus 48 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~-- 123 (263)
T cd06625 48 VNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN-- 123 (263)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3568899999999999999999999999999999999999999999986543 488999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce-eccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++.++.++|+|||++........... .....++..|+|||++.+..++.++||||||+++|+|++|
T Consensus 124 ~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 599999999999999999999999999875432211111 1234578899999999998899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.||...+.. ...............+..++..+.+++.+||..+|++|||+.+++++
T Consensus 204 ~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 204 KPPWAEFEAM----------------AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCccccchH----------------HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 9999753211 11111112222234456678899999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=269.18 Aligned_cols=212 Identities=28% Similarity=0.448 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEE-eCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.|.+|+.++++++|+||+++++++. +++..|++|||+++++|.+++.......+++..++.++.+++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~- 121 (256)
T cd05082 43 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN- 121 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 456889999999999999999999764 456789999999999999999766555689999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 179 (311)
+++|+||||+||+++.++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++
T Consensus 122 -~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~ 195 (256)
T cd05082 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred -CEeccccchheEEEcCCCcEEecCCccceecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhC
Confidence 5999999999999999999999999998754322 122334568999999988889999999999999999997
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
|..||...... .....+........+..++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 196 g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 196 GRVPYPRIPLK-----------------DVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 99998754321 11111122222234456788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=261.48 Aligned_cols=227 Identities=23% Similarity=0.265 Sum_probs=182.0
Q ss_pred HhhhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeC----CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHH
Q 021507 13 LHARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87 (311)
Q Consensus 13 ~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 87 (311)
.-+.++..=....++|+++.... .|||||.++++|+.. ..+.+|||.++||.|.+.|+.++...+++.++-.|+.
T Consensus 89 kfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~ 168 (400)
T KOG0604|consen 89 KFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMK 168 (400)
T ss_pred hhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHH
Confidence 34555565566688999988777 699999999998753 3457999999999999999999999999999999999
Q ss_pred HHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCC
Q 021507 88 GAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 164 (311)
Q Consensus 88 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 164 (311)
||+.|+.|||+.+ |.||||||+|+|.+. +..+||+|||+++.-... ....+.+.|+.|.|||++...+|+..
T Consensus 169 qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydks 243 (400)
T KOG0604|consen 169 QIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKS 243 (400)
T ss_pred HHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCC
Confidence 9999999999876 999999999999965 446999999999864332 22455678999999999999999999
Q ss_pred CceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 165 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 165 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
+|+||||+++|-|++|.+||-..... ......+.-...-...+...-...++++..++|+.+|+.+|.+|
T Consensus 244 cdmwSlgVimYIlLCGyPPFYS~hg~----------aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteR 313 (400)
T KOG0604|consen 244 CDMWSLGVIMYILLCGYPPFYSNHGL----------AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTER 313 (400)
T ss_pred CCccchhHHHHHhhcCCCcccccCCc----------cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhh
Confidence 99999999999999999999754320 00011111111112223344456889999999999999999999
Q ss_pred CCHHHHHHHH
Q 021507 245 PRMSEVLAIL 254 (311)
Q Consensus 245 pt~~~~l~~l 254 (311)
.|+++++++-
T Consensus 314 lTI~~~m~hp 323 (400)
T KOG0604|consen 314 LTIEEVMDHP 323 (400)
T ss_pred eeHHHhhcCc
Confidence 9999998764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=275.84 Aligned_cols=213 Identities=26% Similarity=0.349 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+++++.++|+||+.+++.+..++..|++|||+.+++|.+++...+...+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-- 121 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 345788999999999999999999999999999999999999999988665555699999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+|+||||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 122 ~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 499999999999999999999999999875432211 23456899999999998889999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
.||........... ....+.. .....+..++.++.+|+.+||..||++||+ +.++++.
T Consensus 199 ~P~~~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 199 SPFRGRKEKVKREE-------------VDRRVLE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCCCCCCHHHHHHH-------------HHHhhhc-cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 99976432111100 0010100 111234456778999999999999999999 6676654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.70 Aligned_cols=232 Identities=23% Similarity=0.345 Sum_probs=185.2
Q ss_pred ChhHHHhHHHHHHh---hhhH-----HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---ARSL-----LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||.||-+..-+.. +.++ .+..++|.=|++||..++||+||++++.|..++.+||+.|||.||.....+-.-
T Consensus 44 AFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL 123 (1187)
T KOG0579|consen 44 AFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLEL 123 (1187)
T ss_pred cchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHh
Confidence 68999988766543 2211 223445777999999999999999999999999999999999999988876544
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
+ ..+++.++.-+|++++.||.|||+.+ |||||||..|||++.+|.++|+|||.+.... ........++||+.|||
T Consensus 124 ~-r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIGTPYWMA 198 (1187)
T KOG0579|consen 124 G-RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIGTPYWMA 198 (1187)
T ss_pred c-cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccch--hHHhhhccccCCccccc
Confidence 3 45999999999999999999999755 9999999999999999999999999986422 12223457899999999
Q ss_pred ccccc-----cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc-CCCCchHHH
Q 021507 153 PEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAA 226 (311)
Q Consensus 153 PE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (311)
||++. +.+|+.++||||||++|.||..+.+|-..-+. ...+.++....- ....|...+
T Consensus 199 PEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----------------MRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 199 PEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----------------MRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred chheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----------------HHHHHHHhhcCCCcccCcchhh
Confidence 99864 46899999999999999999999998765332 222222222111 112355778
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..+.+++.+||..||..||++.+++++
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 899999999999999999999999965
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=275.88 Aligned_cols=236 Identities=27% Similarity=0.376 Sum_probs=183.8
Q ss_pred ChhHHHhHHHHHH--------------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLEL--------------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
|||+||++..... .........+.+.+|++++++++|+||+++++++.+.+..|+||||+++++|.
T Consensus 17 ~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 96 (275)
T cd05046 17 EFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96 (275)
T ss_pred ceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHH
Confidence 5788887765321 11222335677999999999999999999999999989999999999999999
Q ss_pred HHhhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc
Q 021507 67 NHLFRRGP-------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139 (311)
Q Consensus 67 ~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 139 (311)
+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.........
T Consensus 97 ~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~- 173 (275)
T cd05046 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY- 173 (275)
T ss_pred HHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc--CcccCcCccceEEEeCCCcEEEcccccccccCccccc-
Confidence 99965441 2589999999999999999999965 5999999999999999999999999998653222111
Q ss_pred eeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC
Q 021507 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG 218 (311)
Q Consensus 140 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (311)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...........
T Consensus 174 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----------------~~~~~~~~~~~ 237 (275)
T cd05046 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----------------VLNRLQAGKLE 237 (275)
T ss_pred ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----------------HHHHHHcCCcC
Confidence 1223356778999999988888999999999999999998 888986532110 11111111111
Q ss_pred CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 219 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
...+..++..+.+++.+||..||.+||++.++++.|.
T Consensus 238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 2234456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=268.07 Aligned_cols=216 Identities=26% Similarity=0.389 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|+.+++.++||||+++++++. .+..++||||+.+++|.+++.... .+++..+..++.|++.||+|||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~ 114 (257)
T cd05116 38 ALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET 114 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35667899999999999999999999875 456789999999999999986543 489999999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce-eccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
+++|+||||.||+++.++.+||+|||++........... .....++..|+|||.+.+..++.++|+|||||++|||+
T Consensus 115 --~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05116 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192 (257)
T ss_pred --CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence 599999999999999999999999999976543322111 11223457899999998888999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |..||...... .....+........+..++.++.++|.+||+.||++||++.+|.+.|++.
T Consensus 193 t~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 193 SYGQKPYKGMKGN-----------------EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred hCCCCCCCCCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 8 99999764321 11122222222334556788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.77 Aligned_cols=213 Identities=23% Similarity=0.360 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.|.+|+.+|.+| .|.+||+++||-..++.+||||||=+. +|..+|.++......+ .+..+..|++.++.++|.+
T Consensus 402 tl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~ 479 (677)
T KOG0596|consen 402 TLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH 479 (677)
T ss_pred HHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh
Confidence 455699999999999 599999999999999999999998754 9999997766543333 7778999999999999976
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-----------CCCCCCcee
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----------RLTTKSDVY 168 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~ 168 (311)
+ |||.||||.|+|+ -.|.+||+|||+|..+............+||..||+||.+... +.+.++|||
T Consensus 480 g--IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvW 556 (677)
T KOG0596|consen 480 G--IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVW 556 (677)
T ss_pred c--eeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchh
Confidence 5 9999999999998 4568999999999988777666667788999999999988542 256789999
Q ss_pred hhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH-HHHHHHHHHhcccCCCCCCCCH
Q 021507 169 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA-AHTAATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 169 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rpt~ 247 (311)
|||||||+|+.|+.||..-.. ....+..+.+....-++|..- ..++.++++.||..||++||++
T Consensus 557 SLGCILYqMvYgktPf~~~~n---------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si 621 (677)
T KOG0596|consen 557 SLGCILYQMVYGKTPFGQIIN---------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSI 621 (677)
T ss_pred hhhhHHHHHHhcCCchHHHHH---------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCc
Confidence 999999999999999975321 112233333333333344322 2349999999999999999999
Q ss_pred HHHHHH
Q 021507 248 SEVLAI 253 (311)
Q Consensus 248 ~~~l~~ 253 (311)
.++|++
T Consensus 622 ~eLLqh 627 (677)
T KOG0596|consen 622 PELLQH 627 (677)
T ss_pred HHHhcC
Confidence 999965
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=267.74 Aligned_cols=212 Identities=26% Similarity=0.363 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++.......+++..++.++.+++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~- 120 (256)
T cd08529 42 EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120 (256)
T ss_pred HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4556889999999999999999999999999999999999999999999765445699999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 121 -~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 197 (256)
T cd08529 121 -KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197 (256)
T ss_pred -CcccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence 599999999999999999999999999876543322 12334678899999999988899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||....... ..... ........+..++..+.+++.+||+.+|++||++.+++..
T Consensus 198 ~~p~~~~~~~~----------------~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 198 KHPFDANNQGA----------------LILKI-IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCCCCHHH----------------HHHHH-HcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 99997643110 01111 1111222334677889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=266.34 Aligned_cols=226 Identities=25% Similarity=0.282 Sum_probs=173.3
Q ss_pred HHHHHHHHHHhcCCCCC-ccceEeEEEeCC------eeEEEEecCCCCChHHHhhhcCC--CCCCHHHHHHHHHHHHHHH
Q 021507 23 NWFQTEVNYLGQLHHPN-LVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGL 93 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l 93 (311)
....+|+.+|++|+|+| |+.+++++...+ ..++|+||++. +|..++..... ..++...+..++.||+.||
T Consensus 55 ~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl 133 (323)
T KOG0594|consen 55 STAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGL 133 (323)
T ss_pred chhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHH
Confidence 34678999999999999 999999999877 78999999976 99999976553 3588889999999999999
Q ss_pred HHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHH
Q 021507 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGV 172 (311)
Q Consensus 94 ~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~ 172 (311)
+|||+++ |+||||||+||||+++|.+||+|||+|+...-.... -...++|.+|+|||++.|. .|+...||||+||
T Consensus 134 ~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~Gc 209 (323)
T KOG0594|consen 134 AFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGC 209 (323)
T ss_pred HHHHhCC--eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHH
Confidence 9999755 999999999999999999999999999965433222 3446789999999999987 7999999999999
Q ss_pred HHHHHHhCCCccCCCccchhhh--hhhhccccccchhhhhHhhhcc--cCCCC-c-------hHHHHHHHHHHHhcccCC
Q 021507 173 VLLELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKRKLFRIMDTK--LGGQY-P-------QKAAHTAATLALQCLNNE 240 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~-------~~~~~~l~~li~~~l~~~ 240 (311)
|++||++++..|.+.....+.. +.....|..............+ +.... + ........+++.+||+.+
T Consensus 210 IfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~ 289 (323)
T KOG0594|consen 210 IFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYD 289 (323)
T ss_pred HHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccC
Confidence 9999999999998876522211 1111112111111111111111 00000 1 122247899999999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|.+|.|+..++.+
T Consensus 290 p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 290 PAKRISAKGALTH 302 (323)
T ss_pred cccCcCHHHHhcC
Confidence 9999999999976
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=289.36 Aligned_cols=232 Identities=24% Similarity=0.270 Sum_probs=176.9
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.+.+|+.++.+++|+||+++++.+.+++..|+||||++||+|.+++
T Consensus 13 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l 92 (360)
T cd05627 13 AFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL 92 (360)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHH
Confidence 57888876654321 1111234456888999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-----------
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------- 138 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------- 138 (311)
.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.+|.++|+|||++.........
T Consensus 93 ~~~~--~l~~~~~~~~~~qi~~~L~~lH~~--givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~ 168 (360)
T cd05627 93 MKKD--TLSEEATQFYIAETVLAIDAIHQL--GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168 (360)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCc
Confidence 6543 489999999999999999999965 5999999999999999999999999998654221100
Q ss_pred ----------------------ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh
Q 021507 139 ----------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196 (311)
Q Consensus 139 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 196 (311)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~--- 245 (360)
T cd05627 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY--- 245 (360)
T ss_pred ccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH---
Confidence 0012346899999999999999999999999999999999999999765421110
Q ss_pred hhccccccchhhhhHhhhcccCCCCc--hHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 021507 197 DWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPR---MSEVLAI 253 (311)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt---~~~~l~~ 253 (311)
..+.........+ ..++.++.++|.+|+ .||.+|++ +.+++++
T Consensus 246 -------------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 246 -------------RKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred -------------HHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 1111111111112 235778999999977 49999985 6777654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=270.50 Aligned_cols=231 Identities=29% Similarity=0.447 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
....|.+|++++++++||||+++++++... ...|++|||+.+++|.+++... .+++..++.++.|++.||.|||+
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~ 125 (283)
T cd05080 49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS 125 (283)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999987653 4578999999999999998553 39999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
. +++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|
T Consensus 126 ~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el 203 (283)
T cd05080 126 Q--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203 (283)
T ss_pred C--CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHH
Confidence 5 5999999999999999999999999999865432221 111223456679999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
++|..||........... ..... ...................+..++.++.+++.+||+.||++|||++++++.|+.+
T Consensus 204 ~tg~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 204 LTHCDSKQSPPKKFEEMI-GPKQG-QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred HhCCCCCCCCcchhhhhh-ccccc-ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 999999865432111110 00000 0011111122222222233556788999999999999999999999999999876
Q ss_pred c
Q 021507 258 E 258 (311)
Q Consensus 258 ~ 258 (311)
.
T Consensus 282 ~ 282 (283)
T cd05080 282 H 282 (283)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=281.66 Aligned_cols=232 Identities=21% Similarity=0.270 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|+++++.++||||+++++++..++..|+||||+++++|.+++.......+++..++.++.|++.||+|||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 120 (327)
T cd08227 41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120 (327)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567888999999999999999999999999999999999999999999665445689999999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-----ceeccccccccccCcccccc--CCCCCCCceehhHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGV 172 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~ 172 (311)
+++||||||+||+++.++.++++||+........... .......++..|+|||++.+ ..++.++|||||||
T Consensus 121 --~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 121 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred --CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 4999999999999999999999999865432211100 01122356778999999876 45889999999999
Q ss_pred HHHHHHhCCCccCCCccchhh-hhhhhccccccch-----hh-------------h---------hHhhhcccCCCCchH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDK-----RK-------------L---------FRIMDTKLGGQYPQK 224 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~-----~~-------------~---------~~~~~~~~~~~~~~~ 224 (311)
++|+|++|..||......... .......+...+. .. . ...............
T Consensus 199 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (327)
T cd08227 199 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRT 278 (327)
T ss_pred HHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccc
Confidence 999999999999754321100 0000000000000 00 0 000000000112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++..+.+|+.+||+.||++|||+++++++
T Consensus 279 ~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 279 FSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 56789999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=272.26 Aligned_cols=218 Identities=28% Similarity=0.420 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEE-eCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+.+|+.+++.++||||+++++++. .++..+++|||+.+++|.+++.+.. ...++..+..++.|++.||+|||+.
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~ 117 (262)
T cd05058 39 EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK 117 (262)
T ss_pred HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3467889999999999999999999775 4556799999999999999986543 3367788889999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+++|+||||+||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|+|
T Consensus 118 --~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 195 (262)
T cd05058 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195 (262)
T ss_pred --CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHH
Confidence 5999999999999999999999999998754322111 111233456789999999888899999999999999999
Q ss_pred Hh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 178 LS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 178 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
++ |.+||...+.. .....+........+..++..+.+++.+||..+|++||++.++++.|++
T Consensus 196 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 196 MTRGAPPYPDVDSF-----------------DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred HcCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 99 46666543211 0111111111122234457789999999999999999999999999987
Q ss_pred hc
Q 021507 257 LE 258 (311)
Q Consensus 257 ~~ 258 (311)
+.
T Consensus 259 ~~ 260 (262)
T cd05058 259 IF 260 (262)
T ss_pred Hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.70 Aligned_cols=209 Identities=22% Similarity=0.370 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCe--eEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN--RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..++|..|+.+|+.|+||||+++|+++.+... +.+|+|.+.+|+|..|+++.+. ++...+..|+.||++||.|||+
T Consensus 84 ~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs 161 (632)
T KOG0584|consen 84 ELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHS 161 (632)
T ss_pred HHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhc
Confidence 34678899999999999999999999987655 7799999999999999976654 8889999999999999999999
Q ss_pred CCCCeeecCCCCCceEeCCC-CcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+...|+|||||.+||+|+.+ |.|||+|+|+|....... ....+||+.|||||++. ..|+...||||||++++||
T Consensus 162 ~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEM 236 (632)
T KOG0584|consen 162 QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEM 236 (632)
T ss_pred CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHH
Confidence 99999999999999999765 889999999998754432 34479999999999996 7899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc-hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|+..||..-.. ..++.+.+..+...... .--.++++++|.+||.. ..+|+|+.|+|+.
T Consensus 237 vT~eYPYsEC~n----------------~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 237 VTSEYPYSECTN----------------PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HhccCChhhhCC----------------HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 999999975321 12222222222211111 11256899999999999 9999999999964
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=278.75 Aligned_cols=227 Identities=23% Similarity=0.359 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++.+.+++..|+||||++|++|.+++.+. ..+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~- 118 (308)
T cd06615 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK- 118 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh-
Confidence 4566889999999999999999999999999999999999999999999655 3489999999999999999999962
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
.+++|+||||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 119 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred CCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence 35999999999999999999999999998654322 12345688999999999888899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccc-------------------hhhhhHhhhcccCCCCc-hHHHHHHHHHHHhcccCC
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSD-------------------KRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNE 240 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~ 240 (311)
..||...+................. ................+ ..++.++.+++.+||..|
T Consensus 195 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 274 (308)
T cd06615 195 RYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKN 274 (308)
T ss_pred CCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCC
Confidence 9999754422111111000000000 00000000001111111 135778999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021507 241 PKLRPRMSEVLAIL 254 (311)
Q Consensus 241 p~~Rpt~~~~l~~l 254 (311)
|++||++.++++..
T Consensus 275 P~~Rpt~~~ll~~~ 288 (308)
T cd06615 275 PKERADLKELTKHP 288 (308)
T ss_pred hhhCcCHHHHhcCh
Confidence 99999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=268.40 Aligned_cols=212 Identities=28% Similarity=0.429 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.|.+|++++++++||||+++++++.+.+..|+||||++|++|.+++..... .+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~-- 119 (256)
T cd05059 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN-- 119 (256)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34688899999999999999999999999999999999999999999965443 589999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 120 ~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g 198 (256)
T cd05059 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG 198 (256)
T ss_pred CcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccC
Confidence 4999999999999999999999999998764332111 1112223457999999998899999999999999999999 8
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
..||...... .....+........+..++.++.+++.+||..+|++|||+.++++.|
T Consensus 199 ~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 199 KMPYERFSNS-----------------EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 9999754321 11111122222234455788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.97 Aligned_cols=216 Identities=30% Similarity=0.469 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++|+||+++++++. .+..++||||+.+++|.+++.+.. .+++..+..++.|++.||+|||+.
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~- 114 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK- 114 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc-
Confidence 4567889999999999999999999876 456899999999999999997654 589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 115 -~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 193 (257)
T cd05060 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193 (257)
T ss_pred -CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence 49999999999999999999999999998654332211 1111223467999999988899999999999999999998
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||...+.. .....+........+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 194 ~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 194 YGAKPYGEMKGA-----------------EVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCcccCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 99999764321 111111112222345567789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=272.87 Aligned_cols=218 Identities=22% Similarity=0.369 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.++++++||||+++++++.. ...++||||+.+|+|.+++.+... .+++..++.++.|++.||+|||+
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~-- 127 (279)
T cd05057 52 ANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEE-- 127 (279)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh--
Confidence 44678899999999999999999999887 788999999999999999965433 48999999999999999999996
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 179 (311)
++++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 128 ~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~ 207 (279)
T cd05057 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF 207 (279)
T ss_pred CCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcC
Confidence 4599999999999999999999999999986543322211222233567999999988889999999999999999998
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
|..||...... .+...+........+..++..+.+++.+||..||++||++.++++.|..+..
T Consensus 208 g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 208 GAKPYEGIPAV-----------------EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCHH-----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999764321 1111222222223344566789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=269.08 Aligned_cols=217 Identities=29% Similarity=0.429 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------CCCCCHHHHHH
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMK 84 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~ 84 (311)
...+.+.+|++++.++ +||||+++++++...+..|+||||+++++|.+++.... ...+++..+..
T Consensus 37 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 116 (270)
T cd05047 37 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116 (270)
T ss_pred HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHH
Confidence 3456788999999999 89999999999999999999999999999999986432 12478999999
Q ss_pred HHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCC
Q 021507 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 164 (311)
Q Consensus 85 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 164 (311)
++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... .......+..|+|||++.+..++.+
T Consensus 117 ~~~~i~~al~~lH~~--~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~ 191 (270)
T cd05047 117 FAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTN 191 (270)
T ss_pred HHHHHHHHHHHHHHC--CEeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCch
Confidence 999999999999964 59999999999999999999999999986322110 1111233567999999988889999
Q ss_pred CceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 165 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 165 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
+||||||+++|+|++ |..||...... .....+........+..++.++.+++.+||..||.+
T Consensus 192 ~Di~slG~il~el~~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 254 (270)
T cd05047 192 SDVWSYGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 254 (270)
T ss_pred hhHHHHHHHHHHHHcCCCCCccccCHH-----------------HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhh
Confidence 999999999999997 99999754321 111111121222234456778999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 021507 244 RPRMSEVLAILERLE 258 (311)
Q Consensus 244 Rpt~~~~l~~l~~~~ 258 (311)
|||+.+++..|.++.
T Consensus 255 Rps~~~il~~l~~~~ 269 (270)
T cd05047 255 RPSFAQILVSLNRML 269 (270)
T ss_pred CCCHHHHHHHHHHhh
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=279.34 Aligned_cols=212 Identities=21% Similarity=0.241 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.++..++|+||+++++.+.+.+..|+||||+.+|+|.+++.+.. ..+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~-- 121 (332)
T cd05623 45 TACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL-- 121 (332)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3458889999999999999999999999999999999999999999996533 3489999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc-----cCCCCCCCceehhHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~ 176 (311)
+|+||||||+||+++.++.+||+|||++........ .......||+.|+|||++. ...++.++|||||||++|+
T Consensus 122 ~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred CeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHH
Confidence 499999999999999999999999999875432221 1223457899999999986 3457889999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCC---chHHHHHHHHHHHhcccCCCCC--CCCHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKL--RPRMSEVL 251 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l 251 (311)
|++|..||........ ...+......... ...++.++.+|+.+||..++++ |+++.+++
T Consensus 201 ll~g~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~ 264 (332)
T cd05623 201 MLYGETPFYAESLVET----------------YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFK 264 (332)
T ss_pred HhcCCCCCCCCCHHHH----------------HHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHh
Confidence 9999999976432111 1111111111111 2356888999999999765544 68999998
Q ss_pred HH
Q 021507 252 AI 253 (311)
Q Consensus 252 ~~ 253 (311)
++
T Consensus 265 ~h 266 (332)
T cd05623 265 QH 266 (332)
T ss_pred CC
Confidence 76
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.36 Aligned_cols=220 Identities=21% Similarity=0.328 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
.....+.+|+++++.++||||+++++++.+.+..++++||+++++|.+++... ....+++..++.++.+++.||+|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 123 (267)
T cd08228 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123 (267)
T ss_pred HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 44567889999999999999999999999999999999999999999988532 2244889999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+. +++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 124 ~~--~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 124 SR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred hC--CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHH
Confidence 64 599999999999999999999999999876543221 12234678899999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc-ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
++|..||........ .....+.. .........++..+.+++.+||..+|++||++.++++.+++
T Consensus 200 ~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 200 AALQSPFYGDKMNLF---------------SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred hcCCCCCccccccHH---------------HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 999999865322110 01111111 11112234567889999999999999999999999999987
Q ss_pred hc
Q 021507 257 LE 258 (311)
Q Consensus 257 ~~ 258 (311)
+.
T Consensus 265 ~~ 266 (267)
T cd08228 265 MH 266 (267)
T ss_pred hc
Confidence 63
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=269.96 Aligned_cols=215 Identities=28% Similarity=0.451 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.|.+|++++++++|+||+++++++.+ ...|++|||+++++|.+++.......+++..+..++.+++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~- 121 (260)
T cd05073 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR- 121 (260)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC-
Confidence 34578899999999999999999999887 7789999999999999999765555688999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 179 (311)
+++|+||||+||+++.++.+||+|||.+......... ......++..|+|||++.+..++.++|+||||+++|++++
T Consensus 122 -~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 122 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred -CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 5999999999999999999999999998765332211 1222345677999999988889999999999999999998
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|..||....... ....+........+...+.++.+++.+||..+|++||++.++++.|+.
T Consensus 200 g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 200 GRIPYPGMSNPE-----------------VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCCCHHH-----------------HHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999997643211 111111111222334567789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=275.31 Aligned_cols=218 Identities=24% Similarity=0.377 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------CCCCCHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------PQPLSWAVRMKVAIGAAKGL 93 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~i~~~l 93 (311)
...+.+|+.+++.++||||+++++++.+.+..|+||||+.+|+|.+++.+.. ...++...+..++.|++.||
T Consensus 53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (288)
T cd05061 53 RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132 (288)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999999999999999999999999996532 13356778899999999999
Q ss_pred HHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHH
Q 021507 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 173 (311)
Q Consensus 94 ~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 173 (311)
.|||+. +++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+|||||+
T Consensus 133 ~~lH~~--~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~ 210 (288)
T cd05061 133 AYLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210 (288)
T ss_pred HHHHhC--CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHH
Confidence 999965 599999999999999999999999999875433222222222345678999999988889999999999999
Q ss_pred HHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 174 LLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 174 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
+|+|++ |..||.+..... ....+........+..++..+.+++.+||+.||++|||+.++++
T Consensus 211 l~el~~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 211 LWEITSLAEQPYQGLSNEQ-----------------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred HHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 788987533211 11111111111223455788999999999999999999999999
Q ss_pred HHHhhc
Q 021507 253 ILERLE 258 (311)
Q Consensus 253 ~l~~~~ 258 (311)
.|+...
T Consensus 274 ~l~~~~ 279 (288)
T cd05061 274 LLKDDL 279 (288)
T ss_pred HHHhhc
Confidence 988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=267.37 Aligned_cols=220 Identities=22% Similarity=0.329 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.+.+|+.+++.++|+||+++++++.+++..+++|||+.+++|.+++... ....+++..++.++.+++.||+|||
T Consensus 44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 123 (267)
T cd08229 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123 (267)
T ss_pred HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999988532 2345899999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+. +++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 124 ~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 124 SR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HC--CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence 65 599999999999999999999999999876533221 12335688899999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
++|..||.......... .............+..++..+.+++.+||..||++|||+.++++.+.++
T Consensus 200 ~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 200 AALQSPFYGDKMNLYSL--------------CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HhCCCCcccccchHHHH--------------hhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 99999997543211100 0011111111122345778999999999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=267.34 Aligned_cols=213 Identities=22% Similarity=0.289 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|+.+++.++|+||+++++.+.+++..|++|||+++++|.+++.......+++..++.++.|++.||.+||+.
T Consensus 40 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 119 (255)
T cd08219 40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119 (255)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 34567889999999999999999999999999999999999999999988665555689999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.++|+|||.+........ ......++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 120 --~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred --CcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhh
Confidence 599999999999999999999999999876533221 1234568889999999988889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|..||...+... ....+........+..++..+.+++.+||+.||++||++.+++..
T Consensus 196 g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 196 LKHPFQANSWKN-----------------LILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCCCCCCCHHH-----------------HHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 999997643211 111111111222345567789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=268.33 Aligned_cols=217 Identities=26% Similarity=0.460 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCe------eEEEEecCCCCChHHHhhhc----CCCCCCHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN------RLLVYEFMPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAK 91 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~ 91 (311)
.+.+.+|+++++.++||||+++++++.+... .+++|||+++++|..++... ....+++..+..++.|++.
T Consensus 45 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~ 124 (273)
T cd05035 45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124 (273)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHH
Confidence 4568999999999999999999998876554 79999999999999988432 2245899999999999999
Q ss_pred HHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhH
Q 021507 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 171 (311)
Q Consensus 92 ~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 171 (311)
||.|||+. +++|+||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||
T Consensus 125 aL~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG 202 (273)
T cd05035 125 GMEYLSNR--NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202 (273)
T ss_pred HHHHHHhC--CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHH
Confidence 99999964 5999999999999999999999999999865433222212223346689999999888899999999999
Q ss_pred HHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
|++|||++ |..||...... .....+........+..++..+.+++.+||..||++||++.++
T Consensus 203 ~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~ 265 (273)
T cd05035 203 VTMWEIATRGQTPYPGVENH-----------------EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265 (273)
T ss_pred HHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 99999999 88998653311 1111112222223455678899999999999999999999999
Q ss_pred HHHHHhh
Q 021507 251 LAILERL 257 (311)
Q Consensus 251 l~~l~~~ 257 (311)
++.|+++
T Consensus 266 ~~~l~~~ 272 (273)
T cd05035 266 REVLENI 272 (273)
T ss_pred HHHHHhh
Confidence 9999765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=268.75 Aligned_cols=231 Identities=29% Similarity=0.443 Sum_probs=180.2
Q ss_pred ChhHHHhHHHHHHh----hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCC
Q 021507 1 MFLFNFLHSHLELH----ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP 76 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (311)
|||.||.+...+.. ........+.+.+|+.++++++||||+++++++..+ ..+++|||+.+++|.+++.......
T Consensus 18 ~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~ 96 (254)
T cd05083 18 EFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRAL 96 (254)
T ss_pred CCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCC
Confidence 57777765432211 001112345788999999999999999999998765 4799999999999999997665556
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccc
Q 021507 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 156 (311)
Q Consensus 77 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 156 (311)
+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++...... ......+..|+|||.+
T Consensus 97 ~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~ 169 (254)
T cd05083 97 VSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEAL 169 (254)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHh
Confidence 8999999999999999999996 45999999999999999999999999998753221 1122345679999999
Q ss_pred ccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHh
Q 021507 157 ATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 235 (311)
Q Consensus 157 ~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (311)
.+..++.++|+||||+++|+|++ |..||....... .............+..++..+.+++.+
T Consensus 170 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------------VKECVEKGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence 88889999999999999999997 999997643211 111112222223345677889999999
Q ss_pred cccCCCCCCCCHHHHHHHHHh
Q 021507 236 CLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 236 ~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
||+.+|++||++.++++.|+.
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=269.62 Aligned_cols=214 Identities=31% Similarity=0.505 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++|+||+++++++.+.+..|++|||+++++|.+++.......+++..++.++.|++.||++||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~- 122 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK- 122 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-
Confidence 4567899999999999999999999999999999999999999999999665443389999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 179 (311)
+++|+||||+||+++.++.++|+|||++............ ...++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 123 -~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred -CeeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 5999999999999999999999999999765443222111 2336788999999988889999999999999999998
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|..||...... ..............+..++.++.+++.+||..||++|||+.++++.|
T Consensus 201 g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 201 GESPYPGMSNE-----------------EVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 88888753221 11111122222233445788999999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=276.88 Aligned_cols=212 Identities=21% Similarity=0.229 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|..++..++|+||+++++++.+++..|+||||+.|++|.+++.+.. ..+++..+..++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~-- 121 (331)
T cd05597 45 TACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL-- 121 (331)
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4558899999999999999999999999999999999999999999996533 3489999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-----CCCCCCCceehhHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~ 176 (311)
+|+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 122 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (331)
T cd05597 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200 (331)
T ss_pred CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHH
Confidence 4999999999999999999999999998754332211 1223468999999999863 357789999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC---CCCchHHHHHHHHHHHhcccCCCC--CCCCHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPK--LRPRMSEVL 251 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~--~Rpt~~~~l 251 (311)
|++|+.||......... ..+...... ......++..+.+++.+||..+++ .|+++.+++
T Consensus 201 l~~g~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l 264 (331)
T cd05597 201 MLYGETPFYAESLVETY----------------GKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFK 264 (331)
T ss_pred HhhCCCCCCCCCHHHHH----------------HHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999764321110 011110000 011223678899999998865444 378999998
Q ss_pred HH
Q 021507 252 AI 253 (311)
Q Consensus 252 ~~ 253 (311)
++
T Consensus 265 ~h 266 (331)
T cd05597 265 DH 266 (331)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=270.79 Aligned_cols=207 Identities=25% Similarity=0.405 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
.....|.+|+.++..++||||+++++++..+...++||||+++++|..++.... ..+++..++.++.|++.||+|||+.
T Consensus 46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~ 124 (262)
T cd05077 46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK 124 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC
Confidence 345578889999999999999999999999989999999999999988875433 3489999999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCc-------EEEecccccccCCCCCCcceeccccccccccCccccc-cCCCCCCCceehhH
Q 021507 100 ESQVIYRDFKASNILLDAEFN-------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFG 171 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~-------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG 171 (311)
+++||||||+||+++.++. ++++|||++..... .....++..|+|||++. +..++.++||||||
T Consensus 125 --~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (262)
T cd05077 125 --DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFG 196 (262)
T ss_pred --CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHH
Confidence 5999999999999987664 89999999865422 22345788899999886 45688999999999
Q ss_pred HHHHHHH-hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
|++|+|+ +|..||......... ....... ......+.++.+|+.+||+.||.+||++.++
T Consensus 197 ~~l~el~~~~~~p~~~~~~~~~~-----------------~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~i 257 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTLAEKE-----------------RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAI 257 (262)
T ss_pred HHHHHHHhCCCCCCCCcchhHHH-----------------HHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999998 588888654321100 0000000 1112235678999999999999999999999
Q ss_pred HHHH
Q 021507 251 LAIL 254 (311)
Q Consensus 251 l~~l 254 (311)
+..+
T Consensus 258 l~~~ 261 (262)
T cd05077 258 MRDI 261 (262)
T ss_pred HHhc
Confidence 9876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=265.87 Aligned_cols=214 Identities=29% Similarity=0.419 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++|+||+++++++. .+..|++|||+.+++|.+++.......+++..+..++.+++.||+|||+.
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-- 121 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM-- 121 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456889999999999999999998875 45689999999999999999765555689999999999999999999964
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||+++.++.++|+|||++......... ......++..|+|||...+..++.++||||||+++|+|++ |
T Consensus 122 ~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g 200 (260)
T cd05069 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCC
Confidence 5999999999999999999999999999765332211 1223345678999999988889999999999999999999 9
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
..||.+..... .............+...+..+.+++.+||..||++||+++++++.|+.
T Consensus 201 ~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 201 RVPYPGMVNRE-----------------VLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCCHHH-----------------HHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99997643211 111111111223345577889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=277.00 Aligned_cols=233 Identities=20% Similarity=0.205 Sum_probs=176.1
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... + .......+.+.+|..++..++|+||+++++++.+++..|+||||+.||+|.+++
T Consensus 13 ~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l 92 (331)
T cd05624 13 AFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL 92 (331)
T ss_pred CCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 57788777654321 0 111223345788999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......... ......|+..
T Consensus 93 ~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~--~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~ 168 (331)
T cd05624 93 SKFE-DRLPEDMARFYIAEMVLAIHSIHQL--HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPD 168 (331)
T ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcc
Confidence 6533 3489999999999999999999965 4999999999999999999999999999765432221 1233568999
Q ss_pred ccCcccccc-----CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc--
Q 021507 150 YAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-- 222 (311)
Q Consensus 150 y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (311)
|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.... ...+.........+
T Consensus 169 y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~ 232 (331)
T cd05624 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------------YGKIMNHEERFQFPSH 232 (331)
T ss_pred cCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH----------------HHHHHcCCCcccCCCc
Confidence 999999876 4678899999999999999999999976432110 11111111111111
Q ss_pred -hHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 021507 223 -QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 253 (311)
Q Consensus 223 -~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~ 253 (311)
..++.++.+++.+||..++++ |+++++++++
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 245788999999999876544 4588888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=280.86 Aligned_cols=226 Identities=27% Similarity=0.375 Sum_probs=166.2
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
..+.+|++++++++||||+++++++... ...|+||||+. ++|.+++.... .+++..+..++.|++.||+|||
T Consensus 44 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 44 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred HHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999988643 34799999995 59999886543 4899999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCcccccc--CCCCCCCceehhHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVL 174 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 174 (311)
+.+ |+||||||+|||++.++.+||+|||+++........ .......|+..|+|||++.+ ..++.++|||||||++
T Consensus 121 ~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl 198 (338)
T cd07859 121 TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 198 (338)
T ss_pred HCC--eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence 754 999999999999999999999999999754322211 11234578999999999876 5788999999999999
Q ss_pred HHHHhCCCccCCCccchhhhhh-hhc-cccccc--------hhhhhHhhhcccCCCC---chHHHHHHHHHHHhcccCCC
Q 021507 175 LELLSGRCAVDKTKVGIEQSLV-DWA-KPYLSD--------KRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~-~~~-~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p 241 (311)
|+|++|+.||.+.......... ... .+.... .......+........ ...++..+.+++.+||..||
T Consensus 199 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 278 (338)
T cd07859 199 AEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDP 278 (338)
T ss_pred HHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCc
Confidence 9999999999765432111100 000 000000 0000111111111000 11346678999999999999
Q ss_pred CCCCCHHHHHHH
Q 021507 242 KLRPRMSEVLAI 253 (311)
Q Consensus 242 ~~Rpt~~~~l~~ 253 (311)
++|||+++++++
T Consensus 279 ~~Rpt~~e~l~h 290 (338)
T cd07859 279 KDRPTAEEALAD 290 (338)
T ss_pred ccCCCHHHHhcC
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=295.36 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=173.7
Q ss_pred ChhHHHhHHHHHHh---h-hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC--------CeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---A-RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--------ENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||.+.+.... + +..........+|+.+++.++||||+++++++... ..+++||||+++ +|.++
T Consensus 78 ~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~ 156 (440)
T PTZ00036 78 SFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKY 156 (440)
T ss_pred CCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHH
Confidence 58888887654322 1 11112223456799999999999999999887532 246799999975 88777
Q ss_pred hhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcceecccc
Q 021507 69 LFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 69 l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
+.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....... .....
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~ 231 (440)
T PTZ00036 157 MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYI 231 (440)
T ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCC
Confidence 643 23345899999999999999999999754 99999999999998665 699999999986543221 22356
Q ss_pred ccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-hhhh-ccccccchhhh----hH-----hh
Q 021507 146 GTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPYLSDKRKL----FR-----IM 213 (311)
Q Consensus 146 gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~-~~~~~~~~~~~----~~-----~~ 213 (311)
||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+........ .... ..+........ .. ..
T Consensus 232 ~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 311 (440)
T PTZ00036 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVK 311 (440)
T ss_pred CCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccC
Confidence 79999999998764 68999999999999999999999998754321111 1110 00100000000 00 00
Q ss_pred hcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 214 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.......++...+.++.+||.+||..||.+|||+.+++++
T Consensus 312 ~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 312 PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred chhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0001111233457789999999999999999999999965
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=273.44 Aligned_cols=234 Identities=27% Similarity=0.377 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.|.+|++++++++||||+++++++.. ....++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH 125 (284)
T cd05081 47 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG 125 (284)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999998754 346789999999999999986543 34899999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+. +++|+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++||
T Consensus 126 ~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 203 (284)
T cd05081 126 SK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203 (284)
T ss_pred HC--CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHH
Confidence 65 59999999999999999999999999998654332211 1111223456999999988889999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|++|..++.............. .........+...+........+..++.++.+++.+||..+|++|||+.++++.|+.
T Consensus 204 l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 204 LFTYSDKSCSPPAEFMRMMGND-KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HhhcCCcCCCcchhhhhhcccc-cccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 9998877654321110000000 000000011122222222223345677899999999999999999999999999976
Q ss_pred h
Q 021507 257 L 257 (311)
Q Consensus 257 ~ 257 (311)
+
T Consensus 283 ~ 283 (284)
T cd05081 283 I 283 (284)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=279.89 Aligned_cols=223 Identities=25% Similarity=0.331 Sum_probs=174.3
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... +.+ .....+.+..|..++..+. |++|+++++++.+.+..|+||||++||+|.++
T Consensus 12 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~ 91 (323)
T cd05615 12 SFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYH 91 (323)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHH
Confidence 57888877654321 111 1122345778999998885 57788899999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .......||.
T Consensus 92 i~~~~--~l~~~~~~~i~~qi~~al~~lH~~--~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~ 165 (323)
T cd05615 92 IQQVG--KFKEPQAVFYAAEISVGLFFLHRR--GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTP 165 (323)
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCc
Confidence 86543 489999999999999999999965 59999999999999999999999999987532221 1233456899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||....... ....+... ....+..++.+
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~ 227 (323)
T cd05615 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----------------LFQSIMEH--NVSYPKSLSKE 227 (323)
T ss_pred cccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC--CCCCCccCCHH
Confidence 9999999998899999999999999999999999998643211 01111111 12345567788
Q ss_pred HHHHHHhcccCCCCCCCCH
Q 021507 229 AATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~ 247 (311)
+.+++.+||..||.+|++.
T Consensus 228 ~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHcccCHhhCCCC
Confidence 9999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=281.84 Aligned_cols=218 Identities=28% Similarity=0.412 Sum_probs=188.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..-++.|..|+.+|++++||||++++|++.+ ...|+|||.++.|.|..+++.++. .++......++.||+.+|+|||+
T Consensus 432 ~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeS 509 (974)
T KOG4257|consen 432 PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLES 509 (974)
T ss_pred hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHh
Confidence 3447789999999999999999999999976 478999999999999999987664 49999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
.. +|||||-..|||+....-|||+|||++++..+...+... ...-...|||||.+.-..++.+||||.||+++||++
T Consensus 510 kr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl 586 (974)
T KOG4257|consen 510 KR--FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEIL 586 (974)
T ss_pred hc--hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHH
Confidence 65 999999999999999999999999999998776655433 333466899999999999999999999999999998
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
. |.-||.+-. +......++.+.+...|++|+..+..|+.+||.++|.+||++.++...|..+
T Consensus 587 ~lGvkPfqgvk-----------------NsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 587 SLGVKPFQGVK-----------------NSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred HhcCCcccccc-----------------ccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 8 999998643 2233444566677788999999999999999999999999999999887665
Q ss_pred c
Q 021507 258 E 258 (311)
Q Consensus 258 ~ 258 (311)
.
T Consensus 650 ~ 650 (974)
T KOG4257|consen 650 L 650 (974)
T ss_pred H
Confidence 4
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=280.68 Aligned_cols=250 Identities=20% Similarity=0.235 Sum_probs=172.5
Q ss_pred ChhHHHhHHHHHHh-----hhh---HHHHHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH-----ARS---LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++++.... +.+ .......+.+|++++++++||||+++++++.. +...|++|||+.+ +|.+++.
T Consensus 13 ~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (317)
T cd07868 13 TYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIK 91 (317)
T ss_pred CCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHH
Confidence 58899988754211 111 11123457889999999999999999999864 4568999999965 8888774
Q ss_pred hc-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe----CCCCcEEEecccccccCCCCCCc-
Q 021507 71 RR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRT- 138 (311)
Q Consensus 71 ~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~- 138 (311)
.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++........
T Consensus 92 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 169 (317)
T cd07868 92 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169 (317)
T ss_pred hcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccc
Confidence 32 123589999999999999999999965 49999999999999 45678999999999865433211
Q ss_pred ceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhh----------hhhhhc-cccccch
Q 021507 139 HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ----------SLVDWA-KPYLSDK 206 (311)
Q Consensus 139 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~~-~~~~~~~ 206 (311)
.......+|..|+|||++.+. .++.++|||||||++|+|++|..||......... ...... .+.....
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T cd07868 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW 249 (317)
T ss_pred cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHh
Confidence 112345789999999998774 5889999999999999999999999754432110 000000 0000000
Q ss_pred hh---------hhHhhhcccC---------CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 207 RK---------LFRIMDTKLG---------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 207 ~~---------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.. .......... .......+..+.+||.+||..||.+|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 250 EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000000000 00001124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=265.76 Aligned_cols=212 Identities=30% Similarity=0.511 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.+++.++|+||+++++++.+....|+||||+++++|.+++.......+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~- 121 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK- 121 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4567889999999999999999999999889999999999999999999766555699999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 179 (311)
+++|+||||+||+++.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|++++
T Consensus 122 -~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred -CccchhcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhc
Confidence 59999999999999999999999999997652221 12334567999999988889999999999999999997
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|..||...... .+...+........+..++..+.+++.+||..+|++||++.++++.|++
T Consensus 196 g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 196 GRVPYPRIPLK-----------------DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCCCCCHH-----------------HHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 99999754321 1111111122223345567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=280.07 Aligned_cols=240 Identities=27% Similarity=0.355 Sum_probs=181.1
Q ss_pred ChhHHHhHHHHHHh--------h------hhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeC-CeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH--------A------RSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEG-ENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~------~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~ 64 (311)
+||+||.+.+.... + .......+.+.+|+.++.++ +||||+++++++... ...+++|||+++|+
T Consensus 19 ~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~ 98 (343)
T cd05103 19 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 98 (343)
T ss_pred ccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCc
Confidence 68999988643211 1 11122345688999999999 689999999987654 46789999999999
Q ss_pred hHHHhhhcC-----------------------------------------------------------------CCCCCH
Q 021507 65 LENHLFRRG-----------------------------------------------------------------PQPLSW 79 (311)
Q Consensus 65 L~~~l~~~~-----------------------------------------------------------------~~~~~~ 79 (311)
|.+++.... ...+++
T Consensus 99 L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (343)
T cd05103 99 LSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTL 178 (343)
T ss_pred HHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCH
Confidence 999985432 123678
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC
Q 021507 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 159 (311)
Q Consensus 80 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 159 (311)
..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++................++..|+|||.+.+.
T Consensus 179 ~~~~~~~~qi~~al~~lH~~--~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 256 (343)
T cd05103 179 EDLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 256 (343)
T ss_pred HHHHHHHHHHHHHHHHHHhC--CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCC
Confidence 88899999999999999965 5999999999999999999999999999764332221112233456789999999888
Q ss_pred CCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhccc
Q 021507 160 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 238 (311)
Q Consensus 160 ~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (311)
.++.++||||||+++|+|++ |..||....... .....+........+...+..+.+++.+||.
T Consensus 257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----------------HHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999999999997 999987532210 0111111111222233456789999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhc
Q 021507 239 NEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 239 ~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.||++|||+.++++.|+.+.
T Consensus 321 ~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 321 GEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CChhhCcCHHHHHHHHHHHH
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=284.35 Aligned_cols=244 Identities=21% Similarity=0.226 Sum_probs=174.2
Q ss_pred ChhHHHhHHHHHHh---h-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH---A-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~ 64 (311)
+||+||++.+.... + .......+.+.+|+.+++.++||||+++++++.... ..|+||||+.+ +
T Consensus 33 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 111 (359)
T cd07876 33 AQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-N 111 (359)
T ss_pred CCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-C
Confidence 57777777554321 0 011223456778999999999999999999986543 47999999976 7
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .....
T Consensus 112 l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 182 (359)
T cd07876 112 LCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPY 182 (359)
T ss_pred HHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCC
Confidence 7776632 388899999999999999999965 59999999999999999999999999997543221 12345
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-hhh-hccccccchhh----hhHhhhcc--
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRK----LFRIMDTK-- 216 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~----~~~~~~~~-- 216 (311)
.+|..|+|||++.+..++.++|||||||++|+|++|..||.+.+...... ... ...+....... ........
T Consensus 183 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (359)
T cd07876 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQ 262 (359)
T ss_pred cccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCC
Confidence 68999999999999999999999999999999999999998654311100 000 00000000000 00000000
Q ss_pred ----------------cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 217 ----------------LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 217 ----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.........+..+.+||.+||..||++|||+.|++++-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 263 YPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred CCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00011123456789999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=289.60 Aligned_cols=229 Identities=21% Similarity=0.264 Sum_probs=166.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
..+.+.+|+++|++++||||+++++++.+.+..|+|++++.+ +|.+++.... ........+..++.|++.||+|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 455688999999999999999999999999999999999964 8888774332 112345677889999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+. +|+||||||+|||++.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|||
T Consensus 285 ~~--gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DK--KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hC--CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 65 599999999999999999999999999986543221 123345789999999999999999999999999999999
Q ss_pred HhCCC-ccCCCccchhhhhhhhc-------cccccchhhhhHhhhcccCCCCc---------hHHHHHHHHHHHhcccCC
Q 021507 178 LSGRC-AVDKTKVGIEQSLVDWA-------KPYLSDKRKLFRIMDTKLGGQYP---------QKAAHTAATLALQCLNNE 240 (311)
Q Consensus 178 ~~g~~-pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~ 240 (311)
++|.. ||..........+.... ..+......+...+........+ ...+..+.+++.+||..|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 99875 44433222111111100 00111111112211111100000 123456788899999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|++|||+.|++.+
T Consensus 442 P~~Rpsa~elL~h 454 (501)
T PHA03210 442 WHLRPGAAELLAL 454 (501)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999975
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.62 Aligned_cols=247 Identities=23% Similarity=0.259 Sum_probs=174.8
Q ss_pred ChhHHHhHHHHHHh---hhhH-------HHHHHHHHHHHHHHhcC---CCCCccceEeEEEe-----CCeeEEEEecCCC
Q 021507 1 MFLFNFLHSHLELH---ARSL-------LLITNWFQTEVNYLGQL---HHPNLVKLIGYCLE-----GENRLLVYEFMPK 62 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-----~~~~~lv~e~~~~ 62 (311)
+||+||++.+.+.. +.+. ......+.+|+.+++.+ +||||+++++++.. ....+++|||+.+
T Consensus 12 ~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~ 91 (288)
T cd07863 12 AYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ 91 (288)
T ss_pred CCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc
Confidence 57888887665422 1110 01123456677777665 79999999998864 2457999999975
Q ss_pred CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceec
Q 021507 63 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142 (311)
Q Consensus 63 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 142 (311)
+|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 92 -~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~ 165 (288)
T cd07863 92 -DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LT 165 (288)
T ss_pred -CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccccccCccc---CC
Confidence 8999887655556999999999999999999999754 99999999999999999999999999976532211 23
Q ss_pred cccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-hhhhcc-ccccchhhhhHhhhccc---
Q 021507 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSDKRKLFRIMDTKL--- 217 (311)
Q Consensus 143 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~--- 217 (311)
...++..|+|||++.+..++.++|||||||++|+|++|.+||.......... ...... +................
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T cd07863 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPR 245 (288)
T ss_pred CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCC
Confidence 3467889999999998899999999999999999999999997643321110 010000 00000000000000000
Q ss_pred ----CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 ----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.......++..+.+++.+||+.||++|||+.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 246 GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001112456788999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=301.81 Aligned_cols=242 Identities=19% Similarity=0.229 Sum_probs=183.0
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
|||+||++.+.... ........+.|.+|++++++++||||+++++++.+++..|+||||++|++|.+++
T Consensus 14 gfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL 93 (932)
T PRK13184 14 GMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLL 93 (932)
T ss_pred CCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHH
Confidence 57888887654321 1112345667999999999999999999999999999999999999999999988
Q ss_pred hhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC---
Q 021507 70 FRRG---------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--- 137 (311)
Q Consensus 70 ~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 137 (311)
.+.. ....+...++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 94 ~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~--GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~ 171 (932)
T PRK13184 94 KSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171 (932)
T ss_pred HHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC--CccccCCchheEEEcCCCCEEEEecCcceeccccccccc
Confidence 5421 12356677889999999999999965 599999999999999999999999999976521110
Q ss_pred -------------cceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhcccccc
Q 021507 138 -------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204 (311)
Q Consensus 138 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 204 (311)
........||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 172 ~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~---------- 241 (932)
T PRK13184 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY---------- 241 (932)
T ss_pred ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh----------
Confidence 001123568999999999999999999999999999999999999997633210000
Q ss_pred chhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhhcC
Q 021507 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLEA 259 (311)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~~l~~l~~~~~ 259 (311)
...............++..+.+++.+||..||++|+ +++++++.|+....
T Consensus 242 -----~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 242 -----RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred -----hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000000000011234677899999999999999997 67778888877643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=281.72 Aligned_cols=217 Identities=25% Similarity=0.389 Sum_probs=192.6
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.|++|+.+|+.++|||+|+++++|..+-.+|||+|||..|+|.++|+..++..++....+.++.||..|++||..+
T Consensus 307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-- 384 (1157)
T KOG4278|consen 307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-- 384 (1157)
T ss_pred HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh--
Confidence 445899999999999999999999999999999999999999999999888877788889999999999999999964
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
++|||||-..|+|+.++..|||+|||+++.+...... ......-...|.|||-+....++.++|||+||++|||+.| |
T Consensus 385 nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 385 NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcC
Confidence 4999999999999999999999999999987544322 2333334678999999999999999999999999999999 8
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
..||.+-+ .......+++.++...|.+|+..+.+||+.||+++|.+||++.|+-..++.+-
T Consensus 464 MsPYPGid-----------------lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 464 MSPYPGID-----------------LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCCCCcc-----------------HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 89988643 34567788899999999999999999999999999999999999998887653
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=280.37 Aligned_cols=248 Identities=23% Similarity=0.260 Sum_probs=178.0
Q ss_pred ChhHHHhHHHHHHh---h------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---A------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+.... + .........+.+|++++++++||||+++++++..++..|+||||+.+ +|.+++..
T Consensus 18 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 96 (309)
T cd07872 18 TYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD 96 (309)
T ss_pred CCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh
Confidence 57778876543321 1 11111234577899999999999999999999999999999999975 89888855
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ......++..|+
T Consensus 97 ~~-~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~ 171 (309)
T cd07872 97 CG-NIMSMHNVKIFLYQILRGLAYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYR 171 (309)
T ss_pred cC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECccccceecCCCcc--cccccccccccc
Confidence 43 3488999999999999999999965 599999999999999999999999999875432221 122346788999
Q ss_pred Ccccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhc-cccc------cchhhhhHhhhcccC----
Q 021507 152 APEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWA-KPYL------SDKRKLFRIMDTKLG---- 218 (311)
Q Consensus 152 aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~-~~~~------~~~~~~~~~~~~~~~---- 218 (311)
|||++.+ ..++.++|||||||++|+|++|+.||...+........ ... .+.. ...............
T Consensus 172 aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (309)
T cd07872 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPL 251 (309)
T ss_pred CCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCch
Confidence 9998865 46788999999999999999999999765432211111 000 0000 000000000000000
Q ss_pred CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 219 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
......++.++.++|.+||..||.+|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 252 INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 001124677899999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=263.89 Aligned_cols=219 Identities=23% Similarity=0.364 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..+.+.+|++++++++|+||+++++++.+++..++||||+++++|.+++... ....+++..++.++.+++.||+|||+
T Consensus 45 ~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 124 (267)
T cd08224 45 ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124 (267)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 4567889999999999999999999999999999999999999999988542 23458999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
. +++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 125 ~--~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 125 K--RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred C--CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 5 5999999999999999999999999998764332211 22346788999999998888999999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCch-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ-KAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+|..||........ .....+........+. .++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 201 ~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 201 ALQSPFYGDKMNLY---------------SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HCCCCcccCCccHH---------------HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 99999965432110 0111111111112222 5677899999999999999999999999999876
Q ss_pred c
Q 021507 258 E 258 (311)
Q Consensus 258 ~ 258 (311)
.
T Consensus 266 ~ 266 (267)
T cd08224 266 H 266 (267)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=273.70 Aligned_cols=212 Identities=24% Similarity=0.332 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeC------CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
...+.+|+.+++++ +|+||+++++++... ...|++|||+.+++|.+++.......+++..+..++.|++.||+
T Consensus 46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~ 125 (272)
T cd06637 46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125 (272)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence 34678899999999 799999999998753 45799999999999999997655556899999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc-----cCCCCCCCceeh
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYS 169 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s 169 (311)
|||+. +++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++. +..++.++|+||
T Consensus 126 ~LH~~--~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 201 (272)
T cd06637 126 HLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201 (272)
T ss_pred HHHHC--CCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence 99975 499999999999999999999999999876432211 133456889999999986 335788999999
Q ss_pred hHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 170 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 170 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
|||++|+|++|..||......... ...............++..+.+|+.+||..||.+|||+.+
T Consensus 202 lGv~l~el~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 202 LGITAIEMAEGAPPLCDMHPMRAL----------------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred HHHHHHHHHhCCCCccccCHHHHH----------------HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 999999999999999753321110 0111111111223346778999999999999999999999
Q ss_pred HHHH
Q 021507 250 VLAI 253 (311)
Q Consensus 250 ~l~~ 253 (311)
++++
T Consensus 266 il~~ 269 (272)
T cd06637 266 LMKH 269 (272)
T ss_pred HhhC
Confidence 9763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=284.23 Aligned_cols=206 Identities=27% Similarity=0.413 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+..+.|.+|+... +||.++.++..|...+++|.||||+.||++..+++. ..+++..+.-++..++.||.|||+
T Consensus 412 Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~-- 486 (694)
T KOG0694|consen 412 VESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHE-- 486 (694)
T ss_pred HHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHh--
Confidence 34577899998888 599999999999999999999999999995544322 349999999999999999999996
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
++|||||||.+|||++.+|.+||+|||+++...... ....+++||+.|||||++.+..|+.+.|-||||++||||+.|
T Consensus 487 ~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~G 564 (694)
T KOG0694|consen 487 NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVG 564 (694)
T ss_pred cCceeeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcC
Confidence 459999999999999999999999999998643222 246789999999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 252 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~ 252 (311)
+.||.+.++.. ++..+. .....+|..++.+..++|+++|..||++|.. +++|..
T Consensus 565 q~PF~gddEee-----------------~FdsI~-~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 565 ESPFPGDDEEE-----------------VFDSIV-NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred CCCCCCCCHHH-----------------HHHHHh-cCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 99999765421 111111 1223578889999999999999999999984 455554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=268.18 Aligned_cols=246 Identities=24% Similarity=0.297 Sum_probs=177.5
Q ss_pred hhHHHhHHHHHHh---h-hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeEEEEecCCCCChHHHhhhc
Q 021507 2 FLFNFLHSHLELH---A-RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 2 ~~~~~~~~~~~~~---~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~ 72 (311)
||.||-+...+.. + +++..-.+.--+|+++|+.++|||||++..+|.... ...+||||++. +|.+.++..
T Consensus 37 Fg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~ 115 (364)
T KOG0658|consen 37 FGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHY 115 (364)
T ss_pred cceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHH
Confidence 6666655555442 1 111111222347999999999999999998887432 23599999976 999998631
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC-CcEEEecccccccCCCCCCcceecccccccc
Q 021507 73 --GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 73 --~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
....++...+.-+..||++||+|||+.+ |+||||||+|+|+|.+ |.+||||||.|+....+.. +.....|..
T Consensus 116 ~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep---niSYicSRy 190 (364)
T KOG0658|consen 116 TRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP---NISYICSRY 190 (364)
T ss_pred hhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC---ceeEEEecc
Confidence 2345888889999999999999999754 9999999999999987 8999999999998755443 345567999
Q ss_pred ccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-hhhhccccccch----------hhhhHhhhccc
Q 021507 150 YAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDK----------RKLFRIMDTKL 217 (311)
Q Consensus 150 y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~ 217 (311)
|+|||.+.|. .|+.+.||||.||++.||+-|++.|.+.....+.. .++....+..+. ....++.....
T Consensus 191 YRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~ 270 (364)
T KOG0658|consen 191 YRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPW 270 (364)
T ss_pred ccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccc
Confidence 9999999886 69999999999999999999999998865432221 111111111100 00011111111
Q ss_pred CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
........+.++.+|+.++|.++|.+|.++.+++.+
T Consensus 271 ~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 271 HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 112345678899999999999999999999999864
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=264.76 Aligned_cols=218 Identities=24% Similarity=0.439 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.|.+|+.++++++||||+++++++.+++..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 47 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~ 125 (269)
T cd05065 47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM 125 (269)
T ss_pred HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678999999999999999999999999999999999999999999986543 3489999999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecc-c--cccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-V--MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+++|+||||+||+++.++.++|+|||++.............. . ..+..|+|||.+.+..++.++|||||||++||
T Consensus 126 --g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e 203 (269)
T cd05065 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 203 (269)
T ss_pred --CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHH
Confidence 599999999999999999999999999876433221111111 1 12457999999988899999999999999999
Q ss_pred HHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 177 LLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 177 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
+++ |..||....... ....+........+..++..+.+++.+||..+|.+||++.+++..|+
T Consensus 204 ~l~~g~~p~~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 204 VMSYGERPYWDMSNQD-----------------VINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred HhcCCCCCCCCCCHHH-----------------HHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 886 999997643211 11111111122233456778999999999999999999999999987
Q ss_pred hh
Q 021507 256 RL 257 (311)
Q Consensus 256 ~~ 257 (311)
++
T Consensus 267 ~~ 268 (269)
T cd05065 267 KM 268 (269)
T ss_pred hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=263.57 Aligned_cols=213 Identities=24% Similarity=0.330 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++.+.....+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~- 120 (256)
T cd08221 42 ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120 (256)
T ss_pred HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3456889999999999999999999999999999999999999999999765455689999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 121 -~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08221 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL 197 (256)
T ss_pred -CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC
Confidence 499999999999999999999999999876533321 23345689999999999888889999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
..||....... ....+.. ......+..++.++.+++.+||..+|.+||++.++++.+
T Consensus 198 ~~~~~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 198 KRTFDATNPLN----------------LVVKIVQ-GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCCCCCHHH----------------HHHHHHc-CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 99997643211 0111111 111122345678899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=288.38 Aligned_cols=248 Identities=24% Similarity=0.280 Sum_probs=178.2
Q ss_pred ChhHHHhHHHHHHh---hh-------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH---AR-------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~~~L 65 (311)
+||+||++.+.... +. ......+.+.+|+++++.++|+||+++++++...+ ..|+||||+. ++|
T Consensus 12 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l 90 (372)
T cd07853 12 AFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDL 90 (372)
T ss_pred CCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCH
Confidence 57788876653221 00 11123456889999999999999999999998776 7899999996 488
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccc
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......... ......
T Consensus 91 ~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~ 165 (372)
T cd07853 91 HKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEV 165 (372)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCC
Confidence 8887543 3489999999999999999999965 4999999999999999999999999999764332211 123346
Q ss_pred ccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh-h-ccccccchh----hhhHhhhc-cc
Q 021507 146 GTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-W-AKPYLSDKR----KLFRIMDT-KL 217 (311)
Q Consensus 146 gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~-~~~~~~~~~----~~~~~~~~-~~ 217 (311)
++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+. . ..+...... .....+.. ..
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 245 (372)
T cd07853 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPH 245 (372)
T ss_pred cCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCC
Confidence 78899999998775 47889999999999999999999998755322111110 0 001000000 00000000 00
Q ss_pred C-------CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 218 G-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 218 ~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
. .......+.++.+||.+||..||.+|||+.+++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 246 KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 0 011223467899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=269.25 Aligned_cols=206 Identities=29% Similarity=0.436 Sum_probs=163.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
....|.+|+.+++.++||||+++++++.++...|+||||+++++|..++.... ..+++..+..++.|++.||+|||+.
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~- 136 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK- 136 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC-
Confidence 44568889999999999999999999999999999999999999999885433 3488999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCC-------cEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHH
Q 021507 101 SQVIYRDFKASNILLDAEF-------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGV 172 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~ 172 (311)
+++||||||+||+++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+
T Consensus 137 -~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~ 209 (274)
T cd05076 137 -NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGT 209 (274)
T ss_pred -CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHH
Confidence 599999999999997654 3899999988643221 22356788999998865 46889999999999
Q ss_pred HHHHHH-hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 173 VLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 173 il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
++||++ +|..||......... ...... ...+......+.+++.+||..+|++|||+.+++
T Consensus 210 ~l~el~~~g~~p~~~~~~~~~~-----------------~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il 270 (274)
T cd05076 210 TLLEICFDGEVPLKERTPSEKE-----------------RFYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270 (274)
T ss_pred HHHHHHhCCCCCccccChHHHH-----------------HHHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHH
Confidence 999985 699999754321110 000111 112223345789999999999999999999999
Q ss_pred HHH
Q 021507 252 AIL 254 (311)
Q Consensus 252 ~~l 254 (311)
+.|
T Consensus 271 ~~L 273 (274)
T cd05076 271 RDL 273 (274)
T ss_pred Hhh
Confidence 876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=261.97 Aligned_cols=215 Identities=30% Similarity=0.460 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++++.+.+..|+||||+.|++|.+++.... ..+++..+..++.+++.+|+|||+
T Consensus 35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~-- 111 (251)
T cd05041 35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES-- 111 (251)
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--
Confidence 45678999999999999999999999999999999999999999999986543 348899999999999999999996
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 179 (311)
++++|+||||+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 112 ~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~ 191 (251)
T cd05041 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191 (251)
T ss_pred CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhc
Confidence 4599999999999999999999999999976432211111112233567999999988889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
|..||....... ....+........+...+.++.+++.+||..+|++||++.++++.|+
T Consensus 192 ~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 192 GDTPYPGMSNQQ-----------------TRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCCCccCCHHH-----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 888887643211 11111111122334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=308.45 Aligned_cols=215 Identities=27% Similarity=0.367 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
-...+...+|..+|..|+|||+|++|++=.+.+..+|.||||.||+|.+++.... ..++.....+-.|++.|++|||+
T Consensus 1275 ~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~ 1352 (1509)
T KOG4645|consen 1275 HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE 1352 (1509)
T ss_pred cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh
Confidence 4455567889999999999999999999999999999999999999999985543 37777778899999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceeccccccccccCccccccC---CCCCCCceehhHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVV 173 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i 173 (311)
++ ||||||||+||+++.+|.+|++|||.|......... ...+...||+.|||||++.+. +...++|||||||+
T Consensus 1353 ~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCV 1430 (1509)
T KOG4645|consen 1353 HG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCV 1430 (1509)
T ss_pred cC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccce
Confidence 55 999999999999999999999999999876544211 123356899999999999875 35668999999999
Q ss_pred HHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 174 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.||+||+.||...+ .+..+.-.+...-..+.|..++.+.+++|.+||..||++|.++.+++++
T Consensus 1431 VlEM~tGkrPW~~~d----------------ne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1431 VLEMATGKRPWAELD----------------NEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred EEEeecCCCchhhcc----------------chhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 999999999997633 2223333444555567788899999999999999999999999998865
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=284.50 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=173.0
Q ss_pred ChhHHHhHHHHHHhhhhHHH--HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCC
Q 021507 1 MFLFNFLHSHLELHARSLLL--ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS 78 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 78 (311)
+||+||++.+.........+ .......|+.++++++|+||+++++++.+.+..++|||++.+ +|.+++.... ..++
T Consensus 78 ~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~ 155 (357)
T PHA03209 78 SEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRS-RPLP 155 (357)
T ss_pred CCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHHhcc-CCCC
Confidence 47788877654432111111 122345799999999999999999999999999999999964 8988886543 4589
Q ss_pred HHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc
Q 021507 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 158 (311)
Q Consensus 79 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 158 (311)
+..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+
T Consensus 156 ~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 230 (357)
T PHA03209 156 IDQALIIEKQILEGLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLAR 230 (357)
T ss_pred HHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCC
Confidence 999999999999999999965 49999999999999999999999999987532211 1234568999999999999
Q ss_pred CCCCCCCceehhHHHHHHHHhCCCc-cCCCccchhh-------hhhhhcc-----c--cc--cchhhhhHhhhcccCCC-
Q 021507 159 GRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQ-------SLVDWAK-----P--YL--SDKRKLFRIMDTKLGGQ- 220 (311)
Q Consensus 159 ~~~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~-------~~~~~~~-----~--~~--~~~~~~~~~~~~~~~~~- 220 (311)
..++.++|||||||++|||+++..+ |......... .+..... + +. .........+.......
T Consensus 231 ~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (357)
T PHA03209 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQ 310 (357)
T ss_pred CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCC
Confidence 9999999999999999999985544 4432221100 0000000 0 00 00000000000000000
Q ss_pred --------CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 221 --------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 221 --------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
....++..+.+||.+||..||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 311 PYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 011345677889999999999999999999865
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=263.69 Aligned_cols=217 Identities=26% Similarity=0.450 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.|.+|+.++++++||||+++++++.+++..|+||||+++++|.+++.... ..+++..++.++.|++.||++||+.
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~- 125 (267)
T cd05066 48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM- 125 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678999999999999999999999999999999999999999999996543 3489999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce-eccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 126 -~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~ 204 (267)
T cd05066 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204 (267)
T ss_pred -CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhc
Confidence 499999999999999999999999999986543221111 111223567999999988889999999999999999886
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
|..||....... ....+........+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 205 ~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 205 YGERPYWEMSNQD-----------------VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCcccCCHHH-----------------HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 999997643211 0111111111223345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=279.39 Aligned_cols=233 Identities=25% Similarity=0.415 Sum_probs=191.9
Q ss_pred HhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 021507 13 LHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 92 (311)
Q Consensus 13 ~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~ 92 (311)
++.......++.|.+|+++|.+|+||||++++++|..++.+++|+||+++|+|..++.......+.......|+.||+.|
T Consensus 570 Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasg 649 (807)
T KOG1094|consen 570 LRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASG 649 (807)
T ss_pred cCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHH
Confidence 44566667789999999999999999999999999999999999999999999999977654445666777899999999
Q ss_pred HHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 93 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 93 l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
++||.+.+ +|||||.+.|||+++++++||+|||.++..-...........+-..+|||+|.+..++++.+||+|+||+
T Consensus 650 maYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgv 727 (807)
T KOG1094|consen 650 MAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 727 (807)
T ss_pred HHHHHhhc--hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHH
Confidence 99999866 9999999999999999999999999999766666676677777788999999999999999999999999
Q ss_pred HHHHHHh--CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 173 VLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 173 il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
++||+++ ...||........ ..+-..+........-...|.-++..+.++|.+||..|-++||+++++
T Consensus 728 TlwE~~~~C~e~Py~~lt~e~v----------ven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 728 TLWEVFMLCREQPYSQLTDEQV----------VENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred HHHHHHHHHhhCchhhhhHHHH----------HHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 9999876 6678875432111 011111112122222234567789999999999999999999999999
Q ss_pred HHHHHhh
Q 021507 251 LAILERL 257 (311)
Q Consensus 251 l~~l~~~ 257 (311)
-..|...
T Consensus 798 h~~lq~~ 804 (807)
T KOG1094|consen 798 HLFLQED 804 (807)
T ss_pred HHHHHHh
Confidence 9888654
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=264.34 Aligned_cols=217 Identities=26% Similarity=0.443 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++.+++.+.+..|+||||+.+++|.+++.... ..+++..+..++.+++.||+|||+.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~- 126 (268)
T cd05063 49 QRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM- 126 (268)
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 35668899999999999999999999999999999999999999999986543 3489999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce-eccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.+||+|||++........... ......+..|+|||++.+..++.++|||||||++|+|++
T Consensus 127 -~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~ 205 (268)
T cd05063 127 -NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205 (268)
T ss_pred -CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHh
Confidence 599999999999999999999999999876543221111 111223457999999988889999999999999999997
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
|..||...... .....+........+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus 206 ~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 206 FGERPYWDMSNH-----------------EVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCcCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999653311 11111111122223345678899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=273.00 Aligned_cols=217 Identities=24% Similarity=0.392 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~-- 128 (303)
T cd05110 53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER-- 128 (303)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc--
Confidence 34688999999999999999999988654 4679999999999999986543 3488999999999999999999964
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 129 ~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g 208 (303)
T cd05110 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208 (303)
T ss_pred CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCC
Confidence 599999999999999999999999999986543322211223345678999999988899999999999999999997 8
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
..||.+...... ...+........+..++..+.+++.+||..+|++||++.++++.|..+..
T Consensus 209 ~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 209 GKPYDGIPTREI-----------------PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCCCCCHHHH-----------------HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999975432111 11111111112233456788999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.67 Aligned_cols=212 Identities=24% Similarity=0.366 Sum_probs=168.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++...+..++||||+++++|..+. .+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~- 114 (279)
T cd06619 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL- 114 (279)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4456889999999999999999999999999999999999999987542 378889999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 115 -~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 189 (279)
T cd06619 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189 (279)
T ss_pred -CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhC
Confidence 5999999999999999999999999999754322 13345789999999999988999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC-CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ-YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
..||.......... ................ .....+.++.+++.+||..||++||+++++++..
T Consensus 190 ~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 190 RFPYPQIQKNQGSL----------MPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCchhhccccccc----------chHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 99997532111000 0000111111111111 1234567899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.31 Aligned_cols=212 Identities=25% Similarity=0.317 Sum_probs=166.6
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
..+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||+. +
T Consensus 51 ~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~ 126 (267)
T cd06645 51 AVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK--G 126 (267)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--C
Confidence 457889999999999999999999999999999999999999999986544 489999999999999999999965 5
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc---cCCCCCCCceehhHHHHHHHHh
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~ 179 (311)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++. ...++.++|+|||||++|+|++
T Consensus 127 i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~ 204 (267)
T cd06645 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc
Confidence 9999999999999999999999999987543221 1123457899999999874 4568889999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|..||............... ...... ......++..+.+++.+||..+|++||++++++++
T Consensus 205 ~~~p~~~~~~~~~~~~~~~~-----------~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 205 LQPPMFDLHPMRALFLMTKS-----------NFQPPK--LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCcccccchhhHHhhhcc-----------CCCCCc--ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 99998653321110000000 000000 00111356678999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=263.61 Aligned_cols=212 Identities=25% Similarity=0.440 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~- 125 (267)
T cd06628 49 MLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR- 125 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc-
Confidence 44678899999999999999999999999999999999999999999996543 488999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc----ceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+++|+||+|+||+++.++.++|+|||.++........ .......++..|+|||.+.+..++.++|+|||||++|+
T Consensus 126 -~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~ 204 (267)
T cd06628 126 -GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVE 204 (267)
T ss_pred -CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHH
Confidence 5999999999999999999999999998765422111 01123457889999999988889999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|++|..||...... ........ ......+..++..+.++|.+||+.||.+||++.++++.
T Consensus 205 l~~g~~p~~~~~~~----------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 205 MLTGKHPFPDCTQL----------------QAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HhhCCCCCCCccHH----------------HHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 99999999764321 11111111 12223445678889999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=281.96 Aligned_cols=243 Identities=20% Similarity=0.213 Sum_probs=175.2
Q ss_pred ChhHHHhHHHHHHhh----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELHA----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~ 64 (311)
+||+||.+.+..... .......+.+.+|+.+++.++||||+++++++... ...|+||||+++ +
T Consensus 29 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 107 (355)
T cd07874 29 AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-N 107 (355)
T ss_pred CCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-c
Confidence 578888776543221 11122345677899999999999999999988643 346999999976 7
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 108 l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~--givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 178 (355)
T cd07874 108 LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPY 178 (355)
T ss_pred HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCc
Confidence 7777643 388899999999999999999965 59999999999999999999999999997643321 12345
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-hh-hhccccccchh----hhhHhhhcc--
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LV-DWAKPYLSDKR----KLFRIMDTK-- 216 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-~~~~~~~~~~~----~~~~~~~~~-- 216 (311)
.+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+...... .. ....+...... .........
T Consensus 179 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (355)
T cd07874 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258 (355)
T ss_pred cccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCc
Confidence 78999999999999899999999999999999999999998754321110 00 00000000000 000000000
Q ss_pred ----------------cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 217 ----------------LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 217 ----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.........+..+.+||.+||..||++|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0001122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=263.27 Aligned_cols=218 Identities=27% Similarity=0.362 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
....+.+.+|+.++++++||||+++++++.+ +..|+||||+++++|.+++.... ..+++..++.++.+++.||+|||+
T Consensus 48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~ 125 (270)
T cd05056 48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES 125 (270)
T ss_pred HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3455678999999999999999999998875 45789999999999999996543 348999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
. +++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+++
T Consensus 126 ~--~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 202 (270)
T cd05056 126 K--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202 (270)
T ss_pred C--CeeccccChheEEEecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence 4 5999999999999999999999999998765433211 112223456799999998888999999999999999998
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |..||........ ...+........+..++..+.+++.+||..+|.+|||+.++++.|+++
T Consensus 203 ~~g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 203 MLGVKPFQGVKNNDV-----------------IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred HcCCCCCCCCCHHHH-----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 6 9999976432110 111111112233456778999999999999999999999999999886
Q ss_pred c
Q 021507 258 E 258 (311)
Q Consensus 258 ~ 258 (311)
.
T Consensus 266 ~ 266 (270)
T cd05056 266 L 266 (270)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.44 Aligned_cols=215 Identities=26% Similarity=0.316 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++|+||+++++.+.++...|+||||+.|++|.+++.+.....+++..+..++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~- 122 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL- 122 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4456889999999999999999999999999999999999999999998765555699999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc---------------------------ceeccccccccccCc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---------------------------HVSTQVMGTHGYAAP 153 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------~~~~~~~gt~~y~aP 153 (311)
+++|+||||+||+++.++.++|+|||++......... .......|+..|+||
T Consensus 123 -~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP 201 (316)
T cd05574 123 -GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP 201 (316)
T ss_pred -CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH
Confidence 5999999999999999999999999998654221110 011234678899999
Q ss_pred cccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 154 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 154 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
|++.+..++.++||||||+++|+|++|..||...+... ..................+..+.+++
T Consensus 202 E~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li 265 (316)
T cd05574 202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE----------------TFSNILKKEVTFPGSPPVSSSARDLI 265 (316)
T ss_pred HHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH----------------HHHHHhcCCccCCCccccCHHHHHHH
Confidence 99998889999999999999999999999997654211 11111111111111223688999999
Q ss_pred HhcccCCCCCCCC----HHHHHHH
Q 021507 234 LQCLNNEPKLRPR----MSEVLAI 253 (311)
Q Consensus 234 ~~~l~~~p~~Rpt----~~~~l~~ 253 (311)
.+||..||++||+ +++++.+
T Consensus 266 ~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 266 RKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHccCCHhHCCCchhhHHHHHcC
Confidence 9999999999999 7777653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=264.43 Aligned_cols=216 Identities=29% Similarity=0.364 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---QPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~l 96 (311)
...+.|.+|+++++.++|+||+++++.+.+....|+||||+++|+|.+++..... ...++..+..++.|++.||+||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 116 (269)
T cd05042 37 DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116 (269)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH
Confidence 3455788999999999999999999999999999999999999999999965432 2356778899999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-------CCCCCCCceeh
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYS 169 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s 169 (311)
|+. +|+||||||+||+++.++.+||+|||++................++..|+|||++.. ..++.++||||
T Consensus 117 H~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05042 117 HQA--DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194 (269)
T ss_pred Hhc--CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence 965 499999999999999999999999999865432221111223345678999998743 35678999999
Q ss_pred hHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhc---c-cCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 170 FGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT---K-LGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 170 lG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
|||++|+|++ |..||........ ....... . .....+..++..+.+++..|| .||++|
T Consensus 195 lG~~l~el~~~~~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~R 257 (269)
T cd05042 195 LGVTMWELFTAADQPYPDLSDEQV----------------LKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETR 257 (269)
T ss_pred HHHHHHHHHhCCCCCCCcCCHHHH----------------HHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccc
Confidence 9999999999 7888875432100 0000000 0 011223456778888999998 599999
Q ss_pred CCHHHHHHHH
Q 021507 245 PRMSEVLAIL 254 (311)
Q Consensus 245 pt~~~~l~~l 254 (311)
||++++++.|
T Consensus 258 pt~~~v~~~l 267 (269)
T cd05042 258 PTAEEVHELL 267 (269)
T ss_pred cCHHHHHHHh
Confidence 9999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=271.19 Aligned_cols=213 Identities=26% Similarity=0.393 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.+.+|++++++++|+||+++++.+...+..|+||||++|++|.+++.... ...+++..+..++.+++.||.|||+.
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~- 121 (286)
T cd06622 43 FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121 (286)
T ss_pred HHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-
Confidence 3568899999999999999999999999999999999999999999886531 23589999999999999999999962
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC------CCCCCceehhHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVVL 174 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il 174 (311)
.+++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+.. ++.++|+|||||++
T Consensus 122 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 197 (286)
T cd06622 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197 (286)
T ss_pred CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHH
Confidence 359999999999999999999999999987543221 23345788999999986543 47899999999999
Q ss_pred HHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|+|++|..||........ ......+. .......+..++.++.+++.+||..+|++||++.+++..
T Consensus 198 ~~l~~g~~pf~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 198 LEMALGRYPYPPETYANI-------------FAQLSAIV-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHhCCCCCCCcchhhH-------------HHHHHHHh-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 999999999975321100 00111111 112223455688899999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.70 Aligned_cols=234 Identities=26% Similarity=0.374 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
....+.+.+|+++++.++||||+++++++.+. ...++||||++|++|.+++.... ..+++..++.++.+++.||+||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~l 125 (284)
T cd05079 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYL 125 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 33456799999999999999999999998775 56799999999999999986543 3489999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 175 (311)
|+. +++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|
T Consensus 126 H~~--gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 126 GSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HHC--CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 964 5999999999999999999999999999865433221 1122345677899999998888999999999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
+|+++..|+.............. ............+........+..++..+.+|+.+||+.||++||++.++++.++
T Consensus 204 ellt~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 204 ELLTYCDSESSPMTLFLKMIGPT--HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred hhhcCCCCCccccchhhhhcccc--cccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 99998766533211000000000 0000001111111222222334567889999999999999999999999999997
Q ss_pred hh
Q 021507 256 RL 257 (311)
Q Consensus 256 ~~ 257 (311)
.+
T Consensus 282 ~~ 283 (284)
T cd05079 282 AI 283 (284)
T ss_pred hh
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=263.12 Aligned_cols=215 Identities=29% Similarity=0.456 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.++++++|+||+++++++......++||||+++++|.+++.......+++..+..++.+++.||.|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~-- 122 (261)
T cd05034 45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-- 122 (261)
T ss_pred HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356889999999999999999999999888999999999999999999766555699999999999999999999964
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
+++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus 123 ~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g 201 (261)
T cd05034 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred CcccCCcchheEEEcCCCCEEECccccceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCC
Confidence 599999999999999999999999999876543211 11122234568999999998889999999999999999998 9
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
+.||.+.... ..............+...+.++.+++.+||..+|++||+++++.+.|+.
T Consensus 202 ~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 202 RVPYPGMTNR-----------------EVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999754321 1111111112223344557789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.79 Aligned_cols=212 Identities=28% Similarity=0.391 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++||||+++++++...+..|+||||+++++|.+++.+.....+++..+..++.|++.||.|||+.
T Consensus 37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-- 114 (277)
T cd05577 37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114 (277)
T ss_pred hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 445678999999999999999999999999999999999999999999766655699999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 115 ~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~ 191 (277)
T cd05577 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191 (277)
T ss_pred CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCC
Confidence 59999999999999999999999999987543211 123345788999999998888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 252 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~ 252 (311)
.||......... ..+.... .......+...+..+.++|.+||+.||.+|| ++.+++.
T Consensus 192 ~p~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 192 SPFRQRKEKVEK-------------EELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCCCCCcccccH-------------HHHHhcc-ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 999764321110 0000100 1112233455688899999999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=262.55 Aligned_cols=231 Identities=26% Similarity=0.305 Sum_probs=186.7
Q ss_pred hhHHHhHHHHHHh------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCC
Q 021507 2 FLFNFLHSHLELH------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ 75 (311)
Q Consensus 2 ~~~~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (311)
||.|+-+-|.+-. ..-+..-.+.+.+|+.|++++++|+||++|+.+.....+|+|||||..|++.+.++.+. +
T Consensus 46 YGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~-K 124 (502)
T KOG0574|consen 46 YGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR-K 124 (502)
T ss_pred chHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc-C
Confidence 6777777666632 12222234457889999999999999999999999999999999999999999885543 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccc
Q 021507 76 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 155 (311)
Q Consensus 76 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 155 (311)
++++.++..++.+.++||+|||... -+|||||..|||++.+|..||+|||.+..+.+.. ....+.+||+.|||||+
T Consensus 125 ~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEV 200 (502)
T KOG0574|consen 125 PLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEV 200 (502)
T ss_pred CccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHH
Confidence 6999999999999999999999765 8999999999999999999999999997654332 12456789999999999
Q ss_pred cccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhh-cccCCCCchHHHHHHHHHHH
Q 021507 156 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLAL 234 (311)
Q Consensus 156 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 234 (311)
+..-.|+.++||||||++..||..|++||.+-... ..++-+-. ..-....|...++++.++++
T Consensus 201 I~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 201 IEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred HHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 99999999999999999999999999999763321 11111000 01112345677899999999
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 021507 235 QCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 235 ~~l~~~p~~Rpt~~~~l~~ 253 (311)
+||.++|++|-|+.+++++
T Consensus 265 ~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHhcCCHHHHHHHHHHhhh
Confidence 9999999999999998865
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=269.65 Aligned_cols=213 Identities=23% Similarity=0.355 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|+++++.++|+||+++++.+..++..|+||||+++++|..++.+.. ..+++..+..++.|++.+|+|||+.
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~ 129 (292)
T cd06644 51 EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM 129 (292)
T ss_pred HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 345668889999999999999999999999999999999999999988775433 3489999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-----CCCCCCCceehhHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVL 174 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il 174 (311)
+++|+||||+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++|+|||||++
T Consensus 130 --~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred --CeeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 59999999999999999999999999886532221 11234567889999998853 3467899999999999
Q ss_pred HHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|+|++|..||...+.. .. ..+..... .....+..++.++.+++.+||..||++||+++++++.
T Consensus 206 ~el~~g~~p~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 206 IEMAQIEPPHHELNPM--RV--------------LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHhcCCCCCccccHH--HH--------------HHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9999999999753311 00 00110000 0111234566789999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=271.36 Aligned_cols=233 Identities=23% Similarity=0.286 Sum_probs=175.6
Q ss_pred ChhHHHhHHHHHHh---h----hhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEe------CCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH---A----RSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLE------GENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~----~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~------~~~~~lv~e~~~~~~L~ 66 (311)
+||+||++.+.+.. + .........+..|+.+++++ +|+||+++++++.. ....|++|||+.+++|.
T Consensus 28 ~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~ 107 (282)
T cd06636 28 TYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT 107 (282)
T ss_pred CCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHH
Confidence 46677765553321 0 11112335688899999999 79999999999853 45789999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
+++.......+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ......|
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~ 183 (282)
T cd06636 108 DLVKNTKGNALKEDWIAYICREILRGLAHLHAH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIG 183 (282)
T ss_pred HHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccc
Confidence 999765555688999999999999999999965 499999999999999999999999999875432211 1234568
Q ss_pred cccccCccccc-----cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCC
Q 021507 147 THGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 221 (311)
Q Consensus 147 t~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (311)
+..|+|||.+. +..++.++|+|||||++|+|++|..||........ .............
T Consensus 184 ~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~ 247 (282)
T cd06636 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----------------LFLIPRNPPPKLK 247 (282)
T ss_pred cccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----------------hhhHhhCCCCCCc
Confidence 88999999875 34678899999999999999999999965321100 0111111111112
Q ss_pred chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 222 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...++.++.++|.+||..||.+||++.++++.
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 23567889999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=281.43 Aligned_cols=222 Identities=22% Similarity=0.259 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.+.+.+|+.+++.++||||+++++++... ...|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|
T Consensus 67 ~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~ 141 (364)
T cd07875 67 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKH 141 (364)
T ss_pred HHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999987643 357999999975 88887742 37889999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 175 (311)
||+. +|+||||||+||+++.++.+||+|||+++...... ......+|..|+|||++.+..++.++|||||||++|
T Consensus 142 LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 142 LHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216 (364)
T ss_pred HhhC--CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHH
Confidence 9965 59999999999999999999999999997643321 123456899999999999999999999999999999
Q ss_pred HHHhCCCccCCCccchhhhh-hhh-ccccccchhhh----hHhhh------------------cccCCCCchHHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSL-VDW-AKPYLSDKRKL----FRIMD------------------TKLGGQYPQKAAHTAAT 231 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~~~~~~----~~~~~------------------~~~~~~~~~~~~~~l~~ 231 (311)
+|++|+.||.+.+....... ... ..+.......+ ..... ...........+..+.+
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 296 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHH
Confidence 99999999976543211110 000 00000000000 00000 00000111123567899
Q ss_pred HHHhcccCCCCCCCCHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
||.+||..||.+|||+.+++++
T Consensus 297 ll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 297 LLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhcCcCcccCCCHHHHhcC
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=263.50 Aligned_cols=220 Identities=25% Similarity=0.290 Sum_probs=166.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
....+.+|+.++++++||||+++++++.+....++||||+++|+|.+++.... ....++..+..++.|++.||+|||
T Consensus 38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (269)
T cd05087 38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 33468889999999999999999999999889999999999999999986532 234667788899999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-------CCCCCCceehh
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-------RLTTKSDVYSF 170 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~sl 170 (311)
+. +++|+||||+||+++.++.+||+|||.+................++..|+|||++.+. .++.++|||||
T Consensus 118 ~~--~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 195 (269)
T cd05087 118 KN--NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSL 195 (269)
T ss_pred HC--CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHH
Confidence 65 5999999999999999999999999998754332222222334567889999988642 35789999999
Q ss_pred HHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 171 GVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 171 G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
|+++|+|++ |..||............ .................+..+.+++.+|| .+|++|||+++
T Consensus 196 G~~l~el~~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~ 262 (269)
T cd05087 196 GVTIWELFELGSQPYRHLSDEQVLTYT------------VREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEE 262 (269)
T ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHH------------hhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHH
Confidence 999999996 99999754321110000 00000000001112235677889999999 68999999999
Q ss_pred HHHHHH
Q 021507 250 VLAILE 255 (311)
Q Consensus 250 ~l~~l~ 255 (311)
++..|+
T Consensus 263 l~~~l~ 268 (269)
T cd05087 263 VHLLLS 268 (269)
T ss_pred HHHHhc
Confidence 998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=280.54 Aligned_cols=242 Identities=23% Similarity=0.252 Sum_probs=172.2
Q ss_pred ChhHHHhHHHHHHhh----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELHA----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~ 64 (311)
+||+||.+.+..... .......+.+.+|++++++++||||+++++++... ...|++++++ +++
T Consensus 27 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 105 (343)
T cd07878 27 AYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GAD 105 (343)
T ss_pred CCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCC
Confidence 577787776543221 01112334577899999999999999999988643 3468999998 679
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ....
T Consensus 106 l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~ 175 (343)
T cd07878 106 LNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGY 175 (343)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CeecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCc
Confidence 9888743 2499999999999999999999965 4999999999999999999999999999864332 2345
Q ss_pred cccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-hhhhc-cccccch----hhhhHhhhccc
Q 021507 145 MGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDK----RKLFRIMDTKL 217 (311)
Q Consensus 145 ~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~~----~~~~~~~~~~~ 217 (311)
.|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+...... ..... .+..... ...........
T Consensus 176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07878 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL 255 (343)
T ss_pred cccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhcc
Confidence 68999999999877 468899999999999999999999997654321110 00000 0000000 00000000000
Q ss_pred CC-------CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 GG-------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.. ......+..+.+|+.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0011234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=266.01 Aligned_cols=234 Identities=23% Similarity=0.336 Sum_probs=178.0
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||.+.+.... ........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.+++...
T Consensus 20 ~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 99 (268)
T cd06624 20 TYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK 99 (268)
T ss_pred CceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh
Confidence 46777777543311 1222334567899999999999999999999999999999999999999999998654
Q ss_pred C-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 73 G-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 73 ~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
. ....++..+..++.|++.||+|||+. +++|+||||+||+++. ++.++|+|||.+........ ......++..|
T Consensus 100 ~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~ 175 (268)
T cd06624 100 WGPLKDNEQTIIFYTKQILEGLKYLHDN--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQY 175 (268)
T ss_pred cccCCCcHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccc
Confidence 2 21237888899999999999999964 5999999999999976 67899999999875432221 12234578899
Q ss_pred cCccccccCC--CCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 151 AAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 151 ~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
+|||++.+.. ++.++|+||||+++|+|++|..||........ ..............+..++.+
T Consensus 176 ~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---------------AMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred cChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---------------hHhhhhhhccCCCCCcccCHH
Confidence 9999986643 78899999999999999999999975321100 000111111122345567788
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+++.+||..+|++|||+.+++.+
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.95 Aligned_cols=210 Identities=25% Similarity=0.347 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.+++.++|+||+++++.+..+...|+||||++|++|.+++.+. .+++..+..++.|++.||+|||+.
T Consensus 61 ~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~-- 135 (296)
T cd06654 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN-- 135 (296)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 466889999999999999999999999999999999999999999998543 378999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 136 gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~ 213 (296)
T cd06654 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (296)
T ss_pred CcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 599999999999999999999999999875432221 122346788999999998888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||........... ...........+..++..+.+++.+||..||++||++.+++..
T Consensus 214 ~pf~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 214 PPYLNENPLRALYL---------------IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCCHHHhHHH---------------HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 99975432110000 0000001112244567889999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=269.83 Aligned_cols=236 Identities=27% Similarity=0.401 Sum_probs=178.0
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++++.... ............+|+.++++++||||+++++++.+....++|||++.+++|.+++.
T Consensus 11 ~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~ 90 (260)
T PF00069_consen 11 GFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ 90 (260)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH
T ss_pred CCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc
Confidence 46666666665543 11112222234569999999999999999999999999999999999999999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
... .+++..++.++.|+++||++||+.+ ++|+||||+||+++.++.++|+|||.+..... .........++..|
T Consensus 91 ~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y 164 (260)
T PF00069_consen 91 KNK--PLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEY 164 (260)
T ss_dssp HHS--SBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGG
T ss_pred ccc--ccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence 333 3899999999999999999999754 99999999999999999999999999975311 12224456789999
Q ss_pred cCccccc-cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 151 AAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 151 ~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
+|||++. +..++.++|+||||+++|+|++|..||............. ........... .........+
T Consensus 165 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~--~~~~~~~~~l 233 (260)
T PF00069_consen 165 MAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---------KILKRPLPSSS--QQSREKSEEL 233 (260)
T ss_dssp SCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---------HHHHTHHHHHT--TSHTTSHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhh---------hcccccccccc--cccchhHHHH
Confidence 9999998 7889999999999999999999999998752111111000 00000000000 0111124889
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+++.+||+.||++||++.+++++
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=268.94 Aligned_cols=212 Identities=27% Similarity=0.387 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.|.+|++++++++|+||+++++++.++...|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~- 122 (280)
T cd06611 45 ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH- 122 (280)
T ss_pred HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34568899999999999999999999999999999999999999999886543 3599999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc-----cCCCCCCCceehhHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~ 175 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+. +..++.++|+||||+++|
T Consensus 123 -~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred -CcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 599999999999999999999999998865432211 123356888999999875 345677999999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|++|..||........ ........ .....+..++.++.+++.+||..+|.+||++.++++.
T Consensus 200 ~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 200 ELAQMEPPHHELNPMRV----------------LLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHhCCCCcccCCHHHH----------------HHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 99999999976432110 00111000 0112234567789999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=260.93 Aligned_cols=221 Identities=22% Similarity=0.292 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.|.+|+.+++.++||||+++++.+.+....|+||||+++|+|.+++.+.. ....+...+..++.|++.||+|||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 345689999999999999999999999999999999999999999999996542 234677788899999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-------CCCCCCCceehh
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSF 170 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~sl 170 (311)
+. +++|+||||+||+++.++.++|+|||++................++..|+|||++.+ ..++.++|||||
T Consensus 117 ~~--~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 194 (268)
T cd05086 117 KH--NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL 194 (268)
T ss_pred HC--CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHH
Confidence 65 499999999999999999999999999864322211112234567889999998753 235778999999
Q ss_pred HHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 171 GVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 171 G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
|+++|+|++ |..||............ .............+..++..+.+++..|| .+|++||++++
T Consensus 195 G~~l~el~~~~~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~ 261 (268)
T cd05086 195 GVTLWELFENAAQPYSHLSDREVLNHV------------IKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEE 261 (268)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHH------------HhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence 999999997 57788653321100000 00000000111223346778889999999 68999999999
Q ss_pred HHHHHH
Q 021507 250 VLAILE 255 (311)
Q Consensus 250 ~l~~l~ 255 (311)
+++.|.
T Consensus 262 i~~~l~ 267 (268)
T cd05086 262 VHRLLT 267 (268)
T ss_pred HHHHhc
Confidence 998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=260.34 Aligned_cols=212 Identities=23% Similarity=0.325 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+.+|++++++++|+||+++++.+.. +...|++|||+++++|.+++.......+++.+++.++.+++.||++||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~ 121 (257)
T cd08223 42 ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121 (257)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34568899999999999999999998764 44679999999999999999765555689999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 122 --~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred --CeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc
Confidence 599999999999999999999999999876533221 2334567889999999999889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|..||...+... ..... ........+..++..+.+++.+||..||++||++.+++++
T Consensus 198 g~~~~~~~~~~~----------------~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 198 LKHAFNAKDMNS----------------LVYRI-IEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCCCCCHHH----------------HHHHH-HhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 999997543210 00111 1111122345677899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=268.76 Aligned_cols=206 Identities=26% Similarity=0.377 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++.+++..|+||||+.+++|.+++.... .+++..+..++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~- 120 (290)
T cd05580 44 QVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL- 120 (290)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34668899999999999999999999999999999999999999999996653 489999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|.||+++.++.+||+|||++...... .....++..|+|||.+.+...+.++||||||+++|+|++|
T Consensus 121 -~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 194 (290)
T cd05580 121 -DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194 (290)
T ss_pred -CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence 5999999999999999999999999998765433 2334678899999999888889999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
..||....... ....+.. .....+...+..+.+++.+||..||.+|+ ++++++++
T Consensus 195 ~~p~~~~~~~~----------------~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 195 YPPFFDDNPIQ----------------IYEKILE--GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCCCCCCCHHH----------------HHHHHhc--CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 99997643110 0011111 11233455678899999999999999999 67777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=260.91 Aligned_cols=214 Identities=26% Similarity=0.340 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++.+++..|++|||+.+++|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~- 120 (262)
T cd06613 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET- 120 (262)
T ss_pred hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45678899999999999999999999999999999999999999999886542 3489999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC---CCCCCCceehhHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~l 177 (311)
+++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|
T Consensus 121 -~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197 (262)
T ss_pred -CceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHH
Confidence 59999999999999999999999999987643321 112345678899999998776 788999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
++|..||............. ...............+.++.+++.+||..+|.+|||+.+++.
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 198 AELQPPMFDLHPMRALFLIS-------------KSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHH-------------hccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999997643211110000 000000111223456788999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=263.10 Aligned_cols=213 Identities=24% Similarity=0.348 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++||||+++++++..++..|+||||+.+++|..++.+.. .++++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~- 122 (282)
T cd06643 45 ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN- 122 (282)
T ss_pred HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34568889999999999999999999999999999999999999998875432 3589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc-----cCCCCCCCceehhHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~ 175 (311)
+++|+||||+||+++.++.++|+|||++....... .......++..|+|||++. +..++.++|+|||||++|
T Consensus 123 -~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~ 199 (282)
T cd06643 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199 (282)
T ss_pred -CeeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHH
Confidence 59999999999999999999999999987543221 1123356888999999874 345778999999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc-ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+|++|..||....... ........ ......+..++.++.++|.+||..||.+||++.+++++-
T Consensus 200 el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 200 EMAQIEPPHHELNPMR----------------VLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHccCCCCccccCHHH----------------HHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 9999999997533110 00111000 111123445678899999999999999999999987553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.81 Aligned_cols=250 Identities=21% Similarity=0.233 Sum_probs=172.3
Q ss_pred ChhHHHhHHHHHHh-----hhh---HHHHHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH-----ARS---LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++++.... +.+ .......+.+|++++++++||||+++++++.. +...|+||||+.+ +|.+++.
T Consensus 13 ~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (317)
T cd07867 13 TYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIK 91 (317)
T ss_pred CCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHH
Confidence 68899988753211 111 11123457889999999999999999998853 4678999999965 8888774
Q ss_pred hc-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe----CCCCcEEEecccccccCCCCCCc-
Q 021507 71 RR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRT- 138 (311)
Q Consensus 71 ~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~- 138 (311)
.. ....+++..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+++........
T Consensus 92 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 169 (317)
T cd07867 92 FHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169 (317)
T ss_pred hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccc
Confidence 21 123588999999999999999999965 49999999999999 45678999999999865433211
Q ss_pred ceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-------hh---hhcc-ccccch
Q 021507 139 HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-------LV---DWAK-PYLSDK 206 (311)
Q Consensus 139 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~---~~~~-~~~~~~ 206 (311)
.......+|..|+|||++.+. .++.++|||||||++|+|++|..||.......... .. .... +.....
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T cd07867 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDW 249 (317)
T ss_pred cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhh
Confidence 112345689999999998764 57889999999999999999999997644321100 00 0000 000000
Q ss_pred hh---------hhHhhhcc---------cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 207 RK---------LFRIMDTK---------LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 207 ~~---------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.. ........ ............+.+|+.+||..||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 250 EDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 00000000 0000111234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=274.43 Aligned_cols=251 Identities=22% Similarity=0.232 Sum_probs=179.2
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++++.... ........+.+.+|+.+++.++||||++++++|..++..|+||||+.+++|.+++.
T Consensus 12 ~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~ 91 (328)
T cd08226 12 NLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLK 91 (328)
T ss_pred CceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHH
Confidence 46778888765421 11112234678999999999999999999999999999999999999999999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-----eecccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-----VSTQVM 145 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~ 145 (311)
+.....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.......... ......
T Consensus 92 ~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (328)
T cd08226 92 TYFPEGMSEALIGNILFGALRGLNYLHQN--GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169 (328)
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccccc
Confidence 76555699999999999999999999964 59999999999999999999999998654321111100 011123
Q ss_pred ccccccCccccccC--CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhcc---cccc----chhhh-------
Q 021507 146 GTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK---PYLS----DKRKL------- 209 (311)
Q Consensus 146 gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~----~~~~~------- 209 (311)
++..|+|||++.+. .++.++|||||||++|+|++|..||................ +... .....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (328)
T cd08226 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSG 249 (328)
T ss_pred CccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhh
Confidence 45679999998764 47889999999999999999999997653211110000000 0000 00000
Q ss_pred ----------h-----HhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 210 ----------F-----RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 210 ----------~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
. ..............++..+.+|+.+||..||++|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 250 VDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0000001111234567889999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=264.96 Aligned_cols=230 Identities=25% Similarity=0.323 Sum_probs=190.1
Q ss_pred HHHhHHHHHHhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHH
Q 021507 4 FNFLHSHLELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83 (311)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 83 (311)
..|.|+.++....+...-..-..+|..||++++.+.||.+-..|+..+.+|+|+..|.||+|.-+|.+.+...+++..+.
T Consensus 211 KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~ 290 (591)
T KOG0986|consen 211 KMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRAR 290 (591)
T ss_pred hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHH
Confidence 34555666655444444455577899999999999999999999999999999999999999999988887889999999
Q ss_pred HHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCC
Q 021507 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 163 (311)
Q Consensus 84 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 163 (311)
.++.+|+.||++||.. +||+|||||+|||+|+.|+++|+|+|+|..+..... ....+||.+|||||++.+..|+.
T Consensus 291 FYAAEi~cGLehlH~~--~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~ 365 (591)
T KOG0986|consen 291 FYAAEIICGLEHLHRR--RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDF 365 (591)
T ss_pred HHHHHHHhhHHHHHhc--ceeeccCChhheeeccCCCeEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccC
Confidence 9999999999999965 499999999999999999999999999987655443 33458999999999999999999
Q ss_pred CCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 164 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 164 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
..|-|||||+||||+.|+.||......... +............++...++++.++....|..||.+
T Consensus 366 s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------------eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~ 431 (591)
T KOG0986|consen 366 SPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------------EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEK 431 (591)
T ss_pred CccHHHHHhHHHHHHcccCchhhhhhhhhH--------------HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHH
Confidence 999999999999999999999865432211 111112222344577889999999999999999999
Q ss_pred CCC-----HHHHHH
Q 021507 244 RPR-----MSEVLA 252 (311)
Q Consensus 244 Rpt-----~~~~l~ 252 (311)
|.. ++++.+
T Consensus 432 RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 432 RLGCRGEGAQEVKE 445 (591)
T ss_pred hccCCCcCcchhhh
Confidence 974 445554
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=263.62 Aligned_cols=213 Identities=26% Similarity=0.323 Sum_probs=167.2
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+.+.+|+.++++++||||+++++++..++..|+||||+.+++|.+++.... .+++..+..++.|++.||.|||+. +
T Consensus 51 ~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~ 126 (267)
T cd06646 51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK--G 126 (267)
T ss_pred HHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--C
Confidence 457889999999999999999999999999999999999999999886543 489999999999999999999965 5
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc---cCCCCCCCceehhHHHHHHHHh
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~ 179 (311)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+. ...++.++|+|||||++|+|++
T Consensus 127 i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~ 204 (267)
T cd06646 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred ccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999976532211 122346788999999874 3457789999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|..||............ .. . ... .........++..+.+++.+||..||++||+++++++.+
T Consensus 205 g~~p~~~~~~~~~~~~~--~~------~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 205 LQPPMFDLHPMRALFLM--SK------S----NFQ-PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCccccchhhhheee--ec------C----CCC-CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 99998643211100000 00 0 000 000011224567899999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=287.09 Aligned_cols=245 Identities=17% Similarity=0.202 Sum_probs=171.7
Q ss_pred ChhHHHhHHHHHHh---hhhH----HHHHHHHHHHHHHHhcCCC------CCccceEeEEEeC-CeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH---ARSL----LLITNWFQTEVNYLGQLHH------PNLVKLIGYCLEG-ENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~----~~~~~~~~~E~~~l~~l~h------pnIv~~~~~~~~~-~~~~lv~e~~~~~~L~ 66 (311)
+||+||++.+.... +.+. ....+.+..|+++++.++| .+|+.+++++..+ .+.|+|||++ |++|.
T Consensus 141 ~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~ 219 (467)
T PTZ00284 141 TFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLL 219 (467)
T ss_pred cCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHH
Confidence 58899988765432 1111 1233456678888777754 4588888888754 5789999998 67999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC----------------cEEEecccccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----------------NAKLSDFGLAK 130 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----------------~~kl~Dfg~~~ 130 (311)
+++.+.. .+++..+..++.||+.||+|||+. .+|+||||||+|||++.++ .+||+|||.+.
T Consensus 220 ~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~ 296 (467)
T PTZ00284 220 DWIMKHG--PFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC 296 (467)
T ss_pred HHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccc
Confidence 9886553 489999999999999999999963 3599999999999998765 49999999875
Q ss_pred cCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhcccccc-----
Q 021507 131 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLS----- 204 (311)
Q Consensus 131 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~----- 204 (311)
.... ......||..|+|||++.+..++.++|||||||++|||++|+.||++.+.......+ ........
T Consensus 297 ~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~ 371 (467)
T PTZ00284 297 DERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGR 371 (467)
T ss_pred cCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhh
Confidence 4221 133467899999999999999999999999999999999999999875432111111 00000000
Q ss_pred ----chhhhhHhhhcc------------cCC-CC-chHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 205 ----DKRKLFRIMDTK------------LGG-QY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 205 ----~~~~~~~~~~~~------------~~~-~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
....+....... ... .. .......+.+||.+||..||++|||++|++++-
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 372 CGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred ccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 000000000000 000 00 001245678999999999999999999999753
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=258.93 Aligned_cols=212 Identities=22% Similarity=0.317 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++.+.+..|+||||+.+++|.+++.......+++..++.++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~- 120 (256)
T cd08218 42 EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR- 120 (256)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3457889999999999999999999999999999999999999999998665445589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+...+.++|+|||||++|+|++|
T Consensus 121 -~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08218 121 -KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL 197 (256)
T ss_pred -CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcC
Confidence 599999999999999999999999999976533221 12234678899999999888899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||...+... ..... ........+..++.++.+++.+||+.+|++||++.+++++
T Consensus 198 ~~~~~~~~~~~----------------~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 198 KHAFEAGNMKN----------------LVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCccCCCHHH----------------HHHHH-hcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 99997532110 01111 1111222345678889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=259.53 Aligned_cols=211 Identities=26% Similarity=0.347 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++|+||+++++++.+....|+++||+.+++|.+++.... ..+++..+..++.+++.||.|||+.
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~-- 118 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN-- 118 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 5679999999999999999999999999999999999999999999986433 4589999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 119 ~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~ 196 (256)
T cd06612 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196 (256)
T ss_pred CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCC
Confidence 599999999999999999999999999876543221 123345788999999998889999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhh-cccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||.......... .... .......+..++..+.+++.+||+.||++|||+.++++.
T Consensus 197 ~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 197 PPYSDIHPMRAIF----------------MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCCCcchhhhhh----------------hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 9997543211000 0000 001111234567789999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=262.75 Aligned_cols=232 Identities=28% Similarity=0.409 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..+.|.+|+++++.++|+||+++++++.. ....+++|||+++++|.+++..... .+++..+..++.|++.||+|||+
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~ 127 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGS 127 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHh
Confidence 46679999999999999999999999887 5578999999999999999965443 48999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
. +++|+||||+||+++.++.++|+|||.+.......... ......++..|++||.+.+..++.++||||||+++|+|
T Consensus 128 ~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 128 Q--RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred C--CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 4 59999999999999999999999999998764322211 11122345679999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
++|..||............. .............+........+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGI--AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred eccCCCcccccchhcccccc--ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 99999986533211110000 0000011112222222222333455678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=258.73 Aligned_cols=211 Identities=28% Similarity=0.450 Sum_probs=170.5
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+.|.+|++++++++||||+++++++......|+||||+.+++|.+++.... ..+++..++.++.+++.+|++||+. +
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~ 120 (256)
T cd05112 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS--N 120 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC--C
Confidence 468899999999999999999999999999999999999999999986543 3488999999999999999999965 4
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~ 181 (311)
++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 121 i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred ccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999875433211 11222334678999999988889999999999999999998 99
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.||....... ....+........+...+..+.+++.+||..+|++||++.++++.|
T Consensus 200 ~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 200 TPYENRSNSE-----------------VVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCcCCHHH-----------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 9997543211 1111111111122334578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=260.15 Aligned_cols=210 Identities=25% Similarity=0.360 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.++++++|+||+++++++.++...|+||||++|++|.+++... ++++..+..++.+++.||++||+.
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~- 120 (277)
T cd06640 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE- 120 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3467889999999999999999999999999999999999999999998542 488999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 121 -~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg 197 (277)
T cd06640 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred -CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC
Confidence 599999999999999999999999999976533221 12234578889999999888899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
..||........ ............+..++..+.+++.+||..+|++||++.+++.+.
T Consensus 198 ~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 198 EPPNSDMHPMRV-----------------LFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCCCCcChHhH-----------------hhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 999975432110 011111112234456788899999999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.31 Aligned_cols=216 Identities=21% Similarity=0.274 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++||||+++++.+..++..|+||||++|++|.+++.... .+++..+..++.+++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~- 120 (305)
T cd05609 44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY- 120 (305)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34567899999999999999999999999999999999999999999996553 489999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-------------ceeccccccccccCccccccCCCCCCCce
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------HVSTQVMGTHGYAAPEYVATGRLTTKSDV 167 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 167 (311)
+++|+||||+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++|+
T Consensus 121 -~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 121 -GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred -CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 5999999999999999999999999988642111100 01112457888999999988889999999
Q ss_pred ehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC-CCCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 168 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 168 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
|||||++|+|++|..||.+..... ........... ......++.++.++|.+||+.||++||+
T Consensus 200 ~slG~vl~el~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 263 (305)
T cd05609 200 WAMGIILYEFLVGCVPFFGDTPEE----------------LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLG 263 (305)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccC
Confidence 999999999999999997543210 00111111100 0111246788999999999999999998
Q ss_pred HHHHHHHHHh
Q 021507 247 MSEVLAILER 256 (311)
Q Consensus 247 ~~~~l~~l~~ 256 (311)
..++.+.|+.
T Consensus 264 ~~~~~~ll~~ 273 (305)
T cd05609 264 TGGAFEVKQH 273 (305)
T ss_pred ccCHHHHHhC
Confidence 6555555533
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=264.65 Aligned_cols=210 Identities=25% Similarity=0.355 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.+++.++||||+++++++..++..|+|+||+.+++|.+++... .+++..+..++.+++.||+|||+.
T Consensus 59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~- 134 (296)
T cd06655 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN- 134 (296)
T ss_pred hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456889999999999999999999999999999999999999999988543 389999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 135 -~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg 211 (296)
T cd06655 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (296)
T ss_pred -CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 499999999999999999999999999875433221 12234678899999999888899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhh-cccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||...+...... .... .......+..++..+.+++.+||..||++||++.+++++
T Consensus 212 ~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 212 EPPYLNENPLRALY----------------LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCCCCCCCHHHHHH----------------HHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 99997643211100 0000 001112344567889999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=259.50 Aligned_cols=212 Identities=28% Similarity=0.420 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++++.+.+..|+++||++|++|.+++.+.. .+++..+..++.|++.||+|||+.
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~- 121 (265)
T cd06631 45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN- 121 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 34568999999999999999999999999999999999999999999996543 488999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC----cceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR----THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|+
T Consensus 122 -~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ 200 (265)
T cd06631 122 -CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200 (265)
T ss_pred -CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHH
Confidence 499999999999999999999999999875422111 111223467889999999988889999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc-ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
|++|..||...+..... ...... ......+..++.++.+++.+||..+|.+||++.+++.
T Consensus 201 l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 201 MATGKPPLASMDRLAAM----------------FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHhCCCccccCChHHHH----------------HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999754321110 000000 1112234567888999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.12 Aligned_cols=227 Identities=23% Similarity=0.258 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.+.+|+.++++++||||+++++++.+++..|+||||+. ++|.+++..... ..+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~- 120 (285)
T cd07861 43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120 (285)
T ss_pred hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3567889999999999999999999999999999999997 489888855332 4589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.++|+|||||++|+|++
T Consensus 121 -~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred -CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 599999999999999999999999999875433221 12234568899999988664 57889999999999999999
Q ss_pred CCCccCCCccchhhh-hhh-hcccc---cc---chhhhhHhhh---cccCCCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 180 GRCAVDKTKVGIEQS-LVD-WAKPY---LS---DKRKLFRIMD---TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 180 g~~pf~~~~~~~~~~-~~~-~~~~~---~~---~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
|+.||.+........ ... ...+. .. .......... ..........++.++.++|.+||..||.+|||+.
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 999997643211100 000 00000 00 0000000000 0000111234678889999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++++
T Consensus 278 ~ll~~ 282 (285)
T cd07861 278 KALNH 282 (285)
T ss_pred HHhcC
Confidence 99753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=259.90 Aligned_cols=216 Identities=25% Similarity=0.456 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++++.+++..++||||+.|++|.+++.+.. ++++..+..++.|++.||+|||+.
T Consensus 46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~- 122 (268)
T cd06630 46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN- 122 (268)
T ss_pred HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 55779999999999999999999999999999999999999999999986543 488999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCc--ceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+++|+||+|+||+++.++ .++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 123 -~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 201 (268)
T cd06630 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201 (268)
T ss_pred -CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHH
Confidence 599999999999998776 5999999998765432111 112234678899999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||......... ...............+..++.++.+++.+||..+|.+||++.++++.
T Consensus 202 ~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 202 ATAKPPWNAEKHSNHL-------------ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HhCCCCCCCCCCcchH-------------HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 9999999754321100 01111111122234556678899999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.49 Aligned_cols=214 Identities=25% Similarity=0.344 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
..+.+.+|++++++++|+||+++++++.. +...|++|||+++++|.+++... ....+++..++.++.+++.||++|
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 121 (265)
T cd08217 42 EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121 (265)
T ss_pred HHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999998764 45679999999999999998653 234589999999999999999999
Q ss_pred hhC---CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHH
Q 021507 97 HDA---ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 173 (311)
Q Consensus 97 H~~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 173 (311)
|.. ..+++|+||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++|+||||++
T Consensus 122 H~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~i 199 (265)
T cd08217 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCL 199 (265)
T ss_pred hcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHH
Confidence 933 34599999999999999999999999999987544322 1233468899999999988889999999999999
Q ss_pred HHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 174 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|+|++|..||...... ...+.+........+...+..+.+++.+||..+|++||++.+++++
T Consensus 200 l~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 200 IYELCALSPPFTARNQL-----------------QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHCCCcccCcCHH-----------------HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 99999999999864311 1111122222233455677899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=261.68 Aligned_cols=210 Identities=25% Similarity=0.369 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++||||+++++++..++..|+||||+++++|.+++.. ..+++..+..++.+++.||.|||+
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~- 119 (277)
T cd06642 44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHS- 119 (277)
T ss_pred HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc-
Confidence 3456789999999999999999999999999999999999999999998853 348999999999999999999996
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
++++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 120 -~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 120 -ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred -CCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh
Confidence 4599999999999999999999999999876433211 1223457889999999988889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|..||........ ...+........+..++.++.+++.+||..+|++||++.+++++
T Consensus 197 g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 197 GEPPNSDLHPMRV-----------------LFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccchhhH-----------------HhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 9999875322110 00111111112334567789999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=257.04 Aligned_cols=210 Identities=27% Similarity=0.396 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++||||+++++.+..++..++||||+++++|.+++.......+++..+..++.+++.+|+|||+.
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-- 120 (256)
T cd08220 43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-- 120 (256)
T ss_pred HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 457889999999999999999999999999999999999999999999766555689999999999999999999964
Q ss_pred CeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 121 ~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~ 197 (256)
T cd08220 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL 197 (256)
T ss_pred CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence 599999999999998654 579999999986543321 2234678899999999888889999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||...+... .............+..++..+.+++.+||..||++|||+.+++.+
T Consensus 198 ~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 198 KRAFEAANLPA-----------------LVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCcccCchHH-----------------HHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 99997643211 011111111223345578889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=258.23 Aligned_cols=212 Identities=27% Similarity=0.409 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..+.+.+|+.++++++||||+++++++.+. ...++++||+++++|.+++.+.. .+++..++.++.|++.||+|||+
T Consensus 47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~ 124 (266)
T cd06651 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS 124 (266)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh
Confidence 445688999999999999999999988753 56789999999999999996544 38899999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
. +++|+||+|+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++|+|||||++|+|
T Consensus 125 ~--~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el 202 (266)
T cd06651 125 N--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202 (266)
T ss_pred C--CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHH
Confidence 4 5999999999999999999999999998754321111 112234578899999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||...... ...............+..++..+.+++ +||..+|++||++++++++
T Consensus 203 ~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 203 LTEKPPWAEYEAM----------------AAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHCCCCccccchH----------------HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 9999999754211 011111111112233455677788888 6888899999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=260.25 Aligned_cols=208 Identities=26% Similarity=0.369 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+++++.++|+||+++++++.++...|+|+||+.+++|.+++... .+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~-- 117 (274)
T cd06609 43 IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE-- 117 (274)
T ss_pred HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 346889999999999999999999999999999999999999999998654 589999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 118 ~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~ 195 (274)
T cd06609 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195 (274)
T ss_pred CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 499999999999999999999999999976543321 123456788999999999888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||...+... ....+........+.. ++..+.+++.+||..+|++|||+++++++
T Consensus 196 ~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 196 PPLSDLHPMR-----------------VLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCcccCchHH-----------------HHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9997543110 0011111111122222 67789999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=263.63 Aligned_cols=210 Identities=26% Similarity=0.322 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++||||+++++.+.++...|+|+||+.|++|.+++... ..+++..+..++.|+++||.|||+.
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~ 119 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK 119 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 34567899999999999999999999999999999999999999999999655 3589999999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|+||++++++.++|+|||++....... ......++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 120 --~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 120 --GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred --CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh
Confidence 59999999999999999999999999987654332 1234567889999999988889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM--SEVL 251 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~--~~~l 251 (311)
|..||......... ........ .....+...+..+.++|.+||..||.+||++ .+++
T Consensus 195 g~~p~~~~~~~~~~--------------~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 195 GKRPYRGHSRTIRD--------------QIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CCCCCCCCCccHHH--------------HHHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 99999865421111 01111111 2233455677899999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=257.11 Aligned_cols=204 Identities=27% Similarity=0.411 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.|.+|+.++++++||||+++++++.. ...++||||+.+++|.+++..... .+++..+..++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~-- 120 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK-- 120 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC--
Confidence 5678899999999999999999999988 778999999999999999865442 589999999999999999999964
Q ss_pred CeeecCCCCCceEeCCCC-------cEEEecccccccCCCCCCcceeccccccccccCccccccC--CCCCCCceehhHH
Q 021507 102 QVIYRDFKASNILLDAEF-------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGV 172 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~ 172 (311)
+++|+||||+||+++.++ .+||+|||++..... .....++..|+|||++.+. .++.++||||||+
T Consensus 121 ~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred CeecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 599999999999999887 799999999876432 2233467789999999876 7889999999999
Q ss_pred HHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 173 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 173 il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
++|+|++ |..||............ .. ....+......+.+++.+||..+|.+|||+.+++
T Consensus 195 ~~~~l~~~~~~p~~~~~~~~~~~~~-----------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 255 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSSEKERFY-----------------QD--QHRLPMPDCAELANLINQCWTYDPTKRPSFRAIL 255 (259)
T ss_pred HHHHHHhCCCCCcccCCchhHHHHH-----------------hc--CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHH
Confidence 9999999 57777654321110000 00 0011111237889999999999999999999999
Q ss_pred HHH
Q 021507 252 AIL 254 (311)
Q Consensus 252 ~~l 254 (311)
+.|
T Consensus 256 ~~l 258 (259)
T cd05037 256 RDL 258 (259)
T ss_pred Hhc
Confidence 876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=257.31 Aligned_cols=213 Identities=26% Similarity=0.336 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|+++++.++||||+++++++.++...|++|||+++++|.+++.+.. .+++..+..++.|++.||+|||+.
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~ 112 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNR 112 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC
Confidence 345678999999999999999999999999999999999999999999996543 389999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.+..++.++|+||||+++|+|++
T Consensus 113 --~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~ 187 (262)
T cd05572 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT 187 (262)
T ss_pred --CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHh
Confidence 59999999999999999999999999998654332 1233467889999999988889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
|..||....... ................+...+.++.++|.+||..||++||+ +.|++++
T Consensus 188 g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 188 GRPPFGEDDEDP--------------MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCcCCCCCCH--------------HHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 999997654210 01111111112223345556789999999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.13 Aligned_cols=217 Identities=24% Similarity=0.384 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.++++++|+||+++++++...+..++||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.
T Consensus 51 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~- 127 (272)
T cd06629 51 MVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK- 127 (272)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 44578899999999999999999999999999999999999999999996653 489999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC--CCCCCceehhHHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~ 178 (311)
+++|+||+|+||+++.++.++|+|||++................++..|+|||.+.... ++.++|+||||+++|+++
T Consensus 128 -~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~ 206 (272)
T cd06629 128 -GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206 (272)
T ss_pred -CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence 59999999999999999999999999997643322111223345788999999987654 788999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|..||........ ..... ...............++..+.+++.+||..+|++||++++++.+
T Consensus 207 ~g~~p~~~~~~~~~--~~~~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 207 AGRRPWSDEEAIAA--MFKLG----------NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hCCCCCcCcchHHH--HHHhh----------ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 99999965332100 00000 00000111112223467899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=260.56 Aligned_cols=215 Identities=25% Similarity=0.362 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++.+++|+||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~ 118 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK 118 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc
Confidence 34667999999999999999999999999999999999999999999999655 4589999999999999999999961
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
.+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 119 -~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t 195 (264)
T cd06623 119 -RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL 195 (264)
T ss_pred -CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh
Confidence 45999999999999999999999999998765432221 224467889999999988889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|..||...... ........+........+.. ++..+.+++.+||..+|++||++.++++.
T Consensus 196 g~~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 196 GKFPFLPPGQP--------------SFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCcccccc--------------CHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 99999765320 00111111111222223334 77899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=263.14 Aligned_cols=211 Identities=24% Similarity=0.348 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.+++.++|+||+++++.+..++..|+||||+++++|.+++... .+++..+..++.|++.||+|||+.
T Consensus 62 ~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~- 137 (292)
T cd06658 62 RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ- 137 (292)
T ss_pred HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4556889999999999999999999999999999999999999999988432 388999999999999999999975
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 138 -~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g 214 (292)
T cd06658 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214 (292)
T ss_pred -CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 499999999999999999999999999875432221 12335688899999999888899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||......... .......... ......++..+.+++.+||..||.+|||++++++.
T Consensus 215 ~~p~~~~~~~~~~-------------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 215 EPPYFNEPPLQAM-------------RRIRDNLPPR--VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCCCCCCHHHHH-------------HHHHhcCCCc--cccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 9999754321000 0000000000 01122456789999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=259.50 Aligned_cols=224 Identities=25% Similarity=0.397 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|+++++.++||||+++++++...+..|+||||+++++|.+++...+ .+++..+..++.+++.+|.|||+.
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~ 122 (284)
T cd06620 45 SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV 122 (284)
T ss_pred hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHh
Confidence 346678999999999999999999999999999999999999999999886543 489999999999999999999962
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
.+++|+||+|+||+++.++.++|+|||++....... .....|+..|+|||++.+..++.++|+|||||++|++++
T Consensus 123 -~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t 197 (284)
T cd06620 123 -HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197 (284)
T ss_pred -cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh
Confidence 359999999999999999999999999886532211 223568999999999988889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc-hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|..||........... ....................+ ..++..+.+|+.+||..||++|||+.+++++..-
T Consensus 198 g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 198 GKFPFAFSNIDDDGQD------DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred CCCCCcccchhhhhhh------hhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 9999986432110000 000000001111111111111 2366789999999999999999999999986533
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=272.99 Aligned_cols=214 Identities=25% Similarity=0.406 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
+.++|++|+.+|.+|+|+|++++||++.+ ....||||.+++|+|.+.|.+.....|.......++.||+.|+.||.++.
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 78899999999999999999999999987 67889999999999999998756666888899999999999999999755
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCccee-ccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+|||||-..|+++.....|||+|||+.+.++.+...... ....-...|+|||.+....++.+||+|++|++||||++
T Consensus 233 --lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 233 --LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred --hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 999999999999999999999999999987655443322 22233557999999999999999999999999999999
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|..||-+.. ...+.+.++.+.+...|..|+..+++++++||..+|.+|||+..|.+.+
T Consensus 311 yGEePW~G~~-----------------g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 311 YGEEPWVGCR-----------------GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCCCC-----------------HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 889998754 2334555566666778889999999999999999999999999997443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=262.89 Aligned_cols=226 Identities=22% Similarity=0.301 Sum_probs=168.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|+.++++++||||+++++++...+..|+||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~-- 123 (301)
T cd07873 48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR-- 123 (301)
T ss_pred hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 34577899999999999999999999999999999999975 9999886543 3488999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 124 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg 201 (301)
T cd07873 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201 (301)
T ss_pred CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhC
Confidence 599999999999999999999999999975432221 12234568899999988664 578899999999999999999
Q ss_pred CCccCCCccchhhhhh-hhc-cccccchhhhhH-----hhh-cccC----CCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 181 RCAVDKTKVGIEQSLV-DWA-KPYLSDKRKLFR-----IMD-TKLG----GQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~-~~~-~~~~~~~~~~~~-----~~~-~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
..||...+........ ... .+.......... ... .... ......++..+.+||.+||..||.+|||+.
T Consensus 202 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 281 (301)
T cd07873 202 RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281 (301)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 9999865432111110 000 000000000000 000 0000 011134677899999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++++
T Consensus 282 eil~h 286 (301)
T cd07873 282 EAMKH 286 (301)
T ss_pred HHhcC
Confidence 99864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=262.77 Aligned_cols=210 Identities=24% Similarity=0.351 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.+++.++|+||+++++++..++..|+||||+++++|.+++.+. .+++..+..++.+++.||.|||+.
T Consensus 60 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~-- 134 (297)
T cd06656 60 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN-- 134 (297)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456889999999999999999999999999999999999999999998543 388999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus 135 ~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~ 212 (297)
T cd06656 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (297)
T ss_pred CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 499999999999999999999999999875433221 123346788999999998888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||...+........ ..........+..++..+.+++.+||..||++||++.+++++
T Consensus 213 ~pf~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 213 PPYLNENPLRALYLI---------------ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCCcchheeee---------------ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999754321100000 000000112234567788999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=255.30 Aligned_cols=210 Identities=30% Similarity=0.463 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++|+||+++++++.++...|+++||+++++|.+++.+.. .+++..+..++.|++.||+|||+.
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~- 121 (258)
T cd06632 45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR- 121 (258)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678899999999999999999999999999999999999999999996543 488999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC-CCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|+||+++.++.+||+|||.+....... ......++..|++||.+.... ++.++|+||||+++|+|++
T Consensus 122 -~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~ 197 (258)
T cd06632 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197 (258)
T ss_pred -CcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence 49999999999999999999999999987643322 123456788999999987766 8899999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|..||...... ...............+..++..+.+++.+||..+|++||++.+++..
T Consensus 198 g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 198 GKPPWSQLEGV----------------AAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCCCcccCcHH----------------HHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 99999764310 00111111111223345677889999999999999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.77 Aligned_cols=232 Identities=21% Similarity=0.264 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++|+||+++++++.+.+..|++|||+.+++|.+++.......+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~- 120 (314)
T cd08216 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK- 120 (314)
T ss_pred HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456899999999999999999999999999999999999999999999765555689999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC-----cceeccccccccccCccccccC--CCCCCCceehhHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVV 173 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~i 173 (311)
+|+|+||||+||+++.++.+||+|||.+........ ........++..|+|||++.+. .++.++|+|||||+
T Consensus 121 -~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~i 199 (314)
T cd08216 121 -GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT 199 (314)
T ss_pred -CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHH
Confidence 499999999999999999999999998865432211 0112234567789999998663 57889999999999
Q ss_pred HHHHHhCCCccCCCccchhh-hhhhhcccc-cc------chh--------hhhHhhhcccCCCCchHHHHHHHHHHHhcc
Q 021507 174 LLELLSGRCAVDKTKVGIEQ-SLVDWAKPY-LS------DKR--------KLFRIMDTKLGGQYPQKAAHTAATLALQCL 237 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~-~~------~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 237 (311)
+|+|++|..||......... .......+. .. ... .................++.++.+++.+||
T Consensus 200 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 279 (314)
T cd08216 200 ACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCL 279 (314)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHh
Confidence 99999999999764321110 000000000 00 000 000000111112233456788999999999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 021507 238 NNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 238 ~~~p~~Rpt~~~~l~~l 254 (311)
..||++|||+++++++.
T Consensus 280 ~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 280 QRDPESRPSASQLLNHS 296 (314)
T ss_pred hcCCCcCcCHHHHhcCc
Confidence 99999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.90 Aligned_cols=212 Identities=26% Similarity=0.369 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCC------eeEEEEecCCCCChHHHhhhcC--CCCCCHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKG 92 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~ 92 (311)
.+.+.+|+.+++++ +|+||+++++++.+.. ..|+||||+++++|.+++.... ...+++..+..++.|++.|
T Consensus 46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~a 125 (275)
T cd06608 46 EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125 (275)
T ss_pred HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHH
Confidence 46789999999999 7999999999997644 4899999999999999886533 3568999999999999999
Q ss_pred HHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-----CCCCCCCce
Q 021507 93 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDV 167 (311)
Q Consensus 93 l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di 167 (311)
|.|||+. +++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.. ..++.++||
T Consensus 126 l~~lH~~--~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 126 LAYLHEN--KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred HHHHhcC--CcccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccH
Confidence 9999965 499999999999999999999999999875433221 1234568889999998754 346778999
Q ss_pred ehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc-CCCCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 168 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 168 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
||||+++|+|++|..||....... .......... ....+...+..+.+++.+||..||++|||
T Consensus 202 ~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt 265 (275)
T cd06608 202 WSLGITAIELADGKPPLCDMHPMR----------------ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF 265 (275)
T ss_pred HHhHHHHHHHHhCCCCccccchHH----------------HHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC
Confidence 999999999999999997532211 0011111110 11122346778999999999999999999
Q ss_pred HHHHHHH
Q 021507 247 MSEVLAI 253 (311)
Q Consensus 247 ~~~~l~~ 253 (311)
+.+++++
T Consensus 266 ~~~ll~~ 272 (275)
T cd06608 266 MEELLEH 272 (275)
T ss_pred HHHHhcC
Confidence 9999753
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=255.17 Aligned_cols=212 Identities=26% Similarity=0.374 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..+.+.+|++++++++||||+++++++.+. ...+++|||++|++|.+++.+.. .+++..+..++.+++.||+|||+
T Consensus 47 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~ 124 (265)
T cd06652 47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS 124 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh
Confidence 346788999999999999999999988764 46789999999999999986543 37889999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
.+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++|+|||||++|+|
T Consensus 125 ~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 125 NM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CC--EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHH
Confidence 54 999999999999999999999999998754321111 112234578899999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||...... ...............+...+..+.+++.+||. +|++||++++++.+
T Consensus 203 ~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 203 LTEKPPWAEFEAM----------------AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hhCCCCCCccchH----------------HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 9999999753211 11111111112233456677889999999995 99999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=255.96 Aligned_cols=218 Identities=28% Similarity=0.386 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+.+|+++++.++|+||+++++.+...+..|+|||++++++|.+++..... ..+++..+..++.|++.||++||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456789999999999999999999999999999999999999999999966433 4589999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceeccccccccccCccccccC-CCCCCCceehhHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~ 176 (311)
+++|+||+|+||++++++.++|+|||++......... .......++..|+|||++... .++.++|+||||+++|+
T Consensus 122 --~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~ 199 (267)
T cd06610 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIE 199 (267)
T ss_pred --CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHH
Confidence 5999999999999999999999999998765443222 123345688999999998777 78899999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC-CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ-YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|++|..||........ ...... ......... ....++..+.+++.+||..||++||++.+++++
T Consensus 200 l~~g~~p~~~~~~~~~--~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 200 LATGAAPYSKYPPMKV--LMLTLQ-----------NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHhCCCCccccChhhh--HHHHhc-----------CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9999999976432110 000000 000000000 113567889999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=255.35 Aligned_cols=215 Identities=23% Similarity=0.365 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhc-CCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 21 ITNWFQTEVNYLGQ-LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 21 ~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
..+.+.+|+.++.+ ++||||+++++++.+++..|++|||++|++|.+++.. .....+++..++.++.|++.||.|||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 33457789988875 7999999999999999999999999999999998743 22345899999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+. .+++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|
T Consensus 131 ~~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l 206 (269)
T cd08528 131 KE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206 (269)
T ss_pred cC-CceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHH
Confidence 52 469999999999999999999999999997644332 23345688899999999988899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
++|..||......... ...............++..+.+++.+||..||++||++.++..++.
T Consensus 207 ~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 207 CTLQPPFYSTNMLSLA----------------TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HhCCCcccccCHHHHH----------------HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9999999754321100 0111111111112245678999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=255.33 Aligned_cols=217 Identities=27% Similarity=0.426 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEEEEecCCCCChHHHhhhc----CCCCCCHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAK 91 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~ 91 (311)
.+.+.+|++++++++||||+++++++.... ..++++||+.+++|.+++... ....++...+..++.|++.
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 124 (273)
T cd05074 45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124 (273)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Confidence 456889999999999999999999886542 247899999999999887432 2234788999999999999
Q ss_pred HHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhH
Q 021507 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 171 (311)
Q Consensus 92 ~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 171 (311)
||+|||+. +++|+||||+||+++.++.+||+|||+++...............++..|++||.+.+..++.++||||||
T Consensus 125 ~l~~lH~~--~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG 202 (273)
T cd05074 125 GMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202 (273)
T ss_pred HHHHHHhC--CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHH
Confidence 99999964 5999999999999999999999999998865433222222233456789999999888899999999999
Q ss_pred HHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
|++|+|++ |..||...+... .............+...+..+.+++.+||..+|++||++.++
T Consensus 203 ~il~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~ 265 (273)
T cd05074 203 VTMWEIMTRGQTPYAGVENSE-----------------IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265 (273)
T ss_pred HHHHHHhhCCCCCCCCCCHHH-----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 99999999 889987543211 111111111112233466789999999999999999999999
Q ss_pred HHHHHhh
Q 021507 251 LAILERL 257 (311)
Q Consensus 251 l~~l~~~ 257 (311)
+..|+++
T Consensus 266 ~~~l~~~ 272 (273)
T cd05074 266 RDQLELI 272 (273)
T ss_pred HHHHHhh
Confidence 9999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=256.62 Aligned_cols=216 Identities=27% Similarity=0.414 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++||||+++++++..++..++++||+.+++|.+++.... ..+++..+..++.|++.||+|||+
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~- 118 (265)
T cd06605 41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE- 118 (265)
T ss_pred HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC-
Confidence 455678899999999999999999999999999999999999999999986543 458999999999999999999996
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
..+++|+||||+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 119 ~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 194 (265)
T cd06605 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT 194 (265)
T ss_pred CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 1459999999999999999999999999986543221 112567889999999988899999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|..||........ ......+..........+.. ++.++.++|.+||..||++|||+.+++..
T Consensus 195 g~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 195 GRFPYPPENDPPD------------GIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCCCccccccc------------cHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 9999975431100 00001111111111122233 77889999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.00 Aligned_cols=211 Identities=23% Similarity=0.318 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++.. ..+++..++.++.|++.||+|||+.
T Consensus 61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~- 136 (297)
T cd06659 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ- 136 (297)
T ss_pred hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 345688999999999999999999999999999999999999999998744 2389999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 137 -~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 213 (297)
T cd06659 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213 (297)
T ss_pred -CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 599999999999999999999999999865432211 12335688999999999888899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||............. . ...........++..+.+++.+||..+|++||++++++++
T Consensus 214 ~~p~~~~~~~~~~~~~~-------------~--~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 214 EPPYFSDSPVQAMKRLR-------------D--SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCCCCCHHHHHHHHh-------------c--cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 99997543211000000 0 0000111223456788999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=261.16 Aligned_cols=208 Identities=27% Similarity=0.392 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 22 TNWFQTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
.+.+.+|+.++++++ ||||+++++++.++...|+||||++|++|.+++... .+++..++.++.+++.||.|||+
T Consensus 43 ~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~ 119 (277)
T cd06917 43 VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK 119 (277)
T ss_pred HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh
Confidence 456888999999996 999999999999999999999999999999988543 48999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l 177 (311)
. +++|+||+|+||+++.++.++|+|||++......... .....|+..|+|||.+.++ .++.++|+||||+++|+|
T Consensus 120 ~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l 195 (277)
T cd06917 120 V--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEM 195 (277)
T ss_pred C--CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHH
Confidence 5 5999999999999999999999999999765443211 2334688899999988654 568899999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc-hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||........... .........+ ..++.++.+++.+||..||++||++.+++..
T Consensus 196 l~g~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 196 ATGNPPYSDVDAFRAMML-----------------IPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HhCCCCCCCCChhhhhhc-----------------cccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 999999976432111000 0000001111 1266789999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=254.63 Aligned_cols=211 Identities=24% Similarity=0.361 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++|+||+++++.+.+++..|+|+||+.+++|.+++.......+++..+..++.+++.||.|||+.
T Consensus 43 ~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-- 120 (257)
T cd08225 43 KEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120 (257)
T ss_pred hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456889999999999999999999999999999999999999999999765555689999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCc-EEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||++++++. ++|+|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 121 ~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 5999999999999988864 69999999876543221 12334688899999999888899999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||...+.... ...... ..........+..+.+++.+||..+|++|||+.++++.
T Consensus 199 ~~p~~~~~~~~~----------------~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 199 KHPFEGNNLHQL----------------VLKICQ-GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCccHHHH----------------HHHHhc-ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 999975432110 001111 11112234567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=256.91 Aligned_cols=210 Identities=24% Similarity=0.337 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.+++.++||||+++++++..++..|+++||+.|++|.+++.. ..+++..+..++.|++.||++||+.
T Consensus 60 ~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~-- 134 (285)
T cd06648 60 RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ-- 134 (285)
T ss_pred HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 45688999999999999999999999999999999999999999999865 2489999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++||||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 135 ~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~ 212 (285)
T cd06648 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212 (285)
T ss_pred CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCC
Confidence 599999999999999999999999998865432211 123356889999999998888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||...+......... .. .......+..++..+.+++.+||..+|++||++.+++++
T Consensus 213 ~p~~~~~~~~~~~~~~-------------~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 213 PPYFNEPPLQAMKRIR-------------DN--LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCCcCCCHHHHHHHHH-------------hc--CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 9997543211100000 00 000011123367789999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=259.75 Aligned_cols=213 Identities=28% Similarity=0.367 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++||||+++++.+..+...|++|||+.+++|.+++.+.. .+++..+..++.|++.||+|||+.
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~ 112 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN 112 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc
Confidence 445678899999999999999999999999999999999999999999996644 489999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC------cceeccccccccccCccccccCCCCCCCceehhHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 173 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 173 (311)
+++|+||+|+||+++.++.++|+|||++........ ........++..|++||...+...+.++|+||||++
T Consensus 113 --~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~ 190 (265)
T cd05579 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCI 190 (265)
T ss_pred --CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHH
Confidence 599999999999999999999999999875433211 112234567889999999988888999999999999
Q ss_pred HHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH--HHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 174 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK--AAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
+|++++|..||....... ....+.. .....+.. .+..+.+++.+||+.+|.+|||+.++.
T Consensus 191 ~~~l~~g~~p~~~~~~~~-----------------~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~ 252 (265)
T cd05579 191 LYEFLVGIPPFHGETPEE-----------------IFQNILN-GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIE 252 (265)
T ss_pred HHHHHhCCCCCCCCCHHH-----------------HHHHHhc-CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHH
Confidence 999999999997643210 0111111 00112222 378899999999999999999994444
Q ss_pred HHH
Q 021507 252 AIL 254 (311)
Q Consensus 252 ~~l 254 (311)
+.|
T Consensus 253 ~~l 255 (265)
T cd05579 253 EIK 255 (265)
T ss_pred HHh
Confidence 443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=260.51 Aligned_cols=225 Identities=23% Similarity=0.239 Sum_probs=165.3
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
..+.+|++++++++||||+++++++.+.+..|+|+||+.+ +|.+++.... ..+++..++.++.||++||.|||+. +
T Consensus 44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~--~ 119 (284)
T cd07839 44 SSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH--N 119 (284)
T ss_pred cchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--C
Confidence 4577899999999999999999999999999999999975 8888875433 3489999999999999999999965 4
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~ 181 (311)
++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 120 i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999876433221 12234568899999998765 4788999999999999999999
Q ss_pred CccCCCccchhh--hhhhhcc-ccccchhhhhHhhhcccC---------CCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 182 CAVDKTKVGIEQ--SLVDWAK-PYLSDKRKLFRIMDTKLG---------GQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 182 ~pf~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
.||......... ....... +................. ......++.++.+++.+||..||.+|||+++
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 198 RPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 886433221110 0000000 000000000000000000 0112346788999999999999999999999
Q ss_pred HHHH
Q 021507 250 VLAI 253 (311)
Q Consensus 250 ~l~~ 253 (311)
++++
T Consensus 278 il~h 281 (284)
T cd07839 278 ALQH 281 (284)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=254.95 Aligned_cols=211 Identities=27% Similarity=0.394 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++|+||+++++.+...+..|+++||++|++|.+++.... ..+++..++.++.+++.||++||+ .
T Consensus 59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~--~ 135 (286)
T cd06614 59 KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS--Q 135 (286)
T ss_pred HHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh--C
Confidence 4568899999999999999999999999999999999999999999997654 359999999999999999999996 4
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
|++|+||+|+||+++.++.++|+|||++........ ......++..|++||++.+..++.++|+||||+++|+|++|.
T Consensus 136 gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~ 213 (286)
T cd06614 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213 (286)
T ss_pred CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence 599999999999999999999999998865433221 123345788999999998888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhccc-CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||........ ......... ....+..++..+.+++.+||+.+|.+||++.+++..
T Consensus 214 ~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 214 PPYLREPPLRA----------------LFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCCCCCCHHHH----------------HHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 99975432110 001101111 111223367889999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=256.88 Aligned_cols=227 Identities=24% Similarity=0.290 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++++......++||||+++++|..++... ..+++..+..++.|++.||+|||+.
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~- 119 (286)
T cd07847 43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH- 119 (286)
T ss_pred ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456889999999999999999999999999999999999998887766433 3489999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 120 -~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~ 196 (286)
T cd07847 120 -NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196 (286)
T ss_pred -CceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh
Confidence 599999999999999999999999999986543321 1223457889999999876 457889999999999999999
Q ss_pred CCCccCCCccchhhh-hhhhccccccchhhh------hHhhhccc-CC-----CCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 180 GRCAVDKTKVGIEQS-LVDWAKPYLSDKRKL------FRIMDTKL-GG-----QYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 180 g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~-~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
|..||.+........ ............... ........ .. .....++..+.+++.+||..||++||+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 276 (286)
T cd07847 197 GQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS 276 (286)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC
Confidence 999997654321110 000000000000000 00000000 00 001235778999999999999999999
Q ss_pred HHHHHHH
Q 021507 247 MSEVLAI 253 (311)
Q Consensus 247 ~~~~l~~ 253 (311)
+.+++.+
T Consensus 277 ~~eil~~ 283 (286)
T cd07847 277 CEELLEH 283 (286)
T ss_pred HHHHhcC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=263.26 Aligned_cols=217 Identities=24% Similarity=0.342 Sum_probs=166.3
Q ss_pred HHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHh---hhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL---FRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.....+.+|+.++.++. |+||+++++++..++..+++|||+.+ +|.++. .......+++..+..++.+++.||+|
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 34567889999999995 99999999999999999999999964 666543 22233459999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC---CCCCCCceehhHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGV 172 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~ 172 (311)
||+. .+++||||||+||+++.++.++|+|||++........ .....++..|+|||++.+. .++.++|||||||
T Consensus 123 lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~ 198 (288)
T cd06616 123 LKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGI 198 (288)
T ss_pred Hhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHH
Confidence 9963 3599999999999999999999999999875433211 2234578899999998776 6889999999999
Q ss_pred HHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
++|+|++|..||........ ..... ............+..++.++.+|+.+||..||++|||++++++
T Consensus 199 il~el~~g~~p~~~~~~~~~-~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 199 TLYEVATGKFPYPKWNSVFD-QLTQV-----------VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHHhCCCCchhcchHHH-HHhhh-----------cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999975431000 00000 0000001111222347788999999999999999999999987
Q ss_pred H
Q 021507 253 I 253 (311)
Q Consensus 253 ~ 253 (311)
.
T Consensus 267 ~ 267 (288)
T cd06616 267 H 267 (288)
T ss_pred C
Confidence 5
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=251.00 Aligned_cols=213 Identities=28% Similarity=0.407 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++.... .+++..+..++.+++.||+|||+.
T Consensus 41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~ 118 (264)
T cd06626 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH 118 (264)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC
Confidence 456778999999999999999999999999999999999999999999986543 378899999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce--eccccccccccCccccccCC---CCCCCceehhHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV--STQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVL 174 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il 174 (311)
+++|+||+|+||+++.++.+||+|||++........... .....++..|+|||++.+.. .+.++||||||+++
T Consensus 119 --~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il 196 (264)
T cd06626 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196 (264)
T ss_pred --CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHH
Confidence 499999999999999999999999999976543322111 11346788999999998766 78899999999999
Q ss_pred HHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCch--HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ--KAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
|++++|..||......... ............+. .++..+.+++.+||+.+|++||++.+++.
T Consensus 197 ~~l~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 197 LEMATGKRPWSELDNEFQI----------------MFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHhCCCCccCCcchHHH----------------HHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999999754211000 00011111112222 34788899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=259.66 Aligned_cols=194 Identities=24% Similarity=0.311 Sum_probs=158.1
Q ss_pred CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe
Q 021507 36 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 115 (311)
Q Consensus 36 ~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~ 115 (311)
+|+||+++++.+...+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~ 142 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLY 142 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE
Confidence 79999999999999999999999999999999996554 5999999999999999999999654 9999999999999
Q ss_pred CCCC-cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhh
Q 021507 116 DAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 194 (311)
Q Consensus 116 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 194 (311)
+.++ .++|+|||++...... ....++..|+|||++.+..++.++|+||||+++|+|++|..||........
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-- 214 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-- 214 (267)
T ss_pred eCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--
Confidence 9998 9999999998764322 223578899999999988899999999999999999999999975432110
Q ss_pred hhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 021507 195 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAI 253 (311)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~~~l~~ 253 (311)
....+.... ......+...+..+.++|.+||+.||.+|++ +++++++
T Consensus 215 ----------~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 215 ----------DLESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ----------hHHHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000111111 1111233467889999999999999999995 6988753
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=255.76 Aligned_cols=228 Identities=24% Similarity=0.299 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.++++++||||+++++++..+...|+||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ 119 (286)
T cd07832 42 IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG 119 (286)
T ss_pred hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3467889999999999999999999999999999999999 899999986544 45999999999999999999999754
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++||||||+++|+|++
T Consensus 120 --i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred --eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999986543321 112234688899999988654 46889999999999999999
Q ss_pred CCCccCCCccchhhhh-hh-hccccccchh------hhhHhhhccc----CCCCchHHHHHHHHHHHhcccCCCCCCCCH
Q 021507 180 GRCAVDKTKVGIEQSL-VD-WAKPYLSDKR------KLFRIMDTKL----GGQYPQKAAHTAATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~-~~-~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 247 (311)
|.++|.+......... .. ...+...... .......... ........+..+.+++.+||..||.+||++
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred CCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 9888866442211100 00 0000000000 0000000000 000112356889999999999999999999
Q ss_pred HHHHHH
Q 021507 248 SEVLAI 253 (311)
Q Consensus 248 ~~~l~~ 253 (311)
++++.+
T Consensus 277 ~~~l~h 282 (286)
T cd07832 277 AEALRH 282 (286)
T ss_pred HHHhhC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=255.89 Aligned_cols=213 Identities=27% Similarity=0.373 Sum_probs=165.3
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEE-----eCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCL-----EGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGL 93 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l 93 (311)
.+.+.+|+.+++.+ +||||+++++++. .++..++||||++|++|.+++... ....+++..+..++.|++.||
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 45688899999999 7999999999874 345689999999999999987532 224588999999999999999
Q ss_pred HHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-----CCCCCCCcee
Q 021507 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVY 168 (311)
Q Consensus 94 ~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~ 168 (311)
.|||+. +++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.. ..++.++|+|
T Consensus 138 ~~lH~~--~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 213 (286)
T cd06638 138 QHLHVN--KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW 213 (286)
T ss_pred HHHHhC--CccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhh
Confidence 999965 499999999999999999999999999876433211 1233468899999998753 4478899999
Q ss_pred hhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc-ccCCCCchHHHHHHHHHHHhcccCCCCCCCCH
Q 021507 169 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 169 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 247 (311)
||||++|+|++|..||........ ....... ......+..++..+.+++.+||..||++|||+
T Consensus 214 slGvi~~el~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 277 (286)
T cd06638 214 SLGITAIELGDGDPPLADLHPMRA----------------LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTV 277 (286)
T ss_pred hHHHHHHHHhcCCCCCCCCchhHH----------------HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCH
Confidence 999999999999999975432110 0000000 00111233356789999999999999999999
Q ss_pred HHHHHHH
Q 021507 248 SEVLAIL 254 (311)
Q Consensus 248 ~~~l~~l 254 (311)
.++++.+
T Consensus 278 ~ell~~~ 284 (286)
T cd06638 278 SDLLQHV 284 (286)
T ss_pred HHHhhcc
Confidence 9998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=257.51 Aligned_cols=201 Identities=26% Similarity=0.367 Sum_probs=161.2
Q ss_pred HHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCC
Q 021507 30 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 109 (311)
Q Consensus 30 ~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlk 109 (311)
++++...||||+.+++++.+.+..|+||||+.|++|.+++...+ .+++..+..++.|++.||+|||+. +++|+|||
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~di~ 124 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR--FVVYRDLK 124 (278)
T ss_pred HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CEEcCCCC
Confidence 34555689999999999999999999999999999999886543 489999999999999999999975 49999999
Q ss_pred CCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCc
Q 021507 110 ASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTK 188 (311)
Q Consensus 110 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~ 188 (311)
|+||+++.++.++|+|||++....... .....|+..|+|||++.+. .++.++||||||+++|+|++|..||....
T Consensus 125 p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 125 PANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred HHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999987543221 2334689999999998754 68899999999999999999999997643
Q ss_pred cchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 189 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
..... ..... ........+..++..+.+++.+||..+|.+|| ++.+++++
T Consensus 201 ~~~~~--------------~~~~~-~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 201 TKDKH--------------EIDRM-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ccchH--------------HHHHH-hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 21100 00010 11112234455688999999999999999999 89999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=244.92 Aligned_cols=213 Identities=24% Similarity=0.382 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
+..+++...++++..- ++|+||+++|+|..+..+++.||.|.. .++.++++ -..++++..+-++...++.||.||-.
T Consensus 132 ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKe 209 (391)
T KOG0983|consen 132 EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKE 209 (391)
T ss_pred HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHH
Confidence 3344566666665554 599999999999999999999999953 66666644 34569999999999999999999987
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc---CCCCCCCceehhHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ 175 (311)
+ ++|+|||+||+|||+++.|++|+||||++..+.+.. ......|.+.|||||.+.- ..|+.++||||||++++
T Consensus 210 K-H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlv 285 (391)
T KOG0983|consen 210 K-HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLV 285 (391)
T ss_pred h-cceeecccCccceEEccCCCEEeecccccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchh
Confidence 3 579999999999999999999999999997654432 3445678999999998854 46889999999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC-CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|+.||+.||.+.+.. ...+.+++...-.. ....+++..+.+++..||..|+.+||...+++++
T Consensus 286 eLaTg~yPy~~c~td---------------Fe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 286 ELATGQYPYKGCKTD---------------FEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred hhhcccCCCCCCCcc---------------HHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999875431 22222222211111 1122478999999999999999999999999875
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=263.24 Aligned_cols=227 Identities=25% Similarity=0.351 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++||||+++++++..++..|+||||+.+++|.++.... ..+++..+..++.|++.||+|||+.
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~- 119 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH- 119 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4556889999999999999999999999999999999999998888876433 2389999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 120 -~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~ 196 (286)
T cd07846 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196 (286)
T ss_pred -CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc
Confidence 499999999999999999999999999876433221 12334678899999988753 57789999999999999999
Q ss_pred CCCccCCCccchhh-hhhhhccccccchhhhhH---hhhcc----cC-----CCCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 180 GRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFR---IMDTK----LG-----GQYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 180 g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~----~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
|..||......... .................. ..... .. ......++..+.+++.+||..+|++||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 276 (286)
T cd07846 197 GEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276 (286)
T ss_pred CCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh
Confidence 99999754321110 001000000000000000 00000 00 0012346788999999999999999999
Q ss_pred HHHHHHH
Q 021507 247 MSEVLAI 253 (311)
Q Consensus 247 ~~~~l~~ 253 (311)
+.++++.
T Consensus 277 ~~~il~~ 283 (286)
T cd07846 277 SSQLLHH 283 (286)
T ss_pred HHHHhcC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=257.99 Aligned_cols=226 Identities=23% Similarity=0.277 Sum_probs=167.6
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+.+.+|++++++++||||+++++++.+++..++||||+. ++|.+++.......+++..+..++.|++.||+|||+. +
T Consensus 44 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--~ 120 (284)
T cd07860 44 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--R 120 (284)
T ss_pred hHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--C
Confidence 568899999999999999999999999999999999996 5899988665555689999999999999999999965 4
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC-CCCCCceehhHHHHHHHHhCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~ 181 (311)
++|+||+|+||+++.++.+||+|||++........ ......++..|+|||++.+.. ++.++|+||||+++|+|++|.
T Consensus 121 i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~ 198 (284)
T cd07860 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198 (284)
T ss_pred eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999876433221 122335678899999887654 588899999999999999999
Q ss_pred CccCCCccchhh-hhhhhcccccc-------chhhhhHhhhcccC---CCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 182 CAVDKTKVGIEQ-SLVDWAKPYLS-------DKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 182 ~pf~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
.||......... ........... .............. ......++.++.++|.+||+.||.+|||++++
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 199 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 999764321110 00000000000 00000000000000 00112356778999999999999999999999
Q ss_pred HHH
Q 021507 251 LAI 253 (311)
Q Consensus 251 l~~ 253 (311)
+++
T Consensus 279 l~~ 281 (284)
T cd07860 279 LAH 281 (284)
T ss_pred hcC
Confidence 854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=255.33 Aligned_cols=208 Identities=25% Similarity=0.331 Sum_probs=163.8
Q ss_pred HHHHHHHHHh---cCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 24 WFQTEVNYLG---QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 24 ~~~~E~~~l~---~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.+|..+++ ..+||||+.+++++..++..|+||||+.|++|.+++...+ .+++..+..++.|++.||+|||+.+
T Consensus 40 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ 117 (279)
T cd05633 40 LALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF 117 (279)
T ss_pred HHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3445554444 3479999999999999999999999999999999886544 4899999999999999999999754
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~ 179 (311)
++|+||||+||+++.++.++|+|||++....... .....|+..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 118 --ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 191 (279)
T cd05633 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191 (279)
T ss_pred --cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999986543221 223468999999998864 568899999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAIL 254 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~l 254 (311)
|..||......... .. ...........+..++.++.+++.+||..||.+|+ ++++++++.
T Consensus 192 g~~pf~~~~~~~~~--------------~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 192 GHSPFRQHKTKDKH--------------EI-DRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CCCCcCCCCCcCHH--------------HH-HHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 99999754321100 00 11111122234556788999999999999999999 588887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=257.19 Aligned_cols=227 Identities=26% Similarity=0.278 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
....+.+|++++++++|+||+++++++.+++..|+||||+ +++|.+++.... ..+++..+..++.|+++||+|||+.
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~- 121 (298)
T cd07841 45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN- 121 (298)
T ss_pred hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4456778999999999999999999999999999999999 889999996544 3599999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+|||||++|+|++
T Consensus 122 -~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 122 -WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred -CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc
Confidence 4999999999999999999999999999765433211 222356788999998865 457889999999999999999
Q ss_pred CCCccCCCccchhhhh-hhh-ccccccchh---hhhHhhhccc-----CCCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 180 GRCAVDKTKVGIEQSL-VDW-AKPYLSDKR---KLFRIMDTKL-----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~-~~~-~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
|.++|........... ... ..+...... .......... ........+..+.+++.+||..||++|||+.+
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 9888865442111100 000 000000000 0000000000 00111345778999999999999999999999
Q ss_pred HHHH
Q 021507 250 VLAI 253 (311)
Q Consensus 250 ~l~~ 253 (311)
++.+
T Consensus 279 ~l~~ 282 (298)
T cd07841 279 ALEH 282 (298)
T ss_pred HhhC
Confidence 9874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.42 Aligned_cols=209 Identities=26% Similarity=0.371 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.++.+++||||+++++++.++...|+||||+.+++|.+++.+. .+++..+..++.+++.++.+||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~-- 119 (277)
T cd06641 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS-- 119 (277)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHcc--
Confidence 3456889999999999999999999999999999999999999999988543 48999999999999999999996
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
++++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 120 ~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (277)
T cd06641 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 4599999999999999999999999999875433211 12234678899999999888889999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||....... ....+........+..++.++.+++.+||..+|.+||++.+++.+
T Consensus 198 ~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 198 EPPHSELHPMK-----------------VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCccchHH-----------------HHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99997533210 001111111122344567889999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=256.02 Aligned_cols=227 Identities=26% Similarity=0.310 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++++..++..++||||+.++.+..++.+. ..+++..++.++.+++.||+|||+.
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~- 119 (288)
T cd07833 43 VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH- 119 (288)
T ss_pred chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4567899999999999999999999999999999999999986666555332 3489999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|+||+++.++.+||+|||++......... ......++..|+|||++.+. .++.++|+||||+++|+|++
T Consensus 120 -~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred -CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 5999999999999999999999999998765443321 12345678899999999888 78899999999999999999
Q ss_pred CCCccCCCccchhhhh-hhhccccccchhhh------hHh---h----hcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 180 GRCAVDKTKVGIEQSL-VDWAKPYLSDKRKL------FRI---M----DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~------~~~---~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
|..||........... .............. ... . ........+..++.++.+++.+||..+|++||
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 277 (288)
T cd07833 198 GEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc
Confidence 9999976432111000 00000000000000 000 0 00000112334578899999999999999999
Q ss_pred CHHHHHH
Q 021507 246 RMSEVLA 252 (311)
Q Consensus 246 t~~~~l~ 252 (311)
+++++++
T Consensus 278 s~~~il~ 284 (288)
T cd07833 278 TCDELLQ 284 (288)
T ss_pred cHHHHhc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=257.48 Aligned_cols=210 Identities=25% Similarity=0.364 Sum_probs=161.5
Q ss_pred HHHHHHHH-HhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 24 WFQTEVNY-LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 24 ~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+..|+.+ ++.++||||+++++++..++..|++|||++ ++|.+++... ....+++..++.++.|++.||+|||+.
T Consensus 45 ~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~- 122 (283)
T cd06617 45 RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK- 122 (283)
T ss_pred HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-
Confidence 44556665 566699999999999999999999999997 4888887542 224589999999999999999999963
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc----CCCCCCCceehhHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 176 (311)
.+++||||||+||+++.++.+||+|||++....... ......++..|+|||++.+ ..++.++|+|||||++|+
T Consensus 123 ~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCeecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 259999999999999999999999999987643221 1223457889999998865 346889999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|++|..||....... ..+...............++.++.+++.+||..+|++||++.++++.
T Consensus 200 l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 200 LATGRFPYDSWKTPF---------------QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhCCCCCCccccCH---------------HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999996432110 01111111111111123467889999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=256.10 Aligned_cols=210 Identities=25% Similarity=0.360 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.++++++||||+++++++...+..|+|+||+++++|.+++.+. .+++..+..++.+++.||+|||+.
T Consensus 60 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~-- 134 (293)
T cd06647 60 KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN-- 134 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456889999999999999999999999999999999999999999998543 378999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|.
T Consensus 135 gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~ 212 (293)
T cd06647 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (293)
T ss_pred CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 599999999999999999999999998875433221 123346788999999998888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||...+......... .........+..++..+.+++.+||..+|++||++.+++.+
T Consensus 213 ~pf~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 213 PPYLNENPLRALYLIA---------------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCChhhheeehh---------------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9997643211100000 00000111233467789999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=246.40 Aligned_cols=229 Identities=25% Similarity=0.287 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 19 LLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
..++.+..+|++++.+. .|+||++++++|+++...|+|||.+.||+|..+|.++. -+++.++..+.++|+.||.|||
T Consensus 116 gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH 193 (463)
T KOG0607|consen 116 GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH 193 (463)
T ss_pred chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh
Confidence 34677788999999999 69999999999999999999999999999999997664 4999999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCc---EEEecccccccCCCCC-----CcceeccccccccccCcccccc-----CCCCCC
Q 021507 98 DAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGD-----RTHVSTQVMGTHGYAAPEYVAT-----GRLTTK 164 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~ 164 (311)
. +||.||||||+|||....+. ||||||.+..-..... ......+.+|+..|||||+..- ..|+.+
T Consensus 194 ~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKr 271 (463)
T KOG0607|consen 194 T--KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKR 271 (463)
T ss_pred h--cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccccccccc
Confidence 5 45999999999999976654 8999998875432211 1112235688999999997642 358889
Q ss_pred CceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhh-cc--cCCCCchHHHHHHHHHHHhcccCCC
Q 021507 165 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TK--LGGQYPQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 165 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~l~~li~~~l~~~p 241 (311)
+|.||||+|+|-|++|.+||.+.=.. +-. .+-..+.-.....++.-+. .+ +...-...++.+..+++..+|..|+
T Consensus 272 CDlwSLGvIlYImLsGYpPFvG~Cg~-dCG-WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda 349 (463)
T KOG0607|consen 272 CDLWSLGVILYIMLSGYPPFVGHCGA-DCG-WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDA 349 (463)
T ss_pred ccHHHHHHHHHHHHhCCCCccCccCC-cCC-ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccH
Confidence 99999999999999999999764220 000 0001111112223333222 22 2333345789999999999999999
Q ss_pred CCCCCHHHHHHH
Q 021507 242 KLRPRMSEVLAI 253 (311)
Q Consensus 242 ~~Rpt~~~~l~~ 253 (311)
.+|.++..++.+
T Consensus 350 ~~rlsa~~vlnh 361 (463)
T KOG0607|consen 350 KQRLSAAQVLNH 361 (463)
T ss_pred HhhhhhhhccCC
Confidence 999999999874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=265.21 Aligned_cols=205 Identities=26% Similarity=0.388 Sum_probs=176.0
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
.+-+|+++|+.|+|||||+++.+.+....+|+||||+.+|.+.+++.+.+. ..+..+..++.|++.+++|||++. |
T Consensus 101 k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~--i 176 (596)
T KOG0586|consen 101 KLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN--I 176 (596)
T ss_pred HHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc--e
Confidence 378899999999999999999999999999999999999999999987765 666889999999999999999755 9
Q ss_pred eecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCC-CCCCceehhHHHHHHHHhCCC
Q 021507 104 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRC 182 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~ 182 (311)
||||||.+|||++.+.++||+|||++..+... ....+.+|++.|.|||++.+..+ +..+|+||||+++|.|+.|.+
T Consensus 177 vHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsL 253 (596)
T KOG0586|consen 177 VHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSL 253 (596)
T ss_pred eccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccc
Confidence 99999999999999999999999999876533 34667899999999999999876 458999999999999999999
Q ss_pred ccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 183 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 183 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
||++.+...... +.+..+ ...+.-++-++.++|+++|..+|.+|++++++.+.
T Consensus 254 PFDG~~lk~Lr~----------------rvl~gk--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 254 PFDGQNLKELRP----------------RVLRGK--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccCCcccccccc----------------hheeee--ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 999866432211 111111 23455678899999999999999999999999864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=255.21 Aligned_cols=208 Identities=28% Similarity=0.371 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++||||+++++++.+++..|+||||+.| +|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 58 ~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~- 134 (307)
T cd06607 58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH- 134 (307)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345688999999999999999999999999999999999975 8877775433 3589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc---cCCCCCCCceehhHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l 177 (311)
+++|+||+|+||+++.++.++|+|||++...... ....++..|+|||++. ...++.++||||||+++|+|
T Consensus 135 -~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 135 -ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred -CceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 5999999999999999999999999998754322 2346788999999874 35678899999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++|..||...+..... ............+..++..+.+++.+||..||++||++.+++.+.
T Consensus 208 ~tg~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 208 AERKPPLFNMNAMSAL----------------YHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HcCCCCCCCccHHHHH----------------HHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 9999999764321110 000001111111234677899999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=248.55 Aligned_cols=213 Identities=24% Similarity=0.350 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.+.+|+++++.++|+|++++.+.+..+...++|+||+++++|.+++.+.. ...+++..+..++.+++.||++||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 120 (258)
T cd08215 41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 445568899999999999999999999999999999999999999999996643 356999999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+. +++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 121 ~~--~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l 196 (258)
T cd08215 121 SR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL 196 (258)
T ss_pred hC--CEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHH
Confidence 65 59999999999999999999999999997654332 123345688899999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||...... ..............+..++..+.+++.+||..+|++||++.++++.
T Consensus 197 ~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 197 CTLKHPFEGENLL-----------------ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HcCCCCCCCCcHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999764311 1111111112223444677899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=260.71 Aligned_cols=211 Identities=23% Similarity=0.295 Sum_probs=182.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+....|-.||.+...|.||++|-.|.++..+|++||-|-||.|+..+..++. ++..+...++..+++|++|||+++
T Consensus 463 QqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~ 540 (732)
T KOG0614|consen 463 QQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKG 540 (732)
T ss_pred HHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcC
Confidence 444577899999999999999999999999999999999999999999976654 899999999999999999999765
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
||+|||||+|++++.+|-+||.|||+++....+... -+++||+.|.|||++.+...+.++|.||||+++||+++|
T Consensus 541 --iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G 615 (732)
T KOG0614|consen 541 --IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG 615 (732)
T ss_pred --ceeccCChhheeeccCCceEEeehhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence 999999999999999999999999999987666543 367899999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAIL 254 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~~l 254 (311)
.+||.+.+.... ...++.......+|..+.....+||+++...+|.+|.. +.+|.++-
T Consensus 616 ~pPFs~~dpmkt----------------Yn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 616 SPPFSGVDPMKT----------------YNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred CCCCCCCchHHH----------------HHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 999998653211 12223333334577889999999999999999999974 77777664
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=253.55 Aligned_cols=212 Identities=29% Similarity=0.378 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeC-----CeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGL 93 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l 93 (311)
.+.+.+|+.+++++ +||||+++++++... +..|+||||++|++|.+++... ....+++..++.++.|++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 45678899999999 899999999998754 3579999999999999988532 234589999999999999999
Q ss_pred HHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-----CCCCCCcee
Q 021507 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVY 168 (311)
Q Consensus 94 ~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~ 168 (311)
+|||+. +++|+||||+||+++.++.+||+|||++......... .....++..|+|||++... .++.++|||
T Consensus 142 ~~lH~~--~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 217 (291)
T cd06639 142 QHLHNN--RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217 (291)
T ss_pred HHHHhC--CeeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchH
Confidence 999965 5999999999999999999999999998764332211 2234678899999987543 367899999
Q ss_pred hhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchHHHHHHHHHHHhcccCCCCCCCCH
Q 021507 169 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 169 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 247 (311)
||||++|+|++|+.||........ ........ .....+......+.+++.+||..||++||++
T Consensus 218 slGvi~~el~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 281 (291)
T cd06639 218 SLGITAIELGDGDPPLFDMHPVKT----------------LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281 (291)
T ss_pred HHHHHHHHHhhCCCCCCCCcHHHH----------------HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCH
Confidence 999999999999999976432100 01110000 0111233456689999999999999999999
Q ss_pred HHHHHH
Q 021507 248 SEVLAI 253 (311)
Q Consensus 248 ~~~l~~ 253 (311)
.+++++
T Consensus 282 ~~il~~ 287 (291)
T cd06639 282 THLLEH 287 (291)
T ss_pred HHHhcC
Confidence 999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=259.50 Aligned_cols=207 Identities=29% Similarity=0.394 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++|||++++++++.+....|+||||+.+ +|.+++.... ..+++..+..++.|++.+|.|||+.
T Consensus 64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~- 140 (313)
T cd06633 64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH- 140 (313)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345688899999999999999999999999999999999965 8888775433 4589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc---cCCCCCCCceehhHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l 177 (311)
+++|+||+|+||+++.++.++|+|||++..... .....|+..|+|||++. +..++.++|+||||+++|+|
T Consensus 141 -gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 141 -NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred -CeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHH
Confidence 599999999999999999999999998864221 22356788999999974 35688899999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||...+..... ...............++..+.+++.+||+.+|.+||++.+++..
T Consensus 214 ~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 214 AERKPPLFNMNAMSAL----------------YHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HhCCCCCCCCChHHHH----------------HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999764321110 11111111111223456679999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=254.04 Aligned_cols=213 Identities=28% Similarity=0.382 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++|+|++++++++.++...|+||||+.| +|.+.+.... ..+++..+..++.+++.||.|||+.
T Consensus 67 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~ 144 (317)
T cd06635 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH 144 (317)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3445688999999999999999999999999999999999975 8888775433 4489999999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc---cCCCCCCCceehhHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~ 176 (311)
+++|+||+|+||+++.++.++|+|||++..... .....++..|+|||++. +..++.++|+|||||++|+
T Consensus 145 --~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~e 216 (317)
T cd06635 145 --NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216 (317)
T ss_pred --CcccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHH
Confidence 599999999999999999999999998865332 22346788999999874 4568889999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|++|..||....... .................++..+.+++.+||+.+|.+||++.++++.+..
T Consensus 217 l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 217 LAERKPPLFNMNAMS----------------ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHhCCCCCCCccHHH----------------HHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 999999987532111 0111111111112233467789999999999999999999999987655
Q ss_pred hc
Q 021507 257 LE 258 (311)
Q Consensus 257 ~~ 258 (311)
+.
T Consensus 281 ~~ 282 (317)
T cd06635 281 LR 282 (317)
T ss_pred hc
Confidence 43
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=254.83 Aligned_cols=215 Identities=23% Similarity=0.233 Sum_probs=166.0
Q ss_pred hhHHHhHHHHHHh---hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCC
Q 021507 2 FLFNFLHSHLELH---ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS 78 (311)
Q Consensus 2 ~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 78 (311)
|+.||++.+.... +.+.......+.+|...+....||||+++++++.+.+..|+||||+.|++|.+++.+.. .++
T Consensus 6 ~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~ 83 (237)
T cd05576 6 IDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIP 83 (237)
T ss_pred cceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--CCC
Confidence 4556665554332 11112222235566666667789999999999999999999999999999999986543 389
Q ss_pred HHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc
Q 021507 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 158 (311)
Q Consensus 79 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 158 (311)
+..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+...... .....++..|+|||.+.+
T Consensus 84 ~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 84 EECVKRWAAEMVVALDALHRE--GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGI 156 (237)
T ss_pred HHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCC
Confidence 999999999999999999965 5999999999999999999999999987654322 122345678999999988
Q ss_pred CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhccc
Q 021507 159 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 238 (311)
Q Consensus 159 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (311)
..++.++|+||||+++|+|++|..||....... ........+..++..+.+++.+||+
T Consensus 157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~li~~~l~ 214 (237)
T cd05576 157 SEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIPEWVSEEARSLLQQLLQ 214 (237)
T ss_pred CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCcccCCHHHHHHHHHHcc
Confidence 888999999999999999999998875422100 0000112344567889999999999
Q ss_pred CCCCCCCCH
Q 021507 239 NEPKLRPRM 247 (311)
Q Consensus 239 ~~p~~Rpt~ 247 (311)
.||++|+++
T Consensus 215 ~dp~~R~~~ 223 (237)
T cd05576 215 FNPTERLGA 223 (237)
T ss_pred CCHHHhcCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=248.20 Aligned_cols=215 Identities=27% Similarity=0.411 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.+.+|++++++++|+||+++++.+.+. ...++++||+.+++|.+++.+.. .+++..++.++.+++.+|+|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh 118 (260)
T cd06606 41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH 118 (260)
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999988 88999999999999999996654 5999999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
+. +++|+||+|+||+++.++.++|+|||.+................++..|++||.+.+...+.++|+||||+++|+|
T Consensus 119 ~~--~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (260)
T cd06606 119 SN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEM 196 (260)
T ss_pred HC--CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHH
Confidence 64 5999999999999999999999999999876544321113345678899999999888899999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||....... ...............+...+..+.+++.+||..||++||++.+++.+
T Consensus 197 ~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 197 ATGKPPWSELGNPM---------------AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HhCCCCCCCCCchH---------------HHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 99999997654100 01111111122233455668899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=254.07 Aligned_cols=224 Identities=23% Similarity=0.281 Sum_probs=163.5
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
..+.+|++++++++|+||+++++++.+++..|+||||+.+ +|.+++..... .+++..+..++.|++.||.|||+. +
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~--~ 123 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR--R 123 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC--C
Confidence 3467899999999999999999999999999999999975 99998865443 589999999999999999999965 5
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~ 181 (311)
++|+||||+||+++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 124 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~ 201 (291)
T cd07844 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201 (291)
T ss_pred eecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875432211 1222346788999998876 45788999999999999999999
Q ss_pred CccCCCccchhhh--hhhhcc-ccccchhhhhH---hhhcccC-------CCCchHHH--HHHHHHHHhcccCCCCCCCC
Q 021507 182 CAVDKTKVGIEQS--LVDWAK-PYLSDKRKLFR---IMDTKLG-------GQYPQKAA--HTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 182 ~pf~~~~~~~~~~--~~~~~~-~~~~~~~~~~~---~~~~~~~-------~~~~~~~~--~~l~~li~~~l~~~p~~Rpt 246 (311)
.||.......... ...... +.......... ....... ........ ..+.+++.+||..+|++|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps 281 (291)
T cd07844 202 PLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281 (291)
T ss_pred CCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC
Confidence 9997654211110 000000 00000000000 0000000 00001122 67889999999999999999
Q ss_pred HHHHHH
Q 021507 247 MSEVLA 252 (311)
Q Consensus 247 ~~~~l~ 252 (311)
+.+++.
T Consensus 282 ~~e~l~ 287 (291)
T cd07844 282 AAEAMK 287 (291)
T ss_pred HHHHhc
Confidence 999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=248.75 Aligned_cols=213 Identities=25% Similarity=0.357 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.+.+|++++++++|+||+++++++.+. ...++++||+++++|.+++...+ .+++..+..++.|++.||.|||
T Consensus 46 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH 123 (264)
T cd06653 46 KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH 123 (264)
T ss_pred HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 3445789999999999999999999998764 45789999999999999986544 3889999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+. +++|+||||+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.++|+|||||++|+
T Consensus 124 ~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 201 (264)
T cd06653 124 SN--MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVE 201 (264)
T ss_pred hC--CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHH
Confidence 65 5999999999999999999999999999764321111 11223468889999999988889999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+++|..||..... .....+..........+..+++.+.+++.+||. ++..||++.+++.+
T Consensus 202 l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 202 MLTEKPPWAEYEA----------------MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHhCCCCCCccCH----------------HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 9999999975321 111122222222334567788999999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=246.74 Aligned_cols=230 Identities=21% Similarity=0.259 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCCCCChHHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFR---RGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
+...-||+.+++.++||||+.+..+|.. +..+|+++||.+. +|...|+- ...+.++...+..++.||+.|+.|||
T Consensus 71 S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH 149 (438)
T KOG0666|consen 71 SMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH 149 (438)
T ss_pred CHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh
Confidence 3456789999999999999999999987 7789999999987 99998842 22356999999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCC----CcEEEecccccccCCCCCCcc-eeccccccccccCccccccC-CCCCCCceehhH
Q 021507 98 DAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFG 171 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG 171 (311)
+.. |+||||||.|||+..+ |.|||+|||+++.+...-... .....+-|.+|+|||.+.|. .|+.+.|+||.|
T Consensus 150 ~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 150 SNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIG 227 (438)
T ss_pred hhh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHH
Confidence 766 9999999999999887 899999999999876554332 23446779999999999887 588899999999
Q ss_pred HHHHHHHhCCCccCCCccchhhh-------hhh----hccccccch------hhh---hHhhhcccCCCC--c------h
Q 021507 172 VVLLELLSGRCAVDKTKVGIEQS-------LVD----WAKPYLSDK------RKL---FRIMDTKLGGQY--P------Q 223 (311)
Q Consensus 172 ~il~~l~~g~~pf~~~~~~~~~~-------~~~----~~~~~~~~~------~~~---~~~~~~~~~~~~--~------~ 223 (311)
||+.||++..+.|.+........ +.. ...|...+. .+. ............ . .
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 99999999999998765533221 000 001111110 000 000110000000 0 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 224 KAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.-++...+|+.++|.+||.+|.|++++++..
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1233478999999999999999999999764
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=251.70 Aligned_cols=218 Identities=26% Similarity=0.344 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
..+.+.+|++++++++||||+++++++.+. +..|+||||++|++|.+++.. .....+++..+..++.|++.||+||
T Consensus 42 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l 121 (287)
T cd06621 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121 (287)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 456688999999999999999999988654 468999999999999988743 2234588999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
|+. +++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 122 H~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~ 195 (287)
T cd06621 122 HSR--KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195 (287)
T ss_pred HHC--CcccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 965 59999999999999999999999999986543221 123456889999999988889999999999999999
Q ss_pred HHhCCCccCCCccc--hhhhhhhhccccccchhhhhHhhhcccCCCC--chHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 177 LLSGRCAVDKTKVG--IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 177 l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
|++|..||...... .......+.. ........... ....+..+.+++.+||..||.+|||+.|+++
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 196 VAQNRFPFPPEGEPPLGPIELLSYIV----------NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHhCCCCCCcccCCCCChHHHHHHHh----------cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 99999999865320 0000000000 00000000000 1235678999999999999999999999987
Q ss_pred HH
Q 021507 253 IL 254 (311)
Q Consensus 253 ~l 254 (311)
.-
T Consensus 266 ~~ 267 (287)
T cd06621 266 HP 267 (287)
T ss_pred Cc
Confidence 43
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=249.08 Aligned_cols=204 Identities=23% Similarity=0.251 Sum_probs=160.3
Q ss_pred HHHHHHH-HhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 25 FQTEVNY-LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 25 ~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
+..|..+ ....+|+||+++++++..++..|+||||+.|++|.+++.... .+++..+..++.|++.||.|||+. ++
T Consensus 43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~--~i 118 (260)
T cd05611 43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR--GI 118 (260)
T ss_pred HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--Ce
Confidence 3445444 445589999999999999999999999999999999986543 489999999999999999999965 49
Q ss_pred eecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCc
Q 021507 104 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 183 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 183 (311)
+|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 119 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred ecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999875322 2234678899999999888889999999999999999999999
Q ss_pred cCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 184 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 184 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
|...+........ ..............++..+.+++.+||..||++||++.++.+
T Consensus 193 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 193 FHAETPDAVFDNI--------------LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred CCCCCHHHHHHHH--------------HhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 9764321110000 000001111223356788999999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=254.47 Aligned_cols=225 Identities=23% Similarity=0.285 Sum_probs=167.5
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+|+.++++++||||+++++++... +..|+||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~- 125 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN- 125 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4567899999999999999999998877 889999999975 9999886543 3589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++
T Consensus 126 -~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 202 (293)
T cd07843 126 -WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202 (293)
T ss_pred -CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh
Confidence 499999999999999999999999999986543321 12234578899999988765 46889999999999999999
Q ss_pred CCCccCCCccchhhhhh-h-hccccccchh-----------hhhHhhhcccCCCCchH-HHHHHHHHHHhcccCCCCCCC
Q 021507 180 GRCAVDKTKVGIEQSLV-D-WAKPYLSDKR-----------KLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~-~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rp 245 (311)
|..||............ . ...+...... .............++.. ++..+.++|.+||+.||++||
T Consensus 203 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 282 (293)
T cd07843 203 KKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI 282 (293)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccC
Confidence 99999765432111100 0 0000000000 00000000111122222 578899999999999999999
Q ss_pred CHHHHHHH
Q 021507 246 RMSEVLAI 253 (311)
Q Consensus 246 t~~~~l~~ 253 (311)
|+.|+++.
T Consensus 283 t~~ell~~ 290 (293)
T cd07843 283 SAEDALKH 290 (293)
T ss_pred CHHHHhcC
Confidence 99999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=245.90 Aligned_cols=210 Identities=29% Similarity=0.424 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++.+..++..++++||+++++|.+++.... ..+++..+..++.+++.+|++||+
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~-- 116 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS-- 116 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc--
Confidence 45678999999999999999999999999999999999999999999986543 458999999999999999999996
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
.+++|+||+|+||+++.++.++|+|||.+........ .....++..|++||.+.+...+.++|+||||+++|+|++|
T Consensus 117 ~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g 193 (253)
T cd05122 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193 (253)
T ss_pred CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC
Confidence 5599999999999999999999999999876543321 2345678899999999888889999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCC--chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||......... ..... ...... ...++..+.+++.+||..||++|||+.+++++
T Consensus 194 ~~p~~~~~~~~~~----------------~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 194 KPPYSELPPMKAL----------------FKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCCCCCchHHHH----------------HHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999764311100 00000 101111 12236789999999999999999999999853
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=252.72 Aligned_cols=211 Identities=23% Similarity=0.318 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.+++.++|+||+++++++..++..|+||||+++++|.+++... .+++..+..++.|++.+|+|||+.
T Consensus 60 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~- 135 (292)
T cd06657 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ- 135 (292)
T ss_pred HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4567889999999999999999999999999999999999999999987433 388999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++|
T Consensus 136 -givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg 212 (292)
T cd06657 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212 (292)
T ss_pred -CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 599999999999999999999999998865433221 12334678899999999888889999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||............ ....... ......++..+.+++.+||..||.+||++.+++.+
T Consensus 213 ~~p~~~~~~~~~~~~~-------------~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 213 EPPYFNEPPLKAMKMI-------------RDNLPPK--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCCCCCCCHHHHHHHH-------------HhhCCcc--cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 9999754321110000 0000000 01123456788999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=247.35 Aligned_cols=210 Identities=25% Similarity=0.369 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
....+.+|+++++.++|+||+++++++.+....|+||||+++++|.+++.+.. ...+++..++.++.+++.||++||+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~ 121 (256)
T cd08530 42 EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121 (256)
T ss_pred HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 34567889999999999999999999999999999999999999999986522 2458999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
. +++|+||+|.||+++.++.+||+|||++...... ......++..|++||.+.+..++.++|+||||+++|+|+
T Consensus 122 ~--~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~ 195 (256)
T cd08530 122 Q--KILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195 (256)
T ss_pred C--CcccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH
Confidence 5 5999999999999999999999999999765443 123346788999999998888999999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|+.||...+.. ..............+...+.++.+++.+||..+|++||++.+++..
T Consensus 196 ~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 196 TFAPPFEARSMQ-----------------DLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hCCCCCCCCCHH-----------------HHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 999999764321 1111111222223344678889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=254.48 Aligned_cols=214 Identities=27% Similarity=0.334 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+.+|+++++++ +|+||+++++.+..+...|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~ 124 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL 124 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456688999999999 69999999999999999999999999999999996553 488999999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC--CCCCCCceehhHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l 177 (311)
+++|+||+|+||+++.++.++|+|||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|
T Consensus 125 --~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~l 201 (290)
T cd05613 125 --GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201 (290)
T ss_pred --CeeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHH
Confidence 5999999999999999999999999998765332211 12235688899999998753 467899999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 252 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~ 252 (311)
++|..||........ .......+.. .....+..++..+.+++.+||..||++|| +++++++
T Consensus 202 l~g~~p~~~~~~~~~-------------~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 202 LTGASPFTVDGEKNS-------------QAEISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hcCCCCCCcCCcccc-------------HHHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 999999964321100 0111111111 11123455678899999999999999997 6777765
Q ss_pred H
Q 021507 253 I 253 (311)
Q Consensus 253 ~ 253 (311)
+
T Consensus 268 ~ 268 (290)
T cd05613 268 H 268 (290)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=257.04 Aligned_cols=213 Identities=14% Similarity=0.119 Sum_probs=157.5
Q ss_pred HHHHHHhcCCCCCccceEeEEEeCC----eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 27 TEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 27 ~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
.+...+..++|+||+++++.+.... ..+++++++.. ++.+.+.... ..++..+..++.|++.||+|||+. +
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~ 146 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH--G 146 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC--C
Confidence 3445566779999999998766443 34788898854 7777764432 367888999999999999999965 4
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-----ceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
++||||||+|||++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 147 iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el 226 (294)
T PHA02882 147 ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW 226 (294)
T ss_pred eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999999999999765322111 112234689999999999999999999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++|..||............. .......+... ......+++.+.+++..||..+|++||+++++++.+
T Consensus 227 ~~g~~P~~~~~~~~~~~~~~--------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 227 AGIKLPWKGFGHNGNLIHAA--------KCDFIKRLHEG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhCCCCCCccccchHHHHHh--------HHHHHHHhhhh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99999997653211110000 00011111100 011234578899999999999999999999998876
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=252.40 Aligned_cols=227 Identities=22% Similarity=0.245 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++||||+++++++.+++..|+||||+.+ +|.+++.......+++..+..++.||+.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-- 121 (294)
T PLN00009 45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121 (294)
T ss_pred hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC--
Confidence 35688999999999999999999999999999999999964 888888665555578889999999999999999965
Q ss_pred CeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 102 QVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|+||+++. ++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++
T Consensus 122 ~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t 199 (294)
T PLN00009 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199 (294)
T ss_pred CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 5999999999999985 45799999999976433211 12234568899999988664 57889999999999999999
Q ss_pred CCCccCCCccchhhh-hhh-hcccccc---chhhhhHh--hhcccCC----CCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 180 GRCAVDKTKVGIEQS-LVD-WAKPYLS---DKRKLFRI--MDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 180 g~~pf~~~~~~~~~~-~~~-~~~~~~~---~~~~~~~~--~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
|..||.......... ... ...+... ....+... ....... .....++..+.+++.+||+.+|++||++.
T Consensus 200 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ 279 (294)
T PLN00009 200 QKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR 279 (294)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHH
Confidence 999997643211110 000 0000000 00000000 0000000 01234567899999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++++
T Consensus 280 ~~l~~ 284 (294)
T PLN00009 280 AALEH 284 (294)
T ss_pred HHhcC
Confidence 99864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.34 Aligned_cols=208 Identities=25% Similarity=0.361 Sum_probs=167.8
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++.. .....+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-- 125 (260)
T cd08222 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-- 125 (260)
T ss_pred HHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc--
Confidence 466799999999999999999999999999999999999999998854 2234589999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||+|+||+++. +.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 126 ~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 126 RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred CccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 5999999999999975 5799999999876433221 123345788999999998888899999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||....... ..... ........+..++.++.++|.+||..||++||++.++++.
T Consensus 203 ~~~~~~~~~~----------------~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 203 HAFEGQNFLS----------------VVLRI-VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCccHHH----------------HHHHH-HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 9997533110 00011 1111222345678899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=244.27 Aligned_cols=209 Identities=29% Similarity=0.471 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++++.+++..+++|||+.+++|.+++... ..+++..++.++.+++.+|.+||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~- 118 (254)
T cd06627 42 ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ- 118 (254)
T ss_pred HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 4567899999999999999999999999999999999999999999998655 3489999999999999999999964
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+...+.++|+||||+++|+|++|
T Consensus 119 -~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g 195 (254)
T cd06627 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195 (254)
T ss_pred -CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC
Confidence 5999999999999999999999999999865443221 2335678899999999888888999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
..||...... ....... .......+..++..+.+++.+||..+|++||++.+++.
T Consensus 196 ~~p~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 196 NPPYYDLNPM----------------AALFRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCccHH----------------HHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 9999753310 0011111 11122345567889999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=293.81 Aligned_cols=245 Identities=31% Similarity=0.474 Sum_probs=177.5
Q ss_pred ChhHHHhHHHHHHh---h-hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCC
Q 021507 1 MFLFNFLHSHLELH---A-RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP 76 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (311)
+||.||.+.+.... + +..........+|++++++++|||||++++++.+.+..|+||||+++|+|.+++. .
T Consensus 702 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~ 776 (968)
T PLN00113 702 KKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----N 776 (968)
T ss_pred CCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----c
Confidence 47777776543211 1 1111112223467999999999999999999999999999999999999999984 2
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhC-CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccc
Q 021507 77 LSWAVRMKVAIGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 155 (311)
Q Consensus 77 ~~~~~~~~~~~~i~~~l~~lH~~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 155 (311)
+++..+..++.+++.||+|||.. ..+++||||||+||+++.++..++. ||....... .....++..|+|||+
T Consensus 777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~ 849 (968)
T PLN00113 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPET 849 (968)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCccc
Confidence 88999999999999999999954 3569999999999999998887775 555433211 122367899999999
Q ss_pred cccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC--CCCchHHHHHHHHHH
Q 021507 156 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLA 233 (311)
Q Consensus 156 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li 233 (311)
+.+..++.++|||||||++|||++|+.||+..... ......|....... ......++.... ...+.....++.+++
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 927 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLA 927 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHH
Confidence 99999999999999999999999999999643221 11122221111110 001111111111 122334566788999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.+||+.||++|||+.++++.|+++..
T Consensus 928 ~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 928 LHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999988754
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=252.12 Aligned_cols=227 Identities=23% Similarity=0.253 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++||||+++++++.+++..|++|||+. ++|.+++.......+++..++.++.|++.||+|||+.
T Consensus 42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-- 118 (283)
T cd07835 42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-- 118 (283)
T ss_pred hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3567889999999999999999999999999999999995 5999998665544689999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.++|+||||+++|+|++|
T Consensus 119 ~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC
Confidence 5999999999999999999999999999764332211 2223568899999988664 568899999999999999999
Q ss_pred CCccCCCccchhh-hhhhhccccccch-------hhhhHhhhc---ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 181 RCAVDKTKVGIEQ-SLVDWAKPYLSDK-------RKLFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 181 ~~pf~~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
..||......... ............. ......... .........++..+.+++.+||+.||.+|||+++
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 9999764321110 0000000000000 000000000 0000112345678999999999999999999999
Q ss_pred HHHH
Q 021507 250 VLAI 253 (311)
Q Consensus 250 ~l~~ 253 (311)
+++.
T Consensus 277 il~~ 280 (283)
T cd07835 277 ALQH 280 (283)
T ss_pred HhcC
Confidence 9753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=262.69 Aligned_cols=204 Identities=26% Similarity=0.312 Sum_probs=167.6
Q ss_pred HHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 23 NWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 23 ~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+-.+|+.++... +||||+++++++.++.+.|+|||.+.|+-|.+.+.... .....+..|+.+|+.++.|||++
T Consensus 360 ~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~-- 434 (612)
T KOG0603|consen 360 DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ-- 434 (612)
T ss_pred cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc--
Confidence 3466788777777 89999999999999999999999999998888875443 33367778999999999999975
Q ss_pred CeeecCCCCCceEe-CCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILL-DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
|+|||||||+|||+ +..|+++|+|||.++..... ....+-|..|.|||++....++.++|+||||++||+|++|
T Consensus 435 gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G 509 (612)
T KOG0603|consen 435 GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTG 509 (612)
T ss_pred CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhC
Confidence 59999999999999 68999999999999875443 2234568899999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
+.||.....+ ..+........+...++++.++|+..||+.||.+|+++.+++.+-.
T Consensus 510 ~tp~~~~P~~-------------------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 510 RTLFAAHPAG-------------------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred CCccccCCch-------------------HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 9999875432 1111111222233778999999999999999999999999987643
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=250.28 Aligned_cols=210 Identities=29% Similarity=0.368 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+++++.++|+|++++++++......|+||||+. |+|.+++.... ..+++..+..++.+++.||.|||+.
T Consensus 58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~- 134 (308)
T cd06634 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH- 134 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 34567889999999999999999999999999999999996 58888775433 3489999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc---cCCCCCCCceehhHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l 177 (311)
+++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...++.++|||||||++|+|
T Consensus 135 -~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred -CcccCCCCHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHH
Confidence 599999999999999999999999999875432 22345788999999874 34578899999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
++|..||....... .................++..+.++|.+||..+|++||++.++++....
T Consensus 208 ~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 208 AERKPPLFNMNAMS----------------ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred HcCCCCCccccHHH----------------HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 99999986532110 0011111111111233567889999999999999999999999977543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=257.31 Aligned_cols=223 Identities=22% Similarity=0.254 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
..+.+.+|+.++++++|+||+++++++... ...|+||||+.+ +|.+.+... ++...+..++.|++.||+
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~ 132 (353)
T cd07850 58 HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIK 132 (353)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHH
Confidence 345577899999999999999999988643 357999999965 888887432 888999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 174 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 174 (311)
|||+. +++|+||||+||+++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++
T Consensus 133 ~LH~~--gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 207 (353)
T cd07850 133 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (353)
T ss_pred HHHhC--CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHH
Confidence 99965 599999999999999999999999999986543221 2234678899999999999999999999999999
Q ss_pred HHHHhCCCccCCCccchhhh-hhhh-cccccc---ch----------------hhhhHhhhc----ccCCCCchHHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIEQS-LVDW-AKPYLS---DK----------------RKLFRIMDT----KLGGQYPQKAAHTA 229 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~-~~~~-~~~~~~---~~----------------~~~~~~~~~----~~~~~~~~~~~~~l 229 (311)
|+|++|..||...+...... .... ..+... .. ......... ......+...+..+
T Consensus 208 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
T cd07850 208 GEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQA 287 (353)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHH
Confidence 99999999997654311110 0000 000000 00 000000000 00000122456778
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.++|.+||..||++|||+.+++.+
T Consensus 288 ~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 288 RDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=265.09 Aligned_cols=182 Identities=27% Similarity=0.342 Sum_probs=150.6
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~L 65 (311)
|||.||..++-+.. .....+-++..-+|+++|++|+|+|||+++++=++.. ...+|||||.||||
T Consensus 25 a~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL 104 (732)
T KOG4250|consen 25 AFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSL 104 (732)
T ss_pred ccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcH
Confidence 68888888865532 1112334566778999999999999999998765443 35799999999999
Q ss_pred HHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC--CCC--cEEEecccccccCCCCCCcce
Q 021507 66 ENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEF--NAKLSDFGLAKAGPTGDRTHV 140 (311)
Q Consensus 66 ~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~--~~~--~~kl~Dfg~~~~~~~~~~~~~ 140 (311)
...+.+- +..++++.+++.++.+++.||.|||. +||+||||||.||++. .+| ..||+|||.|+...++. .
T Consensus 105 ~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~ 179 (732)
T KOG4250|consen 105 RKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---L 179 (732)
T ss_pred HHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---e
Confidence 9999542 33569999999999999999999994 5699999999999983 333 47999999999876554 4
Q ss_pred eccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCC
Q 021507 141 STQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKT 187 (311)
Q Consensus 141 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~ 187 (311)
....+||..|.+||.+.. ..|+..+|.|||||++|+++||..||...
T Consensus 180 ~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 180 FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 667899999999999985 78999999999999999999999999654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=247.32 Aligned_cols=238 Identities=21% Similarity=0.283 Sum_probs=186.2
Q ss_pred ChhHHHhHHHHH---------------HhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLE---------------LHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~ 64 (311)
||+.||-+-++. |.-.+...+.+-..+|.+|.+.|+||.||++|++|.- .+.+|-|+|||+|.+
T Consensus 475 GFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGND 554 (775)
T KOG1151|consen 475 GFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGND 554 (775)
T ss_pred cHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCc
Confidence 799999887765 2234445566677899999999999999999999974 456789999999999
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCcc--
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTH-- 139 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~-- 139 (311)
|.-+|++.. .+++.++..|+.||+.||.||......|||-||||.|||+-. -|.+||+|||+++.+.+.....
T Consensus 555 LDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vd 632 (775)
T KOG1151|consen 555 LDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVD 632 (775)
T ss_pred hhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCccc
Confidence 999997664 399999999999999999999988889999999999999944 4679999999999876654332
Q ss_pred ---eeccccccccccCccccccC----CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHh
Q 021507 140 ---VSTQVMGTHGYAAPEYVATG----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 212 (311)
Q Consensus 140 ---~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (311)
......||.+|++||++.-+ +++.+.||||.|+|+|.++.|+-||+...... .+. ....+.+.
T Consensus 633 GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dIL--------qeNTIlkA 702 (775)
T KOG1151|consen 633 GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DIL--------QENTILKA 702 (775)
T ss_pred ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHH--------hhhchhcc
Confidence 23346799999999987543 57889999999999999999999998643211 000 00011111
Q ss_pred hhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 213 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
........+.++.+..++|++||.+.-++|..+.++..
T Consensus 703 --tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 703 --TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111223568899999999999999999999888764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=234.96 Aligned_cols=250 Identities=24% Similarity=0.274 Sum_probs=182.6
Q ss_pred hhHHHhHHHHHHhhhhHHHH----------HHHHHHHHHHHhcCCCCCccceEeEEEe--------CCeeEEEEecCCCC
Q 021507 2 FLFNFLHSHLELHARSLLLI----------TNWFQTEVNYLGQLHHPNLVKLIGYCLE--------GENRLLVYEFMPKG 63 (311)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------~~~~~lv~e~~~~~ 63 (311)
||.||.+++-+...+..... -....+|+++|..|+|+|++.++++|.. ...+|+||++|+.
T Consensus 30 fgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh- 108 (376)
T KOG0669|consen 30 FGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH- 108 (376)
T ss_pred HHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-
Confidence 78899999887654421111 1124689999999999999999887753 2347999999987
Q ss_pred ChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce--e
Q 021507 64 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV--S 141 (311)
Q Consensus 64 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~--~ 141 (311)
+|..++.+.. ..++..++.++++++..||.|+|+.+ |+|||+|++|+||+.+|.+||+|||+++.+........ -
T Consensus 109 DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpry 185 (376)
T KOG0669|consen 109 DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRY 185 (376)
T ss_pred hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCc
Confidence 9999885443 45999999999999999999999765 99999999999999999999999999976543322211 1
Q ss_pred ccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhh--------ccccccchhhhhHh
Q 021507 142 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--------AKPYLSDKRKLFRI 212 (311)
Q Consensus 142 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 212 (311)
+..+-|.+|++||.+.|. .|+.+.|||+-|||+.||+++.+-+.+.........+.. ..|... +-.+.+.
T Consensus 186 tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d-~lpL~~s 264 (376)
T KOG0669|consen 186 TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD-NLPLYQS 264 (376)
T ss_pred ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc-cchHHHh
Confidence 234569999999998886 689999999999999999999999988766544433321 011111 1111111
Q ss_pred hhcc-cCC---------CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 213 MDTK-LGG---------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 213 ~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
++.. +.. ..|..-.++..+|+.++|..||.+|+++++++++-.-
T Consensus 265 ie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 265 IELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred ccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 1000 000 0122234578899999999999999999999976543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=249.43 Aligned_cols=225 Identities=23% Similarity=0.251 Sum_probs=163.2
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
..+.+|+.+++.++|+||+++++++..++..|+||||+. ++|.+++.... ..+++..+..++.|++.||+|||+. +
T Consensus 48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~--~ 123 (291)
T cd07870 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ--H 123 (291)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC--C
Confidence 357789999999999999999999999999999999996 58887775433 3478888999999999999999965 5
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~ 181 (311)
++|+||||+||+++.++.++|+|||+++....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 124 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 201 (291)
T cd07870 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201 (291)
T ss_pred cccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875432211 12234568899999998764 5788999999999999999999
Q ss_pred CccCCCccchhhhhhhh---ccccccchhhhhH------h-hhcccCCCC-----chHHHHHHHHHHHhcccCCCCCCCC
Q 021507 182 CAVDKTKVGIEQSLVDW---AKPYLSDKRKLFR------I-MDTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~------~-~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
.||.............+ ..+.......... . ......... ....+..+.+++.+||..||.+|||
T Consensus 202 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t 281 (291)
T cd07870 202 PAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281 (291)
T ss_pred CCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC
Confidence 99976543211100000 0000000000000 0 000000000 0012567889999999999999999
Q ss_pred HHHHHHH
Q 021507 247 MSEVLAI 253 (311)
Q Consensus 247 ~~~~l~~ 253 (311)
+.+++.+
T Consensus 282 ~~~~l~h 288 (291)
T cd07870 282 AQDALLH 288 (291)
T ss_pred HHHHhcC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=249.23 Aligned_cols=218 Identities=26% Similarity=0.330 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
...+.+.+|++++.++ +||||+++++.+..+...|+||||+.+++|.+++.... .+++..+..++.|++.+|.|||+
T Consensus 46 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~ 123 (288)
T cd05583 46 KTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQ 123 (288)
T ss_pred hHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999 69999999999999999999999999999999986543 48899999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC--CCCCCceehhHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLE 176 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~ 176 (311)
. +++|+||+|.||+++.++.++|+|||++......... ......++..|+|||.+.+.. .+.++|+||||+++|+
T Consensus 124 ~--~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~e 200 (288)
T cd05583 124 L--GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200 (288)
T ss_pred C--CeeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHH
Confidence 4 5999999999999999999999999998764333211 122345788999999987654 7889999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|++|..||........ .....+.... .....+..++..+.+++.+||..||++|||+.++.+.|+.
T Consensus 201 l~tg~~p~~~~~~~~~-------------~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 201 LLTGASPFTVDGEQNS-------------QSEISRRILK-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHhCCCCcccCcccch-------------HHHHHHHHHc-cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 9999999964321100 0001111111 1123345567889999999999999999998877666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=263.83 Aligned_cols=227 Identities=25% Similarity=0.308 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
..+.+.+|+.++++++|+||+++++++... ...|+|+||+.+ +|.+++.. ..+++..+..++.|++.||++
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~ 121 (336)
T cd07849 46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKY 121 (336)
T ss_pred hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999987644 357999999965 88887743 348999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCcccccc-CCCCCCCceehhHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVV 173 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~i 173 (311)
||+. +++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||||+
T Consensus 122 LH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvi 199 (336)
T cd07849 122 IHSA--NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCI 199 (336)
T ss_pred HHhC--CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHH
Confidence 9965 4999999999999999999999999998764332211 11223567899999998755 468889999999999
Q ss_pred HHHHHhCCCccCCCccchhhhhh-hhc-cccccchhh--------hhHhhhcccCCC---CchHHHHHHHHHHHhcccCC
Q 021507 174 LLELLSGRCAVDKTKVGIEQSLV-DWA-KPYLSDKRK--------LFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~~-~~~-~~~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~ 240 (311)
+|+|++|+.||.+.+........ ... .+....... ............ ....++.++.+++.+||+.|
T Consensus 200 l~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 279 (336)
T cd07849 200 LAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN 279 (336)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCC
Confidence 99999999999765432111100 000 000000000 000000000000 01234678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|.+|||+.+++++
T Consensus 280 P~~Rpt~~e~l~h 292 (336)
T cd07849 280 PHKRITVEEALAH 292 (336)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999976
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=246.00 Aligned_cols=230 Identities=19% Similarity=0.224 Sum_probs=173.8
Q ss_pred hhHHHHHHHHHHHHHHHhcCC--CC----CccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHH
Q 021507 16 RSLLLITNWFQTEVNYLGQLH--HP----NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 89 (311)
Q Consensus 16 ~~~~~~~~~~~~E~~~l~~l~--hp----nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i 89 (311)
+.+..+++..+-|+++|+++. .| .+|++.+||...++.|+|+|.+ |-|+.+++..++..+++...+..++.|+
T Consensus 123 k~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL 201 (415)
T KOG0671|consen 123 KNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQL 201 (415)
T ss_pred HHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHH
Confidence 345556777778999999993 22 4788899999999999999999 6699999999888999999999999999
Q ss_pred HHHHHHhhhCCCCeeecCCCCCceEeCC--------------------CCcEEEecccccccCCCCCCcceecccccccc
Q 021507 90 AKGLTFLHDAESQVIYRDFKASNILLDA--------------------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 90 ~~~l~~lH~~~~~ivH~dlkp~Nil~~~--------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
+++++|||+.+ ++|-||||+|||+.. +-.|+|+|||.|+..... ....+.|..
T Consensus 202 ~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRH 274 (415)
T KOG0671|consen 202 LESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRH 274 (415)
T ss_pred HHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccc
Confidence 99999999654 999999999999832 234899999999864332 345678999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-hhhhccccccch--hh-hhHhhhcc---------
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDK--RK-LFRIMDTK--------- 216 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~--~~-~~~~~~~~--------- 216 (311)
|+|||++.+.+++.++||||+||||+|+++|...|...+...... ......|..... .. -.+....+
T Consensus 275 YRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~ 354 (415)
T KOG0671|consen 275 YRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSS 354 (415)
T ss_pred cCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccc
Confidence 999999999999999999999999999999999998766322111 111111111100 00 00000000
Q ss_pred -------cCC--------CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 217 -------LGG--------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 217 -------~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
... ........++.+||.+||..||.+|+|+.|++.+
T Consensus 355 ~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 355 KGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred cccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 000 0112345579999999999999999999999875
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=252.78 Aligned_cols=229 Identities=21% Similarity=0.263 Sum_probs=166.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHh
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
.+.+.+|+.++++++||||+++++++.+. ...|+||||+.+ +|.+++.... ...+++..++.++.|++.||+||
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 124 (316)
T cd07842 46 SQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124 (316)
T ss_pred cHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999988 789999999975 7877764322 23589999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCC----CCcEEEecccccccCCCCCC-cceeccccccccccCccccccC-CCCCCCceehh
Q 021507 97 HDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSF 170 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~sl 170 (311)
|+.+ ++|+||||+||+++. ++.+||+|||++........ ........++..|+|||++.+. .++.++|||||
T Consensus 125 H~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 202 (316)
T cd07842 125 HSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI 202 (316)
T ss_pred HhCC--EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence 9654 999999999999999 89999999999986543322 1112334678899999988764 57889999999
Q ss_pred HHHHHHHHhCCCccCCCccchhh-------h---hhhhcccccc-------chhhhhHhhhcccCCCCc-----------
Q 021507 171 GVVLLELLSGRCAVDKTKVGIEQ-------S---LVDWAKPYLS-------DKRKLFRIMDTKLGGQYP----------- 222 (311)
Q Consensus 171 G~il~~l~~g~~pf~~~~~~~~~-------~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~----------- 222 (311)
||++|+|++|..||......... . .......... .................+
T Consensus 203 G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (316)
T cd07842 203 GCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKH 282 (316)
T ss_pred HHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhc
Confidence 99999999999999765432200 0 0000000000 000000000000000111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 223 QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...+..+.+++.+||..||++|||+.+++++
T Consensus 283 ~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 283 KKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred cCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1345678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=246.76 Aligned_cols=218 Identities=24% Similarity=0.290 Sum_probs=162.3
Q ss_pred HHHHHHHHhcCC-CCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 25 FQTEVNYLGQLH-HPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 25 ~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
..+|+.++.++. |+||+++++++.++ +..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~-- 119 (282)
T cd07831 44 NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN-- 119 (282)
T ss_pred HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 347899999984 99999999999987 889999999975 8888886543 3589999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||+|+||+++. +.+||+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|
T Consensus 120 ~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~ 195 (282)
T cd07831 120 GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL 195 (282)
T ss_pred CceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcC
Confidence 5999999999999999 9999999999976533221 123457889999997654 4578899999999999999999
Q ss_pred CCccCCCccchhhhhh-hhccccccchhhhhHhhhcc--cCC-----------CCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 181 RCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRIMDTK--LGG-----------QYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
..||.+.+........ ...... ...+....... ... .....++..+.++|.+||..||++||+
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 272 (282)
T cd07831 196 FPLFPGTNELDQIAKIHDVLGTP---DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272 (282)
T ss_pred CcCCCCCCHHHHHHHHHHHcCCC---CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC
Confidence 9999765432111000 000000 00000000000 000 011245789999999999999999999
Q ss_pred HHHHHHH
Q 021507 247 MSEVLAI 253 (311)
Q Consensus 247 ~~~~l~~ 253 (311)
+++++..
T Consensus 273 ~~~~l~~ 279 (282)
T cd07831 273 AKQALRH 279 (282)
T ss_pred HHHHhhC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=251.13 Aligned_cols=224 Identities=25% Similarity=0.270 Sum_probs=164.0
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+|+.++++++|+||+++++++.+. +..|+||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.+
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~- 128 (309)
T cd07845 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF- 128 (309)
T ss_pred hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 456899999999999999999998765 468999999975 8988886533 45899999999999999999999654
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g 180 (311)
++|+||||+||+++.++.+||+|||++......... .....++..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 129 -i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 205 (309)
T cd07845 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205 (309)
T ss_pred -eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999865433211 222345778999999866 4578899999999999999999
Q ss_pred CCccCCCccchhhhhh-hhccccccchhhhhHhhh---------cccC--CCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 181 RCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRIMD---------TKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
..||...+........ .................. .... .......+..+.++|.+||..||++|||++
T Consensus 206 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 285 (309)
T cd07845 206 KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE 285 (309)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHH
Confidence 9999765432211111 100000000000000000 0000 000112467889999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++.+
T Consensus 286 ~il~h 290 (309)
T cd07845 286 EALES 290 (309)
T ss_pred HHhcC
Confidence 99865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=242.74 Aligned_cols=208 Identities=31% Similarity=0.400 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++|+||+++++.+..+...|+||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~-- 111 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHS-- 111 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--
Confidence 44578899999999999999999999999999999999999999999996553 48999999999999999999996
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
++++|+||+|+||+++.++.++|+|||.+....... .......++..|++||...+...+.++|+||||+++|++++|
T Consensus 112 ~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g 189 (250)
T cd05123 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189 (250)
T ss_pred CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC
Confidence 459999999999999999999999999987643321 113345678899999999888889999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCH---HHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM---SEVLA 252 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~---~~~l~ 252 (311)
..||...... .....+.. .....+...+..+.+++.+||..||++||++ +++++
T Consensus 190 ~~p~~~~~~~-----------------~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 190 KPPFYAEDRK-----------------EIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCCCCCHH-----------------HHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 9999764320 00111111 1223455568889999999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=248.66 Aligned_cols=226 Identities=21% Similarity=0.217 Sum_probs=163.1
Q ss_pred HHHHHHHHHHhcCC-CCCccceEeEEEeCCe-----eEEEEecCCCCChHHHhhhcC---CCCCCHHHHHHHHHHHHHHH
Q 021507 23 NWFQTEVNYLGQLH-HPNLVKLIGYCLEGEN-----RLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGL 93 (311)
Q Consensus 23 ~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l 93 (311)
+.+.+|+.+++.+. |+||+++++++...+. .|+||||+.+ +|.+++.... ...+++..++.++.|++.||
T Consensus 45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L 123 (295)
T cd07837 45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123 (295)
T ss_pred hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHH
Confidence 46788999999995 6999999999987665 7999999986 8988885432 24589999999999999999
Q ss_pred HHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhH
Q 021507 94 TFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFG 171 (311)
Q Consensus 94 ~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG 171 (311)
.|||+. +++|+||+|+||+++. ++.+||+|||++......... .....++..|+|||++.+ ..++.++|+||||
T Consensus 124 ~~LH~~--~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG 199 (295)
T cd07837 124 AHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199 (295)
T ss_pred HHHHHC--CeeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHH
Confidence 999965 5999999999999998 889999999998754332111 122356788999998865 4578899999999
Q ss_pred HHHHHHHhCCCccCCCccchhhh-hhhhc-cccccc---hhhhhHhhhcc-----cCCCCchHHHHHHHHHHHhcccCCC
Q 021507 172 VVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSD---KRKLFRIMDTK-----LGGQYPQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 172 ~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p 241 (311)
+++|+|++|..||.+........ ..... .+.... ........... ........++..+.++|.+||..||
T Consensus 200 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 279 (295)
T cd07837 200 CIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP 279 (295)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCCh
Confidence 99999999999997643211110 00000 000000 00000000000 0000112467789999999999999
Q ss_pred CCCCCHHHHHHH
Q 021507 242 KLRPRMSEVLAI 253 (311)
Q Consensus 242 ~~Rpt~~~~l~~ 253 (311)
.+||++.+++.+
T Consensus 280 ~~R~~~~eil~~ 291 (295)
T cd07837 280 AKRISAKAALTH 291 (295)
T ss_pred hhcCCHHHHhcC
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.51 Aligned_cols=227 Identities=24% Similarity=0.308 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.+.+|++++++++|+||+++++++.+.+..++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~- 119 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34577899999999999999999999999999999999985 8998886543 24589999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||||+||++++++.++|+|||++........ ......++..|++||++.+. .++.++|+||||+++|+|++
T Consensus 120 -~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred -CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 499999999999999999999999999975433211 12234568899999988664 56889999999999999999
Q ss_pred CCCccCCCccchhhh-hhh-hccccccchhhhhH--hhhcccC-------CCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 180 GRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKLFR--IMDTKLG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 180 g~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
|..||...+...... ... ...+.......+.. ....... ......++..+.+++.+||+.||.+||++.
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 276 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAH 276 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHH
Confidence 999997654321110 000 00000000000000 0000000 001123567889999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
++++.
T Consensus 277 ~~l~~ 281 (284)
T cd07836 277 DALQH 281 (284)
T ss_pred HHhcC
Confidence 99753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=247.77 Aligned_cols=226 Identities=27% Similarity=0.314 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++|+||+++++++..++..++|+||+.+ +|.+++.... ..+++..+..++.+++.||.|||+.
T Consensus 42 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~-- 117 (283)
T cd05118 42 PKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH-- 117 (283)
T ss_pred HHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45688899999999999999999999999999999999976 8988886543 4589999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|
T Consensus 118 ~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 49999999999999999999999999997654432 112234578889999998776 788999999999999999999
Q ss_pred CCccCCCccchhhhhh-h-hccccccchhhhhH---h----hhcccC---CCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 181 RCAVDKTKVGIEQSLV-D-WAKPYLSDKRKLFR---I----MDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~-~-~~~~~~~~~~~~~~---~----~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
+.||...+........ . ...+.......... . ...... ......++.++.++|.+||..||.+||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 275 (283)
T cd05118 196 RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAE 275 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHH
Confidence 9999765431111100 0 00000000000000 0 000000 011234678899999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++..
T Consensus 276 ~ll~~ 280 (283)
T cd05118 276 QALAH 280 (283)
T ss_pred HHhhC
Confidence 99864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=250.38 Aligned_cols=227 Identities=24% Similarity=0.289 Sum_probs=162.4
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCC--------eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGE--------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
..+.+|++++++++||||+++++++...+ ..|+||||+.+ +|.+++.... ..+++..++.++.|++.||+
T Consensus 56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~ 133 (310)
T cd07865 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLY 133 (310)
T ss_pred hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999987553 35999999965 8888885543 35899999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceeccccccccccCccccccC-CCCCCCceehhH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFG 171 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG 171 (311)
|||+. +++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+. .++.++||||||
T Consensus 134 ~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 134 YIHRN--KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred HHHHC--CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 99965 5999999999999999999999999999765332211 112234578889999988665 468899999999
Q ss_pred HHHHHHHhCCCccCCCccchhhhhhhhcc-ccc----cch--hhhhHhhh--cc----cCCC-CchHHHHHHHHHHHhcc
Q 021507 172 VVLLELLSGRCAVDKTKVGIEQSLVDWAK-PYL----SDK--RKLFRIMD--TK----LGGQ-YPQKAAHTAATLALQCL 237 (311)
Q Consensus 172 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~----~~~--~~~~~~~~--~~----~~~~-~~~~~~~~l~~li~~~l 237 (311)
+++|+|++|..||...+............ ... ... ........ .. .... .+...+..+.++|.+||
T Consensus 212 ~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l 291 (310)
T cd07865 212 CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291 (310)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHh
Confidence 99999999999997654322111111000 000 000 00000000 00 0000 01113456789999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 021507 238 NNEPKLRPRMSEVLAI 253 (311)
Q Consensus 238 ~~~p~~Rpt~~~~l~~ 253 (311)
..||.+|||+++++++
T Consensus 292 ~~~P~~R~t~~e~l~h 307 (310)
T cd07865 292 VLDPAKRIDADTALNH 307 (310)
T ss_pred cCChhhccCHHHHhcC
Confidence 9999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=251.86 Aligned_cols=225 Identities=28% Similarity=0.367 Sum_probs=164.8
Q ss_pred HHHHHHHHHHhcC-CCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 23 NWFQTEVNYLGQL-HHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 23 ~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+|+.++.++ +||||+++++++... ...|+||||+.+ +|.+++... .+++..+..++.|++.||+|||+.
T Consensus 51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~ 126 (337)
T cd07852 51 QRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG 126 (337)
T ss_pred hhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567899999999 999999999998653 367999999975 999988554 488899999999999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc---ceeccccccccccCcccccc-CCCCCCCceehhHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ 175 (311)
+++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 127 --~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~ 204 (337)
T cd07852 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILG 204 (337)
T ss_pred --CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHH
Confidence 5999999999999999999999999999765433221 12234568889999998765 45788999999999999
Q ss_pred HHHhCCCccCCCccchhhhh-hhhccc-cccch--------hhhhHhhhccc---CCCCchHHHHHHHHHHHhcccCCCC
Q 021507 176 ELLSGRCAVDKTKVGIEQSL-VDWAKP-YLSDK--------RKLFRIMDTKL---GGQYPQKAAHTAATLALQCLNNEPK 242 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~-~~~~~~-~~~~~--------~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~ 242 (311)
+|++|+.||........... ...... ..... ........... .......++.++.+++.+||+.||+
T Consensus 205 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 284 (337)
T cd07852 205 EMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN 284 (337)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcc
Confidence 99999999975432211110 000000 00000 00000000000 0011123578899999999999999
Q ss_pred CCCCHHHHHHH
Q 021507 243 LRPRMSEVLAI 253 (311)
Q Consensus 243 ~Rpt~~~~l~~ 253 (311)
+|||+.++++.
T Consensus 285 ~Rps~~~il~~ 295 (337)
T cd07852 285 KRLTAEEALEH 295 (337)
T ss_pred cccCHHHHhhC
Confidence 99999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=224.81 Aligned_cols=246 Identities=24% Similarity=0.272 Sum_probs=182.9
Q ss_pred hhHHHhHHHHHHh---hh-------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 2 FLFNFLHSHLELH---AR-------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 2 ~~~~~~~~~~~~~---~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
|||||-++.-+.+ +. ..+-+--...+|+-+|+.++|.|||+++++...+..+-+|+|||. .+|..+...
T Consensus 15 ygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfds 93 (292)
T KOG0662|consen 15 YGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS 93 (292)
T ss_pred ceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHh
Confidence 6788877766644 11 111223347889999999999999999999999999999999996 499998865
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
-+. .++.+.+..++.|++.||.|+|+++ +.||||||+|.+|+.+|.+|++|||+++.++.... .-...+-|.+|+
T Consensus 94 lng-~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvr--cysaevvtlwyr 168 (292)
T KOG0662|consen 94 LNG-DLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSAEVVTLWYR 168 (292)
T ss_pred cCC-cCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeeceeeeeecc
Confidence 443 4899999999999999999999866 99999999999999999999999999998655432 233446799999
Q ss_pred CccccccCC-CCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhh--hhccccccchhhhhHhhhcccCCCCc-----
Q 021507 152 APEYVATGR-LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV--DWAKPYLSDKRKLFRIMDTKLGGQYP----- 222 (311)
Q Consensus 152 aPE~~~~~~-~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~----- 222 (311)
+|.++.|.+ |+.+.|+||-|||+.|+.. |++.|.+.+...+...+ ....+..+....+.+.-+.+.-..++
T Consensus 169 ppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattsw 248 (292)
T KOG0662|consen 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSW 248 (292)
T ss_pred CcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchH
Confidence 999998875 7889999999999999988 77778776654322211 11111111111111111111111111
Q ss_pred ----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 223 ----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 223 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.....-++++.+.|.-+|.+|.++++.+++
T Consensus 249 sqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 249 SQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2345567899999999999999999998754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=247.19 Aligned_cols=210 Identities=27% Similarity=0.416 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.+.+|++++++++ |+||+++++++..++..++|||++.+++|.+++.+.. .+++..++.++.|++.||.+||+.
T Consensus 45 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~- 121 (280)
T cd05581 45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK- 121 (280)
T ss_pred HHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 466889999999998 9999999999999999999999999999999996654 499999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc------------------ceeccccccccccCccccccCCCC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------------------HVSTQVMGTHGYAAPEYVATGRLT 162 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~ 162 (311)
+++|+||+|+||+++.++.++|+|||++......... .......++..|+|||+..+..++
T Consensus 122 -~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~ 200 (280)
T cd05581 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG 200 (280)
T ss_pred -CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC
Confidence 4999999999999999999999999998765432211 112234578899999999888899
Q ss_pred CCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCC
Q 021507 163 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 242 (311)
Q Consensus 163 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 242 (311)
.++|+||||+++|++++|..||....... ...... ......+..++..+.+++.+||..||+
T Consensus 201 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~ 262 (280)
T cd05581 201 KSSDLWALGCIIYQMLTGKPPFRGSNEYL----------------TFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQ 262 (280)
T ss_pred hhhhHHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHh
Confidence 99999999999999999999998653210 001111 122234556688899999999999999
Q ss_pred CCCCH----HHHHHH
Q 021507 243 LRPRM----SEVLAI 253 (311)
Q Consensus 243 ~Rpt~----~~~l~~ 253 (311)
+||++ ++++++
T Consensus 263 ~R~~~~~~~~~ll~~ 277 (280)
T cd05581 263 DRLGVNEGYDELKAH 277 (280)
T ss_pred hCCCcccCHHHHhcC
Confidence 99999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=271.92 Aligned_cols=232 Identities=24% Similarity=0.256 Sum_probs=185.6
Q ss_pred ChhHHHhHHHHHH---hhhhHHH--------HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLEL---HARSLLL--------ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~---~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
|||.|.+.+|... -+.+... -.-.|+.|-.+|-.-+.+-|+.++..|.++.++|+||||++||+|..++
T Consensus 87 aFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLl 166 (1317)
T KOG0612|consen 87 AFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLL 166 (1317)
T ss_pred ccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHH
Confidence 6888888777432 2333322 1335888999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.. .+++..+..++..|+.||.-||+.| +|||||||+|||++..|++||+|||.+-.+...+.. .....+|||-
T Consensus 167 Sk~~--~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPD 241 (1317)
T KOG0612|consen 167 SKFD--RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPD 241 (1317)
T ss_pred hhcC--CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCC
Confidence 6655 5999999999999999999999765 999999999999999999999999999877654433 3556789999
Q ss_pred ccCcccccc-----CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc--
Q 021507 150 YAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-- 222 (311)
Q Consensus 150 y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (311)
|++||++.. +.|+..+|.||+|+++|||+.|..||-....-. ...+++.-+-...+|
T Consensus 242 YISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve----------------TY~KIm~hk~~l~FP~~ 305 (1317)
T KOG0612|consen 242 YISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE----------------TYGKIMNHKESLSFPDE 305 (1317)
T ss_pred ccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH----------------HHHHHhchhhhcCCCcc
Confidence 999999853 568899999999999999999999997643211 112233332222344
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCC---HHHHHHHH
Q 021507 223 QKAAHTAATLALQCLNNEPKLRPR---MSEVLAIL 254 (311)
Q Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt---~~~~l~~l 254 (311)
..++.++.+||.+.+. +|+.|.. ++++..+.
T Consensus 306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 4589999999998775 5888887 99988753
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=254.57 Aligned_cols=229 Identities=22% Similarity=0.307 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
..+.+.+|+.++++++||||+++++++.. ....|+||||+. ++|.+++.... .+++..+..++.|++.||+||
T Consensus 47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~L 123 (334)
T cd07855 47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYI 123 (334)
T ss_pred chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999998763 356799999996 59999885543 389999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceeccccccccccCcccccc-CCCCCCCceehhHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVV 173 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~i 173 (311)
|+. +++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||||+
T Consensus 124 H~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 201 (334)
T cd07855 124 HSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201 (334)
T ss_pred HHC--CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHH
Confidence 965 5999999999999999999999999999764332211 11234568889999998866 468899999999999
Q ss_pred HHHHHhCCCccCCCccchhhhhhh--hccccccc-----hhhh---hHhhhcccCC---CCchHHHHHHHHHHHhcccCC
Q 021507 174 LLELLSGRCAVDKTKVGIEQSLVD--WAKPYLSD-----KRKL---FRIMDTKLGG---QYPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~-----~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~ 240 (311)
+|+|++|+.||...+......... ...+.... .... .......... ......+..+.++|.+||+.+
T Consensus 202 l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 281 (334)
T cd07855 202 FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD 281 (334)
T ss_pred HHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCC
Confidence 999999999997654321111100 00000000 0000 0000000000 011345788999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021507 241 PKLRPRMSEVLAIL 254 (311)
Q Consensus 241 p~~Rpt~~~~l~~l 254 (311)
|.+||++.+++.+.
T Consensus 282 P~~Rpt~~~~l~~~ 295 (334)
T cd07855 282 PEERITVEQALQHP 295 (334)
T ss_pred hhhCcCHHHHHhCh
Confidence 99999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=265.34 Aligned_cols=219 Identities=26% Similarity=0.425 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC------C--------CCCCHHHHHH
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------P--------QPLSWAVRMK 84 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~--------~~~~~~~~~~ 84 (311)
...+.+..|+++|+.+ +|+||+.+.+.+...+..++|+||+..|+|.++++... . ..++....+.
T Consensus 343 ~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLls 422 (609)
T KOG0200|consen 343 SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLS 422 (609)
T ss_pred HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHH
Confidence 4567899999999999 69999999999999999999999999999999996654 0 1388999999
Q ss_pred HHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccc--ccccccCccccccCCCC
Q 021507 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM--GTHGYAAPEYVATGRLT 162 (311)
Q Consensus 85 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~ 162 (311)
++.||+.|++||++.. +|||||-..|||++++..+||+|||+++........... ... -...|||||.+....|+
T Consensus 423 fa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft 499 (609)
T KOG0200|consen 423 FAYQIANGMEYLASVP--CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFT 499 (609)
T ss_pred HHHHHHHHHHHHhhCC--ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCccc
Confidence 9999999999999755 999999999999999999999999999865444333212 122 23459999999999999
Q ss_pred CCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCC
Q 021507 163 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 163 ~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 241 (311)
.+|||||+|+++||+++ |..||.+.. ....+.+.+....+...|..++.++.++|+.||+.+|
T Consensus 500 ~kSDVWSfGI~L~EifsLG~~PYp~~~----------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p 563 (609)
T KOG0200|consen 500 SKSDVWSFGILLWEIFTLGGTPYPGIP----------------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADP 563 (609)
T ss_pred ccchhhHHHHHHHHHhhCCCCCCCCCC----------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCc
Confidence 99999999999999999 889987621 1223345666777778899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 021507 242 KLRPRMSEVLAILERL 257 (311)
Q Consensus 242 ~~Rpt~~~~l~~l~~~ 257 (311)
++||++.++.+.++..
T Consensus 564 ~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 564 EDRPTFSECVEFFEKH 579 (609)
T ss_pred ccCCCHHHHHHHHHHH
Confidence 9999999999999884
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=242.98 Aligned_cols=225 Identities=24% Similarity=0.278 Sum_probs=166.2
Q ss_pred HHHHHHHHHHhcC---CCCCccceEeEEEeCCe-----eEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 23 NWFQTEVNYLGQL---HHPNLVKLIGYCLEGEN-----RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 23 ~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
..+.+|+.+++++ +|+||+++++++...+. .+++|||+.+ +|.+++.......+++..++.++.|++.||.
T Consensus 43 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~ 121 (287)
T cd07838 43 LSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121 (287)
T ss_pred hhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence 4566788777666 69999999999988776 8999999975 8999887655456899999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 174 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 174 (311)
|||+. +++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||++.+..++.++|+|||||++
T Consensus 122 ~LH~~--~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 122 FLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred HHHHC--CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 99965 599999999999999999999999999876533321 1233578889999999988999999999999999
Q ss_pred HHHHhCCCccCCCccchhhhhh-hhccc-c----ccchhhhhHhhhcccC---CCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 175 LELLSGRCAVDKTKVGIEQSLV-DWAKP-Y----LSDKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~-~~~~~-~----~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
|+|++|..||............ ..... . ................ ......++..+.+++.+||..||.+||
T Consensus 197 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 9999999999765432111100 00000 0 0000000000000000 011124567889999999999999999
Q ss_pred CHHHHHHH
Q 021507 246 RMSEVLAI 253 (311)
Q Consensus 246 t~~~~l~~ 253 (311)
++.+++.+
T Consensus 277 ~~~~il~~ 284 (287)
T cd07838 277 SAFEALQH 284 (287)
T ss_pred CHHHHhcC
Confidence 99999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=250.45 Aligned_cols=225 Identities=21% Similarity=0.240 Sum_probs=165.0
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
.+.+|++++++++|+||+++++++..++..|+||||+. ++|.+++.... .+++..+..++.|++.||+|||+. ++
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~--~i 140 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW--YF 140 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--Ce
Confidence 47789999999999999999999999999999999997 49999886543 489999999999999999999965 59
Q ss_pred eecCCCCCceEeCCCCcEEEecccccccCCCCCC------------cceeccccccccccCccccccC-CCCCCCceehh
Q 021507 104 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSF 170 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~sl 170 (311)
+|+||+|+||+++.++.++|+|||.+........ ........++..|+|||.+.+. .++.++|+|||
T Consensus 141 ~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred ecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 9999999999999999999999999876541110 0011223467789999998764 46889999999
Q ss_pred HHHHHHHHhCCCccCCCccchhhh-hhhhcc-ccccchhhhh-----Hhhhccc---CCCCchHHHHHHHHHHHhcccCC
Q 021507 171 GVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSDKRKLF-----RIMDTKL---GGQYPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 171 G~il~~l~~g~~pf~~~~~~~~~~-~~~~~~-~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~ 240 (311)
||++|+|++|..||...+...... ...... +......... ....... ........+..+.+++.+||+.+
T Consensus 221 G~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 300 (335)
T PTZ00024 221 GCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN 300 (335)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCC
Confidence 999999999999997654321110 000000 0000000000 0000000 00011234678899999999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|++||++++++.+
T Consensus 301 P~~R~s~~~~l~~ 313 (335)
T PTZ00024 301 PLERISAKEALKH 313 (335)
T ss_pred chhccCHHHHhcC
Confidence 9999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=241.61 Aligned_cols=208 Identities=32% Similarity=0.433 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++.+++++|+||+++++.+......++++||+.+++|.+++..... ++...++.++.+++.++.+||+.
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~-- 106 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSN-- 106 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHc--
Confidence 57899999999999999999999999999999999999999999999865443 88999999999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|++++|.
T Consensus 107 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~ 183 (244)
T smart00220 107 GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK 183 (244)
T ss_pred CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 59999999999999999999999999998654332 233456788999999998888899999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH--HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK--AAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
.||..... .......+........... ++.++.+++.+||..+|++||++.++++
T Consensus 184 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 184 PPFPGDDQ----------------LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCCCCc----------------HHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 99976311 1111111111111111111 6788999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=253.19 Aligned_cols=228 Identities=26% Similarity=0.312 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCC-----eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
..+.+.+|+++++.++|+||+++++++.... ..|++|||+.+ +|.+++.+.. .+++..++.++.+++.||++
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~ 118 (330)
T cd07834 42 DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKY 118 (330)
T ss_pred hhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHH
Confidence 4457889999999999999999999988775 78999999975 8999886543 59999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccC-CCCCCCceehhHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVV 173 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~i 173 (311)
||+. +++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+. .++.++|+||||++
T Consensus 119 LH~~--gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~i 196 (330)
T cd07834 119 LHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCI 196 (330)
T ss_pred HHhC--CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHH
Confidence 9965 4999999999999999999999999999865443210 112334678899999999887 78999999999999
Q ss_pred HHHHHhCCCccCCCccchhhhh-hhhcccccc------chhhhhHhhh---ccc---CCCCchHHHHHHHHHHHhcccCC
Q 021507 174 LLELLSGRCAVDKTKVGIEQSL-VDWAKPYLS------DKRKLFRIMD---TKL---GGQYPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~~l~~~ 240 (311)
+|+|++|..||........... ......... ........+. ... .......++..+.+++.+||+.+
T Consensus 197 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 276 (330)
T cd07834 197 FAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFD 276 (330)
T ss_pred HHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCC
Confidence 9999999999977653211110 000000000 0000000000 000 00011235778999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|.+||++++++.+
T Consensus 277 P~~Rpt~~~ll~~ 289 (330)
T cd07834 277 PKKRITADEALAH 289 (330)
T ss_pred hhhCCCHHHHHhC
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=252.12 Aligned_cols=225 Identities=26% Similarity=0.356 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
...+.+|+.+++.++|+||+++++++... ...|+|+||+. ++|.+++... ..+++..+..++.|++.||.||
T Consensus 48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~L 124 (337)
T cd07858 48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYI 124 (337)
T ss_pred hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999988654 34799999996 5899988654 3499999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ 175 (311)
|+. +++|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|
T Consensus 125 H~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 125 HSA--NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred HhC--CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 965 49999999999999999999999999997653322 11233467889999998865 46889999999999999
Q ss_pred HHHhCCCccCCCccchhhhhh-hhccc-------cccch--hhhhHhhhcccC---CCCchHHHHHHHHHHHhcccCCCC
Q 021507 176 ELLSGRCAVDKTKVGIEQSLV-DWAKP-------YLSDK--RKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPK 242 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~-~~~~~-------~~~~~--~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~ 242 (311)
+|++|..||.+.+........ ..... ..... ....+....... ......++..+.+++.+||+.||+
T Consensus 201 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 280 (337)
T cd07858 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS 280 (337)
T ss_pred HHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh
Confidence 999999999765432111100 00000 00000 000000000000 011234678899999999999999
Q ss_pred CCCCHHHHHHH
Q 021507 243 LRPRMSEVLAI 253 (311)
Q Consensus 243 ~Rpt~~~~l~~ 253 (311)
+|||+++++++
T Consensus 281 ~Rps~~ell~h 291 (337)
T cd07858 281 KRITVEEALAH 291 (337)
T ss_pred hccCHHHHHcC
Confidence 99999999976
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=244.03 Aligned_cols=228 Identities=24% Similarity=0.300 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..+.+.+|++++++++|+||+++++++.+. +..++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~ 118 (287)
T cd07840 41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS 118 (287)
T ss_pred chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999988 889999999975 9999886543 359999999999999999999996
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l 177 (311)
. +++|+||+|+||++++++.++|+|||++......... ......++..|+|||.+.+. .++.++||||||+++|+|
T Consensus 119 ~--~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el 195 (287)
T cd07840 119 N--GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAEL 195 (287)
T ss_pred C--CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHH
Confidence 5 5999999999999999999999999999865443211 12234567889999987654 578899999999999999
Q ss_pred HhCCCccCCCccchhhhhh-hhcc-ccccchhhh-----hHhh------hcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 178 LSGRCAVDKTKVGIEQSLV-DWAK-PYLSDKRKL-----FRIM------DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~-~~~~-~~~~~~~~~-----~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
++|..||............ .... +........ .... ...........++..+.+++.+||..+|.+|
T Consensus 196 ~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (287)
T cd07840 196 FLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275 (287)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhC
Confidence 9999999765532111110 0000 000000000 0000 0000000111137789999999999999999
Q ss_pred CCHHHHHHH
Q 021507 245 PRMSEVLAI 253 (311)
Q Consensus 245 pt~~~~l~~ 253 (311)
|++.++++.
T Consensus 276 p~~~~~l~~ 284 (287)
T cd07840 276 ISADQALQH 284 (287)
T ss_pred cCHHHHhhC
Confidence 999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=255.58 Aligned_cols=222 Identities=26% Similarity=0.338 Sum_probs=163.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+.+|++++++++||||+++++++.. ++..|+++||+ +++|.+++... .+++..+..++.|++.||+|||+.
T Consensus 52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~ 127 (328)
T cd07856 52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA 127 (328)
T ss_pred hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34567889999999999999999999875 56789999999 56998887532 378888999999999999999965
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~ 178 (311)
+++|+||+|.||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus 128 --~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 128 --GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred --CcccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 4999999999999999999999999998753221 223456888999998766 56889999999999999999
Q ss_pred hCCCccCCCccchhhh-hhhhccccc--------c-chhhhhHhhhcccCCC---CchHHHHHHHHHHHhcccCCCCCCC
Q 021507 179 SGRCAVDKTKVGIEQS-LVDWAKPYL--------S-DKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~-~~~~~~~~~--------~-~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
+|..||.......... ......... . ........+....... ....++..+.++|.+||..+|++||
T Consensus 201 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 280 (328)
T cd07856 201 EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280 (328)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC
Confidence 9999997654211100 000000000 0 0000000000000000 0123567899999999999999999
Q ss_pred CHHHHHHH
Q 021507 246 RMSEVLAI 253 (311)
Q Consensus 246 t~~~~l~~ 253 (311)
++.+++..
T Consensus 281 t~~ell~~ 288 (328)
T cd07856 281 SAAEALAH 288 (328)
T ss_pred CHHHHhcC
Confidence 99999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=237.39 Aligned_cols=196 Identities=29% Similarity=0.396 Sum_probs=168.8
Q ss_pred HHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeee
Q 021507 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 105 (311)
Q Consensus 26 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 105 (311)
..|-++|+..+||.+..+...|...+++|+||||..||.|.-++.+. +.+++.....+-..|+.||.|||+.+ ||.
T Consensus 216 lTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~--ivY 291 (516)
T KOG0690|consen 216 LTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN--IVY 291 (516)
T ss_pred hhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC--eee
Confidence 45889999999999999999999999999999999999999888553 34999999999999999999999754 999
Q ss_pred cCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccC
Q 021507 106 RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 185 (311)
Q Consensus 106 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 185 (311)
||||.+|.+++.+|++||+|||+++..- ......+.++||+.|+|||++....|+.+.|-|.+|+++|||++|+.||.
T Consensus 292 RDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 292 RDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eechhhhheeccCCceEeeecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 9999999999999999999999998632 22334677899999999999999999999999999999999999999997
Q ss_pred CCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 186 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
..+ ...++..+.. -...+|...+++...|+..+|..||.+|.
T Consensus 370 n~d-----------------h~kLFeLIl~-ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 370 NKD-----------------HEKLFELILM-EDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccc-----------------hhHHHHHHHh-hhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 643 2223332221 12357888999999999999999999996
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=242.71 Aligned_cols=257 Identities=26% Similarity=0.329 Sum_probs=187.1
Q ss_pred ChhHHHhHHHHHH-hhhhH--HHHHHHHHHHHHHHhcC--CCCCccceEeEEEeCC----eeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLEL-HARSL--LLITNWFQTEVNYLGQL--HHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~-~~~~~--~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~ 71 (311)
.||.||-++=.+- -+.++ ....+.|.+|-.|+... +|+||++++++-.... .++||++|.+.|+|.++|..
T Consensus 222 rfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ 301 (534)
T KOG3653|consen 222 RFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA 301 (534)
T ss_pred ccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh
Confidence 3777876654431 23222 23456789999988876 8999999998866554 68999999999999999966
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhh-------CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHD-------AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~-------~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
+- ++|....+++..++.||+|||+ ++..|+|||||..||||.++++..|+|||+|..+............
T Consensus 302 nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~q 378 (534)
T KOG3653|consen 302 NT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQ 378 (534)
T ss_pred cc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhh
Confidence 53 9999999999999999999996 3457999999999999999999999999999887655444445558
Q ss_pred cccccccCccccccCC-CC-----CCCceehhHHHHHHHHhCCCccCCCccchhh-hhhhh--ccccccchhhhhHhhhc
Q 021507 145 MGTHGYAAPEYVATGR-LT-----TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW--AKPYLSDKRKLFRIMDT 215 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~-~~-----~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~ 215 (311)
+||.+|||||++.+.- +. .+.||||+|.++|||++...-++......-+ .+... ..|..++ .....+..
T Consensus 379 VGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~--mq~~VV~k 456 (534)
T KOG3653|consen 379 VGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE--MQELVVRK 456 (534)
T ss_pred hhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH--HHHHHHhh
Confidence 9999999999998752 22 2589999999999999965544321111100 00000 0111111 11122333
Q ss_pred ccCCCCch-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCCCC
Q 021507 216 KLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 262 (311)
Q Consensus 216 ~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~~~ 262 (311)
+.+...+. .....+.+.+..||+.|++.|.|+.=+.+.+..+.....
T Consensus 457 K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 457 KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 33333333 335578899999999999999999999999988765443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=257.60 Aligned_cols=247 Identities=21% Similarity=0.254 Sum_probs=169.9
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC--------------CeeEEEEe
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--------------ENRLLVYE 58 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------------~~~~lv~e 58 (311)
+||+||++.+.... ........+.+.+|+++++.++||||+++++++... ...|+|||
T Consensus 17 ~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 96 (342)
T cd07854 17 SNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE 96 (342)
T ss_pred CCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEee
Confidence 46677766543321 111123446688899999999999999999876644 35789999
Q ss_pred cCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCCCCC
Q 021507 59 FMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDR 137 (311)
Q Consensus 59 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~ 137 (311)
|+.+ +|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++. ++.++|+|||.+........
T Consensus 97 ~~~~-~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~--givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~ 170 (342)
T cd07854 97 YMET-DLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170 (342)
T ss_pred cccc-cHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCceEEECCcccceecCCccc
Confidence 9974 998887432 388999999999999999999965 5999999999999975 45789999999876432211
Q ss_pred c-ceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhcccccc--chhhhhHh-
Q 021507 138 T-HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS--DKRKLFRI- 212 (311)
Q Consensus 138 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 212 (311)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||................+... ........
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07854 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVI 250 (342)
T ss_pred cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence 1 11123457889999998754 4678899999999999999999999976543211111100000000 00000000
Q ss_pred ---hh-cccCCC-----CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 213 ---MD-TKLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 213 ---~~-~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.. ...... ....++.++.+++.+||..||.+|||+.+++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 251 PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 000000 112356789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=245.26 Aligned_cols=226 Identities=26% Similarity=0.262 Sum_probs=163.8
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCC----------eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGE----------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 92 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~ 92 (311)
..+.+|++++++++||||+++++++.+.. ..|+|+||+++ +|.+.+.+. ...+++..+..++.|++.|
T Consensus 51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~a 128 (302)
T cd07864 51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEG 128 (302)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHH
Confidence 46778999999999999999999987654 78999999976 787777544 3358999999999999999
Q ss_pred HHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhH
Q 021507 93 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFG 171 (311)
Q Consensus 93 l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG 171 (311)
|+|||+. +|+|+||||+||++++++.+||+|||++......... ......++..|+|||.+.+. .++.++||||||
T Consensus 129 L~~LH~~--~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 205 (302)
T cd07864 129 LNYCHKK--NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 205 (302)
T ss_pred HHHHHhC--CeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHH
Confidence 9999964 5999999999999999999999999999765433211 11223457789999988654 578899999999
Q ss_pred HHHHHHHhCCCccCCCccchhhhhhhh--ccccccchhhh-----hHhhhcc-----cCCCCchHHHHHHHHHHHhcccC
Q 021507 172 VVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRKL-----FRIMDTK-----LGGQYPQKAAHTAATLALQCLNN 239 (311)
Q Consensus 172 ~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~ 239 (311)
|++|+|++|+.||...........+.. ..+........ ....... ........++..+.+++.+||..
T Consensus 206 ~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 285 (302)
T cd07864 206 CILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285 (302)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccC
Confidence 999999999999976442211111100 00000000000 0000000 00001123577899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021507 240 EPKLRPRMSEVLAI 253 (311)
Q Consensus 240 ~p~~Rpt~~~~l~~ 253 (311)
||.+||++.+++..
T Consensus 286 ~P~~Rp~~~~il~~ 299 (302)
T cd07864 286 DPSKRCTAEEALNS 299 (302)
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=243.05 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=161.8
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
...+.+|+.++.+. +|+||+++++++.+....|++|||+.+ +|.+++.... ..+++..+..++.+++.||+|||+.
T Consensus 57 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~- 133 (296)
T cd06618 57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK- 133 (296)
T ss_pred HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh-
Confidence 34456677766666 599999999999999999999999954 7887775433 3589999999999999999999963
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC----CCCCCceehhHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLE 176 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~ 176 (311)
++++|+||+|+||++++++.+||+|||++........ .....++..|+|||.+.+.. ++.++||||||+++|+
T Consensus 134 ~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~e 210 (296)
T cd06618 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210 (296)
T ss_pred CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHH
Confidence 3599999999999999999999999999876433221 12335778999999987553 7889999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc-CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|++|..||....... ......+.... .......++.++.+++.+||..||++||++++++.+.
T Consensus 211 l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 211 LATGQFPYKNCKTEF---------------EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHhCCCCCCcchhHH---------------HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 999999997532110 00011111100 0011123677899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=247.45 Aligned_cols=227 Identities=24% Similarity=0.281 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeC----CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
.+.+.+|+++++++ +||||+++++.+... ...|+++||+. ++|.+++... ..+++..+..++.|++.||+||
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~L 121 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYI 121 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHH
Confidence 45678899999999 599999999875432 45789999996 5999988544 3489999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceeccccccccccCcccccc-CCCCCCCceehhHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVV 173 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~i 173 (311)
|+. +++|+||||+||+++.++.+||+|||++......... .......|+..|+|||++.+ ..++.++||||||++
T Consensus 122 H~~--givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 122 HSA--NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred HhC--CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 965 5999999999999999999999999999765432211 11223568999999998765 468899999999999
Q ss_pred HHHHHhCCCccCCCccchhh-hhhhhcc-ccccc------hh--hhhHhhhcccCC---CCchHHHHHHHHHHHhcccCC
Q 021507 174 LLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLSD------KR--KLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~------~~--~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~ 240 (311)
+|+|++|..||...+..... ....... +.... .. ............ .....++..+.+++.+||+.|
T Consensus 200 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 279 (332)
T cd07857 200 LAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFD 279 (332)
T ss_pred HHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCC
Confidence 99999999999765421100 0000000 00000 00 000000000000 011234678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|.+|||+.+++..
T Consensus 280 P~~R~t~~~ll~~ 292 (332)
T cd07857 280 PTKRISVEEALEH 292 (332)
T ss_pred cccCCCHHHHhcC
Confidence 9999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=242.03 Aligned_cols=227 Identities=26% Similarity=0.318 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.++++++|+||+++++++.+.+..++||||+.+ +|.+++.+.. ..+++..+..++.+++.||++||+.
T Consensus 41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~- 117 (282)
T cd07829 41 IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH- 117 (282)
T ss_pred ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345678899999999999999999999999999999999975 9999997653 3599999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|++++
T Consensus 118 -~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 194 (282)
T cd07829 118 -RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194 (282)
T ss_pred -CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh
Confidence 499999999999999999999999999876533221 12233457789999998776 78899999999999999999
Q ss_pred CCCccCCCccchhhh-hhhhcc-ccccch---------hhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 180 GRCAVDKTKVGIEQS-LVDWAK-PYLSDK---------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 180 g~~pf~~~~~~~~~~-~~~~~~-~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
|..||.......... ...... +..... ...................+..+.+++.+||..||++||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 274 (282)
T cd07829 195 GKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274 (282)
T ss_pred CCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHH
Confidence 999997654321110 000000 000000 000000000000001123467899999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++..
T Consensus 275 ~~l~~ 279 (282)
T cd07829 275 EALKH 279 (282)
T ss_pred HHhhC
Confidence 99864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=239.77 Aligned_cols=224 Identities=26% Similarity=0.333 Sum_probs=165.9
Q ss_pred HHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 24 WFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 24 ~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
...+|+..+++++ |+||+++++++.+++..|+||||+ +++|.+++.......+++..+..++.|++.+|.|||+. +
T Consensus 43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--~ 119 (283)
T cd07830 43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH--G 119 (283)
T ss_pred HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC--C
Confidence 3457999999998 999999999999999999999999 67999988765545689999999999999999999964 5
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~ 181 (311)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||++.+ ..++.++|+||||+++|+|++|.
T Consensus 120 i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~ 196 (283)
T cd07830 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196 (283)
T ss_pred cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence 99999999999999999999999999976433221 223457889999998754 45788999999999999999999
Q ss_pred CccCCCccchhhh-hhhhccccccc----hhhhhHhhhcccC-------CCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 182 CAVDKTKVGIEQS-LVDWAKPYLSD----KRKLFRIMDTKLG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 182 ~pf~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
.||.......... ........... ............. .......+..+.+++.+||..||++|||+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred CccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 9997654321111 01100000000 0000000000000 0001122577999999999999999999999
Q ss_pred HHHH
Q 021507 250 VLAI 253 (311)
Q Consensus 250 ~l~~ 253 (311)
++..
T Consensus 277 i~~~ 280 (283)
T cd07830 277 ALQH 280 (283)
T ss_pred HhhC
Confidence 9753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=268.41 Aligned_cols=126 Identities=28% Similarity=0.322 Sum_probs=107.1
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... +.+ .......+.+|+.++..++||||+++++++...+..|+||||+.|++|.+++
T Consensus 16 ~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li 95 (669)
T cd05610 16 AFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL 95 (669)
T ss_pred CCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHH
Confidence 57888887765221 111 1223467889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~--~l~~~~~~~i~~qil~aL~yLH~~--gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 96 HIYG--YFDEEMAVKYISEVALALDYLHRH--GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 6543 488999999999999999999965 59999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=244.59 Aligned_cols=227 Identities=25% Similarity=0.312 Sum_probs=161.5
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCC--------eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGE--------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
..+.+|+++++.++||||+++++++.+.. ..|+||||+.+ +|...+.... ..+++..+..++.|+++||+
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~ 129 (311)
T cd07866 52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGIN 129 (311)
T ss_pred hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999875433 46999999965 7887775433 35999999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc---------eeccccccccccCccccccC-CCCCC
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH---------VSTQVMGTHGYAAPEYVATG-RLTTK 164 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~ 164 (311)
|||+. +++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+. .++.+
T Consensus 130 ~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (311)
T cd07866 130 YLHEN--HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207 (311)
T ss_pred HHHhC--CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence 99965 49999999999999999999999999997543322111 11234567889999987654 57889
Q ss_pred CceehhHHHHHHHHhCCCccCCCccchhhhhh-hhccccccchhhhhHhhhc----ccCCCCc-------hHHHHHHHHH
Q 021507 165 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRIMDT----KLGGQYP-------QKAAHTAATL 232 (311)
Q Consensus 165 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~-------~~~~~~l~~l 232 (311)
+|||||||++|+|++|..||.+.......... ................+.. ......+ ......+.++
T Consensus 208 ~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (311)
T cd07866 208 VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDL 287 (311)
T ss_pred hHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHH
Confidence 99999999999999999999765432211110 0000000000000000000 0000000 1234678999
Q ss_pred HHhcccCCCCCCCCHHHHHHH
Q 021507 233 ALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 233 i~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||..||.+|||+.+++.+
T Consensus 288 i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 288 LSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHcccCcccCcCHHHHhcC
Confidence 999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=235.68 Aligned_cols=215 Identities=22% Similarity=0.299 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh---hcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 19 LLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF---RRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
....++|+.|.+..++- ++||||++||..-.++..|+.||.|+- ||..+.+ ......+++...-.|....+.||.
T Consensus 103 ~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~ 181 (361)
T KOG1006|consen 103 EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALD 181 (361)
T ss_pred hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHH
Confidence 45666788888876666 799999999999999999999999965 8776542 223345899999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc--CCCCCCCceehhHH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGV 172 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~ 172 (311)
||-.. ..|+|||+||+|||++..|.+||||||++....... ..+...|...|||||.+.. ..|+.+||+||||+
T Consensus 182 yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 182 YLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGI 257 (361)
T ss_pred HHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcc
Confidence 99763 459999999999999999999999999997653321 2344578899999998854 35899999999999
Q ss_pred HHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC----CCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG----GQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
++||+.||..||.+.+... .++...+..... ......++..+..+|..||.+|...||...
T Consensus 258 TL~EvAtG~fPyr~w~svf---------------eql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~ 322 (361)
T KOG1006|consen 258 TLYEVATGNFPYRKWDSVF---------------EQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYD 322 (361)
T ss_pred eEeeeecCCCCcchHHHHH---------------HHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchh
Confidence 9999999999998643211 111111111110 011124788899999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++++
T Consensus 323 ~Lk~~ 327 (361)
T KOG1006|consen 323 DLKKF 327 (361)
T ss_pred hhhcC
Confidence 99864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=243.49 Aligned_cols=244 Identities=20% Similarity=0.300 Sum_probs=186.3
Q ss_pred hhHHHhHHHHHHh-------hhhHHHHHHHHHHHHHHHhcCC--------CCCccceEeEEEe----CCeeEEEEecCCC
Q 021507 2 FLFNFLHSHLELH-------ARSLLLITNWFQTEVNYLGQLH--------HPNLVKLIGYCLE----GENRLLVYEFMPK 62 (311)
Q Consensus 2 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~~~~~~----~~~~~lv~e~~~~ 62 (311)
|||||||.+.+.. .++...+++....|+++|++++ ..+||++++.|.. +.++|||+|++ |
T Consensus 91 FSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-G 169 (590)
T KOG1290|consen 91 FSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-G 169 (590)
T ss_pred cceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-h
Confidence 9999999998865 4556667778889999999993 2479999999974 56899999999 7
Q ss_pred CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC--------------------------
Q 021507 63 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-------------------------- 116 (311)
Q Consensus 63 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-------------------------- 116 (311)
.+|..+|.....+.++...+..|+.||+.||.|||. ..||||-||||+|||+.
T Consensus 170 dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s 248 (590)
T KOG1290|consen 170 DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPS 248 (590)
T ss_pred hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcc
Confidence 799999998888889999999999999999999998 48899999999999971
Q ss_pred --------------------------------------------------------------------------------
Q 021507 117 -------------------------------------------------------------------------------- 116 (311)
Q Consensus 117 -------------------------------------------------------------------------------- 116 (311)
T Consensus 249 ~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~ 328 (590)
T KOG1290|consen 249 AVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNEN 328 (590)
T ss_pred cccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccc
Confidence
Q ss_pred --------CC----------------------------------------------------CcEEEecccccccCCCCC
Q 021507 117 --------AE----------------------------------------------------FNAKLSDFGLAKAGPTGD 136 (311)
Q Consensus 117 --------~~----------------------------------------------------~~~kl~Dfg~~~~~~~~~ 136 (311)
.. -.|||+|||-|++....
T Consensus 329 ~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh- 407 (590)
T KOG1290|consen 329 GNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH- 407 (590)
T ss_pred cCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh-
Confidence 00 01566777766654322
Q ss_pred CcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccc---hhhhhhh----------------
Q 021507 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG---IEQSLVD---------------- 197 (311)
Q Consensus 137 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~---------------- 197 (311)
.+..+.|..|+|||++.|..|+..+||||++|++|||+||...|+..... .+...+.
T Consensus 408 ----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~ 483 (590)
T KOG1290|consen 408 ----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALG 483 (590)
T ss_pred ----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhc
Confidence 22346788999999999999999999999999999999999999754432 1111110
Q ss_pred --hccccccch-----------hhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 198 --WAKPYLSDK-----------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 198 --~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+...+.... ..+.+++..+ ..++.....++.+|+.-||+.+|++||||.+.+++-
T Consensus 484 Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eK--Y~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP 551 (590)
T KOG1290|consen 484 GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEK--YEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP 551 (590)
T ss_pred CcchHhhhccccceecccccCCCcHHHHHHHH--hCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence 111111111 1122222222 245567788999999999999999999999999764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=246.25 Aligned_cols=222 Identities=22% Similarity=0.273 Sum_probs=163.9
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
..+.+.+|++++++++||||+++++++..+. ..++||||+ |++|.+++.. ..+++..+..++.|++.||+
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~ 132 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLK 132 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHH
Confidence 4456889999999999999999999987653 358999999 6799988753 24899999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVV 173 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~i 173 (311)
|||+. +++|+||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||++
T Consensus 133 ~LH~~--gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~l 205 (343)
T cd07880 133 YIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCI 205 (343)
T ss_pred HHHhC--CeecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 99965 5999999999999999999999999999764322 223456889999998876 357889999999999
Q ss_pred HHHHHhCCCccCCCccchhh-hhhhhccccccc---------hhhhhHhhhcccC---CCCchHHHHHHHHHHHhcccCC
Q 021507 174 LLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD---------KRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~---------~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~ 240 (311)
+|++++|..||...+..... ............ .......+..... ......++..+.+++.+||..|
T Consensus 206 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 285 (343)
T cd07880 206 MAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLD 285 (343)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCC
Confidence 99999999999865431110 000000000000 0000000000000 0112345677999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|++|||+.+++.+
T Consensus 286 P~~R~t~~~~l~~ 298 (343)
T cd07880 286 AESRITAAEALAH 298 (343)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=246.04 Aligned_cols=221 Identities=24% Similarity=0.308 Sum_probs=162.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.+.+.+|+.++++++||||+++++++... ...|++++++ |++|.+++... .+++..+..++.|++.||+|
T Consensus 60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~ 135 (345)
T cd07877 60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKY 135 (345)
T ss_pred HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999988643 3468888887 67998887532 38999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVL 174 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il 174 (311)
||+. +++|+||||+||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++
T Consensus 136 LH~~--~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il 208 (345)
T cd07877 136 IHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 208 (345)
T ss_pred HHHC--CeeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHH
Confidence 9965 4999999999999999999999999998754322 233467889999998866 4688899999999999
Q ss_pred HHHHhCCCccCCCccchhhh-hhhhcc-c------cccc--hhhhhHhhhcccC---CCCchHHHHHHHHHHHhcccCCC
Q 021507 175 LELLSGRCAVDKTKVGIEQS-LVDWAK-P------YLSD--KRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~-~~~~~~-~------~~~~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p 241 (311)
|+|++|..||.......... ...... + .... .......+..... .......+..+.++|.+||..||
T Consensus 209 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 288 (345)
T cd07877 209 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 288 (345)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCCh
Confidence 99999999997543211110 000000 0 0000 0000000000000 00111346788999999999999
Q ss_pred CCCCCHHHHHHH
Q 021507 242 KLRPRMSEVLAI 253 (311)
Q Consensus 242 ~~Rpt~~~~l~~ 253 (311)
.+||++.+++.+
T Consensus 289 ~~R~t~~e~l~h 300 (345)
T cd07877 289 DKRITAAQALAH 300 (345)
T ss_pred hhcCCHHHHhcC
Confidence 999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=247.60 Aligned_cols=220 Identities=22% Similarity=0.293 Sum_probs=160.6
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.+.+.+|+.+++.++||||+++++++.... ..|+|+||+.+ +|.+++. ..+++..+..++.|++.||+|
T Consensus 58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~ 132 (342)
T cd07879 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKY 132 (342)
T ss_pred hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHH
Confidence 455789999999999999999999987543 45899999964 7777652 248999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVL 174 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il 174 (311)
||+. +++||||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+|||||++
T Consensus 133 LH~~--~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil 205 (342)
T cd07879 133 IHSA--GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM 205 (342)
T ss_pred HHHC--CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHH
Confidence 9965 4999999999999999999999999998754322 223457889999999876 4688899999999999
Q ss_pred HHHHhCCCccCCCccchhhhhh-hhccccccc------hhhhhHhhhc--cc-CC---CCchHHHHHHHHHHHhcccCCC
Q 021507 175 LELLSGRCAVDKTKVGIEQSLV-DWAKPYLSD------KRKLFRIMDT--KL-GG---QYPQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~--~~-~~---~~~~~~~~~l~~li~~~l~~~p 241 (311)
|+|++|+.||.+.+........ ......... .......... .. .. ......+..+.++|.+||+.||
T Consensus 206 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 285 (342)
T cd07879 206 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDV 285 (342)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCCh
Confidence 9999999999865432111100 000000000 0000000000 00 00 0012356678999999999999
Q ss_pred CCCCCHHHHHHH
Q 021507 242 KLRPRMSEVLAI 253 (311)
Q Consensus 242 ~~Rpt~~~~l~~ 253 (311)
.+||++.+++.+
T Consensus 286 ~~R~~~~e~l~h 297 (342)
T cd07879 286 DKRLTATEALEH 297 (342)
T ss_pred hhCcCHHHHhcC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.26 Aligned_cols=213 Identities=27% Similarity=0.379 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEE-----eCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCL-----EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
..+.++-|.+||+.+ .|||++.+|++|. .++.+|||||||.|||.-|++++.....+.|..+..|+..++.||.
T Consensus 58 ~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~ 137 (953)
T KOG0587|consen 58 EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLA 137 (953)
T ss_pred ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHH
Confidence 345577889999998 7999999999987 3567899999999999999998777778999999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-----CCCCCCCceeh
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYS 169 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s 169 (311)
+||. +.++|||||-.|||++.+|.|||+|||.+....... ....+.+||+.|||||++.. ..|+..+|+||
T Consensus 138 HLH~--nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~Ws 213 (953)
T KOG0587|consen 138 HLHN--NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWS 213 (953)
T ss_pred HHhh--cceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhh
Confidence 9995 559999999999999999999999999997654332 22556899999999999854 34778999999
Q ss_pred hHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc-CCCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 170 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 170 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
||++..||..|.+|+-++.. ...++.+....- ....+..-+.++.++|..||.+|..+||+..
T Consensus 214 LGITaIEladG~PPl~DmHP----------------mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~ 277 (953)
T KOG0587|consen 214 LGITAIEMAEGAPPLCDMHP----------------MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTE 277 (953)
T ss_pred ccceeehhcCCCCCccCcch----------------hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchh
Confidence 99999999999999876432 122222222221 1223567789999999999999999999999
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++++
T Consensus 278 ~ll~h 282 (953)
T KOG0587|consen 278 ELLKH 282 (953)
T ss_pred hhccC
Confidence 98854
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=249.14 Aligned_cols=221 Identities=24% Similarity=0.307 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCe------eEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN------RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.+.+.+|+.++++++|+||+++++++...+. .|+|+||+ +++|.+++.. ..+++..++.++.|++.||+|
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~ 133 (343)
T cd07851 58 AKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKY 133 (343)
T ss_pred HHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHH
Confidence 3557789999999999999999998876554 89999999 5699998854 349999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVL 174 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il 174 (311)
||+. +++|+||||+||+++.++.++|+|||++...... .....++..|+|||.+.+. .++.++||||||+++
T Consensus 134 LH~~--gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l 206 (343)
T cd07851 134 IHSA--GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred HHHC--CeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHH
Confidence 9965 5999999999999999999999999999765332 2334678899999988653 678899999999999
Q ss_pred HHHHhCCCccCCCccchhhh-hhhhccccc--------cc-hhhhhHhhhcccCCCC---chHHHHHHHHHHHhcccCCC
Q 021507 175 LELLSGRCAVDKTKVGIEQS-LVDWAKPYL--------SD-KRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p 241 (311)
|++++|..||.......... ......... .+ .......+.......+ ....+..+.+++.+||..||
T Consensus 207 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P 286 (343)
T cd07851 207 AELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDP 286 (343)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCCh
Confidence 99999999997654321111 000000000 00 0000000000000000 11347789999999999999
Q ss_pred CCCCCHHHHHHH
Q 021507 242 KLRPRMSEVLAI 253 (311)
Q Consensus 242 ~~Rpt~~~~l~~ 253 (311)
++|||+.+++.+
T Consensus 287 ~~Rpt~~ell~h 298 (343)
T cd07851 287 DKRITAAEALAH 298 (343)
T ss_pred hhCCCHHHHhcC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=256.43 Aligned_cols=211 Identities=27% Similarity=0.382 Sum_probs=162.1
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
-+...+|+..|+.- +|||||++|+.-.+.+..||+.|.|.. +|.+++... ..........+.++.|+++||++||+
T Consensus 546 ~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs 624 (903)
T KOG1027|consen 546 FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS 624 (903)
T ss_pred HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh
Confidence 34567999999999 699999999988888999999999976 999999763 11111113457789999999999998
Q ss_pred CCCCeeecCCCCCceEeCC---C--CcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 99 AESQVIYRDFKASNILLDA---E--FNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~---~--~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
.+ ||||||||+||||+. + ..++|+|||+++....+... .......||.+|+|||++....-+.++|||||||
T Consensus 625 l~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGC 702 (903)
T KOG1027|consen 625 LK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGC 702 (903)
T ss_pred cc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCc
Confidence 66 999999999999976 3 45899999999987655433 2244577999999999999998888999999999
Q ss_pred HHHHHHhC-CCccCCCccchhhhhhhhccccccchhhhhHhhhcccC-CCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 173 VLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 173 il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
++|+.++| ..||+..-.... .++..... .........+..+||.+|++.+|..||++.++
T Consensus 703 vfyYvltgG~HpFGd~~~R~~------------------NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 703 VFYYVLTGGSHPFGDSLERQA------------------NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred eEEEEecCCccCCCchHHhhh------------------hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHH
Confidence 99999995 899986432111 11111100 00001111188999999999999999999999
Q ss_pred HHH
Q 021507 251 LAI 253 (311)
Q Consensus 251 l~~ 253 (311)
+.+
T Consensus 765 L~H 767 (903)
T KOG1027|consen 765 LNH 767 (903)
T ss_pred hCC
Confidence 954
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=243.92 Aligned_cols=210 Identities=22% Similarity=0.271 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+++|+.||+++.||.||.+..-|+..+.+++|||.+.| +..++|-......+++.....++.||+.||.|||..
T Consensus 607 esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k-- 683 (888)
T KOG4236|consen 607 ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK-- 683 (888)
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc--
Confidence 35689999999999999999999999999999999999965 777777555555699999999999999999999954
Q ss_pred CeeecCCCCCceEeCCCC---cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
+|+|+||||+|||+.... .+||||||+++.++... .....+||+.|+|||++....|+..-|+||.|+|+|--+
T Consensus 684 nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL 760 (888)
T KOG4236|consen 684 NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL 760 (888)
T ss_pred ceeeccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEe
Confidence 599999999999996553 59999999999876543 356789999999999999999999999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.|..||.......++ .+.-.-.+.......++.+..+||..+|+..=.+|.|++..+.+
T Consensus 761 SGTFPFNEdEdIndQ----------------IQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 761 SGTFPFNEDEDINDQ----------------IQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred cccccCCCccchhHH----------------hhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 999999864321111 11111112223445788899999999999999999999887754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=234.71 Aligned_cols=196 Identities=30% Similarity=0.430 Sum_probs=166.9
Q ss_pred HHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeee
Q 021507 27 TEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 105 (311)
Q Consensus 27 ~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 105 (311)
.|-++|... +-|.+++++..|..-+.+|+||||+.||+|--+|++.+. +.+..+.-++.+|+-||-|||++ ||++
T Consensus 398 ~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k--gIiY 473 (683)
T KOG0696|consen 398 VEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK--GIIY 473 (683)
T ss_pred hhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC--Ceee
Confidence 466777655 678999999999999999999999999999999987765 88889999999999999999965 4999
Q ss_pred cCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccC
Q 021507 106 RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 185 (311)
Q Consensus 106 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 185 (311)
||||.+||+++.+|.+||+|||+++.--. ......+++||+.|+|||++...+|+.++|-||+|++||||+.|++||+
T Consensus 474 RDLKLDNvmLd~eGHiKi~DFGmcKEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 474 RDLKLDNVMLDSEGHIKIADFGMCKENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred eeccccceEeccCCceEeeeccccccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999985322 2334677899999999999999999999999999999999999999999
Q ss_pred CCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 186 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
+.++. .-...+.+.. ..+|...+.+..++....|.+.|.+|..
T Consensus 552 GeDE~----------------elF~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 552 GEDED----------------ELFQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CCCHH----------------HHHHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 86532 1122222222 3578889999999999999999999973
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=237.99 Aligned_cols=226 Identities=25% Similarity=0.285 Sum_probs=170.2
Q ss_pred ChhHHHhHHHHHHh---hhhHHHHHH--------HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARSLLLITN--------WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~~~~~~--------~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||.|-|++....+ +.+.++-.+ -.+.|-.||..-+.+-||++|..|.+.+.+|+||+|++||++-.+|
T Consensus 641 AFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLL 720 (1034)
T KOG0608|consen 641 AFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL 720 (1034)
T ss_pred ccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHH
Confidence 46776666555443 222222222 2456888999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccC---------CCCCCc--
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG---------PTGDRT-- 138 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~---------~~~~~~-- 138 (311)
.+.+- |++..+..++.++..|+++.|..+ +|||||||+|||||.+|.+||+|||++.-+ ..+...
T Consensus 721 IrmgI--FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~Rq 796 (1034)
T KOG0608|consen 721 IRMGI--FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQ 796 (1034)
T ss_pred HHhcc--CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceeccccccccCCCcccc
Confidence 77654 999999999999999999999655 999999999999999999999999998532 111000
Q ss_pred -----------------------------ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCcc
Q 021507 139 -----------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 189 (311)
Q Consensus 139 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 189 (311)
......+||..|+|||++....++..+|.||.|+|||||+.|+.||-....
T Consensus 797 DSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 797 DSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred ccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 011245799999999999999999999999999999999999999987655
Q ss_pred chhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 190 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
...+..+.-. ...+...+..+++.++.++|.++. .+++.|.
T Consensus 877 ~~tq~kv~nw--------------~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 877 GETQYKVINW--------------RNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred Ccceeeeeeh--------------hhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 4433322111 111112233466778888887644 4566776
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=227.00 Aligned_cols=223 Identities=22% Similarity=0.280 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.++..+|..++..++|+||++++.+|.-. ...|+|||++.. +|...+.- .++.+++..+..|++.|+.+
T Consensus 59 akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~ 133 (369)
T KOG0665|consen 59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKH 133 (369)
T ss_pred chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999998733 346999999975 99998862 27888999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 175 (311)
||+. ||+||||||+||++..++.+||.|||+++..... -..+..+.|..|.|||++.+..+...+||||+||++.
T Consensus 134 lhs~--~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 134 LHSA--GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (369)
T ss_pred HHhc--ceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHH
Confidence 9965 4999999999999999999999999999864433 2345567899999999999999999999999999999
Q ss_pred HHHhCCCccCCCccchhhhhh--hhcccc---ccchhhhhH------------hhhcccC-------CCCchHHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLV--DWAKPY---LSDKRKLFR------------IMDTKLG-------GQYPQKAAHTAAT 231 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~--~~~~~~---~~~~~~~~~------------~~~~~~~-------~~~~~~~~~~l~~ 231 (311)
||++|...|.+.+.-.+...+ ....|. ...-....+ .....+. ...+..-...+++
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ard 288 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARD 288 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHH
Confidence 999999999865432111100 000000 000000000 0000000 0111233567899
Q ss_pred HHHhcccCCCCCCCCHHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++.+||..||++|.+++++|.+-
T Consensus 289 ll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 289 LLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHhhccChhhcccHHHHhcCC
Confidence 99999999999999999999753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=248.60 Aligned_cols=221 Identities=23% Similarity=0.362 Sum_probs=188.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
.+..+.+.+|+.+|.+|+|||++++++++.... +-||++|+++|+|.++++... ..+-....+.|+.||++||.|||.
T Consensus 739 ~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~ 816 (1177)
T KOG1025|consen 739 PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE 816 (1177)
T ss_pred chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh
Confidence 345677999999999999999999999998765 789999999999999997644 448888999999999999999995
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
+ ++|||||-..||||..-..+||.|||+++...............-.+.|||-|.+....++.++||||||+++||++
T Consensus 817 q--rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElm 894 (1177)
T KOG1025|consen 817 Q--RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELM 894 (1177)
T ss_pred c--chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHH
Confidence 4 59999999999999999999999999999765554443334444567899999999999999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
| |..||++... .++...++...+...|+.++.++..+|.+||..|+..||+++++...+.++
T Consensus 895 TFGa~Py~gi~~-----------------~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 895 TFGAKPYDGIPA-----------------EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred hcCCCccCCCCH-----------------HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 9 9999987542 234445555666677889999999999999999999999999999988876
Q ss_pred cCC
Q 021507 258 EAP 260 (311)
Q Consensus 258 ~~~ 260 (311)
...
T Consensus 958 ard 960 (1177)
T KOG1025|consen 958 ARD 960 (1177)
T ss_pred hcC
Confidence 543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-34 Score=226.75 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=178.9
Q ss_pred ChhHHHhHHH---------HHH-hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSH---------LEL-HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~---------~~~-~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L 65 (311)
+||.||-..+ .++ +.-...-..+.+.+|+++|..++|.||+..+++..-. +.+|+++|.+.. +|
T Consensus 65 AFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DL 143 (449)
T KOG0664|consen 65 AFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DL 143 (449)
T ss_pred ceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hh
Confidence 5888882221 121 2233344566788899999999999999998876533 236899999965 88
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccc
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
...| ..+..++.+.+.-++.||+.||+|||+.+ |.||||||.|.|++.+..+||||||+++........... ..+
T Consensus 144 HKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT-qEV 218 (449)
T KOG0664|consen 144 HKII--VSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT-HEV 218 (449)
T ss_pred hhee--ccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhhhH-HHH
Confidence 8887 45566999999999999999999999765 999999999999999999999999999976544433322 345
Q ss_pred ccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh--hccccccchhhh-----hHhhhccc
Q 021507 146 GTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD--WAKPYLSDKRKL-----FRIMDTKL 217 (311)
Q Consensus 146 gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~ 217 (311)
-|..|+|||++.|. .|+.+.||||.|||+.|++..+..|...+.-....++. ...|.....+.- ..++....
T Consensus 219 VTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~ 298 (449)
T KOG0664|consen 219 VTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGL 298 (449)
T ss_pred HHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCC
Confidence 68899999999887 68999999999999999999999998765533333221 112222111110 01111111
Q ss_pred CCC---------CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 218 GGQ---------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 218 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
... -+..-..+...++.++|..||++|.+.++.+..+
T Consensus 299 k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 299 RAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred CCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000 1123344677889999999999999999988764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=252.40 Aligned_cols=178 Identities=26% Similarity=0.403 Sum_probs=130.8
Q ss_pred eEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccC
Q 021507 53 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132 (311)
Q Consensus 53 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 132 (311)
+||-||||+..+|.+++.++... -.....|+++.+|++||+|+|+.+ +|||||||.||+++.++.|||+|||++...
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhh
Confidence 48999999985566655444321 146789999999999999999655 999999999999999999999999999761
Q ss_pred C----------------CCCCcceeccccccccccCccccccCC---CCCCCceehhHHHHHHHHhCCCccCCCccchhh
Q 021507 133 P----------------TGDRTHVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 193 (311)
Q Consensus 133 ~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 193 (311)
. ........+..+||..|+|||++.+.. |+.|+|+||||+||+||+. ||+..-+.
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--- 821 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--- 821 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH---
Confidence 1 001111344678999999999997754 9999999999999999986 46543211
Q ss_pred hhhhhccccccchhhhhHhhh-cccC--CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 194 SLVDWAKPYLSDKRKLFRIMD-TKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
......+. ..++ ..+.......-..+|+.||+.||.+||||.|+|+
T Consensus 822 -------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 822 -------------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred -------------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 00111111 1111 1223344556678999999999999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=211.68 Aligned_cols=164 Identities=25% Similarity=0.346 Sum_probs=137.9
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 19 LLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
....+...+|+.+..+. .+|.+|.+|+.+...+..|+.||.++. ||..+-.. .....+++..+-+|+..+++||.|
T Consensus 85 ~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~ 163 (282)
T KOG0984|consen 85 SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEF 163 (282)
T ss_pred hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHH
Confidence 44556677888887776 799999999999999999999999975 88776533 233459999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc----CCCCCCCceehhH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFG 171 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG 171 (311)
||++ -.++|||+||+|||++.+|+||+||||++..+.+.. ..+...|...|||||.+.. ..|+.+|||||||
T Consensus 164 L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLG 239 (282)
T KOG0984|consen 164 LHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLG 239 (282)
T ss_pred HHHH-hhhhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhh
Confidence 9985 569999999999999999999999999998754432 1223568889999998754 3689999999999
Q ss_pred HHHHHHHhCCCccCCC
Q 021507 172 VVLLELLSGRCAVDKT 187 (311)
Q Consensus 172 ~il~~l~~g~~pf~~~ 187 (311)
++++||.+++.||+..
T Consensus 240 ItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 240 ITMIEMAILRFPYESW 255 (282)
T ss_pred hhhhhhhhcccccccc
Confidence 9999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=230.82 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=177.9
Q ss_pred hhHHHhHHHHHHh-hhhHHHHH--HHHHHHHHHHhcC--CCCCccceEeEEEeC----CeeEEEEecCCCCChHHHhhhc
Q 021507 2 FLFNFLHSHLELH-ARSLLLIT--NWFQTEVNYLGQL--HHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 2 ~~~~~~~~~~~~~-~~~~~~~~--~~~~~E~~~l~~l--~hpnIv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
||.||..++..-. +.++...+ +.+.||.+|++.. +|+||+.+++.-..+ ..+|||++|.+.|||.|+|.+
T Consensus 224 yGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r- 302 (513)
T KOG2052|consen 224 FGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR- 302 (513)
T ss_pred ccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-
Confidence 7888888776533 44444333 3577899999887 999999999876543 246999999999999999965
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhh------CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC--cceeccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHD------AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--THVSTQV 144 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~------~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~ 144 (311)
..++.+..++++..++.||++||. .+..|.|||||..||||.++|.+-|+|+|+|........ .......
T Consensus 303 --~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~r 380 (513)
T KOG2052|consen 303 --NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPR 380 (513)
T ss_pred --ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCc
Confidence 349999999999999999999994 234699999999999999999999999999976543321 1223456
Q ss_pred cccccccCccccccCC----C-C-CCCceehhHHHHHHHHhC----------CCccCCCccchhhhhhhhccccccchhh
Q 021507 145 MGTHGYAAPEYVATGR----L-T-TKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRK 208 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~----~-~-~~~Di~slG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 208 (311)
+||.+|||||++...- + + ..+||||||.++||++.. ++||.+.. |......+
T Consensus 381 VGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V------------p~DPs~ee 448 (513)
T KOG2052|consen 381 VGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV------------PSDPSFEE 448 (513)
T ss_pred cceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC------------CCCCCHHH
Confidence 8999999999996532 2 1 258999999999999862 23443211 11111122
Q ss_pred hhHhhhcc-cCCCC-----chHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 209 LFRIMDTK-LGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 209 ~~~~~~~~-~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
+.+.+-.. .+... ...+-..+..+|+.||..||..|.|+--+.+.|.++..
T Consensus 449 MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 449 MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22221111 11111 23456678899999999999999999999999988753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=218.41 Aligned_cols=217 Identities=23% Similarity=0.326 Sum_probs=181.5
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeC-CeeEEEEecCCCCChHHHhhh------cCCCCCCHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFR------RGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
...+..|..++..+.|||+.++.++..+. ...++++.+..-|+|..++.. ...+.++..+...++.|++.|++
T Consensus 331 v~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~ 410 (563)
T KOG1024|consen 331 VNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAME 410 (563)
T ss_pred HHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999998754 567889999988999999962 23456788888899999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 174 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 174 (311)
|||+++ +||.||-..|++|++...|||+|-.+++-.-..+.............||++|.+....|+.++|+||||+++
T Consensus 411 hlh~~~--ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 411 HLHNHG--VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred HHHhcC--cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 999765 999999999999999999999999999865444433334444567789999999999999999999999999
Q ss_pred HHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 175 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 175 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|||+| |+.||..-+. .++...+..+.+...|.+|++++..+|..||...|++||+++++..-
T Consensus 489 WELmtlg~~PyaeIDP-----------------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDP-----------------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred HHHHhcCCCCccccCH-----------------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 99999 9999875432 23334445555666788999999999999999999999999999998
Q ss_pred HHhh
Q 021507 254 LERL 257 (311)
Q Consensus 254 l~~~ 257 (311)
|..+
T Consensus 552 LseF 555 (563)
T KOG1024|consen 552 LSEF 555 (563)
T ss_pred HHHH
Confidence 8765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=250.57 Aligned_cols=199 Identities=17% Similarity=0.197 Sum_probs=132.3
Q ss_pred EeCCeeEEEEecCCCCChHHHhhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCC
Q 021507 48 LEGENRLLVYEFMPKGSLENHLFRRGPQ------------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 109 (311)
Q Consensus 48 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlk 109 (311)
..+...++||||+.+++|.+++...... ......+..++.|++.||+|||+. +|+|||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~--gIiHRDLK 282 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST--GIVHRDVK 282 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC--CEEeCcCC
Confidence 3456789999999999999988643210 112344667999999999999965 59999999
Q ss_pred CCceEeCC-CCcEEEecccccccCCCCCCcceeccccccccccCccccccC----------------------CCCCCCc
Q 021507 110 ASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----------------------RLTTKSD 166 (311)
Q Consensus 110 p~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 166 (311)
|+|||++. ++.+||+|||+++........ ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 578999999999754332221 23456789999999976432 2334669
Q ss_pred eehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC------CchHHHHHHHHHHHhcccCC
Q 021507 167 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ------YPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 167 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~ 240 (311)
||||||++|||+++..+++.........+.. ...+...+........... ..........+||.+||..|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKR----NDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHh----cCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999999877655322111111100 0000111111111110000 01112335668999999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|++|||+.+++++
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=216.76 Aligned_cols=209 Identities=29% Similarity=0.463 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.++...|-.+..+- +||.+|-++..|..+..+++|.||++||+|--++++. +.++++.+..+...|+.||.|||+++
T Consensus 294 idwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg 371 (593)
T KOG0695|consen 294 IDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG 371 (593)
T ss_pred chhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC
Confidence 35677888888887 7999999999999999999999999999998777544 34999999999999999999999654
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
|+.||||.+|||++..|.+||+|+|.++.-... .....+++||+.|.|||++.|..|+.+.|.|+||++++||+.|
T Consensus 372 --iiyrdlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmag 447 (593)
T KOG0695|consen 372 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 447 (593)
T ss_pred --eeeeeccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcC
Confidence 999999999999999999999999999864332 2346678999999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
+.||+.-... .+......-+++++..+ .-..|...+-....+++..|++||.+|..
T Consensus 448 rspfdivgm~---------n~d~ntedylfqvilek-qiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 448 RSPFDIVGMD---------NPDMNTEDYLFQVILEK-QIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred CCCcceecCC---------CcccchhHHHHHHHhhh-cccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 9999753321 11122223333333222 12456667777888999999999999963
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=231.74 Aligned_cols=245 Identities=20% Similarity=0.148 Sum_probs=179.6
Q ss_pred hhHHHhHHHHHHhhhh-------HHHHHHHHHHHHHHHhcCC------CCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 2 FLFNFLHSHLELHARS-------LLLITNWFQTEVNYLGQLH------HPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 2 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
||+|..|.+.+-.... .+..-+.-++|++||++|+ --|+++++-.|...+++|||+|-+.. +|.+.
T Consensus 445 Fs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Lsl-NLRev 523 (752)
T KOG0670|consen 445 FSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREV 523 (752)
T ss_pred eeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhc-hHHHH
Confidence 7788777776643221 1223345668999999995 35899999999999999999999965 99999
Q ss_pred hhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcceeccccc
Q 021507 69 LFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 69 l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
|+..+ ..++....+..++.|++.||..|-. +||+|.||||+||||++.. .+||||||.|.....+... -..-
T Consensus 524 LKKyG~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit----PYLV 597 (752)
T KOG0670|consen 524 LKKYGRNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT----PYLV 597 (752)
T ss_pred HHHhCcccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCcceeeeccCcccccccccccc----HHHH
Confidence 97644 3568889999999999999999995 5599999999999998764 5799999999876544322 2234
Q ss_pred cccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhc-cc---------------------cc-
Q 021507 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA-KP---------------------YL- 203 (311)
Q Consensus 147 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~---------------------~~- 203 (311)
+..|.|||++.|.+|+...|+||.||+|||+.||+..|.+...+....+.... .+ ++
T Consensus 598 SRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~ 677 (752)
T KOG0670|consen 598 SRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLY 677 (752)
T ss_pred HHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEE
Confidence 66899999999999999999999999999999999999876543221111000 00 00
Q ss_pred ------------------cchhhhhHhhhccc-CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 204 ------------------SDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 204 ------------------~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..-..+...+.... ...-....-..+.+|+.+||..||++|.|+.++|++
T Consensus 678 ~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 678 IEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred EeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 00011111111110 111123456789999999999999999999999865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=255.56 Aligned_cols=199 Identities=20% Similarity=0.203 Sum_probs=140.3
Q ss_pred HhcCCC-CCccceEeEEE-------eCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 32 LGQLHH-PNLVKLIGYCL-------EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 32 l~~l~h-pnIv~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
.+.++| +||+.++++|. +...++.++||+ +++|.++|... ...+++.+++.++.||+.||+|||+. +|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~--gI 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ--GI 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC--Ce
Confidence 456667 68888999872 334567889988 55999999643 34599999999999999999999964 59
Q ss_pred eecCCCCCceEeCCCC-------------------cEEEecccccccCCCCCC--------------cceeccccccccc
Q 021507 104 IYRDFKASNILLDAEF-------------------NAKLSDFGLAKAGPTGDR--------------THVSTQVMGTHGY 150 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~-------------------~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y 150 (311)
+||||||+|||++..| .+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 455666666643211000 0001123578899
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
+|||++.+..++.++|||||||++|||++|..|+......... +.. .... ...........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~---------------~~~---~~~~-~~~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSS---------------LRH---RVLP-PQILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHH---------------HHH---hhcC-hhhhhcCHHHH
Confidence 9999999999999999999999999999998887532110000 000 0000 00011123456
Q ss_pred HHHHhcccCCCCCCCCHHHHHHH
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.++.+||..||.+||++.+++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 88899999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=201.60 Aligned_cols=165 Identities=25% Similarity=0.245 Sum_probs=125.4
Q ss_pred CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceec
Q 021507 63 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142 (311)
Q Consensus 63 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 142 (311)
|+|.+++..++ ..+++..++.++.|++.||+|||+.+ ||+||+++.++.+|+ ||.+......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-------
Confidence 58999996543 45999999999999999999999643 999999999999999 9998764332
Q ss_pred cccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc--CCC
Q 021507 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQ 220 (311)
Q Consensus 143 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 220 (311)
...|++.|+|||++.+..++.++|||||||++|||++|..||........ .. ..+........ ...
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~-----------~~~~~~~~~~~~~~~~ 130 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-IL-----------EILLNGMPADDPRDRS 130 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HH-----------HHHHHHhccCCccccc
Confidence 12578999999999999999999999999999999999999965432100 00 00000000000 001
Q ss_pred CchHHHH--HHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 221 YPQKAAH--TAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 221 ~~~~~~~--~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
.+..+.. .+.+++.+||..||.+||++.++++++..+
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 1233444 699999999999999999999999988765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=201.16 Aligned_cols=242 Identities=18% Similarity=0.263 Sum_probs=172.4
Q ss_pred hhHHHhHHHHHHhhhhHHH-----HHHHHHHHHHHHhcCC-CCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcC
Q 021507 2 FLFNFLHSHLELHARSLLL-----ITNWFQTEVNYLGQLH-HPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
||.||-...+.-+.+++.. -.+.+.+|++||+.|. ||||+++++++.+. ....+|+||+.+.+...+.
T Consensus 51 YSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---- 126 (338)
T KOG0668|consen 51 YSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---- 126 (338)
T ss_pred HhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh----
Confidence 5666666655544333322 1335889999999996 99999999999865 4567999999987766654
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcceeccccccccccC
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
..++...+..++.++++||.|+|+.| |.|||+||.|++|+... .++|+|+|+|..+....... -.+.+..|--
T Consensus 127 -~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKG 200 (338)
T KOG0668|consen 127 -PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKG 200 (338)
T ss_pred -hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCceee---eeeehhhcCC
Confidence 23788889999999999999999866 99999999999998654 59999999998765543332 2245667889
Q ss_pred ccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-----------hhhhccccccc-hhhhhHhhh-----
Q 021507 153 PEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-----------LVDWAKPYLSD-KRKLFRIMD----- 214 (311)
Q Consensus 153 PE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----------~~~~~~~~~~~-~~~~~~~~~----- 214 (311)
||.+... .|+.+-|+|||||++..|++.+.||.....+.++- +..+...+.-. ......++.
T Consensus 201 PELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk 280 (338)
T KOG0668|consen 201 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRK 280 (338)
T ss_pred chheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccc
Confidence 9988765 58889999999999999999999986554433221 00111110000 001111111
Q ss_pred ---cccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 215 ---TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 215 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.-.......-++++..+|+.++|..|-++|+|+.|++.+
T Consensus 281 ~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 281 PWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111122223456899999999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-31 Score=227.51 Aligned_cols=177 Identities=23% Similarity=0.343 Sum_probs=147.2
Q ss_pred ChhHHHhHHHHHHhhhhHHH-HH------H-H--------HHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEecC-
Q 021507 1 MFLFNFLHSHLELHARSLLL-IT------N-W--------FQTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFM- 60 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~-~~------~-~--------~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~- 60 (311)
|||+||+|-|-+-+...+.+ +. + + .--|++||..|+ |+||++++++|++++.+|++||--
T Consensus 573 AyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg 652 (772)
T KOG1152|consen 573 AYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHG 652 (772)
T ss_pred ccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCC
Confidence 68999999887755322211 11 1 1 225999999997 999999999999999999999975
Q ss_pred CCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce
Q 021507 61 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140 (311)
Q Consensus 61 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 140 (311)
+|-+|.++|.... .+++.++..|+.|++.|+++||+.+ |||||||-+||+++.+|.+||+|||.+.+...+.
T Consensus 653 ~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgsaa~~ksgp---- 724 (772)
T KOG1152|consen 653 EGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP---- 724 (772)
T ss_pred CCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccchhhhcCCC----
Confidence 4568999996554 3999999999999999999999765 9999999999999999999999999997644332
Q ss_pred eccccccccccCccccccCCCC-CCCceehhHHHHHHHHhCCCccC
Q 021507 141 STQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVD 185 (311)
Q Consensus 141 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~ 185 (311)
...++||..|.|||++.|.+|- ..-|||+||+++|.++....||-
T Consensus 725 fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 725 FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 4467899999999999998874 46899999999999999888874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=221.97 Aligned_cols=223 Identities=20% Similarity=0.217 Sum_probs=151.5
Q ss_pred HHHHHHHHHhcCCCCCc-----cceEeEEEe--------CCeeEEEEecCCCCChHHHhhhcCC----------------
Q 021507 24 WFQTEVNYLGQLHHPNL-----VKLIGYCLE--------GENRLLVYEFMPKGSLENHLFRRGP---------------- 74 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnI-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------- 74 (311)
.+..|+.++.+++|.++ ++++++|.. .+..|+||||+.+++|.+++.....
T Consensus 218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l 297 (507)
T PLN03224 218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI 297 (507)
T ss_pred hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence 34457777778866554 566676653 3567999999999999998854210
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 75 ------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 75 ------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
..+++..+..++.|++.+|.|||+. +|+||||||+||+++.++.+||+|||++......... ......+++
T Consensus 298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~--~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp 374 (507)
T PLN03224 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRI--GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDP 374 (507)
T ss_pred hhhcccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCc
Confidence 1246678889999999999999965 4999999999999999999999999999754332211 111234478
Q ss_pred cccCccccccCC--------------------C--CCCCceehhHHHHHHHHhCCC-ccCCCccchhhhhhhhccccccc
Q 021507 149 GYAAPEYVATGR--------------------L--TTKSDVYSFGVVLLELLSGRC-AVDKTKVGIEQSLVDWAKPYLSD 205 (311)
Q Consensus 149 ~y~aPE~~~~~~--------------------~--~~~~Di~slG~il~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~ 205 (311)
.|+|||.+.... + ..+.|+||+||++|+|++|.. ||......... . .....+
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~----~~~~~~ 449 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-L----RQYDND 449 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-H----hhccch
Confidence 999999875432 1 124799999999999999875 76542211000 0 000001
Q ss_pred hhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCC---CCCCCHHHHHHHH
Q 021507 206 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP---KLRPRMSEVLAIL 254 (311)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rpt~~~~l~~l 254 (311)
...+................+....+|+.+||..+| .+|+|+++++++-
T Consensus 450 ~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 450 LNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred HHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 111111111122222344578899999999999866 6899999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=197.26 Aligned_cols=178 Identities=34% Similarity=0.531 Sum_probs=155.4
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+++++.++|++|+++++++......++++|++.|++|.+++.... ..++...++.++.+++.++++||+.
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~-- 111 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN-- 111 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4678999999999999999999999999899999999999899999986542 3489999999999999999999965
Q ss_pred CeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHh
Q 021507 102 QVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||..... ..+.++|+|+||++++++
T Consensus 112 ~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-- 187 (215)
T cd00180 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-- 187 (215)
T ss_pred CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--
Confidence 5999999999999999 89999999999976543321 12334578889999998777 788899999999999998
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..+.+++.+||..||++||++.++++.
T Consensus 188 -----------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=200.09 Aligned_cols=230 Identities=23% Similarity=0.327 Sum_probs=161.7
Q ss_pred hhHHHhHHHHHHhhhhH-------HHHHHHHHHHHHHHhcC-CCCCccceEeE-EEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 2 FLFNFLHSHLELHARSL-------LLITNWFQTEVNYLGQL-HHPNLVKLIGY-CLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 2 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~E~~~l~~l-~hpnIv~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
||.+.||+|..-+...+ ....++|.+|...--.| -|.||+..|++ |+..+.+++++||++-|+|.+-+..
T Consensus 37 FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~- 115 (378)
T KOG1345|consen 37 FGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA- 115 (378)
T ss_pred eeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-
Confidence 55566666655432222 22345688888776677 58999998876 5566777899999999999987744
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC--CCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
.++-+....+++.|++.|+.|||+.+ +||||||.+||||.. .-.|||||||.++..+.. ......+..|
T Consensus 116 --~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y 186 (378)
T KOG1345|consen 116 --AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNY 186 (378)
T ss_pred --ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce-----ehhhhhhccc
Confidence 34889999999999999999999765 999999999999943 346999999999764332 3334457789
Q ss_pred cCccccccC-----CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH
Q 021507 151 AAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 225 (311)
Q Consensus 151 ~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
.+||..... ...+.+|+|.||+++|.++||..||+.... .......| ..+.+......+. .-...
T Consensus 187 ~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~--------~~w~~rk~~~~P~-~F~~f 256 (378)
T KOG1345|consen 187 HAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEW--------EQWLKRKNPALPK-KFNPF 256 (378)
T ss_pred CCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHH--------HHHhcccCccCch-hhccc
Confidence 999977543 246689999999999999999999984332 11111111 1111111111111 11235
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
+..+..+.++-|..++++|--..++.
T Consensus 257 s~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred CHHHHHHHHHhcCCcccccchhHHHH
Confidence 67788899999999999994333333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=221.64 Aligned_cols=227 Identities=26% Similarity=0.313 Sum_probs=173.9
Q ss_pred hhHHHhHHHHHHh---hhhHHH--H---HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 2 FLFNFLHSHLELH---ARSLLL--I---TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 2 ~~~~~~~~~~~~~---~~~~~~--~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
||-||-+++.... +.++.+ . ..-+..|+-+++..+||||+.+++.+......|++||||.||+|.+.-+-.
T Consensus 28 ygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~T- 106 (829)
T KOG0576|consen 28 YGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT- 106 (829)
T ss_pred ccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec-
Confidence 5667777665543 222111 1 122557999999999999999999999999999999999999999965434
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
.++++.++..++...++||+|||+.+ -+|||||-.||+++..|.+|+.|||.+..+.... ...+.++||+.||||
T Consensus 107 -gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmap 181 (829)
T KOG0576|consen 107 -GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAP 181 (829)
T ss_pred -ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccch
Confidence 35999999999999999999999655 8999999999999999999999999987654322 235678999999999
Q ss_pred ccc---ccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC-----CCCchHH
Q 021507 154 EYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-----GQYPQKA 225 (311)
Q Consensus 154 E~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 225 (311)
|+. ..+.|...+|||++|++..|+-.-++|-...... +.+ .+..+.. ...+..-
T Consensus 182 Evaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm----------------r~l--~LmTkS~~qpp~lkDk~kw 243 (829)
T KOG0576|consen 182 EVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM----------------RAL--FLMTKSGFQPPTLKDKTKW 243 (829)
T ss_pred hHHHHHhcccccccccccccccchhhhhhcCCcccccchH----------------HHH--HHhhccCCCCCcccCCccc
Confidence 976 3467899999999999999998877775432110 000 0111111 1122345
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
+..+.+|++.+|.++|++||+++.++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 778999999999999999999988764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=196.27 Aligned_cols=245 Identities=24% Similarity=0.266 Sum_probs=173.0
Q ss_pred hhHHHhHHHHHH---------hhhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 2 FLFNFLHSHLEL---------HARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 2 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
|++|+.+...+- +.-.....-..+.+|+++|..+ .+.||+++.+.+..++...+|+||++...-.++...
T Consensus 49 Fssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~ 128 (418)
T KOG1167|consen 49 FSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS 128 (418)
T ss_pred hhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc
Confidence 788888877771 1222223345588999999999 699999999999999999999999999888887632
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC-CcEEEecccccccCCCCC--------------
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGD-------------- 136 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~-------------- 136 (311)
++...+..++..++.||+++|+ +|||||||||.|+|.+.. +.-.|+|||++.......
T Consensus 129 -----l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~ 201 (418)
T KOG1167|consen 129 -----LSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHAT 201 (418)
T ss_pred -----CCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCC
Confidence 7788999999999999999995 569999999999999765 568999999997210000
Q ss_pred -------------------C---------cceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCC
Q 021507 137 -------------------R---------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKT 187 (311)
Q Consensus 137 -------------------~---------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~ 187 (311)
. ........||++|+|||++... ..+++.||||-|+|+..+++++.||...
T Consensus 202 ~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 202 PAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccC
Confidence 0 0001123599999999998775 5688999999999999999999999643
Q ss_pred ccchhh--hhh----------------h--hcc-c---cccchhhhhHhh-----hcc-----cCCCCchHHHHHHHHHH
Q 021507 188 KVGIEQ--SLV----------------D--WAK-P---YLSDKRKLFRIM-----DTK-----LGGQYPQKAAHTAATLA 233 (311)
Q Consensus 188 ~~~~~~--~~~----------------~--~~~-~---~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~l~~li 233 (311)
...... +.. . ... . ...+...-+..+ .+. .........+..+.+|+
T Consensus 282 ~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlL 361 (418)
T KOG1167|consen 282 KDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLL 361 (418)
T ss_pred ccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHH
Confidence 321110 000 0 000 0 000000011111 000 00111223455899999
Q ss_pred HhcccCCCCCCCCHHHHHHH
Q 021507 234 LQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||..||.+|.|++++|++
T Consensus 362 dk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 362 DKCLELNPQKRITAEDALKH 381 (418)
T ss_pred HHHccCChhhcccHHHHhcC
Confidence 99999999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=186.70 Aligned_cols=162 Identities=33% Similarity=0.422 Sum_probs=140.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++.+++++|+|++++++++......++++|++.+++|.+++...... +++..+..++.+++.++.+||+.
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~- 117 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL- 117 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4567899999999999999999999999889999999999999999998654322 78999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccc-ccCCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+++|+||+|.||+++.++.++|+|||.+......... ......++..|++||.+ ....++.++|+|+||+++|+|++
T Consensus 118 -~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 118 -GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred -CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH
Confidence 5999999999999999999999999999875443210 12334677889999998 66677889999999999999999
Q ss_pred CCCccCC
Q 021507 180 GRCAVDK 186 (311)
Q Consensus 180 g~~pf~~ 186 (311)
|+.||..
T Consensus 196 g~~pf~~ 202 (225)
T smart00221 196 GPEPFSG 202 (225)
T ss_pred CCCCccc
Confidence 9999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-27 Score=214.25 Aligned_cols=215 Identities=20% Similarity=0.268 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCee
Q 021507 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 104 (311)
Q Consensus 25 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 104 (311)
+..|..+-..|.|+|++.....+.+....+-.||||++ +|..++.... .++...+..+++|++.|++|+|+.+ |.
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G--ia 442 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG--LA 442 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC--ce
Confidence 66788888899999999988887776666666999999 9999996653 3888899999999999999999765 99
Q ss_pred ecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceeccccccccccCccccccCCCCC-CCceehhHHHHHHHHhCC
Q 021507 105 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTT-KSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 105 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~ 181 (311)
|||||++|++++.+|.+||+|||.+......... ......+|+..|+|||++.+..|+. ..||||.|++++.|++|+
T Consensus 443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 9999999999999999999999999876544433 4556788999999999999999887 579999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||............ ........+.. -.......++.+.+.+|.+||+.||.+|.|+++|++.
T Consensus 523 ~~Wk~a~~~~~~~~~-------~~~~~~~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKT-------NNYSDQRNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred Cccccccccccchhh-------hcccccccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 999754432221100 00000000000 0011223567788999999999999999999999863
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=178.68 Aligned_cols=214 Identities=22% Similarity=0.392 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
.++.++|..|.-.|+-+.||||+.+++.|....++.++..|++.|+|+..+........+..++.+++.+++.|++|||+
T Consensus 228 ~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhs 307 (448)
T KOG0195|consen 228 ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS 307 (448)
T ss_pred hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh
Confidence 45677899999999999999999999999999999999999999999999987776668888999999999999999999
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEe--cccccccCCCCCCcceeccccccccccCccccccCCCC---CCCceehhHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLS--DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT---TKSDVYSFGVV 173 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Di~slG~i 173 (311)
...-|----|....++++++.+.+|. |--++.. .......+.||+||.+...+.+ .++|+|||+++
T Consensus 308 lep~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfail 378 (448)
T KOG0195|consen 308 LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAIL 378 (448)
T ss_pred cchhhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHH
Confidence 76545555788999999998776653 3222211 1223457899999999876543 37899999999
Q ss_pred HHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 174 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+||+.|...||..-.. .+--.++-...++...|++++..+..|+.-|+..||.+||.++.++-.
T Consensus 379 lwel~trevpfadlsp----------------mecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpi 442 (448)
T KOG0195|consen 379 LWELNTREVPFADLSP----------------MECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPI 442 (448)
T ss_pred HHHhhccccccccCCc----------------hhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhh
Confidence 9999999999976332 111123334455667789999999999999999999999999999988
Q ss_pred HHhh
Q 021507 254 LERL 257 (311)
Q Consensus 254 l~~~ 257 (311)
|+++
T Consensus 443 lekm 446 (448)
T KOG0195|consen 443 LEKM 446 (448)
T ss_pred HHHh
Confidence 8875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=186.27 Aligned_cols=243 Identities=21% Similarity=0.192 Sum_probs=180.3
Q ss_pred ChhHHHhHHHHHHh----hhhHHHHH-----HHHHHHHHHHhcCC----CCCccceEeEE-EeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH----ARSLLLIT-----NWFQTEVNYLGQLH----HPNLVKLIGYC-LEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~~~~~~~~-----~~~~~E~~~l~~l~----hpnIv~~~~~~-~~~~~~~lv~e~~~~~~L~ 66 (311)
|||+||++.+.+.. +.+.+... ..+..|..++..+. ..++..+++.+ ..+...|+||+.+ |.+|.
T Consensus 30 ~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~ 108 (322)
T KOG1164|consen 30 GFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLE 108 (322)
T ss_pred CCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHH
Confidence 58888888866542 22222221 15778999999996 36999999999 5777889999999 78999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC-----CcEEEecccccc--cCCCCCCc-
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-----FNAKLSDFGLAK--AGPTGDRT- 138 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-----~~~kl~Dfg~~~--~~~~~~~~- 138 (311)
++........++..+++.++.|++.+|++||+.+ ++||||||+|+++... ..+.|.|||+++ .+......
T Consensus 109 dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~ 186 (322)
T KOG1164|consen 109 DLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGN 186 (322)
T ss_pred HHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcc
Confidence 9886666577999999999999999999999655 9999999999999765 359999999998 43222211
Q ss_pred ----ce-eccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhh
Q 021507 139 ----HV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 213 (311)
Q Consensus 139 ----~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (311)
.. .....||..|.++.+..+...+.+.|+||++.++.+++.|..||......... ....+..
T Consensus 187 ~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-------------~~~~~~~ 253 (322)
T KOG1164|consen 187 LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-------------SKFEKDP 253 (322)
T ss_pred cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-------------HHHHHHh
Confidence 11 22456999999999999999999999999999999999999999664421111 1111111
Q ss_pred hcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 214 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
............+.++..++..+-..+...+|....+...+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1111111233455677777777777999999999999998876543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=169.85 Aligned_cols=218 Identities=33% Similarity=0.462 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHHhcCCCC-CccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHP-NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..+.+.+|+.++..+.|+ +|+++++.+......+++++++.++++.+++..... ..+.......++.+++.++.++|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 567799999999999988 799999999877778999999999999977644331 258999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcc----eeccccccccccCcccccc---CCCCCCCceehh
Q 021507 99 AESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTH----VSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSF 170 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~sl 170 (311)
.+ ++|||+||+||+++..+ .++++|||.+.......... ......|+..|++||.+.+ ...+...|+|++
T Consensus 120 ~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~ 197 (384)
T COG0515 120 KG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197 (384)
T ss_pred CC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHH
Confidence 55 99999999999999998 69999999997544333221 2356789999999999988 578889999999
Q ss_pred HHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc----CCCCc----hHHHHHHHHHHHhcccCCCC
Q 021507 171 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL----GGQYP----QKAAHTAATLALQCLNNEPK 242 (311)
Q Consensus 171 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~l~~li~~~l~~~p~ 242 (311)
|++++++++|..||...... .........+.... ..... ......+.+++.+++..+|.
T Consensus 198 g~~~~~~~~~~~p~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (384)
T COG0515 198 GITLYELLTGLPPFEGEKNS-------------SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPK 264 (384)
T ss_pred HHHHHHHHhCCCCCCCCCcc-------------ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCch
Confidence 99999999999997765421 00000000000000 00111 12236788999999999999
Q ss_pred CCCCHHHHHHH
Q 021507 243 LRPRMSEVLAI 253 (311)
Q Consensus 243 ~Rpt~~~~l~~ 253 (311)
.|.+..+....
T Consensus 265 ~r~~~~~~~~~ 275 (384)
T COG0515 265 NRLSSSSDLSH 275 (384)
T ss_pred hcCCHHHHhhc
Confidence 99988877654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=174.74 Aligned_cols=216 Identities=25% Similarity=0.381 Sum_probs=161.9
Q ss_pred HhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCC
Q 021507 32 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 111 (311)
Q Consensus 32 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~ 111 (311)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.+.+.. ....+++.-...++.++++||+|+|...- ..|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccc
Confidence 4678999999999999999999999999999999999966 34568888999999999999999997542 399999999
Q ss_pred ceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC-------CCCCCceehhHHHHHHHHhCCCcc
Q 021507 112 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-------LTTKSDVYSFGVVLLELLSGRCAV 184 (311)
Q Consensus 112 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~g~~pf 184 (311)
|++++....+||+|||+.....................|.|||.+.+.. .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987653211111122233466799999997741 466799999999999999999999
Q ss_pred CCCccchhh-hhhhhccccccchhhhhHhhhcccCCCCc-h-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 185 DKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTKLGGQYP-Q-KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 185 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
+........ ..+..... ......+.... . ...+++..++.+||..+|.+||+++.+...++.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~----------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK----------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHh----------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 875432211 11111000 00000000111 1 344578999999999999999999999988876644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=161.64 Aligned_cols=217 Identities=19% Similarity=0.223 Sum_probs=170.0
Q ss_pred HHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 24 WFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 24 ~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+++.|.+.++.| ..+.|..+|.+..++.+..||+|.+ |.||+|++.-.+ +.|+..++..+++|++.-++++|++.
T Consensus 69 QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~-- 144 (449)
T KOG1165|consen 69 QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKD-- 144 (449)
T ss_pred hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcc--
Confidence 477899999999 5799999999999998999999999 789999875444 45999999999999999999999766
Q ss_pred eeecCCCCCceEeCCCC-----cEEEecccccccCCCCC-----CcceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 103 VIYRDFKASNILLDAEF-----NAKLSDFGLAKAGPTGD-----RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~-----~~kl~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
+|.|||||+|+||...+ .+.|+|||+++.+.+.. .....+..-||.+||+-....|...+.+.|+-|||-
T Consensus 145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 99999999999996543 48999999999876543 223345678999999999999999999999999999
Q ss_pred HHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC---CCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
++.+.+-|.+||.+-...... ....++-+++... .+..+++.++..-+.-.-..+-.+-|..+.
T Consensus 225 vFmYFLRGsLPWQGLKA~tnK-------------~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 225 VFMYFLRGSLPWQGLKADTNK-------------EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred hhhhhccCCCccccccCcchH-------------HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 999999999999875432111 1111221222111 122456778888888777778888888887
Q ss_pred HHHHHHhh
Q 021507 250 VLAILERL 257 (311)
Q Consensus 250 ~l~~l~~~ 257 (311)
+...+..+
T Consensus 292 lr~Lf~dv 299 (449)
T KOG1165|consen 292 LRKLFDDV 299 (449)
T ss_pred HHHHHHHH
Confidence 77665443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-22 Score=166.07 Aligned_cols=197 Identities=22% Similarity=0.297 Sum_probs=142.1
Q ss_pred CCCCccceEeEEEe---------------------------CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHH
Q 021507 36 HHPNLVKLIGYCLE---------------------------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 88 (311)
Q Consensus 36 ~hpnIv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 88 (311)
+|||||.++..|.+ +...|+||..++. +|..++-.+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 69999999988764 2346999999976 9999995543 566677778999
Q ss_pred HHHHHHHhhhCCCCeeecCCCCCceEe--CCCC--cEEEecccccccCCCCC----CcceeccccccccccCccccccCC
Q 021507 89 AAKGLTFLHDAESQVIYRDFKASNILL--DAEF--NAKLSDFGLAKAGPTGD----RTHVSTQVMGTHGYAAPEYVATGR 160 (311)
Q Consensus 89 i~~~l~~lH~~~~~ivH~dlkp~Nil~--~~~~--~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~ 160 (311)
+++|+.|||.++ |.|||+|.+|||+ +.++ .++|+|||++-...... .....-+.-|.-.-||||+....+
T Consensus 350 lLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 350 LLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999765 9999999999999 3343 37999999875422210 001112334677789999986532
Q ss_pred ------CCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHH
Q 021507 161 ------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 234 (311)
Q Consensus 161 ------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 234 (311)
.-.++|.|+.|.+.||+++...||-+..... ++. .. .........+..++..+++++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-----------L~~-r~----Yqe~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-----------LDT-RT----YQESQLPALPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-----------ech-hh----hhhhhCCCCcccCChHHHHHHH
Confidence 1248999999999999999999997633210 000 00 0111122456788999999999
Q ss_pred hcccCCCCCCCCHHHHHHHH
Q 021507 235 QCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 235 ~~l~~~p~~Rpt~~~~l~~l 254 (311)
..|+.||.+|++..=..+.|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999866555544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=174.55 Aligned_cols=153 Identities=18% Similarity=0.087 Sum_probs=109.9
Q ss_pred ChhHHHhHHHHHHh----hhh----------HHHHHHHHHHHHHHHhcCCCCCccc-eEeEEEeCCeeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH----ARS----------LLLITNWFQTEVNYLGQLHHPNLVK-LIGYCLEGENRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~~~----------~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~e~~~~~~L 65 (311)
+||+||++.+.... +.+ .....+.|.+|+++|++++|+||+. +++ .+..|+||||++|++|
T Consensus 30 ~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L 105 (365)
T PRK09188 30 VFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPL 105 (365)
T ss_pred CcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCH
Confidence 68899988654311 111 1123567999999999999999985 443 2457999999999999
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCC-CCCceEeCCCCcEEEecccccccCCCCCCcce----
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAKLSDFGLAKAGPTGDRTHV---- 140 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~---- 140 (311)
.. +.. .. ...++.+++++|.|||+. ||+|||| ||+|||++.++.+||+|||+++..........
T Consensus 106 ~~-~~~-----~~---~~~~~~~i~~aL~~lH~~--gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~ 174 (365)
T PRK09188 106 HL-ARP-----HG---DPAWFRSAHRALRDLHRA--GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAY 174 (365)
T ss_pred HH-hCc-----cc---hHHHHHHHHHHHHHHHHC--CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhh
Confidence 63 211 11 146788999999999965 5999999 99999999999999999999986543321111
Q ss_pred --eccccccccccCccccccCC------CCCCCcee
Q 021507 141 --STQVMGTHGYAAPEYVATGR------LTTKSDVY 168 (311)
Q Consensus 141 --~~~~~gt~~y~aPE~~~~~~------~~~~~Di~ 168 (311)
.....++..|+|||.+.-.. .+..+|-|
T Consensus 175 ~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 175 EDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 13456788899999885432 33446666
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=179.31 Aligned_cols=213 Identities=27% Similarity=0.311 Sum_probs=170.4
Q ss_pred ChhHHHhHHHHHHhhhhHH-------------HHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELHARSLL-------------LITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
.||.||+++...-+-.... ..+.....|..++...+ ||.+|+++..+..+...++++++..||.|.
T Consensus 6 ~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lf 85 (612)
T KOG0603|consen 6 SYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLF 85 (612)
T ss_pred CCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhh
Confidence 4788888887764311111 11113456888888886 999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
..+.... .+.+.....+...++.+++++|+.+ ++|+|+|++||+++.+|.+++.|||+++...... ..+|
T Consensus 86 t~l~~~~--~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cg 155 (612)
T KOG0603|consen 86 TRLSKEV--MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACG 155 (612)
T ss_pred hccccCC--chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhh------hccc
Confidence 8875443 4788888889999999999999654 9999999999999999999999999998654322 1288
Q ss_pred cccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 147 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|..|||||++. ....++|-||||++.++|++|..||... ....++..+ ...|...+
T Consensus 156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~~~--~~~p~~l~ 211 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILKAE--LEMPRELS 211 (612)
T ss_pred chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhhhc--cCCchhhh
Confidence 99999999997 5677899999999999999999999851 112222222 25678889
Q ss_pred HHHHHHHHhcccCCCCCCCCH
Q 021507 227 HTAATLALQCLNNEPKLRPRM 247 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~ 247 (311)
..+.+++..++..+|..|.-.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 999999999999999999744
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=187.14 Aligned_cols=206 Identities=22% Similarity=0.269 Sum_probs=148.6
Q ss_pred HHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecC
Q 021507 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 107 (311)
Q Consensus 28 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~d 107 (311)
|++ ...+++||++.+.-+.+.+...|||-+|... +|+|.|..+.. +...+...|+.|++.||..+|..+ |+|||
T Consensus 72 ~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~g--VcHGD 145 (1431)
T KOG1240|consen 72 EIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLG--VCHGD 145 (1431)
T ss_pred HHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcC--ccccc
Confidence 444 5556999999999888888888999999977 99999966654 777888899999999999999655 99999
Q ss_pred CCCCceEeCCCCcEEEeccccccc--CCCCCCcc---eeccccccccccCccccccC----------C-CCCCCceehhH
Q 021507 108 FKASNILLDAEFNAKLSDFGLAKA--GPTGDRTH---VSTQVMGTHGYAAPEYVATG----------R-LTTKSDVYSFG 171 (311)
Q Consensus 108 lkp~Nil~~~~~~~kl~Dfg~~~~--~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Di~slG 171 (311)
||.+||||+.=+.+.|+||...+- ...+.... ...+...-..|.|||.+... + .+++-||||+|
T Consensus 146 IKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G 225 (1431)
T KOG1240|consen 146 IKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG 225 (1431)
T ss_pred cccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence 999999999999999999976642 22111111 11112233469999977431 1 56788999999
Q ss_pred HHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
|++.|+++ |+++|.-... ..+- .......+.+..+. ....++.++..|++.||.+|.++++.
T Consensus 226 CViaELf~Eg~PlF~LSQL------~aYr----~~~~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedy 288 (1431)
T KOG1240|consen 226 CVIAELFLEGRPLFTLSQL------LAYR----SGNADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDY 288 (1431)
T ss_pred HHHHHHHhcCCCcccHHHH------HhHh----ccCccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHH
Confidence 99999998 7899874321 0000 00001111111111 12368899999999999999999999
Q ss_pred HHHHHh
Q 021507 251 LAILER 256 (311)
Q Consensus 251 l~~l~~ 256 (311)
|+.-+.
T Consensus 289 L~~yrG 294 (1431)
T KOG1240|consen 289 LQKYRG 294 (1431)
T ss_pred HHhhhc
Confidence 987444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=153.96 Aligned_cols=173 Identities=18% Similarity=0.129 Sum_probs=123.6
Q ss_pred ChhHHHhHHHHHHhhh-------hH---HHHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELHAR-------SL---LLITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~-------~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+|++....+.... .. ......|.+|+++|++|. |++|.+++++ +..|++|||+.|.+|...+
T Consensus 14 ~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~ 89 (218)
T PRK12274 14 TFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRP 89 (218)
T ss_pred CcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhh
Confidence 5778876666443321 00 112335889999999995 5889999886 3469999999998887543
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCC-CCCceEeCCCCcEEEecccccccCCCCCCc----c-----
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAKLSDFGLAKAGPTGDRT----H----- 139 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~----- 139 (311)
.. ....++.+++.+|.++|+.+ |+|||| ||+|||++.+|.++|+|||++......... .
T Consensus 90 ~~---------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~ 158 (218)
T PRK12274 90 PR---------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLR 158 (218)
T ss_pred hh---------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHH
Confidence 11 11357789999999999654 999999 799999999999999999999864432210 0
Q ss_pred --eeccccccccccCccccccC-CCC-CCCceehhHHHHHHHHhCCCccCCCc
Q 021507 140 --VSTQVMGTHGYAAPEYVATG-RLT-TKSDVYSFGVVLLELLSGRCAVDKTK 188 (311)
Q Consensus 140 --~~~~~~gt~~y~aPE~~~~~-~~~-~~~Di~slG~il~~l~~g~~pf~~~~ 188 (311)
.......++.|++|+...-. ..+ ...+.++.|+-+|.++|+..++-+.+
T Consensus 159 ~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 159 HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 01122367788888854332 333 45688899999999999998876544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=169.06 Aligned_cols=170 Identities=26% Similarity=0.373 Sum_probs=127.2
Q ss_pred CeeEEEEecCCCCChHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEeccccc
Q 021507 51 ENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129 (311)
Q Consensus 51 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 129 (311)
...|+.|++|.-.+|.+||.++ .....+......++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 3578999999999999999633 33457778889999999999999 34 999999999999999999999999999
Q ss_pred ccCCCCC----CcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhcccccc
Q 021507 130 KAGPTGD----RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS 204 (311)
Q Consensus 130 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 204 (311)
....... .........||.+||+||++.+..|+.++||||||++++|++. -...|.....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t--------------- 468 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT--------------- 468 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---------------
Confidence 7654443 1223445689999999999999999999999999999999998 2222221100
Q ss_pred chhhhhHhhhcccCCCCchH---HHHHHHHHHHhcccCCCCCCCCHH
Q 021507 205 DKRKLFRIMDTKLGGQYPQK---AAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
+.-.....+|+. -.+.-..|+.++|...|.+||++.
T Consensus 469 --------~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 469 --------LTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --------hhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 000000111211 112345899999999999999443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=145.31 Aligned_cols=217 Identities=19% Similarity=0.187 Sum_probs=163.8
Q ss_pred HHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 24 WFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 24 ~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
.+..|.++++.|+ ...|..+..++.+.....+||+.+ |.||++++.-.. +.++..+++-++.|++.-++|+|.+ +
T Consensus 56 qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r--~ 131 (341)
T KOG1163|consen 56 QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR--N 131 (341)
T ss_pred chhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh--c
Confidence 3667999999996 467777888888888999999999 789999875433 4599999999999999999999965 4
Q ss_pred eeecCCCCCceEeCCC---CcEEEecccccccCCCCC-----CcceeccccccccccCccccccCCCCCCCceehhHHHH
Q 021507 103 VIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD-----RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 174 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 174 (311)
++||||||+|+|+.-+ ..+.++|||+++.+.+.. .........||.+|.+-....+...+.+.|+-|+|.++
T Consensus 132 fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 132 FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 9999999999999643 468999999998764432 22334566899999998877777788899999999999
Q ss_pred HHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC---CCchHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
.++--|..||++....... ++.-++.+.+... ....+.+.++.-.+.-|-..--++-|....+.
T Consensus 212 mYfnrG~LPWQglka~tk~-------------QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylr 278 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKK-------------QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLR 278 (341)
T ss_pred eeeecCCCcccccchhhHH-------------HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHH
Confidence 9999999999986532211 1112222222211 12235577777788888777777788877776
Q ss_pred HHHHhh
Q 021507 252 AILERL 257 (311)
Q Consensus 252 ~~l~~~ 257 (311)
..+.-+
T Consensus 279 qlFriL 284 (341)
T KOG1163|consen 279 QLFRIL 284 (341)
T ss_pred HHHHHH
Confidence 655443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-20 Score=149.30 Aligned_cols=129 Identities=12% Similarity=0.181 Sum_probs=99.5
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeC--------CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEG--------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.+.+|++.+.++.|++|..+.+++... +..+++|||++|.+|.++.. +++ ....+++.+|..
T Consensus 81 ~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~ 150 (232)
T PRK10359 81 YYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIES 150 (232)
T ss_pred HHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHH
Confidence 478999999999999999999987643 35789999999999988631 333 245689999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 175 (311)
+|+. |++|||+||+||+++.+| ++|+|||........... ..+.....++.++|+|+||+++.
T Consensus 151 lH~~--gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 151 LHQH--GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLL 213 (232)
T ss_pred HHHc--CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeeh
Confidence 9965 599999999999999988 999999988654221110 00333445667999999999887
Q ss_pred HHHh
Q 021507 176 ELLS 179 (311)
Q Consensus 176 ~l~~ 179 (311)
.+..
T Consensus 214 ~~~~ 217 (232)
T PRK10359 214 IYKK 217 (232)
T ss_pred HHHH
Confidence 6543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.2e-20 Score=152.36 Aligned_cols=161 Identities=20% Similarity=0.283 Sum_probs=105.8
Q ss_pred EEEEecCCCCChHHHhh---hcCCC--CCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccc
Q 021507 54 LLVYEFMPKGSLENHLF---RRGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 128 (311)
Q Consensus 54 ~lv~e~~~~~~L~~~l~---~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 128 (311)
+++|+.+.+ +|.+++. ..... .+.......+..|+++.+++||+++ ++|+||+|+|++++.+|.++|+||+.
T Consensus 115 ~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~ 191 (288)
T PF14531_consen 115 FLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQDGGVFLGDFSS 191 (288)
T ss_dssp EEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TTS-EEE--GGG
T ss_pred hhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCCCCEEEcChHH
Confidence 678888865 9988763 22221 2333344556689999999999766 99999999999999999999999998
Q ss_pred cccCCCCCCcceeccccccccccCccccccC--------CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhcc
Q 021507 129 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200 (311)
Q Consensus 129 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 200 (311)
....+... .. ...+..|.+||..... .++.+.|.|+||+++|.|.+|..||+..........
T Consensus 192 ~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----- 261 (288)
T PF14531_consen 192 LVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----- 261 (288)
T ss_dssp EEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----
T ss_pred HeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----
Confidence 87643321 21 3345789999976442 467789999999999999999999986532111100
Q ss_pred ccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 201 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
.+ ..+. ++++.+..||..+|+.||.+|
T Consensus 262 ---------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ---------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ---------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 11 1233 789999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-19 Score=166.43 Aligned_cols=138 Identities=26% Similarity=0.344 Sum_probs=105.7
Q ss_pred HHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-------------ceeccccccccccCcccc
Q 021507 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------HVSTQVMGTHGYAAPEYV 156 (311)
Q Consensus 90 ~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~ 156 (311)
+.+++|+|+.+ |+|||+||+|.+|+.-|.+|++|||+++........ ...+..+||+.|+|||++
T Consensus 153 vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 77899999755 999999999999999999999999999753322111 112345899999999999
Q ss_pred ccCCCCCCCceehhHHHHHHHHhCCCccCCCccch-hhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHh
Q 021507 157 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI-EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 235 (311)
Q Consensus 157 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (311)
....|+...|.|++|+|+|+.+-|..||.+..... ...++.....+ .+-....+.++++++.+
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w----------------pE~dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW----------------PEEDEALPPEAQDLIEQ 294 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc----------------cccCcCCCHHHHHHHHH
Confidence 99999999999999999999999999998864211 11111111000 01123467789999999
Q ss_pred cccCCCCCCC
Q 021507 236 CLNNEPKLRP 245 (311)
Q Consensus 236 ~l~~~p~~Rp 245 (311)
+|+.+|..|-
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999997
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-18 Score=134.11 Aligned_cols=103 Identities=17% Similarity=0.258 Sum_probs=80.9
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL-HDAES 101 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~ 101 (311)
....+|++++.++.+++|.....+... ..++||||++|+++...+... ..++...+..++.|++.+|.++ |+.
T Consensus 64 ~~~~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~-- 137 (190)
T cd05147 64 TWAEKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC-- 137 (190)
T ss_pred HHHHHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 344569999999988887554433222 238999999987776543222 3588999999999999999999 654
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 132 (311)
||+||||||+||+++ ++.++|+|||++...
T Consensus 138 giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 138 RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 599999999999998 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=134.08 Aligned_cols=101 Identities=16% Similarity=0.156 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHhcC-----CCCCccceEeEEEeCC---eeE-EEEec--CCCCChHHHhhhcCCCCCCHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-----HHPNLVKLIGYCLEGE---NRL-LVYEF--MPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 90 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~ 90 (311)
.+.+.+|+++++++ +||||++++++++++. ..+ +|+|| +.+++|.+++.+. .+++. ..++.+++
T Consensus 40 ~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L 114 (210)
T PRK10345 40 DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLL 114 (210)
T ss_pred HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHH
Confidence 45689999999999 6799999999998873 434 78999 5578999999553 25555 35677888
Q ss_pred HHH-HHhhhCCCCeeecCCCCCceEeCCC----CcEEEeccccc
Q 021507 91 KGL-TFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLA 129 (311)
Q Consensus 91 ~~l-~~lH~~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~ 129 (311)
.++ +|||+++ |+||||||+||+++.. +.++|+||+.+
T Consensus 115 ~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 115 KKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 777 9999655 9999999999999743 37999995444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=131.06 Aligned_cols=106 Identities=17% Similarity=0.170 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
..++.+|.+.+.++.|++|.....+... ..|+||||++|+++....... ..++......++.+++.++.++|+. .
T Consensus 63 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~-~ 137 (190)
T cd05145 63 FAWAEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQE-A 137 (190)
T ss_pred HHHHHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHh-C
Confidence 3456789999999999988665554433 248999999987554432222 2478889999999999999999971 4
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 133 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 133 (311)
||+||||||+||+++ ++.++|+|||++....
T Consensus 138 givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 138 GLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 599999999999998 7899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3e-18 Score=157.75 Aligned_cols=218 Identities=25% Similarity=0.301 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+....|..+-+.+. |.|++.+++...+.+..++++++..|+++.+-+........+....-.++.|+..++.|+|.
T Consensus 63 ~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~- 141 (601)
T KOG0590|consen 63 SSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP- 141 (601)
T ss_pred hhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-
Confidence 3344555888888886 99999999999999999999999999999987732222246667778899999999999994
Q ss_pred CCCeeecCCCCCceEeCCCC-cEEEecccccccCCC-CCCcceeccccc-cccccCccccccC-CCCCCCceehhHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPT-GDRTHVSTQVMG-THGYAAPEYVATG-RLTTKSDVYSFGVVLL 175 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Di~slG~il~ 175 (311)
+.++.|+||||+|.+++..+ ..++.|||++..+.. ..........+| +..|+|||...+. ......|+||.|+++.
T Consensus 142 ~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~ 221 (601)
T KOG0590|consen 142 ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLS 221 (601)
T ss_pred ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccc
Confidence 34599999999999999999 999999999988766 444555566778 9999999999884 5567889999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
.+++|..||+....... ....|.. ..................+++.+++..+|..|.+.+++..
T Consensus 222 ~~~~g~~p~~~~~~~~~-~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 222 AMLTGELPWDFPSRKDG-RYSSWKS------------NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccCCCCccccccccc-cceeecc------------cccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 99999999976543221 0011100 0011122344567778889999999999999999988753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9e-17 Score=151.56 Aligned_cols=228 Identities=17% Similarity=0.152 Sum_probs=153.3
Q ss_pred ChhHHHhHHHHHHhhhhHHH------HHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELHARSLLL------ITNWFQTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
|||+||.+.+.+-+ ..+++ ..+.+. -.+++.+|+ -+-|..+...+...+..++|+||.+.|+|.+++.
T Consensus 710 ~y~~vy~a~~~~~~-~~alK~e~P~~~WEfYI-~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N- 786 (974)
T KOG1166|consen 710 SYGSVYVATHSNGK-LVALKVEKPPNPWEFYI-CLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN- 786 (974)
T ss_pred cceEEEEeecCCCc-EEEEEeecCCCceeeee-hHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-
Confidence 56777777766622 11111 112122 234445555 2334444444555667789999999999999996
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-------CCcEEEecccccccCCCCCCcceeccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------EFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
..+.+++..+..+..|++..++.||..+ |||+||||+|+||.. .-.++|+|||.+.-+.--.........
T Consensus 787 -~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~ 863 (974)
T KOG1166|consen 787 -TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAV 863 (974)
T ss_pred -cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeee
Confidence 4455999999999999999999999766 999999999999943 234899999998644322222345567
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK 224 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
++|..+--+|...|.+++...|.|.|+.+++.|++|+.-=. . +.. ...+.. .++.-
T Consensus 864 ~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-----------------~-~g~--~~~~~~----~~~Ry 919 (974)
T KOG1166|consen 864 WHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-----------------K-NGS--SWMVKT----NFPRY 919 (974)
T ss_pred eccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-----------------c-CCc--ceeccc----cchhh
Confidence 88999999999999999999999999999999999973210 0 000 000000 01111
Q ss_pred HH-HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 225 AA-HTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 225 ~~-~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.. +...+++..+|+.|-..=|.+.++...++.+.
T Consensus 920 ~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 920 WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 22 23455677777755555577888887776653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.4e-16 Score=144.36 Aligned_cols=97 Identities=22% Similarity=0.300 Sum_probs=85.8
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+++++.++|++|+....++.+....++||||++|++|.+++. ....++.+++.+|.+||+.
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~-- 447 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA-- 447 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC--
Confidence 3568899999999999999988887777778899999999999999874 3467899999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
+++||||||+||++ .++.++|+|||+++.
T Consensus 448 giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 448 GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 59999999999999 677899999999965
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=123.13 Aligned_cols=101 Identities=22% Similarity=0.317 Sum_probs=88.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|++++..+.|++|.....++...+..+++|||++|++|.+++.... . ....++.+++.+|.++|+.
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~-- 114 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA-- 114 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC--
Confidence 4568899999999999999888878777788899999999999999885422 1 7788999999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
+++|+|++|.||+++ ++.++|+|||.+..
T Consensus 115 ~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 115 GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 499999999999998 78899999998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-16 Score=129.44 Aligned_cols=203 Identities=23% Similarity=0.317 Sum_probs=139.2
Q ss_pred HHhcCCCCCccceEeEEEeCC-----eeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 31 YLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 31 ~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
-|-++.|.|||+++.|+.+.. ...+++||+..|+|..+|++. ....+....-.+|+.||+.||.|||+....+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344667999999999887543 467899999999999999653 2345778888899999999999999999999
Q ss_pred eecCCCCCceEeCCCCcEEEecccccccCCCCC--CcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 104 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
+|+++..+.|++..+|-+|++----...-..-. .........+.++|.+||.-.....+.++|||+||++..+|..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999999988875321111000000 000011234567899999877777888999999999999998876
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.--....... ............. ....-+.++.+||+..|..||++.+++-+
T Consensus 280 iq~tnseS~~-------------~~ee~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 280 IQSTNSESKV-------------EVEENIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eccCCCccee-------------ehhhhhhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 4321111000 0000000000000 01122468899999999999999998743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.2e-15 Score=119.78 Aligned_cols=98 Identities=20% Similarity=0.317 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++..+.|+++.....++...+..++||||++|++|.+++..... .++.+++.+|.+||+.
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~-- 109 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKA-- 109 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC--
Confidence 35678999999999988776666666677778999999999999998743211 7899999999999965
Q ss_pred CeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
+++|+|++|.||+++ ++.++++|||++..
T Consensus 110 gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 110 GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 499999999999998 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.9e-15 Score=122.02 Aligned_cols=103 Identities=17% Similarity=0.198 Sum_probs=80.1
Q ss_pred HHHHHHHHHHHHhcCCCC--CccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
+...+.+|++++.++.+. .+.+++++ . ..++||||+.|.+|....... ..+.......++.|++.+|++||+
T Consensus 93 ~~~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 93 VRLWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh
Confidence 344678999999999753 33444432 2 358999999998887654322 235666778999999999999995
Q ss_pred CCCC-eeecCCCCCceEeCCCCcEEEecccccccC
Q 021507 99 AESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAG 132 (311)
Q Consensus 99 ~~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 132 (311)
.+ ++|+||||+||+++ ++.++|+|||.+...
T Consensus 167 --~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 167 --EGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred --cCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 56 99999999999998 788999999998753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.6e-15 Score=120.77 Aligned_cols=101 Identities=26% Similarity=0.205 Sum_probs=79.8
Q ss_pred HHHHHHHHHHHhcCCCCCc--cceEeEEEeCCe----eEEEEecCCC-CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNL--VKLIGYCLEGEN----RLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~~~----~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
...+.+|++++.+|.|++| +..+++...... .++|||+++| .+|.+++... .++... +.+++.+|.
T Consensus 84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~ 156 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIA 156 (239)
T ss_pred hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHH
Confidence 3467889999999988775 667766443322 3599999997 6899887542 255443 568899999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
+||+. ||+|+||||+|||++.++.++|+|||.+..
T Consensus 157 ~lH~~--GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 157 RFHDA--GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHC--CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99965 599999999999999988999999998865
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.6e-14 Score=125.92 Aligned_cols=148 Identities=19% Similarity=0.256 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+..++.++.|+.++||||+++++.++.++..|+|+|.+. .|..++.+. ....+..-+.||+.||.|||. .
T Consensus 52 ~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~-d 123 (690)
T KOG1243|consen 52 VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEVCLGLFQILAALSFLND-D 123 (690)
T ss_pred hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhc-c
Confidence 34557788999999999999999999999999999999995 688877553 356677788999999999986 3
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
++++|++|.-+.|+|+..|..||++|.++........ ......--..|..|+.+.... ...|.|.|||++++++.|
T Consensus 124 ~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 124 CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 5699999999999999999999999988865432221 112222333466666542222 456999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.6e-14 Score=125.74 Aligned_cols=205 Identities=23% Similarity=0.271 Sum_probs=154.5
Q ss_pred HHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHH----HHHHhhhCC
Q 021507 26 QTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK----GLTFLHDAE 100 (311)
Q Consensus 26 ~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~----~l~~lH~~~ 100 (311)
.+|+...+.+ .|+|.++.+..+++.+..|+-+|+|. .+|.++...... -++....+....+... ||..+|+.
T Consensus 165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~- 241 (524)
T KOG0601|consen 165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN- 241 (524)
T ss_pred cchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC-
Confidence 3566666677 59999999999999999999999995 699998865543 2788888889999988 99999964
Q ss_pred CCeeecCCCCCceEeCCC-CcEEEecccccccCCCCCCcc---eeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTH---VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+++|.|+||.||+...+ ..++++|||+...+....-.. ......|...|++||.. .+-++.++|||+||.++.+
T Consensus 242 -~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 242 -NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILE 319 (524)
T ss_pred -cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHh
Confidence 49999999999999999 889999999998765544221 22233678899999987 4457789999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
..++......+... .| .+.-..-...++....+..+...+..|++.+|..|++++.+.+
T Consensus 320 ~~l~~~~~~~g~~~------~W-----------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 320 AILGSHLPSVGKNS------SW-----------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hHhhcccccCCCCC------Cc-----------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 99987665443110 00 0000000122233345666777999999999999999988875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=111.45 Aligned_cols=98 Identities=17% Similarity=0.065 Sum_probs=78.0
Q ss_pred HHHHHHHHHHHhcCCCC--CccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 22 TNWFQTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+|..++..+.|. .+...++ ....++||||++|++|...... .....++.+++.++.++|+.
T Consensus 77 ~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~ 144 (198)
T cd05144 77 RLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH 144 (198)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC
Confidence 34578899999999877 4444443 2456899999999998775421 23567889999999999964
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCC
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 133 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 133 (311)
+++|+||||+||+++.++.++|+|||.+....
T Consensus 145 --gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 --GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred --CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 59999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.6e-13 Score=104.00 Aligned_cols=101 Identities=21% Similarity=0.143 Sum_probs=86.1
Q ss_pred HHHHHHHHHHHhcCCC--CCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 22 TNWFQTEVNYLGQLHH--PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+|+.+++.+.+ .++.+++.++...+..+++|||+.|+.+..+ +......++.+++.+|+.+|..
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~ 105 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQL 105 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCC
Confidence 3568899999999976 5899999988887889999999998777653 4456677899999999999964
Q ss_pred C-CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 100 E-SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
. .+++|+|++|+||++++.+.++++|||.+..
T Consensus 106 ~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 2 4699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-11 Score=93.74 Aligned_cols=99 Identities=22% Similarity=0.300 Sum_probs=77.6
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
-.+.-.+|++++.++.--.|.-..=++.+.....|+|||++|..|.+.+... ...++..+-.-+.-||.
T Consensus 42 rr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~-- 110 (204)
T COG3642 42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHK-- 110 (204)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh--
Confidence 3445678999999996555544444555666778999999998898888544 24567777888889995
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
++|+|+||.++||++..++ +.++|||++..
T Consensus 111 ~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 111 AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 5599999999999997765 99999999964
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-11 Score=96.48 Aligned_cols=103 Identities=14% Similarity=0.186 Sum_probs=76.1
Q ss_pred HHHHHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCCCChHH-HhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 20 LITNWFQTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLEN-HLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
.+..+.++|++.|+++. .-++.+++++ ...++||||+.+..+.. .+.. ..++......+..+++.+|..|
T Consensus 68 ~~~~wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l 140 (197)
T cd05146 68 IIRMWAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQL 140 (197)
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHH
Confidence 34456779999999994 3566666654 45689999997643322 2221 1255566777889999999998
Q ss_pred -hhCCCCeeecCCCCCceEeCCCCcEEEecccccccC
Q 021507 97 -HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132 (311)
Q Consensus 97 -H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 132 (311)
|. .++||+||++.||++. ++.+.|+|||.+...
T Consensus 141 ~H~--~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 141 YKE--CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHh--CCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 75 4599999999999996 467999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-11 Score=97.68 Aligned_cols=97 Identities=20% Similarity=0.156 Sum_probs=70.3
Q ss_pred HHHHHHHhcCCCC--CccceEeEEEeCCeeEEEEecCCCCChHH-HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 26 QTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGSLEN-HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 26 ~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
..|.+.+.++.+. .+.++++. ...++||||++|+++.. .+.... .. .....++.+++.++.++|+. .+
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~-~~ 135 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYRE-AG 135 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhc-cC
Confidence 5677777777544 34555443 24689999999854322 111111 11 56788999999999999961 45
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAG 132 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 132 (311)
++|+||||+||+++ ++.++|+|||.+...
T Consensus 136 ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 136 LVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred cCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999999 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.2e-12 Score=119.04 Aligned_cols=192 Identities=24% Similarity=0.293 Sum_probs=141.1
Q ss_pred CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe
Q 021507 36 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 115 (311)
Q Consensus 36 ~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~ 115 (311)
.+|-++.....+.-....+++++|+.|++|...+++.+ ..+.+-....+..+..++++||+.. +.|+|++|.|+++
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLI 937 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch--hhcccccccchhh
Confidence 34555555444455667899999999999999886554 3566666677888899999999754 8999999999999
Q ss_pred CCCCcEEEecccccccCCCC-----------------------------CCcceeccccccccccCccccccCCCCCCCc
Q 021507 116 DAEFNAKLSDFGLAKAGPTG-----------------------------DRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 166 (311)
Q Consensus 116 ~~~~~~kl~Dfg~~~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 166 (311)
..+|..++.|||........ ..........+|+.|.+||...+......+|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 99999999999833221100 0001123457899999999999999999999
Q ss_pred eehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-c-CCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 167 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-L-GGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 167 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
.|++|+++++.++|..||...... ..++.+... . ....+...+.+..+++.+.|..+|.+|
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na~tpq-----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQ-----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCCcchh-----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhc
Confidence 999999999999999999865421 111111111 0 112234567788999999999999999
Q ss_pred CCHH
Q 021507 245 PRMS 248 (311)
Q Consensus 245 pt~~ 248 (311)
..+.
T Consensus 1081 ~~a~ 1084 (1205)
T KOG0606|consen 1081 LGAK 1084 (1205)
T ss_pred cCcc
Confidence 8766
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1e-10 Score=89.40 Aligned_cols=111 Identities=20% Similarity=0.217 Sum_probs=85.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCC-CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+++-++|+++|.++.--.|....-++.+...-.++|||++| .++.+++...............++..|-+.+.-||
T Consensus 51 kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH 130 (229)
T KOG3087|consen 51 KLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH 130 (229)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh
Confidence 34556778899999999755666555567777777899999987 47788886554433444444789999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCc---EEEeccccccc
Q 021507 98 DAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKA 131 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~ 131 (311)
. ++|+|+||..+||++..+|. +.++|||++..
T Consensus 131 ~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 131 D--NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred h--CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 5 55999999999999976653 58999999865
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-11 Score=111.26 Aligned_cols=160 Identities=20% Similarity=0.280 Sum_probs=112.8
Q ss_pred CHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce-------eccccccccc
Q 021507 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-------STQVMGTHGY 150 (311)
Q Consensus 78 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y 150 (311)
.-+....=+.+++.|+.|+|.+ .++||++|.|++|.++..|.+||+.|+++........+.. ..-......|
T Consensus 97 aTe~~f~nl~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f 175 (700)
T KOG2137|consen 97 ATEDGFANLGNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNF 175 (700)
T ss_pred cccHhhhhhhcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccc
Confidence 3344455566777999999974 5799999999999999999999999998865443211110 1112345579
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHH-hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
.|||++.+...+.++|+||||+++|.+. .|+.-+............ ..........+...++.++
T Consensus 176 ~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el 241 (700)
T KOG2137|consen 176 LAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSEL 241 (700)
T ss_pred ccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHH
Confidence 9999999988889999999999999998 566666543321111111 1111111122346788999
Q ss_pred HHHHHhcccCCCCCCCCHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
.+-+.+++..+...||++..+..
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhhc
Confidence 99999999999999998777654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.1e-11 Score=92.88 Aligned_cols=95 Identities=22% Similarity=0.155 Sum_probs=70.0
Q ss_pred HHHHHHHHHhcCCCCCc-cceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC--
Q 021507 24 WFQTEVNYLGQLHHPNL-VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE-- 100 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-- 100 (311)
.+.+|+++++.+.+.++ .+++.+. ....++||||++|.++.+. . . ....++.+++.+|+.||+.+
T Consensus 38 ~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~ 105 (170)
T cd05151 38 NRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLP 105 (170)
T ss_pred CHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCC
Confidence 46789999999865554 4455443 3345899999999887643 0 1 11235678999999999653
Q ss_pred -CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 -SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 -~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 106 ~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 106 DLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 1259999999999998 66899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.9e-11 Score=105.97 Aligned_cols=103 Identities=17% Similarity=0.150 Sum_probs=71.4
Q ss_pred HHHHHHHHHhcCC-----CCCccceEeEE-EeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHH-HHHHh
Q 021507 24 WFQTEVNYLGQLH-----HPNLVKLIGYC-LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK-GLTFL 96 (311)
Q Consensus 24 ~~~~E~~~l~~l~-----hpnIv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~-~l~~l 96 (311)
+|.+|++.+.++. +++|. +-.++ ......++||||++|++|.++..... .... ...++..++. .+..+
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHH
Confidence 4777888777773 34332 22222 22345689999999999988764321 1122 2345555555 46778
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCC
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 133 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 133 (311)
|. .|++|+|++|.||+++.+|.++++|||++....
T Consensus 274 ~~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LR--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred Hh--CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 85 459999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.6e-10 Score=93.76 Aligned_cols=105 Identities=16% Similarity=0.158 Sum_probs=79.5
Q ss_pred HHHHHHHHHhcCCC--CCccceEeEEEe-----CCeeEEEEecCCCC-ChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 24 WFQTEVNYLGQLHH--PNLVKLIGYCLE-----GENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 24 ~~~~E~~~l~~l~h--pnIv~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.+.+|.+.+.+|.. -.+..+.++++. ....++|||++++. +|.+++........+......++.+++..+..
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 37788888888832 233444445543 23568999999885 79988854323346677788899999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCC-------CCcEEEecccccc
Q 021507 96 LHDAESQVIYRDFKASNILLDA-------EFNAKLSDFGLAK 130 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~ 130 (311)
||.. ||+|+|+++.|||++. +..+.++||+.+.
T Consensus 154 LH~~--Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAA--GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHC--cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9965 5999999999999975 4679999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.5e-09 Score=91.77 Aligned_cols=200 Identities=15% Similarity=0.166 Sum_probs=129.7
Q ss_pred eEEEEecCCCCC-hHHHh----hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEeccc
Q 021507 53 RLLVYEFMPKGS-LENHL----FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 127 (311)
Q Consensus 53 ~~lv~e~~~~~~-L~~~l----~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 127 (311)
+.++|..+.|.- +.+++ .++......|.-.++.+..++.+.+.||.++ .+-+|++++|+|+++++.|.|.|-.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEccc
Confidence 678888887742 22222 1122234788999999999999999999655 8889999999999999999999865
Q ss_pred ccccCCCCCCcceeccccccccccCccccc-----cCCCCCCCceehhHHHHHHHHhC-CCccCCCccchhhh-----hh
Q 021507 128 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQS-----LV 196 (311)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~-----~~ 196 (311)
..... .......-.+|...|.+||.-. +..-+...|.|.||+++++++.| +.||.+-....... -+
T Consensus 163 sfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 163 SFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 54432 1112233357889999999754 33456789999999999999996 99998643211100 00
Q ss_pred hhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHHhhcC
Q 021507 197 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN--EPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.... +... .+...-....-......-.+..+..+..+|+.. ++.-|||++.++..|..+..
T Consensus 240 a~g~-f~ya-~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 240 AHGR-FAYA-SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hcce-eeec-hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0000 0000 000000000001111234577888899999864 36789999999988876643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-11 Score=107.60 Aligned_cols=199 Identities=21% Similarity=0.161 Sum_probs=143.1
Q ss_pred HHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCee
Q 021507 26 QTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 104 (311)
Q Consensus 26 ~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 104 (311)
..|+-+...+ .|.+++.++..+....+.|+=-|||+++++...+ .-...+.+...+.+..+++.++.++|+.. ++
T Consensus 313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~ 388 (524)
T KOG0601|consen 313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL--FV 388 (524)
T ss_pred hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh--hh
Confidence 3566666666 6899999888888888888999999999887766 22344888899999999999999999655 99
Q ss_pred ecCCCCCceEeCCC-CcEEEecccccccCCCCCCcceecccccccccc--CccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 105 YRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA--APEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 105 H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
|+|+||.||++..+ +..+++|||....+... .....+..++. ++.......+..+.|+|+||..+.+.+++.
T Consensus 389 ~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 389 HLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred cccccccceeeccchhhhhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCc
Confidence 99999999999886 67799999988642221 11122333444 555556667888999999999999999976
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
..-... .....+.... ..........+..+...+...++..||.+.++..+.
T Consensus 464 ~ls~~~-------------------~~~~~i~~~~--~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 464 PLSESG-------------------VQSLTIRSGD--TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ccCccc-------------------ccceeeeccc--ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 322211 1111111111 112233447888899999999999999998876544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-09 Score=96.33 Aligned_cols=182 Identities=15% Similarity=0.214 Sum_probs=128.2
Q ss_pred HHHHHHhcCCCCCccceEeEEE----eCCeeEEEEecCCC-CChHHHhhhcC-------------CCCCCHHHHHHHHHH
Q 021507 27 TEVNYLGQLHHPNLVKLIGYCL----EGENRLLVYEFMPK-GSLENHLFRRG-------------PQPLSWAVRMKVAIG 88 (311)
Q Consensus 27 ~E~~~l~~l~hpnIv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~~~~-------------~~~~~~~~~~~~~~~ 88 (311)
.-+++++++.|+|||++.++|. .+..+++|++|+++ ++|.++..... +...++..+|.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 3478899999999999999987 34567999999986 57777553221 235888999999999
Q ss_pred HHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCcee
Q 021507 89 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 168 (311)
Q Consensus 89 i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 168 (311)
+..||.++|+.| +.-+-|.+.+|+++++.+++|...|+......... |-+.+ -.+-|.=
T Consensus 402 LtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq~D~~ 460 (655)
T KOG3741|consen 402 LTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------EPLES---QQQNDLR 460 (655)
T ss_pred HHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCCCC----------------cchhH---HhhhhHH
Confidence 999999999765 88899999999999999999987776654332210 11111 1245888
Q ss_pred hhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 169 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 169 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
.||.++..|.||..--...+. ....- .......++.++++++.-....++++ -++.
T Consensus 461 ~lG~ll~aLAt~~~ns~~~d~---------------~~~s~--------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~ 516 (655)
T KOG3741|consen 461 DLGLLLLALATGTENSNRTDS---------------TQSSH--------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQ 516 (655)
T ss_pred HHHHHHHHHhhcccccccccc---------------hHHHH--------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHH
Confidence 999999999998532100000 00000 01123457788888888888888886 6677
Q ss_pred HHHHH
Q 021507 249 EVLAI 253 (311)
Q Consensus 249 ~~l~~ 253 (311)
+++.+
T Consensus 517 ~llp~ 521 (655)
T KOG3741|consen 517 DLLPM 521 (655)
T ss_pred HHHHH
Confidence 77754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.9e-10 Score=87.92 Aligned_cols=105 Identities=23% Similarity=0.283 Sum_probs=68.0
Q ss_pred hHHHHHHHHHHHHHHHhcCCCC--CccceEeEEEeCCeeEEEEecCC--CCChHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 021507 17 SLLLITNWFQTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMP--KGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 92 (311)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~ 92 (311)
.....+.+.++|++.|.++..- ++.+++++. ..++||||+. |..+..+. ... ++......++.+++..
T Consensus 47 ~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~ 118 (188)
T PF01163_consen 47 WRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEE 118 (188)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHH
Confidence 3445667889999999999655 566666542 3469999998 65554433 221 1133445567777775
Q ss_pred HHH-hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccC
Q 021507 93 LTF-LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132 (311)
Q Consensus 93 l~~-lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 132 (311)
+.. +|. .|++|+||++.||+++++ .+.|+|||.+...
T Consensus 119 ~~~~~~~--~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 119 IIKMLHK--AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHHHHC--TTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHHHHh--cCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 555 564 459999999999999887 8999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.2e-09 Score=84.59 Aligned_cols=104 Identities=23% Similarity=0.217 Sum_probs=80.4
Q ss_pred HHHHHHHHHhcCC--CCCccceEeEEEeC----CeeEEEEecCCC-CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 24 WFQTEVNYLGQLH--HPNLVKLIGYCLEG----ENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 24 ~~~~E~~~l~~l~--hpnIv~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
...+|...+..|. .=.+.+.+++.+.. ...++|+|++++ .+|.+++..... .+......++.+++..++-|
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHH
Confidence 3667888777773 33355566666542 235899999988 479998865333 56667788999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCC---cEEEeccccccc
Q 021507 97 HDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKA 131 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~ 131 (311)
|.. ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 135 H~~--gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA--GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC--cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 965 599999999999999887 799999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.3e-10 Score=103.04 Aligned_cols=102 Identities=15% Similarity=0.091 Sum_probs=65.5
Q ss_pred HHHHHHHHHhcCC----CCCccceEeEEEe-CCeeEEEEecCCCCChHHH--hhhcCC--CCCCHHHHHHHHHHHHHHHH
Q 021507 24 WFQTEVNYLGQLH----HPNLVKLIGYCLE-GENRLLVYEFMPKGSLENH--LFRRGP--QPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 24 ~~~~E~~~l~~l~----hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~~--~~~~~~~~~~~~~~i~~~l~ 94 (311)
+|.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.+. +...+. ..+....+..++.|++
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif---- 277 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF---- 277 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH----
Confidence 3556666665552 3333333333332 4456899999999999874 222221 1233334444444444
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCC----cEEEecccccccCCC
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPT 134 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 134 (311)
. .|++|+|+||.||+++.+| .++++|||++.....
T Consensus 278 ---~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ---R--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---h--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2 3599999999999999888 899999999976543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.1e-09 Score=85.17 Aligned_cols=107 Identities=22% Similarity=0.276 Sum_probs=82.4
Q ss_pred HHHHHHHHHHHhcCCC--CCccceEeEEEeC---CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 22 TNWFQTEVNYLGQLHH--PNLVKLIGYCLEG---ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
...+.+|+++++.+.+ .++.+++.+.... +..++||||++|.++.+.+.. ..++......++.+++.+|..|
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~l 115 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAAL 115 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHH
Confidence 4568899999999965 4467777776654 256899999999888775521 2367777777888888888888
Q ss_pred hhC------------------------------------------------------CCCeeecCCCCCceEeCC--CCc
Q 021507 97 HDA------------------------------------------------------ESQVIYRDFKASNILLDA--EFN 120 (311)
Q Consensus 97 H~~------------------------------------------------------~~~ivH~dlkp~Nil~~~--~~~ 120 (311)
|+. ...++|+|+++.||+++. ++.
T Consensus 116 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~ 195 (223)
T cd05154 116 HSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRV 195 (223)
T ss_pred hCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcE
Confidence 841 135799999999999988 566
Q ss_pred EEEeccccccc
Q 021507 121 AKLSDFGLAKA 131 (311)
Q Consensus 121 ~kl~Dfg~~~~ 131 (311)
+.|+||+.+..
T Consensus 196 ~~iID~e~~~~ 206 (223)
T cd05154 196 VAVLDWELATL 206 (223)
T ss_pred EEEEecccccc
Confidence 89999988864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.3e-08 Score=76.65 Aligned_cols=106 Identities=19% Similarity=0.139 Sum_probs=80.1
Q ss_pred HHHHHHHHHHhcCCCC--CccceEeEEE-e--C--CeeEEEEecCCC-CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 23 NWFQTEVNYLGQLHHP--NLVKLIGYCL-E--G--ENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hp--nIv~~~~~~~-~--~--~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
..|.+|...+++|..- .+.++. ++. . + -..+||+|-+.| .+|.+++.+....+.+......++.+++..++
T Consensus 64 ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia 142 (216)
T PRK09902 64 PTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFK 142 (216)
T ss_pred hHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHH
Confidence 3588899999998432 244444 222 1 1 235799998864 58988886654445678888899999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCc--EEEeccccccc
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKA 131 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~ 131 (311)
-||+.+ +.|+|+.+.||+++.+|. ++++||--++.
T Consensus 143 ~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 143 KMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999655 999999999999987777 99999976653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.8e-07 Score=75.31 Aligned_cols=97 Identities=15% Similarity=0.095 Sum_probs=68.4
Q ss_pred HHHHHHHHHHHHhcCCCC--CccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
.+...++|.++|++|... .|.+.+++ +.-.+|||+++|.-|...- ++....-.++..|++-+..+-.
T Consensus 152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~ 220 (304)
T COG0478 152 SRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR 220 (304)
T ss_pred HHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH
Confidence 444678999999999655 77777653 4567999999996665432 1222233344444444444442
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
.|+||+|+++-||+++++|.+.++||-.+.
T Consensus 221 --~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 221 --RGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred --cCccccCCchheEEEecCCCEEEEeCcccc
Confidence 459999999999999999999999996554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.1e-06 Score=65.44 Aligned_cols=102 Identities=24% Similarity=0.236 Sum_probs=78.7
Q ss_pred HHHHHHHhcCCC-CCccceEeEEEeCCeeEEEEecCCCCChHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHhhhCC-CC
Q 021507 26 QTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR-RGPQPLSWAVRMKVAIGAAKGLTFLHDAE-SQ 102 (311)
Q Consensus 26 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~ 102 (311)
..|.-+++.+.+ +++.+++|+|- .++|.||...+++...-.. ......+|..+.+++.++++.+.+++... ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999965 69999999983 3578999987666421000 01123789999999999999999998532 23
Q ss_pred eeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
+.-.|++++|+-++++|.+|++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77799999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.3e-06 Score=69.18 Aligned_cols=108 Identities=11% Similarity=0.103 Sum_probs=63.8
Q ss_pred HHHHHHHHHHhcCCCC--CccceEeEEEeCCeeEEEEecCCCCC-hHHHh---------------------hhcCCCCCC
Q 021507 23 NWFQTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGS-LENHL---------------------FRRGPQPLS 78 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l---------------------~~~~~~~~~ 78 (311)
....+|.++++.+..- .+.+.+++...++..++|||+++|.+ +...+ +.-......
T Consensus 37 ~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~ 116 (226)
T TIGR02172 37 ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTST 116 (226)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3468899999998533 35777888877888899999999863 21111 110000111
Q ss_pred HHHHHH-HHHH----------HHH-HHHHh--hhCCCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 79 WAVRMK-VAIG----------AAK-GLTFL--HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 79 ~~~~~~-~~~~----------i~~-~l~~l--H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
...... +..+ +.. ...+| +.....++|+|+.|.||++++++ +.|+||+.+..
T Consensus 117 l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 117 FQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred HHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 111000 0000 000 01111 12234589999999999999888 99999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.3e-06 Score=82.44 Aligned_cols=197 Identities=21% Similarity=0.229 Sum_probs=136.4
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCee----EEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...-|...+.++.|+|++.++.|..+.... .+..++|...++...+...+. .+....+.+..++.+||+++|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHh
Confidence 345588888899999999999987654332 355678888888888865544 78888999999999999999976
Q ss_pred CCCeeecCCCCC---ceEeCCCCcEEEe--cccccccCCCCCCcceeccccccccccCccccccCCCCC--CCceehhHH
Q 021507 100 ESQVIYRDFKAS---NILLDAEFNAKLS--DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT--KSDVYSFGV 172 (311)
Q Consensus 100 ~~~ivH~dlkp~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di~slG~ 172 (311)
. +.|.-|... +..++.++.+.++ ||+.+......... .....+..|.++|......+.. ..|+|++|.
T Consensus 306 ~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c--cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 4 555544444 4444556667766 88888765444322 2233455678888776655444 479999999
Q ss_pred HHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
....+..|..+-.... ..... .+.....+..+.+.+|+.-+.++|+++.+++.
T Consensus 381 l~~~~~~~~~i~~~~~-------------------~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA-------------------VPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHhhhhhcCccccccc-------------------chhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 9999988764321110 00010 11112226788999999999999999999987
Q ss_pred HH
Q 021507 253 IL 254 (311)
Q Consensus 253 ~l 254 (311)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 65
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.2e-07 Score=85.60 Aligned_cols=151 Identities=19% Similarity=0.173 Sum_probs=112.5
Q ss_pred HHHHHHHHhcCCCCC-ccceEeEEEeCCeeEEEEecCCCC-ChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 25 FQTEVNYLGQLHHPN-LVKLIGYCLEGENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 25 ~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
..-++++|.+++||| .+..++-+..+...+++++++.++ +-.... ....-.+.+-+...++..-+++++++|+..
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~~-- 356 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSSY-- 356 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC-ChhhHhhhhhhhhhhhhhhccccccccccc--
Confidence 345889999999999 777777777777889999999876 222211 111122444555667777788999999653
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 182 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 182 (311)
-+|+| ||+..+ +..+..||+....+.... ......+++.|+|||+..+..+...-|.|++|.--.++.-|.+
T Consensus 357 ~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 357 KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCC
Confidence 48888 777755 578999999887654433 2455678999999999999999999999999987777777777
Q ss_pred ccCC
Q 021507 183 AVDK 186 (311)
Q Consensus 183 pf~~ 186 (311)
|-..
T Consensus 429 Pr~~ 432 (829)
T KOG0576|consen 429 PRSS 432 (829)
T ss_pred CCCC
Confidence 7543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=8e-07 Score=71.08 Aligned_cols=66 Identities=15% Similarity=0.143 Sum_probs=51.0
Q ss_pred eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 52 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 52 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
..+++|||++|..|.+... +++ .+...+.+++.-+|+.| ++|+|.+|.|+++++++ ++++||+..+
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEEEECcccc
Confidence 4468999999988876431 232 24456778899999765 99999999999998654 9999997665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.9e-06 Score=69.19 Aligned_cols=107 Identities=17% Similarity=0.113 Sum_probs=64.7
Q ss_pred HHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHh-------------------hhcC--CCCCCHH-
Q 021507 24 WFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-------------------FRRG--PQPLSWA- 80 (311)
Q Consensus 24 ~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l-------------------~~~~--~~~~~~~- 80 (311)
.+.+|+++++.+. +--+.+++++...++..++|||+++|.+|.... ++.. ..++...
T Consensus 37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~ 116 (244)
T cd05150 37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRL 116 (244)
T ss_pred chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhH
Confidence 4678999998883 444667777777666789999999998776432 0000 0011100
Q ss_pred -HHHHH-----------------------HHHHHHHHHHhh--hCCCCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 81 -VRMKV-----------------------AIGAAKGLTFLH--DAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 81 -~~~~~-----------------------~~~i~~~l~~lH--~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
..... ..++...|.... .....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 117 DRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 00000 111111111110 012359999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.9e-06 Score=75.66 Aligned_cols=109 Identities=14% Similarity=0.106 Sum_probs=71.0
Q ss_pred HHHHHHHHHHHHhcCC-----CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLH-----HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~-----hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
..-+|.+|+..+.++. .++|.-..=|.+-.+.-.++|||++|..+.+...-.. .+.+...+.....++.--.-+
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL 282 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 3335778888887772 4444333223333456789999999988888742222 335544444333333322222
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCC
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 134 (311)
-| |++|+|.+|.||+++.+|.+.+.|||+......
T Consensus 283 ~d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RD----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hc----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 23 499999999999999999999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.6e-06 Score=66.72 Aligned_cols=106 Identities=20% Similarity=0.210 Sum_probs=74.1
Q ss_pred HHHHHHHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCCCC-hHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 18 LLLITNWFQTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGS-LENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 18 ~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
-..+..|..+|..-|+++. +-.+.+.+++. ...|||||+.... -.-.|. ..++.......+..++++.+.
T Consensus 108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~ 180 (268)
T COG1718 108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMR 180 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHH
Confidence 3445567889999999994 45566666544 3469999995431 111111 122334367777888888888
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccC
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 132 (311)
-|-. ..++||+||+.-|||+. ++.+.|+|||.+...
T Consensus 181 ~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 181 RLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHH-hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 8875 24699999999999998 788999999988653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.7e-05 Score=65.47 Aligned_cols=31 Identities=19% Similarity=0.243 Sum_probs=26.1
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
..++|+|+.+.||++++++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3489999999999998776567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.3e-05 Score=60.41 Aligned_cols=95 Identities=22% Similarity=0.285 Sum_probs=67.5
Q ss_pred HHHHHHHHHHHhcCC------CCCccceEeEEEeCCeeEEEEecCCC------CChHHHhhhcCCCCCCHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLH------HPNLVKLIGYCLEGENRLLVYEFMPK------GSLENHLFRRGPQPLSWAVRMKVAIGA 89 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~i 89 (311)
.+...+|+..+.++. +.+|.+++|+.+++....+|+|.+.+ .+|.+++.... ++. .....+.++
T Consensus 55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f 130 (199)
T PF10707_consen 55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEF 130 (199)
T ss_pred hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHH
Confidence 445666777666665 88999999999999889999998643 36888884433 555 455555555
Q ss_pred HHHHHHhhhCCCCeeecCCCCCceEeCCCC----cEEEec
Q 021507 90 AKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSD 125 (311)
Q Consensus 90 ~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~D 125 (311)
.+ +|-+ ++|+.+|++|.||++...+ .+.|+|
T Consensus 131 ~~---~l~~--~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 131 KR---YLLD--HHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HH---HHHH--cCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 44 4443 2399999999999995432 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.4e-05 Score=73.38 Aligned_cols=42 Identities=17% Similarity=0.333 Sum_probs=33.0
Q ss_pred HHHHHHHHHHhcCC-CCCc--cceEeEEEeC---CeeEEEEecCCCCC
Q 021507 23 NWFQTEVNYLGQLH-HPNL--VKLIGYCLEG---ENRLLVYEFMPKGS 64 (311)
Q Consensus 23 ~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~---~~~~lv~e~~~~~~ 64 (311)
..+.+|+++|+.+. |.+| .+++.++.+. +..|+||||++|..
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 46889999999995 6665 7777777654 46799999999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00011 Score=66.82 Aligned_cols=101 Identities=19% Similarity=0.167 Sum_probs=64.3
Q ss_pred HHHHHHHHHhcC----CCCC------ccceEeEEEeCCeeEEEEecCCCCChHHH--hhhcCCCCCCHHHHHHHHHHHHH
Q 021507 24 WFQTEVNYLGQL----HHPN------LVKLIGYCLEGENRLLVYEFMPKGSLENH--LFRRGPQPLSWAVRMKVAIGAAK 91 (311)
Q Consensus 24 ~~~~E~~~l~~l----~hpn------Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~~~i~~ 91 (311)
+|.+|++-..++ .|-+ |.++|-.+ .....|+|||++|..+.+. |.+.+ ++...+...+.+...
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL 314 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH
Confidence 355566554444 3444 44444333 2356899999999876654 33333 555555444444443
Q ss_pred HHHHhhhCCCCeeecCCCCCceEeCC----CCcEEEecccccccCC
Q 021507 92 GLTFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGP 133 (311)
Q Consensus 92 ~l~~lH~~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~ 133 (311)
-+-+.| | ++|+|=+|.||++.. ++.+.+.|||+.....
T Consensus 315 ~qIf~~--G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 315 EQIFKT--G--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHhc--C--CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 333333 4 999999999999983 5679999999987643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00013 Score=59.90 Aligned_cols=111 Identities=19% Similarity=0.202 Sum_probs=58.1
Q ss_pred HHHHHHHHHHHHHhcCCCC--CccceEeEEE---eCCeeEEEEecCCCCChHH----------------Hh---hhc--C
Q 021507 20 LITNWFQTEVNYLGQLHHP--NLVKLIGYCL---EGENRLLVYEFMPKGSLEN----------------HL---FRR--G 73 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~---~~~~~~lv~e~~~~~~L~~----------------~l---~~~--~ 73 (311)
.....+.+|+.+++.+... .+.+++.+.. .....+++|++++|..+.. .+ .+. .
T Consensus 32 ~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~ 111 (239)
T PF01636_consen 32 DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPP 111 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTT
T ss_pred CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhccccccc
Confidence 3455677899988888432 3556665443 3345689999999987776 11 111 0
Q ss_pred CCCCCHHHH--H----H---H------------HHHHHH-HHHHhhh-----CCCCeeecCCCCCceEeC-CCCcEEEec
Q 021507 74 PQPLSWAVR--M----K---V------------AIGAAK-GLTFLHD-----AESQVIYRDFKASNILLD-AEFNAKLSD 125 (311)
Q Consensus 74 ~~~~~~~~~--~----~---~------------~~~i~~-~l~~lH~-----~~~~ivH~dlkp~Nil~~-~~~~~kl~D 125 (311)
...+..... . . . ...+.. .+..+++ ....++|+|+.|.||+++ +++.+-|+|
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID 191 (239)
T PF01636_consen 112 FSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIID 191 (239)
T ss_dssp CCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--
T ss_pred ccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEe
Confidence 011111100 0 0 0 011111 2333331 235699999999999999 566668999
Q ss_pred ccccc
Q 021507 126 FGLAK 130 (311)
Q Consensus 126 fg~~~ 130 (311)
|+.+.
T Consensus 192 ~e~a~ 196 (239)
T PF01636_consen 192 FEDAG 196 (239)
T ss_dssp GTT-E
T ss_pred cccce
Confidence 98764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=3e-06 Score=83.75 Aligned_cols=157 Identities=12% Similarity=0.010 Sum_probs=115.0
Q ss_pred HHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhC---
Q 021507 27 TEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDA--- 99 (311)
Q Consensus 27 ~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--- 99 (311)
.|...++...|+++...+.-... +...|.+++|+.+|.+.+.|.++.. ..+...-+...-.+.+....-+|+.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34445555688888776655442 3345899999999999998865432 3344444544445546667776654
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
++--+|++||+-|.+|..+-.++++++|+.+... ......+...+++.|+.+++...-.++.++|+|..|+-+|+...
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 3348899999999999999999999999998322 12222445677888999999988889989999999999999988
Q ss_pred CCCccC
Q 021507 180 GRCAVD 185 (311)
Q Consensus 180 g~~pf~ 185 (311)
|..+|-
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 876663
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0002 Score=59.94 Aligned_cols=29 Identities=24% Similarity=0.274 Sum_probs=25.7
Q ss_pred CeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
.++|+|+.|.||++++++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999877 78999988854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00066 Score=58.13 Aligned_cols=43 Identities=19% Similarity=0.115 Sum_probs=33.8
Q ss_pred HHHHHHHHHHhcCCC---CCccceEeEEEeC---CeeEEEEecCCCCCh
Q 021507 23 NWFQTEVNYLGQLHH---PNLVKLIGYCLEG---ENRLLVYEFMPKGSL 65 (311)
Q Consensus 23 ~~~~~E~~~l~~l~h---pnIv~~~~~~~~~---~~~~lv~e~~~~~~L 65 (311)
..|.+|++.|+.|.. -.|.++++++..+ +..++|||+++|.++
T Consensus 52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 478999999999842 4678888877543 668999999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00033 Score=59.85 Aligned_cols=106 Identities=20% Similarity=0.234 Sum_probs=69.0
Q ss_pred HHHHHHHHHHHHHHhcCCC--CCccceEeEEEeCC--eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHH-HHHHHHH
Q 021507 19 LLITNWFQTEVNYLGQLHH--PNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGL 93 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~-~~i~~~l 93 (311)
........+|.++++.+.- --+...++++.++. ..|.||+|++|..+.+..... +.. ..++ ..++..|
T Consensus 62 ~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~-----~~~--~~~~~~~l~~~L 134 (321)
T COG3173 62 VESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE-----SLG--RQFALDALADFL 134 (321)
T ss_pred chhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-----cch--HHHHHHHHHHHH
Confidence 3344456778888888743 23344455565554 669999999986544433111 111 1122 3555566
Q ss_pred HHhhh--------------------------------------------------------CCCCeeecCCCCCceEeCC
Q 021507 94 TFLHD--------------------------------------------------------AESQVIYRDFKASNILLDA 117 (311)
Q Consensus 94 ~~lH~--------------------------------------------------------~~~~ivH~dlkp~Nil~~~ 117 (311)
+.||+ ....++|+|+.+.|++++.
T Consensus 135 a~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~ 214 (321)
T COG3173 135 AELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDP 214 (321)
T ss_pred HHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeC
Confidence 66664 1225999999999999999
Q ss_pred CCcEEEeccccccc
Q 021507 118 EFNAKLSDFGLAKA 131 (311)
Q Consensus 118 ~~~~kl~Dfg~~~~ 131 (311)
++.+=|+||+.+..
T Consensus 215 ~~~~gVlDwe~~~l 228 (321)
T COG3173 215 GRPTGVLDWELATL 228 (321)
T ss_pred CCeeEEEecccccc
Confidence 98899999999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00032 Score=62.79 Aligned_cols=164 Identities=26% Similarity=0.317 Sum_probs=90.6
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeC-CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
.+.....+++.+.|+|..+++++.... ....+|||++. .||++.+..+... .... + -| +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~---~~s~----------~--~~----~ 87 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLK---DESL----------L--AH----G 87 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccc---hhhh----------c--cc----c
Confidence 356678899999999999999876533 34789999995 5999988655411 1111 0 11 2
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 182 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 182 (311)
+.|- |+ ++.+| -+... . | .+..+++|||++|.++.++.-|..
T Consensus 88 ~~~~-----~~-------~~~td-~~~t~----~----------------~-----~~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 88 VLHL-----NI-------IYITD-HFLTK----Y----------------P-----SPIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ccee-----hh-------hhccc-ccccc----C----------------C-----CCCCcchhhhhHHHHHHHHHHhhH
Confidence 3332 12 23333 11110 0 0 011149999999999999999987
Q ss_pred ccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 183 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 183 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
.+...........+ ..+...+.......... ..--.+.....++..+|+-..|..||...++.
T Consensus 130 l~~~~~~s~~l~~i---~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 130 LEAELTESEYLEIL---LKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHH---HHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 66543221111110 00011111111100000 11123556677888999999999888665544
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00092 Score=55.11 Aligned_cols=30 Identities=20% Similarity=0.285 Sum_probs=26.3
Q ss_pred CCeeecCCCCCceEeCC-CCcEEEecccccc
Q 021507 101 SQVIYRDFKASNILLDA-EFNAKLSDFGLAK 130 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 130 (311)
..++|+|+.+.||++++ ++.+.|+||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 35999999999999998 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00071 Score=57.91 Aligned_cols=31 Identities=29% Similarity=0.329 Sum_probs=27.1
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.004 Score=53.71 Aligned_cols=73 Identities=19% Similarity=0.168 Sum_probs=56.4
Q ss_pred CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEeccccc
Q 021507 50 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129 (311)
Q Consensus 50 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 129 (311)
....|++|++- |++|.. + ....++++..++.+.+..++-+.. +-.+-|||+.-.||||+ +|+|.|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence 34557888876 556653 2 115567888888888877777775 34689999999999999 999999999999
Q ss_pred cc
Q 021507 130 KA 131 (311)
Q Consensus 130 ~~ 131 (311)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 84
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.01 Score=52.66 Aligned_cols=31 Identities=19% Similarity=0.278 Sum_probs=25.8
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
...++|||+.+.||++..+ .++|+||-++..
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 3469999999999999776 589999977654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0017 Score=55.08 Aligned_cols=93 Identities=16% Similarity=0.093 Sum_probs=61.8
Q ss_pred HHHHHHHHHhcCC-C-CCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 24 WFQTEVNYLGQLH-H-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 24 ~~~~E~~~l~~l~-h-pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+|...|+.|. | =-|.+.++ .+.-++|||++.|..|...-.- .+...+..-+. .-+--|- ++
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm---~~Iv~la--~~ 221 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLM---GLIVRLA--NH 221 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-----CChHHHHHHHH---HHHHHHH--Hc
Confidence 4567888888883 3 23444444 3456899999999877653211 22233333333 3334444 34
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
|+||+|..-=||++.+++.++++||-...
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhh
Confidence 59999999999999999999999996543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0066 Score=53.15 Aligned_cols=30 Identities=20% Similarity=0.297 Sum_probs=26.0
Q ss_pred CeeecCCCCCceEeCC-CCcEEEeccccccc
Q 021507 102 QVIYRDFKASNILLDA-EFNAKLSDFGLAKA 131 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 131 (311)
.++|+|+++.||++++ ++.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5999999999999976 46799999988753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.011 Score=49.99 Aligned_cols=30 Identities=27% Similarity=0.417 Sum_probs=25.4
Q ss_pred CeeecCCCCCceEeCCCCc-EEEeccccccc
Q 021507 102 QVIYRDFKASNILLDAEFN-AKLSDFGLAKA 131 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~ 131 (311)
.++|+|+++.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.011 Score=51.43 Aligned_cols=30 Identities=20% Similarity=0.257 Sum_probs=25.7
Q ss_pred CeeecCCCCCceEeCC-CCcEEEeccccccc
Q 021507 102 QVIYRDFKASNILLDA-EFNAKLSDFGLAKA 131 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 131 (311)
-++|+|+.+.||++++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3899999999999975 46899999988853
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.01 Score=45.97 Aligned_cols=97 Identities=11% Similarity=0.042 Sum_probs=63.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCccc-eEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVK-LIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
.-+..+..|+++|..+...++-. +|.|..+ ++.|||+.|..|.++-.. .+...+. .+++.---|..
T Consensus 57 s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~-----~~rk~l~----~vlE~a~~LD~ 123 (201)
T COG2112 57 SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIG-----GDRKHLL----RVLEKAYKLDR 123 (201)
T ss_pred cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhc-----ccHHHHH----HHHHHHHHHHH
Confidence 34567899999999998777644 5554433 356999999888876521 1233333 33444333342
Q ss_pred CCCCeeecCCC-CCceEeCCCCcEEEeccccccc
Q 021507 99 AESQVIYRDFK-ASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 99 ~~~~ivH~dlk-p~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
.||-|+.|+ |...++.+++.+.|+||..|+.
T Consensus 124 --~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 124 --LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred --hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 348898887 4444454555899999988874
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.029 Score=45.46 Aligned_cols=44 Identities=27% Similarity=0.472 Sum_probs=35.6
Q ss_pred HHHHHHHHHHhcC---CCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 23 NWFQTEVNYLGQL---HHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 23 ~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
.-|..|+.-|+.| +.-+|.+++.+..+.++.|+||||++.+.+.
T Consensus 53 ~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 53 SMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred HHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 4577888877777 4467888899999999999999999876554
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.018 Score=49.47 Aligned_cols=32 Identities=28% Similarity=0.228 Sum_probs=27.4
Q ss_pred CCCeeecCCCCCceEeCCC----CcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~ 131 (311)
...++|+|+.+.||+++++ +.+.++||..+..
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 3469999999999999885 7899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.041 Score=47.82 Aligned_cols=105 Identities=17% Similarity=0.203 Sum_probs=70.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHH--HhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN--HLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~--~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
..++-|..+|++-|.+|..-.|.-.--+... ...|||+++. .+-+. .| ....++...+..+-.+++.-+.-|
T Consensus 207 KMVk~WAEKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlG-rdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~l 280 (520)
T KOG2270|consen 207 KMVKTWAEKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLG-RDGWAAPKL---KDASLSTSKARELYQQCVRIMRRL 280 (520)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCceeee--cceEeeeecc-CCCCcCccc---ccccCChHHHHHHHHHHHHHHHHH
Confidence 3455678899999999965443322211111 2368999994 33221 22 123366667777777777777777
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
-. .+++||.||.--|+|+ .+|.+.|+|.+.+..
T Consensus 281 Y~-~c~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 281 YQ-KCRLVHADLSEFNLLY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred HH-HhceeccchhhhhheE-ECCEEEEEEcccccc
Confidence 54 3669999999999999 556899999987754
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.017 Score=48.61 Aligned_cols=50 Identities=18% Similarity=0.098 Sum_probs=37.4
Q ss_pred HHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 82 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
..+.+..+-..+.-.+....-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33455555555666664323599999999999999989999999988754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.029 Score=49.73 Aligned_cols=29 Identities=24% Similarity=0.170 Sum_probs=24.1
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
..++|.|+-+.||+.+++ .+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 358999999999998654 59999997774
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.017 Score=49.94 Aligned_cols=32 Identities=25% Similarity=0.293 Sum_probs=26.8
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
..++||+|+.+.||+++++...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 34799999999999998765568999998853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.011 Score=47.62 Aligned_cols=86 Identities=16% Similarity=0.125 Sum_probs=55.3
Q ss_pred HHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCee
Q 021507 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 104 (311)
Q Consensus 25 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 104 (311)
|.++.+++.++. .|+++..- .+-.+.++.|+|..... .. ..++..=+..|...|+...+.+
T Consensus 105 y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~----~N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF----SNFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch----hHHHHHhHHHHHHhhccCCCee
Confidence 456666666552 34554421 22234588888853111 11 1112222466788897778899
Q ss_pred ecCCCCCceEeCCCCcEEEeccccc
Q 021507 105 YRDFKASNILLDAEFNAKLSDFGLA 129 (311)
Q Consensus 105 H~dlkp~Nil~~~~~~~kl~Dfg~~ 129 (311)
|+|..|+||+-+..|.+||.|=+..
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCCCEEecChhhh
Confidence 9999999999999999999996543
|
The function of this family is unknown. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.0091 Score=47.00 Aligned_cols=29 Identities=24% Similarity=0.251 Sum_probs=25.7
Q ss_pred CeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
..+|+|+.|.|++++++| ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998877 89999998854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.021 Score=49.22 Aligned_cols=32 Identities=28% Similarity=0.327 Sum_probs=27.7
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
..+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 35799999999999999888778999988753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.15 Score=45.48 Aligned_cols=31 Identities=10% Similarity=0.216 Sum_probs=25.1
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
...++||||.+.||+++.++ .+++|.-++.+
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~ 259 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAFY 259 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence 34699999999999998875 78888765543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.048 Score=46.96 Aligned_cols=30 Identities=23% Similarity=0.307 Sum_probs=25.8
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 56999999999999987 5789999987643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.15 Score=40.64 Aligned_cols=88 Identities=32% Similarity=0.447 Sum_probs=59.8
Q ss_pred HHHHHHHHHHHHHhcCC---CCCc--cceEeEEEeCC------------------eeEEEEecCCCCChHHHhhhcCCCC
Q 021507 20 LITNWFQTEVNYLGQLH---HPNL--VKLIGYCLEGE------------------NRLLVYEFMPKGSLENHLFRRGPQP 76 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~---hpnI--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (311)
...+-|..|.+...+|+ +.++ |+++||..-.. ...||.||..... .
T Consensus 96 ~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~ 164 (207)
T PF13095_consen 96 HYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------P 164 (207)
T ss_pred hhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------c
Confidence 34457889999888884 4556 99999884221 1247777776533 1
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEeccccc
Q 021507 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129 (311)
Q Consensus 77 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 129 (311)
+... -+.++.+-+..+|.. ||+-+|+++.|.. + -+|+|||.+
T Consensus 165 ~~~~----~~~~~~~dl~~~~k~--gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQIR----DIPQMLRDLKILHKL--GIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred cchh----HHHHHHHHHHHHHHC--CeeeccCcccccc---C--CEEEecccC
Confidence 2222 345666677889964 5999999999985 3 378999864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.015 Score=47.06 Aligned_cols=29 Identities=31% Similarity=0.418 Sum_probs=20.8
Q ss_pred CeeecCCCCCceEe-CCCCcEEEecccccc
Q 021507 102 QVIYRDFKASNILL-DAEFNAKLSDFGLAK 130 (311)
Q Consensus 102 ~ivH~dlkp~Nil~-~~~~~~kl~Dfg~~~ 130 (311)
.++|+|+.+.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888899999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.043 Score=46.62 Aligned_cols=42 Identities=24% Similarity=0.399 Sum_probs=27.2
Q ss_pred HHHHHHHHHHHhcC---CCCCccceEeEEEeCCeeEEEEecCCCC
Q 021507 22 TNWFQTEVNYLGQL---HHPNLVKLIGYCLEGENRLLVYEFMPKG 63 (311)
Q Consensus 22 ~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 63 (311)
...|..|++-|+.| ..-.|.+++++....+..|+||||++.+
T Consensus 53 ~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 53 RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34578898888888 3456788999988887889999999875
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.035 Score=44.38 Aligned_cols=31 Identities=26% Similarity=0.314 Sum_probs=25.8
Q ss_pred CCeeecCCCCCceEeCCCC-----cEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEF-----NAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~~~~ 131 (311)
+.++|||+.+.||++..++ .+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4699999999999997543 589999988754
|
subfamily of choline kinases |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.049 Score=46.61 Aligned_cols=52 Identities=19% Similarity=0.133 Sum_probs=32.2
Q ss_pred HHHHHHHHHHHHHHHh-hhC-CCCeeecCCCCCceEeCCCC------------------cEEEecccccccC
Q 021507 81 VRMKVAIGAAKGLTFL-HDA-ESQVIYRDFKASNILLDAEF------------------NAKLSDFGLAKAG 132 (311)
Q Consensus 81 ~~~~~~~~i~~~l~~l-H~~-~~~ivH~dlkp~Nil~~~~~------------------~~kl~Dfg~~~~~ 132 (311)
-+.-+..|++.-.-.+ .-. -.+++|.||||+|||+.... .++|.||.+++..
T Consensus 280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 3445667776443222 111 13599999999999994432 2567777777653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.25 E-value=0.03 Score=48.08 Aligned_cols=52 Identities=17% Similarity=0.180 Sum_probs=32.1
Q ss_pred HHHHHHHHHHHHHHhhhC--CCCeeecCCCCCceEeCCC------------------CcEEEecccccccCC
Q 021507 82 RMKVAIGAAKGLTFLHDA--ESQVIYRDFKASNILLDAE------------------FNAKLSDFGLAKAGP 133 (311)
Q Consensus 82 ~~~~~~~i~~~l~~lH~~--~~~ivH~dlkp~Nil~~~~------------------~~~kl~Dfg~~~~~~ 133 (311)
+.-+..|++.-.--+-.. -.+++|.||||+|||+-+. -.++|.||.+++..+
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 344666665332112110 1359999999999999432 236788888887643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.091 Score=45.30 Aligned_cols=31 Identities=16% Similarity=0.200 Sum_probs=28.0
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
.+++|+|+.++||++++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4699999999999999998999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.044 Score=47.48 Aligned_cols=29 Identities=28% Similarity=0.450 Sum_probs=26.0
Q ss_pred eeecCCCCCceEeCCCCc-EEEeccccccc
Q 021507 103 VIYRDFKASNILLDAEFN-AKLSDFGLAKA 131 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~ 131 (311)
+||+|+.|.||+++.+.. +.++|||.+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 899999999999998874 89999998853
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 311 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-47 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 430 bits (1109), Expect = e-153
Identities = 92/236 (38%), Positives = 145/236 (61%), Gaps = 7/236 (2%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF-RRGPQPLSWAVRM 83
F E+ + + H NLV+L+G+ +G++ LVY +MP GSL + L G PLSW +R
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K+A GAA G+ FLH E+ I+RD K++NILLD F AK+SDFGLA+A +T ++++
Sbjct: 137 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
++GT Y APE + G +T KSD+YSFGVVLLE+++G AVD+ + Q L+D +
Sbjct: 195 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIE 251
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259
+++ + +D K+ + ++A QCL+ + RP + +V +L+ + A
Sbjct: 252 DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-143
Identities = 97/242 (40%), Positives = 141/242 (58%), Gaps = 5/242 (2%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ--PLSWAVR 82
F+TE+ L HP+LV LIG+C E +L+Y++M G+L+ HL+ +SW R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+++ IGAA+GL +LH +I+RD K+ NILLD F K++DFG++K G D+TH+ST
Sbjct: 142 LEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
V GT GY PEY GRLT KSDVYSFGVVL E+L R A+ ++ +L +WA
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 203 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 262
+ +L +I+D L + ++ A++CL + RP M +VL LE +
Sbjct: 260 H-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
Query: 263 SA 264
S
Sbjct: 319 SV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-127
Identities = 104/255 (40%), Positives = 154/255 (60%), Gaps = 7/255 (2%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ--PLSWAVR 82
FQTEV + H NL++L G+C+ RLLVY +M GS+ + L R PL W R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 83 MKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
++A+G+A+GL +LH + ++I+RD KA+NILLD EF A + DFGLAK D THV+
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 192
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWA 199
T V GT G+ APEY++TG+ + K+DV+ +GV+LLEL++G+ A D ++ + L+DW
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 200 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259
K L +K+ L ++D L G Y + +AL C + P RP+MSEV+ +LE
Sbjct: 253 KGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
Query: 260 PKNSAKLSQSEPHRQ 274
+ + + E RQ
Sbjct: 312 AERWEEWQKEEMFRQ 326
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 8e-69
Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 25/256 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGEN----RLLVYEFMPKGSLENHLFRRGPQPLSWA 80
+ EV L + H N+++ IG G + L+ F KGSL + L +SW
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWN 121
Query: 81 VRMKVAIGAAKGLTFLHDAESQ--------VIYRDFKASNILLDAEFNAKLSDFGLAKAG 132
+A A+GL +LH+ + +RD K+ N+LL A ++DFGLA
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 133 PTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKT 187
G + +GT Y APE + + D+Y+ G+VL EL S A D
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 188 KVGIEQSLVD--WAKPYLSDKRKL--FRIMDTKLGGQYPQKAAHTA-ATLALQCLNNEPK 242
+ P L D +++ + L + + A +C +++ +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 243 LRPRMSEVLAILERLE 258
R V + +++
Sbjct: 302 ARLSAGCVGERITQMQ 317
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-55
Identities = 68/252 (26%), Positives = 118/252 (46%), Gaps = 29/252 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRM 83
F EV + +L HPN+V +G + N +V E++ +GSL L + G + L R+
Sbjct: 81 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+A AKG+ +LH+ +++R+ K+ N+L+D ++ K+ DFGL++ + + S
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKS 198
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 202
GT + APE + KSDVYSFGV+L EL + + +P+
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------------------QPWG 240
Query: 203 -LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 261
L+ + + + + P+ A + C NEP RP + ++ +L L
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL---- 296
Query: 262 NSAKLSQSEPHR 273
K + P+R
Sbjct: 297 --IKSAVPPPNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-54
Identities = 73/259 (28%), Positives = 112/259 (43%), Gaps = 31/259 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-LSWAVRM 83
F E+ L +++HPN+VKL G CL LV E+ GSL N L P P + A M
Sbjct: 48 FIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 105
Query: 84 KVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVS 141
+ ++G+ +LH + + +I+RD K N+LL A K+ DFG A D
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHM 160
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
T G+ + APE + K DV+S+G++L E+++ R KP
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------------------KP 202
Query: 202 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL---QCLNNEPKLRPRMSEVLAILERLE 258
+ FRIM G P + + +C + +P RP M E++ I+ L
Sbjct: 203 FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262
Query: 259 APKNSAKLSQSEPHRQTGP 277
A P + + P
Sbjct: 263 RYFPGADEPLQYPCQHSLP 281
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-54
Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 32/241 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
F E L HPN++ ++G C + L+ +MP GSL N L + +
Sbjct: 54 FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA 113
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+K A+ A+G+ FLH E + + ++++D + A++S + + S
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSP 166
Query: 143 QVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
M + APE +D++SF V+L EL++
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE------------------ 208
Query: 200 KPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
P+ LS+ ++ L P + + L C+N +P RP+ ++ ILE++
Sbjct: 209 VPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
Query: 258 E 258
+
Sbjct: 269 Q 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 55/266 (20%), Positives = 98/266 (36%), Gaps = 30/266 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F EV + L HPN++K IG + + + E++ G+L + + W+ R+
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVS 112
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------------AG 132
A A G+ +LH +I+RD + N L+ N ++DFGLA+
Sbjct: 113 FAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 133 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 192
V+G + APE + K DV+SFG+VL E++ A
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----DYL 226
Query: 193 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+D+ + P + + ++C + +P+ RP ++
Sbjct: 227 PRTMDFGLNVRGFLDRYC-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 253 ILERLEAPKNSAKLSQSEPHRQTGPV 278
LE L + +
Sbjct: 276 WLETLRMHLAGHLPLGPQLEQLDRGF 301
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-52
Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 31/241 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
FQ EV + L+HPN+VKL G +V EF+P G L + L P+ W+V+++
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL-LDKAHPIKWSVKLR 126
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLD-----AEFNAKLSDFGLAKAGPTGDRTH 139
+ + A G+ ++ + +++RD ++ NI L A AK++DFGL++ H
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVH 181
Query: 140 VSTQVMGTHGYAAPEYVATGRL---TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196
+ ++G + APE T K+D YSF ++L +L+G D +
Sbjct: 182 SVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKI 236
Query: 197 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256
+ + + P+ + C + +PK RP S ++ L
Sbjct: 237 KFINMIREEGLRP----------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 257 L 257
L
Sbjct: 287 L 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-51
Identities = 59/242 (24%), Positives = 105/242 (43%), Gaps = 31/242 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F+ EV L + H N++ +GY +V ++ SL +HL + +
Sbjct: 67 FKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLID 124
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A+G+ +LH +I+RD K++NI L + K+ DFGLA +H Q+
Sbjct: 125 IARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 145 MGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
G+ + APE + + +SDVY+FG+VL EL++G+ P
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL------------------P 224
Query: 202 Y--LSDKRKLFRIMDTKL----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
Y ++++ ++ ++ + L +CL + RP +LA +E
Sbjct: 225 YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
Query: 256 RL 257
L
Sbjct: 285 EL 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-51
Identities = 68/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E L HPN++ L G CL+ N LV EF G L L + + + +
Sbjct: 53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVN 109
Query: 85 VAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEF--------NAKLSDFGLAKAGPTG 135
A+ A+G+ +LHD A +I+RD K+SNIL+ + K++DFGLA+
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EW 166
Query: 136 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 195
RT + G + + APE + + SDV+S+GV+L ELL+G
Sbjct: 167 HRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------------- 212
Query: 196 VDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
P+ + + + KL P A L C N +P RP + +L
Sbjct: 213 -----PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
Query: 254 LERL 257
L +
Sbjct: 268 LTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-50
Identities = 50/285 (17%), Positives = 93/285 (32%), Gaps = 39/285 (13%)
Query: 23 NWFQ-TEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRGPQP 76
N+ + + + H N+ + I LLV E+ P GSL +L
Sbjct: 51 NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HT 107
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQ-------VIYRDFKASNILLDAEFNAKLSDFGLA 129
W ++A +GL +LH + + +RD + N+L+ + +SDFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
Query: 130 K------AGPTGDRTHVSTQVMGTHGYAAPEY-------VATGRLTTKSDVYSFGVVLLE 176
G+ + + +GT Y APE + D+Y+ G++ E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 177 LLSGRCAVDKTKVGIEQSLVDWAK-----PYLSDKRKLFRIMDTKL----GGQYPQKAAH 227
+ RC + + + + P D + L + + A
Sbjct: 228 IFM-RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR 286
Query: 228 TAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPH 272
+ C + + + R + L K H
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-49
Identities = 53/260 (20%), Positives = 97/260 (37%), Gaps = 42/260 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F+ EV Q H N+V +G C+ + ++ +L + + R L +
Sbjct: 76 FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQ 134
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVS 141
+A KG+ +LH ++++D K+ N+ D ++DFGL G R
Sbjct: 135 IAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKL 191
Query: 142 TQVMGTHGYAAPEYVATGRL---------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 192
G + APE + + SDV++ G + EL +
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW---------- 241
Query: 193 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA----ATLALQCLNNEPKLRPRMS 248
P+ + I+ G P + + + L C E + RP +
Sbjct: 242 --------PF--KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFT 291
Query: 249 EVLAILERLEAPKNSAKLSQ 268
+++ +LE+L PK + +LS
Sbjct: 292 KLMDMLEKL--PKRNRRLSH 309
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-45
Identities = 55/268 (20%), Positives = 97/268 (36%), Gaps = 39/268 (14%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLSW 79
+ +TE+ + H N++ I ++G L+ ++ GSL ++L L
Sbjct: 77 FRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDA 133
Query: 80 AVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--KA 131
+K+A + GL LH + +RD K+ NIL+ ++D GLA
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193
Query: 132 GPTGDRTHVSTQVMGTHGYAAPEYVATGRL-------TTKSDVYSFGVVLLELLSGRCAV 184
T + +GT Y PE V L +D+YSFG++L E+ RC
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVS 251
Query: 185 DKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 234
V + S D + K + + + ++ L
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP-SFPNRWSSDECLRQMGK----LMT 306
Query: 235 QCLNNEPKLRPRMSEVLAILERLEAPKN 262
+C + P R V L ++ ++
Sbjct: 307 ECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-45
Identities = 56/264 (21%), Positives = 96/264 (36%), Gaps = 38/264 (14%)
Query: 24 WFQ-TEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLS 78
WF+ TE+ L H N++ I + + L+ + GSL ++L L
Sbjct: 47 WFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLD 103
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--K 130
+++ + A GL LH + +RD K+ NIL+ ++D GLA
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 131 AGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSGRCAV 184
+ T + +GT Y APE V + D+++FG+VL E+ R
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVS 222
Query: 185 DKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 234
+ V + S D K D+++ I + A L
Sbjct: 223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIPNRWFSDPTLTSLAK----LMK 277
Query: 235 QCLNNEPKLRPRMSEVLAILERLE 258
+C P R + L +++
Sbjct: 278 ECWYQNPSARLTALRIKKTLTKID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 53/262 (20%), Positives = 94/262 (35%), Gaps = 27/262 (10%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLSW 79
+ + E+ L H N++ I + LV ++ GSL ++L R ++
Sbjct: 82 FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTV 138
Query: 80 AVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--KA 131
+K+A+ A GL LH + +RD K+ NIL+ ++D GLA
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198
Query: 132 GPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSGRCAVD 185
T +GT Y APE + ++D+Y+ G+V E+ RC++
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIG 257
Query: 186 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-----GGQYPQKAAHTAATLALQCLNNE 240
+ D S + + + KL +A A + +C
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317
Query: 241 PKLRPRMSEVLAILERLEAPKN 262
R + L +L +
Sbjct: 318 GAARLTALRIKKTLSQLSQQEG 339
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 66/248 (26%), Positives = 101/248 (40%), Gaps = 40/248 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E L Q HPN+V+LIG C + + +V E + G L R L ++
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQ 217
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ AA G+ +L I+RD A N L+ + K+SDFG+++ G
Sbjct: 218 MVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-----A 270
Query: 145 MGTHGY-----AAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
G APE + GR +++SDV+SFG++L E S G
Sbjct: 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS---------------- 314
Query: 199 AKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
PY LS+++ + GG P+ L QC EP RP S + L
Sbjct: 315 --PYPNLSNQQTREFVEK---GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
Query: 255 ERL-EAPK 261
+ + + +
Sbjct: 370 QSIRKRHR 377
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 28/256 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + ++ HPNLV+L+G C ++ EFM G+L ++L Q +S V +
Sbjct: 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 322
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A + + +L + I+R+ A N L+ K++DFGL++ TGD
Sbjct: 323 MATQISSAMEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGA 379
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC---AVDKTKVGIEQSLVDWAK 200
+ APE +A + + KSDV++FGV+L E+ + G +D ++V
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------Y 429
Query: 201 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EA 259
L ++ R P+ L C P RP +E+ E + +
Sbjct: 430 ELLEKDYRMER----------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
Query: 260 PKNSAKLSQSEPHRQT 275
S ++ + R T
Sbjct: 480 SSISDEVEKELGKRGT 495
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 67/271 (24%), Positives = 128/271 (47%), Gaps = 40/271 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +GQ HPN+++L G + + ++V E+M GSL++ L + Q + +
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVG 151
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ G A G+ +L ++ ++RD A NIL+++ K+SDFGL + +T+
Sbjct: 152 MLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR- 208
Query: 145 MGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 200
G + +PE +A + T+ SDV+S+G+VL E++S G +
Sbjct: 209 -GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE------------------R 249
Query: 201 PY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
PY +S++ + + + G + P A + L L C + RP+ ++++I
Sbjct: 250 PYWEMSNQDVIKAVDE---GYRLPPPMDCPAALY---QLMLDCWQKDRNNRPKFEQIVSI 303
Query: 254 LERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 284
L++L S K+ S R + + + +
Sbjct: 304 LDKLIRNPGSLKIITSAAARPSNLLLDQSNV 334
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 44/264 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + ++ HPNLV+L+G C ++ EFM G+L ++L Q +S V +
Sbjct: 56 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A + + +L + I+RD A N L+ K++DFGL++ ++
Sbjct: 116 MATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDT 165
Query: 145 MGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 196
H A APE +A + + KSDV++FGV+L E+ + G
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------- 211
Query: 197 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
PY + + + + P+ L C P RP +E+
Sbjct: 212 ----PYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264
Query: 253 ILERL-EAPKNSAKLSQSEPHRQT 275
E + + S ++ + R T
Sbjct: 265 AFETMFQESSISDEVEKELGKRGT 288
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 67/245 (27%), Positives = 108/245 (44%), Gaps = 46/245 (18%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F E + + QL H NLV+L+G +E + L +V E+M KGSL ++L RG L +
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K ++ + + +L + ++RD A N+L+ + AK+SDFGL K S+
Sbjct: 293 KFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASST 342
Query: 144 VMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 199
+ APE + + +TKSDV+SFG++L E+ S GR
Sbjct: 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----------------- 385
Query: 200 KPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
PY + K + R+ MD P + C + + RP ++
Sbjct: 386 -PYPRIPLKDVVPRVEKGYKMDA------PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438
Query: 253 ILERL 257
LE +
Sbjct: 439 QLEHI 443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 20/242 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
+ E+ L L+H N+VK G C E L+ EF+P GSL+ +L + ++ +
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQ 128
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+K A+ KG+ +L Q ++RD A N+L+++E K+ DFGL KA T +
Sbjct: 129 LKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186
Query: 143 QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
+ APE + + SDV+SFGV L ELL+ C D + + + ++
Sbjct: 187 D----DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIG 241
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILE 255
++ R + + + G + P L +C +P R ++ E
Sbjct: 242 PTHGQMTVTRLVNTLKE---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
Query: 256 RL 257
L
Sbjct: 299 AL 300
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 68/264 (25%), Positives = 120/264 (45%), Gaps = 40/264 (15%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E +GQ H N+++L G + + +++ E+M G+L+ L R S +
Sbjct: 93 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVG 151
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ G A G+ +L A ++RD A NIL+++ K+SDFGL++ +T
Sbjct: 152 MLRGIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS- 208
Query: 145 MGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 200
G + APE ++ + T+ SDV+SFG+V+ E+++ G +
Sbjct: 209 -GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE------------------R 249
Query: 201 PY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
PY LS+ + I D G + P A + L +QC E RP+ +++++I
Sbjct: 250 PYWELSNHEVMKAIND---GFRLPTPMDCPSAIY---QLMMQCWQQERARRPKFADIVSI 303
Query: 254 LERLEAPKNSAKLSQSEPHRQTGP 277
L++L +S K R +
Sbjct: 304 LDKLIRAPDSLKTLADFDPRVSIR 327
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 36/241 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L H LV+L E E +V E+M KGSL + L + L +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A G+ ++ ++RD +A+NIL+ K++DFGLA+ + T
Sbjct: 285 MAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGA 341
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 202
+ APE GR T KSDV+SFG++L EL + GR PY
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR------------------VPYP 383
Query: 203 -LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256
+ ++ L ++ M P + + L QC EP+ RP + A LE
Sbjct: 384 GMVNREVLDQVERGYRMPC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
Query: 257 L 257
Sbjct: 438 Y 438
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 65/254 (25%), Positives = 101/254 (39%), Gaps = 54/254 (21%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F + + +L H +LV G C+ G+ +LV EF+ GSL+ +L ++ ++ +++
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLE 117
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGD 136
VA A + FL E+ +I+ + A NILL E + KLSD G++
Sbjct: 118 VAKQLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT----- 170
Query: 137 RTHVSTQVMGTHGY------AAPEYVATGRL-TTKSDVYSFGVVLLELLS-GRCAVDKTK 188
V+ PE + + +D +SFG L E+ S G
Sbjct: 171 -------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD------- 216
Query: 189 VGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 246
KP L +RKL D Q P A A L C++ EP RP
Sbjct: 217 -----------KPLSALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPS 262
Query: 247 MSEVLAILERLEAP 260
++ L L P
Sbjct: 263 FRAIIRDLNSLFTP 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 58/244 (23%), Positives = 100/244 (40%), Gaps = 23/244 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
F+ E+ L L H N+VK G C R L+ E++P GSL ++L + + +
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKL 116
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
++ KG+ +L + I+RD NIL++ E K+ DFGL K P
Sbjct: 117 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK 174
Query: 143 QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
+ G + APE + + + SDV+SFGVVL EL + + +
Sbjct: 175 E----PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI-- 228
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQY----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
+ +F +++ L P + +C NN RP ++
Sbjct: 229 GNDKQ--GQMIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
Query: 254 LERL 257
++++
Sbjct: 286 VDQI 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-34
Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 42/244 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HP LVK G C + +V E++ G L N+L G L + ++
Sbjct: 50 FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLE 108
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ +G+ FL Q I+RD A N L+D + K+SDFG+ R + Q
Sbjct: 109 MCYDVCEGMAFL--ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT-------RYVLDDQY 159
Query: 145 MGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 197
+ + G ++APE + ++KSDV++FG+++ E+ S G+
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK---------------- 203
Query: 198 WAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
PY ++ + ++ G P A+ T + C + P+ RP ++L+
Sbjct: 204 --MPYDLYTNSEVVLKVSQ---GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258
Query: 254 LERL 257
+E L
Sbjct: 259 IEPL 262
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-34
Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 38/242 (15%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E + + +P++ +L+G CL L+ + MP G L +++ R + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ AKG+ +L + ++++RD A N+L+ + K++DFGLAK ++ +
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY----- 174
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
G + A E + T +SDV+S+GV + EL++ G
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS----------------- 217
Query: 199 AKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
KPY D I G+ P + +C + RP+ E++
Sbjct: 218 -KPY--DGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274
Query: 256 RL 257
++
Sbjct: 275 KM 276
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 68/244 (27%), Positives = 105/244 (43%), Gaps = 42/244 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HP LV+L G CLE LV EFM G L ++L R + +
Sbjct: 50 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLG 108
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + +G+ +L E+ VI+RD A N L+ K+SDFG+ R + Q
Sbjct: 109 MCLDVCEGMAYL--EEACVIHRDLAARNCLVGENQVIKVSDFGMT-------RFVLDDQY 159
Query: 145 MGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 197
+ G +A+PE + R ++KSDV+SFGV++ E+ S G+
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK---------------- 203
Query: 198 WAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
PY S+ + I G P+ A+ + C P+ RP S +L
Sbjct: 204 --IPYENRSNSEVVEDIST---GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258
Query: 254 LERL 257
L +
Sbjct: 259 LAEI 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 69/246 (28%), Positives = 110/246 (44%), Gaps = 48/246 (19%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F E + + QL H NLV+L+G +E + L +V E+M KGSL ++L RG L +
Sbjct: 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K ++ + + +L + ++RD A N+L+ + AK+SDFGL + STQ
Sbjct: 121 KFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQ 171
Query: 144 VMG------THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 196
G T APE + + +TKSDV+SFG++L E+ S GR
Sbjct: 172 DTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRV-------------- 213
Query: 197 DWAKPY--LSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
PY + K + R+ G P + C + + +RP ++
Sbjct: 214 ----PYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 265
Query: 252 AILERL 257
LE +
Sbjct: 266 EQLEHI 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 21/243 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
F+ E+ L L H N+VK G C R L+ E++P GSL ++L + + +
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKL 147
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
++ KG+ +L + I+RD NIL++ E K+ DFGL K P +
Sbjct: 148 LQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 205
Query: 143 QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
G + APE + + + SDV+SFGVVL EL + + + +
Sbjct: 206 ----EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
+ + + + + P + +C NN RP ++ +
Sbjct: 262 DKQGQMIVFHLIELLKN----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
Query: 255 ERL 257
+++
Sbjct: 318 DQI 320
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 65/246 (26%), Positives = 116/246 (47%), Gaps = 44/246 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F +E + +GQ HPN+++L G G ++V E+M GSL+ L R + +
Sbjct: 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVG 155
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ G G+ +L ++ ++RD A N+L+D+ K+SDFGL++ +T
Sbjct: 156 MLRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT- 212
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
G + APE +A ++ SDV+SFGVV+ E+L+ G
Sbjct: 213 ---GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE----------------- 252
Query: 199 AKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVL 251
+PY ++++ + + + G + P A H L L C + + RPR S+++
Sbjct: 253 -RPYWNMTNRDVISSVEE---GYRLPAPMGCPHALH---QLMLDCWHKDRAQRPRFSQIV 305
Query: 252 AILERL 257
++L+ L
Sbjct: 306 SVLDAL 311
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 20/268 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
FQ E+ L LH +VK G ++ LV E++P G L + L R + L +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRL 129
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ + KG+ +L + ++RD A NIL+++E + K++DFGLAK P
Sbjct: 130 LLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DY 183
Query: 143 QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
V+ G + APE ++ + +SDV+SFGVVL EL + C + ++
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMG 242
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILE 255
+ + R L + + G + P A A L C P+ RP S + L+
Sbjct: 243 CERDVPALSRLLELLEE---GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
Query: 256 RLEAPKNSAKLSQSEPHRQTGPVTVRKS 283
L + + H + ++ S
Sbjct: 300 MLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 36/241 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L H LV+L E E +V E+M KGSL + L + L +
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A G+ ++ ++RD +A+NIL+ K++DFGLA+ + T
Sbjct: 368 MAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGA 424
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 202
+ APE GR T KSDV+SFG++L EL + GR PY
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR------------------VPYP 466
Query: 203 -LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256
+ ++ L ++ M P + + L QC EP+ RP + A LE
Sbjct: 467 GMVNREVLDQVERGYRMPC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
Query: 257 L 257
Sbjct: 521 Y 521
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 64/259 (24%), Positives = 101/259 (38%), Gaps = 37/259 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E + QL +P +V+LIG C E +LV E G L L + + + + +
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAE 114
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + G+ +L E ++RD A N+LL AK+SDFGL+KA D + +
Sbjct: 115 LLHQVSMGMKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS- 171
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
G + APE + + +++SDV+S+GV + E LS G+
Sbjct: 172 ---AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ----------------- 211
Query: 199 AKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
KPY K K +M G+ P + L C + + RP V +
Sbjct: 212 -KPY--KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
Query: 256 RLEAPKNSAKLSQSEPHRQ 274
S H
Sbjct: 269 ACYYSLASKVEGHHHHHHH 287
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 53/244 (21%), Positives = 99/244 (40%), Gaps = 42/244 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + L H LV+L G C + ++ E+M G L N+L R ++
Sbjct: 66 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLE 124
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + + +L Q ++RD A N L++ + K+SDFGL+ R + +
Sbjct: 125 MCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDDEY 175
Query: 145 MGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 197
+ G ++ PE + + ++KSD+++FGV++ E+ S G+
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK---------------- 219
Query: 198 WAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
PY ++ I G P A+ T+ C + + RP +L+
Sbjct: 220 --MPYERFTNSETAEHIAQ---GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274
Query: 254 LERL 257
+ +
Sbjct: 275 ILDV 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 42/244 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E N + L H LVKL + E ++ EFM KGSL + L +
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ A+G+ F+ + I+RD +A+NIL+ A K++DFGLA+ + T
Sbjct: 289 FSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--- 343
Query: 145 MGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 200
G + APE + G T KSDV+SFG++L+E+++ GR
Sbjct: 344 -GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI------------------ 384
Query: 201 PY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
PY +S+ + + M P+ + ++C N P+ RP + ++
Sbjct: 385 PYPGMSNPEVIRALERGYRMPR------PENCPEELYNIMMRCWKNRPEERPTFEYIQSV 438
Query: 254 LERL 257
L+
Sbjct: 439 LDDF 442
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 56/293 (19%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
+ EV L + HPN+V+ E + +V ++ G L + + +
Sbjct: 71 RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQV 144
+ L +HD ++++RD K+ NI L + +L DFG+A+ T + +
Sbjct: 131 FVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACI 186
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
GT Y +PE KSD+++ G VL EL + + A + + ++LV
Sbjct: 187 -GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLV-------- 234
Query: 205 DKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLE 258
+I+ G + ++ +L Q P+ RP ++ +L I +R+E
Sbjct: 235 -----LKIIS----GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285
Query: 259 APKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR 311
+ +++ + + P ++ S N + + +
Sbjct: 286 KFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYG 338
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 40/244 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-PLSWAVRM 83
F EVN + L H NL++L G L +V E P GSL + L + L R
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
A+ A+G+ +L + I+RD A N+LL K+ DFGL +A P D +V +
Sbjct: 127 --AVQVAEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 144 VMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 197
H + APE + T + SD + FGV L E+ + G+
Sbjct: 183 ----HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---------------- 222
Query: 198 WAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAI 253
+P+ +I+ K G + P+ + +QC ++P+ RP +
Sbjct: 223 --EPW--IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278
Query: 254 LERL 257
L
Sbjct: 279 LLEA 282
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 63/245 (25%), Positives = 102/245 (41%), Gaps = 44/245 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E N + QL H LV+L + E ++ E+M GSL + L L+ +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A+G+ F+ E I+RD +A+NIL+ + K++DFGLA+ +
Sbjct: 114 MAAQIAEGMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGLAR--------LIEDNE 163
Query: 145 MGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 196
A APE + G T KSDV+SFG++L E+++ GR
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI-------------- 209
Query: 197 DWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
PY +++ + + G + P L C P+ RP + +
Sbjct: 210 ----PYPGMTNPEVIQNLER---GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
Query: 253 ILERL 257
+LE
Sbjct: 263 VLEDF 267
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 68/243 (27%), Positives = 109/243 (44%), Gaps = 24/243 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
++ E++ L L+H +++K G C + + LV E++P GSL ++L R L+ +
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLL 138
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
A +G+ +LH I+RD A N+LLD + K+ DFGLAKA P G
Sbjct: 139 F--AQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EY 190
Query: 143 QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
+ G + APE + + SDV+SFGV L ELL+ C D ++ + L
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HC--DSSQSPPTKFLEL 247
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
+ + R+ + G+ P K L C E RP ++ IL
Sbjct: 248 IGIAQ--GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
Query: 255 ERL 257
+ +
Sbjct: 306 KTV 308
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E N + QL +P +V++IG C E+ +LV E G L +L + + +
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL- 122
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ G+ +L ES ++RD A N+LL + AK+SDFGL+KA + + +
Sbjct: 123 -VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT- 178
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
HG + APE + + ++KSDV+SFGV++ E S
Sbjct: 179 ---HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 44/247 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F TE + HPN++ L+G CL E L+V +M G L N + + +
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLI 131
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVS 141
+ AKG+ +L A + ++RD A N +LD +F K++DFGLA+ + H
Sbjct: 132 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 142 TQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 194
T M A E + T + TTKSDV+SFGV+L EL++ G
Sbjct: 190 TGAKLPVKWM------ALESLQTQKFTTKSDVWSFGVLLWELMTRGA------------- 230
Query: 195 LVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250
PY ++ ++ G P+ + L+C + + ++RP SE+
Sbjct: 231 -----PPYPDVNTFDITVYLLQ---GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 282
Query: 251 LAILERL 257
++ + +
Sbjct: 283 VSRISAI 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 33/235 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCL---EGENRLLVY-EFMPKGSLENHLFRRGPQPLSWA 80
F+ E L L HPN+V+ +G+ +++ E M G+L+ +L R +
Sbjct: 72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIK 129
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTH 139
V KGL FLH +I+RD K NI + + K+ D GLA R
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RAS 185
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
+ V+GT + APE DVY+FG+ +LE+ +
Sbjct: 186 FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEY----------------- 227
Query: 200 KPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAAT-LALQCLNNEPKLRPRMSEVL 251
PY + +++R + + + K A + C+ R + ++L
Sbjct: 228 -PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 61/281 (21%), Positives = 118/281 (41%), Gaps = 38/281 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ +G L H ++V+L+G C + LV +++P GSL +H+ R+ L + +
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLN 119
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ AKG+ +L E +++R+ A N+LL + +++DFG+A P D Q+
Sbjct: 120 WGVQIAKGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQL 172
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
+ + + A E + G+ T +SDV+S+GV + EL++ G
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA----------------- 215
Query: 199 AKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
+PY +L + D G+ PQ + ++C + +RP E+
Sbjct: 216 -EPY--AGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272
Query: 256 RLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTP 296
R+ + + E P ++ + + P
Sbjct: 273 RMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEP 313
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 38/242 (15%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E + + +P++ +L+G CL L+ + MP G L +++ + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 121
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ AKG+ +L + ++++RD A N+L+ + K++DFGLAK ++ +
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY----- 174
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
G + A E + T +SDV+S+GV + EL++ G
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS----------------- 217
Query: 199 AKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
KPY D I G+ P + ++C + RP+ E++
Sbjct: 218 -KPY--DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274
Query: 256 RL 257
++
Sbjct: 275 KM 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-32
Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 44/253 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-LSWAVRM 83
F +E + L HP++VKLIG E E ++ E P G L ++L R + V
Sbjct: 60 FMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
++ K + +L ++RD NIL+ + KL DFGL++ D +
Sbjct: 119 --SLQICKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS 172
Query: 144 VMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 197
+ +PE + R TT SDV+ F V + E+LS G+
Sbjct: 173 ----VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK---------------- 212
Query: 198 WAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253
+P+ L +K + + G P TL +C + +P RPR +E++
Sbjct: 213 --QPFFWLENKDVIGVLEK---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267
Query: 254 LERL-EAPKNSAK 265
L + + K+ A
Sbjct: 268 LSDVYQMEKDIAM 280
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 49/273 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QP 76
F E + + + + ++V+L+G +G+ L++ E M +G L+++L P P
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
S + +++A A G+ +L ++ ++RD A N ++ +F K+ DFG+ + D
Sbjct: 135 PSLSKMIQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 137 --RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKV 189
R + M +PE + G TT SDV+SFGVVL E+ +
Sbjct: 193 YYRKGGKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------- 238
Query: 190 GIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRP 245
+PY LS+++ L +M+ GG P L C PK+RP
Sbjct: 239 ----------QPYQGLSNEQVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRP 285
Query: 246 RMSEVLAILER-LEAPKNSAKLSQSEPHRQTGP 277
E+++ ++ +E SE ++ P
Sbjct: 286 SFLEIISSIKEEMEPGFREVSFYYSEENKLPEP 318
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 29/253 (11%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRM 83
E++ L QL+HPN++K +E +V E G L + F++ + +
Sbjct: 80 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K + L +H +V++RD K +N+ + A KL D GL + + T +
Sbjct: 140 KYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSL 196
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
V GT Y +PE + KSD++S G +L E+ + + P+
Sbjct: 197 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFY 237
Query: 204 SDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259
DK L+ + YP + L C+N +P+ RP ++ V + +R+ A
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
Query: 260 PKNSAKLSQSEPH 272
++ L H
Sbjct: 298 CT-ASSLEHHHHH 309
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 65/243 (26%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + Q HP++VKLIG E ++ E G L + L R L A +
Sbjct: 63 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLIL 120
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A + L +L + ++RD A N+L+ + KL DFGL++ ST
Sbjct: 121 YAYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYY 172
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
+ G + APE + R T+ SDV+ FGV + E+L G
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV----------------- 215
Query: 199 AKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
KP+ + + + RI + G P T +L +C +P RPR +E+ A L
Sbjct: 216 -KPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271
Query: 255 ERL 257
+
Sbjct: 272 STI 274
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 68/257 (26%), Positives = 104/257 (40%), Gaps = 53/257 (20%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------- 74
FQ E L L H ++V+ G C EG L+V+E+M G L L GP
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 75 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131
PL + VA A G+ +L A ++RD N L+ K+ DFG+++
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207
Query: 132 GPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAV 184
+ D V + M PE + + TT+SDV+SFGVVL E+ + G+
Sbjct: 208 IYSTDYYRVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGK--- 258
Query: 185 DKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNE 240
+P+ LS+ + I G + P+ + C E
Sbjct: 259 ---------------QPWYQLSNTEAIDCITQ---GRELERPRACPPEVYAIMRGCWQRE 300
Query: 241 PKLRPRMSEVLAILERL 257
P+ R + +V A L+ L
Sbjct: 301 PQQRHSIKDVHARLQAL 317
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 44/247 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F E + L+HPN++ LIG L E + +M G L + + +
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLI 127
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK----AGPTGDRTH 139
+ A+G+ +L AE + ++RD A N +LD F K++DFGLA+ + H
Sbjct: 128 SFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185
Query: 140 VSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 194
++ A E + T R TTKSDV+SFGV+L ELL+ G
Sbjct: 186 RHARLPVKWT------ALESLQTYRFTTKSDVWSFGVLLWELLTRGA------------- 226
Query: 195 LVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250
PY + + G P+ + + QC +P +RP +
Sbjct: 227 -----PPYRHIDPFDLTHFLAQ---GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVL 278
Query: 251 LAILERL 257
+ +E++
Sbjct: 279 VGEVEQI 285
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-31
Identities = 66/258 (25%), Positives = 104/258 (40%), Gaps = 54/258 (20%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------- 74
FQ E L L H ++VK G C +G+ ++V+E+M G L L GP
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 75 ----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130
L + + +A A G+ +L A ++RD N L+ A K+ DFG+++
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 131 AGPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 183
+ D V M PE + + TT+SDV+SFGV+L E+ + G+
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQ- 234
Query: 184 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNN 239
P+ LS+ + I G + P+ + L C
Sbjct: 235 -----------------PWFQLSNTEVIECITQ---GRVLERPRVCPKEVYDVMLGCWQR 274
Query: 240 EPKLRPRMSEVLAILERL 257
EP+ R + E+ IL L
Sbjct: 275 EPQQRLNIKEIYKILHAL 292
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 65/246 (26%), Positives = 107/246 (43%), Gaps = 42/246 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F TE + HPN++ L+G CL E L+V +M G L N + + +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLI 195
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+ AKG+ FL A + ++RD A N +LD +F K++DFGLA+ D
Sbjct: 196 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFD 248
Query: 144 VMGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 195
+ A A E + T + TTKSDV+SFGV+L EL++ G
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-------------- 294
Query: 196 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
PY ++ ++ G P+ + L+C + + ++RP SE++
Sbjct: 295 ----PPYPDVNTFDITVYLLQ---GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 347
Query: 252 AILERL 257
+ + +
Sbjct: 348 SRISAI 353
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-31
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 45/241 (18%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL----------------LVYEFMPKGSLENHLFR 71
EV L +L H N+V G + + EF KG+LE + +
Sbjct: 54 EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131
R + L + +++ KG+ ++H ++I RD K SNI L K+ DFGL +
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 132 -GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 190
G RT GT Y +PE +++ + D+Y+ G++L ELL
Sbjct: 172 LKNDGKRT---RSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV---------- 217
Query: 191 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250
+ + D + + +K L + L+ +P+ RP SE+
Sbjct: 218 --------CDTAFETSKFFTDLRDGIISDIFDKKEKT----LLQKLLSKKPEDRPNTSEI 265
Query: 251 L 251
L
Sbjct: 266 L 266
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + Q HP++VKLIG E ++ E G L + L + L A +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKFSLDLASLIL 495
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A + L +L + ++RD A N+L+ + KL DFGL++ ST
Sbjct: 496 YAYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYY 547
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 198
+ G + APE + R T+ SDV+ FGV + E+L G
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV----------------- 590
Query: 199 AKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254
KP+ + + + RI + G P T +L +C +P RPR +E+ A L
Sbjct: 591 -KPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646
Query: 255 ERL 257
+
Sbjct: 647 STI 649
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 57/266 (21%), Positives = 105/266 (39%), Gaps = 50/266 (18%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLFRRGP---- 74
F E + + HP++ KL+G L + +++ FM G L L
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134
L ++ + A G+ +L + I+RD A N +L + ++DFGL++ +
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 135 GD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKT 187
GD R ++++ + A E +A T SDV++FGV + E+++ G+
Sbjct: 190 GDYYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------ 237
Query: 188 KVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKL 243
PY + + ++ G + P + L QC + +PK
Sbjct: 238 ------------TPYAGIENAEIYNYLIG---GNRLKQPPECMEEVYDLMYQCWSADPKQ 282
Query: 244 RPRMSEVLAILERLEAPKNSAKLSQS 269
RP + + LE + + SQ
Sbjct: 283 RPSFTCLRMELENILGHLSVLSTSQD 308
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 59/304 (19%), Positives = 110/304 (36%), Gaps = 43/304 (14%)
Query: 25 FQTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
++ E+ YL +L + ++L Y + + +V E L + L ++
Sbjct: 54 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS 112
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ + + +H +++ D K +N L+ + KL DFG+A + V
Sbjct: 113 YWKNM--LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 143 QVMGTHGYAAPE-----------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 191
+GT Y PE + +++ KSDV+S G +L + G+
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--------- 218
Query: 192 EQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248
P+ ++ KL I+D ++P + CL +PK R +
Sbjct: 219 ---------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269
Query: 249 EVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHR 305
E+LA + + AK + E G + SP ++ + S SH
Sbjct: 270 ELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN 329
Query: 306 QSPR 309
S
Sbjct: 330 SSSS 333
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 65/268 (24%), Positives = 103/268 (38%), Gaps = 48/268 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSW 79
F E + + +H N+V+ IG L+ R ++ E M G L++ L P L+
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD 136
+ VA A G +L E+ I+RD A N LL AK+ DFG+A+
Sbjct: 140 LDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
Query: 137 --RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKV 189
R + M PE G T+K+D +SFGV+L E+ S G
Sbjct: 198 YYRKGGCAMLPVKWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY-------- 243
Query: 190 GIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRP 245
PY S++ L + GG P+ + QC ++P+ RP
Sbjct: 244 ----------MPYPSKSNQEVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 290
Query: 246 RMSEVLAILERLEAPKNSAKLSQSEPHR 273
+ +L +E + + +
Sbjct: 291 NFAIILERIEYCTQDPDVINTALPIEYG 318
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E + QL +P +V+LIG C E +LV E G L L + + + + +
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAE 440
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + G+ +L E ++R+ A N+LL AK+SDFGL+KA D + +
Sbjct: 441 LLHQVSMGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS- 497
Query: 145 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 179
G + APE + + +++SDV+S+GV + E LS
Sbjct: 498 ---AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 64/267 (23%), Positives = 101/267 (37%), Gaps = 46/267 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSW 79
F E + + +H N+V+ IG L+ R ++ E M G L++ L P L+
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD 136
+ VA A G +L E+ I+RD A N LL AK+ DFG+A+
Sbjct: 181 LDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
Query: 137 RTHVSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVG 190
G PE G T+K+D +SFGV+L E+ S G
Sbjct: 239 YY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY--------- 284
Query: 191 IEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPR 246
PY S++ L + GG P+ + QC ++P+ RP
Sbjct: 285 ---------MPYPSKSNQEVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN 332
Query: 247 MSEVLAILERLEAPKNSAKLSQSEPHR 273
+ +L +E + + +
Sbjct: 333 FAIILERIEYCTQDPDVINTALPIEYG 359
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 58/253 (22%), Positives = 106/253 (41%), Gaps = 49/253 (19%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR-----LLVYEFMPKGSLENHLFRR----GPQ 75
F +E + HPN+++L+G C+E ++ +++ FM G L +L GP+
Sbjct: 83 FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK 142
Query: 76 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 135
+ +K + A G+ +L + ++RD A N +L + ++DFGL+K +G
Sbjct: 143 HIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200
Query: 136 D--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTK 188
D R ++ + A E +A T+KSDV++FGV + E+ + G
Sbjct: 201 DYYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGM------- 247
Query: 189 VGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLR 244
PY + + ++ G + P+ + C +P R
Sbjct: 248 -----------TPYPGVQNHEMYDYLLH---GHRLKQPEDCLDELYEIMYSCWRTDPLDR 293
Query: 245 PRMSEVLAILERL 257
P S + LE+L
Sbjct: 294 PTFSVLRLQLEKL 306
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 5/157 (3%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F+ EV+ QL H N+V +I E + LV E++ +L ++ GP + A+
Sbjct: 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN-- 115
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
G+ HD ++++RD K NIL+D+ K+ DFG+AKA T + V
Sbjct: 116 FTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-V 172
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+GT Y +PE +D+YS G+VL E+L G
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-30
Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 54/256 (21%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------- 74
F+ E +L HPN+V L+G + + +++ + G L L R P
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 75 ----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130
L + + A G+ +L + V+++D N+L+ + N K+SD GL +
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 131 AGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 183
D + ++ + M APE + G+ + SD++S+GVVL E+ S G
Sbjct: 177 EVYAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGL-- 228
Query: 184 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNN 239
+PY S++ + I + P L ++C N
Sbjct: 229 ----------------QPYCGYSNQDVVEMIRN---RQVLPCPDDCPAWVYALMIECWNE 269
Query: 240 EPKLRPRMSEVLAILE 255
P RPR ++ + L
Sbjct: 270 FPSRRPRFKDIHSRLR 285
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 71/274 (25%), Positives = 110/274 (40%), Gaps = 57/274 (20%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-------- 75
F E+ L +L HHPN++ L+G C L E+ P G+L + L +
Sbjct: 72 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 76 ------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
LS + A A+G+ +L ++ Q I+RD A NIL+ + AK++DFGL+
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLS 189
Query: 130 KAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 183
+ V T G + A E + TT SDV+S+GV+L E++S G
Sbjct: 190 RGQ--------EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-- 239
Query: 184 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNN 239
PY ++ ++ G + P L QC
Sbjct: 240 ----------------TPYCGMTCAELYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWRE 280
Query: 240 EPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPH 272
+P RP +++L L R LE K + E
Sbjct: 281 KPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 5/157 (3%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
Q E G+L P++V + + + + L L R+GP AV
Sbjct: 81 MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA-- 138
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ L H A +RD K NIL+ A+ A L DFG+A A T +
Sbjct: 139 IVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-T 195
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+GT Y APE + T ++D+Y+ VL E L+G
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 48/243 (19%), Positives = 92/243 (37%), Gaps = 40/243 (16%)
Query: 25 FQTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
++ E+ YL +L + ++L Y + + +V E L + L ++
Sbjct: 73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKS 131
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ + + +H +++ D K +N L+ + KL DFG+A + V
Sbjct: 132 YWKNM--LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 143 QVMGTHGYAAPE-----------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 191
+GT Y PE + +++ KSDV+S G +L + G+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--------- 237
Query: 192 EQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248
P+ ++ KL I+D ++P + CL +PK R +
Sbjct: 238 ---------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 249 EVL 251
E+L
Sbjct: 289 ELL 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 58/304 (19%), Positives = 110/304 (36%), Gaps = 43/304 (14%)
Query: 25 FQTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
++ E+ YL +L + ++L Y + + +V E L + L ++
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS 159
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ + + +H + +++ D K +N L+ + KL DFG+A + V
Sbjct: 160 YWKNM--LEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 143 QVMGTHGYAAPE-----------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 191
+G Y PE + +++ KSDV+S G +L + G+
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---------- 264
Query: 192 EQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248
P+ ++ KL I+D ++P + CL +PK R +
Sbjct: 265 --------TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 316
Query: 249 EVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHR 305
E+LA + + AK + E G + SP ++ + S SH
Sbjct: 317 ELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN 376
Query: 306 QSPR 309
S
Sbjct: 377 SSSS 380
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 31/167 (18%), Positives = 65/167 (38%), Gaps = 17/167 (10%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E+ + + + + G + + + ++YE+M S+ ++ +
Sbjct: 91 KNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 85 VAIGA------AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
+ + +++H E + +RD K SNIL+D KLSDFG ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTT---KSDVYSFGVVLLELLSGRC 182
GT+ + PE + + K D++S G+ L +
Sbjct: 209 ---G-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 53/226 (23%), Positives = 77/226 (34%), Gaps = 28/226 (12%)
Query: 28 EVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
EV ++ HP V+L EG L E SL+ H G L A
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYL 163
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
L LH +++ D K +NI L KL DFGL T Q G
Sbjct: 164 RDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-G 218
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 206
Y APE + G T +DV+S G+ +LE+
Sbjct: 219 DPRYMAPE-LLQGSYGTAADVFSLGLTILEVACN-------------------MELPHGG 258
Query: 207 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
++ L ++ + ++ + L +PKLR +LA
Sbjct: 259 EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 62/266 (23%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-- 82
FQ E + + +PN+VKL+G C G+ L++E+M G L L P +
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 83 --------------------MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 122
+ +A A G+ +L +E + ++RD N L+ K
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVK 214
Query: 123 LSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176
++DFGL++ + D + + + M PE + R TT+SDV+++GVVL E
Sbjct: 215 IADFGLSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWE 268
Query: 177 LLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAAT 231
+ S G PY ++ + ++ + D G P+
Sbjct: 269 IFSYGLQ------------------PYYGMAHEEVIYYVRD---GNILACPENCPLELYN 307
Query: 232 LALQCLNNEPKLRPRMSEVLAILERL 257
L C + P RP + IL+R+
Sbjct: 308 LMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 65/257 (25%), Positives = 103/257 (40%), Gaps = 52/257 (20%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------- 74
+E+ + L H N+V L+G C G L++ E+ G L N L R+
Sbjct: 96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 75 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131
S + + A+G+ FL A I+RD A N+LL AK+ DFGLA+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR- 212
Query: 132 GPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVD 185
D + S ++ + + APE + T +SDV+S+G++L E+ S G
Sbjct: 213 ----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN--- 265
Query: 186 KTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNE 240
PY L + + + D G Q P A ++ C E
Sbjct: 266 ---------------PYPGILVNSKFYKLVKD---GYQMAQPAFAPKNIYSIMQACWALE 307
Query: 241 PKLRPRMSEVLAILERL 257
P RP ++ + L+
Sbjct: 308 PTHRPTFQQICSFLQEQ 324
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 61/276 (22%), Positives = 112/276 (40%), Gaps = 54/276 (19%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------- 74
+E+ + + H N++ L+G C + ++ E+ KG+L +L R P
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 75 -----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
+ +++ + A+G+ +L A + I+RD A N+L+ K++DFGLA
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 130 KAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 183
+ D ++ T+G + APE + T +SDV+SFGV++ E+ + G
Sbjct: 205 R-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS- 258
Query: 184 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNN 239
PY + + + + G P + + C +
Sbjct: 259 -----------------PYPGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHA 298
Query: 240 EPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPHRQ 274
P RP +++ L+R L N L S+P Q
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQ 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 47/256 (18%), Positives = 91/256 (35%), Gaps = 53/256 (20%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-------------LVYEFMPKGSLENHLFRR 72
+EV L L+H +V+ LE N + + E+ G+L + +
Sbjct: 50 LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE 109
Query: 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-- 130
++ + L+++H +I+RD K NI +D N K+ DFGLAK
Sbjct: 110 N-LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 131 -----------AGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELL 178
G ++++ + GT Y A E + TG K D+YS G++ E++
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM---DTKLGGQYPQKAAHTAATLALQ 235
++ + + + + + +
Sbjct: 226 YPF-------------------STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266
Query: 236 CLNNEPKLRPRMSEVL 251
++++P RP +L
Sbjct: 267 LIDHDPNKRPGARTLL 282
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 55/258 (21%), Positives = 106/258 (41%), Gaps = 53/258 (20%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------- 74
+E+ + + H N++ L+G C + ++ E+ KG+L +L R P
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 75 -----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
+ +++ + A+G+ +L A + I+RD A N+L+ K++DFGLA
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 130 KAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 183
+ D ++ T+G + APE + T +SDV+SFGV++ E+ + G
Sbjct: 251 R-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS- 304
Query: 184 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNN 239
PY + + + + G P + + C +
Sbjct: 305 -----------------PYPGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHA 344
Query: 240 EPKLRPRMSEVLAILERL 257
P RP +++ L+R+
Sbjct: 345 VPSQRPTFKQLVEDLDRI 362
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 60/265 (22%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------- 74
+E N L Q++HP+++KL G C + LL+ E+ GSL L
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 75 ------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 122
+ L+ + A ++G+ +L AE ++++RD A NIL+ K
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMK 190
Query: 123 LSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLEL 177
+SDFGL++ D + V + G + A E + TT+SDV+SFGV+L E+
Sbjct: 191 ISDFGLSR-----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 178 LS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATL 232
++ G PY + +R + G + P + L
Sbjct: 246 VTLGGN------------------PYPGIPPERLFNLLKT---GHRMERPDNCSEEMYRL 284
Query: 233 ALQCLNNEPKLRPRMSEVLAILERL 257
LQC EP RP +++ LE++
Sbjct: 285 MLQCWKQEPDKRPVFADISKDLEKM 309
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 52/227 (22%), Positives = 85/227 (37%), Gaps = 29/227 (12%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E+ L P +V L G EG + E + GSL + + G L +
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYY 155
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK--AGPTGDRTHVST 142
A +GL +LH ++++ D KA N+LL ++ A L DFG A ++ ++
Sbjct: 156 LGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 143 QVM-GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
+ GT + APE V K D++S ++L +L+G P
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------------------HP 255
Query: 202 Y--LSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245
+ +I + + P A A + L EP R
Sbjct: 256 WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 55/270 (20%), Positives = 100/270 (37%), Gaps = 52/270 (19%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGEN---------RLLVY---EFMPKGSLENHL-FRRGP 74
EV L +L HP +V+ LE ++ +Y + K +L++ + R
Sbjct: 53 EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--- 131
+ +V + + + A+ + FLH +++RD K SNI + K+ DFGL A
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 132 -------GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184
T +GT Y +PE + + K D++S G++L ELL
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFST- 229
Query: 185 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH---TAATLALQCLNNEP 241
+E+ L + + ++P + L+ P
Sbjct: 230 -----QMERVRT------------LTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSP 268
Query: 242 KLRPRMSEVLA--ILERLEAPKNSAKLSQS 269
RP ++ + E L+ P + +S
Sbjct: 269 MERPEAINIIENAVFEDLDFPGKTVLRQRS 298
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 9/162 (5%)
Query: 25 FQTEVNYLGQLHHPNLVKL--IGYCLEGENRL--LVYEFMPKGSLENHLFRRGPQPLSWA 80
F+ E L+HP +V + G L +V E++ +L + + GP A
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
+ V A + L F H +I+RD K +NI++ A K+ DFG+A+A +
Sbjct: 119 IE--VIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 141 ST-QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
T V+GT Y +PE + +SDVYS G VL E+L+G
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 56/251 (22%), Positives = 95/251 (37%), Gaps = 33/251 (13%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHL--FRRGPQPLSW 79
Q E + +HPN+++L+ YCL L+ F +G+L N + + L+
Sbjct: 74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGD 136
+ + +G +GL +H +RD K +NILL E L D G G
Sbjct: 134 DQILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 137 RTHVSTQVM----GTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKV 189
R ++ Q T Y APE + + ++DV+S G VL ++ G D
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 190 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249
+ S + + ++ L + +P RP +
Sbjct: 252 KGD-----------SVALAVQNQLSIPQSPRHSSALWQ----LLNSMMTVDPHQRPHIPL 296
Query: 250 VLAILERLEAP 260
+L+ LE L+ P
Sbjct: 297 LLSQLEALQPP 307
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 33/235 (14%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMK 84
E+ L H N+V+ +G E + E +P GSL L + GP +
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQ 143
+GL +LHD +Q+++RD K N+L++ K+SDFG +K +
Sbjct: 127 YTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTET 182
Query: 144 VMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
GT Y APE + G +D++S G ++E+ +G+
Sbjct: 183 FTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK------------------P 223
Query: 201 PYLSDKRK----LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
P+ + + +F++ K+ + P+ + A L+C +P R +++L
Sbjct: 224 PF-YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 277
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 65/267 (24%), Positives = 101/267 (37%), Gaps = 68/267 (25%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------- 74
+E+ L L +H N+V L+G C G L++ E+ G L N L R+
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 75 -------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 127
L + + AKG+ FL A I+RD A NILL K+ DFG
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 128 LAKAGPTGDRTHVSTQVMGTHGYA------------APEYVATGRLTTKSDVYSFGVVLL 175
LA+ + Y APE + T +SDV+S+G+ L
Sbjct: 191 LAR------------DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 176 ELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAA 230
EL S G PY + K ++++ K G P+ A
Sbjct: 239 ELFSLGSS------------------PYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMY 278
Query: 231 TLALQCLNNEPKLRPRMSEVLAILERL 257
+ C + +P RP +++ ++E+
Sbjct: 279 DIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 62/244 (25%), Positives = 96/244 (39%), Gaps = 31/244 (12%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHL--FRRGPQPLSWAV 81
+EVN L +L HPN+V+ ++ N L V E+ G L + + + Q L
Sbjct: 53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 82 RMKVAIGAAKGLTFLHD---AESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDR 137
++V L H V++RD K +N+ LD + N KL DFGLA+
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 138 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
T V GT Y +PE + KSD++S G +L EL +
Sbjct: 173 AK--TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------------ 217
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---IL 254
A K+ ++ +Y + + + LN + RP + E+L IL
Sbjct: 218 -AFSQKELAGKIREGKFRRIPYRYSDELNE----IITRMLNLKDYHRPSVEEILENPLIL 272
Query: 255 ERLE 258
E
Sbjct: 273 EHHH 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 62/275 (22%), Positives = 113/275 (41%), Gaps = 53/275 (19%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------- 74
+E+ + + H N++ L+G C + ++ E+ KG+L +L R P
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 75 -----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
+ LS + A A+G+ +L A + I+RD A N+L+ + K++DFGLA
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 130 KAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 183
+ D H+ T+G + APE + T +SDV+SFGV+L E+ + G
Sbjct: 239 R-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS- 292
Query: 184 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNN 239
PY + + + + G P + + C +
Sbjct: 293 -----------------PYPGVPVEELFKLLKE---GHRMDKPSNCTNELYMMMRDCWHA 332
Query: 240 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 274
P RP +++ L+R+ A ++ ++ H
Sbjct: 333 VPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHH 367
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 21/163 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-----LVYEFMPKGSLENHLFRRGPQPLSW 79
E +L ++ HP++V++ + + +V E++ SL+ P++
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRT 138
A+ + L++LH ++Y D K NI+L E KL D G G
Sbjct: 184 AIA--YLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG--- 235
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+ GT G+ APE + T +D+Y+ G L L
Sbjct: 236 ----YLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL 273
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 59/265 (22%), Positives = 99/265 (37%), Gaps = 59/265 (22%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR- 82
+E+ + QL H N+V L+G C L++E+ G L N+L + + +
Sbjct: 95 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 83 --------------------MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 122
+ A AKG+ FL ++RD A N+L+ K
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVK 212
Query: 123 LSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLEL 177
+ DFGLA+ D S V+ + + APE + G T KSDV+S+G++L E+
Sbjct: 213 ICDFGLAR-----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
Query: 178 LS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATL 232
S G PY + ++++ + G P A +
Sbjct: 268 FSLGVN------------------PYPGIPVDANFYKLI--QNGFKMDQPFYATEEIYII 307
Query: 233 ALQCLNNEPKLRPRMSEVLAILERL 257
C + + RP + + L
Sbjct: 308 MQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 35/226 (15%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E L +++ +V L Y E ++ L LV M G L+ H++ G A R
Sbjct: 233 NEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVF 290
Query: 86 AIG-AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
GL LH +++YRD K NILLD + ++SD GLA P G +V
Sbjct: 291 YAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV 346
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
GT GY APE V R T D ++ G +L E+++G+ P+
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS------------------PFQQ 387
Query: 205 DKRKL------FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
K+K+ + + +Y ++ + A +L Q L +P R
Sbjct: 388 RKKKIKREEVERLVKEVPE--EYSERFSPQARSLCSQLLCKDPAER 431
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-26
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E+ L HPN++++ Y R+ L+ EF P+G L L + G +
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+ A L + H E +VI+RD K N+L+ + K++DFG + P R G
Sbjct: 123 L--ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---G 174
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
T Y PE + K D++ GV+ E L G
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-26
Identities = 69/259 (26%), Positives = 102/259 (39%), Gaps = 53/259 (20%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGP-------- 74
+E+ L + HH N+V L+G C G +++ EF G+L +L +
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 75 ------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 128
L+ + + AKG+ FL A + I+RD A NILL + K+ DFGL
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 129 AKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC 182
A+ D V + APE + T +SDV+SFGV+L E+ S G
Sbjct: 195 AR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 183 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLN 238
PY + + R + K G + P L C +
Sbjct: 250 ------------------PYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWH 289
Query: 239 NEPKLRPRMSEVLAILERL 257
EP RP SE++ L L
Sbjct: 290 GEPSQRPTFSELVEHLGNL 308
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
EV L HPN+++L GY R+ L+ E+ P G++ L +
Sbjct: 59 EVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+ A L++ H +VI+RD K N+LL + K++DFG + P+ RT + G
Sbjct: 118 L--ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---D-LCG 169
Query: 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
T Y PE + K D++S GV+ E L G+
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 58/291 (19%), Positives = 100/291 (34%), Gaps = 51/291 (17%)
Query: 26 QTEVNYLGQL-HHPNLVKLIGYCLEGENR-------LLVYEFMPKGSLENHLFRRGPQ-P 76
EV ++ +L HPN+V+ G+ L+ + KG L L + + P
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GP 133
LS +K+ + + +H + +I+RD K N+LL + KL DFG A P
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 134 TGDRTHVSTQVM-------GTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCA 183
+ ++ T Y PE + + K D+++ G +L L +
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 184 -VDKTKVGIEQSLVDW--AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 240
D K+ I + L R M L
Sbjct: 253 FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAM-----------------------LQVN 289
Query: 241 PKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSP 291
P+ R ++EV+ L+ + A +N ++ P + R P
Sbjct: 290 PEERLSIAEVVHQLQEIAAARN---VNPKSPITELLEQNGGYGSATLSRGP 337
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 34/228 (14%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E L ++H +V L Y E + L LV M G + H++ +
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 85 VAIGA--AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ A GL LH + +IYRD K N+LLD + N ++SD GLA G
Sbjct: 292 IFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKG 348
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
GT G+ APE + D ++ GV L E+++ R P+
Sbjct: 349 YA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG------------------PF 389
Query: 203 LSDKRK-----LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
+ K L + +++ + YP K + + L +P+ R
Sbjct: 390 RARGEKVENKELKQRVLEQAV--TYPDKFSPASKDFCEALLQKDPEKR 435
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 37 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK---G 92
P +V + Y ++L + + M G L HL + G + AA+ G
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-----FYAAEIILG 304
Query: 93 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152
L +H V+YRD K +NILLD + ++SD GLA + H V GTHGY A
Sbjct: 305 LEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGYMA 358
Query: 153 PEYVATGRLTTKS-DVYSFGVVLLELLSGRC--AVDKTKVGIEQSLVDWAKPYLSDKRKL 209
PE + G S D +S G +L +LL G KTK DK ++
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------------DKHEI 402
Query: 210 FR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
R + + + P + +L L + R
Sbjct: 403 DRMTLTMAV--ELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 34/238 (14%)
Query: 28 EVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
EV L + HPN+++ + + + + E +L+ ++ ++ L +
Sbjct: 67 EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLL 124
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDRT-HV 140
GL LH +++RD K NIL+ + A +SDFGL K G +
Sbjct: 125 QQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 141 STQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
+ V GT G+ APE + T D++S G V ++S
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-------------- 228
Query: 198 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLALQCLNNEPKLRPRMSEVLA 252
P+ ++ I+ H A L + + +P+ RP VL
Sbjct: 229 ---PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 75/229 (32%), Positives = 113/229 (49%), Gaps = 26/229 (11%)
Query: 22 TNWFQTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSW 79
+W QTE + Q +HP LV L C + E+RL V E++ G L H+ R+ P
Sbjct: 53 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 111
Query: 80 AVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
A R A I A L +LH E +IYRD K N+LLD+E + KL+D+G+ K G T
Sbjct: 112 A-RFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 139 HVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196
T GT Y APE + G S D ++ GV++ E+++GR D
Sbjct: 167 ---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS------ 216
Query: 197 DWAKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
P + + LF+ I++ ++ + P+ + AA++ LN +PK R
Sbjct: 217 --DNPDQNTEDYLFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 261
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
E++ L H ++V G+ E + + +V E + SL RR A
Sbjct: 62 MSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVST 142
I G +LH ++VI+RD K N+ L+ + K+ DFGLA K G+R V
Sbjct: 121 LRQI--VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC 176
Query: 143 QVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
GT Y APE V + + + + DV+S G ++ LL G+
Sbjct: 177 ---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E + L +++HP +VKL Y + E +L L+ +F+ G L L + + +
Sbjct: 75 MERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYL 132
Query: 86 A-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A + A L LH +IYRD K NILLD E + KL+DFGL+K ++
Sbjct: 133 AELALA--LDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYS 185
Query: 145 M-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP- 201
GT Y APE V R T+S D +SFGV++ E+L+G
Sbjct: 186 FCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT-------------------LP 225
Query: 202 -YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
D+++ I+ KL PQ + A +L P R
Sbjct: 226 FQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
E++ L H ++V G+ E + + +V E + SL RR A
Sbjct: 88 MSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 146
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVST 142
I G +LH ++VI+RD K N+ L+ + K+ DFGLA K G+R V
Sbjct: 147 LRQI--VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC 202
Query: 143 QVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
GT Y APE V + + + + DV+S G ++ LL G+
Sbjct: 203 ---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLS-WAVRMKV 85
EV QL HP++++L Y E N + LV E G + +L R +P S R +
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFM 118
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQV 144
G+ +LH +++RD SN+LL N K++DFGLA + ++ +
Sbjct: 119 H-QIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-- 173
Query: 145 MGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
GT Y +PE +AT +SDV+S G + LL GR
Sbjct: 174 -GTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 3e-23
Identities = 46/243 (18%), Positives = 88/243 (36%), Gaps = 38/243 (15%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAV 81
+ ++ + N V + + + K +L++ + RR + V
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---------- 131
+ + I A+ + FLH +++RD K SNI + K+ DFGL A
Sbjct: 166 CLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 132 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 191
T +GT Y +PE + + K D++S G++L ELL +
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST------QM 277
Query: 192 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH---TAATLALQCLNNEPKLRPRMS 248
E+ + ++D R ++P + L+ P RP +
Sbjct: 278 ERVRI------ITDVRN----------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321
Query: 249 EVL 251
+++
Sbjct: 322 DII 324
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 34/224 (15%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
TE L HP L L Y + +RL V E+ G L HL R A
Sbjct: 53 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG 111
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
I +A L +LH V+YRD K N++LD + + K++DFGL K G + T +
Sbjct: 112 AEIVSA--LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKT 164
Query: 145 M-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP- 201
GT Y APE V ++ D + GVV+ E++ GR P
Sbjct: 165 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL------------------PF 205
Query: 202 YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
Y D +LF I+ ++ ++P+ + A +L L +PK R
Sbjct: 206 YNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 75/227 (33%), Positives = 112/227 (49%), Gaps = 26/227 (11%)
Query: 24 WFQTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAV 81
W QTE + Q +HP LV L C + E+RL V E++ G L H+ R+ P A
Sbjct: 98 WVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA- 155
Query: 82 RMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
R A I A L +LH E +IYRD K N+LLD+E + KL+D+G+ K G T
Sbjct: 156 RFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-- 209
Query: 141 STQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 198
T GT Y APE + G S D ++ GV++ E+++GR D
Sbjct: 210 -TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS-------- 259
Query: 199 AKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
P + + LF+ I++ ++ + P+ + AA++ LN +PK R
Sbjct: 260 DNPDQNTEDYLFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-23
Identities = 50/261 (19%), Positives = 85/261 (32%), Gaps = 37/261 (14%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
Q E++ +HPN+V + +V FM GS ++ + ++ +
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHV---- 140
G K L ++H ++R KAS+IL+ + LS G R V
Sbjct: 134 LQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 141 STQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR---CAVDKTKV------ 189
+ + +PE + KSD+YS G+ EL +G + T++
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 190 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL--------------- 234
G L+D + + G + +
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 235 ----QCLNNEPKLRPRMSEVL 251
QCL P RP S +L
Sbjct: 312 HFVEQCLQRNPDARPSASTLL 332
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 5e-23
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 23/164 (14%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E+ L + + P +V G + E M GSL+ + + + KV
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ--VLKKAGRIPEQILGKV 136
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-- 143
+I KGLT+L + + ++++RD K SNIL+++ KL DFG VS Q
Sbjct: 137 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG------------VSGQLI 183
Query: 144 ------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+GT Y +PE + + +SD++S G+ L+E+ GR
Sbjct: 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 8e-23
Identities = 29/169 (17%), Positives = 55/169 (32%), Gaps = 18/169 (10%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---QPLSWAVRMK 84
+ L +K L +LV E G+L N + + + + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL-----------DAEFNAKLSDFGLAKAGP 133
A+ + +HD E +I+ D K N +L D L D G +
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 134 TGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
+ + T T G+ E + + + + D + + +L G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 16/169 (9%)
Query: 23 NWFQTEVNYLGQLHHPNLVKLI------GYCLEGENRLLVYEFMPKGSLENHLFRRG-PQ 75
W E+ + +L+HPN+V + LL E+ G L +L +
Sbjct: 58 RWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116
Query: 76 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAG 132
L + + L +LH E+++I+RD K NI+L K+ D G AK
Sbjct: 117 GLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174
Query: 133 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
G + T+ +GT Y APE + + T D +SFG + E ++G
Sbjct: 175 DQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-22
Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 38/226 (16%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E N L ++ HP +V LI Y + +L L+ E++ G L L R G A
Sbjct: 69 KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFY 126
Query: 85 VA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+A I A L LH + +IYRD K NI+L+ + + KL+DFGL K T
Sbjct: 127 LAEISMA--LGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---TH 179
Query: 144 VM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
GT Y APE + ++ D +S G ++ ++L+G P
Sbjct: 180 TFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA-------------------P 219
Query: 202 --YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
+++K I+ KL P A L + L R
Sbjct: 220 PFTGENRKKTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASR 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLSWAVRM 83
E+ + L HP LV L Y + E + +V + + G L HL + + V++
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKL 119
Query: 84 KVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
+ + A L +L ++I+RD K NILLD + ++DF +A P + T
Sbjct: 120 FICELVMA--LDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---T 172
Query: 143 QVMGTHGYAAPEYVATGRLT--TKS-DVYSFGVVLLELLSGR 181
+ GT Y APE ++ + + + D +S GV ELL GR
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 67/224 (29%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
TE L HP L L Y + +RL V E+ G L HL R A
Sbjct: 196 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 254
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
I L +LH +E V+YRD K N++LD + + K++DFGL K G T +
Sbjct: 255 AEI--VSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKT 308
Query: 145 M-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP- 201
GT Y APE V ++ D + GVV+ E++ GR P
Sbjct: 309 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL------------------PF 349
Query: 202 YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
Y D KLF I+ ++ ++P+ A +L L +PK R
Sbjct: 350 YNQDHEKLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-22
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 36 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94
+HP L +L C + +RL V EF+ G L H+ + + A I +A L
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA--LM 138
Query: 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYAAP 153
FLH + +IYRD K N+LLD E + KL+DFG+ K G T T GT Y AP
Sbjct: 139 FLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAP 193
Query: 154 EYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRKLFR 211
E + L + D ++ GV+L E+L G P ++ LF
Sbjct: 194 E-ILQEMLYGPAVDWWAMGVLLYEMLCGHA------------------PFEAENEDDLFE 234
Query: 212 -IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
I++ ++ YP A + + P +R
Sbjct: 235 AILNDEV--VYPTWLHEDATGILKSFMTKNPTMR 266
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-22
Identities = 64/214 (29%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 36 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94
HP L + + + L V E++ G L H+ LS A I GL
Sbjct: 76 EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI--ILGLQ 132
Query: 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYAAP 153
FLH ++YRD K NILLD + + K++DFG+ K GD T GT Y AP
Sbjct: 133 FLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAP 187
Query: 154 EYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRKLFR 211
E + G+ S D +SFGV+L E+L G+ P + D+ +LF
Sbjct: 188 E-ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFH 228
Query: 212 -IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
I YP+ A L ++ EP+ R
Sbjct: 229 SIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 36 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94
P L +L C + +RL V E++ G L H+ + G AV I L
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG--LF 135
Query: 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYAAP 153
FL +IYRD K N++LD+E + K++DFG+ K T T+ GT Y AP
Sbjct: 136 FLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAP 190
Query: 154 EYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRKLFR 211
E + + KS D ++FGV+L E+L+G+ P D+ +LF+
Sbjct: 191 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQA------------------PFEGEDEDELFQ 231
Query: 212 -IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
IM+ + YP+ + A + + P R
Sbjct: 232 SIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 7e-22
Identities = 24/174 (13%), Positives = 54/174 (31%), Gaps = 25/174 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYC--LEGENRLLVYEFM--PKGSLENHLFRRGPQ--PLS 78
F + + ++++ + +R +Y M + L L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
R+++ + + L LH +++ + +I+LD L+ F R
Sbjct: 205 HHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLV------RD 256
Query: 139 HVSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGR 181
+ G+ PE A +T D ++ G+V+ +
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 45/172 (26%), Positives = 66/172 (38%), Gaps = 20/172 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL--LVYEFMPKGSLENHLFRRG-PQPLSWAV 81
E L +L+H N+VKL E R L+ EF P GSL L L +
Sbjct: 54 QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDR 137
+ V G+ L E+ +++R+ K NI+ D + KL+DFG A+ D
Sbjct: 114 FLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDD 169
Query: 138 THVSTQVMGTHGYAAPEYVATGRLTT--------KSDVYSFGVVLLELLSGR 181
+ GT Y P+ L D++S GV +G
Sbjct: 170 EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E + + +L HP VKL + + + +L + G L ++ + G + R
Sbjct: 79 RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYT 136
Query: 86 A-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A I +A L +LH +I+RD K NILL+ + + +++DFG AK + +
Sbjct: 137 AEIVSA--LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 145 MGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
+GT Y +PE + T + KS D+++ G ++ +L++G
Sbjct: 193 VGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 65/233 (27%), Positives = 98/233 (42%), Gaps = 38/233 (16%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW-AVRMK 84
Q E+ L Q P + K G L+ ++ E++ GS L GP + A ++
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILR 126
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
KGL +LH + I+RD KA+N+LL KL+DFG+A T + +T
Sbjct: 127 ---EILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNT-F 179
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+GT + APE + +K+D++S G+ +EL G +P S
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG-------------------EPPHS 220
Query: 205 DK---RKLFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+ + LF I L G Y + CLN EP RP E+L
Sbjct: 221 ELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE----ACLNKEPSFRPTAKELL 269
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 37/226 (16%)
Query: 26 QTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+E N L + + HP LV L + + ++L V +++ G L HL R A R
Sbjct: 86 MSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RF 143
Query: 84 KVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
A I +A L +LH ++YRD K NILLD++ + L+DFGL K + T T
Sbjct: 144 YAAEIASA--LGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---T 196
Query: 143 QVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
GT Y APE V + ++ D + G VL E+L G
Sbjct: 197 STFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLP------------------ 237
Query: 201 P-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
P Y + +++ I++ L Q ++A L L + R
Sbjct: 238 PFYSRNTAEMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKR 281
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 45/171 (26%), Positives = 66/171 (38%), Gaps = 20/171 (11%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRL--LVYEFMPKGSLENHLFRRG-PQPLSWAVR 82
E L +L+H N+VKL E R L+ EF P GSL L L +
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRT 138
+ V G+ L E+ +++R+ K NI+ D + KL+DFG A+ D
Sbjct: 115 LIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDE 170
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTT--------KSDVYSFGVVLLELLSGR 181
+ GT Y P+ L D++S GV +G
Sbjct: 171 QFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 38/247 (15%), Positives = 81/247 (32%), Gaps = 51/247 (20%)
Query: 28 EVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMK 84
EV L H ++V+ E ++ L+ E+ GSL + + R A
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLD-------------------AEFNAKLSD 125
+ + +GL ++H +++ D K SNI + + K+ D
Sbjct: 120 LLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 126 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAV 184
G + + G + A E + K+D+++ + ++
Sbjct: 178 LGHVTR-----ISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA---- 227
Query: 185 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
+P + + I +L + PQ + L ++ +P+ R
Sbjct: 228 ---------------EPLPRNGDQWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERR 271
Query: 245 PRMSEVL 251
P ++
Sbjct: 272 PSAMALV 278
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-21
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 5/155 (3%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E++ + Q P++VK G + + +V E+ GS+ + + R + L+ +
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATI 130
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
KGL +LH + I+RD KA NILL+ E +AKL+DFG+A T +T +
Sbjct: 131 LQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVI- 186
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT + APE + +D++S G+ +E+ G
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 36 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94
P L +L C + +RL V E++ G L H+ + G AV I A GL
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI--AIGLF 456
Query: 95 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYAAP 153
FL +IYRD K N++LD+E + K++DFG+ K T T+ GT Y AP
Sbjct: 457 FLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAP 511
Query: 154 EYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRKLFR 211
E + + KS D ++FGV+L E+L+G+ P D+ +LF+
Sbjct: 512 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQA------------------PFEGEDEDELFQ 552
Query: 212 -IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
IM+ + YP+ + A + + P R
Sbjct: 553 SIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-21
Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E+ + + +PN+V + L G+ +V E++ GSL + + + V
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAV 121
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
+ L FLH +QVI+RD K+ NILL + + KL+DFG A T +++ ST V
Sbjct: 122 CRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV- 177
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT + APE V K D++S G++ +E++ G
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 9e-21
Identities = 31/256 (12%), Positives = 59/256 (23%), Gaps = 26/256 (10%)
Query: 6 FLHSHLELHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGY--CLEGENRLLVYEFMPKG 63
F + L + + + P +L N LL+
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SV 172
Query: 64 SLEN-----HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 118
LE + + L +++ F N+ + +
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPD 230
Query: 119 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGVVLLE 176
L D T YA E++ +T T + + G+ +
Sbjct: 231 GRLMLGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285
Query: 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 236
+ GI+ + L L TL +
Sbjct: 286 VWCLFLPFGLVTPGIKG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336
Query: 237 LNNEPKLRPRMSEVLA 252
LN + + R E +
Sbjct: 337 LNFDRRRRLLPLEAME 352
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 36 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGL 93
P LV L Y + E +L L+ +++ G L HL +R ++ V I A L
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVGEIVLA--L 172
Query: 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153
LH + +IYRD K NILLD+ + L+DFGL+K + GT Y AP
Sbjct: 173 EHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAP 229
Query: 154 EYVATGRL-TTKS-DVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAKPYLSDKRK 208
+ V G K+ D +S GV++ ELL+G + + +
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----------------SQAE 273
Query: 209 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244
+ R I+ ++ YPQ+ + A L + L +PK R
Sbjct: 274 ISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 55/262 (20%), Positives = 100/262 (38%), Gaps = 59/262 (22%)
Query: 34 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 93
P +V+ G + + + E M + + L +R P+ + K+ + K L
Sbjct: 80 SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKAL 137
Query: 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG--DRTHVSTQVMGTHGYA 151
+L + + VI+RD K SNILLD KL DFG++ G + G Y
Sbjct: 138 YYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYM 191
Query: 152 APEYVATGRL-----TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 206
APE + ++DV+S G+ L+EL +G+ PY +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQ------------------FPY-KNC 232
Query: 207 RKLFRIMDTKLGGQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVLA--------- 252
+ F ++ L + P H + CL + + RP+ +++L
Sbjct: 233 KTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292
Query: 253 -----------ILERLEAPKNS 263
++ + E+P++
Sbjct: 293 LEVDVASWFKDVMAKTESPRSG 314
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 42/156 (26%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 32 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAIGA 89
+ + P V G + + E M SL+ Q + + K+A+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 90 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149
K L LH + VI+RD K SN+L++A K+ DFG+ +G D G
Sbjct: 119 VKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKDIDA-GCKP 174
Query: 150 YAAPEYVATGRL----TTKSDVYSFGVVLLELLSGR 181
Y APE + + KSD++S G+ ++EL R
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
EV + H N+V++ L GE ++ EF+ G+L + + + L+ V
Sbjct: 90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVR--LNEEQIATV 146
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
+ L +LH VI+RD K+ +ILL + KLSDFG A + D + V
Sbjct: 147 CEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLV- 202
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT + APE ++ T+ D++S G++++E++ G
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 25/173 (14%), Positives = 54/173 (31%), Gaps = 24/173 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPK--GSLENHLFRRGPQ--PLS 78
F + + ++++ + +R +Y M + L L
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
R+++ + + L LH +++ + +I+LD L+ F R
Sbjct: 210 HHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLV------RD 261
Query: 139 HVSTQVMGTHGYAAPEYVA----------TGRLTTKSDVYSFGVVLLELLSGR 181
S G+A PE A +T D ++ G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E+ L HP +VKL+G ++ EF P G+++ + + L+
Sbjct: 63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV 121
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
V + L FLH ++I+RD KA N+L+ E + +L+DFG++ A + +
Sbjct: 122 VCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFI 178
Query: 145 MGTHGYAAPEYVATGRLT-----TKSDVYSFGVVLLELLSG 180
GT + APE V + K+D++S G+ L+E+
Sbjct: 179 -GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 44/167 (26%), Positives = 67/167 (40%), Gaps = 17/167 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQ-PLSWAVR 82
F+ E + L + +L + + EN L LV E+ G L L + G + P A R
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-R 165
Query: 83 MKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
+A I A + +H ++RD K NILLD + +L+DFG
Sbjct: 166 FYLAEIVMA--IDSVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVY-------SFGVVLLELLSGR 181
V GT Y +PE + + Y + GV E+ G+
Sbjct: 222 VAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-M 83
EV L QL HPN++KL + + LV E G L + + R A R +
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHV 140
+ + +T++H ++++RD K N+LL + N ++ DFGL+ +
Sbjct: 133 RQVLSG---ITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK- 186
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+GT Y APE V G K DV+S GV+L LLSG
Sbjct: 187 --DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E++ L L HPN++KL + + LV EF G L + R A +
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
I G+ +LH +++RD K NILL ++ N K+ DFGL+ +
Sbjct: 153 KQI--LSGICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR-- 206
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+GT Y APE V + K DV+S GV++ LL G
Sbjct: 207 -DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 12/166 (7%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E+ + Q HHPN+V + + LV + + GS+ + + + + +
Sbjct: 61 LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 86 AIGAA------KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGD 136
+ A +GL +LH ++ I+RD KA NILL + + +++DFG++ G
Sbjct: 121 STIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
R V +GT + APE + R K+D++SFG+ +EL +G
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 33/234 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
EV L L HPN++KL + + N LV E G L + + R A +
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ G+T+LH +++RD K N+LL + + K+ DFGL+ +
Sbjct: 143 KQV--LSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK-- 196
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
+ +GT Y APE V + K DV+S GV+L LL+G P
Sbjct: 197 -ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------------------PP 236
Query: 202 -YLSDKRKLFR-IMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+++ R + K + + A L Q L + + R + L
Sbjct: 237 FGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 52/262 (19%), Positives = 91/262 (34%), Gaps = 55/262 (20%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSL-----ENHLFRRGPQPLS 78
E+ L + HPN+++ + E +L ++ +
Sbjct: 55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQK 113
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------FNAKLSD 125
+ + A G+ LH ++I+RD K NIL+ +SD
Sbjct: 114 EYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 126 FGLAK---AGPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLL 175
FGL K +G + RT+++ GT G+ APE RLT D++S G V
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-----TKLGGQYPQKAAHTAA 230
+LS P+ + I+ ++ + + A
Sbjct: 231 YILSKGKH-----------------PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEAT 273
Query: 231 TLALQCLNNEPKLRPRMSEVLA 252
L Q ++++P RP +VL
Sbjct: 274 DLISQMIDHDPLKRPTAMKVLR 295
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 16/157 (10%)
Query: 34 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN---HLFRRGPQPLSWAVRMKVAIGAA 90
P +V+ G + + E M S + +++ + + K+ +
Sbjct: 77 SSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG--DRTHVSTQVMGTH 148
K L L + ++I+RD K SNILLD N KL DFG++ G + T+ G
Sbjct: 136 KALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCR 189
Query: 149 GYAAPEYVATGRL----TTKSDVYSFGVVLLELLSGR 181
Y APE + +SDV+S G+ L EL +GR
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 24/166 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 84
E++ + +L H N+V+L LV+EFM K +++ P+ L +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVST 142
+GL F H+ +++++RD K N+L++ KL DFGLA+A P +
Sbjct: 113 FQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS--- 167
Query: 143 QVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
+V+ T Y AP+ Y +T D++S G +L E+++G+
Sbjct: 168 EVV-TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 28 EVNYLGQLHHPNLVKLIGYC-LEGENRL---LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
E+ L +L HPN+VKL L+ N +V+E + +G + + P A
Sbjct: 86 EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFY 142
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+ KG+ +LH ++I+RD K SN+L+ + + K++DFG++ G +S
Sbjct: 143 FQDL--IKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSDALLSNT 197
Query: 144 VMGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGRC 182
V GT + APE ++ R DV++ GV L + G+C
Sbjct: 198 V-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 14/162 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+TE+ L +L+HP ++K+ + + E+ +V E M G L + + +
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ + +LH+ + +I+RD K N+LL + + K++DFG +K
Sbjct: 246 YQM--LLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--- 298
Query: 142 TQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSG 180
+ GT Y APE V T D +S GV+L LSG
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 26 QTEVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
EV + L+HPN+VKL + +E E L L+ E+ G + ++L G A
Sbjct: 62 FREVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
I +A + + H + ++++RD KA N+LLDA+ N K++DFG + G +
Sbjct: 120 FRQIVSA--VQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC- 174
Query: 144 VMGTHGYAAPEYVATGRLTT--KSDVYSFGVVLLELLSGRC 182
G YAAPE + G+ + DV+S GV+L L+SG
Sbjct: 175 --GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-19
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 11/156 (7%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E L ++ P LVKL + N +V E++ G + +HL R G A R A
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAA 148
Query: 87 -IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
I +LH + +IYRD K N+L+D + +++DFG AK RT +
Sbjct: 149 QIVLT--FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LC 199
Query: 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
GT APE + + D ++ GV++ E+ +G
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-19
Identities = 53/160 (33%), Positives = 83/160 (51%), Gaps = 14/160 (8%)
Query: 26 QTEVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+ E+ L HP+++KL Y + +V E++ G L +++ + G A R+
Sbjct: 59 KREIQNLKLFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL 116
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
I +A + + H V++RD K N+LLDA NAK++DFGL+ G+ S
Sbjct: 117 FQQILSA--VDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC- 171
Query: 144 VMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 181
G+ YAAPE V +GRL + D++S GV+L LL G
Sbjct: 172 --GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-19
Identities = 36/168 (21%), Positives = 66/168 (39%), Gaps = 23/168 (13%)
Query: 26 QTEVNYLGQLHHPNLVKLIG-YCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+ E+ L +L H N+++L+ E + ++ +V E+ G E +
Sbjct: 54 KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDS-------VPEK 104
Query: 84 KVAIGAAK--------GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 135
+ + A GL +LH ++++D K N+LL K+S G+A+A
Sbjct: 105 RFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 136 DRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 181
G+ + PE K D++S GV L + +G
Sbjct: 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E+ L+H N+VK G N L E+ G L + + P A R
Sbjct: 55 EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+ A + +LH + +RD K N+LLD N K+SDFGLA +R + ++ G
Sbjct: 114 LMAG--VVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 147 THGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 181
T Y APE + R DV+S G+VL +L+G
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 51/163 (31%), Positives = 72/163 (44%), Gaps = 14/163 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F E + + + P +V+L Y + + L +V E+MP G L N + P WA R
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWA-RF 172
Query: 84 KVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
A + A L +H I+RD K N+LLD + KL+DFG T
Sbjct: 173 YTAEVVLA--LDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 143 QVMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGR 181
V GT Y +PE + G + D +S GV L E+L G
Sbjct: 229 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-18
Identities = 49/160 (30%), Positives = 83/160 (51%), Gaps = 19/160 (11%)
Query: 27 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLSWAVRM 83
E L + HP ++++ + ++ ++ +++ G L + L + P P++ +
Sbjct: 55 DERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA---KF 110
Query: 84 KVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142
A + A L +LH +IYRD K NILLD + K++DFG AK D T+ T
Sbjct: 111 YAAEVCLA--LEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTY--T 162
Query: 143 QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
+ GT Y APE V + + KS D +SFG+++ E+L+G
Sbjct: 163 -LCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E+ L+H N+VK G N L E+ G L + + P A R
Sbjct: 55 EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146
+ A + +LH + +RD K N+LLD N K+SDFGLA +R + ++ G
Sbjct: 114 LMAG--VVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 147 THGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 181
T Y APE + R DV+S G+VL +L+G
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-M 83
EV L +L HPN++KL + + +V E G L + + +R A R +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHV 140
K +T++H +++RD K NILL + + + K+ DFGL+ +
Sbjct: 128 KQVFSG---ITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK- 181
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+GT Y APE V G K DV+S GV+L LLSG
Sbjct: 182 --DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 43/165 (26%), Positives = 67/165 (40%), Gaps = 15/165 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR-RGPQPLSWAVR 82
F+ E + L + L Y + +N L LV ++ G L L + P A R
Sbjct: 121 FREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-R 178
Query: 83 MKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
+A + A + +H + ++RD K NIL+D + +L+DFG S
Sbjct: 179 FYLAEMVIA--IDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 142 TQVMGTHGYAAPEYVATGRLTTKS-----DVYSFGVVLLELLSGR 181
V GT Y +PE + D +S GV + E+L G
Sbjct: 235 VAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-18
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
EV+ L ++ HPN+++L LV++ M KG L ++L + ++
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
A+ + + LH +++RD K NILLD + N KL+DFG + G++ +
Sbjct: 130 MRAL--LEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---RE 182
Query: 144 VMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSG 180
V GT Y APE + D++S GV++ LL+G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-18
Identities = 48/164 (29%), Positives = 68/164 (41%), Gaps = 25/164 (15%)
Query: 26 QTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
EV +L +L HPN ++ G L LV E+ + + L +PL V
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAV 159
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-- 143
GA +GL +LH +I+RD KA NILL KL DFG ++
Sbjct: 160 THGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFG------------SASIMA 205
Query: 144 ----VMGTHGYAAPEYVATGRLTT---KSDVYSFGVVLLELLSG 180
+GT + APE + K DV+S G+ +EL
Sbjct: 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-18
Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
EV L +L HPN++KL + + +V E G L + + +R A R+
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ G+T++H +++RD K NILL + + + K+ DFGL+ +
Sbjct: 128 KQV--FSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--- 180
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+GT Y APE V G K DV+S GV+L LLSG
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 47/163 (28%), Positives = 68/163 (41%), Gaps = 23/163 (14%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L QL HPNLV L+ LV+E+ ++ + L R + + + +
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITW 109
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVM 145
+ + F H I+RD K NIL+ KL DFG A+ GP+ +V
Sbjct: 110 QTLQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---EVA 164
Query: 146 GTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
T Y +PE Y DV++ G V ELLSG
Sbjct: 165 -TRWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 85
E+ L HP+++KL Y + + + +V E++ G L +++ + G + R+
Sbjct: 66 EIQNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
I + + + H V++RD K N+LLDA NAK++DFGL+ G+ S
Sbjct: 124 QILSG--VDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--- 176
Query: 146 GTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 181
G+ YAAPE V +GRL + D++S GV+L LL G
Sbjct: 177 GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 43/170 (25%), Positives = 70/170 (41%), Gaps = 16/170 (9%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGS-LENHLFRRGPQPLSWAVRMKV 85
E+ L ++ H N++K++ E + LV E G L + R A +
Sbjct: 79 EIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145
+ + +L +I+RD K NI++ +F KL DFG A G +
Sbjct: 138 QL--VSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 146 GTHGYAAPEYVATGRLTT--KSDVYSFGVVLLELLSGR---CAVDKTKVG 190
GT Y APE V G + +++S GV L L+ C +++T
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW----- 79
+ E+ L L HPN++K+ + N +V E G L + + +
Sbjct: 67 IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGD 136
A MK + A L + H V+++D K NIL K+ DFGLA+ + +
Sbjct: 127 AELMKQMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ T GT Y APE V +T K D++S GVV+ LL+G
Sbjct: 182 HS---TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 29/166 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 84
E++ L +LHHPN+V LI LV+EFM K L+ + L +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-----KTGLQDSQIKI 123
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVST 142
+G+ H ++++RD K N+L++++ KL+DFGLA+A P TH
Sbjct: 124 YLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH--- 178
Query: 143 QVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
+V+ T Y AP+ Y +T D++S G + E+++G+
Sbjct: 179 EVV-TLWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 48/202 (23%), Positives = 70/202 (34%), Gaps = 48/202 (23%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+TEV + +LHHPN+ +L + + LV E G L + L
Sbjct: 75 IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 85 VAIG-------------------------------AAK-------GLTFLHDAESQVIYR 106
V + L +LH + +R
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHR 192
Query: 107 DFKASNILLDAEFNA--KLSDFGLAK---AGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 161
D K N L + KL DFGL+K G+ ++T+ GT + APE + T
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNE 251
Query: 162 --TTKSDVYSFGVVLLELLSGR 181
K D +S GV+L LL G
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGA 273
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E+ L ++ H N+V L + LV + + G L + + RG A +
Sbjct: 53 LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI 112
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ + +LH+ + +++RD K N+L + ++DFGL+K G +
Sbjct: 113 QQV--LSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ GT GY APE +A + D +S GV+ LL G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-17
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 29/166 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 84
E++ L +L H N+VKL + +LV+E + K L+ L
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKS 104
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVST 142
+ G+ + HD +V++RD K N+L++ E K++DFGLA+A P TH
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--- 159
Query: 143 QVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
+++ T Y AP+ Y +T D++S G + E+++G
Sbjct: 160 EIV-TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 84
EV+ L L H N+V L ++ LV+E++ K L++ ++
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC-----GNIINMHNVKL 104
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVST 142
+GL + H +V++RD K N+L++ KL+DFGLA+A PT +
Sbjct: 105 FLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN--- 159
Query: 143 QVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
+V+ T Y P+ Y +T+ D++ G + E+ +GR
Sbjct: 160 EVV-TLWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 60/267 (22%), Positives = 91/267 (34%), Gaps = 39/267 (14%)
Query: 3 LFNFLHSHLELHARSLLLITNW--FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFM 60
L +L S + + V + L + + + + +
Sbjct: 114 LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
Query: 61 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 120
E L+ + + AKG+ FL A + I+RD A NILL +
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNV 231
Query: 121 AKLSDFGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVL 174
K+ DFGLA+ M APE + T +SDV+SFGV+L
Sbjct: 232 VKICDFGLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLL 285
Query: 175 LELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAA 230
E+ S +G A PY + + R + K G + P
Sbjct: 286 WEIFS---------LG--------ASPYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMY 326
Query: 231 TLALQCLNNEPKLRPRMSEVLAILERL 257
L C + EP RP SE++ L L
Sbjct: 327 QTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 16/55 (29%), Positives = 28/55 (50%), Gaps = 2/55 (3%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLV-YEFMPKGSLENHLFRRGPQPL 77
+E+ L + HH N+V L+G C + L+V EF G+L +L + + +
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 126
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E+ L QL H NLV L+ C + + LV+EF+ ++ + L P L + V K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLF 131
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVM 145
G+ F H +I+RD K NIL+ KL DFG A+ P +V
Sbjct: 132 QIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD---EVA 186
Query: 146 GTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR 181
T Y APE V + DV++ G ++ E+ G
Sbjct: 187 -TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-M 83
F+ E+ + L HPN+++L + + LV E G L + + S A R M
Sbjct: 53 FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 112
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHV 140
K + A + + H V +RD K N L + KL DFGLA G
Sbjct: 113 KDVLSA---VAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-- 165
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+GT Y +P+ V G + D +S GV++ LL G
Sbjct: 166 -RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 15/160 (9%)
Query: 26 QTEVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+ E++YL L HP+++KL Y + + +V E+ G L +++ + R
Sbjct: 57 EREISYLKLLRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
I A + + H ++++RD K N+LLD N K++DFGL+ G+ S
Sbjct: 114 FQQIICA--IEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC- 168
Query: 144 VMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 181
G+ YAAPE V G+L + DV+S G+VL +L GR
Sbjct: 169 --GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 8e-17
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 29/166 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 84
E+ L +L H N+V+L + LV+EF K ++ L +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKS 105
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVST 142
KGL F H V++RD K N+L++ KL++FGLA+A P +
Sbjct: 106 FLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--- 160
Query: 143 QVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
+V+ T Y P+ Y +T D++S G + EL +
Sbjct: 161 EVV-TLWYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAG 199
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ EV+ L Q+ H N++ L + +L+ E + G L + L ++ A
Sbjct: 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHV 140
I G+ +LH ++ + D K NI+L D KL DFGLA G
Sbjct: 122 KQI--LDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ GT + APE V L ++D++S GV+ LLSG
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 29/166 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 84
E+ L +L HPN++ L+ N LV++FM + ++++ L+ +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-----SLVLTPSHIKA 116
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVST 142
+ +GL +LH +++RD K +N+LLD KL+DFGLAK+ P TH
Sbjct: 117 YMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--- 171
Query: 143 QVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
QV+ T Y APE Y D+++ G +L ELL
Sbjct: 172 QVV-TRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 20/167 (11%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLS- 78
+ EV++ Q P++V ++ + L++ E M G L + + RG Q +
Sbjct: 68 ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127
Query: 79 --WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGP 133
A M+ A + FLH + +RD K N+L E +A KL+DFG AK
Sbjct: 128 REAAEIMRDIGTA---IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 134 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ T T Y APE + + D++S GV++ LL G
Sbjct: 183 QNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-17
Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 46/247 (18%)
Query: 24 WFQTEVNYLGQL-HHPNLVKLIG-----YCLEGENRL-LVYEFMPKGSLENHLFRRGPQP 76
+ E+N L + HH N+ G +++L LV EF GS+ + +
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 125
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
L + +GL+ LH + +VI+RD K N+LL KL DFG++ A
Sbjct: 126 LKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRT 182
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLT-----TKSDVYSFGVVLLELLSGRCAVDKTKVGI 191
+T +GT + APE +A KSD++S G+ +E+ G
Sbjct: 183 VGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG----------- 230
Query: 192 EQSLVDWAKPYLSDK---RKLFRIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLR 244
P L D R LF I +L ++ +K CL R
Sbjct: 231 --------APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE----SCLVKNHSQR 278
Query: 245 PRMSEVL 251
P +++
Sbjct: 279 PATEQLM 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 14/162 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+TE+ L +L+HP ++K+ + + E+ +V E M G L + + +
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ + +LH+ + +I+RD K N+LL + + K++DFG +K
Sbjct: 121 YQM--LLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--- 173
Query: 142 TQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSG 180
+ GT Y APE V T D +S GV+L LSG
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 44/168 (26%), Positives = 66/168 (39%), Gaps = 28/168 (16%)
Query: 26 QTEVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
Q E+ L HPN+V+ + L ++ E+ G L + G R
Sbjct: 64 QREIINHRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG--------RF 113
Query: 84 KVAIGAAK------GLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTG 135
G+++ H Q+ +RD K N LLD K+ DFG +K+
Sbjct: 114 SEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 136 DRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 181
+ + V GT Y APE V + +DV+S GV L +L G
Sbjct: 172 SQPK--STV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ EVN L ++ HPN++ L + +L+ E + G L + L + A +
Sbjct: 55 IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 114
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNA-KLSDFGLAKAGPTGDRTHV 140
I G+ +LH ++ + D K NI+L + KL DFG+A G+
Sbjct: 115 KQI--LDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ GT + APE V L ++D++S GV+ LLSG
Sbjct: 169 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 34/159 (21%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
E++ L H N++ L E ++++EF+ + + + L+ + +
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LN----EREIV 105
Query: 88 GAAK----GLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVS 141
L FLH + + D + NI+ ++ K+ +FG A+ GD +
Sbjct: 106 SYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL- 162
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ Y APE ++T +D++S G ++ LLSG
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 65/295 (22%), Positives = 110/295 (37%), Gaps = 38/295 (12%)
Query: 26 QTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E+ L + HPN++ L +G+ +V E M G L + + R+ A +
Sbjct: 63 TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL 122
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHV 140
I K + +LH V++RD K SNIL D N ++ DFG AK + +
Sbjct: 123 FTI--TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GL 176
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
T + APE + D++S GV+L +L+G
Sbjct: 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF-------------ANG 223
Query: 201 PYLSDKRKLFRIMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA-- 252
P + + L RI G++ + TA L + L+ +P R + VL
Sbjct: 224 PDDTPEEILARIGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279
Query: 253 -ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 306
I+ + P+ + + + S + + +SP+ S L R
Sbjct: 280 WIVHWDQLPQYQLNRQDAPHLVKGA-MAATYSALNRNQSPVLEPVGRSTLAQRRG 333
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 15/164 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW----- 79
+ E + L HP++V+L+ +V+EFM L + +R +
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGD 136
+ M+ + A L + H ++ +I+RD K +LL + KL FG+A G+
Sbjct: 133 SHYMRQILEA---LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGE 185
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
V+ +GT + APE V DV+ GV+L LLSG
Sbjct: 186 SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 25 FQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+ E + L Q+ HP+++ LI LV++ M KG L ++L + +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
++ + ++FLH + +++RD K NILLD +LSDFG + G++ +
Sbjct: 206 MRSL--LEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---RE 258
Query: 144 VMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSG 180
+ GT GY APE + D+++ GV+L LL+G
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E++ + QLHHP L+ L + +L+ EF+ G L + + +S A +
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVIN 153
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVST 142
A +GL +H E +++ D K NI+ + + + K+ DFGLA + +
Sbjct: 154 YMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVK 208
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
T +AAPE V + +D+++ GV+ LLSG
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-16
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E +L HPN+V+L E LV++ + G L + R + A
Sbjct: 52 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 111
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVS 141
I + + + H + +++R+ K N+LL ++ KL+DFGLA +
Sbjct: 112 QQI--LESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--- 164
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT GY +PE + + D+++ GV+L LL G
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 30/175 (17%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLE-GENRL-LVYEFMP---KGSLENH---LFRRGPQPLSW 79
E+ L +L HPN++ L L + ++ L++++ ++ H + P L
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA----KLSDFGLAKA--GP 133
+ + G+ +LH + V++RD K +NIL+ E K++D G A+ P
Sbjct: 128 GMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 134 TGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
+ V+ T Y APE Y T D+++ G + ELL+
Sbjct: 186 LKPLADLDPVVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 36/161 (22%), Positives = 68/161 (42%), Gaps = 17/161 (10%)
Query: 28 EVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E+ L P ++ L +L+ E+ G + + + +S
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS----ENDV 133
Query: 87 IGAAK----GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTH 139
I K G+ +LH ++ +++ D K NILL + K+ DFG+++
Sbjct: 134 IRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR 191
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+MGT Y APE + +TT +D+++ G++ LL+
Sbjct: 192 E---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ EV+ L Q+ HPN++ L + +L+ E + G L + L ++ A
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHV 140
I G+ +LH ++ + D K NI+L + KL DFGLA G
Sbjct: 122 KQI--LDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ GT + APE V L ++D++S GV+ LLSG
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 18/170 (10%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
EV L Q H N+++LI + E + LV+E M GS+ +H+ +R A +
Sbjct: 57 VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV 116
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKA-GPTGDRTH 139
+ A L FLH+ + +RD K NIL + K+ DF L GD +
Sbjct: 117 VQDV--ASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 140 VSTQVM----GTHGYAAPEYVATGRLTTKS-----DVYSFGVVLLELLSG 180
+ST + G+ Y APE V D++S GV+L LLSG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 56/281 (19%), Positives = 96/281 (34%), Gaps = 36/281 (12%)
Query: 26 QTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
Q E+ L HPN+VKL + + LV E + G L + ++ + A +
Sbjct: 53 QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM 112
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ ++ +HD V++RD K N+L + K+ DFG A+ P +
Sbjct: 113 RKL--VSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL 166
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
T YAAPE + D++S GV+L +LSG+ +
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHD 213
Query: 202 YLSDKRKLFRIMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA--- 252
IM G + + + A L L +P R +MS +
Sbjct: 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273
Query: 253 ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 293
+ + + N P + ++ N
Sbjct: 274 LQDGSQLSSN----PLMTPDILGSSGAAVHTCVKATFHAFN 310
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 46/159 (28%), Positives = 65/159 (40%), Gaps = 10/159 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL-ENHLFRRGPQPLSWAVRM 83
+ E+ + L HP LV L + +++YEFM G L E AV
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ KGL +H E+ ++ D K NI+ KL DFGL V
Sbjct: 261 MRQV--CKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 315
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT +AAPE + +D++S GV+ LLSG
Sbjct: 316 --TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 10/159 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+TE+ L +L HPN++KL LV E + G L + + +G A
Sbjct: 95 VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
I + + +LH E+ +++RD K N+L + K++DFGL+K
Sbjct: 155 KQI--LEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--- 207
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
V GT GY APE + + D++S G++ LL G
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ EV+ L ++ HPN++ L + +L+ E + G L + L + A
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNA-KLSDFGLAKAGPTGDRTHV 140
I G+ +LH Q+ + D K NI+L + K+ DFGLA G+
Sbjct: 121 KQI--LNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 174
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ GT + APE V L ++D++S GV+ LLSG
Sbjct: 175 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 33/174 (18%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL--------LVYEFMP---KGSLENHLFRRGPQP 76
E+ L L H N+V LI C + LV++F G L N
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVK 120
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPT 134
+ + +V GL ++H +++++RD KA+N+L+ + KL+DFGLA+A
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 135 GDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
+ + T + T Y PE Y D++ G ++ E+ +
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E +L HPN+V+L E LV++ + G L + R + A
Sbjct: 75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVS 141
I + + + H + +++R+ K N+LL ++ KL+DFGLA +
Sbjct: 135 QQI--LESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--- 187
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT GY +PE + + D+++ GV+L LL G
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 8/158 (5%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E++ + QL H NL++L + +LV E++ G L + + L+ +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTIL 191
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVST 142
+G+ +H + +++ D K NIL K+ DFGLA+ ++
Sbjct: 192 FMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---K 246
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT + APE V ++ +D++S GV+ LLSG
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYC---LEGENRL-LVYEFMPKGSLENHLFRRGPQPLS- 78
+ EV + P++V+++ G L +V E + G L + + RG Q +
Sbjct: 101 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 160
Query: 79 --WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGP 133
+ MK A + +LH + +RD K N+L NA KL+DFG AK
Sbjct: 161 REASEIMKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 134 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ + ++T T Y APE + + D++S GV++ LL G
Sbjct: 216 SHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 28 EVNYLGQLH---HPNLVKLI----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSW 79
EV L +L HPN+V+L+ + E ++ LV+E + + L +L + P L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRT 138
+ +GL FLH + +++RD K NIL+ + KL+DFGLA+ T
Sbjct: 120 ETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
V+ T Y APE + T D++S G + E+ +
Sbjct: 178 P---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 16/163 (9%)
Query: 28 EVNYLGQLH---HPNLVKLI----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSW 79
EV L L HPN+V+L + E +L LV+E + + L +L + +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRT 138
+ +GL FLH +V++RD K NIL+ + KL+DFGLA+ T
Sbjct: 120 ETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
V+ T Y APE + T D++S G + E+ +
Sbjct: 178 S---VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 41/171 (23%), Positives = 69/171 (40%), Gaps = 35/171 (20%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 84
EV+ L +L H N+++L L++E+ K ++ + +S V
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN------PDVSMRVIKS 136
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-----KLSDFGLAKA--GPTGDR 137
G+ F H + ++RD K N+LL + K+ DFGLA+A P
Sbjct: 137 FLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 138 THVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 181
TH +++ T Y PE Y +T D++S + E+L
Sbjct: 195 TH---EII-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 9/159 (5%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E L HPN+V+L E + L+++ + G L + R + A
Sbjct: 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 116
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVS 141
I + + H + V++R+ K N+LL A KL+DFGLA
Sbjct: 117 QQI--LEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAW 170
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
GT GY +PE + D+++ GV+L LL G
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 7e-15
Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 25/176 (14%)
Query: 21 ITNWFQT---------EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSL 65
++ FQ E+ + ++H N++ L+ LE + LV E M
Sbjct: 95 LSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM----- 149
Query: 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 125
+ +L + L + G+ LH A +I+RD K SNI++ ++ K+ D
Sbjct: 150 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD 207
Query: 126 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
FGLA+ T + + T + T Y APE + D++S G ++ E++ +
Sbjct: 208 FGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 18/161 (11%)
Query: 28 EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAV 81
E+ + ++H N++ L+ LE + +V E M + +L + L
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELD-HE 127
Query: 82 RMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
RM + G+ LH A +I+RD K SNI++ ++ K+ DFGLA T + +
Sbjct: 128 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFM 182
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
T + T Y APE + D++S G ++ E++ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 39/160 (24%), Positives = 66/160 (41%), Gaps = 15/160 (9%)
Query: 28 EVNYLGQLHH--PNLVKLIGYCLEGENRL-LVYEF-MPKGSLENHLFRRGPQPLSWAVRM 83
EV L ++ +++L+ + E + L+ E P L + + RG A
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVST 142
+ A + H+ V++RD K NIL+D KL DFG A
Sbjct: 155 FWQVLEA--VRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 209
Query: 143 QVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGR 181
GT Y+ PE++ R + V+S G++L +++ G
Sbjct: 210 ---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 22/167 (13%)
Query: 28 EVNYLGQLHHPNLVKLIGY-----CLEGENRL-LVYEFMPKGSLENHL--FRRGPQPLSW 79
E+ + + HPN+V L + + E L LV E++P+ ++ + + Q +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP- 139
Query: 80 AVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKA-GPTGD 136
+ +K+ + + L ++H + +RD K N+LLD KL DFG AK
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 137 RTH-VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
+ ++ Y APE + TT D++S G V+ EL+ G+
Sbjct: 198 NVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 22/167 (13%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRL------LVYEFMPKGSLENHL--FRRGPQPLSW 79
E+ + +L H N+V+L + + LV +++P+ ++ + R Q L
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP- 154
Query: 80 AVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGD- 136
+ +K+ + + L ++H + +RD K N+LLD + KL DFG AK G+
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 137 -RTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
+++ ++ Y APE + T+ DV+S G VL ELL G+
Sbjct: 213 NVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 32 LGQLHHPNLVKLI------GYCLEGENRL-LVYEFMPKGSLENHL--FRRGPQPLSWAVR 82
L LHHPN+V+L G + L +V E++P +L + R +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PIL 130
Query: 83 MKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKA-GPTGDRTH 139
+KV + + + LH V +RD K N+L++ KL DFG AK P+
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 140 -VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181
+ ++ Y APE + + TT D++S G + E++ G
Sbjct: 191 YICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 15/161 (9%)
Query: 28 EVNYLGQLHHPNLVKL----IGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVR 82
E+ L HHPN++ L + + ++L LV E M L + +S
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-AQVIHDQRIVIS-PQH 135
Query: 83 MKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
++ + GL LH+A V++RD NILL + + DF LA+
Sbjct: 136 IQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---K 190
Query: 142 TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
T + Y APE V + TK D++S G V+ E+ + +
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 28 EVNYLGQLH----HPNLVKLIGYCLEGENRL-LVYEF-MPKGSLENHLFRRGPQPLSWAV 81
EV L ++ HP +++L+ + E + LV E +P L +++ +GP +
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHV 140
+ AA + H V++RD K NIL+D KL DFG A +
Sbjct: 143 CFFGQVVAA--IQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTD 197
Query: 141 STQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGR 181
GT Y+ PE+++ + + V+S G++L +++ G
Sbjct: 198 FD---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-12
Identities = 24/157 (15%), Positives = 45/157 (28%), Gaps = 35/157 (22%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ L ++ P + +++ L+V E++ GSL+ + P P+ A+R
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSPV-GAIR-- 133
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A H A V S + + + + L+
Sbjct: 134 AMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA----------------- 174
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
+ D+ G L LL R
Sbjct: 175 -----TMPDA-------NPQDDIRGIGASLYALLVNR 199
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 42/177 (23%), Positives = 76/177 (42%), Gaps = 28/177 (15%)
Query: 21 ITNWFQT---------EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSL 65
++ FQ+ E+ L + H N++ L+ L LV FM
Sbjct: 57 LSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM----- 111
Query: 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 125
+ L + S + KGL ++H A V++RD K N+ ++ + K+ D
Sbjct: 112 QTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILD 169
Query: 126 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
FGLA+ +V T+ Y APE + + ++ D++S G ++ E+L+G+
Sbjct: 170 FGLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 38/209 (18%), Positives = 77/209 (36%), Gaps = 48/209 (22%)
Query: 21 ITNWFQT---------EVNYLGQLHHPNLVKLIGYCLEGENRL------LVYEFMPKGSL 65
+ F+ E+ L +L +++L + ++ L +V E
Sbjct: 59 VNRMFEDLIDCKRILREITILNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIA----- 112
Query: 66 ENHLFR--RGPQPLSWAVRMKVAIG-AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 122
++ L + + P L+ +K + G F+H++ +I+RD K +N LL+ + + K
Sbjct: 113 DSDLKKLFKTPIFLT-EEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVK 169
Query: 123 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP---------EYVAT------------GRL 161
+ DFGLA+ + T++ + +V T
Sbjct: 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229
Query: 162 TTKSDVYSFGVVLLELLSGRCAVDKTKVG 190
T D++S G + ELL+ +
Sbjct: 230 TKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 149
+GL ++H A V++RD K SN+LL+ + K+ DFGLA+ A P D T T+ + T
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 150 YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
Y APE + + TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 21 ITNWFQT---------EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSL 65
+ FQ+ E+ L + H N++ L+ L+ LV FM G+
Sbjct: 58 LYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTD 115
Query: 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 125
L + + L + KGL ++H A +I+RD K N+ ++ + K+ D
Sbjct: 116 LGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILD 171
Query: 126 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
FGLA+ + +V T+ Y APE + T++ D++S G ++ E+++G+
Sbjct: 172 FGLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 42/182 (23%), Positives = 79/182 (43%), Gaps = 45/182 (24%)
Query: 28 EVNYLGQLHHPNLVKLI-------------GYCLEGENRL-LVYEFMPKGSLENHLFRRG 73
E+ + +L H N+VK+ L N + +V E+M + ++ +G
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG 115
Query: 74 P-----------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 121
P Q L +GL ++H A V++RD K +N+ ++ E
Sbjct: 116 PLLEEHARLFMYQLL-------------RGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160
Query: 122 KLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 179
K+ DFGLA+ P ++ + T Y +P + + TK+ D+++ G + E+L+
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 180 GR 181
G+
Sbjct: 221 GK 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 28 EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAV 81
E+ L + H N++ L+ LE N + LV M L N++ + Q L+
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DL-NNIVKC--QKLT-DD 132
Query: 82 RMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
++ I +GL ++H A+ +I+RD K SN+ ++ + K+ DFGLA+
Sbjct: 133 HVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADE 185
Query: 141 STQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
T + T Y APE + ++ D++S G ++ ELL+GR
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 41/172 (23%), Positives = 70/172 (40%), Gaps = 28/172 (16%)
Query: 28 EVNYLGQLHHPNLVKLI----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVR 82
E+ L H N++ + E N + ++ E M + + + Q LS
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST--QMLS-DDH 113
Query: 83 MKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141
++ I + + LH + VI+RD K SN+L+++ + K+ DFGLA+ D +
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLAR---IIDESAAD 168
Query: 142 TQVMGTHGYAAPEYVAT------------GRLTTKSDVYSFGVVLLELLSGR 181
E+VAT + + DV+S G +L EL R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 22/111 (19%)
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150
K + +LH +++RD K SNILL+AE + K++DFGL+++ R + +
Sbjct: 120 KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 151 AAP--------EYVAT------------GRLTTKSDVYSFGVVLLELLSGR 181
+YVAT + T D++S G +L E+L G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 38/185 (20%), Positives = 72/185 (38%), Gaps = 40/185 (21%)
Query: 28 EVNYLGQLHHPNLVKL----IGYCLEGENRL-LVYEFMPKGSLENHLFR--RGPQPLSWA 80
E+ L +L+H ++VK+ I +E + L +V E ++ + R P L+
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTEL 156
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
+ G+ ++H A +++RD K +N L++ + + K+ DFGLA+ + +
Sbjct: 157 HIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 141 STQVMGTHGYAAP--------------EYVAT------------GRLTTKSDVYSFGVVL 174
+ +V T T DV+S G +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 175 LELLS 179
ELL+
Sbjct: 275 AELLN 279
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 12/132 (9%)
Query: 55 LVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKAS 111
++ E++P +L L F R + + + + I + + F+H + +RD K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL--GICHRDIKPQ 170
Query: 112 NILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYS 169
N+L++++ N KL DFG AK + V+ + Y APE + T D++S
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYIC--SRFYRAPELMLGATEYTPSIDLWS 227
Query: 170 FGVVLLELLSGR 181
G V EL+ G+
Sbjct: 228 IGCVFGELILGK 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 20/153 (13%)
Query: 36 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA-VR--MKVAIGAAKG 92
PN++ L + +R F + N F++ Q L+ +R M + K
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL---KA 142
Query: 93 LTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAG-PTGDRTH-VSTQVMGTHG 149
L + H +++RD K N+++D E +L D+GLA+ P + V+++
Sbjct: 143 LDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----- 195
Query: 150 YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 181
+ PE + ++ S D++S G +L ++ +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 38/166 (22%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYC----LEGENRLLVYEFMPKGSLENHLFRRGPQPLS- 78
+ EV + P++V+++ + L+V E + G L + + RG Q +
Sbjct: 57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 116
Query: 79 -WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPT 134
A + +IG A + +LH + +RD K N+L NA KL+DFG AK
Sbjct: 117 REASEIMKSIGEA--IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---- 168
Query: 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180
+ G Y D++S GV++ LL G
Sbjct: 169 --------ETTG-EKY-----------DKSCDMWSLGVIMYILLCG 194
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 24/133 (18%), Positives = 55/133 (41%), Gaps = 13/133 (9%)
Query: 55 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 114
+V+E + +L + + + + +++ GL ++H +I+ D K N+L
Sbjct: 107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVL 164
Query: 115 LDAE------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 168
++ K++D G A H + + Y +PE + +D++
Sbjct: 165 MEIVDSPENLIQIKIADLGNA----CWYDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIW 219
Query: 169 SFGVVLLELLSGR 181
S ++ EL++G
Sbjct: 220 STACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 55 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 114
LV+E + +L + L + +S + K A L FL E +I+ D K NIL
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 191
Query: 115 LDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172
L + K+ DFG + + + Y +PE + D++S G
Sbjct: 192 LCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGC 246
Query: 173 VLLELLSGR 181
+L+E+ +G
Sbjct: 247 ILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 42/202 (20%), Positives = 70/202 (34%), Gaps = 32/202 (15%)
Query: 28 EVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E + + + EG+ ++V E + SLE LF + S + +A
Sbjct: 54 ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLA 111
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK---LSDFGLAKA-GPTGDRTHV-- 140
+ ++H I+RD K N L+ + DFGLAK H+
Sbjct: 112 DQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169
Query: 141 --STQVMGTHGYA---APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 195
+ + GT YA + R + D+ S G VL+ G K
Sbjct: 170 RENKNLTGTARYASINTHLGIEQSR---RDDLESLGYVLMYFNLGSLPWQGLKAA----- 221
Query: 196 VDWAKPYLSDKRKLFRIMDTKL 217
+ ++K RI + K+
Sbjct: 222 --------TKRQKYERISEKKM 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 48/202 (23%), Positives = 77/202 (38%), Gaps = 32/202 (15%)
Query: 28 EVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 86
E L + + + +EG+ +LV + + SLE LF + LS + +A
Sbjct: 52 ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLA 109
Query: 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK---LSDFGLAKA-GPTGDRTHV-- 140
+ F+H ++RD K N L+ A + DFGLAK T H+
Sbjct: 110 DQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Query: 141 --STQVMGTHGYA---APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 195
+ + GT YA + R + D+ S G VL+ L G K G
Sbjct: 168 RENKNLTGTARYASVNTHLGIEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAG----- 219
Query: 196 VDWAKPYLSDKRKLFRIMDTKL 217
+ K+K +I + K+
Sbjct: 220 --------TKKQKYEKISEKKV 233
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 31/177 (17%), Positives = 54/177 (30%), Gaps = 58/177 (32%)
Query: 55 LVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 113
+V+E + G L + + Q L K+ +GL +LH + ++I+ D K NI
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENI 178
Query: 114 LLDAE-------------------------------------------------FNAKLS 124
LL K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 125 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181
D G A + T+ Y + E + T +D++S + EL +G
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 36/128 (28%), Positives = 54/128 (42%), Gaps = 18/128 (14%)
Query: 56 VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 115
+YE + K Q S + K A + L LH ++I+ D K NILL
Sbjct: 185 LYELIKKNKF---------QGFSLPLVRKFAHSILQCLDALHKN--RIIHCDLKPENILL 233
Query: 116 DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 173
+ + K+ DFG + + V T + Y APE + R D++S G +
Sbjct: 234 KQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCI 288
Query: 174 LLELLSGR 181
L ELL+G
Sbjct: 289 LAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 39/189 (20%), Positives = 69/189 (36%), Gaps = 33/189 (17%)
Query: 42 KLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101
+ + EG + +LV + + SLE L + S A + +H+
Sbjct: 70 NVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK-- 125
Query: 102 QVIYRDFKASNILLDAEFNAK-----LSDFGLAKA-GPTGDRTHV----STQVMGTHGYA 151
++YRD K N L+ + + DFG+ K + H+ + GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 152 APEYVAT--GR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 208
+ + T GR + + D+ + G V + L G K ++K+K
Sbjct: 186 S---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------------TNKQK 229
Query: 209 LFRIMDTKL 217
RI + K
Sbjct: 230 YERIGEKKQ 238
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 9/94 (9%)
Query: 42 KLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101
++ + G+ +V E + SLE LF + S + +AI + ++H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK-- 124
Query: 102 QVIYRDFKASNILLDAEFNAK-----LSDFGLAK 130
+IYRD K N L+ N + DF LAK
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 25/102 (24%), Positives = 46/102 (45%), Gaps = 6/102 (5%)
Query: 32 LGQLHHPNLVKLIGY-CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 90
L + +G+ + + R LV + + SL++ L LS ++VA
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRLL 169
Query: 91 KGLTFLHDAESQVIYRDFKASNILLDAEFNAK--LSDFGLAK 130
L FLH E++ ++ + A NI +D E ++ L+ +G A
Sbjct: 170 DALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.35 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.52 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.31 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.2 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.95 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.72 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.79 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.72 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.52 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.05 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.77 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.28 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-59 Score=401.97 Aligned_cols=232 Identities=22% Similarity=0.287 Sum_probs=190.6
Q ss_pred ChhHHHhHHHHHHh---h-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH---A-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
|||+||++++.... + .......+.|.+|+++|++|+|||||++++++.+++.+|||||||+||+|.++|.
T Consensus 36 ~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~ 115 (350)
T 4b9d_A 36 SFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN 115 (350)
T ss_dssp ---CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 68999998776532 1 1122345679999999999999999999999999999999999999999999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
..+...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++..... .......+||+.|
T Consensus 116 ~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~Y 191 (350)
T 4b9d_A 116 AQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYY 191 (350)
T ss_dssp HTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTT
T ss_pred HcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccc
Confidence 766666899999999999999999999755 999999999999999999999999999865321 1123456899999
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
||||++.+..|+.++|||||||++|||++|+.||.+.+... .+.+++... ....+..++.++.
T Consensus 192 mAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----------------~~~~i~~~~-~~~~~~~~s~~~~ 254 (350)
T 4b9d_A 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----------------LVLKIISGS-FPPVSLHYSYDLR 254 (350)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHHTC-CCCCCTTSCHHHH
T ss_pred cCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----------------HHHHHHcCC-CCCCCccCCHHHH
Confidence 99999999999999999999999999999999998754211 111222222 1234567889999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHH
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+||.+||+.||++|||++|++++
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=386.76 Aligned_cols=239 Identities=26% Similarity=0.444 Sum_probs=197.3
Q ss_pred ChhHHHhHHHHHH--------h-----hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLEL--------H-----ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~--------~-----~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||++++... - ........+.|.+|+++|++++|||||++++++.+++..|+|||||+||+|.+
T Consensus 25 ~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~ 104 (299)
T 4asz_A 25 AFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 104 (299)
T ss_dssp -CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred CCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHH
Confidence 6899998754211 0 11223456789999999999999999999999999999999999999999999
Q ss_pred HhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCC
Q 021507 68 HLFRRG-----------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136 (311)
Q Consensus 68 ~l~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 136 (311)
+|.+.+ ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 182 (299)
T 4asz_A 105 FLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182 (299)
T ss_dssp HHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred HHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEEECCcccceecCCCC
Confidence 996532 356999999999999999999999754 9999999999999999999999999998654433
Q ss_pred CcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhc
Q 021507 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 215 (311)
Q Consensus 137 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (311)
.........||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+. ..+...+..
T Consensus 183 ~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----------------~~~~~~i~~ 245 (299)
T 4asz_A 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----------------NEVIECITQ 245 (299)
T ss_dssp CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHHHHHHHH
T ss_pred ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHc
Confidence 3333445678999999999999999999999999999999998 8999986432 112222223
Q ss_pred ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 216 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
......|..++.++.+|+.+||+.||++|||+.++.+.|+++.
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3334567788999999999999999999999999999998875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-57 Score=388.25 Aligned_cols=240 Identities=28% Similarity=0.425 Sum_probs=189.7
Q ss_pred ChhHHHhHHHHHH--------h-----hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLEL--------H-----ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~--------~-----~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||++++... - ........+.|.+|+++|++++|||||++++++.+++..|+|||||++|+|.+
T Consensus 53 ~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~ 132 (329)
T 4aoj_A 53 AFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 132 (329)
T ss_dssp SSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred CCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHH
Confidence 6899998753210 0 11223456789999999999999999999999999999999999999999999
Q ss_pred HhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCC
Q 021507 68 HLFRRG-------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134 (311)
Q Consensus 68 ~l~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 134 (311)
++.+.. ..++++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~ 210 (329)
T 4aoj_A 133 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210 (329)
T ss_dssp HHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred HHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCcEEEcccccceeccC
Confidence 996542 235999999999999999999999754 99999999999999999999999999987654
Q ss_pred CCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhh
Q 021507 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 213 (311)
Q Consensus 135 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (311)
...........||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... .....+
T Consensus 211 ~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-----------------~~~~~i 273 (329)
T 4aoj_A 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-----------------EAIDCI 273 (329)
T ss_dssp ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-----------------HHHHHH
T ss_pred CCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHH
Confidence 444444456789999999999999999999999999999999999 99999864321 112222
Q ss_pred hcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 214 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
........|..+++++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 2233445677889999999999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=384.56 Aligned_cols=231 Identities=22% Similarity=0.314 Sum_probs=192.6
Q ss_pred ChhHHHhHHHHHHh---hh--------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---AR--------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +. ......+.+.+|+++|++++|||||+++++|.+++.+|+|||||+||+|.+++
T Consensus 44 ~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i 123 (311)
T 4aw0_A 44 SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 123 (311)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred cCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHH
Confidence 68899988776543 11 11223467899999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..............+||+.
T Consensus 124 ~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~ 199 (311)
T 4aw0_A 124 RKIG--SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199 (311)
T ss_dssp HHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGG
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcc
Confidence 7654 3999999999999999999999755 99999999999999999999999999987654443334556789999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|||||++.+..|+.++|||||||++|+|++|..||.+.+... ...+++... ..+|..++.++
T Consensus 200 YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----------------~~~~i~~~~--~~~p~~~s~~~ 261 (311)
T 4aw0_A 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----------------IFAKIIKLE--YDFPEKFFPKA 261 (311)
T ss_dssp GCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHTC--CCCCTTCCHHH
T ss_pred cCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHcCC--CCCCcccCHHH
Confidence 999999999999999999999999999999999998654211 111222222 24566788999
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||.+||..||++|||++|++..
T Consensus 262 ~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 262 RDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHHccCCHhHCcChHHHcCC
Confidence 999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-57 Score=382.01 Aligned_cols=239 Identities=24% Similarity=0.359 Sum_probs=185.7
Q ss_pred ChhHHHhHHHHHHhhh-------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHAR-------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
|||+||.+++...-+. ......+.|.+|+++|++++|||||++++++.+ +..|||||||+||+|.++|....
T Consensus 48 ~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~ 126 (307)
T 3omv_A 48 SFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE 126 (307)
T ss_dssp SSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC
T ss_pred CCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC
Confidence 5888888764332111 122345679999999999999999999998764 56899999999999999996543
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
..+++..+..++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+..............+||+.||||
T Consensus 127 -~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAP 203 (307)
T 3omv_A 127 -TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203 (307)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCH
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCH
Confidence 35999999999999999999999754 999999999999999999999999999875443333334567899999999
Q ss_pred ccccc---CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc----cCCCCchHHH
Q 021507 154 EYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----LGGQYPQKAA 226 (311)
Q Consensus 154 E~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 226 (311)
|++.+ ..++.++|||||||++|||+||+.||.+.+... .+...+... .....+..++
T Consensus 204 E~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----------------~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----------------QIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp HHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----------------HHHHHHHTTCCCCCSTTSCTTSC
T ss_pred HHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----------------HHHHHHhcCCCCCCcccccccch
Confidence 99964 358999999999999999999999997643211 111111111 1123456788
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 999999999999999999999999999988753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=388.11 Aligned_cols=238 Identities=23% Similarity=0.212 Sum_probs=191.2
Q ss_pred ChhHHHhHHHHHHh---hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCC
Q 021507 1 MFLFNFLHSHLELH---ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPL 77 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (311)
+||+||++++.... +.+.........+|+.+|++++|||||++++++.+++.+|||||||+||+|.++|.+.+ .+
T Consensus 70 ~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l 147 (336)
T 4g3f_A 70 SFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CL 147 (336)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SC
T ss_pred CCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC--CC
Confidence 69999998876543 33333334445689999999999999999999999999999999999999999997654 49
Q ss_pred CHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCc---ceeccccccccccCc
Q 021507 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT---HVSTQVMGTHGYAAP 153 (311)
Q Consensus 78 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aP 153 (311)
++..+..++.||+.||+|||++ +|+||||||+|||++.+| .+||+|||+++........ ......+||+.||||
T Consensus 148 ~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAP 225 (336)
T 4g3f_A 148 PEDRALYYLGQALEGLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTT--TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCH
T ss_pred CHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCH
Confidence 9999999999999999999965 599999999999999987 5999999999876433211 122346799999999
Q ss_pred cccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchHHHHHHHHH
Q 021507 154 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATL 232 (311)
Q Consensus 154 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 232 (311)
|++.+..++.++|||||||++|||++|+.||.+.+...... .+.... .....+..++.++.+|
T Consensus 226 E~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------------~i~~~~~~~~~~~~~~s~~~~~l 289 (336)
T 4g3f_A 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL----------------KIASEPPPIREIPPSCAPLTAQA 289 (336)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH----------------HHHHSCCGGGGSCTTSCHHHHHH
T ss_pred HHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH----------------HHHcCCCCchhcCccCCHHHHHH
Confidence 99999999999999999999999999999998654321111 111111 0112456788999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 233 ALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 233 i~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|.+||..||.+|||+.|+++.|....
T Consensus 290 i~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 290 IQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999887653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=376.74 Aligned_cols=230 Identities=23% Similarity=0.360 Sum_probs=182.7
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~ 66 (311)
|||+||++.+.... ........+.|.+|+++|++|+|||||+++++|.+ ++.+|+|||||+||+|.
T Consensus 38 ~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~ 117 (290)
T 3fpq_A 38 SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117 (290)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHH
T ss_pred cCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHH
Confidence 68899988765532 11123345679999999999999999999999875 34579999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceecccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
+++.+.. .+++..+..++.||+.||+|||+++.+|+||||||+|||++. +|.+||+|||+|+..... .....+
T Consensus 118 ~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~ 191 (290)
T 3fpq_A 118 TYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVI 191 (290)
T ss_dssp HHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESC
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcc
Confidence 9997654 499999999999999999999976555999999999999974 789999999999864322 244578
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQK 224 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (311)
||+.|||||++.+ .++.++|||||||++|||+||+.||.+.... ..+...+... .....+..
T Consensus 192 GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----------------~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 192 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----------------AQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp SSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----------------HHHHHHHTTTCCCGGGGGC
T ss_pred cCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----------------HHHHHHHHcCCCCCCCCcc
Confidence 9999999999865 6999999999999999999999999754321 1111111111 11122344
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+++++.+||.+||..||++|||+++++++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 56789999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=385.37 Aligned_cols=230 Identities=21% Similarity=0.259 Sum_probs=188.9
Q ss_pred ChhHHHhHHHHHHh---hh-----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---AR-----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... +. ......+.+.+|+++|++++|||||+++++|.+++.+|||||||+||+|.+++.+.
T Consensus 86 ~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~ 165 (346)
T 4fih_A 86 STGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT 165 (346)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS
T ss_pred cCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC
Confidence 58899988776532 11 11223456889999999999999999999999999999999999999999998653
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
.+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....... .....+||+.|||
T Consensus 166 ---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmA 238 (346)
T 4fih_A 166 ---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMA 238 (346)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCC
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCC
Confidence 3999999999999999999999755 99999999999999999999999999987543322 2456789999999
Q ss_pred ccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc-ccCCCCchHHHHHHHH
Q 021507 153 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAAT 231 (311)
Q Consensus 153 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 231 (311)
||++.+..|+.++|||||||++|||++|..||.+.+.... +..+... ......+..++.++.+
T Consensus 239 PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----------------~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----------------MKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------HHHHHcCCCCCCCccccCCHHHHH
Confidence 9999999999999999999999999999999986542111 1111111 1112334578899999
Q ss_pred HHHhcccCCCCCCCCHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
||.+||..||++|||++|++++
T Consensus 303 li~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=387.88 Aligned_cols=230 Identities=21% Similarity=0.259 Sum_probs=188.7
Q ss_pred ChhHHHhHHHHHHh---hh-----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---AR-----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... +. ......+.+.+|+++|++++|||||+++++|.+++.+|||||||+||+|.+++...
T Consensus 163 ~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~ 242 (423)
T 4fie_A 163 STGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT 242 (423)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS
T ss_pred cCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc
Confidence 68899988876532 11 11123456889999999999999999999999999999999999999999998654
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
.+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....... .....+||+.|||
T Consensus 243 ---~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmA 315 (423)
T 4fie_A 243 ---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMA 315 (423)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCC
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCC
Confidence 3999999999999999999999755 99999999999999999999999999987543322 2456789999999
Q ss_pred ccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc-ccCCCCchHHHHHHHH
Q 021507 153 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAAT 231 (311)
Q Consensus 153 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 231 (311)
||++.+..|+.++|||||||++|||++|..||.+.+.... +..+... ......+..++.++.+
T Consensus 316 PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----------------~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----------------MKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------HHHHHcCCCCCCcccccCCHHHHH
Confidence 9999999999999999999999999999999976542111 1111111 1112234567889999
Q ss_pred HHHhcccCCCCCCCCHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
||.+||..||++|||+.|++++
T Consensus 380 li~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=370.72 Aligned_cols=219 Identities=23% Similarity=0.400 Sum_probs=187.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------CCCCCHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKV 85 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~ 85 (311)
...+.|.+|+.++++++|||||++++++.+++..|+|||||++|+|.++|..+. ...+++..++.+
T Consensus 71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 150 (308)
T 4gt4_A 71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150 (308)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence 345789999999999999999999999999999999999999999999996532 135899999999
Q ss_pred HHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCC
Q 021507 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 165 (311)
Q Consensus 86 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 165 (311)
+.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+++...............||+.|||||++.+..++.++
T Consensus 151 ~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ks 228 (308)
T 4gt4_A 151 VAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS 228 (308)
T ss_dssp HHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHhCC--CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccc
Confidence 999999999999755 999999999999999999999999999865443333334556899999999999999999999
Q ss_pred ceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 166 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 166 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
|||||||++|||+| |..||.+.+. ..+...+........|..++.++.+|+.+||+.||++|
T Consensus 229 DVwSfGvvl~El~t~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~R 291 (308)
T 4gt4_A 229 DIWSYGVVLWEVFSYGLQPYCGYSN-----------------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 291 (308)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHC
Confidence 99999999999998 8999986532 11222233333445677889999999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 021507 245 PRMSEVLAILERL 257 (311)
Q Consensus 245 pt~~~~l~~l~~~ 257 (311)
||+.+|++.|+++
T Consensus 292 Ps~~ei~~~L~a~ 304 (308)
T 4gt4_A 292 PRFKDIHSRLRAW 304 (308)
T ss_dssp CCHHHHHHHHHTS
T ss_pred cCHHHHHHHHHhc
Confidence 9999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=365.86 Aligned_cols=227 Identities=25% Similarity=0.359 Sum_probs=175.9
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... + .......+.+.+|+++|++++|||||++++++.+++..|+||||| +|+|.+++
T Consensus 25 ~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l 103 (275)
T 3hyh_A 25 SFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYI 103 (275)
T ss_dssp --CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHH
T ss_pred cCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHH
Confidence 58889988776532 1 112234567999999999999999999999999999999999999 67999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+++ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...... .....+||+.
T Consensus 104 ~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~ 176 (275)
T 3hyh_A 104 VQRD--KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPN 176 (275)
T ss_dssp HHSC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC------------------CT
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcc
Confidence 7654 4999999999999999999999755 9999999999999999999999999998653322 2345789999
Q ss_pred ccCccccccCCC-CCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 150 YAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 150 y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
|||||++.+..+ +.++|||||||++|+|++|+.||.+.+... +.+.+.. .....+..++.+
T Consensus 177 Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-----------------~~~~i~~-~~~~~p~~~s~~ 238 (275)
T 3hyh_A 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-----------------LFKNISN-GVYTLPKFLSPG 238 (275)
T ss_dssp TSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHH-TCCCCCTTSCHH
T ss_pred cCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-----------------HHHHHHc-CCCCCCCCCCHH
Confidence 999999998876 578999999999999999999998643211 1111111 112345678899
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||.+||+.||++|||++|++++
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHccCChhHCcCHHHHHcC
Confidence 9999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=379.04 Aligned_cols=240 Identities=26% Similarity=0.340 Sum_probs=197.3
Q ss_pred ChhHHHhHHHHHHh--------------hhhHHHHHHHHHHHHHHHhcCCC-CCccceEeEEEeC-CeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH--------------ARSLLLITNWFQTEVNYLGQLHH-PNLVKLIGYCLEG-ENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~-~~~~lv~e~~~~~~ 64 (311)
+||+||.+.+.... ........+.|.+|+++|.+++| ||||+++++|.+. +.+|+|||||++|+
T Consensus 76 ~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~ 155 (353)
T 4ase_A 76 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 155 (353)
T ss_dssp SSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEE
T ss_pred CCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCC
Confidence 68888887543321 11122345679999999999976 8999999998764 56899999999999
Q ss_pred hHHHhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 65 LENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 65 L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
|.++|++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 156 L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~vKi~DFGlar 233 (353)
T 4ase_A 156 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 233 (353)
T ss_dssp HHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred HHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeCCCCCEEECcchhhh
Confidence 999996532 234899999999999999999999765 9999999999999999999999999998
Q ss_pred cCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhh
Q 021507 131 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 209 (311)
Q Consensus 131 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (311)
...............||+.|||||++.+..++.++|||||||++|||+| |..||.+... ...+
T Consensus 234 ~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~----------------~~~~ 297 (353)
T 4ase_A 234 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------------DEEF 297 (353)
T ss_dssp CTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----------------SHHH
T ss_pred hcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH----------------HHHH
Confidence 7655444444556789999999999999999999999999999999998 9999986432 1122
Q ss_pred hHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 210 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
...+........|..+++++.++|.+||+.||++|||+.+++++|+.+.
T Consensus 298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 3334444455667788999999999999999999999999999998864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=358.92 Aligned_cols=206 Identities=28% Similarity=0.341 Sum_probs=168.9
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
.+.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+++ |
T Consensus 72 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--I 147 (304)
T 3ubd_A 72 RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG--I 147 (304)
T ss_dssp ------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred HHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--C
Confidence 58889999999999999999999999999999999999999999997654 4999999999999999999999755 9
Q ss_pred eecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCc
Q 021507 104 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 183 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 183 (311)
+||||||+|||++.+|.+||+|||+|+...... ......+||+.|||||++.+..++.++|||||||++|||++|+.|
T Consensus 148 iHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 225 (304)
T 3ubd_A 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225 (304)
T ss_dssp CCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCC
Confidence 999999999999999999999999998643322 124457899999999999999999999999999999999999999
Q ss_pred cCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 021507 184 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM-----SEVLAI 253 (311)
Q Consensus 184 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~~l~~ 253 (311)
|.+.+... ....+... ....|..++.++.+||.+||+.||++|||+ +|++++
T Consensus 226 F~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 226 FQGKDRKE----------------TMTMILKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp SCCSSHHH----------------HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCcCHHH----------------HHHHHHcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 98754211 11122222 224567789999999999999999999984 566643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=355.21 Aligned_cols=229 Identities=24% Similarity=0.347 Sum_probs=168.8
Q ss_pred ChhHHHhHHHHHHh---h------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC------------eeEEEEec
Q 021507 1 MFLFNFLHSHLELH---A------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------------NRLLVYEF 59 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------------~~~lv~e~ 59 (311)
|||+||++++.... + .......+.+.+|+++|++|+|||||++++++.+.+ .+|+||||
T Consensus 17 ~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~ 96 (299)
T 4g31_A 17 GFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQL 96 (299)
T ss_dssp C--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEEC
T ss_pred CCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEec
Confidence 68999988765432 1 122345577999999999999999999999987544 36999999
Q ss_pred CCCCChHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc
Q 021507 60 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138 (311)
Q Consensus 60 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 138 (311)
|+||+|.+++..+.. ...++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+........
T Consensus 97 ~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~ 174 (299)
T 4g31_A 97 CRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174 (299)
T ss_dssp CCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCCCC---------
T ss_pred CCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEccCccceecCCCccc
Confidence 999999999976543 23566778899999999999999755 999999999999999999999999999875433211
Q ss_pred c----------eeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhh
Q 021507 139 H----------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 208 (311)
Q Consensus 139 ~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 208 (311)
. .....+||+.|||||++.+..|+.++|||||||++|||++ ||....... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~---------------~~ 236 (299)
T 4g31_A 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV---------------RT 236 (299)
T ss_dssp -----------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH---------------HH
T ss_pred cccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH---------------HH
Confidence 1 1234579999999999999999999999999999999996 775421100 00
Q ss_pred hhHhhhcccCCCCc---hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 209 LFRIMDTKLGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 209 ~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.... ....| ...++.+.+||.+||+.||++|||+.+++++
T Consensus 237 ~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 237 LTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111 11122 2345567889999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=354.54 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=179.8
Q ss_pred ChhHHHhHHHHHHh-hhh----HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC----eeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH-ARS----LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~ 71 (311)
|||+||.+++.... +.+ .......++.|+..+.+++|||||++++++.+++ ..|||||||+||+|.+++.+
T Consensus 15 ~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 94 (303)
T 3hmm_A 15 RFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 94 (303)
T ss_dssp SSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred CCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh
Confidence 68888887542211 111 1111223345666677889999999999998654 57999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceecc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQ 143 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~ 143 (311)
. ++++..+.+++.|++.||+|||+. ..+|+||||||+|||++.++.+||+|||+++........ .....
T Consensus 95 ~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~ 171 (303)
T 3hmm_A 95 Y---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171 (303)
T ss_dssp C---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC---
T ss_pred C---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccc
Confidence 4 389999999999999999999975 236999999999999999999999999999865433221 12234
Q ss_pred ccccccccCccccccC------CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhH-hhhcc
Q 021507 144 VMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTK 216 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 216 (311)
.+||+.|||||++.+. .++.++|||||||++|||+||..||......... .... .+.......+.. .....
T Consensus 172 ~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~~-~~~~~~~~~~~~~~~~~~ 249 (303)
T 3hmm_A 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDL-VPSDPSVEEMRKVVCEQK 249 (303)
T ss_dssp --CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTT-SCSSCCHHHHHHHHTTSC
T ss_pred ccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-chhc-ccccchHHHHHHHHhccc
Confidence 6799999999999764 3677999999999999999999888654321100 0000 000001111111 12222
Q ss_pred cCCCCc-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 217 LGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 217 ~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.+...| ..++..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 250 ~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 250 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 222333 245678999999999999999999999999998875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=353.51 Aligned_cols=247 Identities=21% Similarity=0.246 Sum_probs=182.6
Q ss_pred ChhHHHhHHHHHHh---hh-------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe------CCeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH---AR-------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE------GENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~~~lv~e~~~~~~ 64 (311)
+||+||++.+.... +. ......+.+.+|+++|++|+|||||++++++.. .+.+|+|||||. |+
T Consensus 66 ~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~ 144 (398)
T 4b99_A 66 AYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SD 144 (398)
T ss_dssp SSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EE
T ss_pred cCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CC
Confidence 68999998776532 11 122344678899999999999999999998764 367899999996 58
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCC--Ccceec
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVST 142 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 142 (311)
|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...... ......
T Consensus 145 L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~ 220 (398)
T 4b99_A 145 LHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 220 (398)
T ss_dssp HHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCC
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccc
Confidence 999996543 5999999999999999999999755 9999999999999999999999999998654322 112244
Q ss_pred cccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh--hccccccch-----hhhhHhhh
Q 021507 143 QVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD--WAKPYLSDK-----RKLFRIMD 214 (311)
Q Consensus 143 ~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~ 214 (311)
..+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+. ...+..... ......+.
T Consensus 221 ~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~ 300 (398)
T 4b99_A 221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQ 300 (398)
T ss_dssp SSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHH
T ss_pred cceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhh
Confidence 57899999999998875 56899999999999999999999998765432221111 011110000 00000000
Q ss_pred cccCCCC-------chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 215 TKLGGQY-------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 215 ~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...... ...++.++.+||.+||..||.+|||+.|++++
T Consensus 301 -~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 301 -SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000010 12457789999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=346.77 Aligned_cols=246 Identities=22% Similarity=0.242 Sum_probs=177.2
Q ss_pred ChhHHHhHHHH-HH--h---hhh---HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHL-EL--H---ARS---LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~-~~--~---~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++++. +. . +.+ .......+.+|+++|+.+ +|||||+++++|.+++++|+|||||+||+|.+++.
T Consensus 33 ~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~ 112 (361)
T 4f9c_A 33 TFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN 112 (361)
T ss_dssp SSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT
T ss_pred cCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc
Confidence 68999988642 11 0 111 112234578999999998 79999999999999999999999999999999983
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC-CcEEEecccccccCCCCCCc-----------
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRT----------- 138 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~----------- 138 (311)
.+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+........
T Consensus 113 -----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 185 (361)
T 4f9c_A 113 -----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQ 185 (361)
T ss_dssp -----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC------
T ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccc
Confidence 3899999999999999999999755 9999999999999876 79999999999754332110
Q ss_pred ---------------ceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhh--hhhhcc
Q 021507 139 ---------------HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAK 200 (311)
Q Consensus 139 ---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~ 200 (311)
......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.........- ......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G 265 (361)
T 4f9c_A 186 ERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRG 265 (361)
T ss_dssp --------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred cccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcC
Confidence 112235799999999999876 58999999999999999999999996544321110 000000
Q ss_pred -c-------------------cccchhhhhHhhh---------------cccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 201 -P-------------------YLSDKRKLFRIMD---------------TKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 201 -~-------------------~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
+ ...+.......+. ..........+++++.+||.+||..||++|+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ 345 (361)
T 4f9c_A 266 SRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRI 345 (361)
T ss_dssp HHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSC
T ss_pred CccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc
Confidence 0 0000000000000 0001112345678899999999999999999
Q ss_pred CHHHHHHH
Q 021507 246 RMSEVLAI 253 (311)
Q Consensus 246 t~~~~l~~ 253 (311)
|++|++++
T Consensus 346 ta~eaL~H 353 (361)
T 4f9c_A 346 TAEEALLH 353 (361)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=362.39 Aligned_cols=230 Identities=23% Similarity=0.272 Sum_probs=183.1
Q ss_pred ChhHHHhHHHHHHh---hh-----------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH---AR-----------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-----------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
|||+||++++.... +. .........++++.+++.++|||||+++++|.+.+.+|+|||||.||+|.
T Consensus 201 ~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~ 280 (689)
T 3v5w_A 201 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280 (689)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred cCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHH
Confidence 68888888765532 11 11111222344577888889999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
++|.+.+ .+++..+..++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+...... ....+|
T Consensus 281 ~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~--gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~G 352 (689)
T 3v5w_A 281 YHLSQHG--VFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 352 (689)
T ss_dssp HHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCS
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccC
Confidence 9997664 399999999999999999999965 59999999999999999999999999998754332 345689
Q ss_pred cccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH
Q 021507 147 THGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 225 (311)
Q Consensus 147 t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
|+.|||||++.+ ..|+.++|+|||||++|||++|..||.+...... ..+.... .......|..+
T Consensus 353 Tp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--------------~~i~~~i-~~~~~~~p~~~ 417 (689)
T 3v5w_A 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEIDRMT-LTMAVELPDSF 417 (689)
T ss_dssp CGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--------------HHHHHHH-HHCCCCCCTTS
T ss_pred CcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--------------HHHHHhh-cCCCCCCCccC
Confidence 999999999964 5799999999999999999999999976432111 0111111 11223456778
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
+.++.+||.+||..||.+|++ ++|++++
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 999999999999999999997 6888764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=363.70 Aligned_cols=231 Identities=21% Similarity=0.259 Sum_probs=188.1
Q ss_pred ChhHHHhHHHHHHhh--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELHA--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+..... .......+.+.+|+++|+.|+|||||+++++|.+++.+|+|||||+||+|.++|...
T Consensus 169 ~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~ 248 (573)
T 3uto_A 169 AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 248 (573)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCT
T ss_pred cCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHh
Confidence 588888887654321 112234567889999999999999999999999999999999999999999998543
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC--CcEEEecccccccCCCCCCcceeccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++...... .....+||+.|
T Consensus 249 ~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y 322 (573)
T 3uto_A 249 H-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEF 322 (573)
T ss_dssp T-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGG
T ss_pred C-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccc
Confidence 3 34999999999999999999999755 9999999999999854 889999999998764432 23456899999
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHT 228 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 228 (311)
||||++.+..|+.++|||||||++|+|++|..||.+.+.... +..+.... ........++.+
T Consensus 323 ~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----------------LRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp CCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------------HHHHHTTCCCCCSGGGTTSCHH
T ss_pred cCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------HHHHHhCCCCCCcccccCCCHH
Confidence 999999999999999999999999999999999987543211 11111111 112223467889
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||.+||..||.+|||+.|++++
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=331.00 Aligned_cols=220 Identities=24% Similarity=0.409 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------------CCCCHHHHHH
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMK 84 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~ 84 (311)
...+.+.+|+++++++ +||||+++++++.+.+..|+||||++||+|.+++..... ..+++..++.
T Consensus 128 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (370)
T 2psq_A 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207 (370)
T ss_dssp HHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHH
Confidence 3456789999999999 899999999999999999999999999999999976532 3489999999
Q ss_pred HHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCC
Q 021507 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 164 (311)
Q Consensus 85 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 164 (311)
++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+..++.+
T Consensus 208 i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 285 (370)
T 2psq_A 208 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 285 (370)
T ss_dssp HHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH
T ss_pred HHHHHHHHHHHHHhCC--eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH
Confidence 9999999999999755 99999999999999999999999999986544333322334567889999999999999999
Q ss_pred CceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 165 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 165 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
+|||||||++|||++ |..||.+.... .+...+........+..++.++.++|.+||..||.+
T Consensus 286 ~DvwslG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 348 (370)
T 2psq_A 286 SDVWSFGVLMWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQ 348 (370)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 999999999999999 99999864321 122223333334556678889999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 021507 244 RPRMSEVLAILERLE 258 (311)
Q Consensus 244 Rpt~~~~l~~l~~~~ 258 (311)
||++.++++.|+++.
T Consensus 349 Rpt~~ell~~L~~il 363 (370)
T 2psq_A 349 RPTFKQLVEDLDRIL 363 (370)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=324.24 Aligned_cols=241 Identities=27% Similarity=0.390 Sum_probs=184.1
Q ss_pred ChhHHHhHHHHHHh-h-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH-A-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++++.... + .......+.|.+|++++++++||||+++++++.+.+..|+||||+++++|.+++...
T Consensus 49 ~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 128 (309)
T 3p86_A 49 SFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128 (309)
T ss_dssp SSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHST
T ss_pred CCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhc
Confidence 57778777532211 0 111233457889999999999999999999999999999999999999999999654
Q ss_pred CC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 73 GP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 73 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.. ..+++..++.++.|++.||+|||+.+.+|+||||||+||+++.++.+||+|||+++...... .......||+.|+
T Consensus 129 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~ 206 (309)
T 3p86_A 129 GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWM 206 (309)
T ss_dssp THHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCcccc
Confidence 32 23899999999999999999999643349999999999999999999999999997543321 1234567899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 231 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (311)
|||++.+..++.++|||||||++|+|++|..||....... ..............+..++..+.+
T Consensus 207 aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----------------VVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp CHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----------------HHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhcCCCCCCCccCCHHHHH
Confidence 9999999999999999999999999999999998643211 111111122333456678889999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 232 LALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
+|.+||..||.+|||+.++++.|+.+..
T Consensus 271 li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=318.31 Aligned_cols=230 Identities=22% Similarity=0.294 Sum_probs=187.0
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... ........+.+.+|+.++++++||||+++++++..++..|+||||+.|++|.+++...
T Consensus 32 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 111 (297)
T 3fxz_A 32 ASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111 (297)
T ss_dssp TTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS
T ss_pred CCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc
Confidence 57888887654322 1112223567889999999999999999999999999999999999999999999654
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ......||+.|+|
T Consensus 112 ---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~a 184 (297)
T 3fxz_A 112 ---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMA 184 (297)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCC
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccC
Confidence 3899999999999999999999755 99999999999999999999999999876543322 2345679999999
Q ss_pred ccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhh-hcccCCCCchHHHHHHHH
Q 021507 153 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAAT 231 (311)
Q Consensus 153 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 231 (311)
||++.+..++.++|||||||++|+|++|..||...+..... .... ........+..++..+.+
T Consensus 185 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----------------YLIATNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp HHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------HHHHHHCSCCCSCGGGSCHHHHH
T ss_pred hhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhCCCCCCCCccccCHHHHH
Confidence 99999999999999999999999999999999764321110 0111 111122345677889999
Q ss_pred HHHhcccCCCCCCCCHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|.+||+.||.+|||+.+++++
T Consensus 249 li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=322.16 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=191.5
Q ss_pred ChhHHHhHHHHHH------------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLEL------------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||.+.+... .........+.|.+|+.++++++||||+++++++.+++..|+||||++|++|.++
T Consensus 61 ~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 140 (325)
T 3kul_A 61 DSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140 (325)
T ss_dssp TTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHH
T ss_pred CCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHH
Confidence 5777777665311 1111334556799999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceecccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGT 147 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt 147 (311)
+.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......... .......+|
T Consensus 141 l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t 217 (325)
T 3kul_A 141 LRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217 (325)
T ss_dssp HHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CC
T ss_pred HHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCc
Confidence 96543 35999999999999999999999755 999999999999999999999999999875443222 122234567
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+........+..++
T Consensus 218 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----------------DVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp GGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCC
T ss_pred ccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHHHcCCCCCCCCCcC
Confidence 78999999999999999999999999999999 99999764321 1222222333344566788
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
..+.+++.+||..||.+|||+.++++.|+.+...
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999997643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=319.23 Aligned_cols=240 Identities=25% Similarity=0.364 Sum_probs=189.3
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||.+.+.... ........+.|.+|++++++++||||+++++++.+++..++||||+++++|.+++...
T Consensus 22 ~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 101 (310)
T 3s95_A 22 CFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM 101 (310)
T ss_dssp SSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHC
T ss_pred CCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhc
Confidence 57788877654422 1112345677999999999999999999999999999999999999999999999764
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc------------e
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH------------V 140 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------------~ 140 (311)
. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......... .
T Consensus 102 ~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (310)
T 3s95_A 102 D-SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178 (310)
T ss_dssp C-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC-------------------
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccc
Confidence 3 35999999999999999999999755 9999999999999999999999999998654332211 0
Q ss_pred eccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC
Q 021507 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 220 (311)
Q Consensus 141 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (311)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ......... ..
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----------~~~~~~~~~----~~ 243 (310)
T 3s95_A 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----------GLNVRGFLD----RY 243 (310)
T ss_dssp -CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------SBCHHHHHH----HT
T ss_pred ccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------hhhhhcccc----cc
Confidence 114579999999999999999999999999999999999999987543211100 000011111 12
Q ss_pred CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 221 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 34556778999999999999999999999999998875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=322.24 Aligned_cols=235 Identities=23% Similarity=0.270 Sum_probs=183.7
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++.+.... ........+.+.+|+.+++.++||||+++++++.+++..|+||||++|++|.+++..
T Consensus 19 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 98 (323)
T 3tki_A 19 AYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98 (323)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT
T ss_pred CCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh
Confidence 57888877554322 112223346688999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++................||+.|+
T Consensus 99 ~--~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 174 (323)
T 3tki_A 99 D--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174 (323)
T ss_dssp T--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGS
T ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCcc
Confidence 4 34999999999999999999999755 9999999999999999999999999997654333333344567999999
Q ss_pred CccccccCCC-CCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 152 APEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 152 aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
|||++.+..+ +.++|||||||++|+|++|..||......... ................++..+.
T Consensus 175 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH---------------HHHHHTTCTTSTTGGGSCHHHH
T ss_pred CcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH---------------HHHHhcccccCCccccCCHHHH
Confidence 9999988765 77899999999999999999999765431110 1111111111122356788899
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHH
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+||.+||..||.+|||+.++++..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHHHccCChhhCcCHHHHhhCh
Confidence 999999999999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=319.87 Aligned_cols=228 Identities=24% Similarity=0.328 Sum_probs=185.8
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++.+.... ........+.+.+|+++++.++||||+++++++.+.+..|+||||++|++|.+++.
T Consensus 27 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~ 106 (328)
T 3fe3_A 27 NFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV 106 (328)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred CCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH
Confidence 57888877664322 11122345568899999999999999999999999999999999999999999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
..+ .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ......||+.|
T Consensus 107 ~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y 179 (328)
T 3fe3_A 107 AHG--RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPY 179 (328)
T ss_dssp HHC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGG
T ss_pred HcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcce
Confidence 654 3999999999999999999999755 9999999999999999999999999997654332 23456799999
Q ss_pred cCccccccCCCC-CCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 151 AAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 151 ~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
+|||++.+..+. .++|||||||++|+|++|..||.+.+..... ..+... ....|..++.++
T Consensus 180 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------------~~i~~~--~~~~p~~~s~~~ 241 (328)
T 3fe3_A 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR----------------ERVLRG--KYRIPFYMSTDC 241 (328)
T ss_dssp CCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHC--CCCCCTTSCHHH
T ss_pred eCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhC--CCCCCCCCCHHH
Confidence 999999888765 7899999999999999999999875421111 111111 123455678899
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+|+.+||..||.+|||+++++++
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=320.70 Aligned_cols=255 Identities=23% Similarity=0.283 Sum_probs=186.8
Q ss_pred ChhHHHhHHHHHHh-hh----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC----eeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH-AR----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++++.+.. +. ........+.+|+.++++++||||+++++++.+.. ..|+||||+++|+|.+++..
T Consensus 36 ~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 115 (322)
T 3soc_A 36 RFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115 (322)
T ss_dssp TTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred CceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh
Confidence 57888877544311 11 11223345667999999999999999999998754 36999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhC--------CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDA--------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 143 (311)
. .+++..++.++.|++.||+|||+. ..+|+||||||+||+++.++.+||+|||+++.............
T Consensus 116 ~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~ 192 (322)
T 3soc_A 116 N---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192 (322)
T ss_dssp C---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTT
T ss_pred c---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCcccccc
Confidence 4 399999999999999999999964 11699999999999999999999999999976554433333445
Q ss_pred ccccccccCccccccC-----CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHh-hhccc
Q 021507 144 VMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTKL 217 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 217 (311)
..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+................. ........ .....
T Consensus 193 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 271 (322)
T 3soc_A 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP-SLEDMQEVVVHKKK 271 (322)
T ss_dssp CCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-CHHHHHHHHTTSCC
T ss_pred CccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC-chhhhhhhhhcccC
Confidence 6799999999999873 45668899999999999999999998654322111111100000 01111111 11111
Q ss_pred CCCC-----chHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 218 GGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 218 ~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.... ....+.++.+||.+||+.||++|||+.++++.|+++..
T Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 272 RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 12456779999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=315.45 Aligned_cols=239 Identities=24% Similarity=0.329 Sum_probs=186.7
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.|.+|+.++++++||||+++++++.+++..|+||||++|++|.+++
T Consensus 23 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l 102 (294)
T 4eqm_A 23 GMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI 102 (294)
T ss_dssp TTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred CCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHH
Confidence 57888877654322 1123345677999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ .......||+.
T Consensus 103 ~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~ 177 (294)
T 4eqm_A 103 ESHG--PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQ 177 (294)
T ss_dssp HHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCS
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCcc
Confidence 7654 4999999999999999999999755 99999999999999999999999999986543221 12334578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc---CCCCchHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL---GGQYPQKAA 226 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 226 (311)
|+|||++.+..++.++||||||+++|+|++|..||.+....... ...+.... ....+..++
T Consensus 178 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA----------------IKHIQDSVPNVTTDVRKDIP 241 (294)
T ss_dssp SCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH----------------HHHHSSCCCCHHHHSCTTSC
T ss_pred ccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH----------------HHHhhccCCCcchhcccCCC
Confidence 99999999999999999999999999999999999875421110 00000000 011234567
Q ss_pred HHHHHHHHhcccCCCCCCC-CHHHHHHHHHhhcCC
Q 021507 227 HTAATLALQCLNNEPKLRP-RMSEVLAILERLEAP 260 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rp-t~~~~l~~l~~~~~~ 260 (311)
..+.+++.+||..||.+|| +++++.+.|+.+...
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 8899999999999999999 899999999887543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=325.67 Aligned_cols=222 Identities=26% Similarity=0.410 Sum_probs=187.8
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------------CCCCHHHHHH
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMK 84 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~ 84 (311)
...+.+.+|+++++++ +||||+++++++.+++..|+||||+++|+|.+++..... ..+++..++.
T Consensus 116 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 195 (382)
T 3tt0_A 116 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195 (382)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHH
Confidence 3456788999999999 999999999999999999999999999999999976542 3599999999
Q ss_pred HHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCC
Q 021507 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 164 (311)
Q Consensus 85 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 164 (311)
++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.+
T Consensus 196 i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 273 (382)
T 3tt0_A 196 CAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 273 (382)
T ss_dssp HHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH
T ss_pred HHHHHHHHHHHHHhCC--EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch
Confidence 9999999999999754 99999999999999999999999999987654433333445567889999999999999999
Q ss_pred CceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 165 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 165 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
+|||||||++|+|++ |..||..... ......+........+..++.++.+++.+||+.||++
T Consensus 274 ~DiwslG~il~ellt~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 336 (382)
T 3tt0_A 274 SDVWSFGVLLWEIFTLGGSPYPGVPV-----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 336 (382)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGG
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhh
Confidence 999999999999999 9999976432 1222333333344456678889999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 021507 244 RPRMSEVLAILERLEAP 260 (311)
Q Consensus 244 Rpt~~~~l~~l~~~~~~ 260 (311)
|||+.++++.|+++...
T Consensus 337 Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 337 RPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHH
Confidence 99999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=328.77 Aligned_cols=238 Identities=26% Similarity=0.349 Sum_probs=190.8
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+.... ........+.|.+|++++++++||||+++++++.+++..|+||||+++|+|.+++..
T Consensus 126 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 205 (377)
T 3cbl_A 126 NFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT 205 (377)
T ss_dssp TTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH
T ss_pred CCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh
Confidence 57777777654221 111123445688999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.+ ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++...............++..|+
T Consensus 206 ~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~ 282 (377)
T 3cbl_A 206 EG-ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282 (377)
T ss_dssp HG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGS
T ss_pred cC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcC
Confidence 43 34899999999999999999999755 9999999999999999999999999998643322111112234577899
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
|||++.+..++.++|||||||++|||++ |..||...... .....+........+..++..+.
T Consensus 283 aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~ 345 (377)
T 3cbl_A 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----------------QTREFVEKGGRLPCPELCPDAVF 345 (377)
T ss_dssp CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHH
Confidence 9999999999999999999999999998 99999864321 12222333334455667888999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
++|.+||+.||++|||+.++++.|+.+.
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=315.39 Aligned_cols=229 Identities=25% Similarity=0.300 Sum_probs=185.7
Q ss_pred ChhHHHhHHHHHHh---hh--------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---AR--------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +. ......+.+.+|+++|+.++||||+++++++.+.+..|+||||++||+|.+++
T Consensus 17 ~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 96 (337)
T 1o6l_A 17 TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL 96 (337)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 57888877654321 10 11223456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++....... ......||+.
T Consensus 97 ~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~ 170 (337)
T 1o6l_A 97 SRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPE 170 (337)
T ss_dssp HHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGG
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChh
Confidence 6654 4899999999999999999999754 99999999999999999999999999976432221 2345679999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|+|||||++|+|++|..||...+... ....+... ....+..++.++
T Consensus 171 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~~ 232 (337)
T 1o6l_A 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILME--EIRFPRTLSPEA 232 (337)
T ss_dssp GCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC--CCCCCTTSCHHH
T ss_pred hCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHHH
Confidence 999999999999999999999999999999999997643211 01111111 223566788999
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.+||.+||..||.+|| ++++++++
T Consensus 233 ~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 9999999999999999 89999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=321.39 Aligned_cols=222 Identities=27% Similarity=0.424 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC----------------------CCC
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG----------------------PQP 76 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~ 76 (311)
....+.|.+|++++++++||||+++++++.+++..|+||||+++++|.+++.... ...
T Consensus 91 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T 1luf_A 91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170 (343)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCC
Confidence 3456779999999999999999999999999999999999999999999997642 146
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccc
Q 021507 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 156 (311)
Q Consensus 77 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 156 (311)
+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++................++..|+|||++
T Consensus 171 l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 171 LSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 248 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence 999999999999999999999755 999999999999999999999999999764333222223445678999999999
Q ss_pred ccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHh
Q 021507 157 ATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 235 (311)
Q Consensus 157 ~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (311)
.+..++.++||||||+++|+|++ |..||...... .....+........+..++..+.+++.+
T Consensus 249 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (343)
T 1luf_A 249 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-----------------EVIYYVRDGNILACPENCPLELYNLMRL 311 (343)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH-----------------HHHHHHhCCCcCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999 99999764321 1111112222234456778899999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhcC
Q 021507 236 CLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 236 ~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
||..||.+|||+.++++.|+++..
T Consensus 312 ~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 312 CWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HcccCcccCCCHHHHHHHHHHHHh
Confidence 999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=316.93 Aligned_cols=242 Identities=22% Similarity=0.331 Sum_probs=180.9
Q ss_pred ChhHHHhHHHHHHhh------hh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCee------EEEEecCC
Q 021507 1 MFLFNFLHSHLELHA------RS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMP 61 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~------~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~------~lv~e~~~ 61 (311)
+||+||.+.+..... .+ .....+.+.+|++++++++||||+++++++...... ++||||+.
T Consensus 35 ~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~ 114 (323)
T 3qup_A 35 EFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK 114 (323)
T ss_dssp TTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCT
T ss_pred CCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEecc
Confidence 578888776544321 11 223356789999999999999999999999877655 99999999
Q ss_pred CCChHHHhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC
Q 021507 62 KGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 137 (311)
Q Consensus 62 ~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 137 (311)
+++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 115 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~ 192 (323)
T 3qup_A 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192 (323)
T ss_dssp TCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCCEEEeecccccccccccc
Confidence 999999985432 225999999999999999999999755 99999999999999999999999999987544433
Q ss_pred cceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcc
Q 021507 138 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 216 (311)
Q Consensus 138 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (311)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... .....+...
T Consensus 193 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~~~~~~~~~ 255 (323)
T 3qup_A 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----------------EIYNYLIGG 255 (323)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTT
T ss_pred ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-----------------HHHHHHhcC
Confidence 333344567889999999999999999999999999999999 99999864421 111222222
Q ss_pred cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCCC
Q 021507 217 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 261 (311)
Q Consensus 217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~~ 261 (311)
.....+..++..+.+++.+||..||.+|||+.++++.|+++....
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 233445677889999999999999999999999999999876433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=326.04 Aligned_cols=231 Identities=22% Similarity=0.219 Sum_probs=183.9
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||+.||+|.+++.
T Consensus 23 ~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~ 102 (444)
T 3soa_A 23 AFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV 102 (444)
T ss_dssp --CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH
T ss_pred CCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH
Confidence 57888877554322 11122345678999999999999999999999999999999999999999999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC---CCCcEEEecccccccCCCCCCcceecccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
.+. .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++........ ......||
T Consensus 103 ~~~--~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt 176 (444)
T 3soa_A 103 ARE--YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGT 176 (444)
T ss_dssp HCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSC
T ss_pred HcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCC
Confidence 654 4999999999999999999999755 99999999999998 467899999999976544322 23446799
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKA 225 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 225 (311)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.... ...+.... ........+
T Consensus 177 ~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL----------------YQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------HHHHHHTCCCCCTTTTTTS
T ss_pred cccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHhCCCCCCccccccC
Confidence 999999999998999999999999999999999999976432111 11111111 111222467
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.++.+||.+||..||.+|||+.+++++
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 8899999999999999999999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=318.35 Aligned_cols=239 Identities=20% Similarity=0.319 Sum_probs=189.3
Q ss_pred ChhHHHhHHHHHHh-------------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH-------------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||.+.+.... ........+.|.+|+.++++++||||+++++++.++. .++|+||+.+|+|.+
T Consensus 27 ~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~ 105 (327)
T 3poz_A 27 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 105 (327)
T ss_dssp TTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHH
T ss_pred CCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHH
Confidence 58888887643211 1112234567999999999999999999999998754 789999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+|
T Consensus 106 ~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 182 (327)
T 3poz_A 106 YVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182 (327)
T ss_dssp HHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCC
T ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCcc
Confidence 997644 35999999999999999999999765 999999999999999999999999999876544433334445678
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+........+..++
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3poz_A 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EISSILEKGERLPQPPICT 245 (327)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTBC
T ss_pred ccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----------------HHHHHHHcCCCCCCCccCC
Confidence 89999999999999999999999999999999 99999864321 1222333333344566788
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
..+.+++.+||..||.+||++.++++.|+.+...
T Consensus 246 ~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 8999999999999999999999999999887643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=310.44 Aligned_cols=256 Identities=38% Similarity=0.609 Sum_probs=197.3
Q ss_pred ChhHHHhHHHHHHh-------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELH-------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++....
T Consensus 51 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 130 (321)
T 2qkw_B 51 VFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130 (321)
T ss_dssp SSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSC
T ss_pred CCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccC
Confidence 57778877642211 01112245678999999999999999999999999999999999999999999986543
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 74 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 74 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++................||..|+
T Consensus 131 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 208 (321)
T 2qkw_B 131 LPTMSMSWEQRLEICIGAARGLHYLHTR--AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208 (321)
T ss_dssp CCSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTC
T ss_pred CCccccCHHHHHHHHHHHHHHHHHhcCC--CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCcccc
Confidence 23589999999999999999999975 49999999999999999999999999998654333333334456899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 231 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (311)
|||++.+..++.++|||||||++|+|++|+.||.............+..... ....+...+........+..++..+.+
T Consensus 209 aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (321)
T 2qkw_B 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGD 287 (321)
T ss_dssp CHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHH
T ss_pred CHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccccHHHhcChhhccccCHHHHHHHHH
Confidence 9999999999999999999999999999999997654322221111111000 011111222233334456788999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 232 LALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
++.+||..||++|||+.++++.|+.+..
T Consensus 288 li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 288 TAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999988653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=323.66 Aligned_cols=221 Identities=26% Similarity=0.370 Sum_probs=182.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC-----CCCCHHHHHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~ 94 (311)
.....+.+|+.++++++||||+++++++.+.+..|+||||++||+|.+++..... ..+++..++.++.|++.||+
T Consensus 116 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 195 (367)
T 3l9p_A 116 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195 (367)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHH
Confidence 3445688999999999999999999999999999999999999999999976432 35899999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCCC---cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 171 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 171 (311)
|||+.+ |+||||||+|||++.++ .+||+|||+++...............+|+.|+|||++.+..++.++||||||
T Consensus 196 ~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG 273 (367)
T 3l9p_A 196 YLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273 (367)
T ss_dssp HHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHhCC--eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH
Confidence 999755 99999999999998655 4999999999753222222223345678999999999999999999999999
Q ss_pred HHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
|++|+|++ |..||..... ......+........+..++..+.+|+.+||+.||.+|||+.++
T Consensus 274 ~il~ellt~g~~pf~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ei 336 (367)
T 3l9p_A 274 VLLWEIFSLGYMPYPSKSN-----------------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 336 (367)
T ss_dssp HHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 99999998 9999986432 11222223333334566778899999999999999999999999
Q ss_pred HHHHHhhcC
Q 021507 251 LAILERLEA 259 (311)
Q Consensus 251 l~~l~~~~~ 259 (311)
++.|+.+..
T Consensus 337 l~~l~~~~~ 345 (367)
T 3l9p_A 337 LERIEYCTQ 345 (367)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhh
Confidence 999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=321.34 Aligned_cols=240 Identities=24% Similarity=0.372 Sum_probs=180.9
Q ss_pred ChhHHHhHHHHH---H---------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLE---L---------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||.+++.. . .........+.|.+|+.++++++||||+++++++.+++..|+||||+++++|.++
T Consensus 57 ~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 136 (373)
T 2qol_A 57 EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136 (373)
T ss_dssp SSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred CCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHH
Confidence 578888776531 0 0111234556799999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eecccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGT 147 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt 147 (311)
+.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......... ......++
T Consensus 137 l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 213 (373)
T 2qol_A 137 LRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213 (373)
T ss_dssp HHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----------------------
T ss_pred HHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcC
Confidence 96543 35999999999999999999999754 9999999999999999999999999998654332111 11223457
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
..|+|||++.+..++.++|||||||++|||++ |..||...... .....+........+..++
T Consensus 214 ~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~ 276 (373)
T 2qol_A 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DVIKAVDEGYRLPPPMDCP 276 (373)
T ss_dssp CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----------------HHHHHHHTTEECCCCTTCB
T ss_pred CCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCcccc
Confidence 78999999999999999999999999999998 99999764321 1122222222333455678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 8999999999999999999999999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=309.99 Aligned_cols=238 Identities=27% Similarity=0.402 Sum_probs=190.9
Q ss_pred ChhHHHhHHHHHHhhh------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELHAR------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||++.+...... ......+.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++....
T Consensus 22 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 100 (269)
T 4hcu_A 22 QFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR- 100 (269)
T ss_dssp SSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-
T ss_pred CccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-
Confidence 5777877765432110 111134568999999999999999999999999999999999999999999996543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ........++..|+|||
T Consensus 101 ~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE 177 (269)
T 4hcu_A 101 GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPE 177 (269)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHH
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHH
Confidence 35899999999999999999999755 9999999999999999999999999998653321 11223345677899999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++||||||+++|+|++ |..||...... .....+........+..++..+.+++
T Consensus 178 ~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li 240 (269)
T 4hcu_A 178 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTGFRLYKPRLASTHVYQIM 240 (269)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred HhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHhcCccCCCCCcCCHHHHHHH
Confidence 9999999999999999999999999 99999864321 11222222233344566788999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.+||+.||.+|||+.++++.|+.+..
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999999988753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=309.88 Aligned_cols=213 Identities=29% Similarity=0.552 Sum_probs=174.4
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+.+.+|++++++++||||+++++++.+.. ++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+.+
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 144 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPP 144 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 67899999999999999999999986654 79999999999999886543 4599999999999999999999964434
Q ss_pred eeecCCCCCceEeCCCCc-----EEEecccccccCCCCCCcceeccccccccccCccccc--cCCCCCCCceehhHHHHH
Q 021507 103 VIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--TGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ 175 (311)
++||||||+||+++.++. +||+|||++..... ......||+.|+|||++. +..++.++|||||||++|
T Consensus 145 ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~ 219 (287)
T 4f0f_A 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219 (287)
T ss_dssp CBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHH
T ss_pred eecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHH
Confidence 999999999999988776 99999999975332 134467899999999984 445788999999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
+|++|..||........ ...............+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus 220 ~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 220 TILTGEGPFDEYSYGKI--------------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp HHHHSSCTTTTCCCCHH--------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCCCCccccccHH--------------HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 99999999976442211 1111222233344556678899999999999999999999999999997
Q ss_pred hh
Q 021507 256 RL 257 (311)
Q Consensus 256 ~~ 257 (311)
++
T Consensus 286 ~l 287 (287)
T 4f0f_A 286 EL 287 (287)
T ss_dssp TC
T ss_pred hC
Confidence 64
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=331.81 Aligned_cols=238 Identities=22% Similarity=0.352 Sum_probs=196.0
Q ss_pred ChhHHHhHHHHHHhh---h----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHA---R----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+.+..... . ......+.|.+|+++|++++||||+++++++.+.+..|+||||+.+|+|.+++....
T Consensus 232 ~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~ 311 (495)
T 1opk_A 232 QYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 311 (495)
T ss_dssp TTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC
T ss_pred CCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcC
Confidence 578888776554221 0 011135679999999999999999999999999999999999999999999998766
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ........++..|+||
T Consensus 312 ~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aP 388 (495)
T 1opk_A 312 RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAP 388 (495)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCH
Confidence 667999999999999999999999755 9999999999999999999999999998754322 1222334567889999
Q ss_pred cccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHH
Q 021507 154 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 232 (311)
Q Consensus 154 E~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 232 (311)
|++.+..++.++|||||||++|||++ |..||.+.... .....+........+..++..+.+|
T Consensus 389 E~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred hHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 99999999999999999999999999 99999865421 1223333344445667788999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 233 ALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 233 i~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|.+||+.||.+|||+.++++.|+.+.
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999998864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=314.07 Aligned_cols=232 Identities=19% Similarity=0.182 Sum_probs=184.5
Q ss_pred ChhHHHhHHHHHHhh---h----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHA---R----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+.+..... . ......+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++|.+++....
T Consensus 17 ~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~ 96 (321)
T 1tki_A 17 EFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA 96 (321)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS
T ss_pred CCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC
Confidence 578888776543220 0 112234568899999999999999999999999999999999999999999996543
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC--CCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
..+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++....... ......||+.|+
T Consensus 97 -~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~ 170 (321)
T 1tki_A 97 -FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYY 170 (321)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGS
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhc
Confidence 35999999999999999999999754 999999999999987 7899999999998754332 234467899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC--CCchHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTA 229 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 229 (311)
|||++.+..++.++|||||||++|+|++|..||........ ...+....... .....++.++
T Consensus 171 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------------IENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH----------------HHHHHcCCCCCChhhhccCCHHH
Confidence 99999988899999999999999999999999976542111 11111111100 0112467889
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.+|+.+||..||.+|||+.+++++-
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCh
Confidence 9999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=317.68 Aligned_cols=239 Identities=20% Similarity=0.313 Sum_probs=186.1
Q ss_pred ChhHHHhHHHHHHhh-------------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELHA-------------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||++.+..... .......+.+.+|+.++++++||||+++++++..+. .++|+||+.+|+|.+
T Consensus 27 ~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~ 105 (327)
T 3lzb_A 27 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 105 (327)
T ss_dssp SSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHH
T ss_pred CCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHH
Confidence 578888776533221 111224567899999999999999999999998764 789999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++................+|
T Consensus 106 ~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t 182 (327)
T 3lzb_A 106 YVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182 (327)
T ss_dssp HHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----------------CCC
T ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCcc
Confidence 997644 34999999999999999999999765 999999999999999999999999999876444333333445678
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+........+..++
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3lzb_A 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EISSILEKGERLPQPPICT 245 (327)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTBC
T ss_pred ccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCccCC
Confidence 89999999999999999999999999999999 99999864321 1222333333444566788
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
.++.+++.+||..||.+||++.++++.|+.+...
T Consensus 246 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 246 IDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 8999999999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=316.98 Aligned_cols=211 Identities=27% Similarity=0.303 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
.+.+.+|+.+++.++||||+++++++.+++..|+||||++|++|.+++... ....+++..++.++.|++.||+|||+.
T Consensus 70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 149 (351)
T 3c0i_A 70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149 (351)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 567899999999999999999999999999999999999999999888543 234589999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCc---EEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+ |+||||||+||+++.++. +||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+
T Consensus 150 ~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 225 (351)
T 3c0i_A 150 N--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225 (351)
T ss_dssp T--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred C--ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHH
Confidence 4 999999999999987655 99999999987544321 2344679999999999999999999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC--CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|++|..||.+...... ..+........ ....++.++.+||.+||..||.+|||+.+++++
T Consensus 226 ll~g~~pf~~~~~~~~-----------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 226 LLSGCLPFYGTKERLF-----------------EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHSSCSSCSSHHHHH-----------------HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHCCCCCCCcHHHHH-----------------HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999986432110 01111111000 012467889999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=317.71 Aligned_cols=229 Identities=27% Similarity=0.324 Sum_probs=181.5
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... + .......+.+.+|.++++.+ +||||+++++++.+.+..|+||||+.||+|.++
T Consensus 35 ~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 114 (353)
T 3txo_A 35 SFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFH 114 (353)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred CCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 57888887655421 1 11222345678899999998 799999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++...... ......+||+
T Consensus 115 l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~ 188 (353)
T 3txo_A 115 IQKSR--RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTP 188 (353)
T ss_dssp HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCG
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCc
Confidence 97654 3999999999999999999999755 9999999999999999999999999997533222 2244568999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+... ....+..++..
T Consensus 189 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~ 250 (353)
T 3txo_A 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----------------LFEAILND--EVVYPTWLHED 250 (353)
T ss_dssp GGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC--CCCCCTTSCHH
T ss_pred CeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHH
Confidence 9999999999999999999999999999999999998654211 11112221 12345667889
Q ss_pred HHHHHHhcccCCCCCCCCH------HHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRM------SEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~------~~~l~~ 253 (311)
+.+||.+||..||.+||++ ++++++
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 9999999999999999998 777754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=310.47 Aligned_cols=226 Identities=24% Similarity=0.339 Sum_probs=184.6
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... + .......+.+.+|+.+++.++||||+++++++.+.+..|+||||++||+|.+++
T Consensus 18 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l 97 (318)
T 1fot_A 18 SFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL 97 (318)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHH
Confidence 57788876654321 0 111123456788999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.+|.+||+|||++...... .....||+.
T Consensus 98 ~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~ 168 (318)
T 1fot_A 98 RKSQ--RFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPD 168 (318)
T ss_dssp HHTS--SCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTT
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCcc
Confidence 7654 489999999999999999999965 5999999999999999999999999999864332 334679999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|+|||||++|+|++|..||...+.. .....++... ...+..++.++
T Consensus 169 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~~~~--~~~p~~~~~~~ 230 (318)
T 1fot_A 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEKILNAE--LRFPPFFNEDV 230 (318)
T ss_dssp TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHCC--CCCCTTSCHHH
T ss_pred ccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCC--CCCCCCCCHHH
Confidence 99999999999999999999999999999999999764321 1111222221 23456778899
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.++|.+||..||.+|| ++++++++
T Consensus 231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 9999999999999999 88998864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=308.82 Aligned_cols=238 Identities=23% Similarity=0.362 Sum_probs=196.2
Q ss_pred ChhHHHhHHHHHHhh-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHA-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+.+..... .......+.+.+|++++++++||||+++++++.+++..|+||||+.|++|.+++....
T Consensus 25 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 104 (288)
T 3kfa_A 25 QYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 104 (288)
T ss_dssp TTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCC
T ss_pred CceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcc
Confidence 577888776654321 1111234678899999999999999999999999999999999999999999998766
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....... ........++..|+||
T Consensus 105 ~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aP 181 (288)
T 3kfa_A 105 RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAP 181 (288)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCH
T ss_pred cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCCh
Confidence 677999999999999999999999765 9999999999999999999999999998764332 2233445678899999
Q ss_pred cccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHH
Q 021507 154 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 232 (311)
Q Consensus 154 E~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 232 (311)
|++.+..++.++||||||+++|+|++ |..||...... .....+........+..++..+.++
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~l 244 (288)
T 3kfa_A 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEKDYRMERPEGCPEKVYEL 244 (288)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhccCCCCCCCCCCHHHHHH
Confidence 99999999999999999999999999 99999764321 1222233333445566788899999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 233 ALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 233 i~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
+.+||..||.+|||+.++++.|+.+.
T Consensus 245 i~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 245 MRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=316.60 Aligned_cols=230 Identities=22% Similarity=0.256 Sum_probs=182.8
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||+.|++|.+++.
T Consensus 41 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 120 (362)
T 2bdw_A 41 AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120 (362)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT
T ss_pred CCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 57778877654321 01112334668899999999999999999999999999999999999999999986
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC---cEEEecccccccCCCCCCcceecccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++........ .....||
T Consensus 121 ~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt 193 (362)
T 2bdw_A 121 ARE--FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193 (362)
T ss_dssp TCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSC
T ss_pred HcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCC
Confidence 543 4899999999999999999999755 99999999999997654 599999999986543321 2346799
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc--CCCCchHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKA 225 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 225 (311)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.... ...+..... .......+
T Consensus 194 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----------------YAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp TTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHTCCCCCTTGGGGS
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHhCCCCCCcccccCC
Confidence 999999999998999999999999999999999999976432111 011111111 11122457
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.++.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 8899999999999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=306.18 Aligned_cols=220 Identities=29% Similarity=0.414 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC----------------------CCC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------------------QPL 77 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~ 77 (311)
...+.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++..... ..+
T Consensus 68 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (314)
T 2ivs_A 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147 (314)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEE
T ss_pred HHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCc
Confidence 3456789999999999999999999999999999999999999999999976432 348
Q ss_pred CHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc
Q 021507 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 157 (311)
Q Consensus 78 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 157 (311)
++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++................++..|+|||++.
T Consensus 148 ~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 148 TMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC--CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 99999999999999999999755 9999999999999999999999999998664443333334456788999999999
Q ss_pred cCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhc
Q 021507 158 TGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 236 (311)
Q Consensus 158 ~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 236 (311)
+..++.++|||||||++|+|++ |..||.+.... .....+........+..++..+.+++.+|
T Consensus 226 ~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 288 (314)
T 2ivs_A 226 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE-----------------RLFNLLKTGHRMERPDNCSEEMYRLMLQC 288 (314)
T ss_dssp HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHhhcCCcCCCCccCCHHHHHHHHHH
Confidence 9899999999999999999999 99999764321 12222233333445667888999999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhhc
Q 021507 237 LNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 237 l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||.+|||+.++++.|+++.
T Consensus 289 l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 289 WKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999998864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=315.99 Aligned_cols=230 Identities=23% Similarity=0.290 Sum_probs=183.7
Q ss_pred ChhHHHhHHHHHHh---hh--------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---AR--------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... +. ......+.+.+|+++|+.++||||+++++++.+.+..|+||||+.||+|.+++
T Consensus 27 ~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l 106 (384)
T 4fr4_A 27 SFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL 106 (384)
T ss_dssp TTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHH
Confidence 57888877654422 11 11123456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||++....... ......||+.
T Consensus 107 ~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~ 179 (384)
T 4fr4_A 107 QQNV--HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKP 179 (384)
T ss_dssp HTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGG
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCcc
Confidence 6543 4999999999999999999999755 9999999999999999999999999998654322 2345679999
Q ss_pred ccCcccccc---CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 150 YAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 150 y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|+|||++.+ ..++.++|||||||++|+|++|..||.......... ...... ......+..++
T Consensus 180 Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~--------------~~~~~~-~~~~~~p~~~s 244 (384)
T 4fr4_A 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE--------------IVHTFE-TTVVTYPSAWS 244 (384)
T ss_dssp GCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH--------------HHHHHH-HCCCCCCTTSC
T ss_pred ccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH--------------HHHHHh-hcccCCCCcCC
Confidence 999999864 458899999999999999999999997543211111 111111 12234566788
Q ss_pred HHHHHHHHhcccCCCCCCCC-HHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPR-MSEVLA 252 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt-~~~~l~ 252 (311)
..+.+||.+||..||.+||+ ++++++
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 99999999999999999998 777765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=317.73 Aligned_cols=221 Identities=27% Similarity=0.400 Sum_probs=183.6
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC------------CCCCCHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------PQPLSWAVRMKVA 86 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~ 86 (311)
...+.+.+|+++++++ +||||+++++++.+++..|+||||+++|+|.+++.... ...+++..++.++
T Consensus 91 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (333)
T 2i1m_A 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170 (333)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence 3456789999999999 89999999999999999999999999999999996532 2358999999999
Q ss_pred HHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCc
Q 021507 87 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 166 (311)
Q Consensus 87 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 166 (311)
.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|
T Consensus 171 ~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 248 (333)
T 2i1m_A 171 SQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248 (333)
T ss_dssp HHHHHHHHHHHHTT--EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhcCC--cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHH
Confidence 99999999999754 9999999999999999999999999998654433333344556788999999999999999999
Q ss_pred eehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC
Q 021507 167 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245 (311)
Q Consensus 167 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (311)
||||||++|+|++ |..||.+.... ......+........+..++..+.+++.+||+.||.+||
T Consensus 249 i~slG~il~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 312 (333)
T 2i1m_A 249 VWSYGILLWEIFSLGLNPYPGILVN----------------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP 312 (333)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCSS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHcCCCCCCcccchh----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCc
Confidence 9999999999998 99999764321 111222222333344556788999999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021507 246 RMSEVLAILERLE 258 (311)
Q Consensus 246 t~~~~l~~l~~~~ 258 (311)
|+.++++.|+.+.
T Consensus 313 s~~~l~~~L~~~~ 325 (333)
T 2i1m_A 313 TFQQICSFLQEQA 325 (333)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=319.26 Aligned_cols=238 Identities=26% Similarity=0.363 Sum_probs=183.7
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +.+ .....+.+.+|..++.++ +||||+++++++.+.+..|+||||+.||+|.++
T Consensus 64 ~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 143 (396)
T 4dc2_A 64 SYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143 (396)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHH
Confidence 57888887655432 111 112234578899999887 899999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++...... ......+||+
T Consensus 144 l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~ 217 (396)
T 4dc2_A 144 MQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTP 217 (396)
T ss_dssp HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCG
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCc
Confidence 97654 4999999999999999999999755 9999999999999999999999999997532222 2244578999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|+|||||++|+|++|..||......... .......+...+. ......+..++.+
T Consensus 218 ~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~--------~~~~~~~~~~~i~-~~~~~~p~~~s~~ 288 (396)
T 4dc2_A 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVIL-EKQIRIPRSLSVK 288 (396)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHHH-HCCCCCCTTSCHH
T ss_pred ccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc--------chhhHHHHHHHHh-ccccCCCCcCCHH
Confidence 999999999999999999999999999999999999753221100 0001111111111 1223456778899
Q ss_pred HHHHHHhcccCCCCCCCCH------HHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRM------SEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~------~~~l~~ 253 (311)
+.+||.+||+.||.+||++ .+++++
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 9999999999999999985 566653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=313.72 Aligned_cols=226 Identities=23% Similarity=0.256 Sum_probs=185.0
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... ........+.+.+|+++++.++||||+++++++.+.+..|+||||++||+|.+++
T Consensus 53 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l 132 (350)
T 1rdq_E 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132 (350)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred cCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHH
Confidence 57788877654321 0111123456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||+++..... .....||+.
T Consensus 133 ~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~ 203 (350)
T 1rdq_E 133 RRIG--RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPE 203 (350)
T ss_dssp HHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGG
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCcc
Confidence 7654 3999999999999999999999755 999999999999999999999999999865332 234579999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||...+... ....+... ....+..++.++
T Consensus 204 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~~ 265 (350)
T 1rdq_E 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----------------IYEKIVSG--KVRFPSHFSSDL 265 (350)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC--CCCCCTTCCHHH
T ss_pred ccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHHH
Confidence 999999999999999999999999999999999997643211 11111111 123456788899
Q ss_pred HHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
.++|.+||..||.+||+ +++++++
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 99999999999999998 8888764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=313.32 Aligned_cols=221 Identities=24% Similarity=0.408 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC--------------CCCCHHHHHH
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMK 84 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~ 84 (311)
...+.+.+|+++++++ +||||+++++++.+.+..|+||||+++++|.+++..... ..+++..++.
T Consensus 82 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (334)
T 2pvf_A 82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161 (334)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHH
Confidence 3456789999999999 899999999999999999999999999999999965432 2489999999
Q ss_pred HHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCC
Q 021507 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 164 (311)
Q Consensus 85 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 164 (311)
++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++................++..|+|||++.+..++.+
T Consensus 162 i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 239 (334)
T 2pvf_A 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239 (334)
T ss_dssp HHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHHhCC--eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH
Confidence 9999999999999754 99999999999999999999999999987654433323334567889999999999889999
Q ss_pred CceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 165 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 165 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
+||||||+++|+|++ |..||.+.... .....+........+..++..+.+++.+||..||.+
T Consensus 240 ~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 302 (334)
T 2pvf_A 240 SDVWSFGVLMWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQ 302 (334)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHHHHHhCCCCCcCcCCHH-----------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 999999999999999 99999764321 112222222233455677889999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 021507 244 RPRMSEVLAILERLEA 259 (311)
Q Consensus 244 Rpt~~~~l~~l~~~~~ 259 (311)
|||+.++++.|+++..
T Consensus 303 Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 303 RPTFKQLVEDLDRILT 318 (334)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999988753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=306.93 Aligned_cols=257 Identities=20% Similarity=0.229 Sum_probs=189.5
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC--eeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++...+ ..|+||||++|++|.+++
T Consensus 21 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 100 (319)
T 4euu_A 21 ATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL 100 (319)
T ss_dssp SSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHH
T ss_pred CCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHH
Confidence 57888877665421 1122234567889999999999999999999998765 779999999999999999
Q ss_pred hhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe----CCCCcEEEecccccccCCCCCCcceeccc
Q 021507 70 FRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 70 ~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
..... ..+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....... ....
T Consensus 101 ~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~ 175 (319)
T 4euu_A 101 EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSL 175 (319)
T ss_dssp HSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCC
T ss_pred HHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeec
Confidence 65432 34999999999999999999999755 9999999999999 7788899999999987544322 2345
Q ss_pred cccccccCccccc--------cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhh--hhhhhc--ccc--ccc----h
Q 021507 145 MGTHGYAAPEYVA--------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWA--KPY--LSD----K 206 (311)
Q Consensus 145 ~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~--~~~--~~~----~ 206 (311)
.||..|+|||++. +..++.++|||||||++|+|++|..||......... ...... .+. ... .
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 255 (319)
T 4euu_A 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE 255 (319)
T ss_dssp CSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECST
T ss_pred ccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhccc
Confidence 7899999999986 467899999999999999999999999754321110 000000 000 000 0
Q ss_pred hhhh-HhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCCCC
Q 021507 207 RKLF-RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 262 (311)
Q Consensus 207 ~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~~~ 262 (311)
.... -.-...........++..+.+++.+||+.||++|||++|++++......+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~ 312 (319)
T 4euu_A 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312 (319)
T ss_dssp TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC---
T ss_pred CCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCC
Confidence 0000 0000111223456889999999999999999999999999999987654443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=318.53 Aligned_cols=251 Identities=19% Similarity=0.218 Sum_probs=183.4
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++++.... ........+.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++.
T Consensus 39 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 118 (389)
T 3gni_B 39 DLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118 (389)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred CceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHh
Confidence 47778877765321 11123456778899999999999999999999999999999999999999999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCC-----Ccceecccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-----RTHVSTQVM 145 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~ 145 (311)
......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+....... .........
T Consensus 119 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 196 (389)
T 3gni_B 119 THFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196 (389)
T ss_dssp HTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCT
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccc
Confidence 765566999999999999999999999755 9999999999999999999999999886432211 111123347
Q ss_pred ccccccCcccccc--CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhhccccccch-----h----------
Q 021507 146 GTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLSDK-----R---------- 207 (311)
Q Consensus 146 gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~-----~---------- 207 (311)
||..|+|||++.+ ..++.++|||||||++|+|++|..||.+......... .....+..... .
T Consensus 197 gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (389)
T 3gni_B 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV 276 (389)
T ss_dssp TTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------
T ss_pred ccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccc
Confidence 8999999999987 5789999999999999999999999976543221110 00000000000 0
Q ss_pred ---hhhHh---------hhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 208 ---KLFRI---------MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 208 ---~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..... .........+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 00000112344567889999999999999999999999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=322.31 Aligned_cols=238 Identities=21% Similarity=0.223 Sum_probs=177.6
Q ss_pred ChhHHHhHHHHHHh---hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEe----CCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... +.+.......+.+|++++.++ +||||+++++++.. .+..|+||||++||+|.+++...
T Consensus 74 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 153 (400)
T 1nxk_A 74 INGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 153 (400)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC
T ss_pred cCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh
Confidence 58888888765432 222222334578899987554 89999999999875 56789999999999999999776
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCcceecccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...... .....+||+.
T Consensus 154 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~ 228 (400)
T 1nxk_A 154 GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228 (400)
T ss_dssp ---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CT
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCC
Confidence 5566999999999999999999999754 999999999999987 7889999999998653322 1335678999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAH 227 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 227 (311)
|+|||++.+..++.++|||||||++|+|++|..||......... ......+.... ........++.
T Consensus 229 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------~~~~~~i~~~~~~~~~~~~~~~s~ 296 (400)
T 1nxk_A 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQYEFPNPEWSEVSE 296 (400)
T ss_dssp TCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC------------CSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc------------HHHHHHHHcCcccCCCcccccCCH
Confidence 99999999999999999999999999999999999765421100 00001111111 11112245788
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
++.+||.+||..||.+|||+.+++++..
T Consensus 297 ~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 297 EVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 9999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.30 Aligned_cols=223 Identities=26% Similarity=0.370 Sum_probs=184.8
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC---------------------CCC
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------------------QPL 77 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~ 77 (311)
...+.+.+|+.+++++ +||||+++++++...+..|+||||+++|+|.+++..... ..+
T Consensus 90 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 169 (344)
T 1rjb_A 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169 (344)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccC
Confidence 3456789999999999 999999999999999999999999999999999965432 237
Q ss_pred CHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc
Q 021507 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 157 (311)
Q Consensus 78 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 157 (311)
++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++................+|+.|+|||++.
T Consensus 170 ~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 247 (344)
T 1rjb_A 170 TFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247 (344)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence 99999999999999999999754 9999999999999999999999999998654444333445566788999999999
Q ss_pred cCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhc
Q 021507 158 TGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 236 (311)
Q Consensus 158 ~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 236 (311)
+..++.++|||||||++|+|++ |..||...... ......+........+..++..+.+++.+|
T Consensus 248 ~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 311 (344)
T 1rjb_A 248 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSC 311 (344)
T ss_dssp HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999999999998 99999765321 112222233333445566788999999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 237 LNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 237 l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
|..||.+|||+.++++.|+.+...
T Consensus 312 l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 312 WAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCCchhCcCHHHHHHHHHHHHHH
Confidence 999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=313.93 Aligned_cols=228 Identities=23% Similarity=0.328 Sum_probs=183.6
Q ss_pred ChhHHHhHHHHHHhhh-----------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELHAR-----------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+...... ......+.+.+|+.+++.++||||+++++++.+.+..|+||||+ +|+|.+++
T Consensus 21 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l 99 (336)
T 3h4j_B 21 SFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI 99 (336)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHH
Confidence 5788888876443211 11122346889999999999999999999999999999999999 67999988
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ......||+.
T Consensus 100 ~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~ 172 (336)
T 3h4j_B 100 VEKK--RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPN 172 (336)
T ss_dssp HHHC--SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTT
T ss_pred HHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcC
Confidence 6654 3999999999999999999999765 9999999999999999999999999998654332 1334579999
Q ss_pred ccCccccccCCC-CCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 150 YAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 150 y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
|+|||++.+..+ +.++|||||||++|+|++|..||......... ..+ .......+..++..
T Consensus 173 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------~~i-~~~~~~~p~~~s~~ 234 (336)
T 3h4j_B 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------KKV-NSCVYVMPDFLSPG 234 (336)
T ss_dssp TSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------CCC-CSSCCCCCTTSCHH
T ss_pred cCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------HHH-HcCCCCCcccCCHH
Confidence 999999988776 67999999999999999999999864321110 000 01112345567889
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+.+||.+||..||.+|||+.+++++-
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 99999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=312.73 Aligned_cols=222 Identities=24% Similarity=0.378 Sum_probs=182.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------CCCCCHHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------PQPLSWAVRMKVAIGAAK 91 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~i~~ 91 (311)
...+.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++.... ...+++..++.++.|++.
T Consensus 70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 149 (322)
T 1p4o_A 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149 (322)
T ss_dssp HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence 345568999999999999999999999999999999999999999999986532 134799999999999999
Q ss_pred HHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhH
Q 021507 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 171 (311)
Q Consensus 92 ~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 171 (311)
||+|||+.+ |+||||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||
T Consensus 150 ~l~~lH~~~--i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 227 (322)
T 1p4o_A 150 GMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 227 (322)
T ss_dssp HHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHHCC--CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHH
Confidence 999999754 999999999999999999999999999764333222223345678899999999999999999999999
Q ss_pred HHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
+++|+|++ |..||...... .....+........+..++..+.+++.+||..||.+|||+.++
T Consensus 228 ~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~ 290 (322)
T 1p4o_A 228 VVLWEIATLAEQPYQGLSNE-----------------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290 (322)
T ss_dssp HHHHHHHHTSCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhcCCCccccCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 99999999 89999764321 1111111222223456778899999999999999999999999
Q ss_pred HHHHHhhcCC
Q 021507 251 LAILERLEAP 260 (311)
Q Consensus 251 l~~l~~~~~~ 260 (311)
++.|++...+
T Consensus 291 l~~L~~~~~~ 300 (322)
T 1p4o_A 291 ISSIKEEMEP 300 (322)
T ss_dssp HHHHGGGSCT
T ss_pred HHHHHHhhcc
Confidence 9999887543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=311.19 Aligned_cols=238 Identities=26% Similarity=0.368 Sum_probs=184.5
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... ........+.+.+|..+++++ +||||+++++++.+.+..|+||||+.||+|.++
T Consensus 21 ~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~ 100 (345)
T 3a8x_A 21 SYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 100 (345)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 57888877654321 111223455688999999988 899999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.+.. .+++..++.++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||+++...... ......+||+
T Consensus 101 l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~ 174 (345)
T 3a8x_A 101 MQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTP 174 (345)
T ss_dssp HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCG
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCc
Confidence 97654 4999999999999999999999755 9999999999999999999999999998533222 1244568999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|+|||||++|+|++|..||........ +.......+...+.. .....+..++.+
T Consensus 175 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------~~~~~~~~~~~~i~~-~~~~~p~~~s~~ 245 (345)
T 3a8x_A 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--------PDQNTEDYLFQVILE-KQIRIPRSLSVK 245 (345)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHHH-CCCCCCTTSCHH
T ss_pred cccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccc--------cccccHHHHHHHHHc-CCCCCCCCCCHH
Confidence 99999999999999999999999999999999999975321100 000011111111111 123456678899
Q ss_pred HHHHHHhcccCCCCCCCCH------HHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRM------SEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~------~~~l~~ 253 (311)
+.+||.+||..||.+||++ .+++++
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 9999999999999999986 566653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=315.87 Aligned_cols=231 Identities=22% Similarity=0.266 Sum_probs=183.7
Q ss_pred ChhHHHhHHHHHHhh--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELHA--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||.+.+..... .........+.+|+++|++++||||+++++++.+.+..|+||||+.|++|.+++...
T Consensus 63 ~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 142 (387)
T 1kob_A 63 AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 142 (387)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT
T ss_pred CCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhh
Confidence 577888776543220 111123456889999999999999999999999999999999999999999998654
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC--CCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++........ .....||+.|
T Consensus 143 ~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y 216 (387)
T 1kob_A 143 D-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEF 216 (387)
T ss_dssp T-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGG
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCc
Confidence 3 35999999999999999999999755 999999999999974 46799999999987543321 3345789999
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc--ccCCCCchHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHT 228 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 228 (311)
+|||++.+..++.++|||||||++|+|++|..||.+.+..... ..+... .........++.+
T Consensus 217 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----------------QNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----------------HHHHHCCCCCCSSTTTTSCHH
T ss_pred cCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhCCCCCCccccccCCHH
Confidence 9999999999999999999999999999999999865421110 111111 1112233467889
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||.+||..||.+|||+.+++++
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhC
Confidence 9999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=310.44 Aligned_cols=209 Identities=25% Similarity=0.367 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
.+.+.+|++++++++||||+++++++.+ ++..|+||||+++++|.+++.. ..+++..++.++.|++.||+|||+.
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3568899999999999999999999986 5688999999999999886532 3599999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC---CCCCCceehhHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLE 176 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~ 176 (311)
+ |+||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 157 ~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 157 K--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp T--EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred C--eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 5 99999999999999999999999999986543321 234567999999999997765 3678999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|++|..||......... ..+............++..+.++|.+||..||++|||+.+++++
T Consensus 233 l~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 233 FVFGQCPFMDERIMCLH----------------SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHSSCSSCCSSHHHHH----------------HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHCCCCCCCccHHHHH----------------HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999999764321100 01111111112234577889999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=311.64 Aligned_cols=220 Identities=28% Similarity=0.392 Sum_probs=182.8
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCe-eEEEEecCCCCChHHHhhhcCC------------------------
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFRRGP------------------------ 74 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~------------------------ 74 (311)
..+.+.+|++++.++ +||||+++++++.+.+. .++||||+.||+|.+++.....
T Consensus 68 ~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (359)
T 3vhe_A 68 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147 (359)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------
T ss_pred HHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccch
Confidence 456789999999999 78999999999987654 8999999999999999965432
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceE
Q 021507 75 ----------------------------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 114 (311)
Q Consensus 75 ----------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil 114 (311)
..+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIl 225 (359)
T 3vhe_A 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNIL 225 (359)
T ss_dssp ------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred hhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEE
Confidence 12899999999999999999999755 999999999999
Q ss_pred eCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhh
Q 021507 115 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 193 (311)
Q Consensus 115 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 193 (311)
++.++.+||+|||++................||..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 226 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 302 (359)
T 3vhe_A 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 302 (359)
T ss_dssp ECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---
T ss_pred EcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---
Confidence 99999999999999987654444444455678999999999999999999999999999999998 99999764421
Q ss_pred hhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 194 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
......+........+..++.++.+++.+||..||.+|||+.+++++|+.+.
T Consensus 303 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 303 -------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1122222333334456667889999999999999999999999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=303.32 Aligned_cols=221 Identities=28% Similarity=0.420 Sum_probs=186.1
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC----------------CCCCHHHH
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------------QPLSWAVR 82 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~ 82 (311)
...+.+.+|+.+++++ +||||+++++++.+++..++||||+++|+|.+++..... ..+++..+
T Consensus 68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (313)
T 1t46_A 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (313)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence 3457799999999999 999999999999999999999999999999999976542 24899999
Q ss_pred HHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCC
Q 021507 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 162 (311)
Q Consensus 83 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 162 (311)
+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++................++..|+|||++.+..++
T Consensus 148 ~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 225 (313)
T 1t46_A 148 LSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (313)
T ss_dssp HHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHCC--eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC
Confidence 999999999999999754 999999999999999999999999999876555443334455678899999999999999
Q ss_pred CCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCC
Q 021507 163 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 163 ~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 241 (311)
.++||||||+++|+|++ |..||...... ......+........+..++..+.+++.+||..||
T Consensus 226 ~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 289 (313)
T 1t46_A 226 FESDVWSYGIFLWELFSLGSSPYPGMPVD----------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCSS----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCcccch----------------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCc
Confidence 99999999999999999 99999765421 11122222223334456678899999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 021507 242 KLRPRMSEVLAILERLE 258 (311)
Q Consensus 242 ~~Rpt~~~~l~~l~~~~ 258 (311)
.+|||+.++++.|+++.
T Consensus 290 ~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 290 LKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=306.60 Aligned_cols=247 Identities=21% Similarity=0.242 Sum_probs=180.1
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||+.+ +|.+++..
T Consensus 33 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 111 (311)
T 3niz_A 33 TYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE 111 (311)
T ss_dssp SSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT
T ss_pred CCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh
Confidence 57888887653211 011222346788999999999999999999999999999999999985 88888865
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ......+|+.|+
T Consensus 112 ~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~ 186 (311)
T 3niz_A 112 NK-TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYR 186 (311)
T ss_dssp CT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTC
T ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcC
Confidence 43 45999999999999999999999754 99999999999999999999999999987543222 233457899999
Q ss_pred Ccccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-h-hccccccchh---hhhHhhhccc--CC----
Q 021507 152 APEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-D-WAKPYLSDKR---KLFRIMDTKL--GG---- 219 (311)
Q Consensus 152 aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~-~~~~~~~~~~---~~~~~~~~~~--~~---- 219 (311)
|||++.+ ..++.++|||||||++|+|++|..||.+.......... . ...+...... .......... ..
T Consensus 187 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (311)
T 3niz_A 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPW 266 (311)
T ss_dssp CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCH
T ss_pred CHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcH
Confidence 9999876 46899999999999999999999999865443221111 0 0000000000 0000000000 00
Q ss_pred -CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 220 -QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.....++.++.+||.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 267 SSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0112456789999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=308.90 Aligned_cols=209 Identities=25% Similarity=0.331 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.+|++++||||+++++++.+.+..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||+.+
T Consensus 59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g- 135 (361)
T 2yab_A 59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK- 135 (361)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678999999999999999999999999999999999999999999996543 4999999999999999999999754
Q ss_pred CeeecCCCCCceEeCCCC----cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
|+||||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 136 -ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~l 211 (361)
T 2yab_A 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (361)
T ss_dssp -EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHH
Confidence 99999999999998877 79999999998754432 13346799999999999998999999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc--CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||.+.+..... ..+..... .......++..+.+||.+||..||.+|||+.+++++
T Consensus 212 l~g~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 212 LSGASPFLGDTKQETL----------------ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHSCCSSCCSSHHHHH----------------HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCCCCCCCCCHHHHH----------------HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999765421111 11111111 001123467889999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=306.28 Aligned_cols=238 Identities=25% Similarity=0.386 Sum_probs=174.9
Q ss_pred ChhHHHhHHHHHHhh-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHA-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+++.+.-+ .......+.|.+|++++++++||||++++++. .....++||||+.+++|.+++....
T Consensus 36 ~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~ 114 (289)
T 3og7_A 36 SFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE 114 (289)
T ss_dssp SSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-
T ss_pred CCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc
Confidence 577777665432111 11233456789999999999999999999965 5567899999999999999985443
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++................||..|+||
T Consensus 115 -~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (289)
T 3og7_A 115 -TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191 (289)
T ss_dssp ---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCH
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCc
Confidence 45999999999999999999999755 999999999999999999999999999765433323233456789999999
Q ss_pred cccc---cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc----cCCCCchHHH
Q 021507 154 EYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----LGGQYPQKAA 226 (311)
Q Consensus 154 E~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 226 (311)
|++. +..++.++||||||+++|+|++|..||....... .....+... ........++
T Consensus 192 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~ 255 (289)
T 3og7_A 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----------------QIIEMVGRGSLSPDLSKVRSNCP 255 (289)
T ss_dssp HHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----------------HHHHHHHHTSCCCCTTSSCTTSC
T ss_pred hhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----------------HHHHHhcccccCcchhhccccCC
Confidence 9986 5678889999999999999999999997643211 111111111 1112334678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
..+.+++.+||..||.+|||+.++++.|+++.
T Consensus 256 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 256 KRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 89999999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=304.97 Aligned_cols=234 Identities=43% Similarity=0.748 Sum_probs=185.7
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhC-C
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDA-E 100 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~ 100 (311)
.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. .
T Consensus 73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 152 (326)
T 3uim_A 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152 (326)
T ss_dssp HHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 58899999999999999999999999999999999999999999996543 23599999999999999999999975 1
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
.+|+||||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 153 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp SCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred CCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence 1599999999999999999999999999987543322 224445699999999999999999999999999999999999
Q ss_pred CCccCCCccch--hhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 181 RCAVDKTKVGI--EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 181 ~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
..||+...... ......+..... .................+...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 232 QRAFDLARLANDDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CCSBCHHHHTTTSCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred CCcccccccccccchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 99996422111 011111111111 111122222333344566788899999999999999999999999999998754
Q ss_pred C
Q 021507 259 A 259 (311)
Q Consensus 259 ~ 259 (311)
.
T Consensus 311 ~ 311 (326)
T 3uim_A 311 L 311 (326)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=307.74 Aligned_cols=217 Identities=24% Similarity=0.427 Sum_probs=178.5
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+.+.+|+.++++++||||+++++++. ++..++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||+.+
T Consensus 60 ~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-- 135 (325)
T 3kex_A 60 QAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG-- 135 (325)
T ss_dssp CSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 45778999999999999999999886 456899999999999999996542 34889999999999999999999765
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~ 181 (311)
|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 136 ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 215 (325)
T 3kex_A 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215 (325)
T ss_dssp CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCC
Confidence 99999999999999999999999999987655444433455678889999999999999999999999999999999 99
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
.||....... ....+........+..++.++.+++.+||..||.+|||+.++++.|+.+...
T Consensus 216 ~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 216 EPYAGLRLAE-----------------VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CTTTTSCTTH-----------------HHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCccccCHHH-----------------HHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9998654221 1122222223344556777889999999999999999999999999988653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=295.47 Aligned_cols=238 Identities=25% Similarity=0.358 Sum_probs=189.9
Q ss_pred ChhHHHhHHHHHHh--h----hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH--A----RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||++++.... + .......+.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++....
T Consensus 20 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 98 (268)
T 3sxs_A 20 QFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG- 98 (268)
T ss_dssp TTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG-
T ss_pred CCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC-
Confidence 57777776443211 0 0011134568999999999999999999999999999999999999999999996543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .......++..|+|||
T Consensus 99 ~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE 175 (268)
T 3sxs_A 99 KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPE 175 (268)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHH
Confidence 34999999999999999999999755 99999999999999999999999999986544322 1233345677899999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++||||||+++|+|++ |..||....... ....+........+..++..+.+++
T Consensus 176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----------------VVLKVSQGHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp HHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----------------HHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred HHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----------------HHHHHHcCCCCCCCCcChHHHHHHH
Confidence 9999899999999999999999999 999997644211 1111222222334556678899999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.+||+.||.+|||+.++++.|+.+..
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 99999999999999999999988754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=310.49 Aligned_cols=229 Identities=24% Similarity=0.318 Sum_probs=184.4
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +.+ .....+.+.+|..++..+ +||||+++++++.+.+..|+||||++||+|.++
T Consensus 32 ~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 111 (353)
T 2i0e_A 32 SFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 111 (353)
T ss_dssp TTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence 57888877665421 111 112345678899999998 899999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.+.. .+++..++.++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||+++...... ......+||+
T Consensus 112 l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~ 185 (353)
T 2i0e_A 112 IQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTP 185 (353)
T ss_dssp HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCG
T ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCc
Confidence 97654 3999999999999999999999754 9999999999999999999999999997533222 1244568999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|+|||||++|+|++|..||.+.+... ....++.. ....+..++.+
T Consensus 186 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~ 247 (353)
T 2i0e_A 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------LFQSIMEH--NVAYPKSMSKE 247 (353)
T ss_dssp GGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC--CCCCCTTSCHH
T ss_pred cccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----------------HHHHHHhC--CCCCCCCCCHH
Confidence 9999999999999999999999999999999999998643211 11112221 22356678899
Q ss_pred HHHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
+.+||.+||..||.+||+ +++++++
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999999995 5777654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=312.60 Aligned_cols=228 Identities=27% Similarity=0.355 Sum_probs=183.5
Q ss_pred ChhHHHhHHHHHHh---hh--------hHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---AR--------SLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +. ......+.+.+|..++..+ +||||+++++++.+.+..|+||||++||+|.++
T Consensus 29 ~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 108 (345)
T 1xjd_A 29 SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 108 (345)
T ss_dssp SSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 57888887664322 11 1112345578899999887 999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.+|.+||+|||+++....... .....+||+
T Consensus 109 l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~ 182 (345)
T 1xjd_A 109 IQSCH--KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTP 182 (345)
T ss_dssp HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCG
T ss_pred HHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCc
Confidence 97654 3999999999999999999999755 99999999999999999999999999975432221 244568999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.... ...+... ....+..++.+
T Consensus 183 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------~~~i~~~--~~~~p~~~s~~ 244 (345)
T 1xjd_A 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----------------FHSIRMD--NPFYPRWLEKE 244 (345)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHC--CCCCCTTSCHH
T ss_pred ccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHHHHhC--CCCCCcccCHH
Confidence 99999999999999999999999999999999999986542111 1111111 12345667889
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHHH
Q 021507 229 AATLALQCLNNEPKLRPRMS-EVLA 252 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~-~~l~ 252 (311)
+.+||.+||..||.+||++. ++++
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHc
Confidence 99999999999999999997 7664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=313.58 Aligned_cols=231 Identities=22% Similarity=0.247 Sum_probs=181.7
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++...
T Consensus 101 ~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~ 180 (373)
T 2x4f_A 101 RFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE 180 (373)
T ss_dssp ---CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHT
T ss_pred cCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhc
Confidence 47888877554321 1111234567899999999999999999999999999999999999999999988654
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe--CCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
. ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++........ .....||+.|
T Consensus 181 ~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y 254 (373)
T 2x4f_A 181 S-YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEF 254 (373)
T ss_dssp G-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTT
T ss_pred C-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcE
Confidence 3 34899999999999999999999755 9999999999999 5678899999999987543322 2345689999
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc--CCCCchHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHT 228 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 228 (311)
+|||++.+..++.++|||||||++|+|++|..||.+.+.... +..++.... .......++.+
T Consensus 255 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET----------------LNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp CCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHHTCCCSCSGGGTTSCHH
T ss_pred eChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhccCCCChhhhccCCHH
Confidence 999999988999999999999999999999999986542111 111111111 11112356789
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||.+||..||.+|||+.+++++
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=304.05 Aligned_cols=239 Identities=26% Similarity=0.368 Sum_probs=185.3
Q ss_pred ChhHHHhHHHHHHh------------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEE-eCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH------------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++. .++..|+||||+.+++|.+
T Consensus 37 ~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~ 116 (298)
T 3f66_A 37 HFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 116 (298)
T ss_dssp TTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHH
T ss_pred CCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHH
Confidence 58888876532211 1122334567899999999999999999999854 5567899999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceecccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVM 145 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~ 145 (311)
++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......... .......
T Consensus 117 ~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 193 (298)
T 3f66_A 117 FIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193 (298)
T ss_dssp HHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CC
T ss_pred HHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCC
Confidence 996533 45899999999999999999999755 999999999999999999999999999865432211 1223446
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK 224 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
+|+.|+|||++.+..++.++||||||+++|+|++ |.+||....... .............+..
T Consensus 194 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~ 256 (298)
T 3f66_A 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----------------ITVYLLQGRRLLQPEY 256 (298)
T ss_dssp BCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----------------HHHHHHTTCCCCCCTT
T ss_pred CCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HHHHHhcCCCCCCCcc
Confidence 7889999999999999999999999999999999 666776543211 1111122222334556
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
++..+.+++.+||..||.+|||+.++++.|+++..
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 78899999999999999999999999999988653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=315.04 Aligned_cols=214 Identities=28% Similarity=0.446 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCC-eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.|.+|+++|++++||||+++++++.+.. ..|+||||+++|+|.+++.......+++..++.++.|++.||+|||+.
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 308 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3467899999999999999999999987665 789999999999999999876655689999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+ ++||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||++
T Consensus 309 ~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t 381 (450)
T 1k9a_A 309 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381 (450)
T ss_dssp T--EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHT
T ss_pred C--eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 5 999999999999999999999999999754322 122356889999999999999999999999999999998
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||...... .....+........+..++..+.++|.+||..||.+|||+.++++.|+.+.
T Consensus 382 ~g~~P~~~~~~~-----------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 382 FGRVPYPRIPLK-----------------DVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp TTCCSSTTSCTT-----------------THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 99999864321 112222333344567788999999999999999999999999999998874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=314.71 Aligned_cols=235 Identities=22% Similarity=0.287 Sum_probs=174.7
Q ss_pred ChhHHHhHHHHHHhh---hh----HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHA---RS----LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||++++..... .+ .....+.+.+|+.++++++||||+++++++.+.+..|+||||+.||+|.+++...+
T Consensus 32 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 111 (361)
T 3uc3_A 32 NFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG 111 (361)
T ss_dssp TTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS
T ss_pred CCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC
Confidence 578888877654321 11 11234568899999999999999999999999999999999999999999996654
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc--EEEecccccccCCCCCCcceecccccccccc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++...... ......||+.|+
T Consensus 112 --~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~ 184 (361)
T 3uc3_A 112 --RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYI 184 (361)
T ss_dssp --SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTS
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcC
Confidence 3999999999999999999999755 999999999999987765 9999999997432221 233457999999
Q ss_pred CccccccCCCCCC-CceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 152 APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 152 aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
|||++.+..++.+ +|||||||++|+|++|..||......... ......+............++..+.
T Consensus 185 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (361)
T 3uc3_A 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY------------RKTIQRILSVKYSIPDDIRISPECC 252 (361)
T ss_dssp CHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH------------HHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred ChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH------------HHHHHHHhcCCCCCCCcCCCCHHHH
Confidence 9999988887665 89999999999999999999764321100 0111112222222222335678999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHH
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+||.+||..||.+|||+.+++++-
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred HHHHHHccCChhHCcCHHHHHhCc
Confidence 999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=307.80 Aligned_cols=217 Identities=26% Similarity=0.374 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
....+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 53 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~ 131 (289)
T 4fvq_A 53 RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE 131 (289)
T ss_dssp GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3456779999999999999999999999999999999999999999999996543 348999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCCCc--------EEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceeh
Q 021507 99 AESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYS 169 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s 169 (311)
.+ |+||||||+||+++.++. +||+|||++..... .....++..|+|||++.+ ..++.++||||
T Consensus 132 ~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 203 (289)
T 4fvq_A 132 NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWS 203 (289)
T ss_dssp TT--CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHH
T ss_pred CC--eECCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHH
Confidence 55 999999999999988877 99999999865422 233457889999999987 67899999999
Q ss_pred hHHHHHHHHhC-CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHH
Q 021507 170 FGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248 (311)
Q Consensus 170 lG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (311)
|||++|+|++| ..||........ ..... .....+...+.++.+++.+||+.||.+|||+.
T Consensus 204 lG~il~el~~g~~~~~~~~~~~~~-----------------~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 264 (289)
T 4fvq_A 204 FGTTLWEICSGGDKPLSALDSQRK-----------------LQFYE--DRHQLPAPKAAELANLINNCMDYEPDHRPSFR 264 (289)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHH-----------------HHHHH--TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHHHcCCCCCccccchHHH-----------------HHHhh--ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999995 455544321110 01111 11223344567789999999999999999999
Q ss_pred HHHHHHHhhcCCCCC
Q 021507 249 EVLAILERLEAPKNS 263 (311)
Q Consensus 249 ~~l~~l~~~~~~~~~ 263 (311)
++++.|+++..+..+
T Consensus 265 ~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 265 AIIRDLNSLFTPDLV 279 (289)
T ss_dssp HHHHHHHTCC-----
T ss_pred HHHHHHHHhcCCCCC
Confidence 999999998765443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=295.23 Aligned_cols=216 Identities=24% Similarity=0.381 Sum_probs=180.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.|.+|+.++++++||||+++++++.+. +..++||||+++++|.+++.......+++..++.++.|++.||+|||
T Consensus 49 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH 128 (271)
T 3kmu_A 49 RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128 (271)
T ss_dssp HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 3456799999999999999999999999877 77899999999999999997766556999999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCC---CCceehhHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT---KSDVYSFGVVL 174 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~slG~il 174 (311)
+.+..++|+||||+||+++.++.++|+|||++.... .....||+.|+|||++.+..++. ++|||||||++
T Consensus 129 ~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il 201 (271)
T 3kmu_A 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201 (271)
T ss_dssp TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHH
T ss_pred cCCCceecCCCccceEEEcCCcceeEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHH
Confidence 654449999999999999999999999998875422 22346899999999998766554 79999999999
Q ss_pred HHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|+|++|..||...... ...............+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 202 ~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 202 WELVTREVPFADLSNM----------------EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp HHHHHCSCTTTTSCHH----------------HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCccccChH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999764321 111222233334455667889999999999999999999999999999
Q ss_pred Hhhc
Q 021507 255 ERLE 258 (311)
Q Consensus 255 ~~~~ 258 (311)
+.+.
T Consensus 266 ~~l~ 269 (271)
T 3kmu_A 266 EKMQ 269 (271)
T ss_dssp HHHC
T ss_pred HHhh
Confidence 9875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=326.50 Aligned_cols=234 Identities=26% Similarity=0.327 Sum_probs=188.9
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... + .......+.+.+|+++|++++||||+++++++.+.+..|+||||++||+|.+++
T Consensus 196 ~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l 275 (576)
T 2acx_A 196 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 275 (576)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence 57888887654321 1 111123456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||++........ ....+||+.
T Consensus 276 ~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~ 350 (576)
T 2acx_A 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVG 350 (576)
T ss_dssp HSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGG
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCcc
Confidence 7766566999999999999999999999755 99999999999999999999999999987543321 334589999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||......... ..+...+. .....++..++.++
T Consensus 351 Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-------------~~i~~~i~-~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------EEVERLVK-EVPEEYSERFSPQA 416 (576)
T ss_dssp GCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-------------HHHHHHHH-HCCCCCCTTSCHHH
T ss_pred ccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-------------HHHHHHhh-cccccCCccCCHHH
Confidence 99999999989999999999999999999999999875421110 11111111 12234556788999
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.+||.+||..||.+|| ++++++++
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 9999999999999999 78888864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=322.00 Aligned_cols=232 Identities=24% Similarity=0.255 Sum_probs=183.8
Q ss_pred ChhHHHhHHHHHHh---hhhHH--------HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARSLL--------LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +.+.. ...+.+.+|+.+++.++||||+++++++.+.+..|+||||++||+|.+++
T Consensus 81 ~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 160 (410)
T 3v8s_A 81 AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160 (410)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence 58888887765432 11111 11224789999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||+++....... ......+||+.
T Consensus 161 ~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~ 234 (410)
T 3v8s_A 161 SNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPD 234 (410)
T ss_dssp HHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGG
T ss_pred HcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCcc
Confidence 654 3899999999999999999999755 99999999999999999999999999986543321 12345689999
Q ss_pred ccCccccccCC----CCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCch
Q 021507 150 YAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQ 223 (311)
Q Consensus 150 y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 223 (311)
|+|||++.+.. ++.++|||||||++|+|++|..||.+.+... ....++... .......
T Consensus 235 Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------------TYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp GCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHTHHHHCCCCTTC
T ss_pred ccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh----------------HHHHHHhccccccCCCcc
Confidence 99999998765 7889999999999999999999998654211 111111111 1112223
Q ss_pred HHHHHHHHHHHhcccCCCCC--CCCHHHHHHHH
Q 021507 224 KAAHTAATLALQCLNNEPKL--RPRMSEVLAIL 254 (311)
Q Consensus 224 ~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~l 254 (311)
.++.++.+||.+||..+|.+ |+++++++++.
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 57889999999999999988 99999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=296.76 Aligned_cols=236 Identities=25% Similarity=0.309 Sum_probs=178.4
Q ss_pred ChhHHHhHHHHHHh------------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH------------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++. ++..|+||||+.+++|.++
T Consensus 27 ~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~ 105 (281)
T 1mp8_A 27 QFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSF 105 (281)
T ss_dssp SSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHH
T ss_pred CCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHH
Confidence 57788876543211 1122345677999999999999999999999984 5678999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......... ......+++
T Consensus 106 l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~ 181 (281)
T 1mp8_A 106 LQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPI 181 (281)
T ss_dssp HHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--------------------CCG
T ss_pred HHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcc
Confidence 96543 35999999999999999999999754 999999999999999999999999999865433211 123345678
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 227 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+........+..++.
T Consensus 182 ~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----------------VIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HHHHHHTTCCCCCCTTCCH
T ss_pred cccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----------------HHHHHHcCCCCCCCCCCCH
Confidence 8999999999999999999999999999997 999998643211 1111222222345567888
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.+.+++.+||..||.+|||+.++++.|+.+.
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999998864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=302.59 Aligned_cols=239 Identities=20% Similarity=0.211 Sum_probs=179.6
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++.+++..|+||||++|++|.+++
T Consensus 46 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 125 (309)
T 2h34_A 46 GMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML 125 (309)
T ss_dssp SSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHH
T ss_pred CCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHH
Confidence 46777776543221 1122344577999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........ .......|+..
T Consensus 126 ~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~ 200 (309)
T 2h34_A 126 RRQG--PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLY 200 (309)
T ss_dssp HHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGG
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcC
Confidence 7654 4899999999999999999999755 99999999999999999999999999976543221 12334568999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAH 227 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 227 (311)
|+|||++.+..++.++||||||+++|+|++|..||......... ..+... .....+..++.
T Consensus 201 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-----------------AHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp GCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-----------------HHHHSCCCCGGGTSTTCCT
T ss_pred ccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-----------------HHhccCCCCccccCCCCCH
Confidence 99999999999999999999999999999999999865421110 111110 01123456778
Q ss_pred HHHHHHHhcccCCCCCCC-CHHHHHHHHHhhcCCC
Q 021507 228 TAATLALQCLNNEPKLRP-RMSEVLAILERLEAPK 261 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rp-t~~~~l~~l~~~~~~~ 261 (311)
.+.+++.+||..||++|| +++++++.|++.....
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 899999999999999999 9999999998865433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=309.83 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=175.1
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCe----eEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN----RLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~~lv~e~~~~~~L 65 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++..... .|+||||++|++|
T Consensus 24 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L 103 (311)
T 3ork_A 24 GMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL 103 (311)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEH
T ss_pred CCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCH
Confidence 57778877654322 11223445678999999999999999999999876543 4999999999999
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccc
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQV 144 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~ 144 (311)
.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 104 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 179 (311)
T 3ork_A 104 RDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179 (311)
T ss_dssp HHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC----------------
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccccccccccccccccc
Confidence 99997654 4999999999999999999999755 999999999999999999999999999865433221 123345
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC--CCc
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYP 222 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 222 (311)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... .......... ...
T Consensus 180 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----------------YQHVREDPIPPSARH 243 (311)
T ss_dssp --CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------------HHHHHCCCCCHHHHS
T ss_pred CcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH----------------HHHhcCCCCCccccc
Confidence 7899999999999999999999999999999999999999765421110 0111110000 012
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHH-HHHHHHhhc
Q 021507 223 QKAAHTAATLALQCLNNEPKLRPRMSE-VLAILERLE 258 (311)
Q Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~-~l~~l~~~~ 258 (311)
..++.++.++|.+||+.||.+||++.+ +.+.+.++.
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 346788999999999999999996554 555665543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=298.89 Aligned_cols=228 Identities=25% Similarity=0.397 Sum_probs=182.4
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.+.+|+.++++++||||+++++++.+.+..|+||||+++++|.+++
T Consensus 21 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l 100 (279)
T 3fdn_A 21 KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL 100 (279)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHH
Confidence 46777777554322 1112233567899999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... .....|+..
T Consensus 101 ~~~~--~~~~~~~~~~~~qi~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~ 172 (279)
T 3fdn_A 101 QKLS--KFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLD 172 (279)
T ss_dssp HHHS--SCCHHHHHHHHHHHHHHHHHHHTT--TCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCT
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCC
Confidence 6654 389999999999999999999964 59999999999999999999999999986543221 334578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++||||||+++|+|++|..||......... ..+ .......+..++..+
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~--~~~~~~~~~~~~~~~ 234 (279)
T 3fdn_A 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----------------KRI--SRVEFTFPDFVTEGA 234 (279)
T ss_dssp TCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HHH--HHTCCCCCTTSCHHH
T ss_pred ccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH----------------HHH--HhCCCCCCCcCCHHH
Confidence 99999999999999999999999999999999999864421111 011 111223456678889
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.+|+.+||+.||.+|||+.+++++.
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHHHHhccChhhCCCHHHHhhCc
Confidence 9999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=302.81 Aligned_cols=211 Identities=24% Similarity=0.345 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.+|++++||||+++++++.+.+..|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.+
T Consensus 58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~- 134 (326)
T 2y0a_A 58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ- 134 (326)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 567899999999999999999999999999999999999999999999654 34999999999999999999999755
Q ss_pred CeeecCCCCCceEeCCCC----cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
|+||||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 135 -ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 210 (326)
T 2y0a_A 135 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210 (326)
T ss_dssp -EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999998887 799999999987543221 3345799999999999988999999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||.+............ ............++..+.+||.+||..||.+|||+.+++++
T Consensus 211 l~g~~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 211 LSGASPFLGDTKQETLANVSA--------------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHSCCSSCCSSHHHHHHHHHH--------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHCcCCCCCCCHHHHHHHHHh--------------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 999999976432111100000 00000001123457789999999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=301.76 Aligned_cols=247 Identities=23% Similarity=0.232 Sum_probs=180.8
Q ss_pred ChhHHHhHHHHHHhh----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELHA----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++.+.+... .......+.+.+|++++++++||||+++++++.+++..|+||||+.+ +|.+.+.
T Consensus 14 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 92 (292)
T 3o0g_A 14 TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD 92 (292)
T ss_dssp SSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH
T ss_pred CCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHH
Confidence 578888876654321 11223446788999999999999999999999999999999999976 7777665
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ......||..|
T Consensus 93 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y 167 (292)
T 3o0g_A 93 SCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWY 167 (292)
T ss_dssp HTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGG
T ss_pred hCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCC
Confidence 433 35999999999999999999999755 99999999999999999999999999986543222 23445789999
Q ss_pred cCccccccCC-CCCCCceehhHHHHHHHHhCCCccCCCccchhh--hhhhh-ccccccchhhhhHhhh---------ccc
Q 021507 151 AAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDW-AKPYLSDKRKLFRIMD---------TKL 217 (311)
Q Consensus 151 ~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~---------~~~ 217 (311)
+|||++.+.. ++.++|||||||++|+|++|..||......... ..... ..+............. ...
T Consensus 168 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T 3o0g_A 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247 (292)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred cChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcc
Confidence 9999997765 799999999999999999988886433221110 00000 0000000000000000 001
Q ss_pred CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.......++..+.+|+.+||+.||++|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 112234577899999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=322.36 Aligned_cols=233 Identities=21% Similarity=0.215 Sum_probs=183.0
Q ss_pred ChhHHHhHHHHHHh---hhhH--------HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARSL--------LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +.+. ....+.+.+|..++..++||||+++++++.+++..|+||||+.||+|.+++
T Consensus 86 ~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l 165 (437)
T 4aw2_A 86 AFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165 (437)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHH
T ss_pred CCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHH
Confidence 58888887665432 1111 111223889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||+++....... ......+||+.
T Consensus 166 ~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~ 241 (437)
T 4aw2_A 166 SKFE-DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPD 241 (437)
T ss_dssp HTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGG
T ss_pred HHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcC
Confidence 6532 34999999999999999999999755 99999999999999999999999999976543322 22344689999
Q ss_pred ccCccccc-----cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc--
Q 021507 150 YAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-- 222 (311)
Q Consensus 150 y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (311)
|+|||++. +..++.++|||||||++|||++|..||.+.+.... ...++........+
T Consensus 242 Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------------YGKIMNHKERFQFPTQ 305 (437)
T ss_dssp GCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHTHHHHCCCCSS
T ss_pred eeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH----------------HHhhhhccccccCCcc
Confidence 99999987 45689999999999999999999999986542111 11111111111122
Q ss_pred -hHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 021507 223 -QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 253 (311)
Q Consensus 223 -~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~ 253 (311)
..++.++.+||.+||..+|++ |+++++++++
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 347889999999999988888 9999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=295.72 Aligned_cols=234 Identities=37% Similarity=0.622 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
...+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++... ....+++..++.++.|++.||+|||+
T Consensus 72 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 151 (307)
T 2nru_A 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151 (307)
T ss_dssp THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 45678999999999999999999999999999999999999999999998643 23459999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
.+ ++|+||||+||+++.++.+||+|||++................||..|+|||++.+ .++.++||||||+++|+|+
T Consensus 152 ~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~ 228 (307)
T 2nru_A 152 NH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEII 228 (307)
T ss_dssp TT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHH
T ss_pred CC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHH
Confidence 54 99999999999999999999999999987554333333445678999999998865 5788999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
+|..||............ ..........+...+.. .....+..++..+.+++.+||..||.+|||+.++++.|+++.
T Consensus 229 ~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 229 TGLPAVDEHREPQLLLDI--KEEIEDEEKTIEDYIDK-KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HCCCSBCTTBSSSBTTHH--HHHHHTTSCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HCCCCcccCcchHHHHHH--HHHhhhhhhhhhhhccc-cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 999999865432111000 00000001111111111 123346678899999999999999999999999999999875
Q ss_pred C
Q 021507 259 A 259 (311)
Q Consensus 259 ~ 259 (311)
+
T Consensus 306 ~ 306 (307)
T 2nru_A 306 A 306 (307)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=308.17 Aligned_cols=230 Identities=26% Similarity=0.322 Sum_probs=182.9
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||+.| +|.+++
T Consensus 66 ~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l 144 (348)
T 1u5q_A 66 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLL 144 (348)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHH
T ss_pred CCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHH
Confidence 57788877654322 112233456789999999999999999999999999999999999974 888888
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... .....||+.
T Consensus 145 ~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~ 215 (348)
T 1u5q_A 145 EVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPY 215 (348)
T ss_dssp HHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGG
T ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcc
Confidence 5433 35999999999999999999999755 99999999999999999999999999976432 234578999
Q ss_pred ccCccccc---cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 150 YAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 150 y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|+|||++. +..++.++|||||||++|+|++|..||....... ..............+..++
T Consensus 216 y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~ 279 (348)
T 1u5q_A 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHIAQNESPALQSGHWS 279 (348)
T ss_dssp GCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHSCCCCCCCTTSC
T ss_pred eeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----------------HHHHHHhcCCCCCCCCCCC
Confidence 99999985 4678899999999999999999999997643211 1111122222222344567
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
..+.++|.+||+.||++|||+.+++++..-
T Consensus 280 ~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 889999999999999999999999976543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=298.37 Aligned_cols=234 Identities=23% Similarity=0.275 Sum_probs=183.4
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+.... ........+.+.+|+.+++.++||||+++++++.+++..|+||||+++++|.+++..
T Consensus 19 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 98 (276)
T 2yex_A 19 AYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98 (276)
T ss_dssp SSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT
T ss_pred CCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh
Confidence 46777776543221 112223457789999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
. ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.+................|+..|+
T Consensus 99 ~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 174 (276)
T 2yex_A 99 D--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174 (276)
T ss_dssp T--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGC
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCcc
Confidence 3 34999999999999999999999755 9999999999999999999999999997653332222234567899999
Q ss_pred CccccccCCC-CCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 152 APEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 152 aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
|||++.+..+ +.++||||||+++|+|++|..||......... ................++..+.
T Consensus 175 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp CGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH---------------HHHHHTTCTTSTTGGGSCHHHH
T ss_pred ChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH---------------HHHhhhcccccCchhhcCHHHH
Confidence 9999987765 67899999999999999999999865421110 0011111111122345788899
Q ss_pred HHHHhcccCCCCCCCCHHHHHHH
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+++.+||..||.+|||+.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHCCCCchhCCCHHHHhcC
Confidence 99999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=317.84 Aligned_cols=228 Identities=25% Similarity=0.356 Sum_probs=184.1
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++|.+++
T Consensus 28 ~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 107 (476)
T 2y94_A 28 TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI 107 (476)
T ss_dssp SSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHT
T ss_pred CCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence 57888877654321 0111123457899999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ......||+.
T Consensus 108 ~~~~--~l~~~~~~~i~~qi~~aL~~LH~~--givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~ 180 (476)
T 2y94_A 108 CKNG--RLDEKESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPN 180 (476)
T ss_dssp TSSS--SCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCST
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CCCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcC
Confidence 6543 499999999999999999999965 59999999999999999999999999998754332 2334679999
Q ss_pred ccCccccccCCC-CCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 150 YAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 150 y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
|+|||++.+..+ +.++|||||||++|+|++|..||........ ...+... ....+..++.+
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----------------~~~i~~~--~~~~p~~~s~~ 242 (476)
T 2y94_A 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL----------------FKKICDG--IFYTPQYLNPS 242 (476)
T ss_dssp TCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH----------------HHHHHTT--CCCCCTTCCHH
T ss_pred eEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH----------------HHHHhcC--CcCCCccCCHH
Confidence 999999988765 6799999999999999999999986542111 1111111 12335567788
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||.+||..||.+|||+.+++++
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhC
Confidence 9999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=308.16 Aligned_cols=237 Identities=23% Similarity=0.300 Sum_probs=164.6
Q ss_pred ChhHHHhHHHHHHh---hhh--HHHHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH---ARS--LLLITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||.+.+.... +.+ .......+.+|+.+++.+. ||||+++++++.+++..|+||||++|++|.+++....
T Consensus 23 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 101 (325)
T 3kn6_A 23 SFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK- 101 (325)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS-
T ss_pred CCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC-
Confidence 58888887765432 111 1123466889999999996 9999999999999999999999999999999997653
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC---cEEEecccccccCCCCCCcceecccccccccc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++........ ......||+.|+
T Consensus 102 -~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~ 176 (325)
T 3kn6_A 102 -HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYA 176 (325)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCcc
Confidence 4999999999999999999999754 99999999999997766 799999999986543221 234457899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhh-hcccCC--CCchHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGG--QYPQKAAHT 228 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~ 228 (311)
|||++.+..++.++|||||||++|+|++|..||......... .........+ ...... .....++.+
T Consensus 177 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (325)
T 3kn6_A 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC----------TSAVEIMKKIKKGDFSFEGEAWKNVSQE 246 (325)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C----------CCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred CHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc----------ccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence 999999999999999999999999999999999865421100 0001111111 111111 111346889
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||.+||..||.+|||+.+++++
T Consensus 247 ~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 247 AKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHCCCChhHCCCHHHHhcC
Confidence 9999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=320.53 Aligned_cols=230 Identities=25% Similarity=0.292 Sum_probs=176.4
Q ss_pred ChhHHHhHHHHHHh---hh--------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---AR--------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... +. ........+.+|+++++.++||||+++++++.+.+..|+||||++|++|.+++
T Consensus 160 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l 239 (446)
T 4ejn_A 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239 (446)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHH
T ss_pred cCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHH
Confidence 57888876654321 10 11223345778999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.|++.||+|||+. ++|+||||||+|||++.++.+||+|||+++...... .......||+.
T Consensus 240 ~~~~--~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~ 314 (446)
T 4ejn_A 240 SRER--VFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPE 314 (446)
T ss_dssp HHHS--CCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGG
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCcc
Confidence 6654 499999999999999999999961 349999999999999999999999999997533222 12345689999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||...+.... ...+... ....+..++.++
T Consensus 315 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------~~~i~~~--~~~~p~~~~~~~ 376 (446)
T 4ejn_A 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------FELILME--EIRFPRTLGPEA 376 (446)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHC--CCCCCTTSCHHH
T ss_pred ccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----------------HHHHHhC--CCCCCccCCHHH
Confidence 9999999999999999999999999999999999976432111 1111111 223456678899
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.+||.+||..||.+|| ++.+++++
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 9999999999999999 99999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=316.80 Aligned_cols=238 Identities=26% Similarity=0.403 Sum_probs=190.0
Q ss_pred ChhHHHhHHHHHHh--h----hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH--A----RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||.+.+.... + .......+.|.+|+++|++++||||+++++++. .+..|+||||+.+|+|.+++.....
T Consensus 200 ~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~ 278 (454)
T 1qcf_A 200 QFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEG 278 (454)
T ss_dssp SSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHH
T ss_pred CceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccC
Confidence 57777777543211 0 001123567999999999999999999999986 5678999999999999999975543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ........++..|+|||
T Consensus 279 ~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE 355 (454)
T 1qcf_A 279 SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 355 (454)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHH
Confidence 45899999999999999999999755 9999999999999999999999999998653321 11122344678899999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++|||||||++|||++ |..||.+.... .....+........+..++.++.++|
T Consensus 356 ~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li 418 (454)
T 1qcf_A 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----------------EVIRALERGYRMPRPENCPEELYNIM 418 (454)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------HHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred HhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999 99999864321 12222233334445667889999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.+||..||++|||+.++++.|+.+..
T Consensus 419 ~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 419 MRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=295.88 Aligned_cols=216 Identities=22% Similarity=0.359 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+
T Consensus 63 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~- 140 (283)
T 3gen_A 63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ- 140 (283)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4568999999999999999999999999999999999999999999996532 34999999999999999999999755
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
++|+||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |
T Consensus 141 -i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g 218 (283)
T 3gen_A 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218 (283)
T ss_dssp -CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTT
T ss_pred -ccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998653321 111223456788999999999999999999999999999998 9
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
..||...... .....+........+..++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 219 ~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 219 KMPYERFTNS-----------------ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccChh-----------------HHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 9999864421 111222222333445567889999999999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=305.47 Aligned_cols=247 Identities=23% Similarity=0.263 Sum_probs=181.3
Q ss_pred ChhHHHhHHHHHHhh---hhHH----------HHHHHHHHHHHHHhcCC---CCCccceEeEEEeCC-----eeEEEEec
Q 021507 1 MFLFNFLHSHLELHA---RSLL----------LITNWFQTEVNYLGQLH---HPNLVKLIGYCLEGE-----NRLLVYEF 59 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~~~----------~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~-----~~~lv~e~ 59 (311)
+||+||++.+..... .+.. .....+.+|+.++++++ ||||+++++++.... ..++||||
T Consensus 21 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 100 (308)
T 3g33_A 21 AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH 100 (308)
T ss_dssp SSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEEC
T ss_pred CCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehh
Confidence 578888887654321 1111 11235677888887775 999999999998765 47999999
Q ss_pred CCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc
Q 021507 60 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 139 (311)
Q Consensus 60 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 139 (311)
+.+ +|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 174 (308)
T 3g33_A 101 VDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--- 174 (308)
T ss_dssp CCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---
T ss_pred hhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---
Confidence 975 9999997776666999999999999999999999765 9999999999999999999999999998654322
Q ss_pred eeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhcc-ccccchhhhhHhhhccc
Q 021507 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAK-PYLSDKRKLFRIMDTKL 217 (311)
Q Consensus 140 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 217 (311)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......... .... +................
T Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (308)
T 3g33_A 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 254 (308)
T ss_dssp CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGS
T ss_pred ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 234567899999999999999999999999999999999999999875432211111 0000 00000000000000000
Q ss_pred CC-------CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 GG-------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.. .....++..+.+||.+||+.||++|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 255 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 0112467789999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=294.07 Aligned_cols=213 Identities=30% Similarity=0.482 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+++++.++||||+++++++.+++..|+||||++|++|.+++.. ..+++..++.++.|++.||+|||+.+.
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~ 126 (271)
T 3dtc_A 50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAI 126 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46789999999999999999999999999999999999999999999853 349999999999999999999997542
Q ss_pred -CeeecCCCCCceEeCC--------CCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 102 -QVIYRDFKASNILLDA--------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 102 -~ivH~dlkp~Nil~~~--------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
+++||||||+||+++. ++.+||+|||++....... .....|+..|+|||++.+..++.++||||||+
T Consensus 127 ~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 202 (271)
T 3dtc_A 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202 (271)
T ss_dssp SCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHH
T ss_pred CceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHH
Confidence 2899999999999986 6789999999997643322 22457899999999999999999999999999
Q ss_pred HHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
++|+|++|..||...... ...............+..++..+.+++.+||+.||.+|||+.++++
T Consensus 203 ~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 203 LLWELLTGEVPFRGIDGL----------------AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp HHHHHHHCCCTTTTSCHH----------------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCCCCCCCHH----------------HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 999999999999864321 1111222233334456677889999999999999999999999999
Q ss_pred HHHhh
Q 021507 253 ILERL 257 (311)
Q Consensus 253 ~l~~~ 257 (311)
.|+++
T Consensus 267 ~L~~l 271 (271)
T 3dtc_A 267 QLTTI 271 (271)
T ss_dssp HHHC-
T ss_pred HHhcC
Confidence 99753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=310.26 Aligned_cols=231 Identities=23% Similarity=0.289 Sum_probs=169.0
Q ss_pred ChhHHHhHHHHHHh---hhh---HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH---ARS---LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||++.+.... +.+ .....+.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++....
T Consensus 65 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 143 (349)
T 2w4o_A 65 ATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG- 143 (349)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS-
T ss_pred CCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC-
Confidence 57888877665422 111 11234568899999999999999999999999999999999999999999996543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++....... ......||+.|+
T Consensus 144 -~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~ 217 (349)
T 2w4o_A 144 -YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYC 217 (349)
T ss_dssp -SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGS
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCcc
Confidence 4899999999999999999999754 999999999999975 8899999999998643321 133467899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTA 229 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 229 (311)
|||++.+..++.++|||||||++|+|++|..||........ ....+.... ........++.++
T Consensus 218 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~~~~~ 282 (349)
T 2w4o_A 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---------------MFRRILNCEYYFISPWWDEVSLNA 282 (349)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---------------HHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---------------HHHHHHhCCCccCCchhhhCCHHH
Confidence 99999998999999999999999999999999976432110 011111111 1112234678899
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||.+||..||++|||+.+++++
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=298.62 Aligned_cols=230 Identities=23% Similarity=0.348 Sum_probs=178.8
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~ 66 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++.. ....|+||||+++++|.
T Consensus 38 ~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (290)
T 1t4h_A 38 SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117 (290)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHH
T ss_pred CCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHH
Confidence 57777776554322 11123446678999999999999999999999875 35689999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC-CCCcEEEecccccccCCCCCCcceecccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
+++.... .+++..++.++.|++.||+|||+.+.+++|+||||+||+++ .++.+||+|||++....... .....
T Consensus 118 ~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~ 191 (290)
T 1t4h_A 118 TYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVI 191 (290)
T ss_dssp HHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESC
T ss_pred HHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----ccccc
Confidence 9997653 38999999999999999999996544599999999999997 78899999999997543321 33457
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhh-cccCCCCchH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQK 224 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 224 (311)
||+.|+|||++. ..++.++|||||||++|+|++|..||........ ....+. .......+..
T Consensus 192 ~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 192 GTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IYRRVTSGVKPASFDKV 254 (290)
T ss_dssp SSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----------------HHHHHTTTCCCGGGGGC
T ss_pred CCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----------------HHHHHhccCCccccCCC
Confidence 899999999886 4589999999999999999999999976432111 111111 1111122334
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+.++.++|.+||..||.+|||+.+++++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 55789999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.99 Aligned_cols=234 Identities=22% Similarity=0.309 Sum_probs=178.1
Q ss_pred ChhHHHhHHHHHHh--h-------hhHHHHHHHHHHHHHHHhcCCC--CCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH--A-------RSLLLITNWFQTEVNYLGQLHH--PNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+.... + .......+.+.+|+.+|++++| +||+++++++.+++..|+|||+ .+++|.+++
T Consensus 21 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l 99 (343)
T 3dbq_A 21 GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL 99 (343)
T ss_dssp SSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHH
T ss_pred CCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHH
Confidence 57778776543211 0 1122344678999999999976 9999999999999999999995 477999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||++................||+.
T Consensus 100 ~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 174 (343)
T 3dbq_A 100 KKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174 (343)
T ss_dssp HHSC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCS
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcC
Confidence 7654 4899999999999999999999755 99999999999996 67899999999987654433333445679999
Q ss_pred ccCcccccc-----------CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC
Q 021507 150 YAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG 218 (311)
Q Consensus 150 y~aPE~~~~-----------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (311)
|+|||++.+ ..++.++|||||||++|+|++|..||...... .......+.....
T Consensus 175 y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------------ISKLHAIIDPNHE 239 (343)
T ss_dssp SCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---------------HHHHHHHHCTTSC
T ss_pred cCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---------------HHHHHHHhcCCcc
Confidence 999999865 56888999999999999999999999753211 1112222333333
Q ss_pred CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 219 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
...+...+..+.+|+.+||..||.+|||+.+++++..
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 4455666788999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=299.63 Aligned_cols=241 Identities=20% Similarity=0.190 Sum_probs=186.3
Q ss_pred ChhHHHhHHHHHHh---hhhH---HHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELH---ARSL---LLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||++.+.... +.+. ....+.+.+|+++++++ +||||+++++++..++..|+||||+ +++|.+++...
T Consensus 21 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~- 98 (330)
T 2izr_A 21 NFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC- 98 (330)
T ss_dssp CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-
T ss_pred CCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc-
Confidence 57888887654332 1111 11234588999999999 9999999999999999999999999 88999999754
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc-----EEEecccccccCCCCCCcc-----eecc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRTH-----VSTQ 143 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~~~-----~~~~ 143 (311)
...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++.......... ....
T Consensus 99 ~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~ 176 (330)
T 2izr_A 99 DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176 (330)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCC
Confidence 345999999999999999999999755 999999999999999887 9999999998654332211 1245
Q ss_pred ccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC---C
Q 021507 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---Q 220 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 220 (311)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+........... .+....... .
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~-------------~i~~~~~~~~~~~ 243 (330)
T 2izr_A 177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ-------------KIGDTKRATPIEV 243 (330)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH-------------HHHHHHHHSCHHH
T ss_pred cCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH-------------HHHhhhccCCHHH
Confidence 679999999999999999999999999999999999999998754221111110 000000000 0
Q ss_pred CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 221 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
....++ ++.+++.+||..||.+||+++++++.|+.+..
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 011245 89999999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=297.95 Aligned_cols=235 Identities=25% Similarity=0.364 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.|.+|++++++++||||+++++++... ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||
T Consensus 53 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH 131 (295)
T 3ugc_A 53 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG 131 (295)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999998643 56899999999999999996643 34999999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+.+ |+||||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+
T Consensus 132 ~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 209 (295)
T 3ugc_A 132 TKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 209 (295)
T ss_dssp HTT--CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cCC--cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHH
Confidence 755 999999999999999999999999999865433221 12233457778999999999999999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|++|..||.............. .............+........+..++.++.+++.+||+.||++|||+.++++.|+.
T Consensus 210 l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 210 LFTYIEKSKSPPAEFMRMIGND-KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHTTCTTCSHHHHHHHHHCTT-CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcccccCCChHHHHhhhcCc-cccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 9999999875432111110000 000001112233333444455677889999999999999999999999999999988
Q ss_pred hc
Q 021507 257 LE 258 (311)
Q Consensus 257 ~~ 258 (311)
+.
T Consensus 289 l~ 290 (295)
T 3ugc_A 289 IR 290 (295)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=314.15 Aligned_cols=238 Identities=27% Similarity=0.375 Sum_probs=185.7
Q ss_pred ChhHHHhHHHHHHh--hhh----HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH--ARS----LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||.+.+.... +.+ .....+.|.+|+++|++++||||+++++++.+ +..|+||||+.+|+|.+++.....
T Consensus 196 ~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~ 274 (452)
T 1fmk_A 196 CFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG 274 (452)
T ss_dssp SSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHH
T ss_pred CCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCC
Confidence 47777776544321 000 01134678999999999999999999999876 678999999999999999975444
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ........++..|+|||
T Consensus 275 ~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE 351 (452)
T 1fmk_A 275 KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351 (452)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHh
Confidence 45899999999999999999999755 9999999999999999999999999998654322 11223345678999999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++||||||+++|||++ |..||.+... ......+........+..++..+.++|
T Consensus 352 ~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li 414 (452)
T 1fmk_A 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVERGYRMPCPPECPESLHDLM 414 (452)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred HHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999 9999976432 112222233334455677889999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.+||..||++|||++++++.|+.+..
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHccCChhhCcCHHHHHHHHHHHhc
Confidence 99999999999999999999988753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=296.33 Aligned_cols=237 Identities=27% Similarity=0.388 Sum_probs=179.5
Q ss_pred ChhHHHhHHHHHHh----hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC-C
Q 021507 1 MFLFNFLHSHLELH----ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-Q 75 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~ 75 (311)
+||+||.+++.... ........+.|.+|++++++++||||+++++++.+ ..|+||||++|++|.+++..... .
T Consensus 20 ~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~ 97 (307)
T 2eva_A 20 AFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLP 97 (307)
T ss_dssp SSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEE
T ss_pred CCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCC
Confidence 46777766432211 01112345678999999999999999999998863 48999999999999999965543 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCC-CCeeecCCCCCceEeCCCCc-EEEecccccccCCCCCCcceeccccccccccCc
Q 021507 76 PLSWAVRMKVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 76 ~~~~~~~~~~~~~i~~~l~~lH~~~-~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
.++...++.++.|++.||+|||+.+ ++|+||||||+||+++.++. +||+|||++...... .....||..|+||
T Consensus 98 ~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aP 172 (307)
T 2eva_A 98 YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAP 172 (307)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceECh
Confidence 4789999999999999999999733 56999999999999988886 799999999754322 2234689999999
Q ss_pred cccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 154 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 154 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
|++.+..++.++||||||+++|+|++|+.||........ ..............+..++..+.+++
T Consensus 173 E~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li 237 (307)
T 2eva_A 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---------------RIMWAVHNGTRPPLIKNLPKPIESLM 237 (307)
T ss_dssp HHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---------------HHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred hhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---------------HHHHHHhcCCCCCcccccCHHHHHHH
Confidence 999999999999999999999999999999975432110 01111112222334556788999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.+||..||.+|||+.++++.|+.+..
T Consensus 238 ~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 238 TRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=295.50 Aligned_cols=231 Identities=23% Similarity=0.267 Sum_probs=184.2
Q ss_pred ChhHHHhHHHHHHh---h-----hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---A-----RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... + .......+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++.+.
T Consensus 57 ~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 136 (321)
T 2c30_A 57 STGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV 136 (321)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC
T ss_pred CCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc
Confidence 57777777554211 1 111223466889999999999999999999999999999999999999999998543
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ......||+.|+|
T Consensus 137 ---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~a 209 (321)
T 2c30_A 137 ---RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMA 209 (321)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCC
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccC
Confidence 4999999999999999999999754 99999999999999999999999999976543322 2345679999999
Q ss_pred ccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchHHHHHHHH
Q 021507 153 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAAT 231 (311)
Q Consensus 153 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 231 (311)
||++.+..++.++||||||+++|+|++|..||......... ....... ........++..+.+
T Consensus 210 PE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM----------------KRLRDSPPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------HHHHHSSCCCCTTGGGSCHHHHH
T ss_pred HhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHhcCCCCCcCccccCCHHHHH
Confidence 99999999999999999999999999999999764321110 0111110 011223456788999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++.+||..||++|||+.+++++.
T Consensus 274 li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHHccCChhhCcCHHHHhcCh
Confidence 99999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=311.35 Aligned_cols=225 Identities=25% Similarity=0.288 Sum_probs=172.6
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHH-HhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNY-LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +.+ .....+.+.+|..+ ++.++||||+++++++.+.+..|+||||+.||+|.++
T Consensus 50 ~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 129 (373)
T 2r5t_A 50 SFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYH 129 (373)
T ss_dssp TTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred CCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 57888887765422 111 11233456677776 5678999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++...... ......+||+
T Consensus 130 l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~ 203 (373)
T 2r5t_A 130 LQRER--CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTP 203 (373)
T ss_dssp HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCC
T ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCc
Confidence 97654 4899999999999999999999755 9999999999999999999999999997532221 1244568999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|+|||||++|||++|..||...+... ....++.. ....+..++..
T Consensus 204 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~~~--~~~~~~~~~~~ 265 (373)
T 2r5t_A 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----------------MYDNILNK--PLQLKPNITNS 265 (373)
T ss_dssp CCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----------------HHHHHHHS--CCCCCSSSCHH
T ss_pred cccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHHhc--ccCCCCCCCHH
Confidence 9999999999999999999999999999999999997643211 11112222 12345567889
Q ss_pred HHHHHHhcccCCCCCCCCHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~ 249 (311)
+.+||.+||..||.+||++.+
T Consensus 266 ~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHHHcccCHHhCCCCCC
Confidence 999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=295.97 Aligned_cols=227 Identities=21% Similarity=0.311 Sum_probs=180.7
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++...
T Consensus 21 ~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 100 (277)
T 3f3z_A 21 SWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK 100 (277)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred CCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc
Confidence 57777776554422 1111223567899999999999999999999999999999999999999999998665
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe---CCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
. .+++..++.++.|++.||+|||+.+ ++|+||||+||++ +.++.+||+|||++....... ......||+.
T Consensus 101 ~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~ 173 (277)
T 3f3z_A 101 R--VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPY 173 (277)
T ss_dssp C--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTT
T ss_pred C--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCC
Confidence 4 3899999999999999999999755 9999999999999 788899999999997654332 2334578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCch----HH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ----KA 225 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 225 (311)
|+|||++.+. ++.++||||||+++|+|++|..||........ ...+..... ..+. .+
T Consensus 174 y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~ 234 (277)
T 3f3z_A 174 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV----------------MLKIREGTF--TFPEKDWLNV 234 (277)
T ss_dssp TCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHCCC--CCCHHHHTTS
T ss_pred ccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHhCCC--CCCchhhhcC
Confidence 9999998654 89999999999999999999999986442111 111111111 1121 46
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+..+.+++.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 235 SPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 7889999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=306.39 Aligned_cols=232 Identities=23% Similarity=0.301 Sum_probs=176.2
Q ss_pred ChhHHHhHHHHHHh---hh------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC--------------------
Q 021507 1 MFLFNFLHSHLELH---AR------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE-------------------- 51 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-------------------- 51 (311)
+||+||++++.... +. ......+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (332)
T 3qd2_B 18 GFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDW 97 (332)
T ss_dssp -CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----------
T ss_pred CCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccc
Confidence 57888877654322 11 12235677999999999999999999999986543
Q ss_pred -------------------------------------eeEEEEecCCCCChHHHhhhcCC-CCCCHHHHHHHHHHHHHHH
Q 021507 52 -------------------------------------NRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGL 93 (311)
Q Consensus 52 -------------------------------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l 93 (311)
..|+||||++|++|.+++..... ...++..++.++.|++.||
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 177 (332)
T 3qd2_B 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177 (332)
T ss_dssp ----------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHH
T ss_pred cccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHH
Confidence 37999999999999999976543 3356677899999999999
Q ss_pred HHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc----------ceeccccccccccCccccccCCCCC
Q 021507 94 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------HVSTQVMGTHGYAAPEYVATGRLTT 163 (311)
Q Consensus 94 ~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ 163 (311)
+|||+.+ |+||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..++.
T Consensus 178 ~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 255 (332)
T 3qd2_B 178 EFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255 (332)
T ss_dssp HHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCT
T ss_pred HHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcc
Confidence 9999755 999999999999999999999999999875443211 1223457999999999999999999
Q ss_pred CCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 164 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 164 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
++|||||||++|+|++|..|+..... .................+..+.+++.+||+.||.+
T Consensus 256 ~~Di~slG~il~el~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 256 KVDIFSLGLILFELLYSFSTQMERVR-------------------IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp HHHHHHHHHHHHHHHSCCCCHHHHHH-------------------HHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred hhhHHHHHHHHHHHHHcCCChhHHHH-------------------HHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 99999999999999998776532110 00111111111112345677899999999999999
Q ss_pred CCCHHHHHHH
Q 021507 244 RPRMSEVLAI 253 (311)
Q Consensus 244 Rpt~~~~l~~ 253 (311)
|||+.+++++
T Consensus 317 Rps~~~~l~~ 326 (332)
T 3qd2_B 317 RPEATDIIEN 326 (332)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhhc
Confidence 9999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=298.69 Aligned_cols=220 Identities=24% Similarity=0.422 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 88 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (333)
T 1mqb_A 88 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM 166 (333)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345678999999999999999999999999999999999999999999996543 4599999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
+ |+||||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|+
T Consensus 167 ~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 244 (333)
T 1mqb_A 167 N--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244 (333)
T ss_dssp T--CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred C--eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHH
Confidence 5 9999999999999999999999999998654332111 122334678899999999899999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |..||...... .....+........+..++..+.+++.+||..||.+||++.++++.|+++
T Consensus 245 t~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 245 TYGERPYWELSNH-----------------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp TTSCCTTTTCCHH-----------------HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cCCCCCcccCCHH-----------------HHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9 99999754321 11122222223334556788999999999999999999999999999887
Q ss_pred cC
Q 021507 258 EA 259 (311)
Q Consensus 258 ~~ 259 (311)
..
T Consensus 308 ~~ 309 (333)
T 1mqb_A 308 IR 309 (333)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=309.16 Aligned_cols=245 Identities=23% Similarity=0.268 Sum_probs=183.0
Q ss_pred ChhHHHhHHHHHHh---hhh----HHHHHHHHHHHHHHHhcCC-----CCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS----LLLITNWFQTEVNYLGQLH-----HPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~----~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... +.+ .....+.+.+|+.+++.+. ||||+++++++...+..|+||||+ +++|.++
T Consensus 47 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~ 125 (360)
T 3llt_A 47 TFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEI 125 (360)
T ss_dssp SSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHH
T ss_pred CCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHH
Confidence 58888888764432 111 1334567888999999996 999999999999999999999999 8899999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-------------------------CCcEEE
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------------------------EFNAKL 123 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-------------------------~~~~kl 123 (311)
+.......+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 126 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 203 (360)
T 3llt_A 126 ITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203 (360)
T ss_dssp HHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEE
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEE
Confidence 98776667999999999999999999999755 999999999999975 788999
Q ss_pred ecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh-hcccc
Q 021507 124 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPY 202 (311)
Q Consensus 124 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~ 202 (311)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............. ...+.
T Consensus 204 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 278 (360)
T 3llt_A 204 IDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPI 278 (360)
T ss_dssp CCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCC
T ss_pred EeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCC
Confidence 999999864332 234578999999999999999999999999999999999999998754322111110 00000
Q ss_pred ccchhh------hhHhh-----hcccC----------------CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 203 LSDKRK------LFRIM-----DTKLG----------------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 203 ~~~~~~------~~~~~-----~~~~~----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...... ..... ..... .......+..+.+||.+||+.||.+|||+.+++++
T Consensus 279 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 279 PKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00000 00000 00011123678899999999999999999999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=320.39 Aligned_cols=233 Identities=23% Similarity=0.316 Sum_probs=185.7
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... + .......+.+.+|++++++++||||+++++++.+.+..|+||||++||+|.+++
T Consensus 197 ~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l 276 (543)
T 3c4z_A 197 GFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHI 276 (543)
T ss_dssp SSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHH
T ss_pred CCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHH
Confidence 57888887654321 1 111122356889999999999999999999999999999999999999999998
Q ss_pred hhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccc
Q 021507 70 FRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 70 ~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++....... .....+||
T Consensus 277 ~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT 352 (543)
T 3c4z_A 277 YNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGT 352 (543)
T ss_dssp HTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSC
T ss_pred HHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCC
Confidence 6543 346999999999999999999999755 99999999999999999999999999987543322 13345899
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhh-HhhhcccCCCCchHHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF-RIMDTKLGGQYPQKAA 226 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 226 (311)
+.|+|||++.+..++.++|+|||||++|+|++|..||........ ...+. .+... ....+..++
T Consensus 353 ~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-------------~~~~~~~i~~~--~~~~p~~~s 417 (543)
T 3c4z_A 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------------NKELKQRVLEQ--AVTYPDKFS 417 (543)
T ss_dssp TTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-------------HHHHHHHHHHC--CCCCCTTSC
T ss_pred ccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-------------HHHHHHHHhhc--ccCCCcccC
Confidence 999999999999999999999999999999999999986532110 01111 11111 224566788
Q ss_pred HHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRM-----SEVLA 252 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~-----~~~l~ 252 (311)
..+.+||.+||..||.+||++ +++++
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 999999999999999999965 66664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=295.59 Aligned_cols=231 Identities=22% Similarity=0.256 Sum_probs=182.8
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++.+++..|+||||+.|++|.+++.
T Consensus 18 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 97 (284)
T 3kk8_A 18 AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 97 (284)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH
Confidence 57777776543321 11122334678899999999999999999999999999999999999999999886
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc---EEEecccccccCCCCCCcceecccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++. +||+|||++........ .....||
T Consensus 98 ~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~ 170 (284)
T 3kk8_A 98 ARE--FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170 (284)
T ss_dssp HHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSC
T ss_pred hcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCC
Confidence 654 3899999999999999999999755 999999999999976655 99999999976543321 2345789
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKA 225 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 225 (311)
+.|+|||++.+..++.++||||||+++|+|++|..||.......... ...... ........+
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA----------------QIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HHHHTCCCCCTTTTTTS
T ss_pred cCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH----------------HHHhccccCCchhhccc
Confidence 99999999999999999999999999999999999997643211110 111111 111222456
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+.++.+++.+||+.||++|||+.+++++-
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 235 TPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 78899999999999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=296.00 Aligned_cols=233 Identities=26% Similarity=0.362 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..+.+.+|++++++++||||+++++++.+. ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~ 144 (302)
T 4e5w_A 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS 144 (302)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc
Confidence 346789999999999999999999999876 66899999999999999995543 349999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
.+ |+|+||||+||+++.++.+||+|||++......... .......+|..|+|||++.+..++.++||||||+++|+|
T Consensus 145 ~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 145 RQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp TT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CC--cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 55 999999999999999999999999999876543322 223345688889999999999999999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
++|..|+............. .............+........+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 223 LTYCDSDSSPMALFLKMIGP--THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HTTTCGGGSHHHHHHHHHCS--CCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHccCCCcchhhHHhhccCC--cccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 99999876432111110000 0001122233333444445556778889999999999999999999999999999876
Q ss_pred c
Q 021507 258 E 258 (311)
Q Consensus 258 ~ 258 (311)
.
T Consensus 301 l 301 (302)
T 4e5w_A 301 L 301 (302)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.23 Aligned_cols=232 Identities=20% Similarity=0.176 Sum_probs=180.4
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +.+ .....+.+.+|..++..++||||+++++++.+.+..|+||||++||+|.+++
T Consensus 73 ~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l 152 (412)
T 2vd5_A 73 AFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL 152 (412)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHH
Confidence 57888887664321 111 1112234789999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.+ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||+++....... ......+||+.
T Consensus 153 ~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~ 228 (412)
T 2vd5_A 153 SKFG-ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPD 228 (412)
T ss_dssp HHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGG
T ss_pred HhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccC
Confidence 7643 34999999999999999999999755 99999999999999999999999999987543322 12334689999
Q ss_pred ccCccccc-------cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--c-CC
Q 021507 150 YAAPEYVA-------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--L-GG 219 (311)
Q Consensus 150 y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~ 219 (311)
|+|||++. +..++.++|+|||||++|||++|..||...+.... ..+++... . ..
T Consensus 229 Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET----------------YGKIVHYKEHLSLP 292 (412)
T ss_dssp GCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHTHHHHCCCC
T ss_pred cCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhcccCcCCC
Confidence 99999987 35689999999999999999999999986542111 11111111 0 01
Q ss_pred CCchHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 021507 220 QYPQKAAHTAATLALQCLNNEPKLR---PRMSEVLAI 253 (311)
Q Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~R---pt~~~~l~~ 253 (311)
..+..++.++.+||.+||. +|.+| +++++++++
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1234578899999999999 99998 589999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=311.66 Aligned_cols=236 Identities=25% Similarity=0.307 Sum_probs=181.7
Q ss_pred ChhHHHhHHHHHHh---hhh-HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCC
Q 021507 1 MFLFNFLHSHLELH---ARS-LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ 75 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (311)
+||+||++.+.... +.+ .......+.+|++++.++ +||||+++++++.+++..|+||||+.||+|.+++....
T Consensus 34 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-- 111 (342)
T 2qr7_A 34 SYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-- 111 (342)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT--
T ss_pred CCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--
Confidence 57888887665432 111 111122356799999888 79999999999999999999999999999999996553
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC----CcEEEecccccccCCCCCCcceecccccccccc
Q 021507 76 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 76 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.+++..+..++.|++.||+|||+.+ |+||||||+||++..+ +.+||+|||++........ ......||+.|+
T Consensus 112 ~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~ 187 (342)
T 2qr7_A 112 FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFV 187 (342)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCcccc
Confidence 4999999999999999999999755 9999999999998543 3599999999986543322 234567899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTA 229 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 229 (311)
|||++.+..++.++|||||||++|+|++|..||........... ...+.... .....+..++.++
T Consensus 188 aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------------~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI-------------LARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH-------------HHHHHHCCCCCCSTTTTTSCHHH
T ss_pred CHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH-------------HHHHccCCcccCccccccCCHHH
Confidence 99999888899999999999999999999999976432111111 01111111 1122345678899
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
.+||.+||..||++|||+.+++++-.
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 99999999999999999999997643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=308.50 Aligned_cols=200 Identities=22% Similarity=0.262 Sum_probs=169.8
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCC-ChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
.+.+|++++++++||||+++++++.+.+..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||+.+
T Consensus 75 ~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~-- 150 (335)
T 3dls_A 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD-- 150 (335)
T ss_dssp EEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5678999999999999999999999999999999999766 9999986543 4999999999999999999999755
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCC-CCCCceehhHHHHHHHHhCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~ 181 (311)
|+||||||+||+++.++.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 151 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 227 (335)
T 3dls_A 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227 (335)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCC
Confidence 99999999999999999999999999987544322 334578999999999988876 78899999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.||...... .. .....+..++.++.+||.+||..||++|||+.++++..
T Consensus 228 ~pf~~~~~~----------------------~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 228 NPFCELEET----------------------VE--AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp CSCSSGGGG----------------------TT--TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred CchhhHHHH----------------------Hh--hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 999753210 00 01122344678899999999999999999999999763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=310.86 Aligned_cols=233 Identities=21% Similarity=0.306 Sum_probs=178.0
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+.... ........+.+.+|+.+|++++ ||||+++++++..++..|+||| +.+++|.+++
T Consensus 68 ~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l 146 (390)
T 2zmd_A 68 GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL 146 (390)
T ss_dssp SSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHH
T ss_pred CCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHH
Confidence 57788876543311 0112334567899999999996 5999999999999999999999 5577999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++...............||+.
T Consensus 147 ~~~~--~~~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 221 (390)
T 2zmd_A 147 KKKK--SIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221 (390)
T ss_dssp HHCS--SCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGG
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCC
Confidence 7654 489999999999999999999965 599999999999995 57899999999987644333223345679999
Q ss_pred ccCcccccc-----------CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC
Q 021507 150 YAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG 218 (311)
Q Consensus 150 y~aPE~~~~-----------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (311)
|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+...+.....
T Consensus 222 y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------------~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------------ISKLHAIIDPNHE 286 (390)
T ss_dssp GCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---------------HHHHHHHHCTTSC
T ss_pred ccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---------------HHHHHHHhCcccc
Confidence 999999865 36888999999999999999999999753211 1112222223333
Q ss_pred CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 219 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
...+...+.++.+||.+||..||.+|||+.+++++.
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 344555577899999999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=295.97 Aligned_cols=207 Identities=24% Similarity=0.400 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++.... .+++..++.++.|++.||+|||+.
T Consensus 57 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~- 133 (284)
T 2vgo_A 57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER- 133 (284)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34678999999999999999999999999999999999999999999997654 389999999999999999999965
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
+++|+||||+||+++.++.+||+|||++....... .....|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 134 -~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (284)
T 2vgo_A 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208 (284)
T ss_dssp -TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred -CceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHC
Confidence 59999999999999999999999999987543321 2345789999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..||........ ...+.. .....+..++..+.++|.+||..||.+|||+.+++++
T Consensus 209 ~~pf~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 209 MPPFDSPSHTET----------------HRRIVN--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp SCTTCCSSHHHH----------------HHHHHT--TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCCCCCCHhHH----------------HHHHhc--cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 999976432111 011111 1123456678899999999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=292.69 Aligned_cols=216 Identities=26% Similarity=0.391 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++ +.+..|+||||+.+++|.+++.... .+++..++.++.|++.||+|||+.+
T Consensus 61 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ 137 (291)
T 1xbb_A 61 LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN 137 (291)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456799999999999999999999999 5677899999999999999997653 4999999999999999999999755
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
++|+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 138 --i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 215 (291)
T 1xbb_A 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215 (291)
T ss_dssp --EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred --eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999998754433221 1223346788999999998889999999999999999999
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||...... .....+........+..++..+.+++.+||..||.+||++.++++.|+.+-
T Consensus 216 ~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 216 YGQKPYRGMKGS-----------------EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp TTCCSSTTCCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99999864321 112222222333456678899999999999999999999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=298.11 Aligned_cols=220 Identities=28% Similarity=0.390 Sum_probs=182.3
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCC-eeEEEEecCCCCChHHHhhhcCC--------------CCCCHHHHHH
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMK 84 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~ 84 (311)
..+.+.+|++++.++ +||||+++++++...+ ..|+||||+++++|.+++..... ..+++..++.
T Consensus 73 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (316)
T 2xir_A 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHH
T ss_pred HHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHH
Confidence 445789999999999 7999999999987754 48999999999999999965432 1288999999
Q ss_pred HHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCC
Q 021507 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 164 (311)
Q Consensus 85 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 164 (311)
++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++................+|..|+|||++.+..++.+
T Consensus 153 ~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 230 (316)
T 2xir_A 153 YSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230 (316)
T ss_dssp HHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccch
Confidence 9999999999999755 99999999999999999999999999987654444333445678899999999999999999
Q ss_pred CceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCC
Q 021507 165 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 243 (311)
Q Consensus 165 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 243 (311)
+|||||||++|+|++ |..||...... ......+........+..++..+.+++.+||+.||.+
T Consensus 231 ~Di~slG~il~~l~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 294 (316)
T 2xir_A 231 SDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 294 (316)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hHHHHHHHHHHHHHhCCCCCCcccchh----------------HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 999999999999998 99999764321 1111222222233445667889999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 021507 244 RPRMSEVLAILERLE 258 (311)
Q Consensus 244 Rpt~~~~l~~l~~~~ 258 (311)
|||+.++++.|+.+.
T Consensus 295 Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 295 RPTFSELVEHLGNLL 309 (316)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=294.40 Aligned_cols=219 Identities=25% Similarity=0.421 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCe-----eEEEEecCCCCChHHHhhh----cCCCCCCHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN-----RLLVYEFMPKGSLENHLFR----RGPQPLSWAVRMKVAIGAAK 91 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~~i~~ 91 (311)
..+.+.+|+.++++++||||+++++++.+.+. .|+||||+.+++|.+++.. .....+++..++.++.|++.
T Consensus 79 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~ 158 (313)
T 3brb_A 79 EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158 (313)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHH
Confidence 34668999999999999999999999987553 4999999999999999843 23356999999999999999
Q ss_pred HHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhH
Q 021507 92 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 171 (311)
Q Consensus 92 ~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 171 (311)
||.|||+. +|+||||||+||+++.++.+||+|||++................++..|+|||++.+..++.++||||||
T Consensus 159 aL~~LH~~--~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 236 (313)
T 3brb_A 159 GMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236 (313)
T ss_dssp HHHHHHTT--TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHH
T ss_pred HHHHHHhC--CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHH
Confidence 99999965 5999999999999999999999999999865443322233445678899999999999999999999999
Q ss_pred HHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
+++|+|++ |..||...... .....+........+..++..+.+++.+||..||.+|||+.++
T Consensus 237 ~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (313)
T 3brb_A 237 VTMWEIATRGMTPYPGVQNH-----------------EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299 (313)
T ss_dssp HHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HHHHHHHhcCCCCCccCCHH-----------------HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 99999999 99999764321 1112222222334556778899999999999999999999999
Q ss_pred HHHHHhhc
Q 021507 251 LAILERLE 258 (311)
Q Consensus 251 l~~l~~~~ 258 (311)
++.|+++.
T Consensus 300 ~~~L~~l~ 307 (313)
T 3brb_A 300 RLQLEKLL 307 (313)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=290.42 Aligned_cols=216 Identities=29% Similarity=0.435 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+
T Consensus 47 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~- 124 (267)
T 3t9t_A 47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC- 124 (267)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678999999999999999999999999999999999999999999996543 35899999999999999999999755
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-C
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 180 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g 180 (311)
++|+||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |
T Consensus 125 -i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp -CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -cccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccC
Confidence 9999999999999999999999999997653221 111233456788999999998999999999999999999999 8
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
..||...... .....+........+..++..+.+++.+||..||.+|||+.++++.|+++.
T Consensus 203 ~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 203 KIPYENRSNS-----------------EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCTTTTCCHH-----------------HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHH-----------------HHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999764321 111122222223345567889999999999999999999999999998875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=299.83 Aligned_cols=247 Identities=21% Similarity=0.246 Sum_probs=178.2
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 15 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 94 (311)
T 4agu_A 15 SYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR 94 (311)
T ss_dssp SSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred CCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh
Confidence 57777777654321 11223446778899999999999999999999999999999999999989988875
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ......||..|
T Consensus 95 ~~--~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y 168 (311)
T 4agu_A 95 YQ--RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWY 168 (311)
T ss_dssp TS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGG
T ss_pred hh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccc
Confidence 44 34999999999999999999999755 99999999999999999999999999986543222 23345789999
Q ss_pred cCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh-hccccccchhhhhHh------hhcccCCC--
Q 021507 151 AAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPYLSDKRKLFRI------MDTKLGGQ-- 220 (311)
Q Consensus 151 ~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~-- 220 (311)
+|||++.+ ..++.++||||||+++|+|++|..||.+........... ............... ........
T Consensus 169 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 4agu_A 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME 248 (311)
T ss_dssp CCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCC
T ss_pred cChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccc
Confidence 99999976 568999999999999999999999998765422211110 000000000000000 00000000
Q ss_pred ----CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 221 ----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 221 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
....++..+.+|+.+||..||.+|||+++++++
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 012467789999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=309.87 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=185.4
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++.+++..|+||||++|++|.+++..
T Consensus 45 ~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 124 (360)
T 3eqc_A 45 NGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124 (360)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH
T ss_pred CCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH
Confidence 57777776654321 111234567799999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.. .+++..+..++.+++.||+|||+. ++|+||||||+||+++.++.+||+|||++...... ......||+.|+
T Consensus 125 ~~--~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~ 197 (360)
T 3eqc_A 125 AG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 197 (360)
T ss_dssp HS--SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTC
T ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeE
Confidence 54 389999999999999999999973 24999999999999999999999999998643211 133457899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhh--------------------------ccccccc
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--------------------------AKPYLSD 205 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------------------------~~~~~~~ 205 (311)
|||++.+..++.++|||||||++|+|++|..||.............. ..+....
T Consensus 198 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
T 3eqc_A 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277 (360)
T ss_dssp CHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCH
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccc
Confidence 99999999999999999999999999999999986543221111000 0000000
Q ss_pred hhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 206 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
...................++.++.+||.+||..||.+|||+.+++++-
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 278 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred hhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0111111112222222334688899999999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=291.98 Aligned_cols=219 Identities=26% Similarity=0.366 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++||||+++++++ ..+..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 52 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~ 129 (287)
T 1u59_A 52 ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK 129 (287)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4566789999999999999999999999 556789999999999999998643 34599999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
+ ++|+||||+||+++.++.+||+|||++......... .......+|..|+|||++.+..++.++||||||+++|+|+
T Consensus 130 ~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 207 (287)
T 1u59_A 130 N--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207 (287)
T ss_dssp T--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred C--EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 5 999999999999999999999999999876433221 1122345688999999999888999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |..||...... .....+........+..++..+.+++.+||..||.+||++.++++.|+.+
T Consensus 208 t~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 208 SYGQKPYKKMKGP-----------------EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TTSCCTTTTCCTH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCcccCCHH-----------------HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 8 99999764321 11122222223345667889999999999999999999999999999887
Q ss_pred cC
Q 021507 258 EA 259 (311)
Q Consensus 258 ~~ 259 (311)
..
T Consensus 271 ~~ 272 (287)
T 1u59_A 271 YY 272 (287)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=296.25 Aligned_cols=218 Identities=28% Similarity=0.431 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC--------------CCCCCHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKV 85 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~ 85 (311)
..+.+.+|+++++++ +||||+++++++.+.+..|+||||+++++|.+++.... ...+++..++.+
T Consensus 68 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 147 (327)
T 1fvr_A 68 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147 (327)
T ss_dssp --CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHH
Confidence 445688999999999 99999999999999999999999999999999996543 245999999999
Q ss_pred HHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCC
Q 021507 86 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 165 (311)
Q Consensus 86 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 165 (311)
+.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ......++..|+|||++.+..++.++
T Consensus 148 ~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~ 222 (327)
T 1fvr_A 148 AADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNS 222 (327)
T ss_dssp HHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHHHHhCC--ccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchh
Confidence 999999999999755 9999999999999999999999999997432211 12234568899999999988899999
Q ss_pred ceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCC
Q 021507 166 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 244 (311)
Q Consensus 166 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (311)
|||||||++|+|++ |..||...... .....+........+..++..+.+++.+||..||.+|
T Consensus 223 Di~slG~il~ellt~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 285 (327)
T 1fvr_A 223 DVWSYGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 285 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred cchHHHHHHHHHHcCCCCCCCCCcHH-----------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999999998 99999765421 1112222222334456778899999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 021507 245 PRMSEVLAILERLEAP 260 (311)
Q Consensus 245 pt~~~~l~~l~~~~~~ 260 (311)
||+.++++.|+.+...
T Consensus 286 ps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 286 PSFAQILVSLNRMLEE 301 (327)
T ss_dssp CCHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHHHHHh
Confidence 9999999999987644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.14 Aligned_cols=225 Identities=18% Similarity=0.161 Sum_probs=174.4
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
.+.+|+.+++.++||||+++++++.+ ....|+||||+ |++|.+++.... .+++..++.++.|++.||+|||+.
T Consensus 94 ~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~ 170 (345)
T 2v62_A 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN 170 (345)
T ss_dssp HHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 47789999999999999999999988 77889999999 899999996654 599999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCC--cEEEecccccccCCCCCC-----cceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 100 ESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
+ |+||||||+||+++.++ .+||+|||+++....... ........||..|+|||++.+..++.++|||||||
T Consensus 171 ~--ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 248 (345)
T 2v62_A 171 E--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGY 248 (345)
T ss_dssp T--EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHH
T ss_pred C--eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHH
Confidence 4 99999999999998877 999999999976532211 11124457899999999999999999999999999
Q ss_pred HHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
++|+|++|..||.............. ...... ....+... .....++.++.+++.+||..||++||++.++++
T Consensus 249 il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 249 CMLRWLCGKLPWEQNLKDPVAVQTAK-TNLLDE---LPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHSSCTTGGGTTCHHHHHHHH-HHHHHT---TTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhCCCCccccccccHHHHHHH-Hhhccc---ccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999965322111100000 000000 00000000 001246778999999999999999999999999
Q ss_pred HHHhhcCC
Q 021507 253 ILERLEAP 260 (311)
Q Consensus 253 ~l~~~~~~ 260 (311)
.|+.+...
T Consensus 322 ~L~~~~~~ 329 (345)
T 2v62_A 322 ILNPHGIP 329 (345)
T ss_dssp HHCTTCCC
T ss_pred HHhccCCc
Confidence 99886543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=304.23 Aligned_cols=243 Identities=24% Similarity=0.300 Sum_probs=183.9
Q ss_pred ChhHHHhHHHHHHh---h-----hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---A-----RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... + .......+.+.+|++++++++||||+++++++.. ....|+||||+.+++|.++
T Consensus 41 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 120 (317)
T 2buj_A 41 GFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE 120 (317)
T ss_dssp -CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHH
T ss_pred CCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHH
Confidence 46777776653322 1 1123455678999999999999999999999873 3467999999999999999
Q ss_pred hhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-------
Q 021507 69 LFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH------- 139 (311)
Q Consensus 69 l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------- 139 (311)
+... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 121 l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 198 (317)
T 2buj_A 121 IERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198 (317)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHH
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccc
Confidence 8652 2355999999999999999999999754 9999999999999999999999999987543211100
Q ss_pred eeccccccccccCccccccCC---CCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc
Q 021507 140 VSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 216 (311)
Q Consensus 140 ~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (311)
......||..|+|||++.+.. ++.++||||||+++|+|++|..||....... ..........
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~~~~~~~~ 263 (317)
T 2buj_A 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---------------DSVALAVQNQ 263 (317)
T ss_dssp HHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---------------SCHHHHHHCC
T ss_pred ccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---------------chhhHHhhcc
Confidence 011245799999999987654 6889999999999999999999996421100 0011111112
Q ss_pred cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 217 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
.....+..++..+.++|.+||+.||.+|||+.++++.|+.+..+
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 22233456788999999999999999999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=290.98 Aligned_cols=217 Identities=26% Similarity=0.366 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|+.++++++||||+++++++.+ +..|+||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 55 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~ 132 (281)
T 3cc6_A 55 DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI 132 (281)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345679999999999999999999999865 45789999999999999996543 3489999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+ ++|+||||+||+++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 133 ~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt 209 (281)
T 3cc6_A 133 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209 (281)
T ss_dssp T--CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred C--cccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHh
Confidence 5 999999999999999999999999999865433211 1233456889999999998999999999999999999998
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||....... ....+........+..++..+.+++.+||..||.+|||+.++++.|+.+.
T Consensus 210 ~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 210 FGKQPFFWLENKD-----------------VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TTCCTTTTSCGGG-----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccCChHH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 999997543211 11112222223345567889999999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=298.44 Aligned_cols=235 Identities=26% Similarity=0.339 Sum_probs=186.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEE--eCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.+.+|++++++++||||+++++++. +.+..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||
T Consensus 66 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH 144 (327)
T 3lxl_A 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG 144 (327)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567999999999999999999999887 4566899999999999999996543 24999999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+.+ |+|+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+
T Consensus 145 ~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 222 (327)
T 3lxl_A 145 SRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 222 (327)
T ss_dssp HTT--EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred hCC--ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHH
Confidence 754 9999999999999999999999999998764433221 2233567888999999999999999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|++|..||............ ..............+........+..++..+.+++.+||..||.+|||+.++++.|+.
T Consensus 223 ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 300 (327)
T 3lxl_A 223 LFTYCDKSCSPSAEFLRMMG--CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300 (327)
T ss_dssp HHTTTCGGGSHHHHHHHHCC------CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCCCCCccccchhhhhcc--cccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 99999999764321111100 0001111223334444445555677889999999999999999999999999999998
Q ss_pred hcC
Q 021507 257 LEA 259 (311)
Q Consensus 257 ~~~ 259 (311)
+..
T Consensus 301 ~~~ 303 (327)
T 3lxl_A 301 LWS 303 (327)
T ss_dssp C--
T ss_pred HHh
Confidence 754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=304.33 Aligned_cols=234 Identities=18% Similarity=0.218 Sum_probs=182.3
Q ss_pred ChhHHHhHHHHHHh---h-------hhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A-------RSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... + .......+.+.+|+.+++.+ .||||+++++++.+.+..|+||||+.|++|.+++
T Consensus 41 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 120 (327)
T 3lm5_A 41 KFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120 (327)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGG
T ss_pred CCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHH
Confidence 57777777554322 1 11112356788999999999 5699999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCcceeccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
.......+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++........ .....|
T Consensus 121 ~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~g 195 (327)
T 3lm5_A 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMG 195 (327)
T ss_dssp SSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CC
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccC
Confidence 6655567999999999999999999999755 999999999999988 78999999999986543221 234578
Q ss_pred cccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 147 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|+.|+|||++.+..++.++|||||||++|+|++|..||........... ...............++
T Consensus 196 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------------i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN--------------ISQVNVDYSEETFSSVS 261 (327)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------------HHHTCCCCCTTTTTTSC
T ss_pred CcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH--------------HHhcccccCchhhcccC
Confidence 9999999999999999999999999999999999999976542111100 01111112223335678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..+.++|.+||..||.+|||+++++++
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 889999999999999999999999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=297.82 Aligned_cols=209 Identities=27% Similarity=0.350 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
....+.+|+.++++++||||+++++++.+++..|+||||++|++|.+++.... .+++..+..++.|++.||+|||+.+
T Consensus 64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ 141 (327)
T 3a62_A 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG 141 (327)
T ss_dssp -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999997654 3899999999999999999999754
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 180 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 180 (311)
|+||||||+||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 142 --ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 217 (327)
T 3a62_A 142 --IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217 (327)
T ss_dssp --CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --EEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHC
Confidence 9999999999999999999999999987533221 123456789999999999999999999999999999999999
Q ss_pred CCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 181 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 181 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
..||...+... ....+... ....+..++.++.++|.+||..||.+|| ++.+++++
T Consensus 218 ~~pf~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 218 APPFTGENRKK----------------TIDKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp SCSCCCSSHHH----------------HHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCCCCCCHHH----------------HHHHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 99998643211 11111111 1234566788999999999999999999 77888865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=294.78 Aligned_cols=232 Identities=28% Similarity=0.408 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.+.+|++++++++||||+++++++.+. ...++||||+++++|.+++.... +++..++.++.|++.||+|||
T Consensus 75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH 151 (318)
T 3lxp_A 75 QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 151 (318)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHH
Confidence 4466799999999999999999999999874 67899999999999999996543 899999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+.+ |+|+||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|+
T Consensus 152 ~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 229 (318)
T 3lxp_A 152 AQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229 (318)
T ss_dssp HTT--EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred hCC--ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHH
Confidence 755 999999999999999999999999999876543322 12334567888999999999899999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|++|..||.......... ... .............+........+..++.++.+||.+||+.||.+|||+.++++.|+.
T Consensus 230 ll~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 230 LLTHCDSSQSPPTKFLEL-IGI-AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HHTTTCGGGSHHHHHHHH-HCS-CCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCCCcccccchhhhhh-hcc-cccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 999999997643211100 000 000111122333444444555677888999999999999999999999999999988
Q ss_pred hc
Q 021507 257 LE 258 (311)
Q Consensus 257 ~~ 258 (311)
+.
T Consensus 308 l~ 309 (318)
T 3lxp_A 308 VH 309 (318)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=295.86 Aligned_cols=232 Identities=25% Similarity=0.301 Sum_probs=175.3
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++..
T Consensus 34 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 113 (285)
T 3is5_A 34 AFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS 113 (285)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHH
T ss_pred CCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHh
Confidence 57788876654321 111122346789999999999999999999999999999999999999999998854
Q ss_pred c--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe---CCCCcEEEecccccccCCCCCCcceeccccc
Q 021507 72 R--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 72 ~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
. ....+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++....... ......|
T Consensus 114 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~ 188 (285)
T 3is5_A 114 AQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAG 188 (285)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CT
T ss_pred hhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCccc
Confidence 3 2345999999999999999999999755 9999999999999 456789999999997643322 1334578
Q ss_pred cccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 147 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|..|+|||++. ..++.++||||||+++|+|++|..||.+.............. .........++
T Consensus 189 t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~ 252 (285)
T 3is5_A 189 TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE---------------PNYAVECRPLT 252 (285)
T ss_dssp TGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------CCCCC--CCCC
T ss_pred ccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC---------------cccccccCcCC
Confidence 99999999985 568889999999999999999999998754321111111000 00001112357
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..+.+++.+||..||.+|||+.++++.
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 789999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=291.00 Aligned_cols=220 Identities=25% Similarity=0.375 Sum_probs=178.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCee-EEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENR-LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
...+.+.+|+.++++++||||+++++++.+.+.. ++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 64 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~ 142 (298)
T 3pls_A 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE 142 (298)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999876655 99999999999999996533 458999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC--cceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
.+ ++||||||+||+++.++.+||+|||++........ ........++..|+|||.+.+..++.++||||||+++|+
T Consensus 143 ~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 220 (298)
T 3pls_A 143 QK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWE 220 (298)
T ss_dssp TT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred CC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHH
Confidence 55 99999999999999999999999999976533221 112234567889999999999999999999999999999
Q ss_pred HHhCCCc-cCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 177 LLSGRCA-VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 177 l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
|++|..| |..... ......+........+..++..+.+++.+||..||.+|||+.++++.|+
T Consensus 221 l~~g~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 221 LLTRGAPPYRHIDP-----------------FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp HHHTSCCTTTTSCG-----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhhCCCCCCccCCH-----------------HHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9995544 443221 1122222222333445667889999999999999999999999999998
Q ss_pred hhcC
Q 021507 256 RLEA 259 (311)
Q Consensus 256 ~~~~ 259 (311)
++..
T Consensus 284 ~~~~ 287 (298)
T 3pls_A 284 QIVS 287 (298)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=303.47 Aligned_cols=220 Identities=27% Similarity=0.393 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
...+.|.+|+.++++++||||+++++++.+ ++..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 132 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~ 210 (373)
T 3c1x_A 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS 210 (373)
T ss_dssp HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345679999999999999999999998654 567899999999999999996543 458999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
.+ |+||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+
T Consensus 211 ~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e 288 (373)
T 3c1x_A 211 KK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288 (373)
T ss_dssp TT--CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CC--EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHH
Confidence 55 999999999999999999999999999865332211 11233457789999999999999999999999999999
Q ss_pred HHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 177 LLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 177 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
|++ |.+||........ ...+........+..++..+.+++.+||..||++|||+.++++.|+
T Consensus 289 llt~~~~p~~~~~~~~~-----------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 289 LMTRGAPPYPDVNTFDI-----------------TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp HHTTSCCSCTTSCSSCH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCcCCCCCCCCHHHH-----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999 7888876432111 1111112222345667889999999999999999999999999999
Q ss_pred hhcC
Q 021507 256 RLEA 259 (311)
Q Consensus 256 ~~~~ 259 (311)
.+..
T Consensus 352 ~i~~ 355 (373)
T 3c1x_A 352 AIFS 355 (373)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=291.17 Aligned_cols=217 Identities=27% Similarity=0.421 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++. .+..++||||+.+++|.+++.......+++..++.++.|++.||+|||+.+
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 129 (279)
T 1qpc_A 51 SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129 (279)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3567899999999999999999999886 456899999999999999996543335999999999999999999999755
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 179 (311)
++|+||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 130 --i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 206 (279)
T 1qpc_A 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (279)
T ss_dssp --EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999987543321 12234456788999999998889999999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||...... .....+........+..++..+.+++.+||..||++|||+.++++.|+.+.
T Consensus 207 g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 207 GRIPYPGMTNP-----------------EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp TCCSSTTCCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccCHH-----------------HHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 99999764321 111222222333445677889999999999999999999999999998864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=316.82 Aligned_cols=230 Identities=26% Similarity=0.293 Sum_probs=181.2
Q ss_pred ChhHHHhHHHHHHh---hhh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH---ARS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++.+.... +.+ .....+.+.+|++++++++||||+++++++.+.+..|+||||+.|++|.+++.
T Consensus 34 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 113 (486)
T 3mwu_A 34 SFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113 (486)
T ss_dssp SSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHH
Confidence 57888887654322 111 11234568899999999999999999999999999999999999999999886
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC---CCCcEEEecccccccCCCCCCcceecccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
... .+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||++....... ......||
T Consensus 114 ~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt 186 (486)
T 3mwu_A 114 KRK--RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGT 186 (486)
T ss_dssp HHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTG
T ss_pred hcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCC
Confidence 654 4999999999999999999999755 99999999999995 45679999999998654332 23345799
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC--CCCchHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKA 225 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 225 (311)
+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... ...+...... ......+
T Consensus 187 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----------------LKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp GGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHTCCCSCSGGGGGS
T ss_pred CCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhCCCCCCCcccCCC
Confidence 99999999875 589999999999999999999999976542111 1111111111 1122457
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+.++.+||.+||..||.+|||+.+++++.
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 88999999999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=319.58 Aligned_cols=230 Identities=26% Similarity=0.301 Sum_probs=183.9
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... +.+ .....+.+.+|+.++++++||||+++++++.+.+..|+||||+.|++|.+++
T Consensus 38 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 117 (484)
T 3nyv_A 38 SFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117 (484)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHH
Confidence 57888877655322 111 1224567899999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe---CCCCcEEEecccccccCCCCCCcceeccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
.... .+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++........ .....|
T Consensus 118 ~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~g 190 (484)
T 3nyv_A 118 ISRK--RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIG 190 (484)
T ss_dssp HTCS--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTT
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCC
Confidence 6544 4999999999999999999999755 9999999999999 5678899999999986543321 334579
Q ss_pred cccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC--CCchH
Q 021507 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQK 224 (311)
Q Consensus 147 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 224 (311)
|+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... ...+....... .....
T Consensus 191 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~ 253 (484)
T 3nyv_A 191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI----------------LKKVEKGKYTFELPQWKK 253 (484)
T ss_dssp GGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHCCCCCCSGGGGG
T ss_pred CccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHcCCCCCCCccccc
Confidence 999999999876 689999999999999999999999987542111 11111111111 12246
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++..+.+||.+||..||.+|||+.+++++-
T Consensus 254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 254 VSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 788999999999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=296.71 Aligned_cols=234 Identities=22% Similarity=0.332 Sum_probs=182.1
Q ss_pred ChhHHHhHHHHHHhh--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELHA--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||.+.+..... .......+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++...
T Consensus 34 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 113 (295)
T 2clq_A 34 TYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK 113 (295)
T ss_dssp SSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHT
T ss_pred CcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhh
Confidence 577888776543221 112234567899999999999999999999999999999999999999999999654
Q ss_pred C-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 73 G-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 73 ~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++. ++.+||+|||++........ ......|+..|
T Consensus 114 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y 189 (295)
T 2clq_A 114 WGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQY 189 (295)
T ss_dssp TCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGG
T ss_pred ccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccc
Confidence 3 345779999999999999999999754 999999999999987 88999999999986543221 13345789999
Q ss_pred cCccccccCC--CCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 151 AAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 151 ~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
+|||++.+.. ++.++||||||+++|+|++|..||........ ..............+..++.+
T Consensus 190 ~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T 2clq_A 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------------AMFKVGMFKVHPEIPESMSAE 254 (295)
T ss_dssp CCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---------------HHHHHHHHCCCCCCCTTSCHH
T ss_pred cChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---------------HHHhhccccccccccccCCHH
Confidence 9999997754 78899999999999999999999975322110 011111112233455677889
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+++.+||..||++||++.+++++
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.47 Aligned_cols=243 Identities=20% Similarity=0.203 Sum_probs=174.2
Q ss_pred ChhHHHhHHHHHHhh----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELHA----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~ 64 (311)
+||+||++.+..... .......+.+.+|+.+|+.++||||+++++++... ...|+||||+.+ +
T Consensus 74 ~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~ 152 (464)
T 3ttj_A 74 AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-N 152 (464)
T ss_dssp SSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-E
T ss_pred CCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-C
Confidence 578888876554321 11233456788999999999999999999999654 457999999976 6
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 153 l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~ 223 (464)
T 3ttj_A 153 LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPY 223 (464)
T ss_dssp HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC---
T ss_pred HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCC
Confidence 7777632 2899999999999999999999765 9999999999999999999999999998654321 23456
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-h-hccccccch----hhhhHhhhccc-
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-D-WAKPYLSDK----RKLFRIMDTKL- 217 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~-~~~~~~~~~----~~~~~~~~~~~- 217 (311)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+ . ...+..... ......+....
T Consensus 224 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~ 303 (464)
T 3ttj_A 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303 (464)
T ss_dssp -CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCC
T ss_pred cccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccc
Confidence 7999999999999999999999999999999999999999876532211110 0 000000000 00000000000
Q ss_pred -----------------CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 -----------------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
........+.++.+||.+||..||++|||++|++++
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011236789999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=297.25 Aligned_cols=221 Identities=26% Similarity=0.369 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC-----CCCCHHHHHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~ 94 (311)
...+.+.+|+.++++++||||+++++++.+.+..|+||||++|++|.+++..... ..+++..++.++.|++.||.
T Consensus 75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 154 (327)
T 2yfx_A 75 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154 (327)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHH
Confidence 3455788999999999999999999999999999999999999999999976532 34899999999999999999
Q ss_pred HhhhCCCCeeecCCCCCceEeCCC---CcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhH
Q 021507 95 FLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 171 (311)
Q Consensus 95 ~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 171 (311)
|||+.+ ++||||||+||+++.+ ..+||+|||++................++..|+|||++.+..++.++||||||
T Consensus 155 ~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 232 (327)
T 2yfx_A 155 YLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232 (327)
T ss_dssp HHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHhhCC--eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence 999755 9999999999999844 45999999999754333222223445678999999999999999999999999
Q ss_pred HHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 172 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 172 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
|++|+|++ |..||...... .....+........+..++..+.+++.+||..||.+||++.++
T Consensus 233 ~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 295 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSNQ-----------------EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 295 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCCCCCCcCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 99999998 99999764321 1112222222334456678899999999999999999999999
Q ss_pred HHHHHhhcC
Q 021507 251 LAILERLEA 259 (311)
Q Consensus 251 l~~l~~~~~ 259 (311)
++.|+.+..
T Consensus 296 l~~l~~~~~ 304 (327)
T 2yfx_A 296 LERIEYCTQ 304 (327)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhc
Confidence 999988754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=308.89 Aligned_cols=255 Identities=20% Similarity=0.217 Sum_probs=189.0
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC--eeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+.+ ..|+||||++|++|.+++
T Consensus 21 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 100 (396)
T 4eut_A 21 ATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL 100 (396)
T ss_dssp SSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHT
T ss_pred CCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHH
Confidence 57888887765422 1122234567889999999999999999999998765 679999999999999999
Q ss_pred hhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe----CCCCcEEEecccccccCCCCCCcceeccc
Q 021507 70 FRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 70 ~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++...... .....
T Consensus 101 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~ 175 (396)
T 4eut_A 101 EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSL 175 (396)
T ss_dssp TSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCS
T ss_pred HhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccc
Confidence 6543 234999999999999999999999755 9999999999999 777889999999998654322 12345
Q ss_pred cccccccCcccccc--------CCCCCCCceehhHHHHHHHHhCCCccCCCccchh--hhhhhh--ccccc--cc----h
Q 021507 145 MGTHGYAAPEYVAT--------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE--QSLVDW--AKPYL--SD----K 206 (311)
Q Consensus 145 ~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~--~~~~~--~~----~ 206 (311)
.||..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...... ..+.. .. .
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 255 (396)
T 4eut_A 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE 255 (396)
T ss_dssp SSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECST
T ss_pred cCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheecc
Confidence 78999999999875 4677899999999999999999999975332110 000000 00000 00 0
Q ss_pred hh-hhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 207 RK-LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 207 ~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
.. ..-.-...........++..+.+++.+||+.||++||++.++++.++.+...
T Consensus 256 ~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00 0000000112234467889999999999999999999999999999887543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=317.53 Aligned_cols=217 Identities=25% Similarity=0.365 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.|.+|+++|++++||||+++++++.. +..|+||||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+
T Consensus 379 ~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ 456 (613)
T 2ozo_A 379 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN 456 (613)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45679999999999999999999999876 5689999999999999999654 345999999999999999999999755
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
|+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++
T Consensus 457 --iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 534 (613)
T 2ozo_A 457 --FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534 (613)
T ss_dssp --CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999875433221 11222345688999999999999999999999999999998
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||...... .....+........+..++.++.+||.+||..||++||++.++++.|+.+.
T Consensus 535 ~G~~Pf~~~~~~-----------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 535 YGQKPYKKMKGP-----------------EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TSCCTTTTCCSH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 99999865421 122223333344566778999999999999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=317.68 Aligned_cols=229 Identities=25% Similarity=0.293 Sum_probs=178.7
Q ss_pred ChhHHHhHHHHHHhh---hh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELHA---RS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++.+..... .+ .....+.+.+|+.+++.++||||+++++++.+.+..|+|||||.||+|.+++.
T Consensus 49 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~ 128 (494)
T 3lij_A 49 AYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128 (494)
T ss_dssp ---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred CCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH
Confidence 588888877654321 11 11224568899999999999999999999999999999999999999999886
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC---CcEEEecccccccCCCCCCcceecccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.. +.+||+|||++....... ......||
T Consensus 129 ~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt 201 (494)
T 3lij_A 129 HRM--KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGT 201 (494)
T ss_dssp HHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSC
T ss_pred HcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCC
Confidence 654 3999999999999999999999755 9999999999999764 459999999998654322 23446799
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC--CCchHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKA 225 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 225 (311)
+.|+|||++. ..++.++|||||||++|+|++|..||.+...... ...+....... .....+
T Consensus 202 ~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~ 264 (494)
T 3lij_A 202 AYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI----------------LRKVEKGKYTFDSPEWKNV 264 (494)
T ss_dssp TTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHTCCCCCSGGGTTS
T ss_pred cCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhCCCCCCchhcccC
Confidence 9999999986 5689999999999999999999999987543111 11111111111 112356
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+..+.+||.+||..||.+|||+.+++++
T Consensus 265 s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 265 SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 7889999999999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=297.00 Aligned_cols=211 Identities=24% Similarity=0.356 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.++++++||||+++++++.+.+..|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~- 128 (283)
T 3bhy_A 52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR- 128 (283)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5679999999999999999999999999999999999999999999996543 4899999999999999999999754
Q ss_pred CeeecCCCCCceEeCCCC----cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
++|+||||+||+++.++ .+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|
T Consensus 129 -i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 204 (283)
T 3bhy_A 129 -IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 204 (283)
T ss_dssp -EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHH
Confidence 99999999999998877 799999999986543221 2345689999999999988999999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||.............. ............++..+.+++.+||..||.+|||+.+++++
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 205 LSGASPFLGETKQETLTNISA--------------VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHSSCTTCCSSHHHHHHHHHT--------------TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHCCCCCCCcchHHHHHHhHh--------------cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 999999986542111100000 00000001113457789999999999999999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=289.66 Aligned_cols=245 Identities=16% Similarity=0.133 Sum_probs=186.4
Q ss_pred ChhHHHhHHHHHHhhhhH------HHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHARSL------LLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+.+........ ....+.+.+|+++++.+ +|+||+++++++.++...|+||||+ +++|.+++....
T Consensus 22 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~ 100 (298)
T 1csn_A 22 SFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG 100 (298)
T ss_dssp SSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT
T ss_pred CCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc
Confidence 467777766433221111 11234588999999999 8999999999999999999999999 889999997543
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc-----EEEecccccccCCCCCCc-----ceecc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRT-----HVSTQ 143 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~~-----~~~~~ 143 (311)
..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++......... .....
T Consensus 101 -~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 177 (298)
T 1csn_A 101 -RKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177 (298)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccC
Confidence 3499999999999999999999965 5999999999999987776 999999999865443221 12345
Q ss_pred ccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCch
Q 021507 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 223 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
..||..|+|||++.+..++.++|||||||++|+|++|..||............... ..............
T Consensus 178 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~ 247 (298)
T 1csn_A 178 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI----------GEKKQSTPLRELCA 247 (298)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----------HHHHHHSCHHHHTT
T ss_pred CCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH----------HhhccCccHHHHHh
Confidence 67999999999999999999999999999999999999999875432111111000 00000000001122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 224 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.++.++.+++.+||+.||++||++.++++.|+++..
T Consensus 248 ~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 467889999999999999999999999999988753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=317.78 Aligned_cols=238 Identities=27% Similarity=0.375 Sum_probs=190.0
Q ss_pred ChhHHHhHHHHHHh--hhh----HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH--ARS----LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||++.+.... +.+ .....+.|.+|+++|++++||||+++++++.+ +..|+||||+.+|+|.+++.....
T Consensus 279 ~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~ 357 (535)
T 2h8h_A 279 CFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG 357 (535)
T ss_dssp SSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHH
T ss_pred CCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCC
Confidence 57777776554321 000 11234679999999999999999999999876 678999999999999999975443
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ........++..|+|||
T Consensus 358 ~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE 434 (535)
T 2h8h_A 358 KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 434 (535)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHH
Confidence 45899999999999999999999755 9999999999999999999999999998654221 11122345678899999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++|||||||++|||++ |..||.+... ......+........+..++..+.+||
T Consensus 435 ~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li 497 (535)
T 2h8h_A 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVERGYRMPCPPECPESLHDLM 497 (535)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999 9999976432 112222233334445667889999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.+||..||++|||+.++++.|+.+..
T Consensus 498 ~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 498 CQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999988753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=291.78 Aligned_cols=214 Identities=28% Similarity=0.450 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeC-CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
..+.+.+|++++++++||||+++++++.+. +..|+||||+++++|.+++.......+++..++.++.|++.||+|||+.
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (278)
T 1byg_A 57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136 (278)
T ss_dssp --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456789999999999999999999987654 4789999999999999999765444488999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
+ ++|+||||+||+++.++.+||+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++
T Consensus 137 ~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 209 (278)
T 1byg_A 137 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209 (278)
T ss_dssp T--CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred C--ccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHh
Confidence 5 999999999999999999999999998754322 223456889999999999999999999999999999998
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
|..||...... .....+........+..++..+.+++.+||..||.+|||+.++++.|+.+.
T Consensus 210 ~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 210 FGRVPYPRIPLK-----------------DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TSCCSCTTSCGG-----------------GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH-----------------HHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 99999764321 111222222233455678889999999999999999999999999998864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=308.18 Aligned_cols=247 Identities=22% Similarity=0.258 Sum_probs=175.1
Q ss_pred ChhHHHhHHHHHHh---hh-------hHHHHHHHHHHHHHHHhcCC-CCCccceEeEEEeCC--eeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH---AR-------SLLLITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGE--NRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~--~~~lv~e~~~~~~L~~ 67 (311)
+||+||.+.+.... +. ......+.+.+|+.+++++. ||||+++++++...+ ..|+||||+.+ +|.+
T Consensus 21 ~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~ 99 (388)
T 3oz6_A 21 AYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHA 99 (388)
T ss_dssp ---CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHHH
Confidence 57888877554322 11 12234456778999999997 999999999997554 68999999975 9999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCC-----------
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD----------- 136 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----------- 136 (311)
++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~ 174 (388)
T 3oz6_A 100 VIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174 (388)
T ss_dssp HHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC
T ss_pred HHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccc
Confidence 88653 4899999999999999999999765 9999999999999999999999999997643211
Q ss_pred --------CcceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh-h-ccccccc
Q 021507 137 --------RTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-W-AKPYLSD 205 (311)
Q Consensus 137 --------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~-~~~~~~~ 205 (311)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+. . ..|....
T Consensus 175 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 254 (388)
T 3oz6_A 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNED 254 (388)
T ss_dssp ---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 1112234579999999999987 578999999999999999999999998765422111110 0 0000000
Q ss_pred --------hhhhhHhhhc-------ccCC------------CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 206 --------KRKLFRIMDT-------KLGG------------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 206 --------~~~~~~~~~~-------~~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.......+.. .... ..+..++.++.+||.+||..||.+|||+++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 255 VESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 0000000000 0000 0112456789999999999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=296.88 Aligned_cols=230 Identities=24% Similarity=0.312 Sum_probs=185.1
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++.+.+..|+||||+++++|.+++..
T Consensus 34 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 113 (303)
T 3a7i_A 34 SFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP 113 (303)
T ss_dssp SSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT
T ss_pred CCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc
Confidence 46777776543321 111123456789999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ......|+..|+
T Consensus 114 ---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~ 186 (303)
T 3a7i_A 114 ---GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWM 186 (303)
T ss_dssp ---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGC
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCcc
Confidence 34999999999999999999999755 99999999999999999999999999976543221 133457899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 231 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (311)
|||++.+..++.++||||||+++|+|++|..||....... ....+........+..++..+.+
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----------------VLFLIPKNNPPTLEGNYSKPLKE 249 (303)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----------------HHHHHHHSCCCCCCSSCCHHHHH
T ss_pred CHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----------------HHHHhhcCCCCCCccccCHHHHH
Confidence 9999999999999999999999999999999997643211 11111112222344567888999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++.+||..||.+|||+.+++++.
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCH
T ss_pred HHHHHcCCChhhCcCHHHHhhCh
Confidence 99999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=296.95 Aligned_cols=230 Identities=22% Similarity=0.327 Sum_probs=180.7
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++...
T Consensus 21 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 100 (304)
T 2jam_A 21 AFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100 (304)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred CCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc
Confidence 46777776654321 0111123456889999999999999999999999999999999999999999998665
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe---CCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
. .+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||++...... ......|++.
T Consensus 101 ~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~ 172 (304)
T 2jam_A 101 G--VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPG 172 (304)
T ss_dssp S--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCC
T ss_pred C--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCC
Confidence 4 3899999999999999999999754 9999999999999 77889999999999754322 1234568999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc--ccCCCCchHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAH 227 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 227 (311)
|+|||++.+..++.++|||||||++|+|++|..||......... ..+... .........++.
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF----------------EKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp BCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------HHHHHCCCCCCTTTTTTSCH
T ss_pred ccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH----------------HHHHcCCCCCCccccccCCH
Confidence 99999999999999999999999999999999999764321110 011111 111223356788
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.+.++|.+||..||.+|||+.+++++.
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=300.33 Aligned_cols=246 Identities=25% Similarity=0.260 Sum_probs=176.8
Q ss_pred ChhHHHhHHHHHHh---h-----hhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---A-----RSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-----~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++.+.... + .......+.+.+|++++.++ +||||+++++++.+++..|+||||++|++|.+++..
T Consensus 25 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 104 (316)
T 2ac3_A 25 AHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104 (316)
T ss_dssp SSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred ceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc
Confidence 47777777654321 1 11122356788999999995 799999999999999999999999999999999976
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc---EEEecccccccCCCCCC-----cceecc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDR-----THVSTQ 143 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~-----~~~~~~ 143 (311)
.. .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++........ ......
T Consensus 105 ~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 180 (316)
T 2ac3_A 105 RR--HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180 (316)
T ss_dssp HS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------------
T ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccccc
Confidence 54 4899999999999999999999754 999999999999988776 99999999876432211 111223
Q ss_pred ccccccccCcccccc-----CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC
Q 021507 144 VMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG 218 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (311)
..||..|+|||++.+ ..++.++|||||||++|+|++|..||............ ..........+...+....
T Consensus 181 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~~- 257 (316)
T 2ac3_A 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR--GEACPACQNMLFESIQEGK- 257 (316)
T ss_dssp -CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------CCHHHHHHHHHHHHHCC-
T ss_pred ccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc--cccchhHHHHHHHHHhccC-
Confidence 468999999999875 45788999999999999999999999765421100000 0000000011111111111
Q ss_pred CCCc----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 219 GQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 219 ~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...+ ..++..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122 2467889999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=302.84 Aligned_cols=246 Identities=19% Similarity=0.170 Sum_probs=170.6
Q ss_pred ChhHHHhHHHHHHhh----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELHA----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++.+..... .......+.+.+|++++++++||||+++++++.+++..|+||||+.| +|.+++.
T Consensus 46 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~ 124 (329)
T 3gbz_A 46 TYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD 124 (329)
T ss_dssp SSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH
T ss_pred CCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHh
Confidence 577888775443221 11223345678999999999999999999999999999999999975 9999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe-----CCCCcEEEecccccccCCCCCCcceecccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~-----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
... .+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++........ ......
T Consensus 125 ~~~--~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~ 198 (329)
T 3gbz_A 125 KNP--DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEI 198 (329)
T ss_dssp HCT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------
T ss_pred hcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCc
Confidence 654 3999999999999999999999755 9999999999999 4555699999999976533221 133456
Q ss_pred ccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hh-ccccccchhhhhH------hhhc-
Q 021507 146 GTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPYLSDKRKLFR------IMDT- 215 (311)
Q Consensus 146 gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~~~~------~~~~- 215 (311)
||..|+|||++.+. .++.++|||||||++|+|++|..||............ .. ..+.......... ....
T Consensus 199 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
T 3gbz_A 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKF 278 (329)
T ss_dssp -CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred CCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhh
Confidence 79999999999875 4899999999999999999999999875432111110 00 0000000000000 0000
Q ss_pred ---ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 216 ---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 216 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
......+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000112356889999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.70 Aligned_cols=210 Identities=25% Similarity=0.303 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.+|++++||||+++++++.+.+..|+|||||+||+|.+++.... .+++..+..++.|++.||+|||+.+
T Consensus 89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ 166 (504)
T 3q5i_A 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN 166 (504)
T ss_dssp THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678999999999999999999999999999999999999999999986654 3999999999999999999999755
Q ss_pred CCeeecCCCCCceEeCCCC---cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
|+||||||+||+++.++ .+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|
T Consensus 167 --ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 240 (504)
T 3q5i_A 167 --IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240 (504)
T ss_dssp --EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHH
T ss_pred --eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHH
Confidence 99999999999998876 69999999998754332 234457999999999986 4689999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC--CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
++|..||.+....... ..+........ ....++.++.+||.+||..||.+|||+.+++++-
T Consensus 241 l~g~~pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 241 LCGYPPFGGQNDQDII----------------KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp HHSSCSSCCSSHHHHH----------------HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HhCCCCCCCCCHHHHH----------------HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 9999999875432111 11111111101 1134678899999999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=319.53 Aligned_cols=215 Identities=26% Similarity=0.389 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.|.+|+++|++++|||||++++++.. +..++||||+.+|+|.+++.... .+++..++.++.||+.||+|||+.+
T Consensus 413 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~ 489 (635)
T 4fl3_A 413 LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN 489 (635)
T ss_dssp GHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45779999999999999999999999864 56899999999999999996543 4899999999999999999999755
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 179 (311)
|+||||||+|||++.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 490 --iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 490 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp --CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999865433221 12233456788999999999999999999999999999998
Q ss_pred -CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 180 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 180 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
|..||.+... ......+........+..++.++.+||.+||..||++||++.++++.|+.+
T Consensus 568 ~G~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 568 YGQKPYRGMKG-----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999986542 122333334444556778899999999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=290.05 Aligned_cols=223 Identities=22% Similarity=0.332 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 19 LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
....+.+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++.. .....+++..++.++.|++.||.||
T Consensus 73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 152 (310)
T 2wqm_A 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152 (310)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 34566789999999999999999999999999999999999999999999854 2335589999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
|+.+ ++|+||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++||||||+++|+
T Consensus 153 H~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 153 HSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp HHTT--CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred hhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHH
Confidence 9755 99999999999999999999999999976533221 1234568999999999999999999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|++|..||.+........ ................++.++.+++.+||..||.+|||+.++++.|++
T Consensus 229 l~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 229 MAALQSPFYGDKMNLYSL--------------CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp HHHSSCTTC---CCHHHH--------------HHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCCCCCcccchhHHHH--------------HHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 999999997643211100 001111111122234578899999999999999999999999999998
Q ss_pred hcC
Q 021507 257 LEA 259 (311)
Q Consensus 257 ~~~ 259 (311)
+.+
T Consensus 295 l~~ 297 (310)
T 2wqm_A 295 MHA 297 (310)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.82 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=179.7
Q ss_pred ChhHHHhHHHHHHh---h------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---A------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++.+.... + .......+.+.+|++++++++||||+++++++.+++..|+||||+.| +|.+++..
T Consensus 17 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~ 95 (317)
T 2pmi_A 17 TYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDS 95 (317)
T ss_dssp --CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHH
T ss_pred CCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHh
Confidence 47777776554321 1 01112235688999999999999999999999999999999999985 99998854
Q ss_pred cC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccc
Q 021507 72 RG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 72 ~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ......||
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t 171 (317)
T 2pmi_A 96 RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVT 171 (317)
T ss_dssp HHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSC
T ss_pred ccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCccc
Confidence 32 245899999999999999999999754 99999999999999999999999999986543221 13345789
Q ss_pred ccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhcc-cccc---ch---------------
Q 021507 148 HGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAK-PYLS---DK--------------- 206 (311)
Q Consensus 148 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~-~~~~---~~--------------- 206 (311)
+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+ .... +... ..
T Consensus 172 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (317)
T 2pmi_A 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPP 251 (317)
T ss_dssp CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCC
T ss_pred ccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccc
Confidence 999999999764 6899999999999999999999999876542211111 0000 0000 00
Q ss_pred hhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 207 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..+...+. ......++.++.+||.+||..||++|||+.+++++
T Consensus 252 ~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 252 RDLRQVLQ----PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCSHHHHG----GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhHHHhhc----ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000 01122457789999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=316.40 Aligned_cols=249 Identities=21% Similarity=0.253 Sum_probs=169.0
Q ss_pred ChhHHHhHHHHHHh---hh-------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH---AR-------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L 65 (311)
+||+||++.+.... +. ......+.+.+|+++|++++||||+++++++... ...|+||||+. ++|
T Consensus 65 ~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L 143 (458)
T 3rp9_A 65 SYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDF 143 (458)
T ss_dssp ---CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEH
T ss_pred CCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cch
Confidence 57888877544321 11 1123346788999999999999999999998533 56899999985 599
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-------
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------- 138 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------- 138 (311)
.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 144 ~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 219 (458)
T 3rp9_A 144 KKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219 (458)
T ss_dssp HHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC--
T ss_pred hhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccC
Confidence 9998654 34999999999999999999999765 999999999999999999999999999875422111
Q ss_pred ------------------ceeccccccccccCcccc-ccCCCCCCCceehhHHHHHHHHh-----------CCCccCCCc
Q 021507 139 ------------------HVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLS-----------GRCAVDKTK 188 (311)
Q Consensus 139 ------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~-----------g~~pf~~~~ 188 (311)
......+||+.|+|||++ .+..++.++|||||||++|||++ |.++|.+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp -------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred ccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence 112345789999999976 45679999999999999999999 666665433
Q ss_pred cchh------------------hh---hhh-hccccccc--------hhhhhHhhhcccCC---CCchHHHHHHHHHHHh
Q 021507 189 VGIE------------------QS---LVD-WAKPYLSD--------KRKLFRIMDTKLGG---QYPQKAAHTAATLALQ 235 (311)
Q Consensus 189 ~~~~------------------~~---~~~-~~~~~~~~--------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~ 235 (311)
.... .. ... ...+.... .......+...... ......+.++.+||.+
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 379 (458)
T 3rp9_A 300 CFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKR 379 (458)
T ss_dssp -----------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHH
T ss_pred cccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 1000 00 000 00000000 00000000000000 0113457889999999
Q ss_pred cccCCCCCCCCHHHHHHHH
Q 021507 236 CLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 236 ~l~~~p~~Rpt~~~~l~~l 254 (311)
||..||.+|||++|++++-
T Consensus 380 mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 380 MLVFNPNKRITINECLAHP 398 (458)
T ss_dssp HSCSSTTTSCCHHHHHHSG
T ss_pred HhccCccccCCHHHHhcCH
Confidence 9999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=290.43 Aligned_cols=247 Identities=21% Similarity=0.255 Sum_probs=177.6
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++++.... ........+.+.+|++++++++||||+++++++.+.+..|+||||+.+ +|.+++..
T Consensus 14 ~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 92 (288)
T 1ob3_A 14 TYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV 92 (288)
T ss_dssp TTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT
T ss_pred CCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh
Confidence 57888877652111 011122346688999999999999999999999999999999999976 99998865
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ......+|+.|+
T Consensus 93 ~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~ 167 (288)
T 1ob3_A 93 CE-GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYR 167 (288)
T ss_dssp ST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTC
T ss_pred cc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--cccccccccccc
Confidence 43 45999999999999999999999754 99999999999999999999999999976432211 123456899999
Q ss_pred CccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhh-ccccccchhhhhHh--hhccc-------CC
Q 021507 152 APEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW-AKPYLSDKRKLFRI--MDTKL-------GG 219 (311)
Q Consensus 152 aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~--~~~~~-------~~ 219 (311)
|||++.+. .++.++|||||||++|+|++|..||.+......... ... ..+........... ..... ..
T Consensus 168 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
T 1ob3_A 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247 (288)
T ss_dssp CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGG
T ss_pred CchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHH
Confidence 99998764 589999999999999999999999987543211110 000 00000000000000 00000 00
Q ss_pred CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 220 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.....++.++.+||.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1123467889999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=293.96 Aligned_cols=209 Identities=25% Similarity=0.329 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|+.++++++||||+++++++.+.+..|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.+
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~- 135 (321)
T 2a2a_A 59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK- 135 (321)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 567899999999999999999999999999999999999999999999654 34899999999999999999999754
Q ss_pred CeeecCCCCCceEeCCCC----cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 102 QVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
++||||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 136 -ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 211 (321)
T 2a2a_A 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (321)
T ss_dssp -EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -eecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHH
Confidence 99999999999999888 799999999986543321 2345689999999999999999999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc--CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||.+........ .+..... .......++..+.++|.+||..||.+|||+.+++++
T Consensus 212 ~~g~~pf~~~~~~~~~~----------------~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 212 LSGASPFLGDTKQETLA----------------NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHSCCSSCCSSHHHHHH----------------HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCCCCCHHHHHH----------------HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 99999997643211110 0100000 000113457789999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=295.89 Aligned_cols=226 Identities=24% Similarity=0.217 Sum_probs=171.3
Q ss_pred ChhHHHhHHHHHHh---hhh-------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARS-------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... +.+ .......+.+|+..+.++ +||||+++++++.+++..|+||||+ +++|.+++
T Consensus 69 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~ 147 (311)
T 3p1a_A 69 SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC 147 (311)
T ss_dssp TTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred CCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHH
Confidence 58888887665322 111 112233445555555555 9999999999999999999999999 56999988
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ......||+.
T Consensus 148 ~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~ 221 (311)
T 3p1a_A 148 EAWG-ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPR 221 (311)
T ss_dssp HHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGG
T ss_pred HhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCcc
Confidence 6654 35999999999999999999999754 9999999999999999999999999987654322 2334568999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+ .++.++|||||||++|+|++|..||...... ............+..++.++
T Consensus 222 y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 222 YMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-------------------QQLRQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp GCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-------------------HHHTTTCCCHHHHTTSCHHH
T ss_pred ccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------------------HHHhccCCCcccccCCCHHH
Confidence 999999876 7899999999999999999997666542110 00000011111223467889
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+++.+||+.||++|||+.+++++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCChhhCcCHHHHHhC
Confidence 999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=303.78 Aligned_cols=242 Identities=21% Similarity=0.238 Sum_probs=178.5
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~ 64 (311)
+||+||.+.+.... ........+.+.+|+++|++++||||+++++++...+ ..|+||||+ +++
T Consensus 37 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~ 115 (367)
T 1cm8_A 37 AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD 115 (367)
T ss_dssp ---CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEE
T ss_pred CCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCC
Confidence 47778777654321 1112334567889999999999999999999998653 459999999 779
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 116 L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~ 185 (367)
T 1cm8_A 116 LGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGY 185 (367)
T ss_dssp HHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSS
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcC
Confidence 99998653 4899999999999999999999755 999999999999999999999999999865332 2345
Q ss_pred cccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhh-ccccccc--------hhhhhHhh
Q 021507 145 MGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW-AKPYLSD--------KRKLFRIM 213 (311)
Q Consensus 145 ~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~~--------~~~~~~~~ 213 (311)
.+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....... ... ..+.... .......+
T Consensus 186 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 265 (367)
T 1cm8_A 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265 (367)
T ss_dssp CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS
T ss_pred cCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhC
Confidence 78999999999887 6789999999999999999999999987653221111 100 0000000 00000000
Q ss_pred hccc---CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 214 DTKL---GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 214 ~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.... ........+..+.+|+.+||..||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 266 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 011223567889999999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=299.91 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=179.0
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++.+.+..|+||||+.+++|.+++.
T Consensus 37 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 116 (331)
T 4aaa_A 37 SYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL 116 (331)
T ss_dssp TTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred CCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh
Confidence 57888877665422 11223456678899999999999999999999999999999999999988888764
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ......|+..|
T Consensus 117 ~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y 190 (331)
T 4aaa_A 117 FP--NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWY 190 (331)
T ss_dssp ST--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTT
T ss_pred hc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccc
Confidence 43 34999999999999999999999755 99999999999999999999999999976433221 23345789999
Q ss_pred cCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhhccccccchhhhhHhh-------hcccCCC-
Q 021507 151 AAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLSDKRKLFRIM-------DTKLGGQ- 220 (311)
Q Consensus 151 ~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-------~~~~~~~- 220 (311)
+|||++.+. .++.++|||||||++|+|++|..||........... .................. .......
T Consensus 191 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
T 4aaa_A 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKERE 270 (331)
T ss_dssp CCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCC
T ss_pred cCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccc
Confidence 999999775 788999999999999999999999987543221111 000000000000000000 0000000
Q ss_pred ----CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 221 ----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 221 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
....++..+.+||.+||..||.+|||+.+++++
T Consensus 271 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 271 PLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 012467889999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=323.45 Aligned_cols=229 Identities=24% Similarity=0.324 Sum_probs=185.7
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... +.+ .....+.+.+|..++..+ +||||+++++++.+.+.+|+||||++||+|.++
T Consensus 353 ~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~ 432 (674)
T 3pfq_A 353 SFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432 (674)
T ss_dssp TTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHH
T ss_pred CCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHH
Confidence 57888877655422 111 112334578899999998 799999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++....... ......||+
T Consensus 433 l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~ 506 (674)
T 3pfq_A 433 IQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTP 506 (674)
T ss_dssp HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCS
T ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCC
Confidence 97654 3999999999999999999999755 99999999999999999999999999986432221 244578999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|||++|..||.+.+.. .....++.. ...++..++.+
T Consensus 507 ~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~ 568 (674)
T 3pfq_A 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQSIMEH--NVAYPKSMSKE 568 (674)
T ss_dssp SSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHSS--CCCCCTTSCHH
T ss_pred cccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHhC--CCCCCccCCHH
Confidence 999999999999999999999999999999999999875421 111122222 23456678999
Q ss_pred HHHHHHhcccCCCCCCCCH-----HHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRM-----SEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~-----~~~l~~ 253 (311)
+.+||.+||..||.+|+++ ++++++
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 9999999999999999987 677653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=301.08 Aligned_cols=233 Identities=23% Similarity=0.293 Sum_probs=175.5
Q ss_pred ChhHHHhHHHHHHhhh---h----HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEe------CCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELHAR---S----LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLE------GENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~---~----~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~------~~~~~lv~e~~~~~~L~ 66 (311)
+||+||.+.+...... + .....+.+.+|+.+++++ +||||+++++++.. .+..|+||||+++++|.
T Consensus 36 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 115 (326)
T 2x7f_A 36 TYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115 (326)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHH
T ss_pred CCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHH
Confidence 4777777765432211 1 011245688999999999 89999999999987 46789999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
+++.......+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ......|
T Consensus 116 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~ 191 (326)
T 2x7f_A 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIG 191 (326)
T ss_dssp HHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCTTTC---------------C
T ss_pred HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccC
Confidence 9997655456999999999999999999999754 99999999999999999999999999976533211 1334578
Q ss_pred cccccCccccc-----cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCC
Q 021507 147 THGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 221 (311)
Q Consensus 147 t~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (311)
+..|+|||++. +..++.++|||||||++|+|++|..||....... ..............
T Consensus 192 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~ 255 (326)
T 2x7f_A 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----------------ALFLIPRNPAPRLK 255 (326)
T ss_dssp CGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHSCCCCCS
T ss_pred CccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----------------HHHHhhcCccccCC
Confidence 99999999987 4568899999999999999999999997643211 11111111122223
Q ss_pred chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 222 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+..++..+.++|.+||..||.+||++.+++++
T Consensus 256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 34567899999999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=307.13 Aligned_cols=248 Identities=18% Similarity=0.144 Sum_probs=186.1
Q ss_pred ChhHHHhHHHHH-----------HhhhhHHHHHHHHHHHHHHHhcCCCCCccc---------------eEeEEEe-CCee
Q 021507 1 MFLFNFLHSHLE-----------LHARSLLLITNWFQTEVNYLGQLHHPNLVK---------------LIGYCLE-GENR 53 (311)
Q Consensus 1 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~---------------~~~~~~~-~~~~ 53 (311)
+||+||.+.+.. .-+.+.....+.+.+|++++++++||||++ +++++.. ++..
T Consensus 54 ~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 133 (352)
T 2jii_A 54 NQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR 133 (352)
T ss_dssp TTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEE
T ss_pred CCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEE
Confidence 577778775432 112222233356889999999999999988 6777776 6788
Q ss_pred EEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC--cEEEeccccccc
Q 021507 54 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKA 131 (311)
Q Consensus 54 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~ 131 (311)
|+||||+ +++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++.
T Consensus 134 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~ 210 (352)
T 2jii_A 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210 (352)
T ss_dssp EEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEETTEEEEEEECCGGGCBC
T ss_pred EEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcCCCCceEEEecCcceee
Confidence 9999999 899999997653456999999999999999999999764 99999999999999998 899999999976
Q ss_pred CCCCCCc-----ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccch
Q 021507 132 GPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 206 (311)
Q Consensus 132 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 206 (311)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~-~~------- 282 (352)
T 2jii_A 211 YCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMK-QK------- 282 (352)
T ss_dssp SSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH-HH-------
T ss_pred ccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHH-HH-------
Confidence 5432111 1123357899999999999989999999999999999999999999865321111000 00
Q ss_pred hhhhHhhhc-ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 207 RKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 207 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
......... .........++.++.+++.+||..||.+|||+.++++.|+.+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 283 QKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp HHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 000000000 00001122457899999999999999999999999999988753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=296.53 Aligned_cols=242 Identities=19% Similarity=0.206 Sum_probs=182.3
Q ss_pred ChhHHHhHHHHHHhhh---h---HHHHHHHHHHHHHHHhcCCCCCccceEeEE-EeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHAR---S---LLLITNWFQTEVNYLGQLHHPNLVKLIGYC-LEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~---~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+.+...... + .....+.+.+|+++++.++|++++..+.++ .+++..++||||+ +++|.+++....
T Consensus 21 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~ 99 (296)
T 4hgt_A 21 SFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS 99 (296)
T ss_dssp SSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT
T ss_pred CCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc
Confidence 5777777764433211 1 112334588999999999988877766655 6777889999999 889999986433
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe---CCCCcEEEecccccccCCCCCCc-----ceecccc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVM 145 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~ 145 (311)
..+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++......... .......
T Consensus 100 -~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 176 (296)
T 4hgt_A 100 -RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176 (296)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCC
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccC
Confidence 34999999999999999999999765 9999999999999 78899999999999865443221 1233567
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC---CCc
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYP 222 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 222 (311)
||..|+|||++.+..++.++|||||||++|+|++|..||............ .......... ...
T Consensus 177 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~ 243 (296)
T 4hgt_A 177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------------ERISEKKMSTPIEVLC 243 (296)
T ss_dssp SCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH-------------HHHHHHHHHSCHHHHT
T ss_pred CCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh-------------hhhhcccccchhhhhh
Confidence 899999999999999999999999999999999999999864432111110 0000000000 011
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 223 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
..++.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 3457789999999999999999999999999988653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=297.61 Aligned_cols=224 Identities=16% Similarity=0.140 Sum_probs=172.1
Q ss_pred HHHHHHHHhcCCCCCccceEeEEEeC----CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 25 FQTEVNYLGQLHHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 25 ~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
+..|+..+..++||||+++++++... ...|+||||+ |++|.+++.... ..+++..++.++.|++.||+|||+.+
T Consensus 95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ 172 (364)
T 3op5_A 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE 172 (364)
T ss_dssp HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45677788889999999999998764 4579999999 899999996643 45999999999999999999999764
Q ss_pred CCeeecCCCCCceEeC--CCCcEEEecccccccCCCCCCc-----ceeccccccccccCccccccCCCCCCCceehhHHH
Q 021507 101 SQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 173 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 173 (311)
|+||||||+|||++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+
T Consensus 173 --iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 173 --YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp --EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred --eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 99999999999998 8899999999999765332111 11233459999999999999999999999999999
Q ss_pred HHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 174 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 174 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|+|++|..||.+........... .. .....+...+.... ....++.++.+++..||..||.+||++.++++.
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDS--KI--RYRENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHH--HH--HHHHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHH--HH--HhhhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 999999999998643221110000 00 00001111111111 113457889999999999999999999999999
Q ss_pred HHhhcC
Q 021507 254 LERLEA 259 (311)
Q Consensus 254 l~~~~~ 259 (311)
|+.+..
T Consensus 324 l~~~~~ 329 (364)
T 3op5_A 324 LLQGLK 329 (364)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 988653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=294.89 Aligned_cols=216 Identities=25% Similarity=0.240 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC---------------------------
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------------------- 73 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------- 73 (311)
..+.+.+|++++++++||||+++++++.+.+..|+||||++||+|.+++....
T Consensus 71 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (345)
T 3hko_A 71 DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150 (345)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccc
Confidence 44678999999999999999999999999999999999999999999884210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC--cEEEecccccccCCCCC--Cc
Q 021507 74 -----------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGD--RT 138 (311)
Q Consensus 74 -----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~--~~ 138 (311)
...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++....... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 228 (345)
T 3hko_A 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228 (345)
T ss_dssp HSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--
T ss_pred ccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCcccc
Confidence 112467788899999999999999765 99999999999998776 89999999997543211 11
Q ss_pred ceeccccccccccCcccccc--CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc
Q 021507 139 HVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 216 (311)
Q Consensus 139 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (311)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....+...
T Consensus 229 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~~~~~~ 292 (345)
T 3hko_A 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD----------------TISQVLNKK 292 (345)
T ss_dssp ------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCC
T ss_pred ccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH----------------HHHHHHhcc
Confidence 12345678999999999875 578899999999999999999999997654211 111122222
Q ss_pred cCCC--CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 217 LGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 217 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.... ....++..+.+||.+||..||.+||++.+++++-
T Consensus 293 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred cccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 1111 1224678999999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=291.30 Aligned_cols=229 Identities=24% Similarity=0.332 Sum_probs=185.9
Q ss_pred ChhHHHhHHHHHHhh-----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELHA-----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+..... .......+.+.+|+.++++++||||+++++++.+.+..|+||||+.+++|.+++
T Consensus 53 ~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 132 (335)
T 2owb_A 53 GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH 132 (335)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHH
Confidence 577787776543210 011235667899999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........ ......|+..
T Consensus 133 ~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~ 206 (335)
T 2owb_A 133 KRRK--ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPN 206 (335)
T ss_dssp HHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCS
T ss_pred hccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCcc
Confidence 6654 4899999999999999999999754 99999999999999999999999999986543221 1334578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++||||||+++|+|++|..||........ ...+... ....+..++..+
T Consensus 207 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~~~~~--~~~~~~~~~~~~ 268 (335)
T 2owb_A 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----------------YLRIKKN--EYSIPKHINPVA 268 (335)
T ss_dssp SCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHHT--CCCCCTTSCHHH
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH----------------HHHHhcC--CCCCCccCCHHH
Confidence 9999999999999999999999999999999999976432111 0111111 123455677889
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.++|.+||..||++|||+.+++++
T Consensus 269 ~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 269 ASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=301.76 Aligned_cols=238 Identities=22% Similarity=0.278 Sum_probs=166.4
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCC-CCCccceEeEEE--------eCCeeEEEEecCCCC
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLH-HPNLVKLIGYCL--------EGENRLLVYEFMPKG 63 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--------~~~~~~lv~e~~~~~ 63 (311)
+||+||++.+.... ........+.+.+|+.+++++. ||||+++++++. .....++||||+. |
T Consensus 40 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g 118 (337)
T 3ll6_A 40 GFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-G 118 (337)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-E
T ss_pred CceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-C
Confidence 57778877654321 1112234567889999999995 999999999984 3345799999996 5
Q ss_pred ChHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc---
Q 021507 64 SLENHLFR-RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--- 139 (311)
Q Consensus 64 ~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--- 139 (311)
+|.+++.. .....+++..++.++.|++.||+|||+.+.+|+||||||+||+++.++.+||+|||++..........
T Consensus 119 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 198 (337)
T 3ll6_A 119 QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198 (337)
T ss_dssp EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------
T ss_pred CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccc
Confidence 99998854 23345999999999999999999999654449999999999999999999999999998654332211
Q ss_pred -------eeccccccccccCcccc---ccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhh
Q 021507 140 -------VSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 209 (311)
Q Consensus 140 -------~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (311)
......||+.|+|||++ .+..++.++|||||||++|+|++|..||......
T Consensus 199 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------------------- 259 (337)
T 3ll6_A 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------------------- 259 (337)
T ss_dssp -------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-------------------
Confidence 11134689999999998 5667888999999999999999999999753321
Q ss_pred hHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 210 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
...............+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 260 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 -RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111111122233445668899999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=288.62 Aligned_cols=220 Identities=26% Similarity=0.373 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.+.+|++++++++||||+++++++.++. .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~ 140 (291)
T 1u46_A 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK 140 (291)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 34567899999999999999999999998764 899999999999999996543 3489999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
+ ++|+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 141 ~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 141 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp T--EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred C--cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 4 9999999999999999999999999998764433221 223345788899999999888999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |..||....... ....+.........+..++..+.+++.+||..||.+|||+.++++.|+++
T Consensus 219 ~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 219 TYGQEPWIGLNGSQ----------------ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp TTSCCTTTTCCHHH----------------HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCcccCCHHH----------------HHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 9 999997653211 11111122222334556788999999999999999999999999999887
Q ss_pred cC
Q 021507 258 EA 259 (311)
Q Consensus 258 ~~ 259 (311)
..
T Consensus 283 ~~ 284 (291)
T 1u46_A 283 QP 284 (291)
T ss_dssp C-
T ss_pred Cc
Confidence 54
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=285.07 Aligned_cols=209 Identities=28% Similarity=0.382 Sum_probs=153.7
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
.+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~- 132 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG- 132 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678999999999999999999999999999999999999999999986543 45999999999999999999999754
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 181 (311)
++|+||||+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 133 -i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 209 (278)
T 3cok_A 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209 (278)
T ss_dssp -EECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSS
T ss_pred -eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986543221 123456899999999999888999999999999999999999
Q ss_pred CccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 182 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 182 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.||......... ..... .....+..++.++.+++.+||..||++|||+.+++++
T Consensus 210 ~p~~~~~~~~~~----------------~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 210 PPFDTDTVKNTL----------------NKVVL--ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CSSCCCSCC---------------------CCS--SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCChhHHHHH----------------HHHhh--cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 999765421110 00000 1112345678899999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=315.47 Aligned_cols=244 Identities=18% Similarity=0.184 Sum_probs=183.8
Q ss_pred ChhHHHhHHHHHHhh---hh---HHHHHHHHHHHHHHHhcCCC-CCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHA---RS---LLLITNWFQTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~---~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||++.+..... .+ .....+.+.+|+++++.|+| ++|..+..++.+.+..|+||||+ +++|.+++....
T Consensus 19 ~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~ 97 (483)
T 3sv0_A 19 SFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS 97 (483)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT
T ss_pred CCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc
Confidence 578888876543321 11 11123358899999999976 56666777777888899999999 889999996533
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe---CCCCcEEEecccccccCCCCCCc-----ceecccc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVM 145 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~ 145 (311)
..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++........ .......
T Consensus 98 -~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 174 (483)
T 3sv0_A 98 -RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174 (483)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCC
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccC
Confidence 35999999999999999999999755 9999999999999 57889999999999865443221 1223567
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 225 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
||..|+|||++.+..++.++|||||||++|+|++|..||............... ...............+
T Consensus 175 gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i----------~~~~~~~~~~~l~~~~ 244 (483)
T 3sv0_A 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----------SEKKVATSIEALCRGY 244 (483)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH----------HHHHHHSCHHHHHTTS
T ss_pred CCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH----------hhccccccHHHHhcCC
Confidence 999999999999999999999999999999999999999875432211111000 0000000000111345
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
+.++.+||.+||..||++||++.+|++.|+.+.
T Consensus 245 p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 245 PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 778999999999999999999999999998864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=300.75 Aligned_cols=234 Identities=15% Similarity=0.111 Sum_probs=181.3
Q ss_pred ChhHHHhHH-----HHHHh---hhhH--HHHHHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHS-----HLELH---ARSL--LLITNWFQTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~-----~~~~~---~~~~--~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||++. +.... +.+. ....+.+.+|+++++.++ |+||+++++++...+..|+||||++||+|.+
T Consensus 77 ~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 156 (365)
T 3e7e_A 77 AFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLN 156 (365)
T ss_dssp SSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHH
T ss_pred CCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHH
Confidence 688899883 33221 1110 112345778888888886 9999999999999999999999999999999
Q ss_pred Hhhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-----------CCcEEEecccccccCC
Q 021507 68 HLFRR---GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----------EFNAKLSDFGLAKAGP 133 (311)
Q Consensus 68 ~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-----------~~~~kl~Dfg~~~~~~ 133 (311)
++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 157 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 157 AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp HHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGG
T ss_pred HHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhh
Confidence 99642 234599999999999999999999965 5999999999999988 8999999999997543
Q ss_pred CCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhh
Q 021507 134 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 213 (311)
Q Consensus 134 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (311)
............||..|+|||++.+..++.++|||||||++|+|++|+.||......... .
T Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------------------~ 295 (365)
T 3e7e_A 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-------------------P 295 (365)
T ss_dssp GSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------------------E
T ss_pred ccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------------------e
Confidence 333333455678999999999999999999999999999999999999999653221000 0
Q ss_pred hcccCCCCchHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhhc
Q 021507 214 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLE 258 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~~l~~l~~~~ 258 (311)
.... ... ..++.+.+++..||+.+|.+|+ ++.++.+.|+.+.
T Consensus 296 ~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 296 EGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp CSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred chhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0000 011 2366788999999999999995 7888888887754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=288.15 Aligned_cols=242 Identities=19% Similarity=0.259 Sum_probs=175.5
Q ss_pred ChhHHHhHHHHHHh-hhhH--HHHHHHHHHHHHHHhc--CCCCCccceEeEEEeC----CeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH-ARSL--LLITNWFQTEVNYLGQ--LHHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-~~~~--~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+++.... +.+. ....+.+.+|.+++.. ++||||+++++++.+. ...|+||||+++|+|.+++..
T Consensus 20 ~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 99 (301)
T 3q4u_A 20 RYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL 99 (301)
T ss_dssp SSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT
T ss_pred CCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh
Confidence 57777776542111 1110 1123445667777766 7999999999987643 457999999999999999954
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc--eecc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQ 143 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~ 143 (311)
. .+++..++.++.|++.||+|||+. .++|+||||||+|||++.++.+||+|||++.......... ....
T Consensus 100 ~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 176 (301)
T 3q4u_A 100 T---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176 (301)
T ss_dssp C---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCC
T ss_pred c---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccc
Confidence 3 499999999999999999999921 2459999999999999999999999999997543322211 1223
Q ss_pred ccccccccCccccccC------CCCCCCceehhHHHHHHHHhC----------CCccCCCccchhhhhhhhccccccchh
Q 021507 144 VMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKR 207 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~ 207 (311)
..||+.|+|||++.+. .++.++|||||||++|+|++| ..||........ ...
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~------------~~~ 244 (301)
T 3q4u_A 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP------------SFE 244 (301)
T ss_dssp CCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC------------CHH
T ss_pred cccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc------------chh
Confidence 4789999999999876 455789999999999999999 777754321100 000
Q ss_pred hhhHhhh-cccCCC-----CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 208 KLFRIMD-TKLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 208 ~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
....... ...... ....++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111110 011111 1235788999999999999999999999999999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=307.13 Aligned_cols=247 Identities=19% Similarity=0.258 Sum_probs=173.9
Q ss_pred ChhHHHhHHHHHHh---h-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH---A-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L 65 (311)
+||+||++.+.... + .......+.+.+|+++|++++||||+++++++... +..|+||||+.+ +|
T Consensus 38 ~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L 116 (432)
T 3n9x_A 38 SYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL 116 (432)
T ss_dssp TTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EH
T ss_pred CCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CH
Confidence 57888887654432 1 11223346788999999999999999999999766 568999999965 99
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-------
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------- 138 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------- 138 (311)
.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 117 ~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 192 (432)
T 3n9x_A 117 KKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192 (432)
T ss_dssp HHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccc
Confidence 9999654 34999999999999999999999765 999999999999999999999999999875433211
Q ss_pred -------------ceeccccccccccCcccc-ccCCCCCCCceehhHHHHHHHHhCCCccCCCccchh------------
Q 021507 139 -------------HVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE------------ 192 (311)
Q Consensus 139 -------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------ 192 (311)
......+||+.|+|||++ .+..++.++|||||||++|||++|..||........
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~ 272 (432)
T 3n9x_A 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLS 272 (432)
T ss_dssp ------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC--
T ss_pred ccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccC
Confidence 112456889999999986 556799999999999999999986555543211000
Q ss_pred --------------hh---hhh-hcccccc-----chhhhhHhhhcccCCCC-------chHHHHHHHHHHHhcccCCCC
Q 021507 193 --------------QS---LVD-WAKPYLS-----DKRKLFRIMDTKLGGQY-------PQKAAHTAATLALQCLNNEPK 242 (311)
Q Consensus 193 --------------~~---~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~ 242 (311)
.. ... ...|... ........+.. ..... ...++.++.+||.+||..||.
T Consensus 273 ~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 351 (432)
T 3n9x_A 273 PDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL-FPHRKPINLKQKYPSISDDGINLLESMLKFNPN 351 (432)
T ss_dssp --------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTT
T ss_pred cccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh-CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcc
Confidence 00 000 0000000 00000111100 00011 134678899999999999999
Q ss_pred CCCCHHHHHHH
Q 021507 243 LRPRMSEVLAI 253 (311)
Q Consensus 243 ~Rpt~~~~l~~ 253 (311)
+|||+++++++
T Consensus 352 ~R~ta~e~L~H 362 (432)
T 3n9x_A 352 KRITIDQALDH 362 (432)
T ss_dssp TSCCHHHHHTC
T ss_pred cCCCHHHHhcC
Confidence 99999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=287.21 Aligned_cols=233 Identities=26% Similarity=0.358 Sum_probs=183.7
Q ss_pred ChhHHHhHHHHHHh---h-hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe----------------CCeeEEEEecC
Q 021507 1 MFLFNFLHSHLELH---A-RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE----------------GENRLLVYEFM 60 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~~lv~e~~ 60 (311)
+||+||.+.+.... + +......+.+.+|++++++++||||+++++++.. ....|+||||+
T Consensus 23 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (284)
T 2a19_B 23 GFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102 (284)
T ss_dssp SSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCC
T ss_pred CceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEecc
Confidence 46777776554221 0 0011112457889999999999999999998864 34579999999
Q ss_pred CCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce
Q 021507 61 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140 (311)
Q Consensus 61 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 140 (311)
++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 177 (284)
T 2a19_B 103 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--- 177 (284)
T ss_dssp CSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---
T ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEEECcchhheecccccc---
Confidence 9999999997655556999999999999999999999754 99999999999999999999999999986543321
Q ss_pred eccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC
Q 021507 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 220 (311)
Q Consensus 141 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (311)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....+. ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------------------~~~~~~---~~~ 235 (284)
T 2a19_B 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-------------------FFTDLR---DGI 235 (284)
T ss_dssp CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------------------HHHHHH---TTC
T ss_pred ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-------------------HHHHhh---ccc
Confidence 2345689999999999999999999999999999999999988753210 001111 112
Q ss_pred CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 221 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
.+..++..+.+++.+||..||.+|||+.++++.|+.+...
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 3345677899999999999999999999999999987643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=285.15 Aligned_cols=230 Identities=24% Similarity=0.321 Sum_probs=186.0
Q ss_pred ChhHHHhHHHHHHhh-----------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELHA-----------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+..... .......+.+.+|+.++++++||||+++++++.+++..|+||||+++++|.+++
T Consensus 27 ~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 106 (294)
T 2rku_A 27 GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH 106 (294)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHH
Confidence 577777766543210 012235667899999999999999999999999999999999999999999988
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ......|+..
T Consensus 107 ~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~ 180 (294)
T 2rku_A 107 KRRK--ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPN 180 (294)
T ss_dssp HHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCS
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCC
Confidence 6654 4899999999999999999999754 99999999999999999999999999986543221 1334578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++||||||+++|+|++|..||........ ...... .....+..++..+
T Consensus 181 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~ 242 (294)
T 2rku_A 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----------------YLRIKK--NEYSIPKHINPVA 242 (294)
T ss_dssp SCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHT--TCCCCCTTSCHHH
T ss_pred cCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhh--ccCCCccccCHHH
Confidence 9999999988899999999999999999999999986542111 011111 1123455677889
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.+++.+||..||++|||+.+++++.
T Consensus 243 ~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 243 ASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred HHHHHHHcccChhhCcCHHHHhhCh
Confidence 9999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=305.20 Aligned_cols=181 Identities=22% Similarity=0.237 Sum_probs=153.0
Q ss_pred ChhHHHhHHHHHHh---hh----hHHHHHHHHHHHHHHHhcC------CCCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH---AR----SLLLITNWFQTEVNYLGQL------HHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~----~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||++.+.... +. ......+.+.+|+++++.+ +|+||+++++++...+..|+||||+. ++|.+
T Consensus 109 ~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~ 187 (429)
T 3kvw_A 109 SFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYE 187 (429)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHH
T ss_pred ccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHH
Confidence 58888888655432 11 1123445677888888887 57799999999999999999999996 59999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc--EEEecccccccCCCCCCcceecccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++...... .....
T Consensus 188 ~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~ 260 (429)
T 3kvw_A 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYI 260 (429)
T ss_dssp HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSC
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccC
Confidence 998776667999999999999999999999765 999999999999999987 999999999764332 23457
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCcc
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 189 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 189 (311)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 261 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp SCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 89999999999999999999999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=283.84 Aligned_cols=213 Identities=20% Similarity=0.264 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEE--eCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 98 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 98 (311)
..+.+.+|++++++++||||+++++++. +.+..|+||||+.++ |.+++.......+++..++.++.|++.||+|||+
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 127 (305)
T 2wtk_C 49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS 127 (305)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999984 456789999999875 8888876656679999999999999999999997
Q ss_pred CCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCC--CCCCCceehhHHHHHH
Q 021507 99 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLE 176 (311)
Q Consensus 99 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~ 176 (311)
.+ ++|+||||+||+++.++.+||+|||++................|+..|+|||++.+.. ++.++||||||+++|+
T Consensus 128 ~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 205 (305)
T 2wtk_C 128 QG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYN 205 (305)
T ss_dssp TT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHH
T ss_pred CC--eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHH
Confidence 55 9999999999999999999999999998754433333344567899999999997654 3779999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
|++|..||....... ....+.. .....+..++..+.+++.+||..||.+|||+.+++++.
T Consensus 206 l~~g~~p~~~~~~~~-----------------~~~~i~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 206 ITTGLYPFEGDNIYK-----------------LFENIGK-GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp HHHSSCSCCCSSHHH-----------------HHHHHHH-CCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred HHhCCCCCCCchHHH-----------------HHHHHhc-CCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 999999998643211 1111111 11234556788999999999999999999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=293.80 Aligned_cols=242 Identities=19% Similarity=0.206 Sum_probs=181.6
Q ss_pred ChhHHHhHHHHHHhhh---h---HHHHHHHHHHHHHHHhcCCCCCccceEeEE-EeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHAR---S---LLLITNWFQTEVNYLGQLHHPNLVKLIGYC-LEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~---~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+.+...... + .....+.+.+|+++++.++|++++..+.++ .+++..++||||+ +++|.+++....
T Consensus 21 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~ 99 (296)
T 3uzp_A 21 SFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS 99 (296)
T ss_dssp TTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT
T ss_pred CCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc
Confidence 4677777764332211 1 011234688999999999988876666555 5677889999999 889999996433
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC---CCCcEEEecccccccCCCCCCc-----ceecccc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRT-----HVSTQVM 145 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~ 145 (311)
..+++..++.++.|++.||+|||+.+ ++||||||+||+++ .++.+||+|||++......... .......
T Consensus 100 -~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 176 (296)
T 3uzp_A 100 -RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176 (296)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCC
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccc
Confidence 35999999999999999999999755 99999999999994 7889999999999865443221 1124567
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC---CCc
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYP 222 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 222 (311)
||..|+|||++.+..++.++|||||||++|+|++|+.||............ ..+....... ...
T Consensus 177 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------------ERISEKKMSTPIEVLC 243 (296)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH-------------HHHHHHHHHSCHHHHT
T ss_pred cccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh-------------hhhcccccCCchHHHH
Confidence 899999999999999999999999999999999999999864321111100 0000000000 012
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 223 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999988653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=290.64 Aligned_cols=225 Identities=16% Similarity=0.177 Sum_probs=176.8
Q ss_pred ChhHHHhHHHHHHh---h-------hhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A-------RSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+.... + .........+.+|+.++..+ +||||+++++++.+.+..|+||||++|++|.+++
T Consensus 23 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 102 (289)
T 1x8b_A 23 EFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 102 (289)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred CceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHH
Confidence 46777776554221 0 01122345688899999999 9999999999999999999999999999999999
Q ss_pred hhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC-------------------CcEEEecccc
Q 021507 70 FRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------------FNAKLSDFGL 128 (311)
Q Consensus 70 ~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-------------------~~~kl~Dfg~ 128 (311)
.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.+ ..+||+|||.
T Consensus 103 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 180 (289)
T 1x8b_A 103 SENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180 (289)
T ss_dssp HHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------------CCCEEECCCTT
T ss_pred HhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEccccc
Confidence 6542 145899999999999999999999755 9999999999999844 4799999999
Q ss_pred cccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchh
Q 021507 129 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 207 (311)
Q Consensus 129 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 207 (311)
+...... ....||..|+|||++.+. .++.++|||||||++|+|++|..++.....
T Consensus 181 ~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------------------ 236 (289)
T 1x8b_A 181 VTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------------------ 236 (289)
T ss_dssp CEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH------------------
T ss_pred ccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH------------------
Confidence 9865432 223589999999999776 566799999999999999999877654221
Q ss_pred hhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 208 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...+........+..++..+.+++.+||..||.+|||+.+++++
T Consensus 237 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 --WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 01111122233455678899999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.02 Aligned_cols=244 Identities=20% Similarity=0.200 Sum_probs=171.1
Q ss_pred ChhHHHhHHHHHHh---h-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH---A-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~ 64 (311)
+||+||++.+.... + .......+.+.+|+.+++.++||||+++++++...+ ..|+||||+.+ +
T Consensus 37 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 115 (371)
T 2xrw_A 37 AQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-N 115 (371)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-E
T ss_pred CCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-C
Confidence 57788877554322 0 112234567889999999999999999999997664 78999999975 8
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 116 l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 186 (371)
T 2xrw_A 116 LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPY 186 (371)
T ss_dssp HHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC----------------
T ss_pred HHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCc
Confidence 8888842 3899999999999999999999754 9999999999999999999999999997643321 23345
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhh-cccccc---ch-hhhhHhhhc---
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW-AKPYLS---DK-RKLFRIMDT--- 215 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~---~~-~~~~~~~~~--- 215 (311)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....... ... ..+... .. .........
T Consensus 187 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (371)
T 2xrw_A 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 266 (371)
T ss_dssp ---CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCC
T ss_pred eecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcc
Confidence 789999999999999999999999999999999999999987553211110 000 000000 00 000000000
Q ss_pred ---------------ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 216 ---------------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 216 ---------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
..........+..+.+||.+||..||.+|||+++++++-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000001123477899999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=303.94 Aligned_cols=244 Identities=21% Similarity=0.254 Sum_probs=182.1
Q ss_pred ChhHHHhHHHHHHh---hh----hHHHHHHHHHHHHHHHhcCC--------CCCccceEeEEE----eCCeeEEEEecCC
Q 021507 1 MFLFNFLHSHLELH---AR----SLLLITNWFQTEVNYLGQLH--------HPNLVKLIGYCL----EGENRLLVYEFMP 61 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~----~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~~~~~----~~~~~~lv~e~~~ 61 (311)
+||+||++.+.... +. ......+.+.+|++++++++ |+||+++++++. .+...|+||||+
T Consensus 49 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~- 127 (397)
T 1wak_A 49 HFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL- 127 (397)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-
T ss_pred CCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-
Confidence 57888888654432 11 11234567889999999995 788999999988 456789999999
Q ss_pred CCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC----------------------
Q 021507 62 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---------------------- 119 (311)
Q Consensus 62 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---------------------- 119 (311)
+++|.+++.......+++..++.++.||+.||+|||+. .+|+||||||+|||++.++
T Consensus 128 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (397)
T 1wak_A 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206 (397)
T ss_dssp CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECCCCSGGGEEECCCHHHHHHHHHHHC-----------
T ss_pred CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCC
Confidence 56888877666556699999999999999999999975 1599999999999998775
Q ss_pred ---------------------------cEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 120 ---------------------------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 120 ---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 281 (397)
T 1wak_A 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTAC 281 (397)
T ss_dssp ----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHH
T ss_pred CCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHH
Confidence 7999999999865432 23457899999999999999999999999999
Q ss_pred HHHHHHhCCCccCCCccchhh---h----hhhhcccc--------------ccch-----------hhhhHhhhcccCCC
Q 021507 173 VLLELLSGRCAVDKTKVGIEQ---S----LVDWAKPY--------------LSDK-----------RKLFRIMDTKLGGQ 220 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~---~----~~~~~~~~--------------~~~~-----------~~~~~~~~~~~~~~ 220 (311)
++|+|++|..||......... . ........ .... ......+. ....
T Consensus 282 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 359 (397)
T 1wak_A 282 MAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV--EKYE 359 (397)
T ss_dssp HHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHH--HTSC
T ss_pred HHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhh--hhcc
Confidence 999999999999765432110 0 00000000 0000 00000000 0113
Q ss_pred CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 221 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+...+..+.+||.+||..||.+|||+.+++++
T Consensus 360 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 360 WSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 456778899999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=290.91 Aligned_cols=235 Identities=25% Similarity=0.359 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCC--eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
...+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||
T Consensus 84 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH 162 (326)
T 2w1i_A 84 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG 162 (326)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567999999999999999999999987654 6899999999999999997653 34899999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
+.+ ++|+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+
T Consensus 163 ~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 240 (326)
T 2w1i_A 163 TKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240 (326)
T ss_dssp HTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred hCC--EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHH
Confidence 754 9999999999999999999999999998764433221 1223456778999999999889999999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
|++|..||.............. .........+...+........+..++.++.++|.+||..||.+|||+.++++.|+.
T Consensus 241 l~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 241 LFTYIEKSKSPPAEFMRMIGND-KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHTTCGGGSHHHHHHHHHCTT-CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCCCCCCCHHHHHHhhccc-cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9999999875321111000000 000000111223333333344566788999999999999999999999999999988
Q ss_pred hc
Q 021507 257 LE 258 (311)
Q Consensus 257 ~~ 258 (311)
+.
T Consensus 320 l~ 321 (326)
T 2w1i_A 320 IR 321 (326)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=294.10 Aligned_cols=243 Identities=23% Similarity=0.292 Sum_probs=167.9
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++..
T Consensus 27 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 106 (303)
T 2vwi_A 27 ATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH 106 (303)
T ss_dssp -CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHH
T ss_pred cceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHH
Confidence 47777777554322 111123456688999999999999999999999999999999999999999999864
Q ss_pred c------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC---cceec
Q 021507 72 R------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR---THVST 142 (311)
Q Consensus 72 ~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 142 (311)
. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ .....
T Consensus 107 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 184 (303)
T 2vwi_A 107 IVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184 (303)
T ss_dssp HHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCHHHHHCC------------
T ss_pred HhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhc
Confidence 1 2345899999999999999999999754 99999999999999999999999999876543221 11223
Q ss_pred cccccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCC
Q 021507 143 QVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 221 (311)
Q Consensus 143 ~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (311)
...||+.|+|||++.+ ..++.++||||||+++|+|++|..||................+. .. .........
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~ 256 (303)
T 2vwi_A 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP-----SL---ETGVQDKEM 256 (303)
T ss_dssp ---CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC-----CT---TC-----CC
T ss_pred ccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC-----cc---ccccccchh
Confidence 4578999999999876 56889999999999999999999999865432111100000000 00 000001122
Q ss_pred chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 222 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...++..+.+++.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 34567789999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=285.63 Aligned_cols=244 Identities=20% Similarity=0.287 Sum_probs=177.2
Q ss_pred ChhHHHhHHHHHHh-hhhH--HHHHHHHHHHHHHHhcC--CCCCccceEeEEEeC----CeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH-ARSL--LLITNWFQTEVNYLGQL--HHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-~~~~--~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++++.... +.+. ......+.+|.+++..+ +||||+++++++... ...|+||||+++|+|.+++..
T Consensus 49 ~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 128 (337)
T 3mdy_A 49 RYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS 128 (337)
T ss_dssp TTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH
T ss_pred CCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc
Confidence 57777776543211 1110 11223455566666665 999999999999887 788999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc--eecc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQ 143 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~ 143 (311)
. .+++..++.++.|++.||+|||+. ..+|+||||||+||+++.++.+||+|||++.......... ....
T Consensus 129 ~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 205 (337)
T 3mdy_A 129 T---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205 (337)
T ss_dssp C---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCS
T ss_pred c---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCC
Confidence 4 399999999999999999999975 1269999999999999999999999999997654332211 1224
Q ss_pred ccccccccCccccccCCCCCC------CceehhHHHHHHHHhCC----------CccCCCccchhhhhhhhccccccchh
Q 021507 144 VMGTHGYAAPEYVATGRLTTK------SDVYSFGVVLLELLSGR----------CAVDKTKVGIEQSLVDWAKPYLSDKR 207 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~~~~~~------~Di~slG~il~~l~~g~----------~pf~~~~~~~~~~~~~~~~~~~~~~~ 207 (311)
..||+.|+|||++.+...+.. +|||||||++|+|++|. .||....... ....
T Consensus 206 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~------------~~~~ 273 (337)
T 3mdy_A 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD------------PSYE 273 (337)
T ss_dssp SCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS------------CCHH
T ss_pred CccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC------------Cchh
Confidence 579999999999988766665 99999999999999994 4443321100 0001
Q ss_pred hhhHhh-hcccCCCCc-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 208 KLFRIM-DTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 208 ~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
...... ........+ ..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 111111 111122222 3678899999999999999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=290.29 Aligned_cols=233 Identities=22% Similarity=0.257 Sum_probs=169.9
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++.+.... ........+.+.++...++.++||||+++++++.+++..|+||||++| +|.+++.
T Consensus 19 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 97 (290)
T 3fme_A 19 AYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYK 97 (290)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHH
T ss_pred CCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHH
Confidence 57777777654322 111223344556666678889999999999999999999999999975 8888775
Q ss_pred h--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 71 R--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 71 ~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
. .....+++..++.++.|++.||+|||+. .+++||||||+||+++.++.+||+|||++....... ......||+
T Consensus 98 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~ 173 (290)
T 3fme_A 98 QVIDKGQTIPEDILGKIAVSIVKALEHLHSK-LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCK 173 (290)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCc
Confidence 4 2334599999999999999999999975 149999999999999999999999999997654322 123346899
Q ss_pred cccCcccc----ccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH
Q 021507 149 GYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK 224 (311)
Q Consensus 149 ~y~aPE~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
.|+|||++ .+..++.++|||||||++|+|++|..||...... ...................
T Consensus 174 ~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---------------FQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp CCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---------------HHHHHHHHHSCCCCCCTTT
T ss_pred cccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---------------HHHHHHHhccCCCCccccc
Confidence 99999996 4567888999999999999999999999753221 1111222222222233446
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++.++.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 78899999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=290.01 Aligned_cols=248 Identities=20% Similarity=0.238 Sum_probs=175.0
Q ss_pred ChhHHHhHHHHHHh---hhh------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---ARS------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++.+.... +.+ .......+.+|++++++++||||+++++++.+++..|+||||+.| +|.+++..
T Consensus 14 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 92 (324)
T 3mtl_A 14 TYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD 92 (324)
T ss_dssp SSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHH
T ss_pred CCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHh
Confidence 57788877654322 111 111111355799999999999999999999999999999999975 99998866
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .......||..|+
T Consensus 93 ~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~ 167 (324)
T 3mtl_A 93 CG-NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYR 167 (324)
T ss_dssp TT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGC
T ss_pred cC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCccccc
Confidence 54 35999999999999999999999755 9999999999999999999999999997643322 1233457899999
Q ss_pred Ccccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hh-ccccccc------hhhhhHhhhcccCC---
Q 021507 152 APEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPYLSD------KRKLFRIMDTKLGG--- 219 (311)
Q Consensus 152 aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~~------~~~~~~~~~~~~~~--- 219 (311)
|||++.+ ..++.++|||||||++|+|++|..||.+.........+ .. ..+.... ..............
T Consensus 168 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (324)
T 3mtl_A 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEAL 247 (324)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCH
T ss_pred ChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhh
Confidence 9999877 56899999999999999999999999876543221111 00 0000000 00000000000000
Q ss_pred -CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 220 -QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.....++.++.+||.+||+.||.+|||+.+++++-
T Consensus 248 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 248 LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 01124577899999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=296.90 Aligned_cols=243 Identities=16% Similarity=0.210 Sum_probs=179.1
Q ss_pred ChhHHHhHHHHHHhhhhH-----HHHHHHHHHHHHHHhcCC-CCCccceEeEEEe--CCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELHARSL-----LLITNWFQTEVNYLGQLH-HPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||.+.+........ ....+.+.+|++++++++ ||||+++++++.+ ....++||||+.+++|.+++..
T Consensus 48 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~- 126 (330)
T 3nsz_A 48 KYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT- 126 (330)
T ss_dssp SSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-
T ss_pred CCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-
Confidence 578888776543321111 113467899999999997 9999999999987 6678999999999999998842
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcceecccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++........ .....++..|+
T Consensus 127 ----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~ 197 (330)
T 3nsz_A 127 ----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFK 197 (330)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGC
T ss_pred ----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---ccccccccccc
Confidence 889999999999999999999755 99999999999999777 899999999986543322 33457899999
Q ss_pred Ccccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh--hhhccc-cc---------cchhhhhHhh-----
Q 021507 152 APEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL--VDWAKP-YL---------SDKRKLFRIM----- 213 (311)
Q Consensus 152 aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~-~~---------~~~~~~~~~~----- 213 (311)
|||++.+ ..++.++|||||||++|+|++|..||........... ...... .. ..........
T Consensus 198 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (330)
T 3nsz_A 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 277 (330)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCC
T ss_pred ChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccc
Confidence 9999877 5789999999999999999999999965432211100 000000 00 0000000000
Q ss_pred ---hcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 214 ---DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 214 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
........+..++.++.+||.+||+.||.+|||+++++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 278 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0111122234478899999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=294.01 Aligned_cols=245 Identities=20% Similarity=0.225 Sum_probs=183.4
Q ss_pred ChhHHHhHHHHHHh----h----hhHHHHHHHHHHHHHHHhcCCCCC------ccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH----A----RSLLLITNWFQTEVNYLGQLHHPN------LVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~----~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
+||+||.+.+.... + .......+.+.+|+++++.++|++ |+++++++.+.+..|+||||+ +++|.
T Consensus 26 ~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~ 104 (339)
T 1z57_A 26 AFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTY 104 (339)
T ss_dssp TTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred CCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHH
Confidence 57888877542211 1 112234567889999999997654 999999999999999999999 78999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-------------------CCcEEEeccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------------------EFNAKLSDFG 127 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-------------------~~~~kl~Dfg 127 (311)
+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 182 (339)
T 1z57_A 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182 (339)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCS
T ss_pred HHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCc
Confidence 9998776667999999999999999999999754 999999999999987 6679999999
Q ss_pred ccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh-hcccccc--
Q 021507 128 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPYLS-- 204 (311)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~-- 204 (311)
++...... .....||..|+|||++.+..++.++|||||||++|+|++|..||...+......... ...+...
T Consensus 183 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~ 257 (339)
T 1z57_A 183 SATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM 257 (339)
T ss_dssp SCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHH
T ss_pred ccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 99764332 234578999999999999999999999999999999999999998755422111110 0000000
Q ss_pred ------------------chhhhhHhhh-----cccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 205 ------------------DKRKLFRIMD-----TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 205 ------------------~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.......... ...........+..+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 258 IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0000000000 000112234568899999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=290.76 Aligned_cols=212 Identities=26% Similarity=0.373 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 19 LLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
....+.+.+|+.+++++ +||||+++++++...+..|+||||++|++|.+++.... .+++..+..++.|++.||.|||
T Consensus 140 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH 217 (365)
T 2y7j_A 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLH 217 (365)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999 89999999999999999999999999999999997553 4999999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC------CCCCCCceehhH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG------RLTTKSDVYSFG 171 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG 171 (311)
+.+ ++|+||||+||+++.+|.+||+|||++........ .....||+.|+|||++.+. .++.++||||||
T Consensus 218 ~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 292 (365)
T 2y7j_A 218 ANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292 (365)
T ss_dssp HTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHH
T ss_pred hCC--eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHH
Confidence 754 99999999999999999999999999986543322 3346789999999998643 578899999999
Q ss_pred HHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCC--chHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 172 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 172 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
|++|+|++|..||......... ..+......... ...++..+.++|.+||..||.+|||+.+
T Consensus 293 ~il~ell~g~~pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 293 VILFTLLAGSPPFWHRRQILML----------------RMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHH----------------HHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHCCCCCCCCCHHHHH----------------HHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999999764321110 011111111000 1235678999999999999999999999
Q ss_pred HHHH
Q 021507 250 VLAI 253 (311)
Q Consensus 250 ~l~~ 253 (311)
++++
T Consensus 357 ll~h 360 (365)
T 2y7j_A 357 ALQH 360 (365)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=288.96 Aligned_cols=218 Identities=25% Similarity=0.321 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHH
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
...+.+.+|++++++++||||+++++++.+ ++..|+||||+++++|.+++... ....+++..++.++.|++.||+|
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 126 (279)
T 2w5a_A 47 AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126 (279)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence 345679999999999999999999998854 56889999999999999999653 23459999999999999999999
Q ss_pred hhhCC---CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHH
Q 021507 96 LHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 172 (311)
Q Consensus 96 lH~~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 172 (311)
||+.+ .+++|+||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++||||||+
T Consensus 127 lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 204 (279)
T 2w5a_A 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204 (279)
T ss_dssp HHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHH
T ss_pred HhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHH
Confidence 99743 2399999999999999999999999999976543221 123457899999999999989999999999999
Q ss_pred HHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 173 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 173 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
++|+|++|..||...... .....+........+..++.++.+++.+||+.||.+|||+.++++
T Consensus 205 il~~l~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 205 LLYELCALMPPFTAFSQK-----------------ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HHHHHHHSSCSSCCSSHH-----------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCCCCcccCHH-----------------HHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 999999999999864321 111111122222345567889999999999999999999999997
Q ss_pred HHHh
Q 021507 253 ILER 256 (311)
Q Consensus 253 ~l~~ 256 (311)
.+..
T Consensus 268 ~~~~ 271 (279)
T 2w5a_A 268 NPLI 271 (279)
T ss_dssp STTC
T ss_pred Chhh
Confidence 7643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=284.30 Aligned_cols=232 Identities=24% Similarity=0.299 Sum_probs=181.9
Q ss_pred ChhHHHhHHHHHHhh---hh---HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELHA---RS---LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||.+.+..... .+ .....+.+.+|+.++++++||||+++++++.+.+..|+||||+.+++|.+++....
T Consensus 41 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~- 119 (314)
T 3com_A 41 SYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN- 119 (314)
T ss_dssp --CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-
T ss_pred CCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC-
Confidence 467777765443210 00 01123568899999999999999999999999999999999999999999986433
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ......|+..|+|||
T Consensus 120 ~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 195 (314)
T 3com_A 120 KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPE 195 (314)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChh
Confidence 35999999999999999999999755 99999999999999999999999999976533211 133457899999999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhh-cccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++||||||+++|+|++|..||......... ..... .......+..++..+.++|
T Consensus 196 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI----------------FMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp HHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------HHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred hcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH----------------HHHhcCCCcccCCcccCCHHHHHHH
Confidence 999989999999999999999999999999764321110 00000 1111123455688999999
Q ss_pred HhcccCCCCCCCCHHHHHHH
Q 021507 234 LQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||..||.+|||+.+++++
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTS
T ss_pred HHHccCChhhCcCHHHHHhC
Confidence 99999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=293.48 Aligned_cols=232 Identities=23% Similarity=0.314 Sum_probs=176.7
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++...
T Consensus 31 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 110 (302)
T 2j7t_A 31 AFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL 110 (302)
T ss_dssp TTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH
T ss_pred CCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh
Confidence 57777777654321 1111223467889999999999999999999999999999999999999999988653
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... ........|+..|+|
T Consensus 111 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~a 185 (302)
T 2j7t_A 111 D-RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMA 185 (302)
T ss_dssp T-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCC
T ss_pred c-cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcC
Confidence 3 34999999999999999999999754 999999999999999999999999987532110 111233568999999
Q ss_pred ccccc-----cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchHHH
Q 021507 153 PEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAA 226 (311)
Q Consensus 153 PE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (311)
||++. +..++.++||||||+++|+|++|..||........ ........ .....+..++
T Consensus 186 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV----------------LLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp HHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHHHSCCCCCSSGGGSC
T ss_pred CeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH----------------HHHHhccCCcccCCccccC
Confidence 99984 56788899999999999999999999986432110 11111111 1112345678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..+.+++.+||..||.+|||+.+++++
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 899999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.35 Aligned_cols=226 Identities=24% Similarity=0.244 Sum_probs=171.3
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+.+.+|++++++++||||+++++++.+.+..|+||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.+
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-- 132 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW-- 132 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4678999999999999999999999999999999999986 8998886543 45889999999999999999999755
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCC
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 181 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~ 181 (311)
|+||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 210 (346)
T 1ua2_A 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210 (346)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 99999999999999999999999999987543322 23345789999999998764 5788999999999999999999
Q ss_pred CccCCCccchhhhh-hh-hccccccchhh---hhHhhhcccCCCC-----chHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 021507 182 CAVDKTKVGIEQSL-VD-WAKPYLSDKRK---LFRIMDTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVL 251 (311)
Q Consensus 182 ~pf~~~~~~~~~~~-~~-~~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 251 (311)
.||.+......... .. ...+....... ............. ...++.++.+||.+||..||.+|||+.+++
T Consensus 211 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 211 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 99987543211110 00 00000000000 0000000000000 134568899999999999999999999998
Q ss_pred HHH
Q 021507 252 AIL 254 (311)
Q Consensus 252 ~~l 254 (311)
++.
T Consensus 291 ~h~ 293 (346)
T 1ua2_A 291 KMK 293 (346)
T ss_dssp TSG
T ss_pred cCh
Confidence 764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=297.51 Aligned_cols=207 Identities=25% Similarity=0.341 Sum_probs=164.9
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
..+.+|++++++++||||+++++++..+. .|+||||+++++|.+++... ..+++..++.++.|++.||+|||+.+
T Consensus 60 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-- 134 (322)
T 2ycf_A 60 LNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG-- 134 (322)
T ss_dssp -CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 45889999999999999999999987654 89999999999999998654 35999999999999999999999755
Q ss_pred eeecCCCCCceEeCCCCc---EEEecccccccCCCCCCcceeccccccccccCccccc---cCCCCCCCceehhHHHHHH
Q 021507 103 VIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~ 176 (311)
++||||||+||+++.++. +||+|||++....... ......||..|+|||++. +..++.++|||||||++|+
T Consensus 135 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~ 211 (322)
T 2ycf_A 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211 (322)
T ss_dssp EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHH
Confidence 999999999999987664 9999999998653321 123456899999999974 4568889999999999999
Q ss_pred HHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC---CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 177 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 177 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|++|..||........ +...+...... .....++..+.+++.+||..||.+|||+.+++++
T Consensus 212 l~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 212 CLSGYPPFSEHRTQVS----------------LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHSSCSSCSTTCSSC----------------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhCCCCCcccchHHH----------------HHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 9999999976432111 00000000000 0112457789999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=309.60 Aligned_cols=221 Identities=15% Similarity=0.149 Sum_probs=167.0
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHH---HHHhcCCCCCccceE-------eEEEeCCe-------
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEV---NYLGQLHHPNLVKLI-------GYCLEGEN------- 52 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~---~~l~~l~hpnIv~~~-------~~~~~~~~------- 52 (311)
+||+||.+.+.... + .......+.|.+|+ +++++++||||++++ +++.+.+.
T Consensus 85 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (377)
T 3byv_A 85 DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164 (377)
T ss_dssp TTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC-
T ss_pred CCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccc
Confidence 57888887764321 1 11223457799999 555556899999998 66665532
Q ss_pred ----------eEEEEecCCCCChHHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC
Q 021507 53 ----------RLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 117 (311)
Q Consensus 53 ----------~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~ 117 (311)
.|+||||+ +|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 165 ~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~ 241 (377)
T 3byv_A 165 LDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ 241 (377)
T ss_dssp -----CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECT
T ss_pred cCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence 78999999 5799999975432 11334888889999999999999765 999999999999999
Q ss_pred CCcEEEecccccccCCCCCCcceeccccccccccCccccccC-----------CCCCCCceehhHHHHHHHHhCCCccCC
Q 021507 118 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----------RLTTKSDVYSFGVVLLELLSGRCAVDK 186 (311)
Q Consensus 118 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~slG~il~~l~~g~~pf~~ 186 (311)
++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 242 ~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~ 315 (377)
T 3byv_A 242 RGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315 (377)
T ss_dssp TCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999985322 2344567 999999999887 899999999999999999999999976
Q ss_pred CccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 187 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
........ .+. .....++.++.+||.+||..||.+|||+.++++
T Consensus 316 ~~~~~~~~----------------~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 316 DAALGGSE----------------WIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp ----CCSG----------------GGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred cccccchh----------------hhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 43211000 000 112346788999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=297.45 Aligned_cols=248 Identities=22% Similarity=0.236 Sum_probs=179.8
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~ 66 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++... ...|+||||+.+ +|.
T Consensus 39 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~ 117 (364)
T 3qyz_A 39 AYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY 117 (364)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHH
T ss_pred CCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHH
Confidence 57788877554322 112233446788999999999999999999999754 368999999975 999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceecccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVM 145 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~ 145 (311)
+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......... .......
T Consensus 118 ~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 192 (364)
T 3qyz_A 118 KLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192 (364)
T ss_dssp HHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCC
T ss_pred HHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccc
Confidence 998654 3999999999999999999999755 999999999999999999999999999865432211 1123457
Q ss_pred ccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhc-cccccchh-----hhhHhh-hcc
Q 021507 146 GTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWA-KPYLSDKR-----KLFRIM-DTK 216 (311)
Q Consensus 146 gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~-~~~~~~~~-----~~~~~~-~~~ 216 (311)
||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+ ... .+...... ...... ...
T Consensus 193 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (364)
T 3qyz_A 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLP 272 (364)
T ss_dssp SCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSC
T ss_pred cccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcC
Confidence 89999999987654 5899999999999999999999999876543221111 000 00000000 000000 000
Q ss_pred cCCC-----CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 217 LGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 217 ~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.... ....++.++.+||.+||..||.+|||+.+++++-
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 273 HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000 1134577899999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=304.87 Aligned_cols=247 Identities=22% Similarity=0.297 Sum_probs=175.4
Q ss_pred ChhHHHhHHHHHHhh---hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCe------eEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELHA---RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN------RLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++++.+... ++.....+...+|+++++.++||||+++++++...+. .|+||||+.+ ++.+.+..
T Consensus 52 ~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 130 (394)
T 4e7w_A 52 SFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRH 130 (394)
T ss_dssp TTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHH
T ss_pred CCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHH
Confidence 588888886544321 1111112334579999999999999999999965433 7899999987 55544421
Q ss_pred --cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC-CCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 72 --RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 72 --~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
.....+++..+..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+
T Consensus 131 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~ 205 (394)
T 4e7w_A 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSR 205 (394)
T ss_dssp HHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCG
T ss_pred HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCc
Confidence 22345999999999999999999999755 99999999999998 789999999999986533322 33457899
Q ss_pred cccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhh-hhhhc-cccccchhhhh-HhhhcccC------
Q 021507 149 GYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKLF-RIMDTKLG------ 218 (311)
Q Consensus 149 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~-~~~~~~~~------ 218 (311)
.|+|||++.+. .++.++|||||||++|+|++|+.||.+........ ..... .+......... ........
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (394)
T 4e7w_A 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP 285 (394)
T ss_dssp GGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCC
T ss_pred CccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCc
Confidence 99999998765 58999999999999999999999998765321111 11100 00000000000 00000000
Q ss_pred --CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 219 --GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 219 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...+..++.++.+||.+||..||.+|||+.+++++
T Consensus 286 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 286 FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 01223467899999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=304.98 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=175.8
Q ss_pred ChhHHHhHHHHHHhh----hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe---------------------------
Q 021507 1 MFLFNFLHSHLELHA----RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE--------------------------- 49 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------------------------- 49 (311)
+||+||.+.+..... +......+...+|+++++.++||||+++++++..
T Consensus 19 ~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (383)
T 3eb0_A 19 SFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNN 98 (383)
T ss_dssp -CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------------------
T ss_pred cCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccccc
Confidence 578888876554321 1111112334579999999999999999999854
Q ss_pred -----------CCeeEEEEecCCCCChHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC
Q 021507 50 -----------GENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 116 (311)
Q Consensus 50 -----------~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~ 116 (311)
+...++||||+++ +|.+.+.. .....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 99 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--gi~H~Dikp~Nil~~ 175 (383)
T 3eb0_A 99 HHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVN 175 (383)
T ss_dssp -----------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCCGGGEEEE
T ss_pred ccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--cCccCccCHHHEEEc
Confidence 3347899999985 88877753 2335699999999999999999999965 599999999999997
Q ss_pred -CCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhh
Q 021507 117 -AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 194 (311)
Q Consensus 117 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 194 (311)
.++.+||+|||+++....... .....+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+........
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 252 (383)
T 3eb0_A 176 SKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLV 252 (383)
T ss_dssp TTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 688999999999986533321 3345789999999998775 48999999999999999999999998754321111
Q ss_pred -hhhhc-cccccchhhhh---Hh------hhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 195 -LVDWA-KPYLSDKRKLF---RI------MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 195 -~~~~~-~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..... .+......... .. .........+..++.++.+||.+||..||.+|||+.+++++
T Consensus 253 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 253 RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11100 00000000000 00 00000011234577889999999999999999999999964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=310.51 Aligned_cols=236 Identities=25% Similarity=0.314 Sum_probs=185.8
Q ss_pred ChhHHHhHHHHHH------------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLEL------------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||.+.+... .........+.|.+|+.++++++||||+++++++. ++..|+||||+++|+|.++
T Consensus 402 ~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~ 480 (656)
T 2j0j_A 402 QFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSF 480 (656)
T ss_dssp SSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHH
T ss_pred CCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHH
Confidence 5788887654221 11123345577999999999999999999999985 4568999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+++
T Consensus 481 l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~ 556 (656)
T 2j0j_A 481 LQVRK-FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPI 556 (656)
T ss_dssp HHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCG
T ss_pred HHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCc
Confidence 96543 35899999999999999999999754 999999999999999999999999999875433221 123345678
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 227 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
.|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+........+..++.
T Consensus 557 ~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----------------DVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHHTCCCCCCTTCCH
T ss_pred ceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCccccH
Confidence 9999999999999999999999999999997 99999864321 11111222223345667888
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.+.++|.+||..||.+|||+.++++.|+.+.
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=278.55 Aligned_cols=208 Identities=26% Similarity=0.425 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|+.+++.++||||+++++++.+.+..|+||||+.+++|.+++.... .+++..++.++.|++.||+|||+.+
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ 131 (276)
T 2h6d_A 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM 131 (276)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34578899999999999999999999999999999999999999999997654 3899999999999999999999755
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCC-CCCCceehhHHHHHHHHh
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~ 179 (311)
++|+||||+||+++.++.+||+|||++....... ......+++.|+|||++.+..+ +.++||||||+++|+|++
T Consensus 132 --i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 206 (276)
T 2h6d_A 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206 (276)
T ss_dssp --SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred --CccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh
Confidence 9999999999999999999999999998654322 1234568999999999987765 679999999999999999
Q ss_pred CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 180 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 180 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|..||....... ....+... ....+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 207 g~~p~~~~~~~~-----------------~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 207 GTLPFDDEHVPT-----------------LFKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SSCSSCCSSHHH-----------------HHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCcHHH-----------------HHHHhhcC-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 999997643211 11111111 112345567889999999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=294.22 Aligned_cols=214 Identities=29% Similarity=0.354 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
.+.+.+|+++++++ +||||+++++++..++..|+||||+++++|.+++.... .+++..+..++.|++.||+|||+.+
T Consensus 102 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ 179 (355)
T 1vzo_A 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG 179 (355)
T ss_dssp GGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34577899999999 69999999999999999999999999999999997654 4899999999999999999999754
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC--CCCCCCceehhHHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~ 178 (311)
|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 180 --ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell 256 (355)
T 1vzo_A 180 --IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256 (355)
T ss_dssp --CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred --cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999976533221 123345799999999999863 4788999999999999999
Q ss_pred hCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 179 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 179 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
+|..||......... ..+...+. ......+..++..+.+||.+||..||.+|| ++++++++
T Consensus 257 ~g~~pf~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 257 TGASPFTVDGEKNSQ-------------AEISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HSSCTTSCTTSCCCH-------------HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HCCCCCccCCccchH-------------HHHHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 999999754321110 01111111 112234567788999999999999999999 99999876
Q ss_pred H
Q 021507 254 L 254 (311)
Q Consensus 254 l 254 (311)
.
T Consensus 323 ~ 323 (355)
T 1vzo_A 323 L 323 (355)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=297.65 Aligned_cols=183 Identities=23% Similarity=0.216 Sum_probs=152.0
Q ss_pred ChhHHHhHHHHHHh---hhh----HHHHHHHHHHHHHHHhcCC-CC-----CccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH---ARS----LLLITNWFQTEVNYLGQLH-HP-----NLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~----~~~~~~~~~~E~~~l~~l~-hp-----nIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||++.+.... +.+ .....+.+.+|+++++.++ |+ +|+++++++...+..|+||||+.+ +|.+
T Consensus 66 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~ 144 (382)
T 2vx3_A 66 SFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYD 144 (382)
T ss_dssp TTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHH
T ss_pred CCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHH
Confidence 57888888654332 111 1223456778999998885 55 499999999999999999999965 9999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC--CCCcEEEecccccccCCCCCCcceecccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
++.......+++..+..++.|++.||.|||+++.+|+||||||+|||++ .++.+||+|||+++..... .....
T Consensus 145 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~ 219 (382)
T 2vx3_A 145 LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYI 219 (382)
T ss_dssp HHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSC
T ss_pred HHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----ccccc
Confidence 9977665669999999999999999999997656799999999999995 4778999999999875432 23457
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCcc
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 189 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 189 (311)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 220 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp SCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 89999999999999999999999999999999999999987553
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=301.38 Aligned_cols=235 Identities=14% Similarity=0.028 Sum_probs=161.6
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcC--CCCCccceE-------eEEEeC----------
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQL--HHPNLVKLI-------GYCLEG---------- 50 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~-------~~~~~~---------- 50 (311)
+||+||++.+.... ........+.+.+|+.+++.| +||||++++ +++...
T Consensus 74 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~ 153 (371)
T 3q60_A 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSP 153 (371)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSC
T ss_pred CCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccC
Confidence 57788877654322 111334456678885444444 699988755 555433
Q ss_pred -------CeeEEEEecCCCCChHHHhhhcCCCCCCHHHH------HHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC
Q 021507 51 -------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR------MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 117 (311)
Q Consensus 51 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~------~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~ 117 (311)
...|+||||+. ++|.+++..... .++...+ +.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 154 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~ 229 (371)
T 3q60_A 154 GQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMP 229 (371)
T ss_dssp C---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEECT
T ss_pred CcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEECC
Confidence 33799999998 799999975432 2445555 677899999999999755 999999999999999
Q ss_pred CCcEEEecccccccCCCCCCcceeccccccccccCcccccc--CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh
Q 021507 118 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 195 (311)
Q Consensus 118 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 195 (311)
++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 230 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~ 304 (371)
T 3q60_A 230 DGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304 (371)
T ss_dssp TSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC
T ss_pred CCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccch
Confidence 999999999999865321 224566799999999987 6789999999999999999999999987532211100
Q ss_pred hhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 196 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
... .................++..+.+||.+||+.||++|||+.+++++
T Consensus 305 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 305 KRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred hhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000001111122234678899999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=286.49 Aligned_cols=209 Identities=28% Similarity=0.364 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++++++.+.+..|+||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ 141 (287)
T 2wei_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN 141 (287)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35678899999999999999999999999999999999999999999886554 4899999999999999999999754
Q ss_pred CCeeecCCCCCceEeCCC---CcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHH
Q 021507 101 SQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 177 (311)
++|+||||+||+++.+ +.+||+|||++........ .....++..|+|||++.+ .++.++||||||+++|+|
T Consensus 142 --i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l 215 (287)
T 2wei_A 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215 (287)
T ss_dssp --CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHH
T ss_pred --eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHH
Confidence 9999999999999764 4699999999986543321 233468999999999865 488999999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCC--chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||........ ...+......... ...++.++.+++.+||..||.+|||+.++++.
T Consensus 216 ~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 216 LSGTPPFYGKNEYDI----------------LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHSSCSSCCSSHHHH----------------HHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HhCCCCCCCCCHHHH----------------HHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 999999986542111 0111111111111 23567889999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.14 Aligned_cols=226 Identities=19% Similarity=0.250 Sum_probs=173.2
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH------hhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH------LFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.++ +.......+++..++.++.|++.||+||
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 7799999999999999999999999999999999999999999998 6554356699999999999999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccC-CCCC-CCceehhHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT-KSDVYSFGVVL 174 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Di~slG~il 174 (311)
|+ .++++|+||||+||+++.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++|||||||++
T Consensus 168 H~-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 242 (348)
T 2pml_X 168 HN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242 (348)
T ss_dssp HH-TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHH
T ss_pred hc-cCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHH
Confidence 97 145999999999999999999999999999865332 24456789999999999887 6666 99999999999
Q ss_pred HHHHhCCCccCCCccchh-hhhhhhc-cccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 175 LELLSGRCAVDKTKVGIE-QSLVDWA-KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
|+|++|..||........ ....... .........................++..+.+|+.+||..||.+|||+.++++
T Consensus 243 ~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 243 YVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999986543111 0000000 00000000000000000001112457889999999999999999999999986
Q ss_pred H
Q 021507 253 I 253 (311)
Q Consensus 253 ~ 253 (311)
+
T Consensus 323 h 323 (348)
T 2pml_X 323 H 323 (348)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=306.11 Aligned_cols=244 Identities=23% Similarity=0.271 Sum_probs=174.2
Q ss_pred ChhHHHhHHHHHHh---hhh-HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH---ARS-LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++.+.... +.+ .....+.+.+|+++|++++||||+++++++... ...++||||+.+ +|.+.+.
T Consensus 66 ~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 144 (420)
T 1j1b_A 66 SFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVAR 144 (420)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHH
T ss_pred CCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHH
Confidence 57888888765422 111 111123355799999999999999999998542 236799999976 7777664
Q ss_pred h--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC-CcEEEecccccccCCCCCCcceecccccc
Q 021507 71 R--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 ~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
. .....+++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++....... .....||
T Consensus 145 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t 219 (420)
T 1j1b_A 145 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 219 (420)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSC
T ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeC
Confidence 3 2335699999999999999999999965 59999999999999965 5689999999986543221 2345789
Q ss_pred ccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhh-hhhhhccccccchhhhhHhhhcc-----cC--
Q 021507 148 HGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTK-----LG-- 218 (311)
Q Consensus 148 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-----~~-- 218 (311)
+.|+|||++.+. .++.++|||||||++|||++|+.||.+....... .......... .......... ..
T Consensus 220 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~---~~~~~~~~~~~~~~~~p~~ 296 (420)
T 1j1b_A 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT---REQIREMNPNYTEFKFPQI 296 (420)
T ss_dssp TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC---HHHHHHHCSCCCCCCCCCC
T ss_pred CCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC---HHHHHhhChhhhhhccCcc
Confidence 999999998765 7899999999999999999999999875432111 1111000000 0000000000 00
Q ss_pred ------CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 219 ------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 219 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..++..++.++.+||.+||..||.+|||+.+++++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00223457889999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.22 Aligned_cols=206 Identities=25% Similarity=0.340 Sum_probs=159.1
Q ss_pred HHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 24 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
.+.+|+++|++++||||+++++++. .+..|+||||+.+++|.+++... ..+++..++.++.|++.||+|||+.+ |
T Consensus 186 ~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i 260 (419)
T 3i6u_A 186 NVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG--I 260 (419)
T ss_dssp CHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 5889999999999999999999975 45689999999999999988654 34999999999999999999999755 9
Q ss_pred eecCCCCCceEeCCCC---cEEEecccccccCCCCCCcceeccccccccccCcccccc---CCCCCCCceehhHHHHHHH
Q 021507 104 IYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 177 (311)
Q Consensus 104 vH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l 177 (311)
+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 261 vHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~l 337 (419)
T 3i6u_A 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337 (419)
T ss_dssp CCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHH
T ss_pred cccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHH
Confidence 9999999999997554 59999999998754322 2345679999999999854 5678899999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCC---CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||........ +...+....... ....++..+.+||.+||..||.+|||+.+++++
T Consensus 338 ltg~~pf~~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 338 LSGYPPFSEHRTQVS----------------LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHSSCSSCCCSSSCC----------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCCCCcchHH----------------HHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 999999976432110 011111110001 112467889999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=279.32 Aligned_cols=212 Identities=28% Similarity=0.367 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 19 LLITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
....+.+.+|+++++++. ||||+++++++.+++..|+||||+++++|.+++.... .+++..++.++.|++.||.|||
T Consensus 64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH 141 (298)
T 1phk_A 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH 141 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 345677899999999995 9999999999999999999999999999999997653 4899999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccc------cCCCCCCCceehhH
Q 021507 98 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA------TGRLTTKSDVYSFG 171 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG 171 (311)
+.+ ++|+||||+||+++.++.+||+|||++........ .....++..|+|||++. ...++.++||||||
T Consensus 142 ~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 216 (298)
T 1phk_A 142 KLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216 (298)
T ss_dssp HTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred HCC--cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence 755 99999999999999999999999999986543321 33457899999999985 34678899999999
Q ss_pred HHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHH
Q 021507 172 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 249 (311)
Q Consensus 172 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (311)
+++|+|++|..||......... ..+.... ........++..+.+++.+||..||.+|||+.+
T Consensus 217 ~~l~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (298)
T 1phk_A 217 VIMYTLLAGSPPFWHRKQMLML----------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHH----------------HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHHCCCCCcCccHHHHH----------------HHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 9999999999999764321110 1111111 111222467889999999999999999999999
Q ss_pred HHHH
Q 021507 250 VLAI 253 (311)
Q Consensus 250 ~l~~ 253 (311)
++++
T Consensus 281 ll~h 284 (298)
T 1phk_A 281 ALAH 284 (298)
T ss_dssp HTTS
T ss_pred HHhC
Confidence 9863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=298.49 Aligned_cols=244 Identities=16% Similarity=0.234 Sum_probs=179.4
Q ss_pred ChhHHHhHHHHHHh---hh----hHHHHHHHHHHHHHHHhcCC-----------CCCccceEeEEEeCC----eeEEEEe
Q 021507 1 MFLFNFLHSHLELH---AR----SLLLITNWFQTEVNYLGQLH-----------HPNLVKLIGYCLEGE----NRLLVYE 58 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~----~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~~~~----~~~lv~e 58 (311)
+||+||++.+.... +. ......+.+.+|++++++++ |+||+++++++...+ ..++|||
T Consensus 31 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e 110 (373)
T 1q8y_A 31 HFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 110 (373)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred CCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEe
Confidence 57888887654332 11 11224567889999999986 899999999998654 7899999
Q ss_pred cCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC------CCCcEEEecccccccC
Q 021507 59 FMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD------AEFNAKLSDFGLAKAG 132 (311)
Q Consensus 59 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~------~~~~~kl~Dfg~~~~~ 132 (311)
|+ +++|.+++.......+++..++.++.||+.||+|||+. .+|+||||||+|||++ ..+.+||+|||++...
T Consensus 111 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~ 188 (373)
T 1q8y_A 111 VL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188 (373)
T ss_dssp CC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEET
T ss_pred cC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChHHeEEeccCCCcCcceEEEccccccccc
Confidence 99 78999999776656699999999999999999999975 1499999999999994 4457999999999765
Q ss_pred CCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchh----h---hhhhhcccccc-
Q 021507 133 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE----Q---SLVDWAKPYLS- 204 (311)
Q Consensus 133 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~---~~~~~~~~~~~- 204 (311)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ . ...........
T Consensus 189 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 263 (373)
T 1q8y_A 189 DEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 263 (373)
T ss_dssp TBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHH
T ss_pred CCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHH
Confidence 432 2345789999999999999999999999999999999999999986542110 0 00000000000
Q ss_pred ---ch---------------------hhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 205 ---DK---------------------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 205 ---~~---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.. ......+. .....+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 264 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 00 00000011 1223567789999999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=295.65 Aligned_cols=238 Identities=21% Similarity=0.235 Sum_probs=156.4
Q ss_pred ChhHHHhHHHHHHh---hhhHHHHHHHHHHHH-HHHhcCCCCCccceEeEEEe----CCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---ARSLLLITNWFQTEV-NYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... +.+.........+|+ ..++.++||||+++++++.. +...|+||||++||+|.+++...
T Consensus 41 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~ 120 (336)
T 3fhr_A 41 VNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120 (336)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC
T ss_pred CCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc
Confidence 57888887665432 111111112223333 34566799999999999976 44589999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCcceecccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
....+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++...... ......+|+.
T Consensus 121 ~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~ 194 (336)
T 3fhr_A 121 GDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPY 194 (336)
T ss_dssp -CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcC
Confidence 6667999999999999999999999754 999999999999976 445999999999764322 1334578999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||.......... ....................++..+
T Consensus 195 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (336)
T 3fhr_A 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------GMKRRIRLGQYGFPNPEWSEVSEDA 264 (336)
T ss_dssp ---------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCTTTSTTCCHHH
T ss_pred ccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------hHHHhhhccccccCchhhccCCHHH
Confidence 999999988889999999999999999999999997643211100 0000000001111112234678899
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.+||.+||..||.+|||+.+++++.
T Consensus 265 ~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 265 KQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCc
Confidence 9999999999999999999999854
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=297.89 Aligned_cols=242 Identities=22% Similarity=0.259 Sum_probs=164.1
Q ss_pred ChhHHHhHHHHHHh---h-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH---A-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~ 64 (311)
+||+||.+.+.... + .......+.+.+|++++++++||||+++++++... ...|+|||++ +++
T Consensus 41 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 119 (367)
T 2fst_X 41 AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD 119 (367)
T ss_dssp --CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEE
T ss_pred CCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCC
Confidence 47778777543322 0 11223456788999999999999999999998754 5679999999 679
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 120 L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~ 189 (367)
T 2fst_X 120 LNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGY 189 (367)
T ss_dssp CC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-------------------
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCc
Confidence 9998854 34999999999999999999999755 999999999999999999999999999764322 3345
Q ss_pred cccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hh-cccccc------c--hhhhhHhh
Q 021507 145 MGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPYLS------D--KRKLFRIM 213 (311)
Q Consensus 145 ~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~------~--~~~~~~~~ 213 (311)
.||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+ .. ..+... . .......+
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 269 (367)
T 2fst_X 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269 (367)
T ss_dssp -CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTS
T ss_pred CcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhcc
Confidence 78999999999877 67899999999999999999999999876532211111 10 000000 0 00000000
Q ss_pred hcccCCC---CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 214 DTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 214 ~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
....... .....+..+.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 012346789999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=285.70 Aligned_cols=244 Identities=21% Similarity=0.268 Sum_probs=180.6
Q ss_pred ChhHHHhHHHHHHh-hhhH--HHHHHHHHHHHHHHhc--CCCCCccceEeEEEeCC----eeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH-ARSL--LLITNWFQTEVNYLGQ--LHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-~~~~--~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||.+.+..-. +.+. ....+.+.+|++++.. ++||||+++++++.... ..|+||||+++|+|.+++.+
T Consensus 54 ~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 133 (342)
T 1b6c_B 54 RFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 133 (342)
T ss_dssp TTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH
T ss_pred CCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc
Confidence 46777766542110 0000 1234567789999887 79999999999998776 78999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc--eecc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQ 143 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~ 143 (311)
. .+++..++.++.|++.||+|||.. .++|+||||||+||+++.++.+||+|||++.......... ....
T Consensus 134 ~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 210 (342)
T 1b6c_B 134 Y---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210 (342)
T ss_dssp C---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCS
T ss_pred c---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccccccccccc
Confidence 4 389999999999999999999931 2459999999999999999999999999997654332211 1234
Q ss_pred ccccccccCccccccCC------CCCCCceehhHHHHHHHHhC----------CCccCCCccchhhhhhhhccccccchh
Q 021507 144 VMGTHGYAAPEYVATGR------LTTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKR 207 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~ 207 (311)
..||..|+|||++.+.. ++.++|||||||++|+|++| ..||........ ...
T Consensus 211 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~------------~~~ 278 (342)
T 1b6c_B 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP------------SVE 278 (342)
T ss_dssp CCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC------------CHH
T ss_pred CCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc------------cHH
Confidence 57899999999997752 33689999999999999999 667754321100 001
Q ss_pred hhhHh-hhcccCCCCc-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 208 KLFRI-MDTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 208 ~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
.+... .........+ ..++..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp HHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 11111 1111222222 3567889999999999999999999999999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=289.27 Aligned_cols=218 Identities=20% Similarity=0.287 Sum_probs=169.2
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+++.... ..+++..++.++.|++.||+|||+.+
T Consensus 74 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-- 150 (319)
T 2y4i_B 74 KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG-- 150 (319)
T ss_dssp CCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 457789999999999999999999999999999999999999999996543 45899999999999999999999755
Q ss_pred eeecCCCCCceEeCCCCcEEEecccccccCCCCC---CcceeccccccccccCcccccc---------CCCCCCCceehh
Q 021507 103 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGTHGYAAPEYVAT---------GRLTTKSDVYSF 170 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Di~sl 170 (311)
++||||||+||+++ ++.+||+|||++....... .........|+..|+|||++.+ ..++.++|||||
T Consensus 151 i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl 229 (319)
T 2y4i_B 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229 (319)
T ss_dssp CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence 99999999999998 6799999999987543211 1111233468999999999875 347889999999
Q ss_pred HHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 021507 171 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 250 (311)
Q Consensus 171 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 250 (311)
||++|+|++|..||........ ................++.++.+++.+||..||.+|||+.++
T Consensus 230 G~il~el~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 293 (319)
T 2y4i_B 230 GTIWYELHAREWPFKTQPAEAI----------------IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293 (319)
T ss_dssp HHHHHHHHHSSCSSSSCCHHHH----------------HHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHH----------------HHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9999999999999986432111 011111111112223467789999999999999999999999
Q ss_pred HHHHHhhcCC
Q 021507 251 LAILERLEAP 260 (311)
Q Consensus 251 l~~l~~~~~~ 260 (311)
++.|+.+...
T Consensus 294 ~~~l~~l~~~ 303 (319)
T 2y4i_B 294 MDMLEKLPKR 303 (319)
T ss_dssp HHHHTTC---
T ss_pred HHHHHHHHHh
Confidence 9999887643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=285.78 Aligned_cols=250 Identities=21% Similarity=0.238 Sum_probs=178.2
Q ss_pred ChhHHHhHHHHHHhhh----------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe--------CCeeEEEEecCCC
Q 021507 1 MFLFNFLHSHLELHAR----------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE--------GENRLLVYEFMPK 62 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------~~~~~lv~e~~~~ 62 (311)
+||+||++.+...... ........+.+|++++++++||||+++++++.. .+..|+||||+.+
T Consensus 29 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 108 (351)
T 3mi9_A 29 TFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 108 (351)
T ss_dssp STTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE
T ss_pred CCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC
Confidence 5788888776432210 111223467899999999999999999999987 4568999999976
Q ss_pred CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ce
Q 021507 63 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HV 140 (311)
Q Consensus 63 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~ 140 (311)
+|.+.+.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 109 -~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 184 (351)
T 3mi9_A 109 -DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184 (351)
T ss_dssp -EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCC
T ss_pred -CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccc
Confidence 8888775443 34999999999999999999999755 999999999999999999999999999865432211 12
Q ss_pred eccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhh-cccccc----c--hhhhhHh
Q 021507 141 STQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW-AKPYLS----D--KRKLFRI 212 (311)
Q Consensus 141 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~----~--~~~~~~~ 212 (311)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.. ...... . .......
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 264 (351)
T 3mi9_A 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 264 (351)
T ss_dssp CCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTS
T ss_pred cCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcc
Confidence 2345789999999998764 579999999999999999999999987654322111110 000000 0 0000000
Q ss_pred hhcccCCC--Cch-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 213 MDTKLGGQ--YPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 213 ~~~~~~~~--~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+....... ... ..+..+.+||.+||..||.+|||+.+++++-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 265 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp SCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 00000000 000 1256789999999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=286.86 Aligned_cols=257 Identities=19% Similarity=0.239 Sum_probs=174.2
Q ss_pred ChhHHHhHHHHHHh-hhhH--HHHHHHHHHHHHH--HhcCCCCCccceEeEEEe-----CCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH-ARSL--LLITNWFQTEVNY--LGQLHHPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-~~~~--~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||.++..+.. +.+. ....+.+..|.++ +..++||||+++++.+.. ....|+||||+++|+|.+++.
T Consensus 25 ~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 104 (336)
T 3g2f_A 25 RYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS 104 (336)
T ss_dssp SSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHH
T ss_pred CCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHh
Confidence 57777776432110 1110 1122334445555 445899999999986542 235689999999999999996
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhC-------CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC------
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDA-------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------ 137 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------ 137 (311)
... .++..++.++.|++.||+|||+. ..+|+||||||+|||++.++.+||+|||++........
T Consensus 105 ~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 181 (336)
T 3g2f_A 105 LHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181 (336)
T ss_dssp HCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-----
T ss_pred hcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccc
Confidence 543 68899999999999999999965 11699999999999999999999999999986543211
Q ss_pred cceeccccccccccCcccccc-------CCCCCCCceehhHHHHHHHHhCCCccCCCccchhh-hhhhhccccccchhhh
Q 021507 138 THVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKL 209 (311)
Q Consensus 138 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~ 209 (311)
........||..|+|||++.+ ..++.++|||||||++|+|++|..||......... ................
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3g2f_A 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM 261 (336)
T ss_dssp ----CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred ccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHH
Confidence 111234579999999999977 35667899999999999999997776443221110 0000000000000001
Q ss_pred hHh-hhcccCCCC------chHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 210 FRI-MDTKLGGQY------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 210 ~~~-~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
... ......... ...++..+.+||.+||..||++|||+.++++.|+.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 262 QVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 111 111111111 234778899999999999999999999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=286.17 Aligned_cols=234 Identities=21% Similarity=0.299 Sum_probs=170.6
Q ss_pred ChhHHHhHHHHHHh-------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe-------------CCeeEEEEecC
Q 021507 1 MFLFNFLHSHLELH-------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE-------------GENRLLVYEFM 60 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------------~~~~~lv~e~~ 60 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++.+ .+..|+||||+
T Consensus 18 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 97 (303)
T 1zy4_A 18 AFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC 97 (303)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECC
T ss_pred CcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecC
Confidence 46777776543221 01122345678899999999999999999998865 35679999999
Q ss_pred CCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC---
Q 021507 61 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--- 137 (311)
Q Consensus 61 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 137 (311)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (303)
T 1zy4_A 98 ENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174 (303)
T ss_dssp CSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC------
T ss_pred CCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhc
Confidence 9999999997543 34888999999999999999999755 99999999999999999999999999976532210
Q ss_pred ---------cceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchh
Q 021507 138 ---------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 207 (311)
Q Consensus 138 ---------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 207 (311)
........|+..|+|||++.+. .++.++|||||||++|+|++ ||....... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--~~~----------- 238 (303)
T 1zy4_A 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--NIL----------- 238 (303)
T ss_dssp -------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HHH-----------
T ss_pred cccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH--HHH-----------
Confidence 1112345689999999999765 68899999999999999998 554321100 000
Q ss_pred hhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 208 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..............+...+..+.+++.+||..||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0000111122233455677889999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.15 Aligned_cols=245 Identities=19% Similarity=0.179 Sum_probs=181.6
Q ss_pred ChhHHHhHHHHHHh----hh----hHHHHHHHHHHHHHHHhcCCCCC------ccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH----AR----SLLLITNWFQTEVNYLGQLHHPN------LVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~~----~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
+||+||.+.+.... +. ......+.+.+|+.++++++|++ ++.+++++...+..|+||||+ +++|.
T Consensus 31 ~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~ 109 (355)
T 2eu9_A 31 TFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTF 109 (355)
T ss_dssp TTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred CCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChH
Confidence 57888877544322 11 11245667889999999997766 999999999999999999999 56888
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe-------------------CCCCcEEEeccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-------------------DAEFNAKLSDFG 127 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~-------------------~~~~~~kl~Dfg 127 (311)
+++.......+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 110 ~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 187 (355)
T 2eu9_A 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187 (355)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCT
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecC
Confidence 888766656699999999999999999999965 59999999999999 567889999999
Q ss_pred ccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhccccccc-
Q 021507 128 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSD- 205 (311)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~- 205 (311)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ....+....
T Consensus 188 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~ 262 (355)
T 2eu9_A 188 SATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM 262 (355)
T ss_dssp TCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHH
Confidence 99764332 23457899999999999999999999999999999999999999875532211111 000000000
Q ss_pred -------------------hhhhhHhhhc-----ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 206 -------------------KRKLFRIMDT-----KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 206 -------------------~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.......... ..........+.++.+||.+||..||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 263 IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 00011233557789999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=293.82 Aligned_cols=241 Identities=20% Similarity=0.232 Sum_probs=175.1
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCee------EEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~------~lv~e~~~~~~ 64 (311)
+||+||++.+.... ........+.+.+|+.+++.++||||+++++++...+.. |+||||+. ++
T Consensus 54 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 132 (371)
T 4exu_A 54 AYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TD 132 (371)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EE
T ss_pred CCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-cc
Confidence 57788877554322 111233456788999999999999999999999877655 99999997 48
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 133 l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~ 201 (371)
T 4exu_A 133 LQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 201 (371)
T ss_dssp HHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC-------------CT
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCc
Confidence 988773 23999999999999999999999754 999999999999999999999999999764332 3345
Q ss_pred cccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhhcccccc-------c--hhhhhHhh
Q 021507 145 MGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLS-------D--KRKLFRIM 213 (311)
Q Consensus 145 ~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~-------~--~~~~~~~~ 213 (311)
.||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....... ......... . .......+
T Consensus 202 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (371)
T 4exu_A 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 281 (371)
T ss_dssp TCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHS
T ss_pred ccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhcc
Confidence 78999999999887 6789999999999999999999999987553221111 000000000 0 00000000
Q ss_pred hcccCCC---CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 214 DTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 214 ~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
....... ....++..+.+||.+||+.||++|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 282 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 113457889999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=293.21 Aligned_cols=246 Identities=22% Similarity=0.224 Sum_probs=173.3
Q ss_pred ChhHHHhHHHHHHhh---hh----HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCe-------eEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELHA---RS----LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN-------RLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-------~~lv~e~~~~~~L~ 66 (311)
+||+||++.+..... .+ .....+.+.+|++.+..++||||+++++++...+. .++||||+.+ +|.
T Consensus 35 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 113 (360)
T 3e3p_A 35 TFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLH 113 (360)
T ss_dssp ----CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHH
Confidence 588888876654321 11 11223456778888899999999999999976433 7899999986 666
Q ss_pred HHhhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceecc
Q 021507 67 NHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQ 143 (311)
Q Consensus 67 ~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 143 (311)
+.+.. .....+++..+..++.|++.||.|||.+.++|+||||||+|||++. ++.+||+|||++........ ...
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 190 (360)
T 3e3p_A 114 RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVA 190 (360)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCS
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---ccc
Confidence 55432 2334589999999999999999999944456999999999999986 89999999999986543321 334
Q ss_pred ccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhhccccccchhhhhHhhhc------
Q 021507 144 VMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLSDKRKLFRIMDT------ 215 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~------ 215 (311)
..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......... ...... ........+..
T Consensus 191 ~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 267 (360)
T 3e3p_A 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC---PSREVLRKLNPSHTDVD 267 (360)
T ss_dssp TTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC---CCHHHHHHHCTTCCCGG
T ss_pred ccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC---CCHHHHHhcccchhhcc
Confidence 5789999999998665 489999999999999999999999987553221111 100000 00000000000
Q ss_pred ----------ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 216 ----------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 216 ----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..........+.++.+||.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 268 LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00011223467899999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=288.01 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=174.1
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEE--------------eCCeeEEEEe
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCL--------------EGENRLLVYE 58 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--------------~~~~~~lv~e 58 (311)
+||+||.+.+.... ........+.+.+|++++++++||||+++++++. +.+..|+|||
T Consensus 23 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (320)
T 2i6l_A 23 GNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQE 102 (320)
T ss_dssp ---CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEE
T ss_pred CCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEee
Confidence 47777777654422 1112334567889999999999999999999873 4467899999
Q ss_pred cCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC-CCCcEEEecccccccCCCCCC
Q 021507 59 FMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDR 137 (311)
Q Consensus 59 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~ 137 (311)
|+. |+|.+++.+ ..+++..++.++.|++.||+|||+.+ ++||||||+||+++ .++.+||+|||++........
T Consensus 103 ~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 176 (320)
T 2i6l_A 103 YME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176 (320)
T ss_dssp CCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC-----
T ss_pred ccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc
Confidence 997 499999854 34899999999999999999999755 99999999999997 567899999999986543211
Q ss_pred c-ceeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhcccccc--chhhhhH--
Q 021507 138 T-HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS--DKRKLFR-- 211 (311)
Q Consensus 138 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~-- 211 (311)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+..............+... .......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (320)
T 2i6l_A 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256 (320)
T ss_dssp ---CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTS
T ss_pred cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcC
Confidence 1 11234467899999998876 6788999999999999999999999987653221111110000000 0000000
Q ss_pred --hhhcccC-C-----CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 212 --IMDTKLG-G-----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 212 --~~~~~~~-~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+..... . .....++.++.++|.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 257 PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000 0 0123467889999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=289.92 Aligned_cols=241 Identities=20% Similarity=0.241 Sum_probs=175.4
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCe------eEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN------RLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~------~~lv~e~~~~~~ 64 (311)
+||+||.+.+.... ........+.+.+|+.++++++||||+++++++...+. .|+||||+.+ +
T Consensus 36 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 114 (353)
T 3coi_A 36 AYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-D 114 (353)
T ss_dssp SSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-E
T ss_pred CCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccC-C
Confidence 57778777554321 01122345678899999999999999999999987654 4999999974 8
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+++.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ....
T Consensus 115 l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~ 183 (353)
T 3coi_A 115 LQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 183 (353)
T ss_dssp GGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----cccc
Confidence 8887732 3999999999999999999999755 999999999999999999999999999764322 2345
Q ss_pred cccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhhc-cccc------cc--hhhhhHhh
Q 021507 145 MGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWA-KPYL------SD--KRKLFRIM 213 (311)
Q Consensus 145 ~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~-~~~~------~~--~~~~~~~~ 213 (311)
.+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....... .... .+.. .. .......+
T Consensus 184 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (353)
T 3coi_A 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 263 (353)
T ss_dssp CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTS
T ss_pred ccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhC
Confidence 78999999999877 6789999999999999999999999987653211110 0000 0000 00 00000001
Q ss_pred hccc---CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 214 DTKL---GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 214 ~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.... .......++..+.+||.+||..||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 264 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1100 112234678899999999999999999999999865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.94 Aligned_cols=247 Identities=20% Similarity=0.230 Sum_probs=177.5
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~ 66 (311)
+||+||.+.+.... ..........+.+|++++++++||||+++++++... ...|+||||+.+ +|.
T Consensus 23 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~ 101 (353)
T 2b9h_A 23 AYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLH 101 (353)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSE-EHH
T ss_pred CCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCc-cHH
Confidence 57777777654321 112233455688999999999999999999988754 678999999974 999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-------
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH------- 139 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------- 139 (311)
+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 102 ~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 176 (353)
T 2b9h_A 102 RVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176 (353)
T ss_dssp HHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC-------------
T ss_pred HHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccc
Confidence 988653 4999999999999999999999754 9999999999999999999999999998654322111
Q ss_pred -eeccccccccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hh-ccccccc------hhhh
Q 021507 140 -VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPYLSD------KRKL 209 (311)
Q Consensus 140 -~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~~------~~~~ 209 (311)
......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+........ .. ..+.... ....
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 2b9h_A 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256 (353)
T ss_dssp ---CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHH
T ss_pred cchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchh
Confidence 1123478999999998765 67899999999999999999999999876532211110 00 0000000 0000
Q ss_pred hHhhhcccCC------CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 210 FRIMDTKLGG------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 210 ~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.......... .....++.++.+||.+||..||++|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0113567889999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=291.24 Aligned_cols=252 Identities=20% Similarity=0.231 Sum_probs=167.5
Q ss_pred ChhHHHhHHHHHH--h---hhh---HHHHHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLEL--H---ARS---LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~--~---~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++++... . +.+ .....+.+.+|+.+|++++||||+++++++.. +...|+||||+.+ +|.+++.
T Consensus 33 ~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 111 (405)
T 3rgf_A 33 TYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIK 111 (405)
T ss_dssp ---EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHH
T ss_pred CCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHH
Confidence 5888888874321 1 111 11223468899999999999999999999964 6789999999975 8888875
Q ss_pred hc-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe----CCCCcEEEecccccccCCCCCCc-
Q 021507 71 RR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRT- 138 (311)
Q Consensus 71 ~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~- 138 (311)
.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++........
T Consensus 112 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 189 (405)
T 3rgf_A 112 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189 (405)
T ss_dssp HHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC---------
T ss_pred HhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCccc
Confidence 32 1234999999999999999999999755 9999999999999 67789999999999865432211
Q ss_pred ceeccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhh----------hhhhh-ccccccch
Q 021507 139 HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ----------SLVDW-AKPYLSDK 206 (311)
Q Consensus 139 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~-~~~~~~~~ 206 (311)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....... ..... ..+.....
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~ 269 (405)
T 3rgf_A 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW 269 (405)
T ss_dssp -------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTC
T ss_pred ccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhc
Confidence 123446789999999999874 5899999999999999999999999765432100 00000 00000000
Q ss_pred ---------hhhhHhhhcc-cCC--------CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 021507 207 ---------RKLFRIMDTK-LGG--------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255 (311)
Q Consensus 207 ---------~~~~~~~~~~-~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~ 255 (311)
.......... ... ......+..+.+||.+||..||.+|||+++++++-.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 270 EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp GGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred chhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 0000000000 000 000112567899999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.49 Aligned_cols=233 Identities=22% Similarity=0.321 Sum_probs=174.9
Q ss_pred ChhHHHhHHHHHHh--h-------hhHHHHHHHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH--A-------RSLLLITNWFQTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+.... + .......+.+.+|++++++++ |+||+++++++.+++..|+|||+ .+++|.+++
T Consensus 40 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l 118 (313)
T 3cek_A 40 GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL 118 (313)
T ss_dssp SSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHH
T ss_pred CCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHH
Confidence 46777776543211 0 112334567899999999997 59999999999999999999994 577999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++ ++.+||+|||++................|++.
T Consensus 119 ~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~ 193 (313)
T 3cek_A 119 KKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193 (313)
T ss_dssp HHCS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGG
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCC
Confidence 7654 4899999999999999999999754 99999999999996 48999999999987544333222345578999
Q ss_pred ccCcccccc-----------CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccC
Q 021507 150 YAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG 218 (311)
Q Consensus 150 y~aPE~~~~-----------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (311)
|+|||++.+ ..++.++||||||+++|+|++|..||....... ............
T Consensus 194 y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---------------~~~~~~~~~~~~ 258 (313)
T 3cek_A 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------------SKLHAIIDPNHE 258 (313)
T ss_dssp GCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------------HHHHHHHCTTSC
T ss_pred cCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---------------HHHHHHHhcccc
Confidence 999999875 467889999999999999999999997543211 111222222233
Q ss_pred CCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 219 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
...+...+..+.+++.+||..||.+||++.++++..
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 344555678899999999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=279.06 Aligned_cols=224 Identities=26% Similarity=0.327 Sum_probs=170.0
Q ss_pred HHHHHHHHHhcC---CCCCccceEeEEE-----eCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 24 WFQTEVNYLGQL---HHPNLVKLIGYCL-----EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 24 ~~~~E~~~l~~l---~hpnIv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
.+.+|+.+++.+ +||||+++++++. .....++||||+. ++|.+++.......+++..++.++.|++.||+|
T Consensus 57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~ 135 (326)
T 1blx_A 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135 (326)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 466788877776 8999999999987 4567899999997 599999977665669999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 175 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 175 (311)
||+.+ ++|+||||+||+++.++.+||+|||++...... .......|+..|+|||++.+..++.++|||||||++|
T Consensus 136 lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (326)
T 1blx_A 136 LHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210 (326)
T ss_dssp HHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHCC--ceeccCCHHHeEEcCCCCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHH
Confidence 99754 999999999999999999999999999764322 1233457899999999999999999999999999999
Q ss_pred HHHhCCCccCCCccchhhhh-hhh-ccccccch-------hhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCC
Q 021507 176 ELLSGRCAVDKTKVGIEQSL-VDW-AKPYLSDK-------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 246 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 246 (311)
+|++|..||.+......... ... ..+..... ..................++..+.+|+.+||..||.+|||
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 290 (326)
T 1blx_A 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290 (326)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC
Confidence 99999999987543221111 000 00000000 0000000000011123457788999999999999999999
Q ss_pred HHHHHHH
Q 021507 247 MSEVLAI 253 (311)
Q Consensus 247 ~~~~l~~ 253 (311)
+.+++++
T Consensus 291 ~~e~l~h 297 (326)
T 1blx_A 291 AYSALSH 297 (326)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=284.72 Aligned_cols=236 Identities=22% Similarity=0.282 Sum_probs=157.1
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHH-HHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||.+.+.... ..........+.+|+. +++.++||||+++++++.+++..|+||||+.+ +|.+++.
T Consensus 34 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 112 (327)
T 3aln_A 34 AYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYK 112 (327)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHH
T ss_pred CCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHH
Confidence 46777776554221 1111223334555555 77888999999999999999999999999986 8888775
Q ss_pred h---cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccc
Q 021507 71 R---RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 ~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
. .....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++....... ......||
T Consensus 113 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt 188 (327)
T 3aln_A 113 YVYSVLDDVIPEEILGKITLATVKALNHLKEN-LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGC 188 (327)
T ss_dssp HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH-HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------------
T ss_pred HHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc-CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCC
Confidence 3 2235599999999999999999999974 149999999999999999999999999997653322 12334689
Q ss_pred ccccCcccc----ccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCch
Q 021507 148 HGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 223 (311)
Q Consensus 148 ~~y~aPE~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
..|+|||++ .+..++.++|||||||++|+|++|..||.......... . ................
T Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~~ 256 (327)
T 3aln_A 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-T-----------QVVKGDPPQLSNSEER 256 (327)
T ss_dssp -----------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------C-----------CCCCSCCCCCCCCSSC
T ss_pred ccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-H-----------HHhcCCCCCCCCcccc
Confidence 999999998 45678899999999999999999999997643211000 0 0000000011111223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 224 KAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.++..+.+|+.+||..||.+|||+.++++.
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 567899999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.37 Aligned_cols=232 Identities=22% Similarity=0.283 Sum_probs=163.4
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||.+.+.... ........+.+.++..+++.++||||+++++++.+++..|+||||+ ++.+..+..
T Consensus 37 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~ 115 (318)
T 2dyl_A 37 TCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK 115 (318)
T ss_dssp ---CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHH
T ss_pred CCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHH
Confidence 46777776554321 1112233445566667888899999999999999999999999999 546655554
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
.. ...+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++....... ......+++.|
T Consensus 116 ~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y 190 (318)
T 2dyl_A 116 RM-QGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAY 190 (318)
T ss_dssp HH-TSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTT
T ss_pred Hh-ccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccc
Confidence 32 34599999999999999999999973 249999999999999999999999999997643322 12345689999
Q ss_pred cCccccc-----cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchH
Q 021507 151 AAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQK 224 (311)
Q Consensus 151 ~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (311)
+|||++. +..++.++|||||||++|+|++|..||........ ......... ........
T Consensus 191 ~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---------------VLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp CCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---------------HHHHHHHSCCCCCCSSSC
T ss_pred cChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH---------------HHHHHhccCCCCCCccCC
Confidence 9999984 45688899999999999999999999976322110 011111111 01111234
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++.++.++|.+||..||.+||++.+++++
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 67889999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=281.97 Aligned_cols=226 Identities=23% Similarity=0.305 Sum_probs=162.3
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEe-----CCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 95 (311)
..+.+.+|++++++++||||+++++++.. ....|+||||+.| +|.+++.... ..+++..++.++.|++.||+|
T Consensus 72 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~ 149 (362)
T 3pg1_A 72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR-IVISPQHIQYFMYHILLGLHV 149 (362)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHH
Confidence 34779999999999999999999999854 3367999999974 8988886443 459999999999999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc-CCCCCCCceehhHHHH
Q 021507 96 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVL 174 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il 174 (311)
||+.+ |+||||||+||+++.++.+||+|||++....... ......+|..|+|||++.+ ..++.++|||||||++
T Consensus 150 lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 150 LHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp HHHTT--CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred HHHCc--CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHH
Confidence 99755 9999999999999999999999999997533222 2334578999999999877 6789999999999999
Q ss_pred HHHHhCCCccCCCccchhhh-hhhhcc-ccccc-----hhhhhHhhhcccCC-------CCchHHHHHHHHHHHhcccCC
Q 021507 175 LELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSD-----KRKLFRIMDTKLGG-------QYPQKAAHTAATLALQCLNNE 240 (311)
Q Consensus 175 ~~l~~g~~pf~~~~~~~~~~-~~~~~~-~~~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~ 240 (311)
|+|++|..||.+........ ...... +.... .............. .....++..+.+||.+||..|
T Consensus 225 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 304 (362)
T 3pg1_A 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304 (362)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCC
Confidence 99999999998754322111 110000 00000 00000000000000 011245678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021507 241 PKLRPRMSEVLAI 253 (311)
Q Consensus 241 p~~Rpt~~~~l~~ 253 (311)
|.+|||+.+++++
T Consensus 305 P~~Rpt~~ell~h 317 (362)
T 3pg1_A 305 PQRRISTEQALRH 317 (362)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHHcC
Confidence 9999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=288.70 Aligned_cols=216 Identities=23% Similarity=0.310 Sum_probs=158.6
Q ss_pred HHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCC-----CCHHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTF 95 (311)
Q Consensus 22 ~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~i~~~l~~ 95 (311)
.+.+.+|+++++++ +||||+++++++.+++..|+|||||. |+|.+++....... .++..++.++.|++.||+|
T Consensus 52 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 130 (434)
T 2rio_A 52 CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130 (434)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHH
Confidence 45678999999986 89999999999999999999999996 59999996544211 1233457899999999999
Q ss_pred hhhCCCCeeecCCCCCceEeCCC-------------CcEEEecccccccCCCCCCcc--eeccccccccccCcccccc--
Q 021507 96 LHDAESQVIYRDFKASNILLDAE-------------FNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEYVAT-- 158 (311)
Q Consensus 96 lH~~~~~ivH~dlkp~Nil~~~~-------------~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-- 158 (311)
||+.+ |+||||||+|||++.+ +.+||+|||++.......... ......||+.|+|||++.+
T Consensus 131 LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 208 (434)
T 2rio_A 131 LHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208 (434)
T ss_dssp HHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCC
T ss_pred HHHCC--ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccc
Confidence 99755 9999999999999654 479999999998764432211 1234579999999999976
Q ss_pred -----CCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHH
Q 021507 159 -----GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 232 (311)
Q Consensus 159 -----~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 232 (311)
..++.++|||||||++|+|++ |..||......... ...... ............++.++.++
T Consensus 209 ~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~-i~~~~~------------~~~~~~~~~~~~~~~~~~~l 275 (434)
T 2rio_A 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN-IIRGIF------------SLDEMKCLHDRSLIAEATDL 275 (434)
T ss_dssp TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH-HHHTCC------------CCCCCTTCCCHHHHHHHHHH
T ss_pred ccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH-HhcCCC------------CcccccccccccchHHHHHH
Confidence 568889999999999999999 99999754321110 000000 00001112245678899999
Q ss_pred HHhcccCCCCCCCCHHHHHHH
Q 021507 233 ALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 233 i~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|.+||..||.+|||+.+++++
T Consensus 276 i~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 276 ISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCChhhCCCHHHHHhC
Confidence 999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=300.31 Aligned_cols=254 Identities=20% Similarity=0.214 Sum_probs=183.3
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe------CCeeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE------GENRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~~~lv~e~~~~~~L 65 (311)
+||+||++.+.... ........+.+.+|++++++++||||+++++++.. ++..|+||||++|++|
T Consensus 26 ~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL 105 (676)
T 3qa8_A 26 GFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL 105 (676)
T ss_dssp SSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBH
T ss_pred CCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCH
Confidence 58888887765422 11123345678999999999999999999998765 6678999999999999
Q ss_pred HHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc---EEEecccccccCCCCCCccee
Q 021507 66 ENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVS 141 (311)
Q Consensus 66 ~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~ 141 (311)
.+++.... ...+++..++.++.+++.||+|||+.+ |+||||||+||+++.++. +||+|||++....... ..
T Consensus 106 ~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~ 180 (676)
T 3qa8_A 106 RKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LC 180 (676)
T ss_dssp HHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CC
T ss_pred HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccccccccccc---cc
Confidence 99996543 235899999999999999999999754 999999999999987765 9999999998754332 23
Q ss_pred ccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhh--hhhhccc---cccchhhhhHh-hhc
Q 021507 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKP---YLSDKRKLFRI-MDT 215 (311)
Q Consensus 142 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~-~~~ 215 (311)
....||..|+|||++.+..++.++|||||||++|+|++|..||.......... ....... ........... ...
T Consensus 181 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~l 260 (676)
T 3qa8_A 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVL 260 (676)
T ss_dssp CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSS
T ss_pred ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccccccc
Confidence 44678999999999999999999999999999999999999997642211000 0000000 00000000000 000
Q ss_pred ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHH-----HHHHHhhcC
Q 021507 216 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV-----LAILERLEA 259 (311)
Q Consensus 216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~-----l~~l~~~~~ 259 (311)
.........++..+.++|.+||..||.+|||+.++ .+.++.+..
T Consensus 261 p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 261 PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 11223455689999999999999999999999884 455555543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=285.57 Aligned_cols=210 Identities=23% Similarity=0.316 Sum_probs=157.9
Q ss_pred HHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 021507 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 103 (311)
Q Consensus 25 ~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 103 (311)
+.+|+++|+++ +||||+++++++.+.+..|+||||+.| +|.+++..... ...+..++.++.|++.||+|||+.+ |
T Consensus 64 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--i 139 (432)
T 3p23_A 64 ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN--I 139 (432)
T ss_dssp CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT--C
T ss_pred HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc--C
Confidence 57899999999 899999999999999999999999965 99999965542 3555567789999999999999765 9
Q ss_pred eecCCCCCceEeCCC-----CcEEEecccccccCCCCCCc-ceeccccccccccCcccccc---CCCCCCCceehhHHHH
Q 021507 104 IYRDFKASNILLDAE-----FNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVL 174 (311)
Q Consensus 104 vH~dlkp~Nil~~~~-----~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il 174 (311)
+||||||+||+++.+ ..+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 140 vHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il 219 (432)
T 3p23_A 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219 (432)
T ss_dssp CCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred EeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence 999999999999532 35889999999875433211 22344679999999999974 5677899999999999
Q ss_pred HHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 175 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 175 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
|+|++ |..||.............. ............+..+.+||.+||+.||.+|||+.+++++
T Consensus 220 ~ellt~g~~pf~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 220 YYVISEGSHPFGKSLQRQANILLGA---------------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHTTSCBTTBSTTTHHHHHHTTC---------------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCCCcchhhHHHHHHHhcc---------------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 99999 9999965432111110000 0000011223456778999999999999999999999953
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=273.21 Aligned_cols=199 Identities=23% Similarity=0.346 Sum_probs=166.9
Q ss_pred HHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCC-CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 23 NWFQTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 23 ~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
+.+.+|+.++++++ |+||+++++++.+.+..++|||++.+ ++|.+++.... .+++..++.++.|++.||+|||+.
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~ 168 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC 168 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34678999999996 59999999999999999999999976 89999997654 489999999999999999999975
Q ss_pred CCCeeecCCCCCceEeC-CCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCC-CCCCceehhHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLEL 177 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l 177 (311)
+ |+||||||+||+++ .++.+||+|||++....... .....||..|+|||++.+..+ +.++|||||||++|+|
T Consensus 169 ~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el 242 (320)
T 3a99_A 169 G--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242 (320)
T ss_dssp T--EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred C--cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHH
Confidence 5 99999999999998 77899999999998654322 234568999999999987765 6789999999999999
Q ss_pred HhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 178 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 178 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++|..||..... .... ....+..++.++.++|.+||..||.+|||+.++++.
T Consensus 243 ~~g~~pf~~~~~----------------------~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 243 VCGDIPFEHDEE----------------------IIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHSSCSCCSHHH----------------------HHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHCCCCCCChhh----------------------hhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999975321 0000 112344567889999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.09 Aligned_cols=199 Identities=26% Similarity=0.416 Sum_probs=163.5
Q ss_pred HHHHHHHHHHhcC----CCCCccceEeEEEeCCeeEEEEec-CCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021507 23 NWFQTEVNYLGQL----HHPNLVKLIGYCLEGENRLLVYEF-MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 97 (311)
Q Consensus 23 ~~~~~E~~~l~~l----~hpnIv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 97 (311)
..+.+|+.++.++ +||||+++++++.+.+..++|||+ +.+++|.+++.... .+++..++.++.|++.||+|||
T Consensus 79 ~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH 156 (312)
T 2iwi_A 79 VTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH 156 (312)
T ss_dssp CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 3466799999999 899999999999999999999999 78899999997654 4899999999999999999999
Q ss_pred hCCCCeeecCCCCCceEeC-CCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCC-CCCceehhHHHHH
Q 021507 98 DAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLL 175 (311)
Q Consensus 98 ~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ 175 (311)
+.+ ++||||||+||+++ .++.+||+|||++....... .....|+..|+|||++.+..+. .++||||||+++|
T Consensus 157 ~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 230 (312)
T 2iwi_A 157 SRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLY 230 (312)
T ss_dssp HHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred HCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHH
Confidence 755 99999999999998 78999999999998754332 2345689999999999877664 4899999999999
Q ss_pred HHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 176 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 176 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+|++|..||..... ... .....+..++..+.++|.+||..||++|||+.+++++
T Consensus 231 ~l~~g~~pf~~~~~----------------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 231 DMVCGDIPFERDQE----------------------ILE--AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHSSCSCCSHHH----------------------HHH--TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHCCCCCCChHH----------------------Hhh--hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999975321 000 1113445678889999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=272.53 Aligned_cols=210 Identities=14% Similarity=0.105 Sum_probs=162.4
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... ........+.|.+|++++.+++||||+++++++.+++..|+||||++|++|.+++
T Consensus 43 ~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l 122 (286)
T 3uqc_A 43 PPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA 122 (286)
T ss_dssp TTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHH
T ss_pred CCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHH
Confidence 57888887765422 1111334577899999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.++ .....+..++.|++.||+|||+.+ |+||||||+||+++.+|.+||+++|.
T Consensus 123 ~~~----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~~--------------------- 175 (286)
T 3uqc_A 123 DTS----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPAT--------------------- 175 (286)
T ss_dssp TTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCCC---------------------
T ss_pred hcC----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEeccc---------------------
Confidence 432 455678899999999999999755 99999999999999999999985432
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc--CCCCchHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAH 227 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 227 (311)
++ .++.++|||||||++|+|++|+.||.+.+........ ........ .......++.
T Consensus 176 -~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~ 234 (286)
T 3uqc_A 176 -MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------------ERDTAGQPIEPADIDRDIPF 234 (286)
T ss_dssp -CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------------CBCTTSCBCCHHHHCTTSCH
T ss_pred -cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------------HHHhccCCCChhhcccCCCH
Confidence 22 3678999999999999999999999875432100000 00000000 0011235678
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
++.++|.+||+.||.+| |+.++++.|+++..
T Consensus 235 ~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 235 QISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 89999999999999999 99999999998764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=303.14 Aligned_cols=219 Identities=23% Similarity=0.314 Sum_probs=171.3
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCe-----eEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGEN-----RLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-----~~lv~e~~~~~~L 65 (311)
|||+||++.+.... ........+.+.+|++++++++||||+++++++.+.+. .|+||||++|++|
T Consensus 92 ~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L 171 (681)
T 2pzi_A 92 GLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL 171 (681)
T ss_dssp TTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEEC
T ss_pred CCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcH
Confidence 68888888765421 11123455678999999999999999999999987665 6999999999999
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccc
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ .+||+|||++...... ....
T Consensus 172 ~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~ 238 (681)
T 2pzi_A 172 KRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLY 238 (681)
T ss_dssp C----C----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCC
T ss_pred HHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccchhcccC------CccC
Confidence 987743 4999999999999999999999755 9999999999999875 8999999999865432 3457
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 225 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
||+.|+|||++.+.. +.++|||||||++|+|++|..||.+..... .. ........
T Consensus 239 gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~-------------~~~~~~~~ 293 (681)
T 2pzi_A 239 GTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP-------------EDDPVLKT 293 (681)
T ss_dssp CCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC-------------TTCHHHHH
T ss_pred CCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------cc-------------cccccccc
Confidence 899999999987654 889999999999999999999887532100 00 00011234
Q ss_pred HHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhh
Q 021507 226 AHTAATLALQCLNNEPKLRP-RMSEVLAILERL 257 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rp-t~~~~l~~l~~~ 257 (311)
+..+.++|.+||..||.+|| +++++.+.|..+
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 56889999999999999999 566666666553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=277.10 Aligned_cols=214 Identities=20% Similarity=0.244 Sum_probs=162.9
Q ss_pred ChhHHHhHHHHHHh---hhhHHHHHHHHHHHHHHH-hcCCCCCccceEeEEEe----CCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---ARSLLLITNWFQTEVNYL-GQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... +.+.....+.+.+|+.++ +.++||||+++++++.. ....|+||||++|++|.+++...
T Consensus 30 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 109 (299)
T 3m2w_A 30 INGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 109 (299)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC
T ss_pred CCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc
Confidence 57778877654332 222223345678899998 55599999999999987 67789999999999999999877
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCcceecccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
....+++..++.++.|++.||+|||+.+ ++||||||+||+++. ++.+||+|||++....
T Consensus 110 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------- 171 (299)
T 3m2w_A 110 GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------- 171 (299)
T ss_dssp TTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------------
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccccccc----------------
Confidence 6667999999999999999999999755 999999999999998 7889999999986421
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc----hHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKA 225 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 225 (311)
+..++.++|||||||++|+|++|..||........... ....... .....+ ..+
T Consensus 172 --------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~ 229 (299)
T 3m2w_A 172 --------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------------MKTRIRM-GQYEFPNPEWSEV 229 (299)
T ss_dssp --------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------------SCCSSCT-TCCSSCHHHHTTS
T ss_pred --------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------------HHHHHhh-ccccCCchhcccC
Confidence 24467789999999999999999999976432110000 0000000 000111 346
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
+.++.+++.+||..||.+|||+.+++++.
T Consensus 230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 78899999999999999999999999754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=275.43 Aligned_cols=221 Identities=15% Similarity=0.120 Sum_probs=159.4
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCC-CCcc---------ceE------------eEE
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHH-PNLV---------KLI------------GYC 47 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~h-pnIv---------~~~------------~~~ 47 (311)
|||+||++.+.... + .......+.|++|+.+++.++| .|+. ... .++
T Consensus 90 ~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (413)
T 3dzo_A 90 DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 169 (413)
T ss_dssp TTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--------
T ss_pred CCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCcccccc
Confidence 68888888765432 1 1112234668999999999987 2211 111 111
Q ss_pred Ee-----CCeeEEEEecCCCCChHHHhh-----hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC
Q 021507 48 LE-----GENRLLVYEFMPKGSLENHLF-----RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 117 (311)
Q Consensus 48 ~~-----~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~ 117 (311)
.. ....+++|+++ +++|.+++. ......+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~ 246 (413)
T 3dzo_A 170 LDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ 246 (413)
T ss_dssp -------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECT
T ss_pred CCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEec
Confidence 11 12357888877 569999884 222344788899999999999999999755 999999999999999
Q ss_pred CCcEEEecccccccCCCCCCcceeccccccccccCcccc----------ccCCCCCCCceehhHHHHHHHHhCCCccCCC
Q 021507 118 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----------ATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 187 (311)
Q Consensus 118 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 187 (311)
++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|+|++|+.||...
T Consensus 247 ~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 247 RGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp TCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred CCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999998764322 344567 999999999 4556888999999999999999999999764
Q ss_pred ccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 021507 188 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252 (311)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 252 (311)
...... ...+. ....++..+.+||.+||..||++||++.++++
T Consensus 321 ~~~~~~----------------~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 321 AALGGS----------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp GGGSCS----------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred chhhhH----------------HHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 321100 00000 11245688999999999999999999888764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.22 Aligned_cols=201 Identities=13% Similarity=0.074 Sum_probs=151.5
Q ss_pred HHHHHHHHHHhcCC---------CCCccceEeEE-----------------Ee-------------CCeeEEEEecCCCC
Q 021507 23 NWFQTEVNYLGQLH---------HPNLVKLIGYC-----------------LE-------------GENRLLVYEFMPKG 63 (311)
Q Consensus 23 ~~~~~E~~~l~~l~---------hpnIv~~~~~~-----------------~~-------------~~~~~lv~e~~~~~ 63 (311)
+.+.+|+.++++++ ||||+++.+++ .+ .+..|+||||+++|
T Consensus 68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g 147 (336)
T 2vuw_A 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence 67889999998886 66666666654 32 67899999999999
Q ss_pred ChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCeeecCCCCCceEeCCCC--------------------cEE
Q 021507 64 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEF--------------------NAK 122 (311)
Q Consensus 64 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~ivH~dlkp~Nil~~~~~--------------------~~k 122 (311)
++.+.+.+ ..+++..+..++.||+.||+||| +.+ |+||||||+|||++.++ .+|
T Consensus 148 ~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vk 222 (336)
T 2vuw_A 148 IDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVS 222 (336)
T ss_dssp EETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEE
T ss_pred ccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEE
Confidence 77776643 34899999999999999999999 766 99999999999999887 899
Q ss_pred EecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHH-HHHHHhCCCccCCCccchhhhhhhhccc
Q 021507 123 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV-LLELLSGRCAVDKTKVGIEQSLVDWAKP 201 (311)
Q Consensus 123 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i-l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 201 (311)
|+|||+++.... ....||+.|+|||++.+.. +.++||||||++ .+++++|..||...... ..
T Consensus 223 L~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~------- 285 (336)
T 2vuw_A 223 IIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HY------- 285 (336)
T ss_dssp ECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HH-------
T ss_pred EeeccccEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hH-------
Confidence 999999986432 2347899999999998776 889999998777 77888899998542100 00
Q ss_pred cccchhhhhHhhh--cccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHH-HH
Q 021507 202 YLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AI 253 (311)
Q Consensus 202 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l-~~ 253 (311)
....+..... .......+..++.++.+||.+||..| |+.+++ ++
T Consensus 286 ---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 286 ---LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp ---HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred ---HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 0000000000 00111123468899999999999977 999988 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=268.01 Aligned_cols=157 Identities=18% Similarity=0.118 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 18 LLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 18 ~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
...-.+.|.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|.+.+. ++.. .|+.||+.||+|+
T Consensus 281 ~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~yl 355 (569)
T 4azs_A 281 SQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAAL 355 (569)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHH
Confidence 344556799999999999 799999999999999999999999999999999976553 6654 4789999999999
Q ss_pred hhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHH
Q 021507 97 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 176 (311)
Q Consensus 97 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 176 (311)
|+++ ||||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+. +..++|+||+|+++++
T Consensus 356 H~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~ 430 (569)
T 4azs_A 356 EKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFN 430 (569)
T ss_dssp HHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CC
T ss_pred HHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCCC-CCCcccccccccchhh
Confidence 9755 99999999999999999999999999987543322 24457899999999999764 5678999999999888
Q ss_pred HHhCCCcc
Q 021507 177 LLSGRCAV 184 (311)
Q Consensus 177 l~~g~~pf 184 (311)
+.++..++
T Consensus 431 l~~~~~~~ 438 (569)
T 4azs_A 431 LPQPWSNW 438 (569)
T ss_dssp CCTTHHHH
T ss_pred hccccchh
Confidence 77765544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-28 Score=222.39 Aligned_cols=150 Identities=17% Similarity=0.224 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+.+|++++++++||||+++..++...+..|+||||++|++|.+++.. +..++.|++.||+|||+.+
T Consensus 382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g 451 (540)
T 3en9_A 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND 451 (540)
T ss_dssp HHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc
Confidence 456789999999999999999666666677788999999999999999854 5679999999999999755
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-----eeccccccccccCcccccc--CCCCCCCceehhHHH
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-----VSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVV 173 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~i 173 (311)
|+||||||+|||++. .+||+|||+++......... ......||+.|+|||++.+ ..|+..+|+|+..+-
T Consensus 452 --IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~ 527 (540)
T 3en9_A 452 --VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILE 527 (540)
T ss_dssp --EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHH
T ss_pred --CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHH
Confidence 999999999999998 99999999998764422111 1235689999999999987 568888999999998
Q ss_pred HHHHHhCCCcc
Q 021507 174 LLELLSGRCAV 184 (311)
Q Consensus 174 l~~l~~g~~pf 184 (311)
..+.+.++.+|
T Consensus 528 ~l~~v~~r~rY 538 (540)
T 3en9_A 528 LMKDVERRARY 538 (540)
T ss_dssp HHHHHHTCSCC
T ss_pred HHHHHHhcccc
Confidence 88888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-20 Score=158.01 Aligned_cols=107 Identities=13% Similarity=0.058 Sum_probs=86.9
Q ss_pred HHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 21 ITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
....+.+|+.++++++ | +++.+++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||+.+
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g 213 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG 213 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999999 4 666665543 45699999999999998 421 124469999999999999755
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 158 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 158 (311)
|+||||||+|||++ ++.+||+|||+++. +..++|||++.+
T Consensus 214 --iiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 214 --IVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp --EECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred --CEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999999 99999999999863 345788998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=5.8e-16 Score=128.79 Aligned_cols=98 Identities=18% Similarity=0.192 Sum_probs=76.9
Q ss_pred HHHHHHHHHHHhcCCCCCc--cceEeEEEeCCeeEEEEecCCC-C----ChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 22 TNWFQTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPK-G----SLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
..++.+|+++|.++.|++| ..+++. +..++||||+.+ | +|.++... .++..+..++.|++.+|.
T Consensus 114 ~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~ 184 (258)
T 1zth_A 114 FIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVK 184 (258)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHH
Confidence 4578999999999988764 344432 356899999942 3 67766532 224467789999999999
Q ss_pred Hhh-hCCCCeeecCCCCCceEeCCCCcEEEecccccccC
Q 021507 95 FLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 132 (311)
Q Consensus 95 ~lH-~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 132 (311)
+|| +.+ |+||||||+|||++. .++|+|||++...
T Consensus 185 ~lH~~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 185 RLYQEAE--LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHTSC--EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHCC--EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999 765 999999999999988 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.35 E-value=6.8e-13 Score=115.11 Aligned_cols=97 Identities=12% Similarity=0.046 Sum_probs=70.8
Q ss_pred HHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 021507 23 NWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 102 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 102 (311)
-+..+|...|.++.+.++.-..-+... ..++||||++|++|.++.. . .....++.|++.+|.+||+. |
T Consensus 158 l~A~kE~~nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~--g 225 (397)
T 4gyi_A 158 LAAIKEFAFMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH--G 225 (397)
T ss_dssp HHHHHHHHHHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT--T
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC--C
Confidence 345678888888865544322222222 2479999999988876431 1 12356789999999999975 4
Q ss_pred eeecCCCCCceEeCCCC----------cEEEeccccccc
Q 021507 103 VIYRDFKASNILLDAEF----------NAKLSDFGLAKA 131 (311)
Q Consensus 103 ivH~dlkp~Nil~~~~~----------~~kl~Dfg~~~~ 131 (311)
||||||||.|||++++| .+.|+||+.+..
T Consensus 226 IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 226 LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999999998776 389999987754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-11 Score=101.37 Aligned_cols=100 Identities=13% Similarity=0.023 Sum_probs=80.9
Q ss_pred HHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC--
Q 021507 24 WFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE-- 100 (311)
Q Consensus 24 ~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-- 100 (311)
.+.+|+++++.+ .+..+.++++++.+.+..|+||||++|.+|.+.+. +......++.+++.+|+.||+..
T Consensus 55 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~ 127 (263)
T 3tm0_A 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDIS 127 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcc
Confidence 488999999998 46788899999999999999999999999987641 11223467889999999999710
Q ss_pred -------------------------------------------------------CCeeecCCCCCceEeCCCCcEEEec
Q 021507 101 -------------------------------------------------------SQVIYRDFKASNILLDAEFNAKLSD 125 (311)
Q Consensus 101 -------------------------------------------------------~~ivH~dlkp~Nil~~~~~~~kl~D 125 (311)
..++|+|++|.||++++++.+.|+|
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lID 207 (263)
T 3tm0_A 128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFID 207 (263)
T ss_dssp TCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECC
T ss_pred cCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEE
Confidence 3499999999999998765567999
Q ss_pred ccccc
Q 021507 126 FGLAK 130 (311)
Q Consensus 126 fg~~~ 130 (311)
|+.+.
T Consensus 208 we~a~ 212 (263)
T 3tm0_A 208 LGRSG 212 (263)
T ss_dssp CTTCE
T ss_pred chhcc
Confidence 98774
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=6.7e-10 Score=96.58 Aligned_cols=106 Identities=14% Similarity=0.234 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHhcCC--CCCccceEeEEEeC---CeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 22 TNWFQTEVNYLGQLH--HPNLVKLIGYCLEG---ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
...+.+|+.+++.|. +..+.+++.++.+. +..|+||||++|..+.+.. ...++......++.+++..|+.|
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~L 155 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAM 155 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHH
Confidence 346888999999996 45688888888766 4579999999998775422 12377888889999999999999
Q ss_pred hhC--------------------------------------------------------CCCeeecCCCCCceEeCCCCc
Q 021507 97 HDA--------------------------------------------------------ESQVIYRDFKASNILLDAEFN 120 (311)
Q Consensus 97 H~~--------------------------------------------------------~~~ivH~dlkp~Nil~~~~~~ 120 (311)
|+. ...++|+|+++.||+++.++.
T Consensus 156 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~ 235 (359)
T 3dxp_A 156 HTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP 235 (359)
T ss_dssp HHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS
T ss_pred hCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC
Confidence 972 246999999999999987753
Q ss_pred --EEEeccccccc
Q 021507 121 --AKLSDFGLAKA 131 (311)
Q Consensus 121 --~kl~Dfg~~~~ 131 (311)
+.|+||+.+..
T Consensus 236 ~v~~viDwe~a~~ 248 (359)
T 3dxp_A 236 RVLAVLDWELSTL 248 (359)
T ss_dssp CEEEECCCTTCEE
T ss_pred cEEEEECcccccc
Confidence 68999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=5.2e-10 Score=92.56 Aligned_cols=99 Identities=19% Similarity=0.119 Sum_probs=74.6
Q ss_pred HHHHHHHHHHhcCCCCC--ccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 021507 23 NWFQTEVNYLGQLHHPN--LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 100 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 100 (311)
..+.+|+.+++.+.+.+ +.++++++..++..|+||||++|.+|. ... ... ..++.+++..|+.||+..
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSC
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCC
Confidence 34788999999995444 566888888888899999999998884 211 121 256777778888888632
Q ss_pred --------------------------------------------------------CCeeecCCCCCceEeCCCCcEEEe
Q 021507 101 --------------------------------------------------------SQVIYRDFKASNILLDAEFNAKLS 124 (311)
Q Consensus 101 --------------------------------------------------------~~ivH~dlkp~Nil~~~~~~~kl~ 124 (311)
..++|+|++|.||++++++.+.|+
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~li 207 (264)
T 1nd4_A 128 PATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFI 207 (264)
T ss_dssp GGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEEC
T ss_pred CCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEE
Confidence 129999999999999877666799
Q ss_pred ccccccc
Q 021507 125 DFGLAKA 131 (311)
Q Consensus 125 Dfg~~~~ 131 (311)
|||.+..
T Consensus 208 D~~~a~~ 214 (264)
T 1nd4_A 208 DCGRLGV 214 (264)
T ss_dssp CCTTCEE
T ss_pred cchhccc
Confidence 9998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=7.8e-10 Score=93.90 Aligned_cols=155 Identities=19% Similarity=0.186 Sum_probs=100.6
Q ss_pred HHHHHHHHHHHHhcC-CCCC--ccceEeEEEeCC---eeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021507 21 ITNWFQTEVNYLGQL-HHPN--LVKLIGYCLEGE---NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 94 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hpn--Iv~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 94 (311)
....+.+|+++|+.+ .+.. +.+++......+ ..|+||++++|.+|.+.... .++..+...++.+++..|+
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la 128 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLS 128 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHH
Confidence 345688999999888 3332 445554443333 34899999999888754321 2677777888888888888
Q ss_pred HhhhCC--------------------------------------------------------CCeeecCCCCCceEeCC-
Q 021507 95 FLHDAE--------------------------------------------------------SQVIYRDFKASNILLDA- 117 (311)
Q Consensus 95 ~lH~~~--------------------------------------------------------~~ivH~dlkp~Nil~~~- 117 (311)
.||+.. ..++|+|++|.||+++.
T Consensus 129 ~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~ 208 (304)
T 3sg8_A 129 ELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE 208 (304)
T ss_dssp HHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT
T ss_pred HHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC
Confidence 888511 24899999999999988
Q ss_pred -CCcEEEecccccccCCCCCCcceeccccccccc---cCcccccc----C-C---------CCCCCceehhHHHHHHHHh
Q 021507 118 -EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY---AAPEYVAT----G-R---------LTTKSDVYSFGVVLLELLS 179 (311)
Q Consensus 118 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~----~-~---------~~~~~Di~slG~il~~l~~ 179 (311)
.+.+.|+||+.+....... .......+ ..|+.... . . .....+.|++|.++|.+.+
T Consensus 209 ~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~ 282 (304)
T 3sg8_A 209 KNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEY 282 (304)
T ss_dssp TTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4567899999886532110 00000011 22222111 0 0 1122589999999999999
Q ss_pred CCCccC
Q 021507 180 GRCAVD 185 (311)
Q Consensus 180 g~~pf~ 185 (311)
|..+|-
T Consensus 283 g~~~~~ 288 (304)
T 3sg8_A 283 GYMDWY 288 (304)
T ss_dssp TCHHHH
T ss_pred CCHHHH
Confidence 987764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=4e-07 Score=77.18 Aligned_cols=107 Identities=17% Similarity=0.143 Sum_probs=73.9
Q ss_pred HHHHHHHHHHHHhcCCCC---CccceEeEEE-eCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 021507 21 ITNWFQTEVNYLGQLHHP---NLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 96 (311)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp---nIv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 96 (311)
....+.+|+++|+.|.+. .|.+++.++. ..+..|+|||+++|.+|.+.... .++......++.++...|+.|
T Consensus 52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~L 127 (306)
T 3tdw_A 52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNEL 127 (306)
T ss_dssp HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHH
Confidence 345789999999999642 3566666664 44567899999999888763211 134445555555555555555
Q ss_pred hhC----------------------------------------------------------CCCeeecCCCCCceEeCC-
Q 021507 97 HDA----------------------------------------------------------ESQVIYRDFKASNILLDA- 117 (311)
Q Consensus 97 H~~----------------------------------------------------------~~~ivH~dlkp~Nil~~~- 117 (311)
|+. ...++|+|+++.||+++.
T Consensus 128 H~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~ 207 (306)
T 3tdw_A 128 SAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLN 207 (306)
T ss_dssp HHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTT
T ss_pred hcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecC
Confidence 532 224799999999999987
Q ss_pred --CCc-EEEeccccccc
Q 021507 118 --EFN-AKLSDFGLAKA 131 (311)
Q Consensus 118 --~~~-~kl~Dfg~~~~ 131 (311)
++. +.|+||+.+..
T Consensus 208 ~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 208 SRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CSSCCEEEECCCTTCEE
T ss_pred CCCCceEEEEehhhcCC
Confidence 355 48999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=3.9e-07 Score=75.67 Aligned_cols=104 Identities=19% Similarity=0.117 Sum_probs=76.2
Q ss_pred HHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-
Q 021507 22 TNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA- 99 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~- 99 (311)
...+.+|+.+|+.+. +--|.++++++.+.+..|+|||+++|.++.+...... .....++.+++..|+.||+.
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~ 136 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIP 136 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSC
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCC
Confidence 345788999998883 3347788899999999999999999988877553211 12234556666666666631
Q ss_pred -------------------------------------------------------CCCeeecCCCCCceEeCCCCcEEEe
Q 021507 100 -------------------------------------------------------ESQVIYRDFKASNILLDAEFNAKLS 124 (311)
Q Consensus 100 -------------------------------------------------------~~~ivH~dlkp~Nil~~~~~~~kl~ 124 (311)
...++|+|+.+.||+++.++.+-|+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~vi 216 (272)
T 4gkh_A 137 VCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCI 216 (272)
T ss_dssp GGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred cccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEE
Confidence 1138999999999999887767799
Q ss_pred ccccccc
Q 021507 125 DFGLAKA 131 (311)
Q Consensus 125 Dfg~~~~ 131 (311)
||+.+..
T Consensus 217 Dwe~a~~ 223 (272)
T 4gkh_A 217 DVGRVGI 223 (272)
T ss_dssp CCTTCEE
T ss_pred ECccccc
Confidence 9987753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=3.9e-06 Score=72.60 Aligned_cols=44 Identities=2% Similarity=0.017 Sum_probs=32.4
Q ss_pred HHHHHHHHHHhcCC-C--CCccceEeEEEeC---CeeEEEEecCCCCChH
Q 021507 23 NWFQTEVNYLGQLH-H--PNLVKLIGYCLEG---ENRLLVYEFMPKGSLE 66 (311)
Q Consensus 23 ~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~---~~~~lv~e~~~~~~L~ 66 (311)
..+.+|+.+++.|. + -.+.+++.++.+. +..|+||||++|.++.
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 34678999988883 2 3577788777655 3568999999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.18 E-value=8.7e-06 Score=64.09 Aligned_cols=141 Identities=14% Similarity=0.051 Sum_probs=90.5
Q ss_pred CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceec
Q 021507 63 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142 (311)
Q Consensus 63 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 142 (311)
-+|.+.|...+ .+++++++|.++.|.+.+|.-+-..... ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccC-CceecCCcceEEecCCceeccc-cccc------------
Confidence 37889886655 5699999999999999998877211111 1233456899999999988764 1110
Q ss_pred cccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc
Q 021507 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 222 (311)
Q Consensus 143 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
.....+.+||... ...+.+.=|||||+++|..+--..| ...+
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-----------------------------------e~eE 139 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-----------------------------------ENEE 139 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-----------------------------------TTEE
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-----------------------------------cccc
Confidence 1133567888752 3345567899999999998763222 1123
Q ss_pred hHHHHHHHHHHHhcccC-------------------------CCCCCCCHHHHHHHHHh
Q 021507 223 QKAAHTAATLALQCLNN-------------------------EPKLRPRMSEVLAILER 256 (311)
Q Consensus 223 ~~~~~~l~~li~~~l~~-------------------------~p~~Rpt~~~~l~~l~~ 256 (311)
..+++.|.+||..|... .+..|.++++|++.-..
T Consensus 140 ~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 140 RELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp ECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred hhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 44677788888888755 24678899999887655
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00013 Score=62.46 Aligned_cols=32 Identities=16% Similarity=0.201 Sum_probs=28.0
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 45699999999999998888899999987753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00024 Score=60.58 Aligned_cols=32 Identities=34% Similarity=0.400 Sum_probs=27.5
Q ss_pred CCCeeecCCCCCceEeCCC----CcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~ 131 (311)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3569999999999999874 6799999998865
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00034 Score=59.10 Aligned_cols=105 Identities=15% Similarity=0.177 Sum_probs=67.3
Q ss_pred HHHHHHHHHHHhcCC---CCCccceEeEEEeCCeeEEEEecCCCCChH--------H---HhhhcCC-C-----------
Q 021507 22 TNWFQTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSLE--------N---HLFRRGP-Q----------- 75 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~--------~---~l~~~~~-~----------- 75 (311)
...+.+|+..|+.|. ...|.+++.+....+..|+||||++|..+. + .+.+... .
T Consensus 72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G 151 (312)
T 3jr1_A 72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLG 151 (312)
T ss_dssp HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEET
T ss_pred HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Confidence 456889999999883 367888998888888899999999987642 1 1222111 0
Q ss_pred --------CCCHHHHHH---HH----------------HHHHHHH-HHh--hhCCCCeeecCCCCCceEeCCCCcEEEec
Q 021507 76 --------PLSWAVRMK---VA----------------IGAAKGL-TFL--HDAESQVIYRDFKASNILLDAEFNAKLSD 125 (311)
Q Consensus 76 --------~~~~~~~~~---~~----------------~~i~~~l-~~l--H~~~~~ivH~dlkp~Nil~~~~~~~kl~D 125 (311)
.-+|...+. +. ..++..+ ..| |.....++|+|+.+.|++++.++ +.|+|
T Consensus 152 ~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD 230 (312)
T 3jr1_A 152 PIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCN 230 (312)
T ss_dssp TEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECS
T ss_pred CcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEc
Confidence 013333221 11 1111112 233 22245699999999999999887 88999
Q ss_pred cc
Q 021507 126 FG 127 (311)
Q Consensus 126 fg 127 (311)
++
T Consensus 231 ~~ 232 (312)
T 3jr1_A 231 PA 232 (312)
T ss_dssp CC
T ss_pred Cc
Confidence 74
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00049 Score=60.27 Aligned_cols=31 Identities=19% Similarity=0.232 Sum_probs=26.2
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
...++|+|+.+.||+++.+ .++|+||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 4569999999999999876 489999987754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00044 Score=58.11 Aligned_cols=30 Identities=17% Similarity=0.068 Sum_probs=25.2
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5566789999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00067 Score=58.90 Aligned_cols=104 Identities=16% Similarity=0.149 Sum_probs=62.4
Q ss_pred HHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHH--------------Hh---hhcC---CCCCC--H
Q 021507 23 NWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLEN--------------HL---FRRG---PQPLS--W 79 (311)
Q Consensus 23 ~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~--------------~l---~~~~---~~~~~--~ 79 (311)
....+|.++++.|. +.-..++++.+.+ .+||||++|.+|.. .+ +... ..... +
T Consensus 98 ~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~ 173 (379)
T 3feg_A 98 DSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLF 173 (379)
T ss_dssp HHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHH
Confidence 44568999998884 3334566665543 29999999865531 11 1111 11122 3
Q ss_pred HHHHHHHHHHHH-------------------HHHHh----hh--CCCCeeecCCCCCceEeCCC----CcEEEecccccc
Q 021507 80 AVRMKVAIGAAK-------------------GLTFL----HD--AESQVIYRDFKASNILLDAE----FNAKLSDFGLAK 130 (311)
Q Consensus 80 ~~~~~~~~~i~~-------------------~l~~l----H~--~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~ 130 (311)
.++.++..++-. .+..| .. ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 174 ~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 174 GTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 444445443321 12222 21 12359999999999999876 689999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00065 Score=60.16 Aligned_cols=39 Identities=21% Similarity=0.190 Sum_probs=25.4
Q ss_pred HHHHHHHHHHhcCCCCC-ccceEeEEEeCCeeEEEEecCCCCCh
Q 021507 23 NWFQTEVNYLGQLHHPN-LVKLIGYCLEGENRLLVYEFMPKGSL 65 (311)
Q Consensus 23 ~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~~~~~~L 65 (311)
+.+.+|+.+++.|...+ ..++++.+.+ .+|+||++|.+|
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 34557999988884333 3566665532 389999987443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.82 E-value=0.008 Score=52.92 Aligned_cols=77 Identities=16% Similarity=0.185 Sum_probs=45.1
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccc--cccccCccccccCC---CCCCCceehhHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG--THGYAAPEYVATGR---LTTKSDVYSFGVVL 174 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~Di~slG~il 174 (311)
...++|+|+++.||+++.++ ++|+||+.+....... ... .... ...|.+|+...... .....++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45699999999999998876 9999999886522110 000 0011 12455655443111 11123445667777
Q ss_pred HHHHhC
Q 021507 175 LELLSG 180 (311)
Q Consensus 175 ~~l~~g 180 (311)
|+.+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777664
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.21 E-value=0.031 Score=49.13 Aligned_cols=29 Identities=17% Similarity=0.346 Sum_probs=25.5
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
..++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 35999999999999 777889999998875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.95 E-value=0.043 Score=45.41 Aligned_cols=24 Identities=21% Similarity=0.187 Sum_probs=20.2
Q ss_pred CCeeecCCCCCceEeCCCCcEEEec
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSD 125 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~D 125 (311)
..++|+|+.+.||+++.++. .++|
T Consensus 188 p~LvHGDlw~gNvl~~~~g~-~~iD 211 (288)
T 3f7w_A 188 PARIHGDLWNGNVLWQDDGA-VVID 211 (288)
T ss_dssp CEEECSCCSGGGEEEETTEE-EECS
T ss_pred CeeeecCCCCCcEEEcCCCe-EEEe
Confidence 46999999999999998874 5666
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.72 E-value=0.0092 Score=50.34 Aligned_cols=30 Identities=27% Similarity=0.258 Sum_probs=25.7
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 469999999999999877656899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.36 E-value=0.046 Score=46.09 Aligned_cols=30 Identities=23% Similarity=0.264 Sum_probs=25.6
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
...++|+|+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34589999999999998 4 899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.79 E-value=0.077 Score=45.62 Aligned_cols=29 Identities=21% Similarity=0.291 Sum_probs=24.4
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
..++|+|+++.||+++.++ +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 4599999999999997655 8999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.72 E-value=0.068 Score=47.54 Aligned_cols=36 Identities=22% Similarity=0.175 Sum_probs=24.9
Q ss_pred HHHHHHHhcCCCCCc-cceEeEEEeCCeeEEEEecCCCCCh
Q 021507 26 QTEVNYLGQLHHPNL-VKLIGYCLEGENRLLVYEFMPKGSL 65 (311)
Q Consensus 26 ~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~L 65 (311)
.+|+.+++.|...++ .++++.+. + .+||||++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 579999998864444 56776662 2 359999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.52 E-value=0.054 Score=46.11 Aligned_cols=31 Identities=19% Similarity=0.201 Sum_probs=27.3
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.05 E-value=0.57 Score=36.84 Aligned_cols=84 Identities=8% Similarity=0.067 Sum_probs=60.3
Q ss_pred CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHH-HhhhCCCCeeecCCCCCceE
Q 021507 36 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT-FLHDAESQVIYRDFKASNIL 114 (311)
Q Consensus 36 ~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~ivH~dlkp~Nil 114 (311)
.||+. -..+-.+++.+.+.++.-+++.=...+ ..++....++++..++.... +++ . -+|--|+|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence 57877 344556666666666654333222333 22788999999999998777 555 3 678899999999
Q ss_pred eCCCCcEEEecccccc
Q 021507 115 LDAEFNAKLSDFGLAK 130 (311)
Q Consensus 115 ~~~~~~~kl~Dfg~~~ 130 (311)
++.++.++|.-.|+-.
T Consensus 117 f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 117 FNRALEPFFLHVGVKE 132 (219)
T ss_dssp ECTTCCEEESCCEETT
T ss_pred EeCCCcEEEEEcCCcc
Confidence 9999999999777653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.77 E-value=0.45 Score=37.32 Aligned_cols=117 Identities=5% Similarity=0.004 Sum_probs=76.6
Q ss_pred CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEe
Q 021507 36 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 115 (311)
Q Consensus 36 ~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~ 115 (311)
.||+.+.. .+-.+++.+.+.++.-. +..++-. -..++....++++..|+....++++ -+|--|.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence 68888876 45556665555555433 2222221 1237889999999999988866663 5788999999999
Q ss_pred CCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCC
Q 021507 116 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 186 (311)
Q Consensus 116 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 186 (311)
+.++.+++.-.|+-..+.... +..|- =.-.+=|++..+++++..|+.
T Consensus 113 ~~~~~p~i~~RGik~~l~P~~--------------~~ee~----------fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVDPLP--------------VSEAE----------FLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CTTSCEEESCCEETTTBSCCC--------------CCHHH----------HHHHHHHHHHHHHCTTCCHHH
T ss_pred cCCCCEEEEEccCccCCCCCC--------------CCHHH----------HHHHHHHHHHHHHcCCCCHHH
Confidence 999999998777643221110 01111 122456788889999888753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.28 E-value=0.14 Score=44.68 Aligned_cols=29 Identities=28% Similarity=0.324 Sum_probs=24.5
Q ss_pred eeecCCCCCceEe------CCCCcEEEeccccccc
Q 021507 103 VIYRDFKASNILL------DAEFNAKLSDFGLAKA 131 (311)
Q Consensus 103 ivH~dlkp~Nil~------~~~~~~kl~Dfg~~~~ 131 (311)
++|+|+.+.||++ ++++.+.++||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4556799999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 311 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-63
Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 21/242 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F+ EV L + H N++ +GY +V ++ SL +HL +
Sbjct: 51 FKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLID 108
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A+G+ +LH +I+RD K++NI L + K+ DFGLA +H Q+
Sbjct: 109 IARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 145 MGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
G+ + APE + + +SDVY+FG+VL EL++G+ + D
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIF 220
Query: 202 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA-- 259
+ + L +CL + RP ++LA +E L
Sbjct: 221 MVGRGYLSPDLSK------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
Query: 260 PK 261
PK
Sbjct: 275 PK 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 9e-56
Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 26/236 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F E + + QL H NLV+L+G +E + L +V E+M KGSL ++L RG L +
Sbjct: 47 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 106
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K ++ + + +L + ++RD A N+L+ + AK+SDFGL K + +
Sbjct: 107 KFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT 159
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
+ APE + + +TKSDV+SFG++L E+ S PY
Sbjct: 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYP 202
Query: 204 SDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258
+ + ++ P + C + + +RP ++ LE ++
Sbjct: 203 RIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 1e-55
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 19/233 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + ++ HPNLV+L+G C ++ EFM G+L ++L Q +S V +
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A + + +L + I+RD A N L+ K++DFGL++ GD
Sbjct: 120 MATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGA 176
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+ APE +A + + KSDV++FGV+L E+ + +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---------------- 220
Query: 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
D +++ +++ + P+ L C P RP +E+ E +
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-54
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E N + QL H LV+L + E ++ E+M GSL + L L+ +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A+G+ F+ E I+RD +A+NIL+ + K++DFGLA+ +
Sbjct: 114 MAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGA 170
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+ APE + G T KSDV+SFG++L E+++
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------------- 214
Query: 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
++ + ++ P L C P+ RP + ++LE
Sbjct: 215 TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-54
Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 22/234 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + L H LV+L G C + ++ E+M G L N+L ++
Sbjct: 46 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLE 104
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + + +L Q ++RD A N L++ + K+SDFGL++ D S
Sbjct: 105 MCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGS 161
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
++ PE + + ++KSD+++FGV++ E+ S PY
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----------------MPYER 204
Query: 205 DK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
+ + L P A+ T+ C + + RP +L+ + +
Sbjct: 205 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 5e-54
Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 44/257 (17%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG----------- 73
FQ E + + +PN+VKL+G C G+ L++E+M G L L
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 74 -----------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 122
P PLS A ++ +A A G+ +L E + ++RD N L+ K
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVK 180
Query: 123 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 182
++DFGL++ + D + PE + R TT+SDV+++GVVL E+ S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 183 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 240
+PY ++ + ++ + D + P+ L C +
Sbjct: 241 -----------------QPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKL 282
Query: 241 PKLRPRMSEVLAILERL 257
P RP + IL+R+
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-53
Identities = 56/254 (22%), Positives = 103/254 (40%), Gaps = 33/254 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E+ L + + P +V G + E M GSL+ L + G + + K
Sbjct: 51 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGK 108
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
V+I KGLT+L + + ++++RD K SNIL+++ KL DFG++ ++
Sbjct: 109 VSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSF 163
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR----------------CAVDKTK 188
+GT Y +PE + + +SD++S G+ L+E+ GR C V+
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223
Query: 189 VGIEQSLVDWAKPYLSD------KRKLFRIMDTKLGGQYPQKAAHT----AATLALQCLN 238
+P S +F ++D + P+ + +CL
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
Query: 239 NEPKLRPRMSEVLA 252
P R + +++
Sbjct: 284 KNPAERADLKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-53
Identities = 60/250 (24%), Positives = 97/250 (38%), Gaps = 34/250 (13%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-------- 75
+E+ L L +H N+V L+G C G L++ E+ G L N L R+
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 76 --------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 127
L + + AKG+ FL I+RD A NILL K+ DFG
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 128 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 187
LA+ V + APE + T +SDV+S+G+ L EL S +
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-- 248
Query: 188 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 247
P + K ++++ P+ A + C + +P RP
Sbjct: 249 -------------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 248 SEVLAILERL 257
+++ ++E+
Sbjct: 296 KQIVQLIEKQ 305
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-53
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 20/233 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L HP LV+L G CLE LV+EFM G L ++ R + +
Sbjct: 47 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLG 105
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ + +G+ +L E+ VI+RD A N L+ K+SDFG+ + D+ ST
Sbjct: 106 MCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGT 162
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+A+PE + R ++KSDV+SFGV++ E+ S + +
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---------------- 206
Query: 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
++ + T P+ A+ + C P+ RP S +L L +
Sbjct: 207 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-52
Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 22/236 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR-LLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F TE + HPN++ L+G CL E L+V +M G L N + P + +
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLI 133
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVS 141
+ AKG+ FL + ++RD A N +LD +F K++DFGLA+ D H
Sbjct: 134 GFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
T + A E + T + TTKSDV+SFGV+L EL++ + + D
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVY 246
Query: 202 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
L +R L P+ + L+C + + ++RP SE+++ + +
Sbjct: 247 LLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-52
Identities = 56/255 (21%), Positives = 95/255 (37%), Gaps = 43/255 (16%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-------- 75
+E+ + QL H N+V L+G C L++E+ G L N+L + +
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 146
Query: 76 -------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 122
L++ + A AKG+ FL ++RD A N+L+ K
Sbjct: 147 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVK 204
Query: 123 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 182
+ DFGLA+ + V + APE + G T KSDV+S+G++L E+ S
Sbjct: 205 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
Query: 183 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 240
PY + ++++ P A + C +
Sbjct: 265 -----------------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307
Query: 241 PKLRPRMSEVLAILE 255
+ RP + + L
Sbjct: 308 SRKRPSFPNLTSFLG 322
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-52
Identities = 48/255 (18%), Positives = 89/255 (34%), Gaps = 25/255 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRL----LVYEFMPKGSLENHLFRRGPQPLSWA 80
+ E+ L H N++ I + LV ++ GSL ++L R ++
Sbjct: 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVE 100
Query: 81 VRMKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134
+K+A+ A GL LH + + +RD K+ NIL+ ++D GLA +
Sbjct: 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160
Query: 135 GDRT--HVSTQVMGTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLELLSGRCAVDK 186
T +GT Y APE + ++D+Y+ G+V E+
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
Query: 187 TKVG----IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 242
+ + D + + ++ +A A + +C
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280
Query: 243 LRPRMSEVLAILERL 257
R + L +L
Sbjct: 281 ARLTALRIKKTLSQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 1e-51
Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 24/245 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F +E + +GQ HPN++ L G + +++ EFM GSL+ R+ + +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQFTVIQLVG 132
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ G A G+ +L D ++RD A NIL+++ K+SDFGL++ T
Sbjct: 133 MLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190
Query: 145 ---MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
+ APE + + T+ SDV+S+G+V+ E++S +P
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----------------RP 233
Query: 202 YLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260
Y + + ++ P L L C + RP+ +++ L+++
Sbjct: 234 YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
Query: 261 KNSAK 265
NS K
Sbjct: 294 PNSLK 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-51
Identities = 53/232 (22%), Positives = 87/232 (37%), Gaps = 27/232 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 80
F+ E L L HPN+V+ + +LV E M G+L+ +L R +
Sbjct: 55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIK 112
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTH 139
V KGL FLH +I+RD K NI + + K+ D GLA R
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRAS 168
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
+ V+GT + APE + DVY+FG+ +LE+ + + + +
Sbjct: 169 FAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------ 221
Query: 200 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
R+ + + A + C+ R + ++L
Sbjct: 222 ---------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-51
Identities = 55/245 (22%), Positives = 111/245 (45%), Gaps = 21/245 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E +GQ H N+++L G + + +++ E+M G+ + R S +
Sbjct: 56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVG 114
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ 143
+ G A G+ +L ++RD A NIL+++ K+SDFGL++ + T+ ++
Sbjct: 115 MLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
+ APE ++ + T+ SDV+SFG+V+ E+++ +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG----------------ERPYWE 216
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAPKN 262
++ + ++ P L +QC E RP+ +++++IL++L AP +
Sbjct: 217 LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
Query: 263 SAKLS 267
L+
Sbjct: 277 LKTLA 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-50
Identities = 64/254 (25%), Positives = 101/254 (39%), Gaps = 32/254 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + +L H LV+L E +V E+M KGSL + L + L +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+A A G+ ++ ++RD +A+NIL+ K++DFGLA+ +
Sbjct: 118 MAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGA 174
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+ APE GR T KSDV+SFG++L EL + +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG------------------RVPYP 216
Query: 205 DK--RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 262
R++ ++ P + + L QC EP+ RP + A LE
Sbjct: 217 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY----- 271
Query: 263 SAKLSQSEPHRQTG 276
+ +EP Q G
Sbjct: 272 ---FTSTEPQYQPG 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-50
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 30/236 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFR--RGPQPLSWA 80
+EVN L +L HPN+V+ ++ N L V E+ G L + + + + Q L
Sbjct: 50 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 109
Query: 81 VRMKVAIGAAKGLTFLH---DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 137
++V L H D V++RD K +N+ LD + N KL DFGLA+
Sbjct: 110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHD 167
Query: 138 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
T + +GT Y +PE + KSD++S G +L EL +
Sbjct: 168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM---------------- 211
Query: 198 WAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
P+ S K +I + K + P + + + + LN + RP + E+L
Sbjct: 212 --PPFTAFSQKELAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-50
Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E N + QL +P +V++IG C E E+ +LV E G L +L + + ++
Sbjct: 55 LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIE 111
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVSTQ 143
+ + G+ +L + S ++RD A N+LL + AK+SDFGL+KA + T
Sbjct: 112 LVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
+ APE + + ++KSDV+SFGV++ E S KPY
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG-----------------QKPYR 212
Query: 204 SDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
K ++ +++ P L C + + RP + V L
Sbjct: 213 GMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-50
Identities = 61/253 (24%), Positives = 103/253 (40%), Gaps = 27/253 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E + QL +P +V+LIG C + E +LV E G L L + + + + +
Sbjct: 56 MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAE 113
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQ 143
+ + G+ +L + ++RD A N+LL AK+SDFGL+KA G +
Sbjct: 114 LLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
+ APE + + +++SDV+S+GV + E LS KPY
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG-----------------QKPYK 214
Query: 204 SDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 262
K ++ ++ + P + L C + + RP V +R+ A
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV---EQRMRACYY 271
Query: 263 S-AKLSQSEPHRQ 274
S A + H
Sbjct: 272 SLASKVEGHHHHH 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 9e-50
Identities = 68/265 (25%), Positives = 106/265 (40%), Gaps = 39/265 (14%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------- 74
F E+ L +L HHPN++ L+G C L E+ P G+L + L +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 75 -----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
LS + A A+G+ +L + Q I+RD A NIL+ + AK++DFGL+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLS 174
Query: 130 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 189
+ + T + A E + TT SDV+S+GV+L E++S
Sbjct: 175 RGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL--------- 222
Query: 190 GIEQSLVDWAKPYLSDKR-KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248
PY +L+ + + P L QC +P RP +
Sbjct: 223 --------GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 249 EVLAILER-LEAPKNSAKLSQSEPH 272
++L L R LE K + E
Sbjct: 275 QILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-49
Identities = 48/234 (20%), Positives = 100/234 (42%), Gaps = 22/234 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E + + +P++ +L+G CL +L + + MP G L +++ +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI-GSQYLLN 115
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ AKG+ +L D ++++RD A N+L+ + K++DFGLAK ++ + +
Sbjct: 116 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+ A E + T +SDV+S+GV + EL++ +KPY
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG-----------------SKPYDG 216
Query: 205 DK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
++ I++ P + ++C + RP+ E++ ++
Sbjct: 217 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 30/229 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ EV L HPN+++L GY + L+ E+ P G++ L +
Sbjct: 53 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTAT 110
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A L++ H +VI+RD K N+LL + K++DFG + P+ RT +
Sbjct: 111 YITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----L 164
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
GT Y PE + K D++S GV+ E L G+ P+ +
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFEA 206
Query: 205 DKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+ + RI + +P A L + L + P RP + EVL
Sbjct: 207 NTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-49
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 31/236 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E++ L HPN+VKL+ N ++ EF G+++ + +PL+ +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQV 114
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
V L +LH ++++I+RD KA NIL + + KL+DFG++ +
Sbjct: 115 VCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170
Query: 145 MGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
+GT + APE V K+DV+S G+ L+E+
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------------------ 212
Query: 200 KPY--LSDKRKLFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
P+ L+ R L +I ++ P + + +CL R S++L
Sbjct: 213 PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-48
Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 20/228 (8%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E+ L+H N+VK G+ EG + L E+ G L + + + +
Sbjct: 50 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQR 107
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
G+ +LH + +RD K N+LLD N K+SDFGLA +R + ++
Sbjct: 108 FFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 145 MGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
GT Y APE + DV+S G+VL +L+G D+ Q DW +
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKT 224
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+K L + L P R + ++
Sbjct: 225 YLN--------------PWKKIDSAPLALLHKILVENPSARITIPDIK 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-48
Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 24/237 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F EVN + L H NL++L G L + +V E P GSL + L + +
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-HFLLGTLSR 115
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQ 143
A+ A+G+ +L + I+RD A N+LL K+ DFGL +A P D +V
Sbjct: 116 YAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 202
+ APE + T + SD + FGV L E+ + +P+
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG-----------------QEPWI 216
Query: 203 -LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258
L+ + L +I P+ + +QC ++P+ RP + L +
Sbjct: 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 2e-48
Identities = 58/232 (25%), Positives = 86/232 (37%), Gaps = 33/232 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
EV +L +L HPN ++ G L LV E+ + + + PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAA 119
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
V GA +GL +LH +I+RD KA NILL KL DFG A +
Sbjct: 120 VTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSF 171
Query: 145 MGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
+GT + APE + G+ K DV+S G+ +EL + P
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------------------PP 213
Query: 202 Y--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
++ L+ I + + CL P+ RP +L
Sbjct: 214 LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-47
Identities = 58/244 (23%), Positives = 111/244 (45%), Gaps = 26/244 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QP 76
F E + + + + ++V+L+G +G+ L++ E M +G L+++L P P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
S + +++A A G+ +L+ ++ ++RD A N ++ +F K+ DFG+ + D
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196
+ + + +PE + G TT SDV+SFGVVL E+ +
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA--------------- 232
Query: 197 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256
+ LS+++ L +M+ L P L C PK+RP E+++ ++
Sbjct: 233 EQPYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
Query: 257 LEAP 260
P
Sbjct: 292 EMEP 295
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-45
Identities = 47/239 (19%), Positives = 88/239 (36%), Gaps = 26/239 (10%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+ E + + +L HP VKL + E + G L ++ + G
Sbjct: 54 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTR 111
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
L +LH +I+RD K NILL+ + + +++DFG AK + +
Sbjct: 112 FYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
+GT Y +PE + SD+++ G ++ +L++G P+
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPFR 211
Query: 204 SDKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260
+ +I+ + +P+K A L + L + R E+ P
Sbjct: 212 AGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-45
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 21/233 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
F E + Q HP++VKLIG E ++ E G L + L R L A +
Sbjct: 55 FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 112
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A + L +L + ++RD A N+L+ + KL DFGL++ + +++
Sbjct: 113 YAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKG 169
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
+ APE + R T+ SDV+ FGV + E+L +
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV---------------KPFQGVK 214
Query: 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257
+ + RI + + P T +L +C +P RPR +E+ A L +
Sbjct: 215 NNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-44
Identities = 58/251 (23%), Positives = 105/251 (41%), Gaps = 35/251 (13%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------- 74
+E+ + + H N++ L+G C + ++ E+ KG+L +L R P
Sbjct: 65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 75 -----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129
+ LS + A A+G+ +L + I+RD A N+L+ + K++DFGLA
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 130 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 189
+ D +T + APE + T +SDV+SFGV+L E+ + +
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------ 236
Query: 190 GIEQSLVDWAKPYL-SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248
PY +LF+++ P + + C + P RP
Sbjct: 237 -----------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
Query: 249 EVLAILERLEA 259
+++ L+R+ A
Sbjct: 286 QLVEDLDRIVA 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-44
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 28/230 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E+ + + +PN+V + L G+ +V E++ GSL + +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAA 120
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
V + L FLH +QVI+RD K+ NILL + + KL+DFG + +
Sbjct: 121 VCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STM 176
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY-- 202
+GT + APE V K D++S G++ +E++ G PY
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------------------PPYLN 218
Query: 203 LSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 251
+ R L+ I + Q P+K + +CL+ + + R E+L
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (381), Expect = 9e-44
Identities = 58/287 (20%), Positives = 96/287 (33%), Gaps = 28/287 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E+ + L HP LV L + +++YEFM G L + +S ++
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVE 128
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHVST 142
KGL +H+ ++ D K NI+ + + KL DFGL
Sbjct: 129 YMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--- 183
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
GT +AAPE + +D++S GV+ LLSG
Sbjct: 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------------- 228
Query: 203 LSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLE 258
+D L + + + L +P R + + L L
Sbjct: 229 -NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287
Query: 259 APKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHR 305
AP +++ S + + + + PL S L HR
Sbjct: 288 APGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHR 334
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-43
Identities = 62/249 (24%), Positives = 96/249 (38%), Gaps = 33/249 (13%)
Query: 25 FQTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQ------- 75
+E+ L HH N+V L+G C + L ++ EF G+L +L + +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 76 -------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 128
L+ + + AKG+ FL + I+RD A NILL + K+ DFGL
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 129 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 188
A+ + APE + T +SDV+SFGV+L E+ S +
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 237
Query: 189 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 248
P + + R + + P L C + EP RP S
Sbjct: 238 ------------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 285
Query: 249 EVLAILERL 257
E++ L L
Sbjct: 286 ELVEHLGNL 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-41
Identities = 55/293 (18%), Positives = 114/293 (38%), Gaps = 36/293 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E++ L H N++ L E ++++EF+ + + L+ +
Sbjct: 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVS 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVST 142
+ L FLH + + D + NI+ ++ K+ +FG A+ GD +
Sbjct: 107 YVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-- 162
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
+ Y APE ++T +D++S G ++ LLSG P+
Sbjct: 163 -LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------------------NPF 203
Query: 203 LSDKRK--LFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILE 255
L++ + + IM+ + + ++ + A + L E K R SE L + +
Sbjct: 204 LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263
Query: 256 RLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSP 308
++E + S K+ ++ HR+ T+ K + S ++ + S
Sbjct: 264 KIE--RVSTKVIRTLKHRRYYH-TLIKKDLNMVVSAARISCGGAIRSQKGVSV 313
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 144 bits (363), Expect = 4e-41
Identities = 57/285 (20%), Positives = 102/285 (35%), Gaps = 40/285 (14%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E++ + QLHHP L+ L + +L+ EF+ G L + + +S A +
Sbjct: 73 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVIN 131
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVST 142
A +GL +H E +++ D K NI+ + + + K+ DFGLA +
Sbjct: 132 YMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK--- 186
Query: 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 202
T +AAPE V + +D+++ GV+ LLSG P+
Sbjct: 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------------------SPF 228
Query: 203 --LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA------ 252
D L + D + + A L EP+ R + + L
Sbjct: 229 AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
Query: 253 ----ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 293
+ R+ + + + + + P S L
Sbjct: 289 DHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLR 333
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (342), Expect = 1e-38
Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 25 FQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
EV+ L ++ HPN+++L LV++ M KG L ++L + LS
Sbjct: 56 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETR 113
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
K+ + + LH +++RD K NILLD + N KL+DFG + G++ +
Sbjct: 114 KIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---RE 168
Query: 144 VMGTHGYAAPEYVATGRL------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 197
V GT Y APE + + D++S GV++ LL+G
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---------------- 212
Query: 198 WAKPYLSDKRK--LFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
P+ K+ L IM + + G + T L + L +P+ R E LA
Sbjct: 213 --PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 135 bits (341), Expect = 1e-38
Identities = 58/243 (23%), Positives = 105/243 (43%), Gaps = 32/243 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 80
F+ E L+HP +V + G +V E++ +L + + GP ++
Sbjct: 54 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPK 111
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTH 139
++V A + L F H ++ +I+RD K +NI++ A K+ DFG+A+ +G+
Sbjct: 112 RAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
Query: 140 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 199
+ V+GT Y +PE + +SDVYS G VL E+L+G
Sbjct: 170 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------------------ 211
Query: 200 KPY--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAIL 254
P+ S ++ + D + + + L+ L P+ R + +E+ A L
Sbjct: 212 PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
Query: 255 ERL 257
R+
Sbjct: 272 VRV 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-37
Identities = 52/234 (22%), Positives = 89/234 (38%), Gaps = 29/234 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ EV+ L ++ HPN++ L + +L+ E + G L + L + A
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF- 118
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTHV 140
G+ +LH Q+ + D K NI+L K+ DFGLA G+
Sbjct: 119 -LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 173
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
+ GT + APE V L ++D++S GV+ LLSG
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------------- 219
Query: 201 PYLSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+ + L + + + +Y + A + L +PK R + + L
Sbjct: 220 ---TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-37
Identities = 60/222 (27%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 25 FQTEVNYLG-QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
E L HP L + EN V E++ G L H+ LS A
Sbjct: 49 TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY 108
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
A GL FLH ++YRD K NILLD + + K++DFG+ K GD
Sbjct: 109 --AAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT 162
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 203
GT Y APE + + D +SFGV+L E+L G+ P+
Sbjct: 163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFH 204
Query: 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245
+ YP+ A L ++ EP+ R
Sbjct: 205 GQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (331), Expect = 9e-37
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 32/235 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
+ E+ L ++ HPN+V L G + L+ + + G L + + +G + +
Sbjct: 54 MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASR 111
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVS 141
+ + +LH + +++RD K N+L D + +SDFGL+K D V
Sbjct: 112 LIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVL 166
Query: 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
+ GT GY APE +A + D +S GV+ LL G P
Sbjct: 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------------------PP 208
Query: 202 Y--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+ +D + +I+ + + Y + +A + +P+ R + L
Sbjct: 209 FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (332), Expect = 2e-36
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 24/226 (10%)
Query: 28 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 87
++ + P +V + + + + M G L HL + G + I
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116
Query: 88 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147
GL +H V+YRD K +NILLD + ++SD GLA +GT
Sbjct: 117 --ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGT 168
Query: 148 HGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 206
HGY APE + G + +D +S G +L +LL G + + DK
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--------------FRQHKTKDK 214
Query: 207 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
++ R+ T + P + +L L + R A
Sbjct: 215 HEIDRMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-35
Identities = 53/239 (22%), Positives = 87/239 (36%), Gaps = 17/239 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E+ L +L HPN++ L+ N LV++FM S
Sbjct: 47 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY- 105
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ +GL +LH + +++RD K +N+LLD KL+DFGLAK+ + +R + T
Sbjct: 106 -MLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQ 160
Query: 145 MGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKT----------KVGIEQ 193
+ T Y APE + R+ D+++ G +L ELL + +
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220
Query: 194 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+ W F+ A L P R ++ L
Sbjct: 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-35
Identities = 48/255 (18%), Positives = 94/255 (36%), Gaps = 26/255 (10%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYC----LEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 79
+ EV + P++V+++ + L+V E + G L + + RG Q +
Sbjct: 51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110
Query: 80 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGD 136
++ + + +LH + +RD K N+L ++ KL+DFG AK + +
Sbjct: 111 REASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 196
T Y APE + + D++S GV++ LL G
Sbjct: 169 SLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS---------- 215
Query: 197 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---I 253
+ + R+ + + + L L EP R ++E + I
Sbjct: 216 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275
Query: 254 LERLEAPKNSAKLSQ 268
++ + P+ S+
Sbjct: 276 MQSTKVPQTPLHTSR 290
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (319), Expect = 5e-35
Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 31/230 (13%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E L + HP ++++ G + + ++ +++ G L + L + P A
Sbjct: 51 TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 110
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ L +LH +IYRD K NILLD + K++DFG AK P T
Sbjct: 111 AEV--CLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---- 162
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY-- 202
GT Y APE V+T D +SFG+++ E+L+G P+
Sbjct: 163 -GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------------------TPFYD 203
Query: 203 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+ + +I++ +L ++P L + + + R +
Sbjct: 204 SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGT 251
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 7e-35
Identities = 54/239 (22%), Positives = 89/239 (37%), Gaps = 20/239 (8%)
Query: 28 EVNYLGQLHHPNLVKLIGYCL----EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+ +L HPN+V+L C + E +L + L +L + +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
+ +GL FLH +V++RD K NIL+ + KL+DFGLA+ T
Sbjct: 120 DMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 174
Query: 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT----------KVGIEQ 193
V+ T Y APE + T D++S G + E+ + + V
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234
Query: 194 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
DW + + R+ F + ++ L L+CL P R L+
Sbjct: 235 GEEDWPRDV-ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 3e-34
Identities = 44/242 (18%), Positives = 72/242 (29%), Gaps = 23/242 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
E + + I +C EG+ ++V E + + F S +
Sbjct: 49 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVL 106
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKA-----GPTG 135
+A + ++H I+RD K N L + DFGLAK
Sbjct: 107 LLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164
Query: 136 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 195
+ + GT YA+ + + D+ S G VL+ G K
Sbjct: 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA------ 218
Query: 196 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 255
+ Y K L YP + A C + +P S + +
Sbjct: 219 ATKRQKYERISEKKMSTPIEVLCKGYPSEFAT----YLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 256 RL 257
L
Sbjct: 275 NL 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (311), Expect = 3e-34
Identities = 38/247 (15%), Positives = 71/247 (28%), Gaps = 31/247 (12%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+ E L + + + EG + +LV + + G L + S
Sbjct: 47 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVA 104
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAK-----AGP 133
A + +H E ++YRD K N L+ + + DFG+ K
Sbjct: 105 MAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162
Query: 134 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 193
+ GT Y + + + D+ + G V + L G
Sbjct: 163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL----------- 211
Query: 194 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLALQCLNNEPKLRPRMSEV 250
++K+K RI + K + A N P +
Sbjct: 212 --PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
Query: 251 LAILERL 257
+ ++
Sbjct: 270 QGLFSKV 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 123 bits (310), Expect = 5e-34
Identities = 46/239 (19%), Positives = 94/239 (39%), Gaps = 16/239 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E++ L +L H N+VKL + +LV+E + + + G L
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKS 104
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+ G+ + HD +V++RD K N+L++ E K++DFGLA+A R + ++
Sbjct: 105 FLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEI 161
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT----------KVGIEQS 194
+ A + + + +T D++S G + E+++G ++ +
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 195 LVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+W L F + + + + + L + L +P R + L
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 8e-34
Identities = 54/239 (22%), Positives = 96/239 (40%), Gaps = 15/239 (6%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E++ L +L+HPN+VKL+ LV+EF+ + L+ + + +
Sbjct: 48 AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKS 106
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
+GL F H +V++RD K N+L++ E KL+DFGLA+A RT+ + +V
Sbjct: 107 YLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEV 163
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC----------AVDKTKVGIEQS 194
+ A + +T D++S G + E+++ R +
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 195 LVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
V W + D + F + + +L Q L+ +P R LA
Sbjct: 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-33
Identities = 59/244 (24%), Positives = 95/244 (38%), Gaps = 18/244 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRM 83
E+ L + H N++ + + ++ + L++ Q LS
Sbjct: 53 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC 112
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVST 142
+GL ++H + V++RD K SN+LL+ + K+ DFGLA+ A P D T T
Sbjct: 113 YFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 143 QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC--AVDKTKVGIEQSLVDWA 199
+ + T Y APE + + TKS D++S G +L E+LS R + L
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 200 KPYLSDKRKLFRIMDTKLGGQYPQK-----------AAHTAATLALQCLNNEPKLRPRMS 248
P D + + P K A A L + L P R +
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
Query: 249 EVLA 252
+ LA
Sbjct: 291 QALA 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-33
Identities = 48/248 (19%), Positives = 92/248 (37%), Gaps = 37/248 (14%)
Query: 25 FQTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 82
EV L ++ +++L+ + ++ +L+ E L +
Sbjct: 54 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELA 112
Query: 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVS 141
+ + H V++RD K NIL+D KL DFG + V
Sbjct: 113 RSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVY 166
Query: 142 TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 200
T GT Y+ PE++ R +S V+S G++L +++ G
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------------------I 208
Query: 201 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLE 258
P+ D+ I+ ++ + Q+ + L CL P RP E+ ++ +
Sbjct: 209 PFEHDE----EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
Query: 259 APKNSAKL 266
P+ +A++
Sbjct: 263 LPQETAEI 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-31
Identities = 53/247 (21%), Positives = 89/247 (36%), Gaps = 23/247 (9%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHL-FRRGPQPL 77
E+ + +L H N+V+L + + LV +++P+ + R Q L
Sbjct: 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 78 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGD 136
+ L ++H + +RD K N+LLD + KL DFG AK G+
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 137 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-----CAVDKTKVGI 191
+ + + A T+ DV+S G VL ELL G+ + V I
Sbjct: 178 PNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 192 EQSLVDWAKPYLSD------KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245
+ L + + + + K +I + + A L + L P R
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 246 RMSEVLA 252
E A
Sbjct: 296 TPLEACA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-30
Identities = 57/230 (24%), Positives = 86/230 (37%), Gaps = 28/230 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
TE L HP L L + V E+ G L HL R + +
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARF 109
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
L +LH V+YRD K N++LD + + K++DFGL K G + T
Sbjct: 110 YGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY-- 202
GT Y APE + D + GVV+ E++ GR P+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------------------LPFYN 207
Query: 203 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+R I+ ++ ++P+ + A +L L +PK R A
Sbjct: 208 QDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-30
Identities = 52/253 (20%), Positives = 90/253 (35%), Gaps = 29/253 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR--------LLVYEFMPKGSLENHLFRRGPQP 76
E+ L L H N+V LI C + LV++F
Sbjct: 56 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT 115
Query: 77 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 136
LS R V GL ++H +++++RD KA+N+L+ + KL+DFGLA+A
Sbjct: 116 LSEIKR--VMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 171
Query: 137 RTHVS--TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR------------ 181
+ + T + T Y PE + R D++ G ++ E+ +
Sbjct: 172 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231
Query: 182 -CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT-LALQCLNN 239
+ + L +K +L + K+ + A L + L
Sbjct: 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291
Query: 240 EPKLRPRMSEVLA 252
+P R + L
Sbjct: 292 DPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 9e-29
Identities = 52/240 (21%), Positives = 81/240 (33%), Gaps = 17/240 (7%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E+ L +L H N+V+L + LV+EF + + G +
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKS 105
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
KGL F H V++RD K N+L++ KL++FGLA+A R + S +V
Sbjct: 106 FLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEV 162
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ----------- 193
+ +T D++S G + EL + + +Q
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 194 SLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+ W L D + T K T L L P R E L
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-27
Identities = 48/247 (19%), Positives = 90/247 (36%), Gaps = 29/247 (11%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLFRRGPQPLS 78
E+ L + H N++ L+ E LV FM G+ L + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LG 119
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
+ KGL ++H + +I+RD K N+ ++ + K+ DFGLA+ +
Sbjct: 120 EDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-------------CAVD 185
++ V+ A + R T D++S G ++ E+++G+ +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 186 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245
T + + + K ++ K A+ A L + L + + R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 246 RMSEVLA 252
E LA
Sbjct: 294 TAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (265), Expect = 4e-27
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 27/221 (12%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 84
E L ++ P LVKL + N +V E++ G + +HL R G S
Sbjct: 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARF 145
Query: 85 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144
A +LH +IYRD K N+L+D + +++DFG AK T +
Sbjct: 146 YAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----L 198
Query: 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 204
GT APE + + D ++ GV++ E+ +G P+ +
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP------------------PFFA 240
Query: 205 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 245
D+ ++P + L L + R
Sbjct: 241 DQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 100 bits (250), Expect = 4e-25
Identities = 43/253 (16%), Positives = 88/253 (34%), Gaps = 35/253 (13%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRL--LVYEFMPKGSLENHLFRRGPQPLSWAV 81
+ E+ L L PN++ L + +R LV+E + + Q L+
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYD 130
Query: 82 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHV 140
K L + H +++RD K N+++D E +L D+GLA+ G
Sbjct: 131 IRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-- 186
Query: 141 STQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ------ 193
+ + + PE + ++ D++S G +L ++ + +Q
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
Query: 194 -----SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---------AATLALQCLNN 239
L D+ Y + F + + + ++ H+ A + L
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305
Query: 240 EPKLRPRMSEVLA 252
+ + R E +
Sbjct: 306 DHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 9e-25
Identities = 64/235 (27%), Positives = 89/235 (37%), Gaps = 30/235 (12%)
Query: 25 FQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
+TE L + P LV L L+ +++ G L HL +R
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143
I L LH +IYRD K NILLD+ + L+DFGL+K D T +
Sbjct: 135 VGEI--VLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYD 189
Query: 144 VMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 201
GT Y AP+ V G D +S GV++ ELL+G P
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------------------SP 231
Query: 202 Y--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
+ +K I L + YPQ+ + A L + L +PK R A
Sbjct: 232 FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 4e-21
Identities = 45/245 (18%), Positives = 85/245 (34%), Gaps = 25/245 (10%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 80
E+ L + H N++ L+ E + G+ N++ + L+
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDD 121
Query: 81 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 140
+ +GL ++H + +I+RD K SN+ ++ + K+ DFGLA+ +
Sbjct: 122 HVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEM 175
Query: 141 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC-----AVDKTKVGIEQSL 195
+ V A + D++S G ++ ELL+GR I + +
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 196 VDWAKPYLSDKRKLFRIMDTKLGGQYPQK--------AAHTAATLALQCLNNEPKLRPRM 247
L + Q P+ A A L + L + R
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 248 SEVLA 252
++ LA
Sbjct: 296 AQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.8 bits (219), Expect = 1e-20
Identities = 48/258 (18%), Positives = 90/258 (34%), Gaps = 40/258 (15%)
Query: 25 FQTEVNYLGQLHHPNLVKLIGYCL------EGENRLLVYEFMPKGSLENHLFRRGPQPLS 78
E+ + ++H N++ L+ E ++ LV E M +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----D 117
Query: 79 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138
+ G+ LH + +I+RD K SNI++ ++ K+ DFGLA+ T
Sbjct: 118 HERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA--------------- 183
T + T Y APE + D++S G ++ E++ +
Sbjct: 176 ---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 184 ---------VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 234
+ K + + + + K KLF ++ + A A L
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 235 QCLNNEPKLRPRMSEVLA 252
+ L +P R + + L
Sbjct: 293 KMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.8 bits (198), Expect = 6e-18
Identities = 35/278 (12%), Positives = 85/278 (30%), Gaps = 46/278 (16%)
Query: 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLF-------- 70
+ T + E+ L +++ + K +LL + + +
Sbjct: 51 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENL 110
Query: 71 -----RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLS 124
+ + + +++ GL ++H +I+ D K N+L++ L
Sbjct: 111 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLI 169
Query: 125 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 184
+A G T + T Y +PE + +D++S ++ EL++G
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 185 DKTKVGIEQSLVD---------------------WAKPYLSDKRKLFRIMDTKL------ 217
+ + D + + + + + L I K
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 218 ---GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 252
++ + A + L +P+ R ++
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 51.3 bits (122), Expect = 2e-08
Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 8/107 (7%)
Query: 24 WFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 83
F + L KL G + Y + L + + +
Sbjct: 52 HFSVLAIRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD 106
Query: 84 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130
+V + + + +++ D N+L+ E + DF +
Sbjct: 107 EVLDMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.75 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.53 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.89 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=367.68 Aligned_cols=234 Identities=23% Similarity=0.271 Sum_probs=186.3
Q ss_pred ChhHHHhHHHHHHh---------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++.+.... ........+.+.+|+++|++++|||||++++++.+++..|+|||||+||+|.+++..
T Consensus 17 ~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~ 96 (271)
T d1nvra_ 17 AYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 96 (271)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT
T ss_pred cCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc
Confidence 58889888765432 112233456789999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
+. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..............+||+.|+
T Consensus 97 ~~--~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~ 172 (271)
T d1nvra_ 97 DI--GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172 (271)
T ss_dssp TT--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGS
T ss_pred CC--CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCcc
Confidence 43 5999999999999999999999755 9999999999999999999999999998764443333445678999999
Q ss_pred CccccccCCC-CCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHH
Q 021507 152 APEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 230 (311)
Q Consensus 152 aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (311)
|||++.+..+ +.++|||||||++|+|++|+.||......... ................++.++.
T Consensus 173 APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp CTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH---------------HHHHHTTCTTSTTGGGSCHHHH
T ss_pred CHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH---------------HHHHhcCCCCCCccccCCHHHH
Confidence 9999988876 56899999999999999999999765421111 1111111112223356788999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHH
Q 021507 231 TLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 231 ~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+||.+||+.||++|||++|++++
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=361.06 Aligned_cols=227 Identities=26% Similarity=0.397 Sum_probs=188.9
Q ss_pred ChhHHHhHHHHHHh---hh--------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---AR--------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... +. ......+.+.+|++++++++|||||++++++.+++..|+|||||+||+|.+++
T Consensus 18 ~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l 97 (263)
T d2j4za1 18 KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL 97 (263)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHH
Confidence 58888888765432 11 12234567899999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .....||+.
T Consensus 98 ~~~~--~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~ 169 (263)
T d2j4za1 98 QKLS--KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLD 169 (263)
T ss_dssp HHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGG
T ss_pred hhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCc
Confidence 7654 3999999999999999999999755 9999999999999999999999999997654322 345679999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|+.||.+.+.... ...+.. .....+..+++++
T Consensus 170 Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----------------~~~i~~--~~~~~p~~~s~~~ 231 (263)
T d2j4za1 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----------------YKRISR--VEFTFPDFVTEGA 231 (263)
T ss_dssp GCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHT--TCCCCCTTSCHHH
T ss_pred ccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH----------------HHHHHc--CCCCCCccCCHHH
Confidence 9999999999999999999999999999999999986542111 111111 1223556788999
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||.+||+.||++|||++|++++
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHHccCCHhHCcCHHHHHcC
Confidence 999999999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=363.95 Aligned_cols=230 Identities=23% Similarity=0.301 Sum_probs=189.3
Q ss_pred ChhHHHhHHHHHHh--------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH--------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... ........+.+.+|+++|++++|||||++++++.+++..|+|||||+||+|.+++.++
T Consensus 32 ~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~ 111 (293)
T d1yhwa1 32 ASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111 (293)
T ss_dssp SSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS
T ss_pred cCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc
Confidence 58899998765432 1112234567999999999999999999999999999999999999999999988653
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
.+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++....... ......||+.|+|
T Consensus 112 ---~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~a 184 (293)
T d1yhwa1 112 ---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMA 184 (293)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCC
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccC
Confidence 3999999999999999999999754 99999999999999999999999999987543322 2445679999999
Q ss_pred ccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhh-cccCCCCchHHHHHHHH
Q 021507 153 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAAT 231 (311)
Q Consensus 153 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 231 (311)
||++.+..++.++|||||||++|+|++|..||.+.+... .+..+.. .......+..++.++.+
T Consensus 185 PE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----------------ALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp HHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred hhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH----------------HHHHHHhCCCCCCCCcccCCHHHHH
Confidence 999999999999999999999999999999997643211 1111111 11223445678899999
Q ss_pred HHHhcccCCCCCCCCHHHHHHH
Q 021507 232 LALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 232 li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
||.+||+.||.+|||+.|++++
T Consensus 249 li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-54 Score=365.38 Aligned_cols=240 Identities=23% Similarity=0.355 Sum_probs=186.0
Q ss_pred ChhHHHhHHHHHH------------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLEL------------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||.+.+... .........+.|.+|+++|++++|||||++++++.+++..|+|||||+||+|.++
T Consensus 38 ~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~ 117 (299)
T d1jpaa_ 38 EFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117 (299)
T ss_dssp SSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred CCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceee
Confidence 6889988764321 1122344566799999999999999999999999999999999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcce---ecccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV---STQVM 145 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~ 145 (311)
+.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......... .....
T Consensus 118 ~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~ 194 (299)
T d1jpaa_ 118 LRQND-GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194 (299)
T ss_dssp HHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----------------------
T ss_pred ecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeeccccc
Confidence 86543 34999999999999999999999754 99999999999999999999999999987544322211 12245
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK 224 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
||+.|+|||++.+..++.++|||||||++|||+| |..||.+... ..+...+........+..
T Consensus 195 ~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~~~~ 257 (299)
T d1jpaa_ 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----------------QDVINAIEQDYRLPPPMD 257 (299)
T ss_dssp -CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHTTCCCCCCTT
T ss_pred CCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcc
Confidence 7899999999999999999999999999999998 8999976432 112222333334455677
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
++.++.+|+.+||+.||++|||+.++++.|+++...
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 889999999999999999999999999999887543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-54 Score=362.39 Aligned_cols=239 Identities=23% Similarity=0.341 Sum_probs=198.5
Q ss_pred ChhHHHhHHHHHHh---hhhH----HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELH---ARSL----LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.+.+.... +.+. ....+.|.+|+++|++++|||||++++++.+++..|+|||||++|+|.+++....
T Consensus 29 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~ 108 (287)
T d1opja_ 29 QYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 108 (287)
T ss_dssp TTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC
T ss_pred CCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcc
Confidence 68999998776543 1111 1235679999999999999999999999999999999999999999999998776
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ........|+..|+||
T Consensus 109 ~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aP 185 (287)
T d1opja_ 109 RQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAP 185 (287)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCH
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHC--CcccCccccCeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccCh
Confidence 67799999999999999999999975 49999999999999999999999999998754432 2233445689999999
Q ss_pred cccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 154 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 154 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
|++.+..++.++|||||||++|||++|..||.... +...+.+.+........+..++.++.+|+
T Consensus 186 E~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERPEGCPEKVYELM 249 (287)
T ss_dssp HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred HHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----------------hHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence 99999999999999999999999999766654322 11223334444455566778899999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.+||+.||++|||++++++.|+.+.
T Consensus 250 ~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999998864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=362.08 Aligned_cols=239 Identities=25% Similarity=0.367 Sum_probs=183.4
Q ss_pred ChhHHHhHHHHHHhhhh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELHARS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||.++....-+.+ .....+.|.+|+++|++++|||||++++++. ++..|+|||||+||+|.+++....
T Consensus 20 ~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~ 98 (276)
T d1uwha_ 20 SFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE 98 (276)
T ss_dssp SSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSC
T ss_pred CCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhcc
Confidence 57888877543211111 1234567999999999999999999999875 456899999999999999996543
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 153 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 153 (311)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............||+.|+||
T Consensus 99 -~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 175 (276)
T d1uwha_ 99 -TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175 (276)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCH
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCH
Confidence 34999999999999999999999754 999999999999999999999999999876544333334567899999999
Q ss_pred cccccC---CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc----cCCCCchHHH
Q 021507 154 EYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----LGGQYPQKAA 226 (311)
Q Consensus 154 E~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 226 (311)
|++.+. .++.++|||||||++|||+||+.||.+...... ....+... .....+..++
T Consensus 176 E~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~----------------~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----------------IIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp HHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----------------HHHHHHHTSCCCCGGGSCTTCC
T ss_pred HHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH----------------HHHHHhcCCCCCcchhccccch
Confidence 998653 578899999999999999999999986432111 11111111 1112345678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
+++.+||.+||+.||++|||+.++++.|+.+..
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 899999999999999999999999999988753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-54 Score=357.39 Aligned_cols=230 Identities=23% Similarity=0.360 Sum_probs=181.6
Q ss_pred ChhHHHhHHHHHHh----------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe----CCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH----------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~ 66 (311)
|||+||.+.+.... ........+.|.+|+++|++++|||||++++++.+ +..+|+|||||+||+|.
T Consensus 21 ~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~ 100 (270)
T d1t4ha_ 21 SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 100 (270)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHH
T ss_pred cCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHH
Confidence 68888888765432 11123345679999999999999999999999875 34679999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC-CCCcEEEecccccccCCCCCCcceecccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
+++.+.. .+++..+..++.||+.||+|||+.+.+|+||||||+|||++ .++.+||+|||+++..... ......
T Consensus 101 ~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~ 174 (270)
T d1t4ha_ 101 TYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVI 174 (270)
T ss_dssp HHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESC
T ss_pred HHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcc
Confidence 9997654 49999999999999999999997555599999999999996 4789999999999864332 234568
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQK 224 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (311)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+.+.+... .....+..
T Consensus 175 GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~----------------~~~~~i~~~~~~~~~~~~ 237 (270)
T d1t4ha_ 175 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----------------QIYRRVTSGVKPASFDKV 237 (270)
T ss_dssp SSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----------------HHHHHHTTTCCCGGGGGC
T ss_pred cCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH----------------HHHHHHHcCCCCcccCcc
Confidence 9999999999865 59999999999999999999999997543211 111111111 11122344
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+++++.+||.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 67789999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=361.05 Aligned_cols=234 Identities=23% Similarity=0.274 Sum_probs=176.5
Q ss_pred ChhHHHhHHHHHHh---h-------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe--CCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---A-------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++++.... + .......+.|.+|+++|++++|||||++++++.+ ++.+|+|||||+||+|.++
T Consensus 16 ~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~ 95 (269)
T d2java1 16 SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASV 95 (269)
T ss_dssp SSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHH
Confidence 58888888765432 1 1122345678999999999999999999999865 4568999999999999999
Q ss_pred hhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCC---CCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecc
Q 021507 69 LFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 143 (311)
Q Consensus 69 l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 143 (311)
+.+. ....+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 96 i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~ 173 (269)
T d2java1 96 ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKA 173 (269)
T ss_dssp HHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------
T ss_pred HHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--Ccccc
Confidence 8542 2345999999999999999999999753 359999999999999999999999999998754322 22345
Q ss_pred ccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCch
Q 021507 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 223 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. .+...+........+.
T Consensus 174 ~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~~ 236 (269)
T d2java1 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----------------ELAGKIREGKFRRIPY 236 (269)
T ss_dssp --CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------------HHHHHHHHTCCCCCCT
T ss_pred CCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCc
Confidence 78999999999999999999999999999999999999999864321 1111112222224556
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 224 KAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+++++.+||.+||+.||.+|||++|++++
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 788999999999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=362.03 Aligned_cols=231 Identities=21% Similarity=0.296 Sum_probs=186.6
Q ss_pred ChhHHHhHHHHHHh---hh--------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---AR--------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +. ......+.+.+|+++|++++||||+++++++.+++..|+|||||+||+|.+++
T Consensus 20 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~ 99 (288)
T d1uu3a_ 20 SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 99 (288)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhh
Confidence 58888888765432 11 11234457899999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||+++...............||+.
T Consensus 100 ~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~ 175 (288)
T d1uu3a_ 100 RKIG--SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175 (288)
T ss_dssp HHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGG
T ss_pred hccC--CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCcc
Confidence 7654 3999999999999999999999755 99999999999999999999999999987654433333455689999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||.+.+... ...++... ....+..+++++
T Consensus 176 Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~~ 237 (288)
T d1uu3a_ 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------------IFQKIIKL--EYDFPEKFFPKA 237 (288)
T ss_dssp GCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHTT--CCCCCTTCCHHH
T ss_pred ccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----------------HHHHHHcC--CCCCCccCCHHH
Confidence 999999999999999999999999999999999998653211 11111111 123566788999
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||.+||+.||.+|||++|+++.
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHHccCCHhHCcCHHHHcCC
Confidence 999999999999999999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=367.96 Aligned_cols=238 Identities=24% Similarity=0.343 Sum_probs=194.9
Q ss_pred ChhHHHhHHHHHHh--------------hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH--------------ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 65 (311)
+||+||.+.+.... ........+.|.+|+.+|.++ +|||||++++++.+.+..|+|||||+||+|
T Consensus 49 ~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L 128 (325)
T d1rjba_ 49 AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128 (325)
T ss_dssp SSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred CCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcH
Confidence 58888887653211 112233445688999999998 899999999999999999999999999999
Q ss_pred HHHhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEe
Q 021507 66 ENHLFRRGP---------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 124 (311)
Q Consensus 66 ~~~l~~~~~---------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 124 (311)
.++|..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Nill~~~~~~Kl~ 206 (325)
T d1rjba_ 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKIC 206 (325)
T ss_dssp HHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEETTTEEEEC
T ss_pred HHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhccccccCCeEEEe
Confidence 999965431 34899999999999999999999754 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccc
Q 021507 125 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL 203 (311)
Q Consensus 125 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 203 (311)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 207 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~-------------- 272 (325)
T d1rjba_ 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-------------- 272 (325)
T ss_dssp CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--------------
T ss_pred eccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH--------------
Confidence 9999987655444444556778999999999999999999999999999999998 8999986432
Q ss_pred cchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 021507 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
...+.+++........+..+++++.+||.+||+.||++|||+++|+++|..
T Consensus 273 --~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 --DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp --SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 122334444445556677889999999999999999999999999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=366.18 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=187.1
Q ss_pred ChhHHHhHHHHHHh---hhh------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---ARS------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++++.... +.+ .....+.+.+|+.+|++++|||||+++++|.+.+..|+||||++||+|.+++.+
T Consensus 18 ~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~ 97 (322)
T d1s9ja_ 18 NGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97 (322)
T ss_dssp SSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH
T ss_pred CCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh
Confidence 68999998765432 111 223457899999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
.+ .+++..+..++.|++.||.|||+. ++|+||||||+|||++.+|.+||+|||+|+..... .....+||+.|+
T Consensus 98 ~~--~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~ 170 (322)
T d1s9ja_ 98 AG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 170 (322)
T ss_dssp HS--SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCC
T ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCcccc
Confidence 54 399999999999999999999963 35999999999999999999999999999864321 234568999999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhh-c-------------------------cccccc
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW-A-------------------------KPYLSD 205 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~-------------------------~~~~~~ 205 (311)
|||++.+..++.++|||||||++|||++|+.||.+.+.......... . .+...
T Consensus 171 APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 249 (322)
T d1s9ja_ 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA- 249 (322)
T ss_dssp CHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCC-
T ss_pred CchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchh-
Confidence 99999999999999999999999999999999987553221110000 0 00000
Q ss_pred hhhhhHhhhcccCCCC-chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 206 KRKLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 206 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
................ ....+.++.+||.+||..||.+|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 250 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp HHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0001111111111111 22457889999999999999999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=353.78 Aligned_cols=237 Identities=28% Similarity=0.410 Sum_probs=182.6
Q ss_pred ChhHHHhHHHHHHh--hhh----HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH--ARS----LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||.+++.... +.+ .....+.|.+|++++++++|||||++++++.+++..|+||||+++|+|.+++....
T Consensus 17 ~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~- 95 (263)
T d1sm2a_ 17 QFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR- 95 (263)
T ss_dssp SSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-
T ss_pred CCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc-
Confidence 58888887654321 111 12245679999999999999999999999999999999999999999999886543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ......||..|+|||
T Consensus 96 ~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE 172 (263)
T d1sm2a_ 96 GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPE 172 (263)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHH
T ss_pred cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChH
Confidence 45899999999999999999999754 999999999999999999999999999865443222 233457899999999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++|||||||++|||+| |.+||..... ..+...+........|..++.++.+|+
T Consensus 173 ~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVVEDISTGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----------------HHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred HhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 9999999999999999999999999 5666654321 112222333334445667788999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.+||+.||++|||++++++.|+++.
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-53 Score=358.85 Aligned_cols=230 Identities=23% Similarity=0.348 Sum_probs=172.6
Q ss_pred ChhHHHhHHHHHHh---hh------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH---AR------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++++.... +. ......+.+.+|+++|++++|||||++++++.+++..|+|||||+||+|.+++..
T Consensus 21 ~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~ 100 (307)
T d1a06a_ 21 AFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE 100 (307)
T ss_dssp GGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT
T ss_pred cCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc
Confidence 68999998765432 11 1123345688999999999999999999999999999999999999999999965
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC---CCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
.+ .+++..+..++.||+.||+|||+.+ |+||||||+||++. +++.+||+|||+++...... .....+||+
T Consensus 101 ~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~ 173 (307)
T d1a06a_ 101 KG--FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 173 (307)
T ss_dssp CS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---------------------C
T ss_pred cc--CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCc
Confidence 43 4999999999999999999999754 99999999999994 57889999999998653322 234567999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAA 226 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (311)
.|+|||++.+..++.++|||||||++|+|++|..||.+...... ...+.... .....+..++
T Consensus 174 ~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL----------------FEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp TTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------HHHHHTTCCCCCTTTTTTSC
T ss_pred cccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH----------------HHHHhccCCCCCCccccCCC
Confidence 99999999999999999999999999999999999986542111 11111111 2223345678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.++.+||.+||..||++|||++|++++
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 899999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=358.27 Aligned_cols=232 Identities=24% Similarity=0.328 Sum_probs=185.5
Q ss_pred ChhHHHhHHHHHHh---hh-----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---AR-----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... +. ......+.|.+|+++|++++|||||++++++.+++..|+|||||+||+|.+++.+.
T Consensus 24 ~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~ 103 (288)
T d2jfla1 24 AFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL 103 (288)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH
T ss_pred CCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhc
Confidence 58888888765432 11 11233456889999999999999999999999999999999999999999987654
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccC
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 152 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 152 (311)
. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++...... ........||+.|+|
T Consensus 104 ~-~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~A 178 (288)
T d2jfla1 104 E-RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMA 178 (288)
T ss_dssp T-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCC
T ss_pred C-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCC
Confidence 3 35999999999999999999999755 999999999999999999999999999753221 112335679999999
Q ss_pred ccccc-----cCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc-cCCCCchHHH
Q 021507 153 PEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAA 226 (311)
Q Consensus 153 PE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (311)
||++. +..++.++|||||||++|+|++|+.||.+.+... .+..+.... .....+..++
T Consensus 179 PE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~s 242 (288)
T d2jfla1 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----------------VLLKIAKSEPPTLAQPSRWS 242 (288)
T ss_dssp HHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----------------HHHHHHHSCCCCCSSGGGSC
T ss_pred HHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----------------HHHHHHcCCCCCCCccccCC
Confidence 99984 4568899999999999999999999998654211 111111111 1223456788
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.++.+||.+||+.||++|||++|++++
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-53 Score=353.51 Aligned_cols=236 Identities=24% Similarity=0.307 Sum_probs=190.9
Q ss_pred ChhHHHhHHHHHH-----------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLEL-----------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||.+.+... .........+.|.+|+++|++++|||||++++++.+ +..|+|||||+||+|.+++
T Consensus 21 ~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l 99 (285)
T d1u59a_ 21 NFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL 99 (285)
T ss_dssp TTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHH
T ss_pred cCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHh
Confidence 6888888743211 111223456679999999999999999999999865 5689999999999999987
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTH 148 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~ 148 (311)
.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........ .......||+
T Consensus 100 ~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~ 176 (285)
T d1u59a_ 100 VGKR-EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176 (285)
T ss_dssp TTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCG
T ss_pred hccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCc
Confidence 5433 45999999999999999999999754 999999999999999999999999999876543322 1223456899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 227 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
.|+|||++.+..++.++|||||||++|||+| |..||.+.... .+...+........|..++.
T Consensus 177 ~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----------------~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------HHHHHHHTTCCCCCCTTCCH
T ss_pred cccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCH
Confidence 9999999999999999999999999999998 99999864321 12222333344456778899
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
++.+||.+||+.||++|||+.++++.|+..
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 999999999999999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-53 Score=357.78 Aligned_cols=227 Identities=26% Similarity=0.339 Sum_probs=185.2
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++.+.... + .......+.+.+|+++|++++|||||++++++.+++..|+|||||.||+|..++
T Consensus 27 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~ 106 (309)
T d1u5ra_ 27 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106 (309)
T ss_dssp SSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH
T ss_pred CCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHH
Confidence 68899988765432 1 112344567899999999999999999999999999999999999998887766
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
..+. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... .....||+.
T Consensus 107 ~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~ 176 (309)
T d1u5ra_ 107 VHKK--PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPY 176 (309)
T ss_dssp HHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGG
T ss_pred HhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCcc
Confidence 5443 4999999999999999999999755 99999999999999999999999999986432 234579999
Q ss_pred ccCcccccc---CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 150 YAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 150 y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+.........+..++
T Consensus 177 Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp GCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCCCCCSCTTSC
T ss_pred ccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhCCCCCCCCCCCC
Confidence 999999864 45889999999999999999999999764321 11222223333333345678
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.++.+||.+||+.||.+|||+++++++
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 899999999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-52 Score=358.71 Aligned_cols=231 Identities=22% Similarity=0.281 Sum_probs=188.5
Q ss_pred ChhHHHhHHHHHHh---hhh-----HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---ARS-----LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++.+.... +.+ .....+.+.+|+++|++++|||||+++++|.+++.+|+|||||+||+|.+++...
T Consensus 41 ~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~ 120 (352)
T d1koba_ 41 AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 120 (352)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT
T ss_pred CCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhc
Confidence 68899988765432 111 1233557889999999999999999999999999999999999999999987544
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeC--CCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
. .++++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++....... ......||+.|
T Consensus 121 ~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y 194 (352)
T d1koba_ 121 D-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEF 194 (352)
T ss_dssp T-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGG
T ss_pred C-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccc
Confidence 3 35999999999999999999999754 99999999999997 57899999999998765432 24456789999
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhc--ccCCCCchHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHT 228 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 228 (311)
+|||++.+..++.++|||||||++|+|++|..||.+..... .+..+... .........++.+
T Consensus 195 ~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------------TLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp CCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------HHHHHHHCCCCCCSSTTTTSCHH
T ss_pred cCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhCCCCCCcccccCCCHH
Confidence 99999999999999999999999999999999998654211 11111111 1222334568899
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||.+||..||.+|||+.|++++
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-52 Score=358.39 Aligned_cols=231 Identities=21% Similarity=0.261 Sum_probs=187.5
Q ss_pred ChhHHHhHHHHHHh---hh-----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---AR-----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
|||+||++++.... +. ......+.+.+|+.+|++++|||||++++++.+++..|+|||||+||+|.+++.+.
T Consensus 38 ~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~ 117 (350)
T d1koaa2 38 AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117 (350)
T ss_dssp TTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCT
T ss_pred cCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhh
Confidence 68899988765432 11 12234567899999999999999999999999999999999999999999998543
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC--CCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...... ......||+.|
T Consensus 118 ~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y 191 (350)
T d1koaa2 118 H-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEF 191 (350)
T ss_dssp T-SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTT
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccc
Confidence 3 34999999999999999999999755 999999999999964 5789999999998754432 23456899999
Q ss_pred cCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHHH
Q 021507 151 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHT 228 (311)
Q Consensus 151 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 228 (311)
+|||++.+..++.++|||||||++|+|++|+.||.+.+.... +..+.... ........++.+
T Consensus 192 ~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----------------LRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHTCCCSCCGGGGGCCHH
T ss_pred cCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhCCCCCCcccccCCCHH
Confidence 999999999999999999999999999999999986542111 11111111 112223467889
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 229 AATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+.+||.+||..||++|||++|++++
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=349.37 Aligned_cols=241 Identities=23% Similarity=0.348 Sum_probs=186.1
Q ss_pred ChhHHHhHHHHHH-------------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLEL-------------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
|||+||.+.+... +........+.|.+|+++|++++|||||++++++.+.+..++||||+.++++.+
T Consensus 19 ~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~ 98 (283)
T d1mqba_ 19 EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 98 (283)
T ss_dssp SSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHH
T ss_pred CCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchh
Confidence 5888887653211 112223345679999999999999999999999999999999999999999998
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC-cceeccccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMG 146 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g 146 (311)
++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ........|
T Consensus 99 ~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~g 175 (283)
T d1mqba_ 99 FLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175 (283)
T ss_dssp HHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----------------CC
T ss_pred hhhccc-ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCC
Confidence 875543 45999999999999999999999755 99999999999999999999999999987543322 122334568
Q ss_pred cccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 147 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 147 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
|+.|+|||++.+..++.++|||||||++|||++|..||.... ....+...+........+..++
T Consensus 176 t~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----------------~~~~~~~~i~~~~~~~~~~~~~ 239 (283)
T d1mqba_ 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------------SNHEVMKAINDGFRLPTPMDCP 239 (283)
T ss_dssp CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----------------CHHHHHHHHHTTCCCCCCTTCB
T ss_pred CccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----------------CHHHHHHHHhccCCCCCchhhH
Confidence 999999999999999999999999999999999655543321 1122233334444555677788
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999999999999999887543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=342.29 Aligned_cols=216 Identities=26% Similarity=0.386 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 021507 20 LITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 99 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 99 (311)
...+.|.+|+++|++++|||||++++++.+ +..|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+.
T Consensus 50 ~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~ 126 (277)
T d1xbba_ 50 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES 126 (277)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC
Confidence 345679999999999999999999999865 46789999999999999996654 499999999999999999999975
Q ss_pred CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccccccccCccccccCCCCCCCceehhHHHHHHHH
Q 021507 100 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 178 (311)
Q Consensus 100 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 178 (311)
+ |+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 127 ~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 127 N--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp T--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred C--cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 4 999999999999999999999999999875443322 2233457899999999999999999999999999999999
Q ss_pred h-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 179 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 179 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
+ |+.||.+... ..+...+........+..++.++.+||.+||+.||++|||++++++.|+..
T Consensus 205 t~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 205 SYGQKPYRGMKG-----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 8 8999986432 112223333344456778899999999999999999999999999887653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=350.56 Aligned_cols=229 Identities=26% Similarity=0.319 Sum_probs=188.9
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +.+ .....+.+.+|+.+|++++||||+++++++.+.+.+|+|||||+||+|.+++
T Consensus 17 ~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~ 96 (337)
T d1o6la_ 17 TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL 96 (337)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred cCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhh
Confidence 58888888765532 111 1223466889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++....... .....+||+.
T Consensus 97 ~~~~--~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~ 170 (337)
T d1o6la_ 97 SRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPE 170 (337)
T ss_dssp HHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGG
T ss_pred hccc--CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHH
Confidence 7654 3899999999999999999999765 99999999999999999999999999986543222 2445789999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|||++|..||.+.+... +.+.... .....|..++.++
T Consensus 171 Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----------------~~~~i~~-~~~~~p~~~s~~~ 232 (337)
T d1o6la_ 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----------------LFELILM-EEIRFPRTLSPEA 232 (337)
T ss_dssp GCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHH-CCCCCCTTSCHHH
T ss_pred HhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-----------------HHHHHhc-CCCCCCccCCHHH
Confidence 999999999999999999999999999999999998754211 1111111 1234567789999
Q ss_pred HHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
.+||.+||+.||.+|++ +++++++
T Consensus 233 ~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhhccCCchhhcccccccHHHHHcC
Confidence 99999999999999994 8888864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=350.33 Aligned_cols=230 Identities=23% Similarity=0.286 Sum_probs=186.0
Q ss_pred ChhHHHhHHHHHHh---hhh-----------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH---ARS-----------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
+||+||++++.... +.+ .....+.|.+|+++|++++|||||++++++.+.+..|+|||||+||+|.
T Consensus 22 ~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~ 101 (293)
T d1jksa_ 22 QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 101 (293)
T ss_dssp SSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCcccc
Confidence 58899988765432 111 1123577999999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC----cEEEecccccccCCCCCCcceec
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVST 142 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~ 142 (311)
+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++....... ...
T Consensus 102 ~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~ 174 (293)
T d1jksa_ 102 DFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFK 174 (293)
T ss_dssp HHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCS
T ss_pred chhcccc--ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhcCCCc---ccc
Confidence 9997654 4999999999999999999999755 99999999999998876 49999999998754332 234
Q ss_pred cccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc--CCC
Q 021507 143 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQ 220 (311)
Q Consensus 143 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 220 (311)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..... ..+..... ...
T Consensus 175 ~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~ 238 (293)
T d1jksa_ 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------------ANVSAVNYEFEDE 238 (293)
T ss_dssp CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHTTCCCCCHH
T ss_pred ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH----------------HHHHhcCCCCCch
Confidence 567899999999999999999999999999999999999999865432111 11111111 111
Q ss_pred CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 221 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+..++.++.+||.+||+.||++|||+++++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123567889999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-51 Score=339.73 Aligned_cols=236 Identities=25% Similarity=0.358 Sum_probs=189.1
Q ss_pred ChhHHHhHHHHHHh--hh----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH--AR----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||.+.+.... +. ......+.|.+|++++++++|||||++++++.+ +..|+||||+++|+|.+++.....
T Consensus 25 ~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~ 103 (272)
T d1qpca_ 25 QFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG 103 (272)
T ss_dssp TTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHH
T ss_pred CCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCC
Confidence 58888877643211 11 111235679999999999999999999998754 567999999999999998865554
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ........||+.|+|||
T Consensus 104 ~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE 180 (272)
T d1qpca_ 104 IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 180 (272)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChH
Confidence 56999999999999999999999754 9999999999999999999999999998764432 22234567899999999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHhCCC-ccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLSGRC-AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++|||||||++|||+||.. ||..... ......+........+..++.++.+|+
T Consensus 181 ~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----------------PEVIQNLERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred HHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHhcCCCCCcccChHHHHHHH
Confidence 9999999999999999999999999654 4443221 122233333444456677889999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhh
Q 021507 234 LQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
.+||+.||++|||++++++.|+.+
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhh
Confidence 999999999999999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=344.21 Aligned_cols=236 Identities=25% Similarity=0.315 Sum_probs=181.9
Q ss_pred ChhHHHhHHHHHH------------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLEL------------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||.+.+... .........+.|.+|+++|++++|||||++++++. ++..|+||||+.+|+|.++
T Consensus 19 ~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~ 97 (273)
T d1mp8a_ 19 QFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSF 97 (273)
T ss_dssp SSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHH
T ss_pred CCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhh
Confidence 5888888755321 12233455678999999999999999999999986 4678999999999999998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+.... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 98 ~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~ 173 (273)
T d1mp8a_ 98 LQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPI 173 (273)
T ss_dssp HHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--------------------CCG
T ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCc
Confidence 75543 45999999999999999999999755 99999999999999999999999999986543322 2234456899
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 227 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
.|+|||++.+..++.++|||||||++|||++ |.+||...... .+...+........+..++.
T Consensus 174 ~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----------------DVIGRIENGERLPMPPNCPP 236 (273)
T ss_dssp GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTCCH
T ss_pred ccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCH
Confidence 9999999999999999999999999999998 89999865421 11222222333456678899
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
++.+||.+||..||++|||+.++++.|+.+.
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-51 Score=346.57 Aligned_cols=226 Identities=24% Similarity=0.330 Sum_probs=187.3
Q ss_pred ChhHHHhHHHHHHh---hh--------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---AR--------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +. ......+.+.+|+.+|++++|||||++++++.+++..|+|||||.||+|..++
T Consensus 16 ~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~ 95 (316)
T d1fota_ 16 SFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL 95 (316)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred cCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccc
Confidence 58889888765432 11 11223467889999999999999999999999999999999999999999988
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
..... +++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++..... .....||+.
T Consensus 96 ~~~~~--~~~~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~ 166 (316)
T d1fota_ 96 RKSQR--FPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPD 166 (316)
T ss_dssp HHTSS--CCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTT
T ss_pred ccccc--ccccHHHHHHHHHHHhhhhhccC--cEEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCccc
Confidence 66543 88999999999999999999965 5999999999999999999999999999875432 345689999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|+.||.+.+... ...++... ....+..++.++
T Consensus 167 Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~~ 228 (316)
T d1fota_ 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------------TYEKILNA--ELRFPPFFNEDV 228 (316)
T ss_dssp TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHC--CCCCCTTSCHHH
T ss_pred ccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----------------HHHHHHcC--CCCCCCCCCHHH
Confidence 999999999999999999999999999999999998654211 11122222 224566788899
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.+++.+||..||.+|+ |+++++++
T Consensus 229 ~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 9999999999999996 89999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=349.73 Aligned_cols=237 Identities=20% Similarity=0.323 Sum_probs=189.2
Q ss_pred ChhHHHhHHHHHHh-------------hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH-------------ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||.+.+.... ........+.|.+|++++++++|||||++++++.++ ..++++|++.+++|.+
T Consensus 21 ~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~ 99 (317)
T d1xkka_ 21 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLD 99 (317)
T ss_dssp SSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHH
T ss_pred CCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccc
Confidence 68999887543211 112234566799999999999999999999999865 5678889999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............||
T Consensus 100 ~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 100 YVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176 (317)
T ss_dssp HHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CC
T ss_pred cccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccC
Confidence 886543 45999999999999999999999754 999999999999999999999999999876554444444456789
Q ss_pred ccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHH
Q 021507 148 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 226 (311)
Q Consensus 148 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
..|+|||++.+..++.++|||||||++|||+| |..||++... ..+...+........+..++
T Consensus 177 ~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGERLPQPPICT 239 (317)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----------------GGHHHHHHHTCCCCCCTTBC
T ss_pred ccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcccC
Confidence 99999999999999999999999999999998 8999986432 12223333344445667788
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 227 HTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
..+.+|+.+||..||.+|||+.++++.|..+.
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999999988764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=345.23 Aligned_cols=238 Identities=26% Similarity=0.354 Sum_probs=184.4
Q ss_pred ChhHHHhHHHHHHhhh------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELHAR------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||++.+.+.... ......+.|.+|+.++++++|||||++++++.+ +..|+||||+++|+|..++.....
T Consensus 29 ~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~ 107 (285)
T d1fmka3 29 CFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG 107 (285)
T ss_dssp SSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHH
T ss_pred CCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhccc
Confidence 5888888865443211 011124679999999999999999999999854 568999999999999998866544
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||
T Consensus 108 ~~l~~~~~~~i~~~i~~gl~~LH~~--~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 108 KYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPE 184 (285)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHH
T ss_pred ccchHHHHHHHHHHHHHHHHHHhhh--heecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChH
Confidence 5699999999999999999999975 499999999999999999999999999986543322 2234467899999999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 234 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 234 (311)
++.+..++.++|||||||++|||++|..||..... .......+........+..++.++.++|.
T Consensus 185 ~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----------------NREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----------------HHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 99999999999999999999999996555543221 12222333333444567788899999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHhhc
Q 021507 235 QCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 235 ~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
+||+.||++|||++++++.|+.+.
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHcccCHhHCcCHHHHHHHHhhhh
Confidence 999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=339.91 Aligned_cols=237 Identities=25% Similarity=0.324 Sum_probs=185.9
Q ss_pred ChhHHHhHHHHH--------------HhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLE--------------LHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
|||+||+++... ..........+.|.+|+++|++++||||+++++++.+ ...++||||+++|+|.
T Consensus 20 ~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~ 98 (273)
T d1u46a_ 20 SFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLL 98 (273)
T ss_dssp --CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred CCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchh
Confidence 588888775321 1122233455679999999999999999999999965 4678999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc-eecccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVM 145 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~ 145 (311)
+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......... ......
T Consensus 99 ~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~ 175 (273)
T d1u46a_ 99 DRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175 (273)
T ss_dssp HHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----
T ss_pred hhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccc
Confidence 9876543 34999999999999999999999754 9999999999999999999999999998765443322 233456
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK 224 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
|+..|+|||++.+..++.++|||||||++|||+| |..||.+.+.. .....+.........+..
T Consensus 176 ~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QILHKIDKEGERLPRPED 239 (273)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHTSCCCCCCCTT
T ss_pred cCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----------------HHHHHHHhCCCCCCCccc
Confidence 7889999999999999999999999999999998 89999865421 112222233334455677
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 225 AAHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
++..+.+|+.+||..||++|||+.++++.|.+.
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 889999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=330.25 Aligned_cols=235 Identities=22% Similarity=0.310 Sum_probs=192.9
Q ss_pred ChhHHHhHHHHHHh--hh----hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCC
Q 021507 1 MFLFNFLHSHLELH--AR----SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP 74 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (311)
+||+||.+++..-. +. ......+.|.+|+.++++++||||+++++++.+++..++||||+++|+|.+++....
T Consensus 16 ~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~- 94 (258)
T d1k2pa_ 16 QFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR- 94 (258)
T ss_dssp TTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG-
T ss_pred CCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc-
Confidence 58888887753211 11 112245679999999999999999999999999999999999999999999875443
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCcc
Q 021507 75 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 154 (311)
Q Consensus 75 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 154 (311)
..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......||..|+|||
T Consensus 95 ~~~~~~~~~~i~~qi~~gl~~LH~~--~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE 171 (258)
T d1k2pa_ 95 HRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPE 171 (258)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHHT--TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHH
T ss_pred cCCcHHHHHHHHHHHHHHHHHHhhc--CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcH
Confidence 3489999999999999999999975 4999999999999999999999999999865443222 233467899999999
Q ss_pred ccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHH
Q 021507 155 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 233 (311)
Q Consensus 155 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (311)
++.+..++.++|||||||++|||+| |+.||.+.... .+...+........|..++.++.+||
T Consensus 172 ~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----------------~~~~~i~~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------ETAEHIAQGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred HhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----------------HHHHHHHhCCCCCCcccccHHHHHHH
Confidence 9999999999999999999999998 89999875421 12222233344456677888999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHh
Q 021507 234 LQCLNNEPKLRPRMSEVLAILER 256 (311)
Q Consensus 234 ~~~l~~~p~~Rpt~~~~l~~l~~ 256 (311)
.+||+.||++|||++++++.|..
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=353.75 Aligned_cols=236 Identities=21% Similarity=0.236 Sum_probs=185.6
Q ss_pred ChhHHHhHHHHHHh---hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEe----CCeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++++.... +.+...-.+.+.+|++++.++ +|||||+++++|.+ +..+|+|||||+||+|.+++.++
T Consensus 24 ~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~ 103 (335)
T d2ozaa1 24 INGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 103 (335)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC
T ss_pred cCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc
Confidence 68999999876543 333333456788999987655 89999999999875 45689999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCcceecccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
+...+++..+..++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||+++....... .....||+.
T Consensus 104 ~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~ 178 (335)
T d2ozaa1 104 GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPY 178 (335)
T ss_dssp SCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCS
T ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHHcC--CccccccccccccccccccccccccccceeeeccCCCc---cccccCCcc
Confidence 6667999999999999999999999755 999999999999975 45799999999987544322 345679999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc--cCCCCchHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAH 227 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 227 (311)
|+|||++.+..++.++|||||||++|+|++|+.||.+.+........ ...+.... ........++.
T Consensus 179 y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------------~~~i~~~~~~~~~~~~~~~s~ 246 (335)
T d2ozaa1 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------KTRIRMGQYEFPNPEWSEVSE 246 (335)
T ss_dssp SCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------CCCSCSSSCCTTHHHHSCH
T ss_pred cCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------------HHHHhcCCCCCCCcccccCCH
Confidence 99999999999999999999999999999999999764321110000 00000001 11111235788
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 228 TAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
++.+||.+||+.||++|||+.+++++
T Consensus 247 ~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 247 EVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 99999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-50 Score=336.10 Aligned_cols=230 Identities=27% Similarity=0.335 Sum_probs=187.5
Q ss_pred ChhHHHhHHHHHHh-----------------hhhHHHHHHHHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCC
Q 021507 1 MFLFNFLHSHLELH-----------------ARSLLLITNWFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPK 62 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~ 62 (311)
+||+||++++.... ........+.+.+|+.++++++ ||||+++++++.+++..|+|||||+|
T Consensus 15 ~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~ 94 (277)
T d1phka_ 15 VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK 94 (277)
T ss_dssp SSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCC
Confidence 47888888765422 1223456678999999999996 99999999999999999999999999
Q ss_pred CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceec
Q 021507 63 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 142 (311)
Q Consensus 63 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 142 (311)
|+|.++|..++ .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ..
T Consensus 95 g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~ 167 (277)
T d1phka_ 95 GELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 167 (277)
T ss_dssp CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BC
T ss_pred chHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchheeEccCCCc---ee
Confidence 99999997654 4999999999999999999999754 99999999999999999999999999987644322 34
Q ss_pred cccccccccCcccccc------CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcc
Q 021507 143 QVMGTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 216 (311)
Q Consensus 143 ~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (311)
...||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... ....+....
T Consensus 168 ~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~----------------~~~~i~~~~ 231 (277)
T d1phka_ 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----------------MLRMIMSGN 231 (277)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHTC
T ss_pred eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH----------------HHHHHHhCC
Confidence 4679999999999864 346789999999999999999999998754211 111122221
Q ss_pred --cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 217 --LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 217 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
........+++++.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1223345788999999999999999999999999764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-50 Score=343.84 Aligned_cols=239 Identities=26% Similarity=0.384 Sum_probs=192.8
Q ss_pred ChhHHHhHHHHH--------------HhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLE--------------LHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
|||+||.++... ++........+.|.+|+++|++++||||+++++++.+.+..+++|||+.+|+|.
T Consensus 25 ~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~ 104 (301)
T d1lufa_ 25 AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104 (301)
T ss_dssp SSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred CCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHH
Confidence 689999886431 111223345678999999999999999999999999999999999999999999
Q ss_pred HHhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEe
Q 021507 67 NHLFRRG----------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 124 (311)
Q Consensus 67 ~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 124 (311)
+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~NILld~~~~~Kl~ 182 (301)
T d1lufa_ 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIA 182 (301)
T ss_dssp HHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEEC
T ss_pred HHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccceEECCCCcEEEc
Confidence 9986432 234889999999999999999999755 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC-CccCCCccchhhhhhhhccccc
Q 021507 125 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYL 203 (311)
Q Consensus 125 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~ 203 (311)
|||+++...............|++.|+|||++.+..++.++|||||||++|||++|. .||.....
T Consensus 183 DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-------------- 248 (301)
T d1lufa_ 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-------------- 248 (301)
T ss_dssp CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------------
T ss_pred cchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH--------------
Confidence 999998654443333344567889999999999999999999999999999999985 57765432
Q ss_pred cchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 204 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
......+........+..++.++.+|+.+||+.||++|||+.++++.|+++.
T Consensus 249 ---~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 ---EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1112222233334456778889999999999999999999999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-50 Score=346.48 Aligned_cols=226 Identities=23% Similarity=0.262 Sum_probs=187.0
Q ss_pred ChhHHHhHHHHHHh---hhh--------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHh
Q 021507 1 MFLFNFLHSHLELH---ARS--------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 69 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (311)
+||+||++++.... +.+ .....+.+.+|+++|++++|||||++++++.+.+..|+||||+.||+|.+++
T Consensus 53 ~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l 132 (350)
T d1rdqe_ 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132 (350)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred cCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhH
Confidence 58889888765432 111 1123456889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccc
Q 021507 70 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 149 (311)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 149 (311)
.+.+ .+++..+..++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+++..... .....||+.
T Consensus 133 ~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~ 203 (350)
T d1rdqe_ 133 RRIG--RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPE 203 (350)
T ss_dssp HHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGG
T ss_pred hhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccc
Confidence 7654 3999999999999999999999755 999999999999999999999999999875432 334679999
Q ss_pred ccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHH
Q 021507 150 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 229 (311)
Q Consensus 150 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (311)
|+|||++.+..++.++|||||||++|+|++|..||.+.+... ....+... ....+..++.++
T Consensus 204 Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~~ 265 (350)
T d1rdqe_ 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----------------IYEKIVSG--KVRFPSHFSSDL 265 (350)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC--CCCCCTTCCHHH
T ss_pred cCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----------------HHHHHhcC--CCCCCccCCHHH
Confidence 999999999999999999999999999999999998643211 11111111 123456788999
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRP-----RMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rp-----t~~~~l~~ 253 (311)
.+||.+||..||.+|+ |+++++++
T Consensus 266 ~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 9999999999999995 89999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.4e-50 Score=347.04 Aligned_cols=230 Identities=24% Similarity=0.273 Sum_probs=182.4
Q ss_pred ChhHHHhHHHHHHh---hhhH--------HHHHHHHH---HHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLELH---ARSL--------LLITNWFQ---TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~--------~~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
|||+||++++.... +.+. ......+. +|+++++.++|||||++++++.+.+..|+|||||+||+|.
T Consensus 16 ~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~ 95 (364)
T d1omwa3 16 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 95 (364)
T ss_dssp SSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHH
Confidence 68888888766532 1111 11122233 4577888889999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccc
Q 021507 67 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 146 (311)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 146 (311)
+++.+.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++...... .....|
T Consensus 96 ~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~G 167 (364)
T d1omwa3 96 YHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167 (364)
T ss_dssp HHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCS
T ss_pred HHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCCCc----cccccc
Confidence 9997654 3899999999999999999999755 9999999999999999999999999998654332 334679
Q ss_pred cccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH
Q 021507 147 THGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 225 (311)
Q Consensus 147 t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.. .........+..+
T Consensus 168 T~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--------------~~~-~~~~~~~~~~~~~ 232 (364)
T d1omwa3 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDR-MTLTMAVELPDSF 232 (364)
T ss_dssp CGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--------------HHH-HSSSCCCCCCSSS
T ss_pred ccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--------------HHH-hcccCCCCCCCCC
Confidence 999999999865 568999999999999999999999998654321111 111 1112223445678
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 226 AHTAATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
+.++.+||.+||..||.+||| +++++++
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 899999999999999999998 6888864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=341.34 Aligned_cols=239 Identities=25% Similarity=0.375 Sum_probs=195.2
Q ss_pred ChhHHHhHHHHHHh----------------hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCC
Q 021507 1 MFLFNFLHSHLELH----------------ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKG 63 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 63 (311)
|||+||+++....+ ..........+.+|...+.++ +|||||++++++.+++..|+||||+++|
T Consensus 25 ~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g 104 (299)
T d1fgka_ 25 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 104 (299)
T ss_dssp ---CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred CCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCC
Confidence 68888887542211 122334456788899999888 8999999999999999999999999999
Q ss_pred ChHHHhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEeccccc
Q 021507 64 SLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 129 (311)
Q Consensus 64 ~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 129 (311)
+|.++|..+. ...+++..++.++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++
T Consensus 105 ~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~~~~~kl~dfg~~ 182 (299)
T d1fgka_ 105 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 182 (299)
T ss_dssp BHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSTTCC
T ss_pred cHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecCCCCeEeccchhh
Confidence 9999996543 235899999999999999999999765 999999999999999999999999999
Q ss_pred ccCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhh
Q 021507 130 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 208 (311)
Q Consensus 130 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 208 (311)
+...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+... ..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----------------~~ 245 (299)
T d1fgka_ 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----------------EE 245 (299)
T ss_dssp CCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HH
T ss_pred ccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----------------HH
Confidence 87655444444556678999999999999999999999999999999998 7889876442 12
Q ss_pred hhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 209 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
+...+........+..+++++.+||.+||+.||.+|||+.|+++.|+++.
T Consensus 246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 22333344445566778899999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=341.85 Aligned_cols=240 Identities=26% Similarity=0.335 Sum_probs=184.2
Q ss_pred ChhHHHhHHHHHH--------------hhhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeC-CeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLEL--------------HARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEG-ENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~ 64 (311)
+||+||.+.+... .........+.+.+|..++.++ .|+||+.+++++.+. +..++|||||++|+
T Consensus 25 ~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~ 104 (299)
T d1ywna1 25 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104 (299)
T ss_dssp SSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCB
T ss_pred CCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCc
Confidence 6888887654321 1112223445677888888887 689999999987654 46899999999999
Q ss_pred hHHHhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 65 LENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 65 L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~~~~~~Kl~DFGla~ 182 (299)
T d1ywna1 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 182 (299)
T ss_dssp HHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECC-----
T ss_pred HHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeECCCCcEEEccCcchh
Confidence 999996532 234899999999999999999999755 9999999999999999999999999998
Q ss_pred cCCCCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC-CCccCCCccchhhhhhhhccccccchhhh
Q 021507 131 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKL 209 (311)
Q Consensus 131 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (311)
...............||+.|+|||++.+..++.++|||||||++|||++| ..||..... ...+
T Consensus 183 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~----------------~~~~ 246 (299)
T d1ywna1 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------------DEEF 246 (299)
T ss_dssp -CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----------------SHHH
T ss_pred hccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH----------------HHHH
Confidence 76544444344566899999999999999999999999999999999986 567865432 1122
Q ss_pred hHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 210 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
...+........+..+++++.++|.+||+.||++|||+.+++++|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2333334444566778899999999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-50 Score=337.65 Aligned_cols=238 Identities=25% Similarity=0.337 Sum_probs=182.7
Q ss_pred ChhHHHhHHHHHHh---h--------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC----eeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH---A--------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~e~~~~~~L 65 (311)
+||+||++.+.... + .......+.|.+|++++++++||||+++++++...+ ..|+||||++|++|
T Consensus 19 ~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L 98 (277)
T d1o6ya_ 19 GMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL 98 (277)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEH
T ss_pred CCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEe
Confidence 68889988766533 1 112345567999999999999999999999998654 37899999999999
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCC-cceeccc
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQV 144 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~ 144 (311)
.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||.+........ .......
T Consensus 99 ~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 174 (277)
T d1o6ya_ 99 RDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174 (277)
T ss_dssp HHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC------------
T ss_pred hhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhccccccccccccc
Confidence 99986654 3999999999999999999999754 99999999999999999999999999875433222 1223456
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhccc--CCCCc
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYP 222 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 222 (311)
.||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.... ..+.+.... .....
T Consensus 175 ~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----------------~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV----------------AYQHVREDPIPPSARH 238 (277)
T ss_dssp ----TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------HHHHHHCCCCCGGGTS
T ss_pred cCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH----------------HHHHHhcCCCCCchhc
Confidence 799999999999999999999999999999999999999986542111 111111111 11223
Q ss_pred hHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhhc
Q 021507 223 QKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLE 258 (311)
Q Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rp-t~~~~l~~l~~~~ 258 (311)
..++.++.++|.+||+.||.+|| |++++++.|.++.
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 45788999999999999999999 8999999988764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=340.29 Aligned_cols=231 Identities=19% Similarity=0.188 Sum_probs=184.8
Q ss_pred ChhHHHhHHHHHHh---hhh----HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELH---ARS----LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||++.+.... +.+ ...-...+.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++...+
T Consensus 17 ~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~ 96 (321)
T d1tkia_ 17 EFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA 96 (321)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS
T ss_pred CCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC
Confidence 58899988766532 111 11123458899999999999999999999999999999999999999999996543
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCC--CcEEEecccccccCCCCCCcceecccccccccc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
..+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++....... ......+|+.|+
T Consensus 97 -~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ 170 (321)
T d1tkia_ 97 -FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYY 170 (321)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGS
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccc
Confidence 34999999999999999999999755 9999999999999854 479999999998754332 234567899999
Q ss_pred CccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCC--CCchHHHHHH
Q 021507 152 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTA 229 (311)
Q Consensus 152 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 229 (311)
|||.+.+..++.++|||||||++|+|++|..||.+.+... ....+....... .....++.++
T Consensus 171 ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------------IIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhCCCCCChhhccCCCHHH
Confidence 9999999999999999999999999999999998754211 111111111110 1112467889
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 021507 230 ATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 230 ~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.+||.+||..||++|||++|++++
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=338.11 Aligned_cols=247 Identities=23% Similarity=0.193 Sum_probs=180.7
Q ss_pred ChhHHHhHHHHHHh---hhhH----------HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH---ARSL----------LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~----------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||++++.... +.+. ....+.+.+|+++|++++|||||++++++.+++..|+||||+.|+++..
T Consensus 10 ~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~ 89 (299)
T d1ua2a_ 10 QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI 89 (299)
T ss_dssp TTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHH
T ss_pred cCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhh
Confidence 58999988775532 1111 1123468899999999999999999999999999999999999876666
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .....+||
T Consensus 90 ~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt 163 (299)
T d1ua2a_ 90 IKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVT 163 (299)
T ss_dssp HTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCC
T ss_pred hhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCcc--cccceecC
Confidence 5532 345899999999999999999999755 99999999999999999999999999987544322 23456799
Q ss_pred ccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hh-ccccccc---hhhhhHhhhcccCCCC
Q 021507 148 HGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPYLSD---KRKLFRIMDTKLGGQY 221 (311)
Q Consensus 148 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~~---~~~~~~~~~~~~~~~~ 221 (311)
+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+ .. ..+.... ................
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
T d1ua2a_ 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243 (299)
T ss_dssp CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCC
T ss_pred hhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCC
Confidence 999999998655 5799999999999999999999999865432211100 00 0000000 0000000000000000
Q ss_pred -----chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 222 -----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 222 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
...++.++.+||.+||..||++|||++|++++
T Consensus 244 ~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 12457789999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=337.56 Aligned_cols=237 Identities=26% Similarity=0.348 Sum_probs=188.7
Q ss_pred ChhHHHhHHHHHHh-----------hhhHHHHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH-----------ARSLLLITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||.+.+.... ........+.|.+|+++|+++ +|||||++++++.+++..|+||||++||+|.++
T Consensus 22 ~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~ 101 (309)
T d1fvra_ 22 NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 101 (309)
T ss_dssp GGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHH
T ss_pred CCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHH
Confidence 58888887654321 111222445799999999999 799999999999999999999999999999999
Q ss_pred hhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCC
Q 021507 69 LFRR--------------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 134 (311)
Q Consensus 69 l~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 134 (311)
|... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEV 179 (309)
T ss_dssp HHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEESSCE
T ss_pred HhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCCceEEccccccccccc
Confidence 9643 2346999999999999999999999755 99999999999999999999999999975432
Q ss_pred CCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCC-CccCCCccchhhhhhhhccccccchhhhhHhh
Q 021507 135 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 213 (311)
Q Consensus 135 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (311)
.. ......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+. ..+...+
T Consensus 180 ~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-----------------~~~~~~i 239 (309)
T d1fvra_ 180 YV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------------AELYEKL 239 (309)
T ss_dssp EC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHG
T ss_pred cc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHH
Confidence 21 123456899999999999999999999999999999999965 56765432 1122222
Q ss_pred hcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 214 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
........+..+++++.+||.+||+.||++|||++++++.|+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 3333445567788999999999999999999999999999988753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=327.33 Aligned_cols=234 Identities=26% Similarity=0.390 Sum_probs=182.2
Q ss_pred ChhHHHhHHHHHHh----hhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCCCCChHHHhhhcCCC
Q 021507 1 MFLFNFLHSHLELH----ARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQ 75 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (311)
+||+||.++..... ..+.....+.|.+|++++++++||||+++++++.+ .+..|+||||+++|+|.+++......
T Consensus 19 ~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~ 98 (262)
T d1byga_ 19 EFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 98 (262)
T ss_dssp SSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH
T ss_pred CCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCC
Confidence 46777766542211 00112345679999999999999999999999865 45689999999999999999765444
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccc
Q 021507 76 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 155 (311)
Q Consensus 76 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 155 (311)
.+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .....++..|+|||+
T Consensus 99 ~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~ 171 (262)
T d1byga_ 99 VLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEA 171 (262)
T ss_dssp HCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHH
T ss_pred CCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHH
Confidence 5899999999999999999999754 999999999999999999999999999764322 334567899999999
Q ss_pred cccCCCCCCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHH
Q 021507 156 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 234 (311)
Q Consensus 156 ~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 234 (311)
+.+..++.++|||||||++|||+| |+.||..... ..+...+........+..+++++.+||.
T Consensus 172 l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------------GGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred HhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 999999999999999999999998 7888876432 1122223334445667778899999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHhhc
Q 021507 235 QCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 235 ~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
+||..||.+|||+.++++.|+.+.
T Consensus 235 ~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999998874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=334.87 Aligned_cols=240 Identities=25% Similarity=0.360 Sum_probs=189.2
Q ss_pred ChhHHHhHHHHHH------------hhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEe-CCeeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLEL------------HARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~ 67 (311)
+||+||.+..... .........+.|.+|+++|++++||||+++++++.+ ++..++|||||++|+|.+
T Consensus 39 ~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~ 118 (311)
T d1r0pa_ 39 HFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 118 (311)
T ss_dssp TTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHH
T ss_pred CCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhh
Confidence 6888887543221 111233345679999999999999999999999876 468899999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ceecccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVM 145 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~ 145 (311)
++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........ .......
T Consensus 119 ~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~ 195 (311)
T d1r0pa_ 119 FIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195 (311)
T ss_dssp HHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSS
T ss_pred hhcccc-ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccccceeccccc
Confidence 886543 45888899999999999999999755 999999999999999999999999999875433222 1233457
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 225 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
||..|+|||.+.+..++.++||||||+++|||++|..||...... ......+........+..+
T Consensus 196 gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----------------~~~~~~i~~g~~~~~p~~~ 259 (311)
T d1r0pa_ 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----------------FDITVYLLQGRRLLQPEYC 259 (311)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------------CHHHHHTTCCCCCCTTC
T ss_pred ccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHcCCCCCCcccC
Confidence 899999999999999999999999999999999988777643211 0111112222233456677
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcC
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 259 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~ 259 (311)
++++.+||.+||..||++||++.|+++.|+++..
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 8899999999999999999999999999998854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=336.73 Aligned_cols=220 Identities=28% Similarity=0.427 Sum_probs=187.3
Q ss_pred HHHHHHHHHHHHHhcC-CCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC----------------CCCCCHHHH
Q 021507 20 LITNWFQTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG----------------PQPLSWAVR 82 (311)
Q Consensus 20 ~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~ 82 (311)
.....|.+|+.+++++ +|||||++++++.+.+..|+|||||++|+|.+++.... ...+++..+
T Consensus 68 ~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 147 (311)
T d1t46a_ 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (311)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHH
Confidence 3455789999999999 69999999999999999999999999999999986543 235899999
Q ss_pred HHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCccccccCCCC
Q 021507 83 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 162 (311)
Q Consensus 83 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 162 (311)
..++.||+.||+|||+++ ++||||||+||+++.++.+|++|||.++...............||+.|+|||++.+..++
T Consensus 148 ~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 225 (311)
T d1t46a_ 148 LSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (311)
T ss_dssp HHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHhCC--eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC
Confidence 999999999999999765 999999999999999999999999999987655555555667899999999999999999
Q ss_pred CCCceehhHHHHHHHHh-CCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCC
Q 021507 163 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 241 (311)
Q Consensus 163 ~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 241 (311)
.++|||||||++|||+| |.+||..... ...+.+.+........+..++..+.+||.+||+.||
T Consensus 226 ~~~DIwS~G~~l~ellt~g~p~~~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP 289 (311)
T d1t46a_ 226 FESDVWSYGIFLWELFSLGSSPYPGMPV----------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289 (311)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCS----------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CcccccchHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCCh
Confidence 99999999999999998 6666655332 122334444455555667788999999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 021507 242 KLRPRMSEVLAILERL 257 (311)
Q Consensus 242 ~~Rpt~~~~l~~l~~~ 257 (311)
++|||++++++.|+++
T Consensus 290 ~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 290 LKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHh
Confidence 9999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=337.38 Aligned_cols=228 Identities=27% Similarity=0.369 Sum_probs=183.8
Q ss_pred ChhHHHhHHHHHHh---hhhH--------HHHHHHHHHHHHHHh-cCCCCCccceEeEEEeCCeeEEEEecCCCCChHHH
Q 021507 1 MFLFNFLHSHLELH---ARSL--------LLITNWFQTEVNYLG-QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 68 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (311)
+||+||++.+.... +.+. ....+.+.+|..++. .++|||||++++++.+++..|+||||++||+|.++
T Consensus 14 ~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~ 93 (320)
T d1xjda_ 14 SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 93 (320)
T ss_dssp SSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred CCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHH
Confidence 58899988776533 1111 112234566777665 68999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccc
Q 021507 69 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 148 (311)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 148 (311)
+..... +++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ......||+
T Consensus 94 i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~ 167 (320)
T d1xjda_ 94 IQSCHK--FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTP 167 (320)
T ss_dssp HHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCG
T ss_pred hhccCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCC
Confidence 976543 899999999999999999999765 99999999999999999999999999986543322 244568999
Q ss_pred cccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHHHHH
Q 021507 149 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 228 (311)
Q Consensus 149 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+... +...+.. .....+..++.+
T Consensus 168 ~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-----------------~~~~i~~-~~~~~p~~~s~~ 229 (320)
T d1xjda_ 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----------------LFHSIRM-DNPFYPRWLEKE 229 (320)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHH-CCCCCCTTSCHH
T ss_pred CcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHc-CCCCCCccCCHH
Confidence 9999999999999999999999999999999999998654211 1111111 122456678899
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHHH
Q 021507 229 AATLALQCLNNEPKLRPRMS-EVLA 252 (311)
Q Consensus 229 l~~li~~~l~~~p~~Rpt~~-~~l~ 252 (311)
+.+||.+||..||.+|||+. ++++
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHh
Confidence 99999999999999999985 6764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=331.51 Aligned_cols=241 Identities=22% Similarity=0.341 Sum_probs=194.8
Q ss_pred ChhHHHhHHHHH--------------HhhhhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChH
Q 021507 1 MFLFNFLHSHLE--------------LHARSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 66 (311)
Q Consensus 1 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (311)
|||+||.+.+.. ++..........|.+|++++++++|||||++++++..++..++||||+.+|+|.
T Consensus 32 ~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~ 111 (308)
T d1p4oa_ 32 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 111 (308)
T ss_dssp SSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred CCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHH
Confidence 588888765421 222233345567999999999999999999999999999999999999999999
Q ss_pred HHhhhc--------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc
Q 021507 67 NHLFRR--------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 138 (311)
Q Consensus 67 ~~l~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 138 (311)
+++... ....+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~ 189 (308)
T d1p4oa_ 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189 (308)
T ss_dssp HHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE
T ss_pred HHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEEeecccceeccCCcce
Confidence 988532 1234789999999999999999999754 999999999999999999999999999865444333
Q ss_pred ceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhC-CCccCCCccchhhhhhhhccccccchhhhhHhhhccc
Q 021507 139 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 217 (311)
Q Consensus 139 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (311)
.......||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+.+. ......+....
T Consensus 190 ~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----------------~~~~~~i~~~~ 252 (308)
T d1p4oa_ 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----------------EQVLRFVMEGG 252 (308)
T ss_dssp EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----------------HHHHHHHHTTC
T ss_pred eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHhCC
Confidence 334455789999999999999999999999999999999998 477765432 11222222333
Q ss_pred CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcCC
Q 021507 218 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 260 (311)
Q Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~~~ 260 (311)
....+..++..+.++|.+||+.||++|||+.++++.|++...+
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 3445677889999999999999999999999999999886543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=332.75 Aligned_cols=248 Identities=22% Similarity=0.243 Sum_probs=183.3
Q ss_pred ChhHHHhHHHHHHh---hhhH-------HHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH---ARSL-------LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||.+.+.+.. +.+. ....+.+.+|+++|++++|||||++++++.+++..|+||||+.+ ++.+++.
T Consensus 14 ~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~ 92 (298)
T d1gz8a_ 14 TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD 92 (298)
T ss_dssp SSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH
T ss_pred cCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhh
Confidence 58899998876532 1111 12356788999999999999999999999999999999999976 6666665
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
......+++..+..++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||+++...... .......||+.|
T Consensus 93 ~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y 168 (298)
T d1gz8a_ 93 ASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWY 168 (298)
T ss_dssp HTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTT
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCc--ccceeeccccee
Confidence 555566999999999999999999999755 9999999999999999999999999998654322 224456799999
Q ss_pred cCccccccCC-CCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhh-ccccccchhhhhHhhh------cccCCC-
Q 021507 151 AAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW-AKPYLSDKRKLFRIMD------TKLGGQ- 220 (311)
Q Consensus 151 ~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~------~~~~~~- 220 (311)
+|||++.... ++.++|||||||++|+|++|+.||.+.+....... ... ..+............. ......
T Consensus 169 ~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T d1gz8a_ 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDF 248 (298)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCH
T ss_pred eehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccch
Confidence 9999887765 57899999999999999999999986543211110 000 0000000000000000 000000
Q ss_pred --CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 221 --YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 221 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
....++.++.+|+.+||..||++|||++|++++
T Consensus 249 ~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 249 SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 012456789999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=324.71 Aligned_cols=253 Identities=21% Similarity=0.234 Sum_probs=178.3
Q ss_pred ChhHHHhHHHHHHh-hhhH--HHHHHH--HHHHHHHHhcCCCCCccceEeEEEeCC----eeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH-ARSL--LLITNW--FQTEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~-~~~~--~~~~~~--~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~ 71 (311)
|||+||.++..... +.+. ....+. ++.|+..+.+++|||||++++++.+.+ ..|+||||+++|+|.+++++
T Consensus 15 ~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~ 94 (303)
T d1vjya_ 15 RFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 94 (303)
T ss_dssp SSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred CCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc
Confidence 58888877532211 1110 111223 334555666789999999999998654 57999999999999999976
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcc--eecc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQ 143 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~ 143 (311)
. ++++..++.++.+++.||+|+|+. .++|+||||||+|||++.++.+||+|||+++......... ....
T Consensus 95 ~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~ 171 (303)
T d1vjya_ 95 Y---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171 (303)
T ss_dssp C---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----
T ss_pred C---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccc
Confidence 4 389999999999999999999963 3579999999999999999999999999998654332221 2335
Q ss_pred ccccccccCccccccCC------CCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhH-hhhcc
Q 021507 144 VMGTHGYAAPEYVATGR------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTK 216 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 216 (311)
..||+.|+|||++.+.. ++.++|||||||++|||+||..||............ . ............ .....
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~ 249 (303)
T d1vjya_ 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-L-VPSDPSVEEMRKVVCEQK 249 (303)
T ss_dssp CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-T-SCSSCCHHHHHHHHTTSC
T ss_pred eecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-c-ccccchHHHHHHHHhccc
Confidence 67999999999987643 567899999999999999999888654321111000 0 000001111111 11112
Q ss_pred cCCCCc-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 217 LGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 217 ~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.....+ ......+.+|+.+||..||.+|||+.|+++.|+++.
T Consensus 250 ~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 250 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 222222 245667999999999999999999999999998864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=330.80 Aligned_cols=221 Identities=21% Similarity=0.295 Sum_probs=177.5
Q ss_pred ChhHHHhHHHHHHhh---hhHHH-----------HHHHHHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCC-C
Q 021507 1 MFLFNFLHSHLELHA---RSLLL-----------ITNWFQTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPK-G 63 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~~~~-----------~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~-~ 63 (311)
+||+||.+.+..... .+... ....+.+|+.+|++++ |||||++++++.+.+..|+||||+.+ +
T Consensus 16 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~ 95 (273)
T d1xwsa_ 16 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 95 (273)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEE
T ss_pred CCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcc
Confidence 688898887765431 11110 1123678999999996 89999999999999999999999976 5
Q ss_pred ChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-CCcEEEecccccccCCCCCCcceec
Q 021507 64 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVST 142 (311)
Q Consensus 64 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 142 (311)
++.+++..+. .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..... ...
T Consensus 96 ~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~ 167 (273)
T d1xwsa_ 96 DLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYT 167 (273)
T ss_dssp EHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBC
T ss_pred hHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceecccc----ccc
Confidence 7778876554 4999999999999999999999755 999999999999985 478999999999864332 234
Q ss_pred cccccccccCccccccCCC-CCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCC
Q 021507 143 QVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 221 (311)
Q Consensus 143 ~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (311)
...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+. +... ....
T Consensus 168 ~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------------i~~~--~~~~ 223 (273)
T d1xwsa_ 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------------IIRG--QVFF 223 (273)
T ss_dssp CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHHC--CCCC
T ss_pred ccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------------------Hhhc--ccCC
Confidence 5679999999999988765 5678999999999999999999975321 0011 1124
Q ss_pred chHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 222 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
+..++.++.+||.+||..||++|||++|++++
T Consensus 224 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 224 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 45678899999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=324.10 Aligned_cols=247 Identities=24% Similarity=0.278 Sum_probs=179.3
Q ss_pred ChhHHHhHHHHHHh----hhhHH-------HHHHHHHHHHHHHhcC---CCCCccceEeEEEe-----CCeeEEEEecCC
Q 021507 1 MFLFNFLHSHLELH----ARSLL-------LITNWFQTEVNYLGQL---HHPNLVKLIGYCLE-----GENRLLVYEFMP 61 (311)
Q Consensus 1 ~~~~~~~~~~~~~~----~~~~~-------~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-----~~~~~lv~e~~~ 61 (311)
+||+||++++.+.. +.+.. .....+.+|+.+|+.| +||||++++++|.. ....|++|||+.
T Consensus 19 ~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~ 98 (305)
T d1blxa_ 19 AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 98 (305)
T ss_dssp TTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS
T ss_pred cCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEecc
Confidence 69999998775432 21111 1233466788887776 79999999999863 246799999998
Q ss_pred CCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCccee
Q 021507 62 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 141 (311)
Q Consensus 62 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 141 (311)
++.+.. ........+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 99 ~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~ 172 (305)
T d1blxa_ 99 QDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 172 (305)
T ss_dssp CBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGG
T ss_pred CCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccC
Confidence 865543 33444456999999999999999999999755 999999999999999999999999998754322 234
Q ss_pred ccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhc-ccccc---ch----hhhhHh
Q 021507 142 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWA-KPYLS---DK----RKLFRI 212 (311)
Q Consensus 142 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~-~~~~~---~~----~~~~~~ 212 (311)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+ ... .+... .. ......
T Consensus 173 ~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (305)
T d1blxa_ 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 252 (305)
T ss_dssp CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC
T ss_pred CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcc
Confidence 5678999999999999999999999999999999999999999876532211111 000 00000 00 000000
Q ss_pred hhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 213 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
............++..+.+||.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 253 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00001112234567889999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.4e-47 Score=318.99 Aligned_cols=247 Identities=20% Similarity=0.223 Sum_probs=177.9
Q ss_pred ChhHHHhHHHHHHh--hhh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhh
Q 021507 1 MFLFNFLHSHLELH--ARS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 71 (311)
Q Consensus 1 ~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 71 (311)
+||+||++++.... +.+ .....+.+.+|+.+|++++||||+++++++.+++..|++||++.++.+..+...
T Consensus 14 ~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~ 93 (286)
T d1ob3a_ 14 TYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC 93 (286)
T ss_dssp TTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS
T ss_pred CCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh
Confidence 58889988764311 111 122356799999999999999999999999999999999999987655555433
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccccccccc
Q 021507 72 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 72 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........ ......+++.|+
T Consensus 94 ~--~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~ 167 (286)
T d1ob3a_ 94 E--GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYR 167 (286)
T ss_dssp T--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTC
T ss_pred c--CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhh
Confidence 3 45999999999999999999999755 99999999999999999999999999986543221 233456899999
Q ss_pred CccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh--hhccccccchhhhhHh---------hhcccCC
Q 021507 152 APEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAKPYLSDKRKLFRI---------MDTKLGG 219 (311)
Q Consensus 152 aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~---------~~~~~~~ 219 (311)
|||.+.+. .++.++|||||||++|||++|+.||.+.+........ ....+........... .......
T Consensus 168 ~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (286)
T d1ob3a_ 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247 (286)
T ss_dssp CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGG
T ss_pred hHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchh
Confidence 99998765 5689999999999999999999999865432211110 0000000000000000 0000011
Q ss_pred CCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 220 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
......+..+.+||.+||..||++|||++|++++
T Consensus 248 ~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234567889999999999999999999999854
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=321.03 Aligned_cols=242 Identities=23% Similarity=0.262 Sum_probs=178.4
Q ss_pred ChhHHHhHHHHHHh---hh-------hHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC------eeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH---AR-------SLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~e~~~~~~ 64 (311)
+||+||++.+.... +. ......+.+.+|+++|++++|||||+++++|...+ ..|+||||+ +++
T Consensus 30 ~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~ 108 (346)
T d1cm8a_ 30 AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD 108 (346)
T ss_dssp ---CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEE
T ss_pred CCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-ccc
Confidence 68999998765432 11 12234567889999999999999999999998654 469999999 568
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|..++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++..... ....
T Consensus 109 l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~ 178 (346)
T d1cm8a_ 109 LGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGY 178 (346)
T ss_dssp HHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSS
T ss_pred HHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceeccCCc-----cccc
Confidence 88776543 3999999999999999999999755 999999999999999999999999999875432 3456
Q ss_pred cccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh-hhcc-cc-------ccc-hhhhhHhh
Q 021507 145 MGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAK-PY-------LSD-KRKLFRIM 213 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~-~~-------~~~-~~~~~~~~ 213 (311)
.||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+........ .... +. ... .......+
T Consensus 179 ~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (346)
T d1cm8a_ 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258 (346)
T ss_dssp CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS
T ss_pred cccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccC
Confidence 789999999998764 5688999999999999999999999876532211110 0000 00 000 00000000
Q ss_pred hc---ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 214 DT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 214 ~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.. .........+++++.+||.+||..||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00111223567889999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=322.68 Aligned_cols=247 Identities=22% Similarity=0.241 Sum_probs=176.2
Q ss_pred ChhHHHhHHHHHHhh---hhH-HHHHHHHHHHHHHHhcCCCCCccceEeEEEeC------CeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELHA---RSL-LLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~~---~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~ 70 (311)
|||+||++++.+... .+. ....+.+.+|+++|++++||||++++++|... .++|+|||||+++ +.+.+.
T Consensus 32 ~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~ 110 (350)
T d1q5ka_ 32 SFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVAR 110 (350)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHH
T ss_pred cCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHH
Confidence 699999998776431 111 11123456899999999999999999998643 3578999999764 444442
Q ss_pred --hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcceecccccc
Q 021507 71 --RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGT 147 (311)
Q Consensus 71 --~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 147 (311)
......+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++....... ......|+
T Consensus 111 ~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt 185 (350)
T d1q5ka_ 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICS 185 (350)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSC
T ss_pred hhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--CCcccCCCcceEEEecCCCceeEecccchhhccCCc---cccccccc
Confidence 23345699999999999999999999965 599999999999999775 89999999998654332 23346799
Q ss_pred ccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh-hhh-ccccccchhhhh-Hhhh--------c
Q 021507 148 HGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW-AKPYLSDKRKLF-RIMD--------T 215 (311)
Q Consensus 148 ~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~~~~~~~-~~~~--------~ 215 (311)
..|+|||.+.+ ..++.++|||||||++|||++|+.||........... ... ..+......... .... .
T Consensus 186 ~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (350)
T d1q5ka_ 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265 (350)
T ss_dssp TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCC
T ss_pred ccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccC
Confidence 99999998765 4689999999999999999999999976543211110 000 000000000000 0000 0
Q ss_pred ccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 216 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
..........++++.+||.+||..||++|||+.|++++
T Consensus 266 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011223567889999999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=318.65 Aligned_cols=248 Identities=21% Similarity=0.220 Sum_probs=177.6
Q ss_pred ChhHHHhHHHHHHh---h------hhHHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCC----eeEEEEecCCCCChHH
Q 021507 1 MFLFNFLHSHLELH---A------RSLLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLEN 67 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~e~~~~~~L~~ 67 (311)
+||+||+|.+.... + .......+.+.+|+++|++++||||+++++++.... ..+++++++.||+|.+
T Consensus 20 ~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~ 99 (345)
T d1pmea_ 20 AYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK 99 (345)
T ss_dssp -CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHH
T ss_pred cCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhh
Confidence 58999998765432 1 112344567889999999999999999999987543 2234445566889999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc-ceeccccc
Q 021507 68 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMG 146 (311)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g 146 (311)
++..+ .+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++......... ......+|
T Consensus 100 ~l~~~---~l~~~~i~~i~~qil~al~yLH~~--~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~g 174 (345)
T d1pmea_ 100 LLKTQ---HLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174 (345)
T ss_dssp HHHHC---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCS
T ss_pred hhhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccc
Confidence 99654 399999999999999999999975 4999999999999999999999999999765332211 12344679
Q ss_pred cccccCcccccc-CCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhh--ccccccch-----hhhhH-hhhccc
Q 021507 147 THGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDK-----RKLFR-IMDTKL 217 (311)
Q Consensus 147 t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~-----~~~~~-~~~~~~ 217 (311)
|+.|+|||++.. ..++.++||||+||++|+|++|+.||.+............ ..+..... ..... ......
T Consensus 175 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (345)
T d1pmea_ 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254 (345)
T ss_dssp CGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred cceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCc
Confidence 999999999854 4678899999999999999999999987654222111100 00000000 00000 000000
Q ss_pred CCC-----CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 GGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
... ....++.++.+|+.+||+.||++|||+++++++
T Consensus 255 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 112456789999999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-45 Score=315.63 Aligned_cols=243 Identities=16% Similarity=0.202 Sum_probs=179.7
Q ss_pred ChhHHHhHHHHHHh---hhhH--HHHHHHHHHHHHHHhcCC-CCCccceEeEEEeC--CeeEEEEecCCCCChHHHhhhc
Q 021507 1 MFLFNFLHSHLELH---ARSL--LLITNWFQTEVNYLGQLH-HPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRR 72 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~ 72 (311)
+||+||++++.... +.+. ....+.+.+|+++|++++ ||||+++++++... ...++|||||.+++|..+.
T Consensus 47 ~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~--- 123 (328)
T d3bqca1 47 KYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 123 (328)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---
T ss_pred cCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---
Confidence 69999999876543 2111 112467899999999995 99999999999743 5689999999999987754
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCC-cEEEecccccccCCCCCCcceecccccccccc
Q 021507 73 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 151 (311)
Q Consensus 73 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 151 (311)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++........ .....+|+.|+
T Consensus 124 --~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~ 196 (328)
T d3bqca1 124 --QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFK 196 (328)
T ss_dssp --TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGC
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCcccc
Confidence 24999999999999999999999755 99999999999998655 589999999986543322 34567899999
Q ss_pred CccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhh--hhhcc-ccc---------cchhhhhHh------
Q 021507 152 APEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL--VDWAK-PYL---------SDKRKLFRI------ 212 (311)
Q Consensus 152 aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~-~~~---------~~~~~~~~~------ 212 (311)
|||.+.+. .++.++|||||||++|+|++|..||........... ..... +.. .........
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (328)
T d3bqca1 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 276 (328)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCC
T ss_pred CcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccc
Confidence 99998775 479999999999999999999999976543221110 00000 000 000000000
Q ss_pred --hhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 213 --MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 213 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
............++.++.+||.+||..||.+|||++|++++
T Consensus 277 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 277 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111122334567899999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=311.67 Aligned_cols=250 Identities=20% Similarity=0.215 Sum_probs=176.2
Q ss_pred ChhHHHhHHHHHHh---hhhH-------HHHHHHHHHHHHHHhcCCCCCccceEeEEEe--------CCeeEEEEecCCC
Q 021507 1 MFLFNFLHSHLELH---ARSL-------LLITNWFQTEVNYLGQLHHPNLVKLIGYCLE--------GENRLLVYEFMPK 62 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------~~~~~lv~e~~~~ 62 (311)
+||+||++++.... +.+. ....+.+.+|+++|++++||||+++++++.. ++..|+||||+.+
T Consensus 22 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~ 101 (318)
T d3blha1 22 TFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 101 (318)
T ss_dssp SSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCE
T ss_pred cCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCC
Confidence 58999998876432 2221 1234568899999999999999999999865 3467999999987
Q ss_pred CChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCc--ce
Q 021507 63 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HV 140 (311)
Q Consensus 63 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~ 140 (311)
+.+.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ..
T Consensus 102 ~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~ 177 (318)
T d3blha1 102 DLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177 (318)
T ss_dssp EHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCC
T ss_pred Cccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceeeeccccccccccc
Confidence 6555443 23345999999999999999999999754 999999999999999999999999999765432221 12
Q ss_pred eccccccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh-hccccccc------hhhhhHh
Q 021507 141 STQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPYLSD------KRKLFRI 212 (311)
Q Consensus 141 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~ 212 (311)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+........... ........ .......
T Consensus 178 ~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T d3blha1 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257 (318)
T ss_dssp CCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-----
T ss_pred ccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhh
Confidence 3345799999999998765 68999999999999999999999998654322211110 00000000 0000000
Q ss_pred hhcccCCCCc-------hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 021507 213 MDTKLGGQYP-------QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 254 (311)
Q Consensus 213 ~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l 254 (311)
.......... ...+.++.+||.+||..||++|||++|++++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp --CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 0000000000 12355778999999999999999999999764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-45 Score=308.20 Aligned_cols=244 Identities=16% Similarity=0.139 Sum_probs=186.2
Q ss_pred ChhHHHhHHHHHHh---hhhHH---HHHHHHHHHHHHHhcCCC-CCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELH---ARSLL---LITNWFQTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~~---~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
|||+||++++.... +.+.. ...+.+.+|+++++.|+| +||+.+++++.++...|+||||+ +++|.+++...+
T Consensus 17 ~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~ 95 (293)
T d1csna_ 17 SFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG 95 (293)
T ss_dssp SSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT
T ss_pred CCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc
Confidence 68999999876543 22211 123347889999999965 89999999999999999999999 679999886544
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC-----CCcEEEecccccccCCCCCCc-----ceecc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----EFNAKLSDFGLAKAGPTGDRT-----HVSTQ 143 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-----~~~~kl~Dfg~~~~~~~~~~~-----~~~~~ 143 (311)
..++...+..++.|++.||+|||+. ||+||||||+||+++. ++.+||+|||+++........ .....
T Consensus 96 -~~~~~~~~~~i~~q~~~~l~~lH~~--giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~ 172 (293)
T d1csna_ 96 -RKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172 (293)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred -cchhhHHHHHHHHHHHHHHHHHHHC--CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCc
Confidence 4599999999999999999999965 4999999999999964 578999999999875432211 12345
Q ss_pred ccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCch
Q 021507 144 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 223 (311)
Q Consensus 144 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
..||+.|+|||++.+..++.++|||||||++|||++|..||.+............ ...............
T Consensus 173 ~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~----------i~~~~~~~~~~~l~~ 242 (293)
T d1csna_ 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER----------IGEKKQSTPLRELCA 242 (293)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH----------HHHHHHHSCHHHHTT
T ss_pred eEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH----------HHhccCCCChHHhcC
Confidence 6799999999999999999999999999999999999999986543221111100 000000000001123
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 021507 224 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 258 (311)
Q Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~~ 258 (311)
.+++++.+++..|+..+|++||+++.+.+.|+.+.
T Consensus 243 ~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 46778999999999999999999999988887753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-45 Score=309.25 Aligned_cols=243 Identities=18% Similarity=0.144 Sum_probs=178.1
Q ss_pred ChhHHHhHHHHHHh---hhhH---HHHHHHHHHHHHHHhcCCCCCc-cceEeEEEeCCeeEEEEecCCCCChHHHhhhcC
Q 021507 1 MFLFNFLHSHLELH---ARSL---LLITNWFQTEVNYLGQLHHPNL-VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 73 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~~---~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (311)
+||+||++.+.... +.+. ....+.+.+|+++++.++|+|+ +.+.+++.+++..++||||+. ++|.+.+....
T Consensus 19 ~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~ 97 (299)
T d1ckia_ 19 SFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCS 97 (299)
T ss_dssp SSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT
T ss_pred CCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhcc
Confidence 58999988765432 1111 1123458889999999987665 555666678888999999994 57777665433
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCC---CCcEEEecccccccCCCCCCc-----ceecccc
Q 021507 74 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRT-----HVSTQVM 145 (311)
Q Consensus 74 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~ 145 (311)
..+++..+..++.|++.||+|||+.+ |+||||||+|||++. +..+||+|||+++........ .......
T Consensus 98 -~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 174 (299)
T d1ckia_ 98 -RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174 (299)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCC
T ss_pred -CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcC
Confidence 45999999999999999999999755 999999999999864 456999999999876443221 1234568
Q ss_pred ccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCchHH
Q 021507 146 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 225 (311)
Q Consensus 146 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
||+.|+|||++.+..++.++|||||||++|||++|..||.............. ................+
T Consensus 175 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~ 244 (299)
T d1ckia_ 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----------ISEKKMSTPIEVLCKGY 244 (299)
T ss_dssp CCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH----------HHHHHHHSCHHHHTTTS
T ss_pred CCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH----------hhcccCCCChhHhccCC
Confidence 99999999999999999999999999999999999999976543211111000 00000000000112356
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 021507 226 AHTAATLALQCLNNEPKLRPRMSEVLAILERL 257 (311)
Q Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~l~~~ 257 (311)
++++.+++.+||+.||++||+++++.+.|+.+
T Consensus 245 p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 78899999999999999999999998888765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=304.98 Aligned_cols=247 Identities=22% Similarity=0.209 Sum_probs=184.9
Q ss_pred ChhHHHhHHHHHHh---hhh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhh
Q 021507 1 MFLFNFLHSHLELH---ARS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 70 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (311)
+||+||++++.... +.+ .....+.+.+|+.+|++++||||+++++++.+....++|++++.|++|..++.
T Consensus 14 ~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~ 93 (292)
T d1unla_ 14 TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS 93 (292)
T ss_dssp SSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH
T ss_pred cCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc
Confidence 68999999876543 222 12356789999999999999999999999999999999999999988887775
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccc
Q 021507 71 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 150 (311)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 150 (311)
.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.++....... ......++..|
T Consensus 94 ~~--~~~~~~~~~~~~~q~~~aL~~lH~~--~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~ 167 (292)
T d1unla_ 94 CN--GDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWY 167 (292)
T ss_dssp TT--TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGG
T ss_pred cc--cccchhHHHHHHHHHHHHHHHhhcC--CEeeecccCcccccccCCceeeeecchhhcccCCCc--cceeeccccch
Confidence 44 3489999999999999999999975 499999999999999999999999999987544322 23345678899
Q ss_pred cCccccccCC-CCCCCceehhHHHHHHHHhCCCccCCCccchhh-h-hhh-hccccccchhhhhHhh---------hccc
Q 021507 151 AAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-S-LVD-WAKPYLSDKRKLFRIM---------DTKL 217 (311)
Q Consensus 151 ~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~-~~~-~~~~~~~~~~~~~~~~---------~~~~ 217 (311)
+|||++.+.. ++.++|||||||++|+|++|..||......... . ... ...+............ ....
T Consensus 168 ~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T d1unla_ 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247 (292)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred hhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccch
Confidence 9999987765 688999999999999999999997543321111 0 000 0000000000000000 0111
Q ss_pred CCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
........+..+.+||.+||+.||.+|||++|++++
T Consensus 248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122334567889999999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=309.53 Aligned_cols=243 Identities=20% Similarity=0.212 Sum_probs=170.9
Q ss_pred ChhHHHhHHHHHHh---hhh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEe------CCeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH---ARS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLE------GENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~~~lv~e~~~~~~ 64 (311)
+||+||++.+.... +.+ .....+.+.+|+.+|++++|||||+++++|.. ..+.|+|||||.+ +
T Consensus 29 ~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~ 107 (355)
T d2b1pa1 29 AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-N 107 (355)
T ss_dssp --CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-E
T ss_pred cCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-H
Confidence 68999999876532 111 12344568899999999999999999999963 3678999999976 5
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
+.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||+++...... .....
T Consensus 108 l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~ 178 (355)
T d2b1pa1 108 LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPY 178 (355)
T ss_dssp HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcccccc---ccccc
Confidence 555553 23899999999999999999999755 9999999999999999999999999987644322 23455
Q ss_pred cccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhh--hhcccccc---c-hh-----------
Q 021507 145 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAKPYLS---D-KR----------- 207 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~---~-~~----------- 207 (311)
.+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+........ ....+... . ..
T Consensus 179 ~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (355)
T d2b1pa1 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258 (355)
T ss_dssp --CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCC
T ss_pred cccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcc
Confidence 7899999999999999999999999999999999999999765432111100 00000000 0 00
Q ss_pred ----hhhHhhhcc---cCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 208 ----KLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 208 ----~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
......... .........+.++.+||.+||..||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 0111123568889999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=303.28 Aligned_cols=234 Identities=28% Similarity=0.317 Sum_probs=182.6
Q ss_pred ChhHHHhHHHHHHh------hhh---------HHHHHHHHHHHHHHHhcCCC-CCccceEeEEEeCCeeEEEEecCCCCC
Q 021507 1 MFLFNFLHSHLELH------ARS---------LLLITNWFQTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGS 64 (311)
Q Consensus 1 ~~~~~~~~~~~~~~------~~~---------~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~~~~ 64 (311)
+||+||++++.... +.+ .....+.+.+|+++|++++| |||+++++++.+....+++|||+.||+
T Consensus 36 ~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~ 115 (322)
T d1vzoa_ 36 AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 115 (322)
T ss_dssp TTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred CCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccH
Confidence 68899987653211 111 11234568899999999977 899999999999999999999999999
Q ss_pred hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccc
Q 021507 65 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 144 (311)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 144 (311)
|.+++..... +++..+..++.||+.||+|||+.+ |+||||||+||+++.+|.+||+|||+++........ .....
T Consensus 116 L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~ 190 (322)
T d1vzoa_ 116 LFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDF 190 (322)
T ss_dssp HHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGG
T ss_pred HHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhhhcccccc-ccccc
Confidence 9999976654 788999999999999999999755 999999999999999999999999999865433222 23456
Q ss_pred cccccccCccccccC--CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhhhccccccchhhhhHhhhcccCCCCc
Q 021507 145 MGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 222 (311)
Q Consensus 145 ~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
.|++.|++||.+.+. .++.++|||||||++|+|++|..||.+....... ..+.+. ........+
T Consensus 191 ~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-------------~~i~~~-~~~~~~~~~ 256 (322)
T d1vzoa_ 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-------------AEISRR-ILKSEPPYP 256 (322)
T ss_dssp GSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-------------HHHHHH-HHHCCCCCC
T ss_pred ccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHHh-cccCCCCCc
Confidence 799999999998765 4678999999999999999999999765432111 011111 111123445
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 021507 223 QKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI 253 (311)
Q Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~~ 253 (311)
..++.++.+||.+||..||++||| ++|++++
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 678999999999999999999994 7888753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=308.90 Aligned_cols=243 Identities=21% Similarity=0.222 Sum_probs=174.8
Q ss_pred ChhHHHhHHHHHHh---hhh-------HHHHHHHHHHHHHHHhcCCCCCccceEeEEEeC-----CeeEEEEecCCCCCh
Q 021507 1 MFLFNFLHSHLELH---ARS-------LLLITNWFQTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSL 65 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L 65 (311)
+||+||++++.... +.+ .....+.+.+|+++|++++|||||++++++... ...+++++++.||+|
T Consensus 30 ~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L 109 (348)
T d2gfsa1 30 AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109 (348)
T ss_dssp TTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEH
T ss_pred CCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCch
Confidence 69999999876543 111 123345688999999999999999999998633 334666777789999
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceecccc
Q 021507 66 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 145 (311)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 145 (311)
.+++..+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+|++|||++..... ......
T Consensus 110 ~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~ 179 (348)
T d2gfsa1 110 NNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYV 179 (348)
T ss_dssp HHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSC
T ss_pred hhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccCc-----cccccc
Confidence 9998543 4999999999999999999999754 99999999999999999999999999975432 234567
Q ss_pred ccccccCccccccC-CCCCCCceehhHHHHHHHHhCCCccCCCccchhhhhhh--hcccccc-----chhhhhHhhhccc
Q 021507 146 GTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD--WAKPYLS-----DKRKLFRIMDTKL 217 (311)
Q Consensus 146 gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~~ 217 (311)
|+..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+. ...+... .............
T Consensus 180 g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (348)
T d2gfsa1 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259 (348)
T ss_dssp HHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSC
T ss_pred ccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcc
Confidence 89999999987665 46889999999999999999999998765422211110 0000000 0000000000000
Q ss_pred CC-C-----CchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 218 GG-Q-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 218 ~~-~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
.. . ....++.++.+||.+||..||.+|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 0 012457789999999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-38 Score=275.02 Aligned_cols=245 Identities=16% Similarity=0.195 Sum_probs=171.6
Q ss_pred ChhHHHhHHHHHHh---hhh----HHHHHHHHHHHHHHHhcCC-----------CCCccceEeEEEeC--CeeEEEEecC
Q 021507 1 MFLFNFLHSHLELH---ARS----LLLITNWFQTEVNYLGQLH-----------HPNLVKLIGYCLEG--ENRLLVYEFM 60 (311)
Q Consensus 1 ~~~~~~~~~~~~~~---~~~----~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~~~--~~~~lv~e~~ 60 (311)
+||+||++++.+.. +.+ .....+.+.+|+++++.++ |+||+++++++... ...+++++++
T Consensus 25 ~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~ 104 (362)
T d1q8ya_ 25 HFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104 (362)
T ss_dssp SSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred CCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeec
Confidence 58999999876543 111 1224567888999998885 57899999888643 4556666666
Q ss_pred CCCC-hHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeeecCCCCCceEeCCCCc------EEEecccccccCC
Q 021507 61 PKGS-LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN------AKLSDFGLAKAGP 133 (311)
Q Consensus 61 ~~~~-L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~------~kl~Dfg~~~~~~ 133 (311)
.++. ............+++..+..++.|++.||+|||+. .||+||||||+|||++.++. ++++|||.+....
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~ 183 (362)
T d1q8ya_ 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183 (362)
T ss_dssp CCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT
T ss_pred ccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeeccCcccccceeeEeecccccccc
Confidence 5443 33334444556699999999999999999999972 45999999999999976653 9999999997643
Q ss_pred CCCCcceeccccccccccCccccccCCCCCCCceehhHHHHHHHHhCCCccCCCccchhh----hhhhh---ccccccc-
Q 021507 134 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ----SLVDW---AKPYLSD- 205 (311)
Q Consensus 134 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~---~~~~~~~- 205 (311)
.. .....||+.|+|||++.+..++.++|||||||++++|++|+.||......... ..... .......
T Consensus 184 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~ 258 (362)
T d1q8ya_ 184 EH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258 (362)
T ss_dssp BC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHH
T ss_pred cc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHH
Confidence 32 34567999999999999999999999999999999999999999764331100 00000 0000000
Q ss_pred ------------------------hhhhhHhhhcccCCCCchHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 021507 206 ------------------------KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 253 (311)
Q Consensus 206 ------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 253 (311)
......... .........+.++.+||.+||..||.+|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hhcccccccccccchhhhccccccCCchhhhcc--cccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000000 1223456788899999999999999999999999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.75 E-value=2.3e-19 Score=140.59 Aligned_cols=126 Identities=13% Similarity=0.056 Sum_probs=91.1
Q ss_pred HHHHHHHHHHHhcCCCCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 021507 22 TNWFQTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 101 (311)
Q Consensus 22 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 101 (311)
...+.+|...+.++.|.+++..+++. ..+++|||+++..+.+ ++......++.|++.+|++||+.+
T Consensus 58 ~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g- 123 (191)
T d1zara2 58 IRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG- 123 (191)
T ss_dssp HHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC-
Confidence 34567799999999999999987653 2379999998865543 333445678999999999999755
Q ss_pred CeeecCCCCCceEeCCCCcEEEecccccccCCCCCCcceeccccccccccCc--cc---cccCCCCCCCceehhHHH
Q 021507 102 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP--EY---VATGRLTTKSDVYSFGVV 173 (311)
Q Consensus 102 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~Di~slG~i 173 (311)
|+||||||+|||++++ .++|+|||.+......... .|... +. +....|+.++|+||+.--
T Consensus 124 -iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 124 -IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp -EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred -EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 9999999999999865 5899999999764322110 11110 00 113567889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=1.8e-07 Score=75.32 Aligned_cols=100 Identities=14% Similarity=0.042 Sum_probs=70.2
Q ss_pred HHHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh----
Q 021507 24 WFQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD---- 98 (311)
Q Consensus 24 ~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---- 98 (311)
.+.+|..++..+. +--+.+++.+..+++..|+||++++|.++.+..... . ....++.++...++.||+
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~ 127 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDIS 127 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCT
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCcc
Confidence 3677888888773 434677888888889999999999998876654211 1 122234455555555553
Q ss_pred -----------------------------------------------------CCCCeeecCCCCCceEeCCCCcEEEec
Q 021507 99 -----------------------------------------------------AESQVIYRDFKASNILLDAEFNAKLSD 125 (311)
Q Consensus 99 -----------------------------------------------------~~~~ivH~dlkp~Nil~~~~~~~kl~D 125 (311)
....++|+|+.|.||++++++..-|+|
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lID 207 (263)
T d1j7la_ 128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFID 207 (263)
T ss_dssp TCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred ccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEee
Confidence 011389999999999998776667999
Q ss_pred ccccc
Q 021507 126 FGLAK 130 (311)
Q Consensus 126 fg~~~ 130 (311)
|+.+.
T Consensus 208 we~a~ 212 (263)
T d1j7la_ 208 LGRSG 212 (263)
T ss_dssp CTTCE
T ss_pred chhcc
Confidence 98775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=3.7e-06 Score=67.00 Aligned_cols=96 Identities=20% Similarity=0.124 Sum_probs=63.0
Q ss_pred HHHHHHHHhcCC--CCCccceEeEEEeCCeeEEEEecCCCCChHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHhhh----
Q 021507 25 FQTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD---- 98 (311)
Q Consensus 25 ~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---- 98 (311)
+.+|+..|+.+. .-.+.+++.+..+++..++||++++|.++.+.. ..... .+.++...|+.||+
T Consensus 51 l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~-------~~~~~---~~~~l~~~la~LH~~~~~ 120 (255)
T d1nd4a_ 51 LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH-------LAPAE---KVSIMADAMRRLHTLDPA 120 (255)
T ss_dssp HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC-------CCHHH---HHHHHHHHHHHHTTSCGG
T ss_pred HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc-------ccHHH---HHHHHHHHHHHHccCChh
Confidence 667888887773 233677788888888899999999986654311 11111 11222333333331
Q ss_pred ----------------------------------------------------CCCCeeecCCCCCceEeCCCCcEEEecc
Q 021507 99 ----------------------------------------------------AESQVIYRDFKASNILLDAEFNAKLSDF 126 (311)
Q Consensus 99 ----------------------------------------------------~~~~ivH~dlkp~Nil~~~~~~~kl~Df 126 (311)
....++|+|+.|.||++++++.+-|+||
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~ 200 (255)
T d1nd4a_ 121 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC 200 (255)
T ss_dssp GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred hCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEc
Confidence 0113899999999999988766789999
Q ss_pred cccc
Q 021507 127 GLAK 130 (311)
Q Consensus 127 g~~~ 130 (311)
+.+.
T Consensus 201 ~~~~ 204 (255)
T d1nd4a_ 201 GRLG 204 (255)
T ss_dssp TTCE
T ss_pred hhcc
Confidence 8774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.43 E-value=0.00017 Score=60.96 Aligned_cols=30 Identities=20% Similarity=0.186 Sum_probs=25.7
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
..++|+|+.+.|||+++++ ++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 3599999999999998764 89999987754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.53 E-value=0.00094 Score=56.35 Aligned_cols=37 Identities=22% Similarity=0.161 Sum_probs=25.9
Q ss_pred HHHHHHHHhcCC-CCCccceEeEEEeCCeeEEEEecCCCCCh
Q 021507 25 FQTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSL 65 (311)
Q Consensus 25 ~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 65 (311)
..+|..+++.+. +.-..++++++.+ ++|+||++|.+|
T Consensus 91 r~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 91 LVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 457899998884 4334577776642 589999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.55 E-value=0.0017 Score=52.74 Aligned_cols=30 Identities=27% Similarity=0.258 Sum_probs=26.8
Q ss_pred CCeeecCCCCCceEeCCCCcEEEecccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 130 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 130 (311)
.|+||+|+.++||+++++...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 469999999999999988777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.89 E-value=0.033 Score=45.04 Aligned_cols=29 Identities=24% Similarity=0.226 Sum_probs=23.8
Q ss_pred CCeeecCCCCCceEeCCCCcEEEeccccccc
Q 021507 101 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 131 (311)
Q Consensus 101 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 131 (311)
.++||+|+.+.|||++++ ..++||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 469999999999999743 45899998864
|